note_id
stringlengths 13
15
| subject_id
int64 10M
20M
| hadm_id
int64 20M
30M
| note_type
stringclasses 1
value | note_seq
int64 2
133
| charttime
stringlengths 19
19
| storetime
stringlengths 19
19
| text
stringlengths 1.56k
52.7k
|
---|---|---|---|---|---|---|---|
10804747-DS-11
| 10,804,747 | 20,366,455 |
DS
| 11 |
2148-12-02 00:00:00
|
2148-12-03 15:45:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Lithium / Wellbutrin / Seroquel
Attending: ___
Chief Complaint:
Left trimalleolar ankle fracture status post-syncope mechanical
fall
Major Surgical or Invasive Procedure:
Re-alignment of left ankle fracture
History of Present Illness:
As per HPI by admitting MD:
___ female history of COPD on 5 L O2, A. fib (on baby aspirin
only), unstable angina who presents with left ankle pain status
post syncopal fall earlier today. The patient was ambulating to
the bathroom without her oxygen when she started feeling
lightheaded and dizzy and passed out. Uncertain whether she hit
her head. Unable to ablate on her left ankle after the fall.
Denies numbness or tingling distally.
On evaluation, patient was treated for hypotension and hypoxia.
Patient was placed back on her 5 L of oxygen improved to normal.
For blood pressure, steadily increased. Patient states that her
blood pressure is always low. Ankles 2+ pulses. Of note, +UA in
ED which was treated with Macrobid for 5 days, starting on
___.
Past Medical History:
PAST MEDICAL HISTORY:
- Pulmonary hypertension with an estimated TR gradient of 32-42
mmHg on TTEs done ___ and ___ measured PASP
42 mmHg on ___
- Right ventricular dilation, hypertrophy and basal hypokinesis
of free wall (TTE ___ improved on TTE ___
- Chronic diastolic heart failure/HFpEF (EF >55%)
- Depression and anxiety, s/p ECT
- Bipolar disorder with history of suicidal ideation
- Anorexia nervosa
- Hypothyroidism
- COPD, O2 dependent, on 5L
- GERD
- Pernicious anemia
- Osteoporosis
- Spinal stenosis
- Right-sided peripheral neuropathy the right leg
- History of DVT
PAST SURGICAL HISTORY:
- Laparoscopy converted to open sigmoid resection with rectopexy
for grade 3 sigmoid OCL and fecal incontinence in ___
- Appendectomy in ___
- C-sections x2 in ___ and in ___
- Carpal tunnel release ___ years ago
Social History:
___
Family History:
- Mother: emphysema
- Sister: O2 dependent
- No relevant cardiac history including premature coronary
artery
disease, cardiomyopathies, arrhythmias or sudden cardiac death
Physical Exam:
ADMISSION PHYSICAL EXAM
Vitals: 24 HR Data (last updated ___ @ 006)
Temp: 98.0 (Tm 98.7), BP: 95/60 (92-135/58-84), HR: 76
(76-85), RR: 18 (___), O2 sat: 88% (88-97), O2 delivery: 5lnc
Fluid Balance (last updated ___ @ 2201)
Last 8 hours Total cumulative -140ml
IN: Total 60ml, PO Amt 60ml
OUT: Total 200ml, Urine Amt 200ml
Last 24 hours Total cumulative -140ml
IN: Total 60ml, PO Amt 60ml
OUT: Total 200ml, Urine Amt 200ml
Physical exam:
Gen: NAD, AxOx3
Card: RRR, no m/r/g
Pulm: CTAB, no respiratory distress
Abd: Soft, non-tender, non-distended, normal bs.
Wounds: c/d/i
Ext: No edema, warm well-perfused. Cast on L foot/leg.
DISCHARGE PHYSICAL EXAM
VITALS: ___ ___ Temp: 97.6 PO BP: 106/67 R Lying HR: 70
RR:
18 O2 sat: 93% O2 delivery: 5l
GENERAL: Elderly female lying comfortably in bed. In no acute
distress.
HEENT: Normocephalic, atraumatic. Poor dentition.
NECK: Supple. JVP just above the clavicle.
CARDIAC: RRR with normal S1 and S2. No murmurs/rubs/gallops.
LUNGS: Normal respiratory effort. Scattered wheezes, bibasilar
inspiratory crackles over the bases. No rhonchi.
ABDOMEN: Normal bowels sounds, non distended, non-tender to deep
palpation in all four quadrants.
EXTREMITIES: Left foot in brace. No lower extremity edema. Left
great toe without swelling or erythema. Mild TTP over MTP joint.
FROM with minimal pain.
NEURO: Alert and interactive. CN II-XII grossly intact. Moves
all
extremities.
SKIN: warm, dry, no rashes
Pertinent Results:
ADMISSION LABS
___ 06:47AM BLOOD WBC-10.4* RBC-4.12 Hgb-13.2 Hct-40.9
MCV-99* MCH-32.0 MCHC-32.3 RDW-15.1 RDWSD-55.3* Plt ___
___ 01:54AM BLOOD WBC-13.0* RBC-3.82* Hgb-12.3 Hct-38.0
MCV-100* MCH-32.2* MCHC-32.4 RDW-15.3 RDWSD-55.9* Plt ___
___ 01:54AM BLOOD Neuts-72.7* Lymphs-16.5* Monos-7.4
Eos-2.5 Baso-0.3 Im ___ AbsNeut-9.48* AbsLymp-2.15
AbsMono-0.96* AbsEos-0.32 AbsBaso-0.04
___ 06:47AM BLOOD Plt ___
___ 05:01AM BLOOD ___ PTT-24.6* ___
___ 01:54AM BLOOD Plt ___
___ 06:47AM BLOOD Glucose-107* UreaN-17 Creat-1.1 Na-144
K-3.5 Cl-104 HCO3-24 AnGap-16
___ 01:54AM BLOOD Glucose-113* UreaN-23* Creat-1.3* Na-140
K-3.7 Cl-105 HCO3-23 AnGap-12
___ 01:54AM BLOOD CK(CPK)-54
___ 07:30PM BLOOD cTropnT-0.02*
___ 05:36AM BLOOD cTropnT-0.02*
___ 05:36AM BLOOD cTropnT-0.01
___ 01:54AM BLOOD cTropnT-0.02*
___ 01:54AM BLOOD CK-MB-3
___ 06:47AM BLOOD Calcium-9.3 Phos-4.3 Mg-2.2
DISCHARGE LABS
___ 07:11AM BLOOD WBC-10.9* RBC-4.22 Hgb-13.5 Hct-42.6
MCV-101* MCH-32.0 MCHC-31.7* RDW-15.0 RDWSD-55.9* Plt ___
___ 07:11AM BLOOD Plt ___
___ 07:11AM BLOOD Glucose-112* UreaN-17 Creat-0.8 Na-143
K-4.0 Cl-106 HCO3-24 AnGap-13
___ 07:11AM BLOOD Phos-4.8* Mg-2.2
___ 07:15AM BLOOD Calcium-9.7 Phos-3.6 Mg-2.3
Imaging
___ L tib fib xray
Trimalleolar fracture.
___ CXR
IMPRESSION:
Stable chronic diffuse interstitial abnormalities without
pulmonary edema or
focal consolidation.
Although no acute or other chest wall lesion is seen,
conventional chest
radiographs are not sufficient for detection or characterization
of most such
abnormalities. If the demonstration of trauma or other soft
tissue abnormality
involving the chest wall is clinically warranted, the location
of any
referable focal findings should be clearly marked and imaged
with either bone
detail radiographs or Chest CT scanning.
___ CT head
1. No acute findings.
2. Advanced brain parenchymal atrophy, most severe at the
frontal lobes.
___ CT C spine
1. No acute findings..
2. Degenerative changes cervical spine.
3. Suggestion of centrilobular emphysema, mild biapical scarring
versus mild
pulmonary edema.
___ L ankle xray
Status post splinting of the known trimalleolar fracture with
similar
alignment. No new fracture.
___ CT LLE
Trimalleolar fracture as described above. There is depression
of a 5 mm
portion of the posterior tibial plafond articular surface.
There is also mild
widening of the medial ankle mortise.
___ CT Torso
1. No traumatic injury identified within the chest, abdomen, or
pelvis. No
fracture identified.
2. Increased pulmonary interstitial scarring with associated
ground-glass
opacities and upper lobe predominant emphysematous changes
compared to study
of ___. No focal consolidations identified.
3. Partially calcified 1 cm right renal artery aneurysm.
___ 2d echo
The left atrium is normal in size. The right atrium is mildly
enlarged. There is no evidence for an atrial septal defect by
2D/color Doppler. The estimated right atrial pressure is ___
mmHg. There is normal left ventricular wall thickness with a
small cavity. There is normal regional and global left
ventricular systolic function. Left ventricular cardiac index is
depressed (less than 2.0 L/min/m2). There is no resting left
ventricular outflow tract gradient. No ventricular septal defect
is seen. Diastolic function could not be assessed. The right
ventricular free wall is hypertrophied. Mildly dilated right
ventricular cavity with moderate global free wall hypokinesis.
There is abnormal interventricular septal motion c/w right
ventricular pressure and volume overload. The aortic sinus
diameter is normal for gender with normal ascending aorta
diameter for gender. The aortic arch diameter is normal with a
mildly dilated descending aorta. There is no evidence for an
aortic arch coarctation. The aortic valve leaflets (3) are
mildly thickened. There is no aortic valve stenosis. There is no
aortic regurgitation. The mitral valve leaflets are mildly
thickened. There is mild [1+] mitral regurgitation. The
tricuspid valve leaflets are mildly thickened. There is moderate
[2+] tricuspid regurgitation. There is SEVERE pulmonary artery
systolic hypertension. There is a very small circumferential
pericardial effusion.
IMPRESSION: Mildly dilated right ventricle with moderate
systolic dysfunction and evidence of pressure/volume overload.
Small left ventricular with normal global systolic function.
Moderate tricuspid regurgitation. Severe pulmonary hypertension.
Compared with the prior TTE (images reviewed) of ___ ,
the degree of pulmonary hypertension has worsened and a very
small pericardial effusion is seen. Syncope and pericardial
effusion are both poor prognostic signs in pulmonary
hypertension.
Brief Hospital Course:
Ms. ___ is a ___ year old female with past medical history
notable for chronic diastolic heart failure/HFPEF, chronic
hypoxic respiration failure (on 5L O2), mild to moderate PASP,
RV dysfunction, depression and anxiety, bipolar disorder,
hypothyroidism, GERD, and history of DVT (not current on AC) who
was admitted to ___ after left ankle fracture, transferred to
medicine for evaluation of the etiology of her fall.
ACUTE PROBLEMS:
================
#Fall
Etiology of current fall likely related to hypoxia in setting of
ambulating without supplemental O2. Despite this, patient does
report numerous falls over the past several months, some of
which occur while wearing O2. She notes feeling unsteady on her
feet and has required wheelchair intermittently. Orthostatics
were negative. Telemetry without events and EKG unchecked from
prior. Prior TTE with RV dysfunction and elevated PASP, repeat
TTE on ___ shows worsening of her pHTN, but otherwise is
stable. ___ was consulted and recommended discharge back to
rehab.
#Left ankle fracture
#Left toe pain
Evaluated in ED by ortho and s/p now non-operative management
with a splint. Also describes left toe pain. Likely sustained an
injury during her fall. She was started on standing
acetaminophen 1000mg Q8h, and oxycodone PRN for pain ___
reviewed). ___ consulted as above. She will follow up with Ortho
trauma in 1 week.
#Chronic hypoxic respiratory failure
Patient typically requires 5L O2 as outpatient. Etiology likely
multifactorial with contribution from pulmonary hypertension and
HF. Repeat TTE on ___ showed worsening of her severe pHTN. The
patient was stable at her baseline currently while inpatient.
She was continued on Fluticasone-Salmeterol, Duoneb PRN,
albuterol PRN, and guaifenesin.
#Dysphagia
Previously been recommended to have a dysphagia diet. Team had
planned for SLP eval and modified diet however she states she
would like to continue a chopped and moist diet (rather than
ground). She declined a SLP eval. She accepts the risk of
aspiration and knows she could suffer from choking,
pneumonia/infection and possibly even death, she even notes she
is DNR/DNI and understands she would not be intubated or
resuscitated if this happened.
#Chronic heart failure with preserved EF
#Pulmonary hypertension
Does not appear to be in decompensated HF currently. JVD just
above clavicle at 60 degrees. Resumed home torsemide upon
discharge. Continued home metoprolol. TTE as noted above.
___ (resolved)
Mild ___ with Cr up to 1.3 from baseline of 1.0. Improved to 1.1
after 1L LR and was trending down at the time of discharge.
CHRONIC ISSUES:
=================
#Depression
#Bipolar disorder
Patient describes history of psychosis for which she was
previously on anti-psychotic and was transitioned to risperidone
many years ago. She was continued on Risperidone 1.5mg QHS,
Clonazepam 0.5mg TID, Sertraline 175mg daily and Bentroprine
0.5mg daily.
#GERD: Continued on home omeprazole 20mg BID
#Hypothyroidism: Continued on home levothyroxine
TRANSITIONAL ISSUES:
====================
[] follow up pain control: discharged on Oxycodone 5mg PO q6hrs
PRN
[] follow up with ortho: scheduled as above
[] if swallowing declines, consider repeat SLP eval-- patient
wants to stay on chopped diet and declined SLP eval while
inpatient
[] follow up with pulmonary team and repeat echo as needed as an
outpatient
* CODE: DNR/DNI
PCP notified of discharge
Time spent: 55 minutes
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY
2. Benztropine Mesylate 0.5 mg PO DAILY
3. Fluticasone Propionate NASAL 1 SPRY NU DAILY
4. GuaiFENesin ER 600 mg PO Q12H
5. Levothyroxine Sodium 50 mcg PO DAILY
6. Oxybutynin 5 mg PO BID
7. Nitroglycerin Patch 0.1 mg/hr TD Q24H
8. Simvastatin 20 mg PO QPM
9. Systane (PF) (peg 400-propylene glycol (PF)) 0.4-0.3 %
ophthalmic (eye) TID
10. Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation
inhalation BID
11. Docusate Sodium 100 mg PO BID
12. RisperiDONE 1.5 mg PO QHS
13. Sertraline 175 mg PO DAILY
14. melatonin 5 mg oral QHS
15. Omeprazole 20 mg PO BID
16. multivitamin with iron 1 tablet oral DAILY
17. Super B/C (B-complex with vitamin C) 150 mg oral DAILY
18. TraMADol 50 mg PO BID
19. Torsemide 20 mg PO DAILY
20. ClonazePAM 0.5 mg PO TID
21. Potassium Chloride 20 mEq PO DAILY
22. Metoprolol Succinate XL 25 mg PO DAILY
23. cranberry 450 mg oral DAILY
24. Aluminum-Magnesium Hydrox.-Simethicone 30 mL PO Q4H:PRN GI
upset
25. Calcium Carbonate 500 mg PO TID:PRN GI upset
26. Milk of Magnesia 30 mL PO DAILY:PRN Constipation - First
Line
27. Sodium Chloride Nasal ___ SPRY NU QID:PRN nasal dryness
28. TraMADol 50 mg PO DAILY:PRN Pain - Moderate
29. Nicotine Polacrilex 2 mg PO Q1H:PRN smoking cessation
30. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheeze
31. Senna 8.6 mg PO QHS:PRN Constipation - First Line
32. GuaiFENesin 10 mL PO Q4H:PRN cough
33. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever
34. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Third
Line
35. Bisacodyl ___AILY:PRN Constipation - Second Line
36. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain
37. Ipratropium-Albuterol Neb 1 NEB NEB Q6H:PRN SOB/wheeze
38. Clotrimazole 1 TROC PO QID:PRN mouth discomfort
Discharge Medications:
1. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain -
Moderate
RX *oxycodone 5 mg 1 capsule(s) by mouth every six (6) hours
Disp #*28 Capsule Refills:*0
2. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever
3. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheeze
4. Aluminum-Magnesium Hydrox.-Simethicone 30 mL PO Q4H:PRN GI
upset
5. Aspirin 81 mg PO DAILY
6. Benztropine Mesylate 0.5 mg PO DAILY
7. Bisacodyl ___AILY:PRN Constipation - Second Line
8. Calcium Carbonate 500 mg PO TID:PRN GI upset
9. ClonazePAM 0.5 mg PO TID
10. Clotrimazole 1 TROC PO QID:PRN mouth discomfort
11. cranberry 450 mg oral DAILY
12. Docusate Sodium 100 mg PO BID
13. Fluticasone Propionate NASAL 1 SPRY NU DAILY
14. GuaiFENesin ER 600 mg PO Q12H
15. GuaiFENesin 10 mL PO Q4H:PRN cough
16. Ipratropium-Albuterol Neb 1 NEB NEB Q6H:PRN SOB/wheeze
17. Levothyroxine Sodium 50 mcg PO DAILY
18. melatonin 5 mg oral QHS
19. Metoprolol Succinate XL 25 mg PO DAILY
20. Milk of Magnesia 30 mL PO DAILY:PRN Constipation - First
Line
21. multivitamin with iron 1 tablet oral DAILY
22. Nicotine Polacrilex 2 mg PO Q1H:PRN smoking cessation
23. Nitroglycerin Patch 0.1 mg/hr TD Q24H
24. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain
25. Omeprazole 20 mg PO BID
26. Oxybutynin 5 mg PO BID
27. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Third
Line
28. Potassium Chloride 20 mEq PO DAILY
29. RisperiDONE 1.5 mg PO QHS
30. Senna 8.6 mg PO QHS:PRN Constipation - First Line
31. Sertraline 175 mg PO DAILY
32. Simvastatin 20 mg PO QPM
33. Sodium Chloride Nasal ___ SPRY NU QID:PRN nasal dryness
34. Super B/C (B-complex with vitamin C) 150 mg oral DAILY
35. Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation
inhalation BID
36. Systane (PF) (peg 400-propylene glycol (PF)) 0.4-0.3 %
ophthalmic (eye) TID
37. Torsemide 20 mg PO DAILY
38. TraMADol 50 mg PO BID
39. TraMADol 50 mg PO DAILY:PRN Pain - Moderate
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
Left trimalleolar ankle fracture status post-syncope mechanical
fall
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: NON-weight bearing in lower extremity, in a
splint . Out of Bed with assistance to chair or wheelchair.
Discharge Instructions:
Dear Ms. ___,
You were admitted to the hospital due to a mechanical fall that
caused a closed left ankle fracture . Your fracture was
re-aligned by the orthopedic team and this was managed
non-operatively in a
splint. You are not allowed to bear weight on your left lower
extremity until you are followed up in clinic. After your ankle
fracture was stable your etiology of syncope (loss of
consciousness) was further worked up by the medicine team. You
were also found to have a positive urinary tract infection and
treated with the antibiotic macrobid. Please take for 5 days as
prescribed , starting on ___.
With proper pain management you are ready to be discharged home
to continue your recovery with the following instructions.
* You should take your pain medication as directed to stay ahead
of the pain. If the pain medication is too sedating take half
the dose and notify your physician.
* Symptomatic relief with ice packs or heating pads for short
periods may ease the pain.
* Narcotic pain medication can cause constipation therefore you
should take a stool softener twice daily and increase your fluid
and fiber intake if possible.
* Do NOT smoke
* If your doctor allows, non-steroidal ___ drugs
are very effective in controlling pain ( ie, Ibuprofen, Motrin,
Advil, Aleve, Naprosyn) but they have their own set of side
effects so make sure your doctor approves.
* Return to the Emergency Room if pain worsen despite pain
medication, there is bleeding or discharge from the wound or
your temperature is greater than 101.1 degree Fahrenheit
Followup Instructions:
___
|
10804747-DS-8
| 10,804,747 | 26,246,594 |
DS
| 8 |
2147-04-12 00:00:00
|
2147-04-12 13:58:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Lithium / Wellbutrin / Seroquel
Attending: ___.
Chief Complaint:
Dyspnea
Major Surgical or Invasive Procedure:
None
History of Present Illness:
Ms. ___ is a ___ year old lady with history of HFpEF, mild to
moderate pulmonary artery systolic hypertension, chronic hypoxic
respiratory failure (multifactorial- COPD, ?old interstitial
pneumonitis and WHO Group 2 pulmonary hypertension) on 3L NC at
home, DVT on warfarin, who presents for evaluation of dyspnea.
At baseline she uses 3L NC oxygen and occasionally walks with a
walker at her assisted living facility. She says that she
generally does not walk very much and is not very active,
preferring to use her computer all day, but is able to perform
all ADL's independently. She is unable to estimate how far she
is able to walk on a good day; prior cardiology notes document
___ class III symptoms.
Around three weeks ago she developed a cough productive of
sputum and worsening shortness of breath associated with low
grade temperatures ~ ___. No chills, no sick contacts, no other
URI symptoms. Her dyspnea is worse when she is sitting up and
also when she lies down- she is unable to lie flat but is unable
to say if this has really changed. She has not noticed increased
lower extremity edema or weight gain. She currently denies any
new chest pain. Her other complaint is that when she nods her
head or extends it backwards she develops dizziness which is
described as a room spinning sensation. No tinnitus, ear
fullness, vision changes, focal weakness. Not triggered when she
moves her head side to side; not particularly worse when getting
up from bed. This has never happened in the past. She says that
she has not been eating or drinking much recently due to
dysphagia and heartburn; this has been evaluated by GI and
thought ___ ___ dysmotility.
Regarding her cardiac and pulmonary history (extracted from
OMR)- she was admitted to ___ in ___ for elective
laparoscopic sigmoid colectomy, complicated by ___
blood loss and hemodynamic instability. During workup for
elevated cardiac markers, echocardiogram demonstrated
hyperdynamic left ventricle (EF >75%) and dilated, hypokinetic
RV with abnormal septal motion consistent with RV
pressure/volume overload, as well as moderately elevated
pulmonary artery systolic pressure (TR gradient ___ mm Hg). Of
note, a prior
echo showed similar findings, and there was concern for acute or
acute on chronic pulmonary embolism. Right heart catheterization
was
performed in ___, which demonstrated only mild pulmonary
hypertension with PA ___ (23), normal filling pressures and
cardiac output. In ___, she presented to ___ ED with
chest pain and had a negative PMIBI examination. Her most recent
TTE from ___ actually demonstrated normal global and regional
biventricular systolic function w/ moderate pulmonary
hypertension (PASP 42 mmHg), improved RV function compared to
___.
Her most recent set of PFTs are from ___, with FEV1/FVC 86%,
FEV1 107% (1.58). Previously in ___ FEV1/FVC 84%, FEV1 99%,
DLCO 45%.
It is thought that the etiology of her chronic hypoxemic
respiratory failure and right ventricular dysfunction is
multifactorial, related to COPD, pulmonary hypertension, and
HFpEF.
In ED initial VS: HR 98 BP 103/49 RR 24 85% 4L NC
Exam: Diffuse wheezing
Labs:
(1) WBC 7.3 Hgb 12.1 Plt 298, 62% neutrophils, 1% bands
(2) INR 3.9, PTT 38.7
(3) Troponin 0.05, ___ 5, BNP 14014
(4) vBG ___
Patient was given:
- Albuterol neb x 1, ipratropium neb x 1, methylprednisolone 125
mg
- Pip/tazo 4.5 g
- Vancomycin 1 mg
- Magnesium sulfate 2gm
Imaging notable for:
CXR- Patchy left basilar opacity, concerning for pneumonia in
the correct clinical setting.
VS prior to transfer: 97.3 HR 80 BP 96/55 94% on BiPAP ___
On arrival to the MICU, she confirms the history as above.
REVIEW OF SYSTEMS:
(+) Per HPI
Past Medical History:
1. Mild to moderate pulmonary hypertension with an estimated TR
gradient of ___ mmHg on echocardiograms done ___ and
___. Right heart catheterization ___ with PASP 42
mmHg.
2. Right ventricular dilation, hypertrophy and basal hypokinesis
of free wall (TTE ___. Improved RV function on TTE ___.
3. Chronic diastolic heart failure/HFpEF (EF >55% on TTE
___.
4. Chronic atypical chest pain. Negative PMIBI ___.
5. Chronic hypoxic respiratory failure on 3L O2
(multifactorial).
6. Esophageal dysmotility
Social History:
___
Family History:
- Mother: emphysema
- Sister: O2 dependent
- No relevant cardiac history including premature coronary
artery
disease, cardiomyopathies, arrhythmias or sudden cardiac death
Physical Exam:
ADMISSION PHYSICAL EXAM
=======================
97.6, 85, 113/60, 19, 93%/6L NC
GENERAL: Alert, oriented, no acute distress
HEENT: Sclera anicteric, MMM, oropharynx clear
NECK: supple, JVP not elevated, no LAD
LUNGS: Crackles at bilateral bases L>R, expiratory wheezing
anteriorly
CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs,
gallops
ABD: soft, ___, bowel sounds present, no
rebound tenderness or guarding, no organomegaly
EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
DISCHARGE PHYSICAL EXAM
=======================
Afebrile, SBPs ___, P ___, RR 18, 92 on 4L
Alert oriented NAD
HEENT: Sclera anicteric, MMM, oropharynx clear
NECK: supple, JVP not elevated, no LAD
Lungs clear to auscultation bilaterally with no wheezing or
crackles
No JVD
No ___
___
Pertinent Results:
ADMISSION LABS
==============
___ 11:37PM BLOOD ___
___ Plt ___
___ 11:37PM BLOOD ___
___
___
___ 11:37PM BLOOD ___
___
___ Tear
___
___ 11:37PM BLOOD ___ ___
___ 11:37PM BLOOD Plt ___ Plt ___
___ 11:37PM BLOOD ___
___
___ 11:37PM BLOOD CK(CPK)-451*
___ 11:37PM BLOOD ___
___ 11:37PM BLOOD ___
___ 11:37PM BLOOD ___
___ 11:44PM BLOOD ___
___ Base XS--3
MICRO
=====
Urine Culture (___): negative
MRSA Screen (___): negative
Sputum Culture (___): cancelled
IMAGES
======
CXR (___):
Patchy left basilar opacity, concerning for pneumonia in the
correct clinical setting.
TTE (___): IMPRESSION: Dilated right ventricle with moderate
global hypokinesis and pressure/volume overload. Normal left
ventricular systolic function. Mild mitral regurgitation. Mild
pulmonary hypertension. Compared with the prior study (images
reviewed) of ___, the right ventricle is dilated and
hypokinetic with signs of pressure/volume overload.
Brief Hospital Course:
Ms. ___ is a ___ year old lady with history of HFpEF, mild to
moderate pulmonary artery systolic hypertension, chronic hypoxic
respiratory failure (multifactorial- COPD, possible interstitial
pneumonitis and WHO Group 2 pulmonary hypertension) on 3L NC at
home, DVT on warfarin, who is admitted to the ICU for hypoxemic
respiratory failure found to have pneumonia and right heart
failure.
=================
ACTIVE ISSUES
=================
# Hypoxemic respiratory failure/Pneumonia: Pt p/w patchy left
basilar opacity in setting of cough and low grade temperatures,
concerning for pneumonia. She has resided in nursing home for
greater than ___ years, which places her at risk for resistant
organisms. She has not improved with levofloxacin in outpatient
setting. Antibiotics were broadened to
vancomycin/ceftazidime/azithromycin (___), vancomycin was
discontinued when MRSA swab returned negative. Likely
respiratory distress worsened by baseline pulmonary
hypertension, COPD and HFpEF. Pt was gently diuresed out of c/f
pulmonary edema and also received a prednisone 40 mg burst (___) out of concern for COPD exacerbation given wheezes on exam.
She will require slow prednisone taper 10mg daily to start in AM
___ to complete her taper in addition to indefinite
azithromycin. TTE showed RV volume overload, discussed below.
# Right Heart Strain. Pt p/w new TWI in inferior leads as well
as ___, rightward axis in addition to an elevated BNP, all c/f
TV strain iso known pulmonary HTN. TTE showed e/o right heart
volume overload, no sign of new ischemic changes and mild
admission troponin of 0.05 ___. Etiology of right heart
strain is unclear as it is out of proportion for underlying
pulmonary hypertension. As discussed, ischemia is unlikely and
PE is unlikely given that pt presented supratherapeutic on
warfarin. Cardiology was consulted and recommneded starting 10
mg torsemide. The patient has follow up scheduled with
cardiology.
# ___: Pt presented with ___ likely ___ given sodium avid
urine lytes. Improved with IVF.
# Supratherapeutic INR: In setting of decreased PO intake d/t
esophageal dysmotility, also possible drug interaction as she
was recently on levofloxacin. Warfarin was held while patient
was supra therapeutic and resumed while hospitalized. INR was
2.1 on discharge. Coumadin will be resumed at 3mg daily.
===============
CHRONIC ISSUES
===============
# Esophageal dysmotility: Per GI, nonspecific dysmotility and
would attempt treatment for spasm, with suggestion for SL nitro
prior to meals. After TTE could consider this w/ close
monitoring of BP as well as swallow evaluation.
# Hypothyroidism: Continue home levothyroxine.
# Depression/anxiety: Continue home sertraline and clonazepam
# Constipation: Continue home linzess 290 mcg daily, senna 2
tabs every 3 days.
====================
TRANSITIONAL ISSUES
====================
CODE: DNR/DNI
HCP: ___ (son)
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Nitroglycerin Patch 0.1 mg/hr TD Q24H
2. Warfarin 3 mg PO DAILY16
3. ClonazePAM 1 mg PO QHS
4. Benztropine Mesylate 0.5 mg PO DAILY
5. Levothyroxine Sodium 50 mcg PO DAILY 8pm
6. TraMADol 50 mg PO TID
7. Loxapine Succinate 30 mg PO DAILY
8. Oxybutynin 5 mg PO BID
9. Symbicort ___ mcg/actuation
inhalation BID
10. Furosemide 40 mg PO BID
11. Omeprazole 20 mg PO BID WIHT LUNCH AND DINNER
12. Fluticasone Propionate NASAL 1 SPRY NU DAILY
13. Sertraline 150 mg PO DAILY
14. Linzess (linaclotide) 290 mcg oral daily
15. Aspirin 81 mg PO DAILY
16. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN CP for up to 3 doses
17. Senna 8.6 mg PO QHS:PRN constipation
18. ClonazePAM 0.25 mg PO DAILY 2PM
19. ClonazePAM 0.5 mg PO DAILY
20. Docusate Sodium 100 mg PO DAILY
21. Simvastatin 20 mg PO QPM
22. RisperiDONE 1 mg PO DAILY
23. Systane Gel (artificial tears(hypromellose);<br>peg
___ glycol) ___ % ophthalmic TID
Discharge Medications:
1. Azithromycin 250 mg PO Q24H
continue until you ___ with your pulmonologist
2. GuaiFENesin ER 600 mg PO Q12H
3. ___ Neb 1 NEB NEB Q6H:PRN wheezing
take PRN for wheezing or shortness of breath
4. Nicotine Patch 14 mg TD DAILY
5. PNEUMOcoccal ___ polysaccharide vaccine 0.5 ml IM NOW
X1
6. PredniSONE 10 mg PO DAILY Duration: 3 Days
7. Torsemide 10 mg PO DAILY
8. Aspirin 81 mg PO DAILY
9. Benztropine Mesylate 0.5 mg PO DAILY
10. ClonazePAM 1 mg PO QHS
11. ClonazePAM 0.25 mg PO DAILY 2PM
12. ClonazePAM 0.5 mg PO DAILY
13. Docusate Sodium 100 mg PO DAILY
14. Fluticasone Propionate NASAL 1 SPRY NU DAILY
15. Levothyroxine Sodium 50 mcg PO DAILY 8pm
16. Linzess (linaclotide) 290 mcg oral daily
17. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN CP for up to 3 doses
18. Omeprazole 20 mg PO BID WIHT LUNCH AND DINNER
19. Oxybutynin 5 mg PO BID
20. RisperiDONE 1 mg PO DAILY
21. Senna 8.6 mg PO QHS:PRN constipation
22. Sertraline 150 mg PO DAILY
23. Simvastatin 20 mg PO QPM
24. Symbicort ___ mcg/actuation
inhalation BID
25. Systane Gel (artificial tears(hypromellose);<br>peg
___ glycol) ___ % ophthalmic TID
26. TraMADol 50 mg PO TID
27. Warfarin 3 mg PO DAILY16
28. HELD- Loxapine Succinate 30 mg PO DAILY This medication was
held. Do not restart Loxapine Succinate until you discuss with
PCP
29. HELD- Nitroglycerin Patch 0.1 mg/hr TD Q24H This medication
was held. Do not restart Nitroglycerin Patch until discuss with
PCP - soft BPs on discharge
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
Pneumonia
COPD exacerbation
Right heart failure, RV Strain
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Ms. ___,
It was a pleasure taking care of you during your recent
admission to ___. You were admitted with shortness of breath
which was likely due to a combination of pneumonia, COPD
exacerbation and fluid in your lungs. You were treated with
Antibiotics, steroids and diuretics and you improved. You were
started on an oral diuretic which you should continue on
discharge. It is important that you follow up with your
cardiologist and pulmonologist after discharge
We wish you the best,
Your ___ care team
Followup Instructions:
___
|
10804747-DS-9
| 10,804,747 | 24,231,179 |
DS
| 9 |
2147-07-04 00:00:00
|
2147-07-15 18:50:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Lithium / Wellbutrin / Seroquel
Attending: ___.
Chief Complaint:
dyspnea
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ female pt w/ hx of HFpEF, mild to moderate pulmonary
artery systolic hypertension, chronic hypoxic respiratory
failure (multifactorial- COPD, ?old interstitial pneumonitis,
WHO Group 2 pulmonary hypertension) on 3L NC at home, RV
hypokinesis but preserved LFEF (>60% per ___ TTE), DVT (x1
in 1960s, x2 Picc-associated in arm ___ on warfarin,
presenting with CP. On ___, chest pain woke her from sleep
~0600. The pain was midsternal and radiated to the right jaw.
States she vomited x2 this am, denies blood in vomit, denies
N/D. Denies recent fevers/chills.
Of note, she states that she has been feeling increasingly SOB
over the last ___. (She says that this might be attributable to
the fact that she has been forgetting to wear and/or turn on her
O2). She states that her current SOB is worse than baseline.
She received nitroglycerin and full dose of aspirin prior to
arrival to ___ ED. She arrived on her home nitro patch, but
this was removed d/t low BPs.
In the ED initial vitals were:
Temp 98.4 HR 88 BP 100/60 RR 18 94% on Nasal Cannula
EKG: no ischemic changes per ED read. On this writer's read, low
voltage of V1 concerning for poor test v poor R wave progression
Labs/studies notable for:
BMP wnl
Trop-T 0.02
H&H ___ with MCV 90
WBC 9.7 with 73.6% PMN
Past Medical History:
1. Mild to moderate pulmonary hypertension with an estimated TR
gradient of 32-42 mmHg on echocardiograms done ___ and
___. Right heart catheterization ___ with PASP 42
mmHg.
2. Right ventricular dilation, hypertrophy and basal hypokinesis
of free wall (TTE ___. Improved RV function on TTE ___.
3. Chronic diastolic heart failure/HFpEF (EF >55% on TTE
___.
4. Chronic atypical chest pain. Negative PMIBI ___.
5. Chronic hypoxic respiratory failure on 3L O2
(multifactorial).
6. Esophageal dysmotility
Social History:
___
Family History:
- Mother: emphysema
- Sister: O2 dependent
- No relevant cardiac history including premature coronary
artery
disease, cardiomyopathies, arrhythmias or sudden cardiac death
Physical Exam:
ADMISSION
GENERAL: Frail-appearing woman in NAD. Mood, affect appropriate.
CARDIAC: PMI located in ___ intercostal space, midclavicular
line. RRR, normal S1, S2. No murmurs/rubs/gallops. No thrills,
lifts.
LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp
were unlabored, but intermittent pursed lip breathing. Ronchi
all fields, crackles at bases. Some mild dyspnea at end of
sentences.
ABDOMEN: Soft, NTND. No HSM or tenderness.
EXTREMITIES: No c/c/e. No femoral bruits.
SKIN: Round ecchymosis 7cm diameter on L thigh. Round ecchymosis
1cm diameter dorsal side of R hand.
PULSES: Distal pulses palpable and symmetric
NEURO: Face grossly symmetric, moving all limbs w/ purpose
against gravity. Low amplitude resting tremor.
DISCHARGE
VITALS: 98.5 PO 87 / 50 R Lying 78 18 90 4L
GENERAL: Cachectic, NAD. Mood, affect appropriate.
HEENT: MMM. Tongue pink and without exudate; no signs thrush.
CARDIAC: RRR, normal S1, S2. No murmurs/rubs/gallops
appreciated.
LUNGS: Intermittent pursed lip breathing. Ronchi in all fields,
crackles at bases. Some mild dyspnea at end of sentences.
ABDOMEN: Soft, NTND.
EXTREMITIES: No c/c/e.
PULSES: Distal pulses palpable and symmetric
NEURO: Face grossly symmetric, moving all limbs w/ purpose
against gravity. Low amplitude resting tremor.
Pertinent Results:
___ 07:26AM BLOOD WBC-8.5 RBC-3.58* Hgb-10.0* Hct-32.9*
MCV-92 MCH-27.9 MCHC-30.4* RDW-17.1* RDWSD-57.2* Plt ___
___ 12:00PM BLOOD Neuts-73.6* Lymphs-17.5* Monos-6.4
Eos-1.9 Baso-0.3 Im ___ AbsNeut-7.13*# AbsLymp-1.69
AbsMono-0.62 AbsEos-0.18 AbsBaso-0.03
___ 10:25AM BLOOD ___
___ 07:26AM BLOOD Glucose-98 UreaN-13 Creat-0.9 Na-145
K-4.1 Cl-104 HCO3-28 AnGap-13
___ 09:30AM BLOOD CK-MB-2 cTropnT-<0.01
___ 07:26AM BLOOD Mg-2.3
___ NUCLEAR STRESS
FINDINGS: The images are adequate but limited due to soft
tissue attenuation
and subdiaphragmatic activity.
Left ventricular cavity size is normal.
Rest and stress perfusion images reveal a moderate,
medium-sized, fixed
anteroseptal defect from the apex to the mid ventricle which
does not completely improve with attenuation correction but is
still favored to be artifact given the EF of 78%.
Gated images reveal mild hypokinesis in the region of the above
defect.
The calculated left ventricular ejection fraction is 78%.
IMPRESSION:
1. No reversible perfusion defects.
2. Normal left ventricular cavity size and normal ejection
fraction. Compared to the prior study on ___ there
is no change.
___ CHEMICAL STRESS
INTERPRETATION: This ___ woman with COPD and pHTN was referred
to
the stress lab for evaluation of chest discomfort. There was
baseline
NSSTTWs on her resting ECG. She was infused with 0.142mg/kg/min
of
dipyradimole over 4min. There was no reported chest, neck, back,
or arm
discomfort thoughout the study. There were no ST segment
deviations
during infusion or recovery. The rhythm was sinus with no
ectopy.
Appropriate hemodynamic response to the infusion and recovery.
The
dipyridamole was reversed with 125 mg of aminophylline IV.
IMPRESSION: No angina or ST segment changes during dipyridamole
infusion. Nuclear report sent separately.
SIGNED: ___
___ TTE IMPRESSION: Dilated right ventricle with moderate
global hypokinesis and pressure/volume overload. Normal left
ventricular systolic function. Mild mitral regurgitation. Mild
pulmonary hypertension. Compared with the prior study (images
reviewed) of ___, the right ventricle is dilated and
hypokinetic with signs of pressure/volume overload.
___ TTE IMPRESSION: Normal global and regional biventricular
systolic function. Moderate pulmonary hypertension. TTE
demonstrating normal global and regional biventricular systolic
function w/ moderate pulmonary hypertension (PASP 42 mmHg),
improved RV function compared to ___.
___ PFTs: FEV1/FVC 86%, FEV1 108% (1.56). [Previously in
___ FEV1/FVC 86%, FEV1 108% | ___ FEV1/FVC 84%, FEV1 99%,
DLCO 45%.]
___: STRESS ECHO IMPRSSION: No angina type symptoms or
ischemic EKG changes.
PMIBI results normal by report.
___ (per written records; report not found): R heart cath
demonstrated only mild pulmonary HTN with PA ___ (23), normal
filling pressures and cardiac output
Brief Hospital Course:
SUMMARY: ___ female pt w/ HFpEF (EG >60% per ___ TTE & RV
hypokinesis), mild to moderate pulmonary artery systolic HTN,
COPD on home O2 (___), DVT (x1 in 1960s, x2 in arm ___ on
warfarin, here w/ chest pain c/f unstable angina. She underwent
nuclear perfusion scan and pharmacologic stress test on ___,
which were both grossly normal.
#ANGINA: Concern for cardiac in origin given acute onset, pain
radiating to jaw, association with N/V. No ECG changes or trop
leak. No evidence of pneumonia, costochonrdritis; therapeutic on
warfarin making PE unlikely. Not c/w pt's GERD pain. However,
nuclear test showing no heart motion abnormality or filling
defect. No angina or ST segment changes during stress test.
Continued home ASA 81, simvastatin 20.
#SUPRATHERAPEUTIC INR: Given dose-reduced warfarin (2mg) on ___
for INR 2.8. On ___, INR 3.4. Not reversed. Held dose ___ pm.
Please recheck on ___ and dose adjust in consult with a
physician as appropriate.
#URINARY HESITANCY: Required straight cathx1 in context of
receiving benztropine (was on her med list from prior discharge;
pt does not actually take at home)
Chronic, stable
# COPD: Overall stable. Recent PFTs similar to ___. On home
oxygen ___ and home medications.
# Hx DVTs: Patient reports 1 spontaneous DVT many years ago and
then PICC-associated DVTs in approximately ___. Continued home
warfarin
# recent hx thrush w/current mouth pain: Wrote for nystatin
swish and spit
# Esophageal dysmotility
# Chronic constipation: Continue home meds, including
omeprazole, maalox, bisacodyl, tums, docusate, senna
# Bipolar Disorder: Continue home medications:
-clonazepam QAM, 2pm, QHS; risperidone; sertraline
# hypothyroidism
- home levothyroxine
# derm: on home doses of
-aquaphor, bengay
# GU
- on home oxybutynin
# HEENT
-on home Flonase, guaifenisen, sodium nasal spray, artificial
tears
# pain
-home tramadol
>30 minutes on discharge planning/coordination of care.
TRANSITIONAL ISSUES
[ ] HOLDING WARFARIN ___ for supratherapeutic INR on ___.
Restart as needed, or discuss discontinuation with
PCP/hematologist given >3 months out past ___-associated DVT
[ ] consider optimizing primary prevention of CAD with
higher-dose statin
[ ] continue to follow Coumadin dosing ___ INR 3.4; holding ___
dose)
[ ] see Cardiology to follow-up on stress test performed ___
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY
2. ClonazePAM 1 mg PO QHS
3. ClonazePAM 0.25 mg PO DAILY 2PM
4. ClonazePAM 0.5 mg PO DAILY
5. Docusate Sodium 100 mg PO DAILY
6. Fluticasone Propionate NASAL 1 SPRY NU DAILY
7. Levothyroxine Sodium 50 mcg PO DAILY 8pm
8. Omeprazole 20 mg PO BID WIHT LUNCH AND DINNER
9. RisperiDONE 1 mg PO DAILY
10. Senna 17.2 mg PO QHS:PRN constipation
11. Sertraline 150 mg PO DAILY
12. TraMADol 50 mg PO TID
13. Warfarin 3 mg PO DAILY16
14. Torsemide 10 mg PO DAILY
15. Linzess (linaclotide) 290 mcg oral before breakfast
16. Nitroglycerin Patch 0.1 mg/hr TD Q24H
17. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN CP for up to 3 doses
18. Oxybutynin 5 mg PO BID
19. Simvastatin 20 mg PO QPM
20. Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation
inhalation BID
21. Ipratropium-Albuterol Neb 1 NEB NEB Q6H:PRN wheezing
22. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever
23. Aluminum-Magnesium Hydrox.-Simethicone 30 mL PO QID:PRN GI
upset
24. Aquaphor Ointment 1 Appl TP Frequency is Unknown dry scabs
on ears
25. Bisacodyl 10 mg PR QHS:PRN constipation
26. Calcium Carbonate 500 mg PO TID:PRN GI upset
27. Levalbuterol Neb 0.63 mg NEB Q6H:PRN sob
28. Loratadine 10 mg PO DAILY
29. melatonin 3 mg oral QHS
30. Milk of Magnesia 30 mL PO DAILY:PRN constipation
31. Multivitamins 1 TAB PO DAILY
32. Nicotine Polacrilex 2 mg PO Q1H:PRN smoking cesation
33. Sodium Chloride Nasal ___ SPRY NU QID:PRN nasal dryness
34. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation
Q6H:PRN wheeze
35. Systane Gel (artificial tears(hypromellose);<br>peg
400-propylene glycol) 0.4-0.3 % ophthalmic TID
36. Bengay Cream 1 Appl TP BID:PRN neck pain
37. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID
38. GuaiFENesin ER 600 mg PO Q12H
39. TraMADol 50 mg PO DAILY:PRN Pain - Moderate
40. GuaiFENesin 10 mL PO Q4H:PRN cough
41. Anbesol (benzocaine) (benzocaine) 20 % mucous membrane
QID:PRN
42. magnesium citrate ___ bottle oral DAILY:PRN
Discharge Medications:
1. Aquaphor Ointment 1 Appl TP DAILY dry scabs on ears
2. Magnesium Citrate 4 oz oral DAILY:PRN constipation
3. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever
4. Aluminum-Magnesium Hydrox.-Simethicone 30 mL PO QID:PRN GI
upset
5. Anbesol (benzocaine) (benzocaine) 20 % mucous membrane
QID:PRN
6. Aspirin 81 mg PO DAILY
7. Bengay Cream 1 Appl TP BID:PRN neck pain
8. Bisacodyl 10 mg PR QHS:PRN constipation
9. Calcium Carbonate 500 mg PO TID:PRN GI upset
10. ClonazePAM 1 mg PO QHS
11. ClonazePAM 0.25 mg PO DAILY 2PM
12. ClonazePAM 0.5 mg PO DAILY
13. Docusate Sodium 100 mg PO DAILY
14. Fluticasone Propionate NASAL 1 SPRY NU DAILY
15. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID
16. GuaiFENesin ER 600 mg PO Q12H
17. GuaiFENesin 10 mL PO Q4H:PRN cough
18. Ipratropium-Albuterol Neb 1 NEB NEB Q6H:PRN wheezing
19. Levalbuterol Neb 0.63 mg NEB Q6H:PRN sob
20. Levothyroxine Sodium 50 mcg PO DAILY 8pm
21. Linzess (linaclotide) 290 mcg oral before breakfast
22. Loratadine 10 mg PO DAILY
23. melatonin 3 mg oral QHS
24. Milk of Magnesia 30 mL PO DAILY:PRN constipation
25. Multivitamins 1 TAB PO DAILY
26. Nicotine Polacrilex 2 mg PO Q1H:PRN smoking cesation
27. Nitroglycerin Patch 0.1 mg/hr TD Q24H
28. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN CP for up to 3 doses
29. Omeprazole 20 mg PO BID WIHT LUNCH AND DINNER
30. Oxybutynin 5 mg PO BID
31. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation
Q6H:PRN wheeze
32. RisperiDONE 1 mg PO DAILY
33. Senna 17.2 mg PO QHS:PRN constipation
34. Sertraline 150 mg PO DAILY
35. Simvastatin 20 mg PO QPM
36. Sodium Chloride Nasal ___ SPRY NU QID:PRN nasal dryness
37. Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation
inhalation BID
38. Systane Gel (artificial tears(hypromellose);<br>peg
400-propylene glycol) 0.4-0.3 % ophthalmic TID
39. Torsemide 10 mg PO DAILY
40. TraMADol 50 mg PO TID
41. TraMADol 50 mg PO DAILY:PRN Pain - Moderate
42. HELD- Warfarin 3 mg PO DAILY16 This medication was held. Do
not restart Warfarin until your INR is checked on ___ and is not
supratherapeutic, or take a lower dose as recommended by your
doctor.
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
Angina
Pulmonary hypertension
Chronic diastolic heart failure (HFpEF)
History of upper extremity DVT
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Dear Ms. ___,
It was a pleasure taking care of you at the ___
___!
WHY WAS I IN THE HOSPITAL?
==========================
You were in the hospital because you had pain in your chest.
WHAT HAPPENED IN THE HOSPITAL?
==============================
In the hospital, your doctors took ___ picture of your heart. It
showed that your heart moves normally, and that your heart is
able to perform well under stress.
WHAT SHOULD I DO WHEN I GO HOME?
================================
When you go home, you should continue to take your medications
as prescribed. You should also make sure to follow up with your
care providers as scheduled.
Thank you for allowing us to be involved in your care, we wish
you all the best!
Your ___ Healthcare Team
#NEW MEDS: none
#CHANGED MEDS: none
#DICONTINUED MEDS: none
#HELD MEDS: Warfarin
Discharge weight: 129.19 lb
Discharge creatinine: 0.9
Code status: DNR/DNI
Followup Instructions:
___
|
10804768-DS-11
| 10,804,768 | 25,038,576 |
DS
| 11 |
2140-02-28 00:00:00
|
2140-02-28 17:04:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
adalimumab / apremilast / bupropion / cefaclor / ceftriaxone /
hydromorphone / nitrofurantoin / Sulfa (Sulfonamide Antibiotics)
Attending: ___
Chief Complaint:
abnormal LFTs
Major Surgical or Invasive Procedure:
EGD ___
History of Present Illness:
___ female with a history of plaque psoriasis, alcohol
abuse, who presented to ___ with abnormal LFTs, referred
to ___ for further management.
Patient reports that she has been feeling "under the weather"
for
the past month, with mild cold-type symptoms including fatigue,
sneezing, congestion, coughing with clear sputum, which most of
her office has had. She also noticed dark urine (light brown in
color), increased abdominal bloating, and changes in bowel
habits
(stool more mucus-y) during this time. She also reports
increased
leg swelling for the past 2 weeks. Of note, she was recently
tried on apremilast (Otezla) for treatment of plaque psoriasis -
she reports taking this for 1 month, then stopping it 1 month
prior to this presentation due to GI side effects with N/V.
She presented for routine PCP appointment about 1 week ago, at
which time she was found to have elevated LFTs. Pt denies prior
h/o liver disease of LFT abnormalities. She was referred in for
an U/S, which was concerning for possible portal vein
thrombosis.
She received CT scan which was negative for portal vein
thrombosis. Outside ED Labs: patient with bilirubin 2.7, alk
phos
249, ALT 27, AST 131, INR 1.37. At that point, she was noted to
be tender in right upper quadrant, no encephalopathy, and was
transferred to ___.
In terms of ETOH use, patient reports drinking close to 4 drinks
daily (range ___, either wine or mixed drink. She has had
increased ETOH intake for the past 4 months. Prior to that was
drinking 1 glass of wine per day, though she notes that ___ year
ago she had a period of time where she had increased life stress
and was drinking more heavily before she saw a therapist and cut
down on ETOH. Last ETOH drink ___.
In the ED initial vitals: 97.8, 101, 112/70, 18, 98% RA
- Exam notable for: +TTP in RUQ, abdominal distension. trace
pitting edema. no jaundice, no asterixis
- Labs notable for:
7.6 12.4 170
>-----<
37.2
137 ___ AGap=13
------------<
4.0 23 0.6
ALT: 19 AST: 111 AP: 218 Tbili: 2.4
INR: 1.8
- negative serum tox
- hep B immune, hep A neg, HCV neg
- AMA, ___, anti smooth muscle ab: negative
- Imaging notable for: CXR - Hypoinflated lungs with bibasilar
atelectasis. No focal consolidation identified.
OSH RUQ U/S with Doppler: 1. findings c/w PVT likely iso
cirrhosis. hepatomegaly and surface contour lobulation. mild
splenomegaly. diffuse parenchymal heterogeneity. superimposed
hepatitis cannot be excluded. focal mass not identified.
2. gallbladder has been removed. slight prominence of
extrahepatic ductal system without intrahepatic ductal
dilatation
is nonspecific and probably reflects the chronic post CCY state.
3. minimal perihepatic free fluid is nonspecific and could
reflect actue hepatitis or portal HTN.
OSH CT A/P with con: 1. diffusely enlarged heterogenous liver
with heterogenous peripheral enhancement. 2. minimal pelvic
ascites. 3. no e/o portal venous thrombosis.
- Liver Consult: Differential broad for acute liver injury.
Based on AST:ALT pattern concern is for alcoholic hepatitis vs
drug induced liver injury. Will send broad workup, trend LFTs
and
decide if liver biopsy is warranted.
- Acute hepatitis panel: HAV, HBV, HCV, ___, AMA, ___,
Ceruloplasmin, alpha1 antitrypsin, CMV, EBV, Serum tox including
acetaminophen level
-Second opinion on CT imaging
-Given INR of 1.8, Vit K challenge 5mg iv x 3 doses
-___ DF based on T bili 2.2 and ___ of 19.8 is 35.8(>32), if
confirmed alc hep, may benefit from steroids, please send CXR
and
UA, rule out potential sources of infection
-Admit to ET service with Dr ___ as attending
- Patient was given: venlafaxine, vit K 10 PO, oxycodone 5 x2,
topical betamethasone
Upon arrival to floor, patient reports history above. Otherwise
she does not have active complaints. Denies f/c, SOB, CP,
dysuria.
Past Medical History:
Plaque psoriasis
Anxiety
?Depression
ETOH use
s/p CCY
s/p "back surgery" x2
ectopic pregnancy s/p salpingectomy
Social History:
___
Family History:
ETOH abuse in mother, maternal grandfather, maternal aunts.
Dad with DM.
Maternal grandfather had cirrhosis ___ ETOH.
Physical Exam:
ADMISSION PHYSICAL EXAMINATION:
===============================
VS: 98.3PO, 114 / 73L Sitting, 91, 18, 97 Ra
GENERAL: NAD
HEENT: AT/NC, EOMI, anicteric sclera, MMM
NECK: supple
HEART: RRR, S1/S2, no murmurs, gallops, or rubs
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably
without use of accessory muscles
ABDOMEN: mild distended, +BS, tympanitic, mildly tender in RUQ
without guarding
EXTREMITIES: no pitting ___, trace soft tissue edema bl
PULSES: 2+ DP pulses bilaterally
NEURO: A&Ox3, moving all 4 extremities with purpose. no
asterixis.
SKIN: warm and well perfused, scattered red plaques with scale
DISCHARGE PHYSICAL EXAMINATION:
===============================
VS: 24 HR Data (last updated ___ @ 748)
Temp: 98.4 (Tm 98.5), BP: 103/68 (103-118/64-72), HR: 91
(91-97), RR: 18, O2 sat: 93% (93-95), O2 delivery: Ra, Wt: 190.4
lb/86.37 kg
GENERAL: NAD
HEENT: AT/NC, EOMI, anicteric sclera, MMM
NECK: supple
HEART: RRR, S1/S2, no murmurs, gallops, or rubs
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably
without use of accessory muscles
ABDOMEN: mildly distended but soft, +BS, tender hepatomegaly
with mildly ttp in RUQ without guarding
EXTREMITIES: trace soft tissue edema bl, non pitting
PULSES: 2+ DP pulses bilaterally
NEURO: A&Ox3, moving all 4 extremities with purpose. no
asterixis.
SKIN: warm and well perfused, scattered red plaques with scale
Pertinent Results:
ADMISSION LABS
==============
___ 01:18AM BLOOD WBC-8.3 RBC-3.27* Hgb-11.7 Hct-35.1
MCV-107* MCH-35.8* MCHC-33.3 RDW-15.3 RDWSD-61.1* Plt ___
___ 01:18AM BLOOD Neuts-71.3* Lymphs-17.8* Monos-8.2
Eos-1.8 Baso-0.7 Im ___ AbsNeut-5.89 AbsLymp-1.47
AbsMono-0.68 AbsEos-0.15 AbsBaso-0.06
___ 01:30AM BLOOD ___ PTT-40.8* ___
___ 01:18AM BLOOD Glucose-75 UreaN-4* Creat-0.6 Na-137
K-4.1 Cl-102 HCO3-23 AnGap-12
___ 01:18AM BLOOD ALT-19 AST-109* AlkPhos-211* TotBili-2.2*
___ 01:18AM BLOOD Lipase-29
___ 11:15AM BLOOD Calcium-8.0* Phos-3.6 Mg-1.8
___ 01:18AM BLOOD HBsAg-NEG HBsAb-POS HBcAb-NEG HAV Ab-NEG
___ 01:18AM BLOOD AMA-NEGATIVE Smooth-NEGATIVE
___ 01:18AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG
Tricycl-NEG
___ 01:18AM BLOOD ___
___ 01:18AM BLOOD HCV Ab-NEG
DISCHARGE LABS
==============
___ 06:52AM BLOOD WBC-7.3 RBC-3.15* Hgb-11.3 Hct-34.1
MCV-108* MCH-35.9* MCHC-33.1 RDW-15.5 RDWSD-61.7* Plt ___
___ 06:52AM BLOOD ___ PTT-41.4* ___
___ 06:52AM BLOOD Glucose-109* UreaN-5* Creat-0.6 Na-139
K-3.5 Cl-103 HCO3-25 AnGap-11
___ 06:52AM BLOOD ALT-16 AST-87* AlkPhos-185* TotBili-1.0
___ 06:52AM BLOOD Albumin-2.8* Calcium-8.0* Phos-2.4*
Mg-2.1
IMAGING/STUDIES
===============
___ Imaging ABDOMEN (SUPINE & ERECT
IMPRESSION:
No evidence of small-bowel obstruction or ileus.
EGD ___
Grade I varices in distal esophagus, 1 cord, nonbleeding. Portal
hypertensive gastropathy in fundus and body
Brief Hospital Course:
___ female with a history of plaque psoriasis, alcohol
use disorder, anxiety, who presented to ___ with
abnormal
LFTs c/f alcoholic hepatitis
ACTIVE ISSUES
=============
# Abnormal LFTs
# Alcoholic hepatitis
Presented with RUQ pain as well as n/v/poor PO, found to have
newly
elevated LFTs with AST>>ALT. Presentation most likely ___ alc
hep, given otherwise negative work up. While Apremilast can lead
to asymptomatic transaminitis during treatment, less likely to
lead to sx this far out. Infectious work up negative with CXR
unremarkable, UA clean, EBV/CMV negative. Autoimmune w/u showing
negative AMA, ___. A1AT and ceruloplasmin wnl. Lipase
unremarkable. Underwent EGD ___ given retching, unclear hx of
liver disease, and no prior hx of EGD. OSH U/S c/f PVT but f/u
CT negative. No known hx of cirrhosis but OSH ___ read of CT
with evidence of nodular liver, portal hypertension,
splenomegaly, and EGD with grade I varices, portal hypertensive
gastropathy all suggestive of cirrhosis. NJT was placed with EGD
and TF were started. DF was 37.8 on admission, but steroids were
deferred given rapid improvement with supportive therapy.
Started on PO PPI bid and standing Zofran. Given IV vit K
challenge x 3d given elevated INR. Given ongoing n/v and
abdominal pain and no BM for 3 days, was ordered for KUB which
was unremarkable. Patient was discharged after tolerating PO and
cycled TF at goal
# ETOH use
Reported alcohol intake of 4 drinks (wine/cocktails) daily.
Inconsistent reports but possibly with increased ETOH intake for
the past 4 months. No clear precipitant, but pt had reported
using ETOH to "self medicate" in past. Pt appeared motivated to
stop drinking. Last drink was ___ with no signs of withdrawal.
Placed on CIWA protocol and consulted SW
CHRONIC ISSUES
===============
# Plaque psoriasis - Continued on home betamethasone topical
# Anxiety / depression - Continued on home venlafaxine.
TRANSITIONAL ISSUES:
===================
Discharge DF 17.1
[] Continue tube feeds until clinically improved (preliminary
recs for ___
[] New diagnosis of cirrhosis - patient should be referred to
hepatology and followed as appropriate
[] Should receive ongoing counseling and possibly psych referral
for alcohol cessation/self-medication
[]Please consider treatment for alcohol cessation/abuse and
consider topomax and on-demand naltrexone.
# CODE: Presumed FULL
# CONTACT: ___
Relationship: ___
Phone: ___
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Venlafaxine XR 37.5 mg PO DAILY
2. Betamethasone Dipro 0.05% Lot. 1 Appl TP BID
3. Multivitamins 1 TAB PO DAILY
4. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB
Discharge Medications:
1. FoLIC Acid 1 mg PO DAILY
RX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet
Refills:*0
2. Polyethylene Glycol 17 g PO DAILY
RX *polyethylene glycol 3350 [Miralax] 17 gram/dose 17 g by
mouth once a day Refills:*0
3. Senna 8.6 mg PO BID
RX *sennosides [Senna Lax] 8.6 mg 1 by mouth once a day Disp
#*30 Tablet Refills:*0
4. Thiamine 100 mg PO DAILY
RX *thiamine HCl (vitamin B1) 100 mg 1 tablet(s) by mouth once a
day Disp #*60 Tablet Refills:*0
5. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB
6. Betamethasone Dipro 0.05% Lot. 1 Appl TP BID
7. Multivitamins 1 TAB PO DAILY
8. Venlafaxine XR 37.5 mg PO DAILY
Discharge Disposition:
Home
Discharge Diagnosis:
PRIMARY
- Alcoholic Hepatitis
- Alcohol Use Disorder
SECONDARY
- Plaque psoriasis
- Major Depressive Disorder
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Ms. ___,
WHY WERE YOU ADMITTED TO THE HOSPITAL?
- You were admitted to the hospital because you were having
abdominal pain and vomiting.
WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL?
- You were monitored for alcoholic hepatitis.
- You were given supportive care and a feeding tube to help you
recover.
- You improved and were ready to leave the hospital.
WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL?
- Please take all of your medications as prescribed and go to
your follow up appointments with your doctors ___ below)
- Weigh yourself every morning, before you eat or take your
medications. Call your doctor if your weight increases by more
than 3 pounds
- Please maintain a low salt diet and monitor your fluid intake
- Seek medical attention if you have new or concerning symptoms
or you develop
It was a pleasure participating in your care. We wish you the
best!
- Your ___ Care Team
Followup Instructions:
___
|
10805203-DS-3
| 10,805,203 | 22,054,032 |
DS
| 3 |
2189-04-15 00:00:00
|
2189-04-15 16:37:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Cipro / Keflex
Attending: ___.
Chief Complaint:
Agitation/Somnolence
Major Surgical or Invasive Procedure:
none
History of Present Illness:
Ms. ___ is a ___ female with history of dementia,
hereditary colon cancer syndrome. retinal melanoma colon cancer
x3 breast cancer x1 who presents with agitation.
The patient's daughter is at bedside and provides history as
patient is somnolent. The patient's daughter reports that over
the past few days the patient has been increasingly agitated.
She was recently diagnosed with UTI and started on antibiotics
yesterday afternoon. Yesterday evening at about 9:30 ___ she was
noted to be speaking to inanimate objects. Her husband was also
concerned that she had decreased ostomy output therefore he
brought her to the emergency department.
The patient initially presented to ___ where a CT
head showed a mass with significant vasogenic edema without
significant mass-effect the patient was transferred to twice
daily and see for neurosurgical evaluation.
While in the emergency department the patient was agitated. At
___ she was given 5 mg Zyprexa x2. At the emergency
department at twice daily MC she received 5 mg Zyprexa IV x2 in
addition to lorazepam 0.5 mg IV x3. The patient is currently
arousable but cannot provide additional history.
ROS: Pertinent positives and negatives as noted in the HPI. All
other systems were reviewed and are negative.
Past Medical History:
-Alzheimer's dementia
-Hereditary cancer syndrome - increased risk for colon and
breast cancer.
-Breast cancer diagnosed at age ___ status post left mastectomy
- Colon cancer diagnosed first at age ___ and subsequently age ___
and then at age ___ status post total colectomy with end
ileostomy
- Retinal melanoma treated with intraocular radiation
Social History:
___
Family History:
Multiple family members with colon cancer.
Physical Exam:
ADMISSION PHYSICAL EXAM:
VS: 97.9 116/74 72 18 99/RA
GENERAL: Somnolent, restless
EYES: Anicteric, pupils 2mm, minimally responsive to light
ENT: Ears and nose without visible erythema, masses, or trauma.
CV: Heart regular, no murmur, no S3, no S4. No JVD.
RESP: Lungs clear on anterior auscultation. Poor cooperation/
GI: Abdomen soft, ostomy in place in mid abdomen with small
hernia. Soft stool in bag.
GU: No suprapubic fullness or tenderness to palpation
MSK: Neck supple, moves all extremities, strength grossly full
and symmetric bilaterally in all limbs
SKIN: No rashes or ulcerations noted
NEURO: Somnolent. Does not track or opens eyes to voice.
PSYCH: unable asses
DISCHARGE PHYSICAL EXAM:
T 97.6, BP 152 / 63, HR 79, RR 18, O2sat 91 on RA
General: restless, agitated
HEENT: sclera anicteric, conjunctiva normal, eyes tracking
appropriately
PULM: lungs clear to auscultation throughout
CV: patient not cooperative with examination of the precordium
GI/GU: abdomen soft, patient not cooperative with remainder of
abdominal exam
MSK: moving all extremities, strength grossly normal
SKIN: no rashes noted
Neuro: Restless. Responds to questioning with word-salad,
incomprehensible but fluent speech. Incomprehensibly ruminating
about the "meaning" and pointing at her legs repeatedly
PYSCH: unable to assess
Pertinent Results:
ADMISSION LABS:
___ 05:08AM BLOOD WBC: 8.9 RBC: 4.90 Hgb: 14.5 Hct: 44.3
MCV: 90 MCH: 29.6 MCHC: 32.7 RDW: 13.8 RDWSD: 46.___
___ 05:08AM BLOOD Glucose: 129* UreaN: 22* Creat: 0.7 Na:
143 K: 7.2* Cl: 111* HCO3: 21* AnGap: 11
___ 05:08AM BLOOD ALT: 17 AST: 46* CK(CPK): 153 AlkPhos: 60
TotBili: 0.7
___ 05:08AM BLOOD Lipase: 111*
___ 05:17AM BLOOD Lactate: 1.7 K: 4.3
___ 05:08AM BLOOD TSH: 0.99
___ 05:08AM BLOOD Albumin: 4.5 Calcium: 8.9 Phos: 4.3 Mg:
3.3*
DISCHARGE LABS:
___ 09:00AM BLOOD WBC-10.7* RBC-4.88 Hgb-14.3 Hct-44.1
MCV-90 MCH-29.3 MCHC-32.4 RDW-13.4 RDWSD-44.3 Plt ___
___ 09:00AM BLOOD Glucose-142* UreaN-8 Creat-0.4 Na-144
K-4.3 Cl-109* HCO3-25 AnGap-10
___ 09:00AM BLOOD Calcium-8.8 Phos-2.3* Mg-2.0
IMAGING:
CT head/brain wo con
Accession Number(s): ___
Date / Time of Exam: ___ 02:30:06
Reason for Study: altered mental status
Interpretation Location: PACSWKS2
Axial CT scans of the head obtained from the base to the vertex
without contrast enhancement. Reformatted coronal and sagittal
images also generated. Brain and bone windows reviewed.
Age related involutional changes bilaterally. Focal areas of
intra-axial low attenuation in the adjacent left frontal and
parietal lobes. Differential diagnosis includes acute cerebral
infarct and metastatic disease. No intracranial hemorrhage or
midline shift. No hydrocephalus. Bone windows demonstrate no
significant osseous abnormality. Imaged paranasal sinuses and
mastoid air cells are clear.
IMPRESSION: Focal areas of intra-axial low attenuation in the
adjacent left frontal and parietal lobes. ? Acute cerebral
infarcts vs metastatic disease. Brain MRI without and with IV
gadolinium recommended for further evaluation.
- CT HEAD WITH CONTRAST (___): Solitary, rim-enhancing lesion
within the posterior left parietal lobe measuring 3.0 x 3.1 x
3.3 cm, with surrounding vasogenic edema. Given its internal
fluid density, findings may be compatible with abscess, however
differential consideration of metastasis or high-grade primary
malignancy cannot be excluded. Recommend further evaluation
with dedicated MRI head with without contrast for
characterization.
- MRI BRAIN ___: 1. Solitary mass with irregular rim
enhancement in the inferior left parietal lobe concerning for
glioblastoma. A solitary metastasis is less likely given the
highly irregular morphology. Diffusion characteristics are not
supportive of an infarct or bacterial abscess. 2. Moderate
surrounding edema with mild effacement of the atrium of the left
lateral ventricle but no shift of midline structures.
- TTE ___: Poor image quality. Bileaflet mitral valve prolapse
without large vegetation in oneview. Mildly thickened aortic
valve without clear vegetation in one view. Endocarditis cannot
beexcluded on the basis of the study, however given poor image
quality. TEE would be necessary toexclude endocarditis. Small
hypertrophied, dynamic left ventricle. No prior TTE available
forcomparison.
- EEG ___: This is an abnormal continuous ICU monitoring study
due to the
presence of 18 brief electrographic seizures arising from the
left parietal
region, with involvement of the left posterior temporal region,
lasting ___
minutes in duration without any consistent clinical change in
behaviors.
Interictally, broad-based sharp waves are seen in the left
parietal and
posterior temporal region, or more broadly over the left
hemisphere,
indicative of potentially epileptogenic cortex in these regions.
Mild
attenuation of activity with bursts of slowing are seen over the
left
hemisphere, indicative of a structural lesion causing focal
cerebral
dysfunction. Diffuse slowing of the background is consistent
with a mild to
moderate encephalopathy, which is nonspecific in etiology, and
can be
associated with toxic/metabolic disturbances and medication
effects.
- ___ EEG: This continuous ICU monitoring study was abnormal
due to: 1)
Frequent independent sharp waves seen in the left > right
temporal regions, at times occurring in pseudoperiodic runs at
___ Hz. These findings are indicative of underlying focal and
epileptogenic areas. 2) There was mild
focal slowing over the left temporal region, and focal slowing
over the right temporal region, suggesting focal cerebral
dysfunction. 4) Generalized background slowing consistent with a
mild encephalopathy, non-specific with regards to etiology.
There were no push button events. Compared to the prior day's
recording, there was no significant change.
Brief Hospital Course:
SUMMARY:
___ is a ___ year old woman with a history of dementia,
and multiple malignancies (including melanoma) admitted with
acute AMS, found to have likely new intracranial malignancy c/b
focal seizures. Surgical, radiation, and medical management of
mass were not within ___ and patient was managed conservatively
with focus on seizure suppression and improvement in mental
status. Pt discharged with all PO meds and regular diet despite
high aspiration risk, per ___. Pt discharged on hospice to
___.
HOSPITAL COURSE:
# Goals of Care: Per discussions at family meetings this
hospitalization, the patient's treatment goals are now
comfort-focused. All medications will be PO and directed towards
comfort, as below. The patient was discharged on ___ ___ with hospice.
# Malignant Intracranial Mass: Patient admitted with acute onset
mental status changes in the setting of subacute decline. NCHCT
with left parietal 3x3cm mass. As patient initially could not
tolerate MRI for agitation, CT brain with contrast demonstrated
hyperenhancement of mass concerning for possible abscess and she
was subsequently started on CTZ/MTZ/vancomycin. However, after
MRI performed with MAC anesthesia, imaging was more consistent
with a malignancy (possibly GBM) with mass effect of surrounding
tissues, but without midline shift or signs of herniation.
Neurosurgery consulted and reviewed at neuro tumor board. After
discussion with patients family, it was determined that
surgical options, chemotherapy, or radiation were not within
patients goals of care, and she was instead started on
dexamethasone to decrease brain swelling at the direction of
neurology. Mass was felt to be cause of seizures (see below).
Patient was eventually tapered down to 1mg dexamethasone BID,
which she will continue indefinitely after discharge.
# Seizures: EEG monitoring demonstrated frequent focal
electrographic seizures origination from left parietal lobe. She
was started on keppra and lacosamide with eventual seizure
suppression. These medications were converted to oral and she
will need to continue these indefinitely aftter discharge. Of
note, if the patient is unable to take keppra and lacosamide
(see toxic-metabolic encephalopathy below), can try clonazepam
wafers instead.
# Toxic-metabolic encephalopathy: Multifactorial. Patient with
baseline dementia. UTI diagnosed 1 day prior to admission (which
may have lower seizure threshold) and metabolic encephalopathy
may have been contributing factor. Seizures additionally
contributed early in hospital course, as did delirium from
hospital setting and steroid use. After seizures suppressed, UTI
treated, EEG leads, tubes and restraints were removed efforts
were made to improve her delirium with ___ olanzapine, frequent
reorientation and family bedside presence and patients
condition improved. SLP evaluation revealed high risk of
aspiration and inattention to many food boluses; however, per
GOC the patient was discharged on a regular diet. SLP
recommended thin liquids rather than thickened liquids as an
option for comfort and improved hydration. The patient was also
discharged on oral medications.
# Hypernatremia: patient initially hypernatremic iso
dehydration/oliguria. Resolved with increased rate of IVFs prior
to discharge. Remained eunatremic on day of discharge after 1
day of discontinuation of all IVFs and IV medications.
# Urinary Retention: patient with ongoing urinary retention.
Foley was ultimately removed, per ___ discussion. Patient
required straight caths for comfort when urine >750 on serial
bladder scans (q6-8 hrs).
# Thrush: initially got IV fluconazole iso difficulty
swallowing, but ultimately tolerated nystatin swish (continue
for comfort)
Transitional Issues:
====================
- regular diet with thin liquieds despite high aspiration risk,
per GOC
- all meds PO, including anti-epileptic medications, which are
indicated to control seizures for comfort
- if patient unable to take oral lacosamide and keppra, can try
clonazepam wafers (0.5 mg BID)
- if possible, please try to give medications when family is
around (patient tolerates oral medications better in the
presence of family). She does best with medications crushed in a
magic cup
Code status: Comfort focused care, DNR/DNI
Time spent coordinating discharge > 30 minutes
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Cephalexin 500 mg PO Q8H
2. Nitrofurantoin (Macrodantin) 100 mg PO BID
Discharge Medications:
1. ClonazePAM 0.5 mg PO BID:PRN If unable to take AEDs
Please provide wafer. Give BID PRN when patient not otherwise
taking anti-epileptics
RX *clonazepam 0.5 mg 1 tablet(s) by mouth twice a day Disp #*10
Tablet Refills:*0
2. Dexamethasone Oral Soln (0.1mg/1mL) 10 mL ORAL BID
if a crushed pill format is available, this might be better
tolerated than the oral formulation
3. LACOSamide 100 mg PO BID
4. LevETIRAcetam Oral Solution 750 mg PO Q12H
5. Nystatin Oral Suspension 5 mL PO QID
6. OLANZapine (Disintegrating Tablet) 5 mg PO QPM
7. Ramelteon 8 mg PO QHS
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
- Intracranial Mass
- Seizures
- Toxic-metabolic encephalopathy
- Hypernatremia
- Urinary Retention
- Difficulty Swallowing
Discharge Condition:
Mental Status: Confused - always.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Dear Ms. ___ and ___,
You were admitted to the hospital with confusion. We found a
mass in the brain. We had a family meeting and it was decided
that treatment of this mass with chemotherapy, radiation, or
surgery would not be within your goals of care. We did treat the
swelling around the mass in the brain with some steroids, as we
discussed in the goals of care meeting. Additionally, we found
evidence of seizure activity in the brain. The seizure activity
was treated with anti-epileptic medications. While in the
hospital, you had difficulty swallowing. Although the risk of
aspiration is high, it was decided in another family meeting
that part of optimizing comfort would include allowing you to
eat a regular diet and take medications by mouth rather than by
IV.
You are now being discharged to ___ to focus on
spending time with your family.
It was a pleasure taking care of you.
- Your ___ Care team
Followup Instructions:
___
|
10805306-DS-14
| 10,805,306 | 28,145,388 |
DS
| 14 |
2156-01-25 00:00:00
|
2156-01-25 15:17:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: SURGERY
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Incarcerated ventral hernia
Major Surgical or Invasive Procedure:
Incisional Hernia Repair with Mesh
History of Present Illness:
___ p/w incarcerated incisional bowel containing umbilical
hernia
Past Medical History:
PMH:
HTN
H. pylori
Polycythemia
PSH:
--s/p cystoscopy, laser lithotripsy and L ureteral stent
placement for L kidney stone on ___
--Hx of perianal fistula drained in ___
Health Maintenance:
Colonoscopy-never had one
PSA in ___
Social History:
___
Family History:
Mother died at age ___ ___ from "old age."
Father died at ___ ___ from stroke; hx of ETOH abuse
2 brothers-health described as "good."
Unaware of any other family history.
Physical Exam:
GENERAL APPEARANCE: Well developed, well nourished, alert and
cooperative, and appears to be in no acute distress.
HEAD: normocephalic.
EYES: PERRL, EOMI. Fundi normal, vision is grossly intact.
EARS: External auditory canals and tympanic membranes clear,
hearing grossly intact.
NOSE: No nasal discharge.
THROAT: Oral cavity and pharynx normal. No inflammation,
swelling, exudate, or lesions. Teeth and gingiva in good general
condition.
NECK: Neck supple, non-tender without lymphadenopathy, masses or
thyromegaly.
CARDIAC: Normal S1 and S2. No S3, S4 or murmurs. Rhythm is
regular. There is no peripheral edema, cyanosis or pallor.
Extremities are warm and well perfused. Capillary refill is less
than 2 seconds. No carotid bruits.
LUNGS: Clear to auscultation and percussion without rales,
rhonchi, wheezing or diminished breath sounds.
ABDOMEN: Positive bowel sounds. Soft, nondistended, nontender.
No guarding or rebound. No masses. Abdominal lap sites c/d/I.
MUSKULOSKELETAL: Adequately aligned spine. ROM intact spine and
extremities. No joint erythema or tenderness. Normal muscular
development. Normal gait.
BACK: Examination of the spine reveals normal gait and posture,
no spinal deformity, symmetry of spinal muscles, without
tenderness, decreased range of motion or muscular spasm.
EXTREMITIES: No significant deformity or joint abnormality. No
edema. Peripheral pulses intact. No varicosities.
LOWER EXTREMITY: Examination of both feet reveals all toes to be
normal in size and symmetry, normal range of motion, normal
sensation with distal capillary filling of less than 2 seconds
without tenderness, swelling, discoloration, nodules, weakness
or deformity; examination of both ankles, knees, legs, and hips
reveals normal range of motion, normal sensation without
tenderness, swelling, discoloration, crepitus, weakness or
deformity.
NEUROLOGICAL: CN II-XII intact. Strength and sensation symmetric
and intact throughout. Reflexes 2+ throughout. Cerebellar
testing normal.
SKIN: Skin normal color, texture and turgor with no lesions or
eruptions.
Pertinent Results:
___ 06:00AM GLUCOSE-115* UREA N-17 CREAT-0.7 SODIUM-139
POTASSIUM-4.0 CHLORIDE-99 TOTAL CO2-26 ANION GAP-14
___ 06:00AM CALCIUM-9.3 PHOSPHATE-3.2 MAGNESIUM-2.1
___ 06:00AM WBC-6.6 RBC-5.43 HGB-16.1 HCT-46.6 MCV-86
MCH-29.7 MCHC-34.5 RDW-13.2 RDWSD-41.0
___ 06:00AM PLT COUNT-226
___ 06:00AM ___ PTT-26.2 ___
___ 07:54PM LACTATE-1.9
___ 07:48PM GLUCOSE-137* UREA N-20 CREAT-0.9 SODIUM-140
POTASSIUM-4.3 CHLORIDE-100 TOTAL CO2-25 ANION GAP-15
___ 07:48PM estGFR-Using this
___ 07:48PM ALT(SGPT)-19 AST(SGOT)-21 ALK PHOS-93 TOT
BILI-1.0
___ 07:48PM ALBUMIN-4.4
___ 07:48PM WBC-7.8 RBC-5.61 HGB-16.3 HCT-47.8 MCV-85
MCH-29.1 MCHC-34.1 RDW-13.0 RDWSD-40.5
___ 07:48PM NEUTS-79.2* LYMPHS-15.2* MONOS-4.8* EOS-0.0*
BASOS-0.3 IM ___ AbsNeut-6.17* AbsLymp-1.18* AbsMono-0.37
AbsEos-0.00* AbsBaso-0.02
___ 07:48PM PLT COUNT-223
Brief Hospital Course:
The patient presented to Emergency Department on ___. Upon
arrival to ED, the acute care surgery service was consulted.
Given findings, the patient was taken to the operating room for
repair of umbilical hernia repair. There were no adverse events
in the operating room; please see the operative note for
details. Pt was extubated, taken to the PACU until stable, then
transferred to the ward for observation.
Neuro: The patient was alert and oriented throughout
hospitalization; pain was managed with oral pain medication once
tolerating a diet.
CV: The patient remained stable from a cardiovascular
standpoint; vital signs were routinely monitored.
Pulmonary: The patient remained stable from a pulmonary
standpoint; vital signs were routinely monitored. Good pulmonary
toilet, early ambulation and incentive spirometry were
encouraged throughout hospitalization.
GI/GU/FEN: The patient was initially kept NPO with IVF. Over the
next few hours, the diet was advanced sequentially to a Regular
diet, which was well tolerated. Patient's intake and output were
closely monitored
ID: The patient's fever curves were closely watched for signs of
infection, of which there were none.
HEME: The patient's blood counts were closely watched for signs
of bleeding, of which there were none.
Prophylaxis: The patient received subcutaneous heparin and ___
dyne boots were used during this stay and was encouraged to get
up and ambulate as early as possible.
At the time of discharge, the patient was doing well, afebrile
and hemodynamically stable. The patient was tolerating a diet,
ambulating, voiding without assistance, and pain was well
controlled. The patient received discharge teaching and
follow-up instructions with understanding verbalized and
agreement with the discharge plan.
Medications on Admission:
1. Simvastatin 20mg QD
Discharge Medications:
1. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain -
Moderate
RX *oxycodone 5 mg 5 tablet(s) by mouth every six (6) hours Disp
#*6 Tablet Refills:*0
2. Simvastatin 20mg QD
Discharge Disposition:
Home
Discharge Diagnosis:
Incarcerated Ventral Hernia
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Please call your doctor or nurse practitioner or return to the
Emergency Department for any of the following:
*You experience new chest pain, pressure, squeezing or
tightness.
*New or worsening cough, shortness of breath, or wheeze.
*If you are vomiting and cannot keep down fluids or your
medications.
*You are getting dehydrated due to continued vomiting, diarrhea,
or other reasons. Signs of dehydration include dry mouth, rapid
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a
bowel movement.
*You experience burning when you urinate, have blood in your
urine, or experience a discharge.
*Your pain in not improving within ___ hours or is not gone
within 24 hours. Call or return immediately if your pain is
getting worse or changes location or moving to your chest or
back.
*You have shaking chills, or fever greater than 101.5 degrees
Fahrenheit or 38 degrees Celsius.
*Any change in your symptoms, or any new symptoms that concern
you.
Please resume all regular home medications, unless specifically
advised not to take a particular medication. Also, please take
any new medications as prescribed.
Please get plenty of rest, continue to ambulate several times
per day, and drink adequate amounts of fluids. Avoid lifting
weights greater than ___ lbs until you follow-up with your
surgeon.
Avoid driving or operating heavy machinery while taking pain
medications.
Incision Care:
*Please call your doctor or nurse practitioner if you have
increased pain, swelling, redness, or drainage from the incision
site.
*Avoid swimming and baths until your follow-up appointment.
*You may shower, and wash surgical incisions with a mild soap
and warm water. Gently pat the area dry.
*If you have staples, they will be removed at your follow-up
appointment.
*If you have steri-strips, they will fall off on their own.
Please remove any remaining strips ___ days after surgery.
JP Drain Care:
*Please look at the site every day for signs of infection
(increased redness or pain, swelling, odor, yellow or bloody
discharge, warm to touch, fever).
*Maintain suction of the bulb.
*Note color, consistency, and amount of fluid in the drain. Call
the doctor, ___, or ___ nurse if the amount
increases significantly or changes in character.
*Be sure to empty the drain frequently. Record the output, if
instructed to do so.
*You may shower; wash the area gently with warm, soapy water.
*Keep the insertion site clean and dry otherwise.
*Avoid swimming, baths, hot tubs; do not submerge yourself in
water.
*Make sure to keep the drain attached securely to your body to
prevent pulling or dislocation.
Followup Instructions:
___
|
10805461-DS-40
| 10,805,461 | 20,178,114 |
DS
| 40 |
2147-05-30 00:00:00
|
2147-06-03 16:27:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Heparin Agents / Cefazolin / Nelfinavir / Morphine / vancomycin
/ Nafcillin / Valium
Attending: ___.
Chief Complaint:
Hypotension at HD
Major Surgical or Invasive Procedure:
None.
History of Present Illness:
Ms. ___ is a ___ female with PMH of ESRD on MWF HD,
cardiomyopathy, severe pHTN, and HIV on HAART ___: CD4
410) who presents to the ED for evaluation of hypotension. She
was last in her USOH until today at ___ when she experienced
hypotension to ___'s over ___ along with light-headedness/AMS.
Dialysis was near the end. She was brought to the ED for
evaluation and had SBP improve to 90's by arrival and was A+Ox3.
In the ED, initial VS were 99.6 100 95/60 18 98% 3L. ED ECG was
read as SR ___ changes. Labs revealed a lactate of 1.6.
There was concern for pneumonia given report of cough with
sputum, baseline immunosuppression, and recent admission for
pneumonia. She received 2LNS, ipratropium and albuterol nebs,
meropenem 500mg IV, and midodrine 10mg. She reportedly had not
received midodrine post HD today. Her blood pressures recovered
to the 80's and 90's systolic. She was admitted to the medical
floor for monitoring. Vitals prior to transfer were 98.1, 110,
21, 92/63, 100%3LNC.
On arrival to the medical floor, VS98.9, 106/60, 101, 20,
98%3LNC. She reports cough with sputum production but no
fevers/chills, no pain, no nausea/vomiting, no fatigue or
light-headedness. The cough has never stopped since her last
presentation to the hospital, although she has remained afebrile
since previous discharge.
ROS: per HPI, 10 pt ROS neg except for above.
Past Medical History:
-HIV ___: CD4 410)
-ESRD on HD MWF
-HTN
-severe pHTN
-Cardiomyopathy ___ LVEF 31%, severe MR/TR
-Lymphocytic interstitial pneumonitis (LIP) followed by Dr.
___ at ___ ___
-anemia of chronic disease
-AVNRT diagnosed at ___
-vaginal bleed s/p conization
-HCV - untreated
-Asthma/COPD on home O2
-h/o MSSA bacteremia and vertebral osteomyelitis
.
PAST SURGICAL HISTORY
-C-section
-R knee surgery
-Ovarian cysts removed
Social History:
___
Family History:
Her mother is living in her ___ and had a stroke, hypertension
and diabetes. Her uncle died of kidney disease. She never met
her father. Her sister was killed in a motor vehicle crash. Her
children are healthy. Her daughter has a single kidney.
Physical Exam:
Physical Exam on Presentation:
Vitals-98.9, 106/60, 101, 20, 98%3LNC
General- Alert, oriented, no acute distress
HEENT- Sclera anicteric, MMM, oropharynx clear
Neck- supple, JVP not elevated, no LAD, right tunneled SC line
is without surrounding erythema or tenderness
Lungs- CTAB no wheezes, rales, rhonchi
CV- RRR, Nl S1, S2, No MRG
Abdomen- soft, NT/ND bowel sounds present, no rebound tenderness
or guarding, no organomegaly
GU- no foley
Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema, left extremity with intact incision from fistula
revision, palpable thrill and bruit auscultated
Neuro- CNs2-12 intact, motor function grossly normal
DISCHARGE PHYSICAL EXAM
Vitals: afebrile satting 98% on 2L
General- Alert, oriented, no acute distress
HEENT- Sclera anicteric, MMM, moonshaped facies
Neck- supple, JVP not elevated, no LAD, right tunneled SC line
is without surrounding erythema or tenderness
Lungs- CTAB no wheezes, rales, rhonchi
CV- RRR, Nl S1, S2, No MRG
Abdomen- soft, NT/ND bowel sounds present, no rebound tenderness
or guarding, no organomegaly
GU- no foley
Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema, left extremity with intact incision from fistula
revision, palpable thrill and bruit auscultated
Neuro- CNs2-12 intact, motor function grossly normal
Pertinent Results:
Lab Results on Presentation:
___ 10:22AM BLOOD WBC-2.4* RBC-3.94* Hgb-10.5* Hct-36.7
MCV-93 MCH-26.7* MCHC-28.7* RDW-19.2* Plt Ct-66*
___ 10:22AM BLOOD Neuts-40.8* Lymphs-46.4* Monos-7.9
Eos-4.5* Baso-0.4
___ 10:22AM BLOOD Plt Ct-66*
___ 10:49AM BLOOD ___ PTT-42.5* ___
___ 10:22AM BLOOD Glucose-81 UreaN-10 Creat-3.7*# Na-143
K-3.8 Cl-104 HCO3-27 AnGap-16
___ 10:22AM BLOOD ___
___ 06:15AM BLOOD Calcium-8.1* Phos-4.7*# Mg-1.9
___ 10:24AM BLOOD Lactate-1.6
Imaging:
Radiology Report CHEST (PORTABLE AP) Study Date of ___
12:41 ___
FINDINGS: Single frontal view of the chest was obtained. There
has been
interval placement of a right-sided large-bore central venous
catheter which terminate in the right atrium. The cardiac and
mediastinal silhouettes are stable. There is stable prominence
of the perihilar vasculature which may be due to vascular
congestion as well as bibasilar opacities which could relate to
atelectasis and scarring, underlying infection or aspiration is
not excluded. Old right-sided rib fractures are again seen.
Radiology Report CT CHEST W/CONTRAST Study Date of ___
6:02 ___
IMPRESSION:
1. Bilateral lower lobe bronchial wall thickening is consistent
with acute infectious bronchitis, most likely bacterial given
the patient's relatively high CD4 count.
2. Increased size and number of mediastinal lymph nodes and
axillary lymph nodes.
2. Moderate splenomegaly and liver morphology in keeping with
known chronic
liver disease.
ECG:
Cardiovascular Report ECG Study Date of ___ 10:30:52 AM
Sinus tachycardia. Possible left atrial abnormality. Diffuse
non-specific
ST-T wave abnormalities that are most marked in the inferior and
anterolateral leads. Compared to the previous tracing of
___ wave abnormalities are slightly more marked.
Cannot rule out ischemia. Clinical correlation and repeat
tracing are suggested.
Cardiovascular Report ECG Study Date of ___ 12:09:52 AM
Sinus rhythm. Possible left atrial abnormality. Diffuse
non-specific
ST-T wave abnormalities that are most marked in the
anterolateral leads.
Compared to tracing #1 no diagnostic change.
CT CHEST WITH IV CONTRAST FINDINGS ___
LUNGS AND AIRWAYS: The airways are patent to the subsegmental
level. There is moderate-to-severe upper lobe predominant
centrilobular emphysema. There is mild to moderate bronchial
wall thickening, more prominent in both lower lobes
(representative image 5:166). Bibasilar dependent atelectasis,
right worse than left, is present but there is no focal
consolidation concerning for pneumonia. Of note, localized left
lower lobe scarring is unchanged from prior exam. Trace
bilateral pleural effusion is unchanged.
MEDIASTINUM: A right-sided tunneled line ends in the right
atrium. Compared with prior exam, there has been mild interval
worsening of mediastinal and axillary lymphadenopathy. For
example, a subcarinal lymph node measuring 16 mm in short axis
diameter (3:28) was 9 mm in the previous exam. Also numerous
lymph nodes in both axillae, more prominently in the left,
appear new or increased in size and conspicuity from the
previous exam. For example, an 18 x 11 mm lymph node in the
left axilla (3:15) was only 15 x 8 mm and had a predominantly
fatty hilum in ___. Multiple thoracic wall lymph nodes in
the left subpectoral region (significant image 3:8 and 3:9)
ranging up to 16 x 8 mm, are also more conspicuous than in the
previous exam.
Otherwise, the thyroid gland is unremarkable. The heart is not
enlarged. The aorta is normal in caliber. The pulmonary artery
is increased in caliber, measuring up to 38 mm of diameter,
suggestive of pulmonary hypertension.
Trace pericardial fluid is physiologic. There is no esophageal
wall
thickening or hiatal hernia.
This study is not tailored for the assessment of
subdiaphragmatic structures. Allowing for limitations of the
truncated imaging frame: Moderate splenomegaly is again seen and
the nodular contour of the liver is compatible with known
chronic liver disease.
OSSEOUS STRUCTURES: There are no lytic or blastic lesions
concerning for
malignancy. Hardware from anterior lower cervical spinal
fixation construct is unremarkable.
IMPRESSION:
1. Bilateral lower lobe bronchial wall thickening is consistent
with acute infectious bronchitis, most likely bacterial given
the patient's relatively high CD4 count.
2. Increased size and number of mediastinal lymph nodes and
axillary lymph nodes.
2. Moderate splenomegaly and liver morphology in keeping with
known chronic liver disease.
Brief Hospital Course:
BRIEF HOSPITAL COURSE
=======================
Ms. ___ was admitted to the hospital for hypotension at HD.
She also had worsening cough from her previous presentation with
pneumonia. She underwent several dialysis sessions in house and
her blood pressure was intermittently low at dialysis without
symptoms. CT chest showed acute bronchitis and she was started
on a course of ceftriaxone, azithromycin, and prednisone. Her
midodrine was increased and her dialysis goal weight was
increased from 63 to 65kg in an effort to limit hypotension.
ACTIVE ISSUES
===============
#Hypotension at HD: Ms. ___ BP dropped to the 30's systolic
at HD 2 days prior per nephrology report. She received a repeat
session and received her midodrine prior to and then during as
well with stable blood pressures. At time of discharge, she was
stable on the floor with SBP ___ which is her baseline. She was
continued on this regimen of midodrine.
- ___ consider increasing midodrine as needed in the future.
#Bronchitis / COPD exacerbation: Diagnosis of bronchitis (felt
to be bacterial) on her CT scan in setting of COPD. Previous
team had low suspicion for resistant organisms despite recent
course of meropenem and patient clinically looked well, as such
was started on prednisone burst and azithromycin x 5 days
(finished while inpatient).
#Pneumonia: Diagnosed on a previous admission and had finished
her course of meropenem while inpatient.
CHRONIC ISSUES
================
#HIV ___: CD4 410): Continued home HAART regimen.
#ESRD on HD MWF: Continued HD at BI, and increased midodrine.
Also continued home meds.
#severe pulmonary hypertension: Continued home sildenafil.
#Cardiomyopathy ___ LVEF 31%, severe MR/TR. Most recent echo
has normalized, with EF 55%. Continued aspirin and low sodium
diet.
#Lymphocytic interstitial pneumonitis (LIP): Continued ___ NC.
#HCV - Untreated, last seen by Dr. ___ ___ and she did not
want treatment at that time, was later deemed to not be a
liver-kidney transplant candidate given comorbidities. Consider
GI/liver referral after discharge for new combination oral
therapy.
#Asthma/COPD on home O2: Treated for bronchitis as above,
otherwise continued oxygen, albuterol, and ipratropium.
TRANSITIONAL ISSUES
====================
- Code status: Full code.
- Emergency contact: ___, daughter, ___.
- Studies pending on discharge: Blood cultures x2 from ___
- Please check an AM cortisol level when patient is off
steroids.
- UNABLE TO CONFIRM CORRECT HOME MEDICATIONS. Patient reported
that dialysis list was incorrect, however pharmacy was closed
for the holiday and HCP was not aware of med list. PCP's office
was contacted several different days w/o response. As such, she
was discharged on her dialysis list of medications. Please do
accurate med rec on next visit.
- A copy of this discharge summary was faxed to Dr. ___
office at ___.
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires
futher investigation.
1. Acetaminophen 325 mg PO Q6H:PRN pain
2. Albuterol 0.083% Neb Soln 1 NEB IH Q2H:PRN shortness of
breath, wheeze
3. Aspirin 81 mg PO DAILY
4. Cinacalcet 30 mg PO 2X/WEEK (MO,FR)
5. Etravirine 200 mg PO BID
6. LaMIVudine 50 mg PO DAILY
7. Pantoprazole 40 mg PO Q24H
8. Pregabalin 25 mg PO QHS
9. Raltegravir 400 mg PO BID
10. Sildenafil 50 mg PO TID
11. Tenofovir Disoproxil (Viread) 300 mg PO ___
12. Thiamine 100 mg PO DAILY
13. Epoetin Alfa 0 UNIT IV PER HD
14. Nephplex Rx (vit B cmplex ___ ox) ___
mg-mg-mcg-mg oral daily
15. QUEtiapine Fumarate 50 mg PO QHS
16. Lactulose 15 mL PO BID
17. Ipratropium Bromide Neb 1 NEB IH Q2H:PRN shortness of
breath, wheeze
18. Midodrine 20 mg PO QMOWEFR
19. Venofer (iron sucrose) 0 units INJECTION PER RENAL
Discharge Medications:
1. Acetaminophen 325 mg PO Q6H:PRN pain
2. Albuterol 0.083% Neb Soln 1 NEB IH Q2H:PRN shortness of
breath, wheeze
3. Aspirin 81 mg PO DAILY
4. Cinacalcet 30 mg PO 2X/WEEK (MO,FR)
5. Etravirine 200 mg PO BID
6. Ipratropium Bromide Neb 1 NEB IH Q2H:PRN shortness of breath,
wheeze
7. Lactulose 15 mL PO BID
8. LaMIVudine 50 mg PO DAILY
9. Pantoprazole 40 mg PO Q24H
10. QUEtiapine Fumarate 50 mg PO QHS
11. Raltegravir 400 mg PO BID
12. Sildenafil 50 mg PO TID
13. Tenofovir Disoproxil (Viread) 300 mg PO ___
14. Thiamine 100 mg PO DAILY
15. Midodrine 15 mg PO QMOWEFR
16. Epoetin Alfa 0 UNIT IV PER HD
per nephrology.
17. Nephplex Rx (vit B cmplex ___ ox) ___
mg-mg-mcg-mg oral daily
18. Pregabalin 25 mg PO QHS
19. Venofer (iron sucrose) 0 units INJECTION PER RENAL
per nephrology.
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
Primary: Hypotension, Bronchitis
Secondary: End-stage Renal disease, HIV
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Ms. ___,
You were admitted to the hospital because of low blood pressure
at dialysis. Also, we found that your cough is likely due to
acute bronchitis. While in the hospital, we worked with the
kidney doctors to ___ your blood pressure up during dialysis.
We also gave a you a treatment of steroids and antibiotics for
your bronchitis. Your blood pressure stayed stable and your
bronchitis began to improve.
Weigh yourself every morning, call MD if weight goes up more
than 3 lbs.
Followup Instructions:
___
|
10805699-DS-21
| 10,805,699 | 22,941,683 |
DS
| 21 |
2132-02-11 00:00:00
|
2132-02-11 17:49:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Bactrim / Cipro / morphine
Attending: ___.
Chief Complaint:
abdominal pain
Major Surgical or Invasive Procedure:
cysto, ureteroscopy, ureteral stent
History of Present Illness:
PCP: ___ (___)
.
CC: R sided abd pain
.
HPI/EVENTS: ___ F h/o obesity, DM2, sarcoidosis, chronic LBP
admitted with increasing R sided abd pain over the past two
days. Reports pain occurred in RUQ/R flank - which worsened
over the past 2 days. Associated with N/V, poor PO intake, but
denies fever/chills. Felt that pain was similar to appendicitis
many years ago, however, able to tolerate PO more recently. Had
BM yesterday. Due to increasing pain came to ED for evaluation.
In ED, vitals sign stable 98.4 70 146/63 18 99%. WBC 9.4,
but Cr increased to 1.9 (from baseline 1.1). U/A negative. RUQ
U/S showed cholelithiasis no cholecyctitis. Abd CT showed 8mm
proximal right ureteral stone w/ evidence of hydronephrosis.
Urology was consulted and plan was for stent placement.
Received toradol 30 mg IV, tylenol, flomax, and 2L IVF NS
bolus. Immediately brought to OR for ureter stenting.
ROS: per HPI, denies fever, chills, night sweats, headache,
vision changes, rhinorrhea, congestion, sore throat, cough,
shortness of breath, chest pain, diarrhea, constipation, BRBPR,
melena, hematochezia, dysuria, hematuria. A 10 pt review of sxs
was otherwise negative.
Past Medical History:
# HTN
# Obesity
# DM2 - renal/ peripheral neuropathy last Hgb A1C 6.2 (___)
- s/p R toe amputation ___
# sarcoidosis - hypercalcemia
# nephrolithiasis
- KUB ___: Skeletal: Two small calcifications project over
the lower pole left kidney. No definite calcifications
visualized over the right renal shadow region
# OSA - ? CPAP
# Chronic LBP - scoliosis, sciatica (L leg)
# compression fx (Lumbar)
- MRI Lumbar ___: Severe rotational scoliosis convex to the
patient's left. Multilevel degenerative changes without
significant progression compared to prior study. Wedge
compression deformity again demonstrated superior endplate of
the L2 vertebral body
# OA
Social History:
___
Family History:
Positive for Diabetes on maternal side. F deceased from colon
CA. M alive - diabetes, ESRD
Physical Exam:
Vital Signs: 97.8 53 107/55 15 96% RA
glucose:
.
GEN: NAD, obese, lying in bed
EYES: PERRL, EOMI, conjunctiva clear, anicteric
ENT: moist mucous membranes, no exudates
NECK: supple
CV: RRR s1s2 nl, no m/r/g
PULM: CTA, no r/r/w
GI: normal BS, R flank pain, otherwise NT/ND, no HSM
EXT: warm, no c/c/e
SKIN: no rashes
NEURO: alert, oriented x 3, answers ? appropriately, follows
commands, non focal
PSYCH: appropriate
ACCESS: PIV
FOLEY: absent
Pertinent Results:
LABS: SEE BELOW
# WBC 9.4, BUN 39, Cr 1.9, U/A <1 WBC 0 RBC, ___ neg
OTHER DATA:
# Abd CT (___): 8 mm obstructing stone within the proximal
right ureter causing mild right hydronephrosis. Multiple
bilateral nonobstructing stones.
# RUQ U/S (___): Cholelithiasis. Multiple nonobstructing renal
stones measuring up to 1.1 cm with mild hydronephrosis.
Brief Hospital Course:
ASSESSMENT & PLAN: ___ F h/o obesity, DM2, sarcoidosis, chronic
LBP admitted with increasing R sided abd pain - found to have
obstructing R ___ ureteric stone.
# Abd pain/flank pain: Ms. ___ was admitted with
abdominal/flank pain attributed to obstructing 8mm ___ ureteric
stone. This was associated with ___, Cr 1.9 (from 1.1).
There were no other pathology on CT scan or RUQ u/s or any
evidence of infection (nl WBC, afebrile, U/A unremarkable).
Urology brought her to operating room semi-urgently to
perform a cystoscopy, uretreroscopy, laser lithotripsy, and
ureteral stent placement. Reportedly, the urology team felt
good about eliminating most of the stone burden in the R
ureter/kidney. After the procedure, her pain was much improved
and did not require any pain medications.
She is scheduled to get stent removed in 9 days time. While
the stent is in place, she should continue to take the flomax.
She understands to take a single dose of antibiotics the morning
of the stent removal. She received a single dose of abx
periprocedurally, but did not require any antibiotics
thereafter.
# DM2: well controlled, with complications (renal/neuropathy).
She was maintained on insulin sliding scale. Given that she was
NPO for most of the day, both the lantus and metformin were
held.
# HTN: controlled. Cont ASA, atenolol, losartan, amlodipine
# Sarcoidosis: outpt methotrexate, leukovorin
# cLBP: cont ultram
#CONSULTS: urology
#CODE STATUS: [X]full code []DNR/DNI
Medications on Admission:
- Aspirin 81 mg Oral Tablet, 1 tab po qd
- atenolol 100 mg daily
- losartan 50 mg daily
- amlodipine 10 mg daily
- Insulin glargine 56u QAM
- Insulin Lispro SS
- Metformin 1000mg BID
- trospium 20 mg daily
- tramadol 50-100 mg Q4h PRN pain
- methotrexate 15 mg SQ Q1 wk
- leucovorin 15 mg Q1wk 10h after MTX
- latanoprost 0.005 % 1gtt both eyes QHS
- triamcinolone 0.1 % Topical Cream, Apply to affected area BID
- CETIRIZINE HCL (CETIRIZINE ORAL), once daily
- ERGOCALCIFEROL, VITAMIN D2, (VITAMIN D ORAL), 2000mg ___
Discharge Medications:
1. Amlodipine 10 mg PO DAILY
2. Atenolol 100 mg PO DAILY
3. Glargine 56 Units Breakfast
Insulin SC Sliding Scale using HUM Insulin
4. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES HS
5. Losartan Potassium 50 mg PO DAILY
6. TraMADOL (Ultram) 50-100 mg PO Q4H:PRN pain
7. Tamsulosin 0.4 mg PO HS
RX *tamsulosin 0.4 mg 1 capsule(s) by mouth at bedtime Disp #*30
Capsule Refills:*0
8. Aspirin 81 mg PO DAILY
9. Cetirizine 10 mg PO DAILY
10. Leucovorin Calcium 15 mg PO 1X/WEEK (MO)
11. MetFORMIN (Glucophage) 1000 mg PO BID
12. Methotrexate 15 mg SC 1X/WEEK (MO)
13. Triamcinolone Acetonide 0.1% Cream 1 Appl TP BID
14. trospium 20 mg oral Daily
15. Vitamin D ___ UNIT PO DAILY
16. Amoxicillin-Clavulanic Acid ___ mg PO ONCE Duration: 1 Dose
please take in the morning of ___ (on the day of stent
removal)
RX *amoxicillin-pot clavulanate 875 mg-125 mg 1 Tabket by mouth
ONCE Disp #*1 Tablet Refills:*0
Discharge Disposition:
Home
Discharge Diagnosis:
Nephrolithiasis
Acute kidney injury
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
It was a pleasure looking after you, Ms. ___. As you
know, you were admitted with abdominal, right flank pain and was
found to have an obstructing kidney stone. This stone was
removed by lithotripsy and a stent was placed in the ureter.
You should follow up with urology to have stent removed on
___. Please take a single dose of augmentin
(antibiotic to be used instead of cipro - due to your allergy)
on the morning of the ___, the day of the stent removal. (see
prescription). Please continue with the flomax (tamsulosin)
while the stent is in place.
If you have any concerns about your recent procedure or
questions about the stent, feel free to call Dr. ___
office (___).
Followup Instructions:
___
|
10806596-DS-8
| 10,806,596 | 28,761,867 |
DS
| 8 |
2163-09-30 00:00:00
|
2163-09-30 13:42:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: ORTHOPAEDICS
Allergies:
Sulfa (Sulfonamide Antibiotics)
Attending: ___.
Chief Complaint:
Left pilon fracture
Major Surgical or Invasive Procedure:
External fixator to left ankle
History of Present Illness:
___ female presents with the above fracture s/p mechanical
fall down stairs. She had pain in the left ankle, inability to
bear weight, and deformity. She went to ___ and was
transferred
to ___.
Past Medical History:
Hx of breast cancer s/p mastectomy
RA
Anxiety
S/p L THA
Social History:
___
Family History:
NC
Physical Exam:
Gen: middle-aged female in no acute distress
Neuro: alert and interactive
CV: palpable DP pulses bilaterally
Pulm: no respiratory distress on room air
LLE: in ankle external fixator, SILT: ___, fires
___, pins sites without erythema or drainage
Pertinent Results:
NONE
Brief Hospital Course:
The patient presented to the emergency department and was
evaluated by the orthopedic surgery team. The patient was found
to have left pilon fracture and was admitted to the orthopedic
surgery service. The patient was taken to the operating room on
___ for external fixation left pilon fracture which the
patient tolerated well. For full details of the procedure please
see the separately dictated operative report. The patient was
taken from the OR to the PACU in stable condition and after
satisfactory recovery from anesthesia was transferred to the
floor. The patient was initially given IV fluids and IV pain
medications, and progressed to a regular diet and oral
medications by POD#1. The patient was given ___
antibiotics and anticoagulation per routine. The patient's home
medications were continued throughout this hospitalization. The
patient worked with ___ who determined that discharge to home was
appropriate. The ___ hospital course was otherwise
unremarkable.
At the time of discharge the patient's pain was well controlled
with oral medications, incisions were clean/dry/intact, and the
patient was voiding/moving bowels spontaneously. The patient is
non-weight-bearing in the left lower extremity, and will be
discharged on lovenox for DVT prophylaxis. The patient will
follow up with Dr. ___ routine. A thorough discussion
was had with the patient regarding the diagnosis and expected
post-discharge course including reasons to call the office or
return to the hospital, and all questions were answered. The
patient was also given written instructions concerning
precautionary instructions and the appropriate follow-up care.
The patient expressed readiness for discharge.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Anastrozole 1 mg PO DAILY
2. LORazepam 0.5 mg PO Q4H:PRN anxiety
Discharge Medications:
1. Acetaminophen 650 mg PO Q6H
2. Docusate Sodium 100 mg PO BID
RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth every
12 hours as needed for constipation Disp #*20 Capsule Refills:*0
3. Enoxaparin Sodium 40 mg SC Q24H
RX *enoxaparin 40 mg/0.4 mL 40 mg subcutaneous daily Disp #*14
Syringe Refills:*0
4. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain -
Moderate
RX *oxycodone 5 mg ___ tablet(s) by mouth every ___ hours as
needed for pain Disp #*50 Tablet Refills:*0
5. Senna 8.6 mg PO QHS
RX *sennosides [senna] 8.6 mg 1 tablet by mouth nightly as
needed for constipation Disp #*20 Tablet Refills:*0
6. Anastrozole 1 mg PO DAILY
7. LORazepam 0.5 mg PO Q4H:PRN anxiety
8.Crutches
Diagnosis: left pilon fracture
Length of Need: 13 months
Prognosis: good
Discharge Disposition:
Home With Service
Facility:
___
___:
Left pilon fracture
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY:
- You were in the hospital for orthopedic surgery. It is normal
to feel tired or "washed out" after surgery, and this feeling
should improve over the first few days to week.
- Resume your regular activities as tolerated, but please follow
your weight bearing precautions strictly at all times.
ACTIVITY AND WEIGHT BEARING:
- non-weight-bearing left lower extremity
MEDICATIONS:
- Please take all medications as prescribed by your physicians
at discharge.
- Continue all home medications unless specifically instructed
to stop by your surgeon.
- Do not drink alcohol, drive a motor vehicle, or operate
machinery while taking narcotic pain relievers.
- Narcotic pain relievers can cause constipation, so you should
drink eight 8oz glasses of water daily and take a stool softener
(colace) to prevent this side effect.
ANTICOAGULATION:
- Please take lovenox daily for 2 weeks
WOUND CARE:
- You may shower. No baths or swimming for at least 4 weeks.
- Any stitches or staples that need to be removed will be taken
out at your 2-week follow up appointment.
- Please remain in your dressing and do not change unless it is
visibly soaked or falling off.
- Splint must be left on until follow up appointment unless
otherwise instructed
- Do NOT get splint wet
Followup Instructions:
___
|
10806634-DS-20
| 10,806,634 | 26,948,347 |
DS
| 20 |
2130-07-15 00:00:00
|
2130-07-15 19:21:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Pravachol
Attending: ___.
Chief Complaint:
Chest pain
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ pt with past history of CAD (has never had stents), Htn who
presents with CP. She has a history of "chest heaviness" on
exertion for years. She will walk, feel CP, stop and sit and the
pain improved and then she walks and feels the pain again. Last
night she wasnt feeling right while laying in bed, denies CP but
didnt feel quite right and then today felt chest heaviness when
laying in bed.
Her children told her to come to the hospital.
Per report she had a positive stress echo in ___ (ST
depressions with WMA) and declined cath at that time.
Vitals in ED were 99.6 63 200/89 20 99%
Labs significant for Na 136, BUN/Cr 95/0.8, H&H 13.8/40.2, WBC
6.1 without left shift. INR 0.9, Troponin T <0.01. Pt took 81mg
ASAx2 at home then x2 again in ED.
Exam was significant for no chest pain, no respiratory distress,
regular HR. CXR was negative for acute cardiopulm process.
EKG showed NSR with <1mm STE in inferior leads, TWI in V2-V6. VS
Pt was given ASA
on xfer to the floor were: 98.3 56 141/85 16 99% RA
.
On arrival to the floor she is chest pain free and feels well.
She made it clear she does not want any invasive procedures,
that she would be ok with medication as treatment only.
Past Medical History:
- CAD (positive stress echo ___ w/ ___epressions and WMA, but patient refuses cardiac
catheterization)
- HTN
- HLD
- GERD
- Anxiety
- Vitamin D deficiency
- Macular degeneration c/b legal blindness R eye
Social History:
___
Family History:
Noncontributory
Physical Exam:
ADMISSION:
VS:50 kg 187/74 50 100%RA
GENERAL: NAD, AxOx3.
HEENT: no elev JVP. PERRL, EOMI. MMM
CARDIAC: bradycardic, no murmur
LUNGS: Resp were unlabored, no accessory muscle use. CTAB, no
crackles, wheezes or rhonchi.
ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not
enlarged by palpation.
EXTREMITIES: trace edema lower ext.
DISCHARGE:
VS: 97.5 141/58 52 18 100%RA
Wt: 50.7KG
GENERAL: NAD, AxOx3.
HEENT: no elev JVP. PERRL, EOMI. MMM
CARDIAC: bradycardic, no murmur
LUNGS: Resp were unlabored, no accessory muscle use. CTAB, no
crackles, wheezes or rhonchi.
ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not
enlarged by palpation.
EXTREMITIES: no edema lower ext.
Pertinent Results:
ADMISSION LABS:
___ 02:55PM BLOOD WBC-6.1 RBC-4.43 Hgb-13.8 Hct-40.2 MCV-91
MCH-31.3 MCHC-34.4 RDW-12.8 Plt ___
___ 02:55PM BLOOD Neuts-55.7 ___ Monos-9.2 Eos-4.7*
Baso-1.0
___ 02:55PM BLOOD Glucose-95 UreaN-20 Creat-0.8 Na-136
K-4.0 Cl-104 HCO3-22 AnGap-14
___ 03:10PM BLOOD cTropnT-<0.01
TREND LABS:
___ 03:10PM BLOOD cTropnT-<0.01
___ 01:12AM BLOOD CK-MB-2 cTropnT-<0.01
___ 06:40AM BLOOD CK-MB-2 cTropnT-<0.01
DISCHARGE LABS:
___ 06:40AM BLOOD WBC-6.3 RBC-4.16* Hgb-12.5 Hct-38.6
MCV-93 MCH-30.0 MCHC-32.4 RDW-13.1 Plt ___
___ 06:40AM BLOOD Glucose-86 UreaN-19 Creat-0.8 Na-141
K-4.3 Cl-107 HCO3-24 AnGap-14
___ 06:40AM BLOOD Calcium-8.9 Phos-3.8 Mg-2.1
___ 06:40AM BLOOD CK-MB-2 cTropnT-<0.01
CXR ___:
No acute cardiopulmonary process. COPD.
Brief Hospital Course:
___ woman with known CAD presented with worsening chest pain
concerning for unstable angina.
ACTIVE ISSUES:
# Chest pain: EKG showed T-wave inversions in anterior and
lateral leads. No prior EKG here for comparison. Cardiac enzymes
negative x 3. Patient is not interested in aggresive care such
as PCI, so managed medically. Started isosorbide mononitrate to
optimize medical management. Continued home ASA 81mg,
metoprolol, losartan. Given her documented allergies to statins
held off on starting any statin.
CHRONIC ISSUES:
# HTN: Initial SBP 200s in ED, down to SBP 120-140 on the floor.
Continued home metoprolol, losartan, started imdur as above.
# HLD: Continued home ezetimibe.
# GERD: Continued lansoprazole.
# Anxiety: Continued home citalopram.
TRANSITIONAL ISSUES:
- consider statin (pt has documented allergy to pravachol, may
tolerate another statin).
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY
2. Citalopram 10 mg PO DAILY
3. Losartan Potassium 100 mg PO DAILY
4. Metoprolol Succinate XL 25 mg PO DAILY
5. lansoprazole 15 mg oral daily
6. Phenazopyridine 100 mg PO DAILY
7. Ezetimibe 10 mg PO DAILY
8. Ocuvite (vit C-vit E-lutein-min-om-3) 150-30-5-150
mg-unit-mg-mg oral daily
9. Multivitamins 1 TAB PO DAILY
Discharge Medications:
1. Aspirin 81 mg PO DAILY
2. Citalopram 10 mg PO DAILY
3. Ezetimibe 10 mg PO DAILY
4. Losartan Potassium 100 mg PO DAILY
5. Multivitamins 1 TAB PO DAILY
6. Ocuvite (vit C-vit E-lutein-min-om-3) 150-30-5-150
mg-unit-mg-mg oral daily
7. Phenazopyridine 100 mg PO DAILY
8. Lansoprazole 15 mg ORAL DAILY
9. Isosorbide Mononitrate 20 mg PO BID
RX *isosorbide mononitrate 20 mg 1 (One) tablet(s) by mouth
twice a day Disp #*60 Tablet Refills:*0
10. Metoprolol Succinate XL 25 mg PO DAILY
Discharge Disposition:
Home
Discharge Diagnosis:
Chest pain
Unstable angina
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Ms. ___,
It was a pleasure participating in your care at ___. You were
admitted to the hospital with chest pain, which resolved on its
own. We have added a new medication to help with your recurrent
chest pain (see list below). Please continue taking all of your
other medications as you have been. Please follow up with your
primary care Dr. ___ in the next week.
Followup Instructions:
___
|
10806859-DS-19
| 10,806,859 | 25,336,602 |
DS
| 19 |
2119-05-28 00:00:00
|
2119-05-30 11:06:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Worsening left testicular pain and swelling
Major Surgical or Invasive Procedure:
___ drainage of hydrocele ___
History of Present Illness:
Mr. ___ is a ___ yo male with h/o HFrEF, CAD s/p CABG, CKD,
BPH, and urinary retention requiring chronic intermittent
catheterization last seen on ___ for L epididymo-orchitis who
presents with progressive L testicular pain and swelling. He
was seen in the ED on ___ and a scrotal ultrasound showed
left epididymal orchitis with a reactive, possibly complex
hydrocele. Urine culture negative at the time. He was started
on a course of ciprofloxacin, which he has been compliant with.
He was seend by Dr. ___ urologist, for increasing scrotal
swelling and tightness on ___, and his cipro course was
extended. Today, patient returns to the ED with progressively
worsening pain that increases with movement, cramps through the
groin, and swelling of the scrotum. He also states that over the
last week he has had chills during the night, but no frank
fevers. He denies any recent right testicular pain or swelling.
No recent sexual contacts. Pt. has been sexually active with
his wife only ___. No h/o STIs and his wife has not had any
STIs either. No dysuria (straight caths), but pt. does endorse
a episode of thick white penile discharge several weeks that
spontaneously resolved and has not reoccurred.
In the ED, initial vitals: 98.2 67 110/64 18 100% RA
- Exam notable for: large firm left testicle without substantial
ttp
- Labs notable for: WBC 13.9 (83%N), Cr 1.4 (baseline), lactate
1.5. UA clear.
- Imaging notable for: Scrotal U/S with right testicular torsion
with features of necrosis and persistent left epididymorchitis,
complex, septated left hydrocele.
- Pt given: 400mg IV cipro
- Vitals prior to transfer: 98.1 69 118/60 18 99% RA
ROS:
No fevers or weight changes. No nausea or vomiting. He endorses
chronic constipation. No dysuria or hematuria.
Past Medical History:
Congestive Heart Failure (LVEF 34% ___ ischemic CM)
CAD s/p 4 vessel CABG (___)
HTN
HLD
Chronic Kidney Disease (not endorsed by pt, but noted on review
of OMR labs; baseline Cr 1.6-1.7; unclear etiology)
Abdominal Aortic Aneurism (max diameter 3.2cm)
Neurogenic Bladder (started after lumbar laminectomy; managed
with intermittent self catheterizations)
Constipation (started after lumbar laminectomy)
BPH
Spinal Stenosis
Lumbar laminectomy (___)
Social History:
___
Family History:
Mother - died age ___ of ___
Father - died age ___ of prostate cancer
Significant coronary disease in his family.
Physical Exam:
EXAM ON ADMISSION:
Vitals- Tc 97.1 BP 135/60 HR 76 RR 18 O2 99%RA
wt 72.2kg
General- pleasant and alert, lying in bed no acute distress
HEENT- Sclerae anicteric, MMM
Neck- supple
Lungs- CTAB no wheezes, rales, rhonchi
CV- RRR, Nl S1 and S2, III/VI holosystolic murmur
Abdomen- soft, NT/ND bowel sounds present, no rebound tenderness
or guarding, no organomegaly
Back- no CVA tenderness, well-healed scar over central mid-back
from laminectomy
Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
Neuro- CNs2-12 intact, motor function grossly normal
GU-
Scrotum: significantly swollen and indurated L scrotum, TTP; no
R scrotum TTP, no R scrotal swelling; No redness, skin intact
Penis: no penile discharge, no skin lesions
EXAM ON DISCHARGE:
Vitals- Tm 100.9 Tc 98.2 BP 110-139/56-94 HR ___ RR 18
O2 100%RA
A and O x3. Remainder of exam unchanged.
Pertinent Results:
==================LABS ON ADMISSION=====================
___ 08:55AM BLOOD WBC-13.9* RBC-2.74* Hgb-8.0* Hct-24.5*
MCV-89 MCH-29.2 MCHC-32.7 RDW-14.8 RDWSD-48.4* Plt ___
___ 08:55AM BLOOD Neuts-83.4* Lymphs-7.5* Monos-7.7
Eos-0.6* Baso-0.2 Im ___ AbsNeut-11.57* AbsLymp-1.04*
AbsMono-1.07* AbsEos-0.09 AbsBaso-0.03
___ 08:55AM BLOOD Glucose-93 UreaN-24* Creat-1.4* Na-140
K-4.4 Cl-103 HCO3-23 AnGap-18
___ 07:13AM BLOOD Calcium-9.1 Phos-4.2 Mg-2.0
___ 09:03AM BLOOD Lactate-1.5
___ 12:00PM URINE Color-Straw Appear-Clear Sp ___
___ 12:00PM URINE Blood-NEG Nitrite-NEG Protein-NEG
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG
=================LABS ON DISCHARGE======================
___ 07:00AM BLOOD WBC-7.9 RBC-2.76* Hgb-7.8* Hct-24.1*
MCV-87 MCH-28.3 MCHC-32.4 RDW-14.0 RDWSD-44.5 Plt ___
___ 07:00AM BLOOD Glucose-96 UreaN-15 Creat-1.2 Na-138
K-4.3 Cl-100 HCO3-23 AnGap-19
___ 07:00AM BLOOD Calcium-8.9 Phos-4.3 Mg-2.2
===================IMAGING===============================
PRIOR Scrotal US ___
1. Left epididymo-orchitis.
2. Equivocally increased vascularity within the right testicle,
most likely reactive.
3. Complex bilateral hydroceles, highly septated on the left,
and may
represent a pyocele.
Scrotal US ___
1. Findings compatible with missed right testicular torsion
with features of necrosis.
2. Persistent left epididymorchitis, complex, septated left
hydrocele.
Pyocele is not excluded.
Scrotal US ___
Right testicular torsion with necrosis and early liquefaction.
Left testicular epididymo- orchitis with associated pyocele.
Ultrasound-guided L Hydrocele Drainage ___
FINDINGS:
Left scrotal multi-septated extratesticular fluid collection,
suggestive
underlying pyocele. Torsed/necrotic right testicle. Please refer
to ultrasound performed ___ for more detail.
IMPRESSION: Successful US-guided drainage of a suspected left
scrotal pyocele.
CXR ___
Comparison with the study ___, there is little change.
Again there isenlargement of the cardiac silhouette with
tortuosity of the aorta. However,no evidence of acute
pneumonia, vascular congestion, or pleural effusion.
=====================OTHER RESULTS======================
URINE CULTURE (Final ___: NO GROWTH.
**FINAL REPORT ___
Chlamydia trachomatis, Nucleic Acid Probe, with Amplification
(Final
___:
Negative for Chlamydia trachomatis by PANTHER System,
APTIMA COMBO 2
Assay.
Validated for use on Urine Samples by the ___
Microbiology
Laboratory. Performance characteristics on urine samples
were found
to be equivalent to those of FDA- approved TIGRIS APTIMA
COMBO 2
and/or COBAS Amplicor methods.
NEISSERIA GONORRHOEAE (GC), NUCLEIC ACID PROBE, WITH
AMPLIFICATION
(Final ___:
Negative for Neisseria gonorrhoeae by PANTHER System,
APTIMA COMBO 2
Assay.
Validated for use on Urine Samples by the ___
Microbiology
Laboratory. Performance characteristics on urine samples
were found
to be equivalent to those of FDA- approved TIGRIS APTIMA
COMBO 2
and/or COBAS Amplicor methods.
GRAM STAIN (Final ___:
2+ ___ per 1000X FIELD): POLYMORPHONUCLEAR
LEUKOCYTES.
NO MICROORGANISMS SEEN.
This is a concentrated smear made by cytospin method,
please refer to
hematology for a quantitative white blood cell count..
FLUID CULTURE (Final ___: NO GROWTH.
ANAEROBIC CULTURE (Preliminary): NO GROWTH.
URINE CULTURE (Final ___: NO GROWTH.
Blood Culture, Routine (Final ___: NO GROWTH.
Brief Hospital Course:
___ with h/o CHF, CAD s/p CABG, CKD, BPH, and urinary
retention requiring chronic intermittent catherizations last
seen on ___ for L epididymo-orchitis presents with progressive
L testicular pain and swelling and found on scrotal US to have
persistent L epididymo-orchitis in addition to new R testicular
torsion w/ necrosis.
#Left epididymo-orchitis
The patient was started on ciprofloxacin by his outpatient
urologist on ___. He presented on ___ to ___ for
increased tenderness and swelling. A scrotal ultrasound showed
persistent left epididymo-orchitis, with complex, septated left
hydrocele c/f possible pyocele. ___ guided biopsy of L
testicular fluid collection was c/w hydrocele (WBCs 33, fluid
culture negative). Urine chlamydia and gonorrhea negative. Given
that he was not improving clinical with cipro and continued to
have leukocytosis and fevers, he was transitioned to
amp-sulbactam IV on ___. His fevers decreased and WBC started
to decline. His physical exam and symptoms, however, remained
unchanged. We suspect this represents chronic
epididymo-orchitis. Urology was involved and deferred any
surgical intervention given high risk of total loss of left
testicle. He was transitioned to amox-clav at discharge for
prolonged antibiotic course of 4 weeks. He was encouraged to
continue wearing supportive underwear as well as icing and
elevating the scrotum as much as possible.
# Right testicular torsion with necrosis
The patient was asymptomatic and his right testicle nontender on
exam. It is unclear how long he has had torsion, but given that
he remained asymptomatic, surgery was deferred.
# Transitional Issue
- ABX: Augmentin 875mg twice a day ___ for 4 week course)
- CONTACT: ___ (daughter) ___
- CODE STATUS: Full
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Atorvastatin 40 mg PO QPM
2. Carvedilol 25 mg PO BID
3. Ciprofloxacin HCl 500 mg PO Q12H
4. Furosemide 20 mg PO BID
5. Ramipril 10 mg PO DAILY
6. Tamsulosin 0.4 mg PO DAILY
7. Acetaminophen 325-650 mg PO Q6H:PRN pain
8. Aspirin 81 mg PO DAILY
9. Docusate Sodium 100 mg PO BID
10. Milk of Magnesia ___ mL PO DAILY
11. Senna 8.6 mg PO BID
Discharge Medications:
1. Acetaminophen 325-650 mg PO Q6H:PRN pain
2. Aspirin 81 mg PO DAILY
3. Atorvastatin 40 mg PO QPM
4. Carvedilol 25 mg PO BID
5. Docusate Sodium 100 mg PO BID
6. Furosemide 20 mg PO BID
7. Milk of Magnesia ___ mL PO DAILY
8. Ramipril 10 mg PO DAILY
9. Senna 8.6 mg PO BID
10. Tamsulosin 0.4 mg PO DAILY
11. Amoxicillin-Clavulanic Acid ___ mg PO Q12H
Please continue until ___.
RX *amoxicillin-pot clavulanate 875 mg-125 mg 1 tablet by mouth
twice daily Disp #*50 Tablet Refills:*0
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
Primary:
Left epididymo-orchitis
Right testicular torsion with necrosis and liquefaction
Secondary:
Heart failure with reduced ejection fraction
Coronary artery disease
Benign prostatic hypertrophy
Urinary retention requiring intermittent catheterization
Constipation
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Dear Mr. ___,
You were admitted to the ___ for worsening left
testicular swelling and pain despite having been on antibiotics
since ___. We think that this swelling is likely due to an
infection. We drained some of the fluid from your scrotum, and
the fluid looked clear and did not look like pus. Based on this
information, your urologist, Dr. ___ not want to proceed
with surgery at this time, given that you have an active
infection and the increased risk of spreading the infection to
the other testicle. You received antibiotics while here, and you
should continue taking the antibiotics until ___.
In addition, we performed an ultrasound of your scrotum, and we
found that there is dead tissue in your right testicle. You did
not have any pain on that side, and Dr. ___ that we
leave it alone.
It was a pleasure taking care of you. We wish you all the best.
Sincerely,
Your ___ Medicine Team
Followup Instructions:
___
|
10807041-DS-8
| 10,807,041 | 24,636,815 |
DS
| 8 |
2161-10-14 00:00:00
|
2161-10-15 07:09:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
carbidopa / carbidopa / levodopa
Attending: ___.
Chief Complaint:
fall, subdural hematoma
Major Surgical or Invasive Procedure:
None
History of Present Illness:
Mr. ___ is a ___ y/o male with a history of ___
disease w/ ___ body dementia (poor baseline mental status),
HTN,
and depression who presents s/p a fall at home, transferred from
___ for subdural hematomas.
History obtained from ___. Patient unable to provide history and
family not available/reachable by phone.
The patient sustained an unwitnessed fall on ___ with his home
health aide and wife nearby. He had a presumed headstrike given
a
new laceration, though unclear if he had LOC. Of note, the
patient has had multiple falls over the past few years and noted
by his family to have a decline in functional status over the
last couple of months. Per other notes, he has been more
confused, fatigued and difficult to arouse in the mornings.
He initially presented to ___ where vitals were
notable
for BP 220/110, HR 70, 95% on RA. He had an eyebrow laceration
that was sutured. Labs were notable for WBC 7.3, H/H 12.6/37.8,
plt 159. CT scan showed bilateral subdural hematomas, prompting
transfer to ___ for neurosurgical evaluation. His aspirin was
held and he was given IV metoprolol and labetalolol for BP
control prior to transfer.
In the ED, initial vitals: Temp ___ BP 189/96 HR 70 RR 17 100%
on RA
Exam notable for: None documented
Labs notable for: Na 139, BUN/Cr ___, WBC 9.3, H/H
12.6/38.4,
plt 163, INR 1.1, VBG 7.41/52
Imaging notable for:
- CXR: No focal consolidation, pleural effusion or pneumothorax.
Pt given: IM olanzapine 2.5 mg x4, IV keppra 500mg x2, PR
acetaminophen, 1L NS
Consults:
- Trauma surgery: repeat head CT given somnolence, trauma
surgery
will perform tertiary survey
- Neurosurgery: No neurosurgical intervention recommended. Goal
BP <160, hold aspirin, Keppra 500mg BID x 7 days for seizure ppx
Vitals prior to transfer: Temp 98.2 BP 136/91 HR 62 RR 16 94%
on
RA
Upon arrival to the floor, the patient is unable to provider
further history.
REVIEW OF SYSTEMS:
Unable to obtain ___ mental status
Past Medical History:
Hypertension
___ disease
Transient ischemic attack (___)
Hallucintations
Depression
OSA
Prostate cancer s/p prostatectomy
Tonsillectomy
Appendectomy
Hernia repair
Knee surgery
Social History:
___
Family History:
Non-contributory.
Physical Exam:
ADMISSION PHYSICAL EXAM:
========================
VITALS: Temp ___ BP 180/82 HR 76 RR 23 99% on 2L NC
GENERAL: Elderly male in NAD. Lying comfortably in bed. Eyes
closed for exam. Mumbling, minimal communication.
HEENT: Laceration over right eyebrown, periorbital ecchymosis on
the right. MMM.
CV: RRR with normal S1/S2, no murmurs, gallops, or rubs
PULM: Normal respiratory effort. CTAB over anterior chest
without
wheezes, rales or rhonchi.
GI: Soft, NT/ND, normaoctive BS. No guarding or masses.
EXTREMITIES: Warm, well perfused. No ___ edema or erythema.
NEURO: Eyes closed, responds to voice. Left pupil 1-2mm,
minimally reactive. Cannot open right ___ pain. Moves all
extremities. Unable to participate further in the exam.
DISCHARGE PHYSICAL EXAM:
========================
VITALS: 24 HR Data (last updated ___ @ 512)
Temp: 98.9 (Tm 98.9), BP: 170/80 (___), HR: 81
(81-171), RR: 20 (___), O2 sat: 81% (81-95)
GENERAL: Elderly male in NAD. Sleeping and not responding to
voice.
HEENT: periorbital ecchymosis which is resolving on the right.
MMM.
PULM: Normal respiratory effort. Unable to auscultate posterior
lung fields
GI: Soft, NT/ND. No grimacing to palpation.
EXTREMITIES: Warm, well perfused.
NEURO: Sleepy and not rousable to voice.
Pertinent Results:
ADMISSION LABS:
===============
___ 10:00AM BLOOD WBC-9.3 RBC-4.11* Hgb-12.6* Hct-38.4*
MCV-93 MCH-30.7 MCHC-32.8 RDW-13.6 RDWSD-46.3 Plt ___
___ 10:00AM BLOOD Neuts-70.6 Lymphs-16.9* Monos-9.1 Eos-2.7
Baso-0.3 Im ___ AbsNeut-6.57* AbsLymp-1.57 AbsMono-0.85*
AbsEos-0.25 AbsBaso-0.03
___ 10:00AM BLOOD ___ PTT-25.4 ___
___ 10:00AM BLOOD Glucose-93 UreaN-23* Creat-0.9 Na-139
K-3.9 Cl-96 HCO3-28 AnGap-15
___ 10:15AM BLOOD ___ pO2-30* pCO2-52* pH-7.41
calTCO2-34* Base XS-5
___ 10:15AM BLOOD O2 Sat-48
MICROBIOLOGY:
=============
__________________________________________________________
___ 7:35 pm BLOOD CULTURE 2 OF 2.
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 10:54 am BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 8:17 am BLOOD CULTURE 2 OF 2.
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 8:11 am BLOOD CULTURE 1 OF 2.
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
IMAGING/STUDIES:
================
CXR ___:
IMPRESSION:
Limited views of the lungs secondary to the patient position and
overlying
facial structures obscuring the lung apices. Within the limits
of the study,
no new focal consolidation. No pleural effusion. No large
pneumothorax.
CT Head ___:
IMPRESSION:
The study is substantially limited by motion artifact. No
significant change
of the Left frontal, right frontotemporal, and Left tentorial
extra-axial
hemorrhage - mostly subdural. No new bleed or rebleed, or
herniation
syndrome.
CXR ___:
IMPRESSION:
Increased prominence of the right infrahilar region could
represent crowding
of vessels, lymph nodes and possibly a pneumonia. If patient is
able to
tolerate, recommend lateral chest radiograph for further
evaluation.
___ - ___:
IMPRESSION:
No evidence of deep venous thrombosis in the left lower
extremity veins.
DISCHARGE LABS:
===============
___ 09:38AM BLOOD WBC-8.1 RBC-3.60* Hgb-11.1* Hct-34.5*
MCV-96 MCH-30.8 MCHC-32.2 RDW-14.4 RDWSD-49.7* Plt ___
___ 09:07AM BLOOD Glucose-83 UreaN-20 Creat-0.7 Na-146
K-3.4* Cl-109* HCO3-26 AnGap-11
___ 09:07AM BLOOD Calcium-8.3* Phos-3.4 Mg-1.8
Brief Hospital Course:
SUMMARY:
========
Mr. ___ is a ___ y/o male with a history ___ body
dementia (poor baseline mental status) c/b parkinsonism, HTN,
and depression who presents s/p a fall at home, transferred from
___ for subdural hematomas. Evalauted by neurosurgery
and ACS who opted for non-operative management. Started on
Keppra for a 7 day course for seizure prophylaxis. Patient was
encephalopathic on admission felt to be in the setting of his
bleeds and his baseline dementia. Made NPO including medications
and blood pressure initially managed with IV Hydralazine.
Patient was severely agitated on admission requiring wrist
restraints to prevent him from pulling at IV/telemetry. He
required Olanzipine for control of his agitation, and also
received IV acetaminophen and Dilaudid for pain control.
Throughout admission, pain and agitation improved and he no
longer required olanzapine or IV pain medication or narcotic
pain medication, no longer required soft wrist restraints or
mitts.
ACUTE ISSUES:
=============
#Goals of care
Given patient's complex medical situation and unclear goals of
care, a family meeting with all of patient's HCPs present
(primary and ___ alternates) was held. The family
requested to minimize interventions that could be contributing
to delirium. We discussed limiting time on IVs by trying to move
towards PO medications. We discussed the risks of moving toward
PO medications and liquids by mouth; specifically, the risk of
aspiration and potential for worsened hypertension without IV
medications. The family understood this risk and wished to
proceed with PO attempts. We discussed minimizing night time
interruptions by holding vital sign checks. We discussed that in
doing so, patient's BP may be high with no interventions
applied. We discussed the increase risk of elevated blood
pressures in patients with brain bleeds. The family understood
these risks and saw the benefit of minimizing interruptions. In
line with this, we held vital signs overnight. We discussed
nutrition, with the family stating that food is a pleasure to
the patient and that food by mouth was their preference with the
understanding of risk. They did not wish to proceed with a
feeding tube after weighing the risks and benefits. The patient
remains DNR/DNI - family ideally would like patient to undergo
trial of rehab to see how he is able to progress, but may
ultimately elect to pursue hospice care for the patient. In line
with ultimate goal of outpatient care facility, the patient was
transitioned to a PO medication regimen. On day of discharge,
patient was intermittently accepting PO nutrition and
medications.
#S/p fall
#Subdural hematomas
#Facial laceration s/p repair
The patient sustained an unwitnessed fall, likely with
headstrike given new laceration, unknown if had LOC. Work up
notable for bilateral subdural hematomas. Evaluated by
neurosurgery who recommended monitoring, particularly given
stable imaging from OSH to here. Mental status had been
declining recently per family. Patient was acutely agitated on
admission felt to be in the setting of delirium, his bleeds, and
baseline dementia. He was placed in wrist restraints and mitts
to prevent pulling at IV and telemetry wires. Patient also
complained of pain, so standing IV acetaminophen was ordered and
supplemented with low dose IV dilaudid. He was started on Keppra
500mg IV BID for seizure ppx with plan to complete a 7 day
course. However, given concern that this was contributing to
patient agitation, he was transitioned to Depakote for both
seizure ppx and delirium, with neurosurgery approving the
transition. Prior to discharge patient was without need for
restraints for >24 hours.
#Recurrent falls
#Confusion, declining mental status
___ disease, ___ body dementia
Reportedly having worsening mental status and recurrent falls
recently at home. Most likely this represents progression of his
underlying ___ body dementia and associated parkinsonism.
Differential also included worsening mental status due to
chronic SDH in the setting of recurrent falls, medication
induced, or infection. Falls felt to be less likely due to
orthostasis, arrhythmia, or seizures. Rivastigmine was held
during this admission initially due to inability to take PO
medications. Rivastigmine was not reinitiated on discharge as
patient was unable to swallow capsules and capsules could not be
crushed. Could consider starting a rivastigmine patch moving
forward.
#Concern for dysphagia
Per family, patient had progressive difficulty communicating at
home, was nonverbal on admission but improved to occasional
coherent responses with mostly mumbling noises to questioning.
Speech and swallow evaluated the patient and felt he was unsafe
to take po , even medications, so home meds were initially held
with patient NPO. However, in line with family/___ meeting
detailed above, the patient was reinitiated on a full, thickened
liquid diet with PO medications crushed prior to discharge.
#Hypertension
Patient with autonomic instability ___ LBD w/ parkinsonism. On 3
antihypertensive medications at home with family reporting SBP
in 200's on regular basis. After ___, neurosurgery
recommendations for SBP<160. To this end, trialed IV medications
(hydral, enalaprilat) and TD Clonidine patch to control
pressures, with limited success. Patient reinitiated on home
medication PO losartan and started on PO labetolol/amlodipine
for additional control after PO medications reinitiated.
Intravenous antihypertensive medications were stopped > 24 hours
prior to discharge.
#Pneumonia
Given rising leukocytosis on ___ and worsening mental status,
infectious work up was repeated and notable for possible PNA.
Patient received 7 day course of CTX and doxy for PNA without
respiratory symptoms/increased O2 requirements.
#Flu exposure
Pt's roommate in the hospital was diagnosed with the flu (lab
confirmed) after having been in the same room with the patient
for several hours. As a result, the patient was started on flu
prophylaxis with Tamiflu (___1 ___.
#Hypokalemia
Recurrently hypokalemic, requiring frequent repletion throughout
admission. Started on standing 40 mEq potassium at discharge.
Will need to be closely followed after discharge for this.
#Hypernatremia
#Free water deficit
Patient was noted to have hypernatremia with free water deficits
calculated and repleted throughout his hosptialization. On day
of discharge this was improved without need for free water
deficit repletion for ~3 days.
#Prolonged QTc
Unclear chronicity/etiology, around 500 ms throughout most of
admission. Avoided medications with QT-prolonging effect.
#Normocytic anemia
Mild anemia, unknown baseline. Low concern for other sources
ofbleeding.
#Hypercarbia
Noted on admission. No known pulmonary disease and lungs CTAB
over anterior chest.
Felt to be possibly secondary to poor mental status. Improved on
subsequent VBG.
#Depression
Held home citalopram in setting of prolonged QTc on admission.
TRANSITIONAL ISSUES:
====================
[] Patient's home metoprolol and HCTZ were held. Home losartan
was initiated prior to discharge. Labetolol, amlodipine,
Clonidine initiated. BP regimen should be monitored as
outpatient.
[] Patient's citalopram held given long QTc. An alternative
agent may be appropriate to initiate in the outpatient setting.
[] Patient's aspirin held indefinitely given brain bleed.
[] Patient's tamsulosin, vitamin D, omeprazole held given desire
to decrease number of PO medications. If patient's PO abilities
improve, these medications could be reinitiated.
[] Patient discharged on 40 mEq oral potassium daily - recommend
checking BMP ___ times/week and adjusting standing potassium as
necessary.
[] Patient with dysphagia; however, taking PO medications and
limited liquids as patient is able per family's wishes. Should
monitor respiratory status as increased risk for aspiration.
#CONTACTS:
HCP: ___ (wife), ___ ___, ___
___ Alt HCP: ___ (son), ___
___, ___, cell 9, ___, cell ___
#CODE STATUS: DNR/DNI, confirmed, MOLST signed on ___
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY
2. Vitamin D ___ UNIT PO DAILY
3. Citalopram 40 mg PO DAILY
4. Hydrochlorothiazide 25 mg PO DAILY
5. Losartan Potassium 100 mg PO DAILY
6. Metoprolol Succinate XL 50 mg PO DAILY
7. rivastigmine tartrate 4.5 mg oral BREAKFAST
8. Tamsulosin 0.4 mg PO QHS
9. TraZODone 25 mg PO QHS
10. rivastigmine tartrate 4.5 mg oral DINNER
11. Omeprazole 20 mg PO DAILY
12. Artificial Tears GEL 1% 1 DROP BOTH EYES Q6H
13. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS
Discharge Medications:
1. amLODIPine 10 mg PO DAILY
2. Bisacodyl ___AILY:PRN Constipation - Second Line
3. Clonidine Patch 0.2 mg/24 hr 1 PTCH TD QFRI
4. Divalproex Sod. Sprinkles 250 mg PO QHS
5. Labetalol 200 mg PO BID
6. OSELTAMivir 30 mg PO DAILY Duration: 9 Days
Last day ___.
7. Potassium Citrate 40 mEq PO DAILY
Hold for K > 4.5
8. Artificial Tears GEL 1% 1 DROP BOTH EYES Q6H
9. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS
10. Losartan Potassium 100 mg PO DAILY
11. rivastigmine tartrate 4.5 mg oral BREAKFAST
12. rivastigmine tartrate 4.5 mg oral DINNER
13. TraZODone 25 mg PO QHS
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
==================
Subdural Hematomas
Subarachnoid Hemorrhage
___ Body Dementia
Encephalopathy
Hypertension
Discharge Condition:
Mental Status: Confused - always.
Level of Consciousness: Lethargic but arousable.
Activity Status: Out of Bed with assistance to chair or
wheelchair.
Discharge Instructions:
Dear Mr. ___,
It was a pleasure caring for you at ___
___.
WHY WERE YOU IN THE HOSPITAL?
- You were admitted to the hospital because you had a fall at
home and were found to have bleeding around your brain
WHAT HAPPENED WHEN YOU WERE IN THE HOSPITAL?
-You were evalauted by our neurosurgeons who felt that
non-operative management was the best course of action for you.
Per your family, this is also in line with your desired care.
-We monitored you closely for signs of worsening bleeding. We
gave you medications through your IV when you were unable to
take medications by mouth.
-You were very confused because of your injury. Your confusion
made you agitated. We gave you medications to help with this and
minimized interventions that could be contributing with
improvement.
-We worked closely with your family to come up with a plan of
care that we felt would be most consistent with your goals to
promote quality of life going forward.
WHAT SHOULD YOU DO AFTER YOU LEAVE THE HOSPITAL?
- Continue to take all your medicines as prescribed below.
- Show up to your appointments as listed below.
We wish you the best!
Sincerely,
Your ___ Team
Followup Instructions:
___
|
10807423-DS-19
| 10,807,423 | 20,073,035 |
DS
| 19 |
2119-03-28 00:00:00
|
2119-03-28 18:03:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: ORTHOPAEDICS
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
R ankle fracture dislocation, open
Major Surgical or Invasive Procedure:
ORIF R ankle and I&D ___
History of Present Illness:
Chief Complaint: ankle pain
Reason for Orthopedics Consult: management of open fracture
HISTORY OF PRESENT ILLNESS:
Patient is a ___ yo male previously healhty presenting w/ fall
from 6 feet, from ladder. Patient landed on LLE w/ forced
eversion and subsequent open fracture/dislocation. Denies head
strike or LOC. Denies neck pain, back pain, chest pain, abd
pain. Denies pelvic or thigh pain.
Was emergently reduced in ED under conscious sedation.
In the ED, initial vitals were 77 160/60 16 100%. Per the ED,
the patient's exam did not show evidence of neurovascular
symptoms.
Review of systems:
(+) Per HPI
(-) Denies fever, chills, night sweats, recent weight loss or
gain. Denies headache, neck or back pain. Denies cough,
shortness of breath, chest pain. Denies nausea, vomiting,
diarrhea, abdominal pain, or changes in bowel habits. Denies
dysuria, frequency, or urgency.
PAST MEDICAL HISTORY:
none
MEDICATIONS:
none
ALLERGIES:
NKDA
SOCIAL HISTORY:
Denies alcohol, drugs, smoking
PHYSICAL EXAM:
GENERAL: Alert, oriented, no acute distress
HEENT: Sclera anicteric, MMM, oropharynx clear
NECK: C-spine is non-tender to palpation
LUNGS: Clear to auscultation bilaterally
CV: Regular rate and rhythm,
ABD: soft, non-tender, non-distended,
PELVIS: stable
EXT: open fracture/likely dislocation of LLE at level of distal
tibia. +DP. Unable to assess. Warm, well perfused, 2+ pulses,
no clubbing, cyanosis or edema. ___
Labs: pending
Images:
ASSESSMENT & PLAN:
___ yo male w/ type II open fracture/dislocation of distal
tib/fib.
1. Ancef 2g, tetanus
2. Imaging
3. Admit to ___ for surgical repair
4. Preop labs
Past Medical History:
none
Social History:
___
Family History:
not contributory
Physical Exam:
AFVSS
NAD
RLE:
dressing c/d/i
___ intact dp/t
___
Brief Hospital Course:
The patient presented to the emergency department and was
evaluated by the orthopedic surgery team. The patient was found
to have right ankle open fracture dislocation and was admitted
to the orthopedic surgery service. The patient was taken to the
operating room on ___ for R ankle I&D and ORIF, which the
patient tolerated well (for full details please see the
separately dictated operative report). The patient was taken
from the OR to the PACU in stable condition and after recovery
from anesthesia was transferred to the floor. The patient was
initially given IV fluids and IV pain medications, and
progressed to a regular diet and oral medications by POD#1. The
patient was given perioperative antibiotics and anticoagulation
per routine. The patients home medications were continued
throughout this hospitalization. The patient worked with ___ who
determined that discharge to home was appropriate. The ___
hospital course was otherwise unremarkable.
At the time of discharge the patient was afebrile with stable
vital signs that were within normal limits, pain was well
controlled with oral medications, incisions were
clean/dry/intact, and the patient was voiding/moving bowels
spontaneously. The patient is NWB in the right lower extremity,
and will be discharged on lovenox for DVT prophylaxis. The
patient will follow up in two weeks per routine. A thorough
discussion was had with the patient regarding the diagnosis and
expected post-discharge course, and all questions were answered
prior to discharge.
Medications on Admission:
none
Discharge Medications:
1. Acetaminophen 1000 mg PO Q8H
2. Docusate Sodium 100 mg PO BID
3. Enoxaparin Sodium 40 mg SC QHS
Start: Today - ___, First Dose: Next Routine Administration
Time
RX *enoxaparin 40 mg/0.4 mL 1 syringe at bedtime Disp #*14
Syringe Refills:*0
4. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain
RX *oxycodone 5 mg ___ tablet(s) by mouth q3hrs Disp #*80 Tablet
Refills:*0
Discharge Disposition:
Home
Discharge Diagnosis:
R ankle fracture dislocation
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
MEDICATIONS:
- Please take all medications as prescribed by your physicians
at discharge.
- Continue all home medications unless specifically instructed
to stop by your surgeon.
- Do not drink alcohol, drive a motor vehicle, or operate
machinery while taking narcotic pain relievers.
- Narcotic pain relievers can cause constipation, so you should
drink eight 8oz glasses of water daily and take a stool softener
(colace) to prevent this side effect.
ANTICOAGULATION:
- Please take lovenox 40mg daily for 2 weeks
WOUND CARE:
- No baths or swimming for at least 4 weeks.
- Any stitches or staples that need to be removed will be taken
out at your 2-week follow up appointment.
- No dressing is needed if wound continues to be non-draining.
- Splint must be left on until follow up appointment unless
otherwise instructed
- Do NOT get splint wet
ACTIVITY AND WEIGHT BEARING:
NWB R ankle
Danger Signs:
Please call your PCP or surgeon's office and/or return to the
emergency department if you experience any of the following:
- Increasing pain that is not controlled with pain medications
- Increasing redness, swelling, drainage, or other concerning
changes in your incision
- Persistent or increasing numbness, tingling, or loss of
sensation
- Fever > 101.4
- Shaking chills
- Chest pain
- Shortness of breath
- Nausea or vomiting with an inability to keep food, liquid,
medications down
- Any other medical concerns
Followup Instructions:
___
|
10807626-DS-3
| 10,807,626 | 24,488,240 |
DS
| 3 |
2175-07-06 00:00:00
|
2175-07-06 12:23:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: SURGERY
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Abdominal pain
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ presenting with 5 days of worsening abdominal pain, nausea,
vomiting and poor appetite. Pain is diffuse but more severe in
the right side of her abdomen. She is passing flatus and had a
small bowel movement ___ in the morning. Denies fevers, chest
pain, SOB, diarrhea.
Last colonoscopy was ___ years ago, normal per patient report.
Past Medical History:
Anemia
Aortic Stenosis
Atrial Fibrillation
Basal Cell Carcinoma
Chronic Obstructive Pulmonary Disease
Chronic Pain Syndrome
Colon and Rectal Cancer
Congestive Heart Failure
Coronary Artery Disease, history of PCI/stenting
Diabetes Mellitus
Fractures - Back, Rib, Wrist
Hyperlipidemia
Hypertension
Hypokalemia
Metabolic Syndrome
Morbid Obesity
Peripheral Vascular Disease
Pulmonary Hypertension
Right Foot Contusion
s/p colorectal surgery ___ for rectal CA
s/p appendectomy
s/p tonsillectomy
s/p basal cell excision
s/p cesarean section
Social History:
___
Family History:
Father - died in war at age ___
Mother - died at age ___
Sister - died of rheumatic disease and 3 heart surgeries.
Sister - died of ___ rupture
Physical Exam:
Admission
Physical Exam
T 97.5 HR 90 BP 111/58 RR 18 SatO2 94% RA
Alert and oriented
RRR
CTA bil
Abdomen is soft, tender to palpation on right side, distended
Extremities no edema
Discharge
Physical Exam
Vital Signs
T 97.8 HR 67 BP 110 / 60 RR 18 SatO2 97%RA
GEN: WD, WN in NAD
HEENT: NCAT, EOMI, anicteric
CV: RRR,
PULM: no respiratory distress
ABD: soft, NT, ND, no mass, no hernia
EXT: WWP, no CCE, no tenderness
NEURO: A&Ox3, no focal neurologic deficits
Pertinent Results:
___ 06:40AM BLOOD WBC-7.1 RBC-3.21* Hgb-9.8* Hct-32.2*
MCV-100* MCH-30.5 MCHC-30.4* RDW-14.9 RDWSD-55.6* Plt ___
___ 07:10AM BLOOD WBC-6.7 RBC-3.23* Hgb-10.0* Hct-32.1*
MCV-99* MCH-31.0 MCHC-31.2* RDW-14.8 RDWSD-54.6* Plt ___
___ 07:25AM BLOOD WBC-7.1 RBC-3.39* Hgb-10.5* Hct-33.5*
MCV-99* MCH-31.0 MCHC-31.3* RDW-14.8 RDWSD-53.8* Plt ___
___ 06:40AM BLOOD ___ PTT-32.5 ___
___ 07:10AM BLOOD ___
___ 07:25AM BLOOD ___ PTT-31.4 ___
___ 06:40AM BLOOD Glucose-103* UreaN-31* Creat-1.4* Na-143
K-4.4 Cl-108 HCO3-25 AnGap-10
___ 07:10AM BLOOD Glucose-113* UreaN-35* Creat-1.5* Na-142
K-4.5 Cl-106 HCO3-25 AnGap-11
___ 07:25AM BLOOD Glucose-94 UreaN-36* Creat-1.5* Na-143
K-4.7 Cl-109* HCO3-20* AnGap-14
___ 06:40AM BLOOD Calcium-8.1* Phos-3.1 Mg-1.8
___ 07:10AM BLOOD Calcium-8.1* Phos-3.5 Mg-2.1
___ 07:25AM BLOOD Calcium-8.3* Phos-3.4 Mg-2.6
CT Abd/pelvis OSH (Wet read by ___ Radiology)
- SBO, possible TP in distal jejunum (RLQ, below umbilicus)
- Chronic appearing R obstructing hydronephrosis
**FINAL REPORT ___
C. difficile DNA amplification assay (Final ___:
Reported to and read back by ___ @ 2238 ON
___ -
___.
CLOSTRIDIUM DIFFICILE.
Positive for toxigenic C difficile by the Cepheid
nucleic
amplification assay. (Reference
Range-Negative).
Brief Hospital Course:
Ms. ___ is a ___ year old female who presents with
obstructive symptoms for 5 days. CT from OSH shows proximal
dilated and distally decompressed bowel with no clear transition
point. The patient was admitted for non-operative management.
She was placed on bowel rest with IV fluids, nasogastric tube,
and serial abdominal exams. The patient was hemodynamically
stable.
Pain was well controlled. Diet was progressively advanced as
tolerated to a regular diet with good tolerability. The patient
voided without problem. She subsequently experienced increased
bowel movements and for this reason a C. difficile test was sent
and that returned positive. For this reason she was put on
vancomycin on the ___ for a ___uring this hospitalization, the patient ambulated early and
frequently, was adherent with respiratory toilet and incentive
spirometry, and actively participated in the plan of care. The
patient had venodyne boots were used during this stay. Her
warfarin was continued during this hospital course and the INR
was appropriately monitored. During this hospital course
physical therapy evaluated the patient and it was recommended as
Ms. ___ was discharged to rehabilitation.
At the time of discharge, the patient was doing well, afebrile
with stable vital signs. The patient was tolerating a regular
diet, ambulating, voiding without assistance, and pain was well
controlled. The patient received discharge teaching and
follow-up instructions with understanding verbalized and
agreement with the discharge plan.
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires
futher investigation.
1. Warfarin 4 mg PO DAILY16
2. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID
3. Aspirin 81 mg PO DAILY
4. Atorvastatin 40 mg PO QPM
5. Vitamin D 1000 UNIT PO DAILY
6. Furosemide 40 mg PO DAILY
7. MetFORMIN (Glucophage) 500 mg PO BID
8. Metoprolol Tartrate 50 mg PO TID
9. Ondansetron 4 mg PO Q8H:PRN nausea
Discharge Medications:
1. Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild
2. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain -
Moderate
Reason for PRN duplicate override: Alternating agents for
similar severity
RX *oxycodone 5 mg 1 tablet(s) by mouth every six (6) hours Disp
#*12 Tablet Refills:*0
3. Vancomycin Oral Liquid ___ mg PO Q6H Duration: 2 Weeks
RX *vancomycin 125 mg 1 capsule(s) by mouth every six (6) hours
Disp #*44 Capsule Refills:*0
4. Aspirin 81 mg PO DAILY
5. Atorvastatin 40 mg PO QPM
6. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID
7. Furosemide 40 mg PO DAILY
8. MetFORMIN (Glucophage) 500 mg PO BID
9. Metoprolol Tartrate 50 mg PO TID
10. Ondansetron 4 mg PO Q8H:PRN nausea
11. Vitamin D 1000 UNIT PO DAILY
12. Warfarin 4 mg PO DAILY16
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
Small bowel obstruction
Clostridium difficile infection
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Ms. ___,
You were admitted to the Acute Care Surgery Service on ___
with abdominal pain and found to have a bowel obstruction. You
were given bowel rest, IV fluids, and had a nasogastric tube to
help decompress your stomach. You had return of bowel function
and therefore the gastric tube was removed and your diet was
slowly advanced to regular. You were noted to be having a lot of
loose stools. A sample was sent to the lab and it tested
positive for clostridium difficile (c. diff). This is a
bacterial infection of the intestines that causes diarrhea.
You are now doing better, tolerating a regular diet, and ready
to be discharged to home to continue your recovery.
Please note the following discharge instructions:
Please call your doctor or nurse practitioner or return to the
Emergency Department for any of the following:
*You experience new chest pain, pressure, squeezing or
tightness.
*New or worsening cough, shortness of breath, or wheeze.
*If you are vomiting and cannot keep down fluids or your
medications.
*You are getting dehydrated due to continued vomiting, diarrhea,
or other reasons. Signs of dehydration include dry mouth, rapid
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a
bowel movement.
*You experience burning when you urinate, have blood in your
urine, or experience a discharge.
*Your pain in not improving within ___ hours or is not gone
within 24 hours. Call or return immediately if your pain is
getting worse or changes location or moving to your chest or
back.
*You have shaking chills, or fever greater than 101.5 degrees
Fahrenheit or 38 degrees Celsius.
*Any change in your symptoms, or any new symptoms that concern
you.
Please resume all regular home medications, unless specifically
advised not to take a particular medication. Also, please take
any new medications as prescribed.
Please get plenty of rest, continue to ambulate several times
per day, and drink adequate amounts of fluids.
Weigh yourself every morning, call MD if weight goes up more
than 3 lbs.
Followup Instructions:
___
|
10807873-DS-15
| 10,807,873 | 28,211,155 |
DS
| 15 |
2166-08-18 00:00:00
|
2166-08-19 14:45:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
unknown
Attending: ___
Chief Complaint:
acute EtOH intoxication and suicidal ideation
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ with PMH MI, CAD, alcohol and cocaine abuse who presented
with acute intoxication and SI. Per reports found in public
park, unable to ambulate, threatening or trying to hurt himself
with a knife. He denies this. He does admit to alcohol use,
however reports only a few beers with last drink this ___ am.
Denies any cocaine or other drug use. Not willing to discuss SI.
Denies HI. Reports some ? sharp and substernal CP and SOB,
possibly started several hours prior to ED presentation. He felt
nauseated but did not vomit. Trops were 0.02, 0.02, and <0.01
and EKG showed NSR, normal axis. New T wave inversion in V2,
isolated 2mm ST elevation in V3. No reciprocal changes. Pt says
he had a "lot" of etoh night prior to presentation, and usually
drinks several times weekly.
This morning in the ED the patient continued to have mild chest
pain and was given SL nitro with relief. Psych saw patient and
felt that patient had psychiatric contraindication to discharge.
___ and 1:1 observation observation were discontinued as
per Psych recs and Psych felt patient could follow up with PCP
as an out patient. As patient was leaving for ED, pt stood up,
became very lightheaded, diaphoretic, tremulous, nauseated, and
vomited several times. No chest pain. He was given 2L IVF,
zofran, and ativan. He was reportedly tachycardic and
hypertensive. His EKG was wnl.
In the ED, initial vital signs were: T 97.6 P 68 BP 126/80 R
18 97% O2 sat.
Exam notable for: Not documented.
Labs were notable for: Trops 0.02, 0.01, and <0.01. Serum
alcohol 316, rest of serum tox negative, Utox negative, WBC 6.0,
Hb 14.3, Platelets 308, Cr 2.1 (baseline 2.1), AST 60, ALT 29,
t.bili 0.03, albumin 4.2
Patient was given: diazepam 10mg X 2, SL nitro 0.4mg X2, zofran,
ativan 1mg, folic acid, thiamine, multivitamin, labetalol 100mg,
2L NS
On arrival to the floor patient feels improved but still is
mildly tremulous. He has a headache in the middle of his
forehead with photophobia, feels "like a bad hangover". No N/V,
does not normally get headaches but used to get migraines as a
child. This HA does not feel like a migraine. No associated
vision changes. Last BM was several days ago. The longest the
patient has gone without drinking is 1 week. No history of
withdrawal seizures/hallucinations/DTs.
Past Medical History:
PAST MEDICAL HISTORY:
HLD
HTN
s/p 2x MI with 2 stents
s/p 2 CVA's
Renal insufficiency
PAST PSYCHIATRIC HISTORY:
Hospitalizations: denies
Current treaters and treatment: denies
Medication and ECT trials: denies
Self-injury: denies
Harm to others: has assaulted neighbor resulting in arrest/jail
Access to weapons: denies
Social History:
B/R in ___ by both parents;
Education: graduated high school
Occupations/Income: no income, applying for disability
Housing: homeless
Relationships/children: has at least 1 daughter
Social Supports: ___
Family History:
N/A
Physical Exam:
ADMISSION PHYSICAL EXAM:
Vitals: 163/36 105 18 93% RA FSG 183-200
General: Alert and oriented, lying in bed with eyes closed
HEENT: PERRL, NC/AT
CV: Distant heart sounds, RRR S1 S2 NMRG
Lungs: faint crackles right lower lung base otherwise CTABL
Abdomen: soft, NT, ND +BS
Neuro: Grossly neurologically in tact
DISCHARGE PHYSICAL EXAM:
Telemetry: NSR except for 26 beats/4 seconds of V.tach
Vitals: 140s-160s/36 105 18 93% RA FSG 183-200
General: Alert and oriented, lying in bed with eyes closed
HEENT: PERRL, NC/AT
CV: Distant heart sounds, RRR S1 S2 NMRG
Lungs: faint crackles right lower lung base otherwise CTABL
Abdomen: soft, NT, ND +BS
Neuro: Grossly neurologically in tact
Pertinent Results:
ADMISSION LABS:
=====================
___ 11:07PM BLOOD WBC-4.5 RBC-4.32* Hgb-14.2 Hct-42.3
MCV-98 MCH-32.9* MCHC-33.6 RDW-14.9 RDWSD-53.6* Plt ___
___ 11:07PM BLOOD Neuts-54.8 ___ Monos-7.6 Eos-2.0
Baso-0.9 Im ___ AbsNeut-2.45 AbsLymp-1.54 AbsMono-0.34
AbsEos-0.09 AbsBaso-0.04
___ 11:07PM BLOOD Plt ___
___ 11:07PM BLOOD Glucose-81 UreaN-23* Creat-2.1* Na-143
K-4.1 Cl-108 HCO3-16* AnGap-23*
___ 11:07PM BLOOD cTropnT-<0.01
___ 11:07PM BLOOD ASA-NEG ___ Acetmnp-NEG
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 11:07PM BLOOD GreenHd-HOLD
IMPORTANT LABS:
========================
___ 12:08PM BLOOD ALT-29 AST-60* AlkPhos-118 TotBili-0.3
___ 04:59AM BLOOD cTropnT-0.01
___ 12:08PM BLOOD CK-MB-7
___ 12:08PM BLOOD cTropnT-0.02*
___ 05:50PM BLOOD cTropnT-0.01
DISCHARGE LABS:
========================
___ 05:40AM BLOOD WBC-3.9* RBC-3.95* Hgb-12.8* Hct-38.0*
MCV-96 MCH-32.4* MCHC-33.7 RDW-14.5 RDWSD-51.8* Plt ___
___ 12:08PM BLOOD Neuts-71.2* ___ Monos-7.2
Eos-0.3* Baso-0.7 Im ___ AbsNeut-4.25# AbsLymp-1.22
AbsMono-0.43 AbsEos-0.02* AbsBaso-0.04
___ 05:40AM BLOOD Plt ___
___ 05:40AM BLOOD Glucose-78 UreaN-23* Creat-1.9* Na-139
K-3.9 Cl-103 HCO3-23 AnGap-17
___ 05:40AM BLOOD Calcium-9.1 Phos-4.0 Mg-1.8
IMAGING:
=========================
CXR ___
IMPRESSION:
Possible minimal bibasilar atelectasis. Otherwise, no acute
pulmonary process identified.
EKG:
========================
___: NSR, normal axis. New T wave inversion in V2, isolated
2mm ST elevation in V3. No reciprocal changes. Unchanged from
prior EKGs, no acute ischemic process suspected.
Repeat ___: Repeat EKG shows no interval change from previous
EKGs.
Brief Hospital Course:
___ presents with history of hypertension, hyperlipidemia, and
MI X 2 with two stents (unknown if drug eluting) presents with
EtOH intoxication, chest pain, and suicidal ideation. His last
drink ___ am, unclear how much patient drinks normally. No
history of seizures or DTs. Initial EKG showed NSR, normal axis
with new T wave inversion in V2, isolated 2mm ST elevation in
V3. No reciprocal changes. Trops peaked at 0.02 and downtrended.
Repeat EKG ___ was unchanged from baseline EKGs obtained
previously and chest pain resolved with diazepam and SL nitro.
Patient was treated for alcohol withdrawal with diazapam 10mg
for CIWA scores > 10, he was given diazepam X 2 in the ED and X
1 on the floor. Psych saw patient for suicidal ideation and felt
that patient had no psychiatric contraindication to discharge.
___ and 1:1 observation observation were discontinued as
per Psych recs and Psych recommended follow up with PCP as an
out patient.
TRANSITIONAL ISSUES:
=
=
=
=
=
================================================================
- suicidal ideation, no active plan
- continue encouraging alcohol abstinence
- continue optimization of medical management of CAD,
hypertension, and hyperlipidemia
- question of whether patient has drug eluting stents and needs
dual anti-platelet therapy
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY
2. Lisinopril 20 mg PO DAILY
3. Atorvastatin 80 mg PO QPM
4. Metoprolol Succinate XL 50 mg PO DAILY
5. Omeprazole 40 mg PO DAILY
6. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY
7. FoLIC Acid 1 mg PO DAILY
8. Multivitamins 1 TAB PO DAILY
9. Acetaminophen 325 mg PO Q6H:PRN pain
10. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain
Discharge Medications:
1. Acetaminophen 325 mg PO Q6H:PRN pain
RX *acetaminophen 325 mg 1 tablet(s) by mouth every 6 hours as
needed Disp #*30 Tablet Refills:*0
2. Aspirin 81 mg PO DAILY
RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet
Refills:*0
3. Atorvastatin 80 mg PO QPM
RX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30
Tablet Refills:*0
4. FoLIC Acid 1 mg PO DAILY
RX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet
Refills:*0
5. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY
RX *isosorbide mononitrate 60 mg 1 tablet(s) by mouth daily Disp
#*30 Tablet Refills:*0
6. Lisinopril 20 mg PO DAILY
RX *lisinopril 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet
Refills:*0
7. Multivitamins 1 TAB PO DAILY
RX *multivitamin [Men's Multi-Vitamin] 1 tablet(s) by mouth
daily Disp #*30 Tablet Refills:*0
8. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain
RX *nitroglycerin 0.4 mg 1 tablet(s) sublingually every 5
minutes as needed Disp #*25 Tablet Refills:*0
9. Omeprazole 40 mg PO DAILY
RX *omeprazole 40 mg 1 capsule(s) by mouth daily Disp #*30
Capsule Refills:*0
10. Thiamine 100 mg PO DAILY
RX *thiamine HCl 100 mg 1 tablet(s) by mouth daily Disp #*30
Tablet Refills:*0
11. Metoprolol Succinate XL 50 mg PO DAILY
RX *metoprolol succinate 50 mg 1 tablet(s) by mouth daily Disp
#*30 Tablet Refills:*0
Discharge Disposition:
Home
Discharge Diagnosis:
Primary diagnosis:
Alcohol withdrawal
Chest pain
Secondary diagnosis:
Hypertension
Hyperlipidemia
CAD
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
It was a pleasure caring for you at ___
___. You were admitted to the hospital for alcohol
withdrawal. You were treated for your withdrawal. Continuing to
drink alcohol increases your risk for infection, end-organ
damage, and death. If you are interested in quitting drinkig
please follow up with your primary care provider. Please
continue to take your medications as perscribed.
It was a pleasure taking care of you.
Sincerely,
Your ___ team
Followup Instructions:
___
|
10807985-DS-19
| 10,807,985 | 21,318,253 |
DS
| 19 |
2137-12-25 00:00:00
|
2137-12-25 15:56:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Cellulitis, AMS
Major Surgical or Invasive Procedure:
Intubation ___, Extubation ___
PICC placement
EGD ___
History of Present Illness:
___ M hx of EtOH abuse, elevated transaminases, DM2, ?COPD, AFib
recently on coumadin who presents as a transfer from ___ after a
fall.
The patient himself is a poor historian and the history is
mainly gathtered from notes and from his primary care
Physician's assistant. He was brought to his PCP by his wife on
___ because he had been fatigued for about three weeks and
had reportedly had multiple falls. Felt "not himself" and was
weak and unable to walk much in the last week. No fevers/chills.
Unclear how much or how frequently he was drinking, he says ___
drinks daily. In his PCP's office, he was sleepy and hypoxic to
86%, so he was sent to the ED at ___.
In the ED at ___ he had labs, notable for elevated AST/ALT,
EToH of 467, ammonia 53, PLTs 53, INR 2.4, negative UA. He had
a non-con CT head which showed (read by our neuroradiologists) a
chronic subdural hematoma without acute blood. A non-con CT of
the abdomen from OSH informally read by our radiologists as
fatty, shrunken, nodular, increased venous collaterals
(umbilical vein) in the abdomen suggestive of portal
hypertension, presence of IVC filter, a partial splenectomy, and
findings concerning for lower abdominal/upper pelvic superficial
cellulitis. He was given lactulose, 1g of Vancomyin IV and
transfered to ___ for further management. Of note he was being
treated for bilateral lower extremity cellulitis with
doxycycline as an outpatient.
In the ED at ___, he was sleepy but arousable, vitals were
unremarkable. Labs notable for ETOH >300, INR 2.3, PLTs 31, HCT
31, MCV 122, albumin 2.7, and lactate of 3.0. He was evaluated
by neurosurgery who, as above, felt that the OSH CT was c/w a
chronic, not acute, subdural hematoma, and recommended no
intervention.
On transfer to the floor he was in AF, Afebrile, HR 83, 103/57
93% on 3L.
===================MICU
TRANSFER====================================
Mr. ___ is a ___ year old gentleman with a history of ETOH
abuse, afib recently on coumadin who initially presented ___ as
a transfer from ___ after a fall. At ___ he was somnolent and
hypoxemic to 86%, found to have elevated LFTs, ETOH 467. NCCT
revealed chronic subdural hematoma. A non-con CT of the abdomen
from ___ showed fatty, shrunken, nodular liver with increased
venous collaterals (umbilical vein) in the abdomen suggestive of
portal hypertension, presence of IVC filter, a partial
splenectomy. He was given lactulose for AMS and vancomycin given
concern for cellulitis prior to transfer.
He was transferred to the MICU on ___ for escalating nursing
needs in the setting of encephalopathy and increasing 02
requirement. He was treated for hepatic encephalopathy and EtOH
withdrawal with phenobarb protocol. Hypoxemic respiratory
failure was attributed to aspiration pneumonia and he was
treated with Unasyn. He was diuresed ~2L and TTE did not show
reduced EF. He was transferred back to the floor ___ with
somewhat improved mental status.
Since going back to the floor ___ his mental status has
worsened, now responsive only to sternal rub. He has been
persistently febrile to 102 despite APAP and was broadened to
vanc/cefepime/metronidazole for possible GI source given
abdominal pain. He has been getting 100g 25% albumin for the
past 2 days for volume. Over the past 3 days his 02 requirement
has been increasing with RR in the ___ now on
non-rebreather. ABG this morning 7.35 44 78. Given concern for
volume overload as a component of his worsening respiratory
status, he was given 80 mg IV lasix with 600-800cc UOP prior to
ICU transfer.
On arrival to the MICU, the patient is minimally responsive to
sternal rub, tachypneic, saturating 88% on 100 non-rebreather.
Given AMS and hypoxemia he was intubated shortly after arrival.
Review of systems: Unable to obtain given AMS
Past Medical History:
PAST MEDICAL HISTORY:
- HCV/ETOH cirrhosis
- Alcohol abuse
- Transaminitis since ___ as above
- Atrial fibrillation - on warfarin recently, has sparse cards
followup. Report of a recent TTE that looked "OK"
- DM2
- COPD: no PFTs
- OSA: On 2L home oxygen for the last year.
PSurgical Hx:
- Tracheostomy in ___
- Partial splenectomy ___
- Partial prostatectomy for prostate Ca
- IVC filter ___ after MVA and inability to anticoagulate for
AFib in setting of polytrauma and abdominal surgery
Social History:
___
Family History:
Father died of lung cancer
Mother died of neck cancer
Physical Exam:
ADMISSION:
Vitals - 98.1 HR 84 AF, 111/47 RR 14 93% on 3L
GENERAL: coughing, appears uncomfortable, tremulous, disheveled,
obese, poor hygeine, smells of alcohol.
NEURO: AOX2, knows year, knows president. Unable to recount much
of his history. Follows commands appropriately.
HEENT: AT/NC, conjunctiva red, sclera slightly icteric. Tongue
tremor. Significant lacrimation.
CARDIAC: irregular rhythm, S1/S2, no murmurs.
LUNG: very poor air movement throughout, inspiratory and
expiratory wheezes.
ABDOMEN: obese, NT. 10-20 cm violaceous patch in RLQ of abdomen.
Not warm, non-tender. Flaky skin beneath pannus.
EXTREMITIES: Anasarcic, pitting edema in hands and to the knee
bilaterally. Woody skin changes in bilateral lower extreities.
Bilateral warm erythema with scabs and some dry ulcers in
bilateral lower extremities.
PULSES: 2+ DP pulses bilaterally
NEURO: No pronator drift. Coarse resting tremor bilaterally. +
Asterexis.
SKIN: small spider angiomata over torso with central flushing
under neck. Armpits and chest hairless.
DISCHARGE:
VS Tmax 98.7 Tc 98.4 HR 75-104 BP 104/57-134/76 RR ___ SpO2
93-96% RA, I/O 24h 520/850+BMx2, 8h 120/300+BMx1,
General: Appears well, NAD. AOx2 (not to date). Unable to spell
world backwards. Interacting appropriately. Less interactive
today.
Neck: Unable to appreciate JVD. No supraclavicular adenopathy.
CV: No murmurs, irregular.
Lungs: clear anteriorly.
Abdomen: Soft, obese, large ecchymosis RLQ. No evidence of
fluid wave suggestive of ascites.
GU: Scrotal edema. Foley in place.
Ext: Trace pitting edema.
Skin: Spider angiomas on chest, no jaundice.
Neuro: Mild asterixis. Otherwise, cranial nerves II-XII grossly
intact. Normal UE and ___ strength and sensation bilaterally.
Unable to assess gait.
Pertinent Results:
ADMISSION
___ 05:30PM CK(CPK)-223
___ 05:30PM IRON-113
___ 05:30PM calTIBC-192* VIT B12-1680* FERRITIN-1849*
TRF-148*
___ 05:30PM HBsAg-NEGATIVE HBs Ab-NEGATIVE HBc
Ab-NEGATIVE
___ 05:30PM HCV Ab-POSITIVE*
___ 05:30PM ___
___ 01:10PM LACTATE-3.2*
___ 12:46PM LIPASE-421*
___ 02:38AM ___ PTT-42.7* ___
___ 01:59AM COMMENTS-GREEN TOP
___ 01:59AM LACTATE-3.4*
___ 01:49AM GLUCOSE-100 UREA N-18 CREAT-1.0 SODIUM-140
POTASSIUM-4.4 CHLORIDE-99 TOTAL CO2-27 ANION GAP-18
___ 01:49AM estGFR-Using this
___ 01:49AM ALT(SGPT)-39 AST(SGOT)-184* ALK PHOS-215* TOT
BILI-3.0*
___ 01:49AM ALBUMIN-2.7*
___ 01:49AM ASA-NEG ___ ACETMNPHN-NEG
bnzodzpn-NEG barbitrt-NEG tricyclic-NEG
___ 01:49AM WBC-8.2 RBC-2.61* HGB-10.1* HCT-31.9*
MCV-122* MCH-38.7* MCHC-31.7 RDW-17.6*
___ 01:49AM NEUTS-75* BANDS-0 LYMPHS-10* MONOS-14* EOS-1
BASOS-0 ___ MYELOS-0 NUC RBCS-2*
___ 01:49AM HYPOCHROM-NORMAL ANISOCYT-3+ POIKILOCY-2+
MACROCYT-3+ MICROCYT-1+ POLYCHROM-OCCASIONAL TARGET-2+
HOW-JOL-OCCASIONAL PAPPENHEI-OCCASIONAL ENVELOP-1+
___ 01:49AM PLT SMR-VERY LOW PLT COUNT-31*
___ 01:49AM RET AUT-2.9
=
=
=
=
=
=
=
======================Imaging===================================
Liver US ___
IMPRESSION:
1. Coarsened liver echogenicity and nodular hepatic contour
consistent with cirrhosis.
2. Sequela of portal hypertension including recanalization of
paraumbilical vein. Patent hepatic and portal venous
vasculature.
3. Dilated common bile duct measuring up to 12 mm without
evidence of filling defect or intrahepatic biliary dilatation,
however the distal aspect of the duct is not visualized. Sludge
in GB also noted. MRCP may be considered if further imaging
evaluation is indicated.
TTE ___
The left atrium and right atrium are normal in cavity size. No
atrial septal defect is seen by 2D or color Doppler. The
estimated right atrial pressure is ___ mmHg. Left ventricular
wall thicknesses and cavity size are normal. Left ventricular
systolic function is hyperdynamic (EF>75%). Doppler parameters
are indeterminate for left ventricular diastolic function. Right
ventricular chamber size and free wall motion are normal. The
aortic valve leaflets (3) are mildly thickened but aortic
stenosis is not present. No aortic regurgitation is seen. The
mitral valve leaflets are mildly thickened. There is no mitral
valve prolapse. Mild (1+) mitral regurgitation is seen. The
estimated pulmonary artery systolic pressure is normal. There is
no pericardial effusion.
IMPRESSION: Hyperdynamic left ventricular systolic function
without outflow tract obstruction. Mild mitral regurgitation.
Normal pulmonary artery systolic pressure. Diastolic function
indices are equivocal.
CT Head
IMPRESSION:
1. Chronic right frontal subdural hematoma causing mild sulcal
effacement. No shift of midline structures.
2. Large posterior fossa hypodensity, which may represent an
arachnoid cyst ___ cisterna magna.
CT Chest
IMPRESSION:
1. Right lower lobe bronchi filled with secretions leading to
atelectasis. Multifocal bilateral patchy ground-glass and
nodular opacities with upper lobe predominance, the possibility
of aspiration pneumonia has to be considered.
2. moderate left and small right pleural effusions.
3. Mild dilatation of the main pulmonary trunk and its major
branches suggests pulmonary arterial hypertension.
4. Please refer to separately dictated CT abdomen and pelvis
report from the same day for full description of
subdiaphragmatic findings.
CT A/P
IMPRESSION:
1. No organized fluid collection to suggest an intra-abdominal
abscess.
2. Mild central intrahepatic and mild extrahepatic biliary
dilatation without evidence of obstruction.
3. A 2.7 cm round soft tissue mass abutting the tail of the
pancreas at the splenectomy bed is thought to represent an
accessory spleen. If further confirmation is needed MRI or a
nuclear medicine sulfur colloid scan may be obtained.
4. Please refer to separately dictated CT chest report from the
same day for full description of intrathoracic findings.
CTA CHEST ___:
1. No evidence of pulmonary embolism.
2. Improvement in bibasilar atelectasis.
3. Right lung base ___ nodules are most likely due to
aspiration or infection. Mucous plugs are present in the
segmental bronchi to the right upper lobe and nonobstructing
secretions in the trachea and right main bronchus. Right upper
lobe airspace ground-glass infiltrate has increased from
previous.
4. Nonspecific lucent lesion in T5 vertebral body which could
represent
hemangioma but is not specific. MRI can be performed for further
characterization as indicated.
EGD
___
no varices
=
=
=
=
===========================Micro================================
___ fungal and mycobacterial isolator culture negative to
date.
C. Diff ___ negative.
BAL ___: HSV-1 grew out of culture, CMV antigen detected.
BAL ___: yeast
___ 10:10 pm SPUTUM Source: Endotracheal.
**FINAL REPORT ___
GRAM STAIN (Final ___:
>25 PMNs and <10 epithelial cells/100X field.
2+ ___ per 1000X FIELD): GRAM NEGATIVE ROD(S).
SMEAR REVIEWED; RESULTS CONFIRMED.
RESPIRATORY CULTURE (Final ___:
Commensal Respiratory Flora Absent.
YEAST. SPARSE GROWTH.
Multiple negative blood cxs
Multiple negative urine cxs
Negative c diff
DISCHARGE:
___ 05:22AM BLOOD WBC-13.0* RBC-2.44* Hgb-9.6* Hct-30.9*
MCV-127* MCH-39.3* MCHC-31.1 RDW-15.9* Plt Ct-84*
___ 05:22AM BLOOD Plt Ct-84*
___ 05:22AM BLOOD ___ PTT-67.4* ___
___ 05:22AM BLOOD Glucose-89 UreaN-13 Creat-0.8 Na-137
K-4.2 Cl-110* HCO3-21* AnGap-10
___ 05:22AM BLOOD ALT-30 AST-76* LD(LDH)-421* AlkPhos-113
TotBili-2.4*
Brief Hospital Course:
___ yo M with PMH of alcohol abuse who presented with
encephalopathy, new cirrhosis, and alcohol withdrawal whose
hospital course was complicated by slow-to-clear encephalopathy,
hypoxemic respiratory failure, and prolonged intubation. Treated
for hepatic encephalopathy, alcohol withdrwal, and
aspiration/hospital acquired pneumonia. At time of discharge
mental status had cleared and he was breathing comfortably on
room air. Etiology of the cirrhosis is either alcoholic, ___
HCV, or NAFLD. He will follow up in the ___.
# Encephalopathy: Initially thought due to alcohol withdrawal
and hepatic encephalopathy. Treated with aggresive lactulose and
rifaximina nd a phenobarbitol taper. His encephalopathy,
however, was slow to clear and he remained delerious and
intermittently agitated, in spite of appropriate treatment for
the above conditions. Systemic illness was likely also causing
decreased level of arousal. Hypernatremia may also have been
contributing. Head CT revealed stable subdural hematoma.
Repeated on admission to MICU given dilated pupils, though
revealed no change from prior. He was continued on
lactulose/rifaximin. His mental status improved significantly on
___. Given his long history of alcohol use, started on oral
thiamine supplementation.
# Hypoxemic respiratory failure: Concern for possible aspiration
in the setting of worsening mental status given productive
cough, elevated WBC, and high fevers. VOlume overload may also
have contributed in the setting of IVF resuscitation on
admission with low albumin and multiple CXRs with vascular
congestion. Did not improve with diuresis. TTE with normal LVEF
and he remained in persistent Afib with rates in low 100s. Low
suspicion for cardiogenic etiologies given absence of valvular
disease and adequate rate control. Initially treated with
Vanc/Zosyn given concern for aspiration pneumonia in the setting
of AMS. He was intubated and remained so for > 7 days given high
PEEP requirements and in the setting of persistent altered
mental status. Once he was more arousable he still required high
levels of PEEP, particularly when sitting upright, though
improved while lying flat. Given concern for intrapulmonary
shunting, a bubble study was performed, though revealed no
evidence of shunt physiology. His respiratory status improved
and he was extubated on ___. No microbiologic soure was
identified. He had GNRs on a sputum gram stain that did not grow
in the culture. He had a BAL that grew HSV-1 and was positive
for CMV antigen, but these were not felt to be respiratoy
pathogens in his case. He had a positive galactomannan and was
briefly treated with voriconazole, but no pathogenic fungi grew
from his blood or respiratory cultures. He completed a 14 day
course of Meropenem on ___.
# Cirrhosis: Diagnosed by labs and OSH CT abdomen/pelvis showing
a nodular liver. Chronicity unclear. RUQUS confirmed cirrhotic
liver appearance. HCV positive and has an extensive drinking
history. HAV negative. HBV non-immune. Started on Lactulose and
Rifaximin. Hepatology followed throughout hospital stay. They
will see him in the ___ as an outpatient for ongoing
monitoring (regular RUQUS, ? treatment of HCV, HBV
immunization). EGD on ___ showed no varices.
# ___: Presented with creatinine of 1.3 from baseline 0.9-1.
Likely secondary to volume depletion. Given history of
cirrhosis, important to consider HRS. His renal function
improved with albumin resuscitation.
# Hypernatremia: Intermittently hypernatremic during hospital
stay. Likely from minimal POs (while without NG access) and
ongoing loose stools from the lactulose.
# Chronic right frontal SDH: Stable on Repeat CT head ___ and
___.
# Afib: CHADS2 of 2. INR was 2.4 despite holding Coumadin, most
likely representing coagulopathy of liver disease. Will continue
to hold Coumadin given this, thrombocytopenia, and SDH. Also, on
discussion with wife, coumadin was initiated for planned
cardioversion, but patient decided not to undergo cardioversion
later, so doesn't really need to be anticoagulated. Rate
controlling with metoprolol. Stopped digoxin given fluctuating
renal function. In discussion with PCP, decision was made to
continue to hold Warfarin at discharge given elevated INR, and
no plans for cardioversion (had been off coumadin for years
before that). Patient started on Aspirin 81 mg PO QDaily at
discharge.
# Macrocytic anemia: Most likely due to a combination of alcohol
use and splenectomy. B12 normal. Will monitor. Started on
B12/folate.
# Thrombocytopenia: Likely cirrhosis. He is s/p partial
splenectomy. No DIC or TTP based on initial labs. Held heparin
for Plt < 50.
# Hypoalbuminemia: Likely due to cirrhosis and poor oral intake.
Was on TF as he failed initial swallow evaluation. However
swallow improved as mental status cleared, pand patient was able
to take adequate PO by time of discharge, and TFs were
discontinued.
TRANSITIONAL:
[]Code status: Full
[]Digoxin discontinued
[]Coumadin discontinued given subdural hematoma and risk for
further bleeds given fall risk, patient started on Aspirin 81 mg
PO QDaily
[] Patient discharged on Lactulose and Rifaximin
[] Lasix 40 mg PO QDaily resumed at discharge, will need to
consider starting Spironolactone at ___
[] Patient will need Hepatology followup
[] Patient will need post-discharge PCP ___
[] Patient will need HBV vaccination
[] Patient will need Liver Ultrasound q 6month for surveillance
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Anoro Ellipta (umeclidinium-vilanterol) 62.5-25 mcg/actuation
inhalation qd dyspnea
2. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation
q6H wheeze
3. Digoxin 0.125 mg PO DAILY
4. Furosemide 40 mg PO DAILY
5. Lisinopril 2.5 mg PO DAILY
6. Metoprolol Succinate XL 100 mg PO DAILY
7. OxyCODONE SR (OxyconTIN) 60 mg PO Q8H
8. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN pain
9. Doxycycline Hyclate 50 mg PO Q12H
10. TraZODone 100 mg PO HS
11. Warfarin 3 mg PO DAILY16
12. potassium chloride 10 mEq oral daily
13. Zovirax Ointment 5% 1 appl Other qd
14. Tiotropium Bromide 1 CAP IH DAILY
Discharge Medications:
1. Furosemide 40 mg PO DAILY
2. Lisinopril 2.5 mg PO DAILY
3. Metoprolol Succinate XL 100 mg PO DAILY
4. Aspirin 81 mg PO DAILY
5. Cyanocobalamin 50 mcg PO DAILY
6. FoLIC Acid 1 mg PO DAILY
7. Lactulose 30 mL PO QID
8. Multivitamins 1 TAB PO DAILY
9. Rifaximin 550 mg PO BID
10. Thiamine 100 mg PO DAILY
11. Anoro Ellipta (umeclidinium-vilanterol) 62.5-25
mcg/actuation inhalation qd dyspnea
12. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation
q6H wheeze
13. Tiotropium Bromide 1 CAP IH DAILY
14. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN pain
RX *oxycodone 5 mg 1 tablet(s) by mouth Q8H:PRN Disp #*20 Tablet
Refills:*0
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
Primary:
Cirrhosis
___
hospital acquire pneumonia
Secondary:
atrial fibrillation
alcoholic hepatitis
diabetes
Discharge Condition:
Alert and oriented x2 (not to date)
Clear and coherent
Deconditioned and weak. Unable to stand without assistance.
Discharge Instructions:
Mr. ___,
You were admitted to the hospital because of fatigue and
confusion. You were found to have evidence of impaired liver
function, a condition called cirrhosis. This was likely the
primary reason for your fatigue and confusion, though withdrawal
from alcohol may also have been initially contributing. We have
started you on two new medications, lactulose and rifaximin,
that will help you from becoming confused in the future.
While in the hospital, you became quite sick and had
worsening difficulty breathing. We transfered you to the medical
ICU where you were placed on a breathing machine for more than
one week. You improved with treatment for pneumonia, and we
think this is probably what caused your breathing trouble.
You came to the hopsital on coumadin. You should stop this
medication for the time being. We have also stopped your
digoxin.
You should also continue to hold your lasix, which you were
taking before coming to the hospital.
We have arranged for you to followup in our ___ here
for onging management of your liver disease.
It has been a pleasure taking care of you at the ___.
-your ___ care team.
Followup Instructions:
___
|
10808090-DS-24
| 10,808,090 | 26,346,806 |
DS
| 24 |
2190-11-12 00:00:00
|
2190-11-12 11:40:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: ORTHOPAEDICS
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Left hip pain
Major Surgical or Invasive Procedure:
___ Left hip hemiarthroplasty
History of Present Illness:
HPI: ___ male with history of lymphoma, hypertension
presenting status post mechanical fall onto his left side with
associated head strike. No loss of consciousness. Patient
complaining of left hip pain. No weakness or numbness in the
left lower extremity. No urinary or bowel incontinence. Patient
is on aspirin and not anticoagulated.
Past Medical History:
lymphoma
hypercholesterolemia
hypertension
Gastritis
Colonic polys
Prostate cancer ___ treated with seed-radiation
h/o pulmonary edema and dilated right pulmonary artery
BPH s/p TURP
appy
inguinal hernia repair
Social History:
___
Family History:
no family history of malignancy
Physical Exam:
PHYSICAL EXAM ON ADMISSION:
Vitals: 98.1 72 115/79 22 93%
In mild distress, AOx3
BUE skin clean and intact
No tenderness, deformity, erythema, edema, induration or
ecchymosis
Arms and forearms are soft
No pain with passive motion
R M U ___
EPL FPL EIP EDC FDP FDI fire
2+ radial pulses
LLE skin clean and intact
Tenderness left lateral hip.No deformity or shortening. No
erythema, edema, induration or ecchymosis.
Thighs and legs are soft
Pain with external rotation and axial loading. Pelvic is stable.
Saph Sural DPN SPN MPN LPN ___ FHL ___ TA PP Fire
1+ ___ and DP pulses
Left knee stable without joint tenderness, swelling or
eccymosis.
RLE skin clean and intact
no tenderness , deformity, erythema, edema, induration or
ecchymosis
Thighs and legs are soft
No pain with passive motion
Saph Sural DPN SPN MPN LPN ___ FHL ___ TA PP Fire
1+ ___ and DP pulses
PHYSICAL EXAM ON DISCHARGE:
A&O x3, calm and comfortable
LLE: ___ fire, warm and well-perfused with ___
pulses
Incision c/d/i with staples in place
Pertinent Results:
___ 05:00AM BLOOD WBC-5.6 RBC-3.29* Hgb-10.3* Hct-28.2*
MCV-86 MCH-31.2 MCHC-36.5* RDW-14.1 Plt ___
___ 05:00AM BLOOD Glucose-94 UreaN-11 Creat-0.9 Na-138
K-3.6 Cl-105 HCO3-26 AnGap-11
Brief Hospital Course:
Mr. ___ was admitted to the Orthopaedic Surgery Trauma
service from the Emergency Department on ___ for further
management of a left femoral neck fracture, including
pre-operative work-up. The following day, he was taken to the
Operating Room to undergo a left hip hemiarthroplasty. The
patient tolerated the procedure well. Please see Operative
Report for full details. Post-operatively, the patient was
taken to the recovery room before being transferred to the floor
for further monitoring and care. He was given Lovenox for DVT
prophylaxis. His pain was well controlled with narcotic
medications, which were eventually transitioned to oral pain
medications. Physical Therapy was consulted, and the patient
made gradual progression and was able to ambulate with
assistance by the date of discharge.
On ___, the patient was transfused 1 unit of packed red
blood cells for acute blood loss anemia. He responded well to
the transfusion, and his hematocrit increased appropriately.
On ___, the patient was in good spirits and expressed
readiness for discharge to a rehabilitation facility. His
incision was clean, dry, and intact, and he was able to tolerate
a regular diet. He was discharged to rehab in stable condition
with detailed precautionary instructions as well as instructions
regarding follow-up.
Medications on Admission:
Lipitor 20 mg Tab daily
Prandin 1 mg Tab daily
Protonix 40 mg Tab daily
AZILECT 0.5 mg Tab daily
Aspirin 81 mg Chewable Tab daily
Verelan ___ 300 mg 24 hr Cap
Microzide 12.5 mg Cap daily
Lactulose 10 gram/15 mL Oral Soln ___ ml b.i.d. p.r.n. for
constipation
Altace 5 mg Cap daily
Bisacodyl 10 mg Rectal Suppository q.h.s. p.r.n. constipation
Miralax 17 gram Oral Powder Packet daily
GlycoLax 17 gram (100 %) Oral Powder Packet daily
Discharge Medications:
1. atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily). Tablet(s)
2. repaglinide 2 mg Tablet Sig: 0.5 Tablet PO TIDAC (3 times a
day (before meals)).
3. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable
PO DAILY (Daily).
4. ramipril 5 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
5. AZILECT 0.5 mg Tablet Sig: One (1) Tablet PO daily ().
6. carbidopa-levodopa ___ mg Tablet Sig: One (1) Tablet PO
TID (3 times a day).
7. pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One
(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).
8. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every
6 hours) as needed for pain.
9. enoxaparin 40 mg/0.4 mL Syringe Sig: One (1) Syringe
Subcutaneous QHS (once a day (at bedtime)) for 2 weeks.
10. oxycodone 5 mg Tablet Sig: ___ Tablets PO Q4H (every 4
hours) as needed for pain.
Disp:*65 Tablet(s)* Refills:*0*
11. insulin regular human 100 unit/mL Solution Sig: AC+HS
Injection ASDIR (AS DIRECTED): Please see printed sliding scale.
12. calcium carbonate 200 mg calcium (500 mg) Tablet, Chewable
Sig: One (1) Tablet, Chewable PO TID (3 times a day).
13. cholecalciferol (vitamin D3) 400 unit Tablet Sig: One (1)
Tablet PO DAILY (Daily).
14. verapamil 300 mg Capsule, 24hr ER Pellet CT Sig: One (1)
Capsule, 24hr ER Pellet CT PO Q24H (every 24 hours).
15. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID
(2 times a day): Hold if loose stool.
16. senna 8.6 mg Tablet Sig: One (1) Tablet PO DAILY (Daily) as
needed for constipation: Hold if loose stool.
17. lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO Q8H
(every 8 hours) as needed for constipation: Hold if loose stool.
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
Left hip fracture
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Wound Care:
- Keep Incision clean and dry.
- You can get the wound wet or take a shower starting from 7
days after surgery, but no baths or swimming for at least 4
weeks.
- Dry sterile dresssing may be changed daily. No dressing is
needed if wound continues to be non-draining.
- Any stitches or staples that need to be removed will be taken
out at your 2-week follow up appointment.
Activity:
- Continue to be weight-bearing as tolerated on your left leg,
with anterior precautions.
- Elevate left leg to reduce swelling and pain.
Other Instructions
- Resume your regular diet.
- Please check electroyltes, including phosphorus and magnesium
in addition to a Basic Metabolic Panel, and replete
appropriately.
- Avoid nicotine products to optimize healing.
- Resume your home medications. Take all medications as
instructed.
- Continue taking the Lovenox to prevent blood clots.
- You have also been given Additional Medications to control
your pain. Please allow 72 hours for refill of narcotic
prescriptions, so plan ahead. You can either have them mailed
to your home or pick them up at the clinic located on ___.
We are not allowed to call in narcotic (oxycontin, oxycodone,
percocet) prescriptions to the pharmacy. In addition, we are
only allowed to write for pain medications for 90 days from the
date of surgery.
- Narcotic pain medication may cause drowsiness. Do not drink
alcohol while taking narcotic medications. Do not operate any
motor vehicle or machinery while taking narcotic pain
medications. Taking more than recommended may cause serious
breathing problems.
- If you have questions, concerns or experience any of the below
danger signs then please call your doctor at ___ or go
to your local emergency room.
Please call the office of Dr. ___ to schedule a follow-up
appointment with ___ in 2 weeks at ___.
Please follow-up with your primary care physician regarding this
admission.
Physical Therapy:
WBAT LLE with anterior precautions
Ambulate twice daily if patient able With Assist: Walker
Treatments Frequency:
Wound care:
Site: Incision
Type: Surgical
Dressing: Gauze - dry
Comment: daily; please overwrap any dressing bleedthrough with
ABDs and ACE
Followup Instructions:
___
|
10808090-DS-26
| 10,808,090 | 26,313,901 |
DS
| 26 |
2192-10-05 00:00:00
|
2192-10-07 22:28:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
weakness, fever
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ with PMH notable for Mantle cell lymphoma s/p chemotherapy
at ___ (___), hypertension, hyperlipidemia and ___
disease presenting with weakness. The patient states that
approximately one hour prior to arrival to the hospital he began
feeling weak and could not stand. He previously felt well in the
early morning. He denies pain in his legs and does not have any
arm weakness. He reports subjective fevers and chills. He denies
cough and dysuria. No chest pressure or chest pain.
In terms of his Mantle cell lymphoma that patient is currently
in remission. His last chemotherapy was in ___. His next
PET scan is scheduled for ___.
In the ED intial vitals were: 101.1, 95, 125/62, 18, 94% RA
- Labs were significant for WBC 5.5 (80% PMN), H/H 12.3/35.9,
plt 150, Na 142, K 3.8, Cl 106, HCO3 25, BUN 21, Cr 1.0, glucose
234 and lactate 2.2. UA was unremarkable
- Imaging significant for CXR w/ ___ lung volumes but no acute
cardiopulmonary process
- Patient was given acetaminophen
Vitals prior to transfer were: 98.1, 74, 128/55, 16, 95% RA
On the floor the patient has no major complaints. He reports
feeling leg weakness this afternoon along with fevers and
chills. He denies diarrrhea, recent travel and sick contacts. He
is accompanied by his son and wife.
Past Medical History:
Actinic keratosis
Mantle cell lymphoma s/p chemotherpay at ___ (___)
Hypercholesterolemia
Hypertension
Gastritis
Colonic polys
Prostate CA s/p seed-radiation
pulm edema w/dilated R pulmonary artery
BPH
Parkinsons
PAST SURGICAL HISTORY:
Cataract surgery (___)
Ultrasound-guided aspiration of left groin abscess (___)
TURP
Appendectomy
Inguinal hernia repair
L hip repair
Social History:
___
Family History:
No family history of malignancy
Physical Exam:
ADMISSION PHYSICAL EXAM:
Vitals- 97.7 132/69 80 20 99% RA
General- well appearing elderaly gentleman in NAD, walker at
bedside
HEENT- PERRL, conjunctiva normal, mild nasal congestion, OP w/o
lesions
Neck- supple, no JVD
Lungs- fine rales b/l at bases otherwise clear
CV- RRR, S1/S2 normal, ___ systolic murmur at ___, no R/G
Abdomen- +BS, S/NT/ND, no HSM
GU- normal genitalia
Ext- WWP, trace ___ edema bilaterally, no clubbing/cyanosis
Neuro- CNII-XII intact, ___ upper and lower extremity strength,
normal lower extremity sensation
DISCHARGE PHYSICAL EXAM:
General- well appearing elderaly gentleman in NAD
HEENT- PERRL, OP w/o lesions, MMM
Neck- supple, no JVD
Lungs- fine rales b/l at bases otherwise clear
CV- RRR, S1/S2 normal, ___ systolic murmur at ___, no R/G
Abdomen- +BS, S/NT/ND, no HSM
Ext- WWP, trace ___ edema bilaterally
Neuro- grossly intact
Pertinent Results:
ADMISSION LABS:
___ 04:25PM BLOOD WBC-5.5 RBC-4.00* Hgb-12.3* Hct-35.9*
MCV-90 MCH-30.7 MCHC-34.2 RDW-14.5 Plt ___
___ 04:25PM BLOOD Neuts-80.8* Lymphs-10.6* Monos-6.9
Eos-1.3 Baso-0.3
___ 04:25PM BLOOD Glucose-234* UreaN-21* Creat-1.0 Na-142
K-3.8 Cl-106 HCO3-25 AnGap-15
___ 06:40AM BLOOD Calcium-8.8 Phos-2.8 Mg-1.7
___ 04:25PM BLOOD ALT-16 AST-22 LD(LDH)-168 CK(CPK)-68
AlkPhos-95 TotBili-0.4
DISCHARGE LABS:
___ 06:40AM BLOOD WBC-4.1 RBC-3.75* Hgb-11.6* Hct-33.8*
MCV-90 MCH-31.0 MCHC-34.3 RDW-14.4 Plt ___
___ 06:40AM BLOOD Glucose-92 UreaN-17 Creat-0.9 Na-142
K-3.5 Cl-107 HCO3-24 AnGap-15
___ 06:40AM BLOOD Calcium-8.8 Phos-2.8 Mg-1.7
PERTINENT LABS:
___ 06:40AM BLOOD TSH-2.8
___ 04:25PM BLOOD CRP-8.4*
___ 04:25PM BLOOD ESR-19*
MICROBIOLOGY:
___ 04:25PM URINE Color-Yellow Appear-Clear Sp ___
___ 04:25PM URINE Blood-NEG Nitrite-NEG Protein-NEG
Glucose-TR Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG
___ BLOOD CULTURE Blood Culture, Routine-PENDING
CXR
___
FINDINGS: Lung volumes are very low, as seen previously. There
is no focal consolidation, pleural effusion or pneumothorax. The
aorta is tortuous. Heart size appears slightly smaller than the
previous exam. The imaged upper abdomen is unremarkable.
IMPRESSION: Low lung volumes but no acute cardiopulmonary
process
.
EKG:
___
Sinus 86, first degree AV block, LAD, T wave inversion in V4
Brief Hospital Course:
___ with PMH notable for Mantle cell lymphoma s/p chemotherapy
at ___ (___), hypertension, hyperlipidemia and ___
disease presenting with weakness / fever.
#FEVER: Patient reported one isolated fever and sudden onset of
generalized weakness with no localizing symptoms other than mild
nasal congestion. CXR neg. No leukocytosis. U/A WNL. Mantle cell
lymphoma in remission with a recent CT scan in ___ at ___.
Patient monitored off anti-pyretics with no recurrent fevers
throughout his course. His generalized malaise/weakness
resolved. Symptoms may have been secondary to mild, transient
viral illness. He did report hip pain, but chronic issue and
unchanged. No exam findings to suggest septic joint, no
leukocytosis, and ESR/CRP not suggestive of infection. He was
evaluated by ___ and arrangements for home ___ were made. Patient
will f/u with PCP and oncology. No antibiotics were
administered during hospitalization.
#DIABETES: Blood sugar on admission in the 240s. He takes
multiple medications at home, including metformin which was
added within the last month. Humalog sliding scale inpatient,
then discharged on home PO meds. No hypoglycemic episodes
throughout course. Counseled regarding importance of checking
fingerstick when symptomatic, including generalized malaise /
weakness, to ensure not hypoglycemic.
#HYPERTENSION: Blood pressure WNL on home regimen of Verapamil
and Ramipril.
#HYPERLIPIDEMIA:Continued Atorvastatin 20 mg PO/NG DAILY.
___ DISEASE: Likely contributed to recent weakness /
unsteadiness. No noticeable tremor on exam. Continued Sinemet
QID. Will f/u with home ___.
TRANSITIONAL ISSUES:
# Code: FULL
# Emergency Contact: Serg ___ ___
-f/u with PCP and oncologist
___ on Admission:
The Preadmission Medication list may be inaccurate and requires
futher investigation.
1. MetFORMIN (Glucophage) 500 mg PO DAILY
2. Azilect (rasagiline) 1 mg oral daily
3. Januvia (sitaGLIPtin) 100 oral daily
4. Atorvastatin 20 mg PO DAILY
5. Repaglinide 2 mg PO TID W/MEALS
6. Pantoprazole 40 mg PO Q24H
7. Carbidopa-Levodopa (___) 1.5 TAB PO TID
8. Carbidopa-Levodopa (___) 1 TAB PO DAILY
9. Docusate Sodium 100 mg PO BID
10. Ramipril 10 mg PO DAILY
11. Verapamil SR 400 mg PO QHS
12. Acetaminophen w/Codeine 1 TAB PO TID:PRN pain
13. Acyclovir 400 mg PO Q12H
14. Polyethylene Glycol 17 g PO DAILY:PRN constipation
15. Aspirin 81 mg PO DAILY
16. Bisacodyl 10 mg PR HS:PRN constipation
Discharge Medications:
1. Acyclovir 400 mg PO Q12H
2. Atorvastatin 20 mg PO DAILY
3. Azilect (rasagiline) 1 mg oral daily
4. Carbidopa-Levodopa (___) 1.5 TAB PO TID
5. Carbidopa-Levodopa (___) 1 TAB PO DAILY
6. Docusate Sodium 100 mg PO BID
7. Pantoprazole 40 mg PO Q24H
8. Polyethylene Glycol 17 g PO DAILY:PRN constipation
9. Ramipril 10 mg PO DAILY
10. Verapamil SR 400 mg PO QHS
11. Acetaminophen w/Codeine 1 TAB PO TID:PRN pain
12. Aspirin 81 mg PO DAILY
13. Bisacodyl 10 mg PR HS:PRN constipation
14. Januvia (sitaGLIPtin) 100 oral daily
15. MetFORMIN (Glucophage) 500 mg PO DAILY
16. Repaglinide 2 mg PO TID W/MEALS
Discharge Disposition:
Home With Service
Facility:
___.
Discharge Diagnosis:
Generalized malaise
h/o mantle cell lymphoma
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Dear Mr ___,
You were admitted to the hospital with an episode of fever and
weakness. You may have had a transient viral illness. You were
monitored here with no recurrent fevers and were feeling much
better prior to discharge. You should follow up with your PCP
for further ___.
Followup Instructions:
___
|
10808282-DS-21
| 10,808,282 | 27,115,454 |
DS
| 21 |
2123-09-20 00:00:00
|
2123-09-21 09:02:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Amoxicillin / Codeine / Latex / Lactose / Shellfish Derived
Attending: ___.
Chief Complaint:
Weakness
Major Surgical or Invasive Procedure:
Hemodialysis
History of Present Illness:
History of Present Illness: ___ year-old male with history of
ESRD on HD, CAD, ___ with resultant cardiac liver chirrosis,
RUE fistula s/p multiple revisions presenting today with
generalized weakness. The patient is on ___ dialysis
sessions.
.
Per the patient's report he has been in usual state of health
for the past several weeks no significant complaints, fevers or
otherwise. On ___ the patient decided that he had had enough
with dialysis and refused to go. His family asked that a social
worker see him at the house, but he was adimant that he would
not go to dialysis. On ___ the patient continued to feel fine
with no complaints. Late ___ night and into ___ morning
the patient developed several episodes of loose stool without
abdominal pian, nausea or vomitting. On the morning of
admission patient states he "felt terrible", was unable to walk
or stand, felt that his legs were going to buckle underneath
him. Also felt that he was tremors and unable to hold a cup of
tea. He denies any fevers, chills, pain, swelling in his arms
or legs, increased abdominal distention or abdominal pain. His
mother called and ambulance and he was brought to the ED.
.
In the ED, initial vs were: 97.9 86 142/86 18 98% RA. Patient
was noted to have chronic ulcerations on bilateral knees, over
chronic venous stasis. Patient was admitted for dialysis prior
to arrival on the floor. HD was uneventful by report.
.
On the floor, patient's vitals were 97.8, 135/85, 86, 20, 96RA.
And he was reporting improvement in his tremor as well as
jerking in his legs. He denied any pain or current abdominal
symptoms.
.
Review of sytems:
(+) Per HPI
(-) Denies fever, chills, night sweats, recent weight loss or
gain. Denies headache, sinus tenderness, rhinorrhea or
congestion. Denied cough, shortness of breath. Denied chest pain
or tightness, palpitations. Denied nausea, vomiting,
constipation or abdominal pain. No recent change in bladder
habits. No dysuria. Denied arthralgias or myalgias.
Past Medical History:
ESRD on HD ___, anemia, CAD, hypertension, systolic CHF,
hypothyroidism, psoriasis, restless leg syndrome, h/o L3 burst
fracture, s/p spinal fusion L2-4 ___, h/o MSSA osteomyelitis,
h/o MSSA epidural abscess, h/o MSSA paraspinal abscess, h/o MSSA
bacteremia.
Social History:
___
Family History:
Father died of MI in ___ mother alive and well ___; 8 siblings,
one of whom has HTN, one who has a cerebral aneurysm; he has no
children.
Physical Exam:
ADMISSION EXAM:
Vitals: 97.8, 135/85, 86, 20, 96RA
General: very caxcectic man, appears very anxious, Alert,
oriented, no acute distress, with a flat yet worried affect
appears mildly disheveled.
HEENT: Sclera mildly icteric, MMM, oropharynx clear, eczemathous
plaque on left ear lobe.
Neck: very little supperficial tissue, easily palpable
lymphnodes that do not appear enlarged, easily palpable thyroid
w/o masses. Lungs: Clear to auscultation bilaterally, no
wheezes, rales, ronchi
CV: Regular rate and rhythm, normal S1 + S2, faint ___ systolic
murmur in the precoridum and apex no rubs, gallops
Abdomen: grossly distented with easily visulaized epigastric
veins, positive fluid wave and distention of the flanks
bilaterally. pingpong ball sized errythematous mass in the LUQ
with small scar below. + bowel sounds, non-tender.
GU: no foley, some errythematous plaques in inguinal area,
easily to palpate, non-tender, mobile lymphnodes. No lesions on
glans or testees.
Ext: very wasted w/ little muscle mass. large protruberent
fistula on RUE, Right tunneled line inplace w/o errythema,
scaling errythematous plaques on plams, arms bilaterally,
chronic venous chagnes in feet and lower extremities with thick
finger and toe nails.
Neuro: CNs2-12 intact, motor function grossly normal w/ 4+
strenght in all extremities, not able to illict DTRs, no
flapping ___, but occasional whole body myoclonic
jerking. + rhomberg, pt unwilling to atempt gait testing. No
sensory defects noticed, normal FNF.
.
DISCHARGE EXAM:
Vitals: 98, 132/84, 73, 18, 97 RA
General: very caxcectic man, NAD, though anxious affect is
remarkable
HEENT: Sclera mildly icteric, MMM, oropharynx clear, eczemathous
plaque on left ear lobe.
Neck: very little supperficial tissue, easily palpable
lymphnodes that do not appear enlarged, easily palpable thyroid
w/o masses. Lungs: Clear to auscultation bilaterally, no
wheezes, rales, ronchi
CV: Regular rate and rhythm, normal S1 + S2, faint ___ systolic
murmur in the precoridum and apex no rubs, gallops
Abdomen: grossly distented with easily visulaized epigastric
veins, positive fluid wave and distention of the flanks
bilaterally. pingpong ball sized errythematous mass in the LUQ
with small scar below. + bowel sounds, non-tender.
Ext: very wasted w/ little muscle mass. large protruberent
fistula on RUE, Right tunneled line inplace w/o errythema,
scaling errythematous plaques on plams, arms bilaterally,
chronic venous chagnes in feet and lower extremities with thick
finger and toe nails.
Pertinent Results:
ADMISSION LABS:
___ 02:00PM BLOOD WBC-6.7 RBC-3.96* Hgb-11.8* Hct-37.0*
MCV-93 MCH-29.7 MCHC-31.8 RDW-16.4* Plt ___
___ 02:00PM BLOOD ___ PTT-36.7* ___
___ 02:00PM BLOOD Glucose-54* UreaN-34* Creat-5.0* Na-134
K-6.8* Cl-94* HCO3-23 AnGap-24*
___ 07:20AM BLOOD ALT-14 AST-29 CK(CPK)-57 AlkPhos-213*
TotBili-0.4
___ 07:20AM BLOOD Albumin-3.2* Calcium-8.9 Phos-5.5* Mg-2.1
___ 06:40AM BLOOD TSH-3.2
DISCHARGE LABS:
___ 06:33AM BLOOD WBC-5.9 RBC-3.68* Hgb-10.5* Hct-33.9*
MCV-92 MCH-28.5 MCHC-30.9* RDW-15.9* Plt ___
___ 06:33AM BLOOD Glucose-105* UreaN-31* Creat-5.4*# Na-138
K-4.9 Cl-94* HCO3-38* AnGap-11
IMAGING:
CXR: FINDINGS: Bilateral pleural effusions persist and are
likely increased slightly. Heart size is again noted to be
enlarged. Pulmonary vascular engorgement persists and is
similar. Lung volumes are low. Linear opacities at the right
base appear similar compared to prior and likely represent
atelectasis or scarring. Lumbar spine hardware is incompletely
imaged. Right-sided dialysis catheter is poorly evaluated on
this study, but likely terminates in the low right atrium. Right
subclavian stent is again noted.
IMPRESSION: Stable cardiomegaly, pulmonary vascular prominence,
and bilateral pleural effusions, probably increased somewhat.
MICROBIOLOGY:
Blood Cultures: Pending
Brief Hospital Course:
Assessment and Plan: ___ yo male with end stage renal, liver,
heart and lung disease along with overlaying depression who was
admitted with weakness after missing a dialysis appointment two
days prior to admission. Patient recieved dialysis with
improvement in his symptoms. Patient was screened by ___ and
determined to need short term rehab.
#WEAKNESS: PER PCP this is indeed the complaints a man with
multiorgan failure and progressive decline over several months.
Patient had some improvement in his symptoms with dialysis
though there was a singificant contribution of his symptoms by
decondidtioning. Patient was seen by physical therapy who
recommended that he receive short term rehabilitation to improve
his endurance and balance. There were no major metabolic,
infectious or hemodynamic causes of his weakness uncovered and
the patient was discharged to rehab. Depression and poor coping
were felt to play a major contribution to his symptoms and a
palliative care consult was placed to discuss long term goals of
care. It was determiend that the patient would go to rehab and
if continued to have progressive decline a move towards comfort
focus care would be made.
.
#ESRD: Patient missed his scheduled dialysis due to
non-compliance per his family's report. He was dialysised
according to his normal schedule while and inpatient and had a
mild improvement in his symptoms of weakness. Patient continued
to recieve all his usual renal medications.
.
#Systolic CHF: patient has a EF of ___ on last ECHO from
___ and stable cardiac exam. Patient continued onaspirin,
lisinopril, metoprolol while in house.
.
#CHIRRHOSIS: patient with history of cardiac induced cirrhosis
from chronic hepatic congestion. Has had infectious as well as
autoimmune workup for chirrohsis in the past which were
negative. No derangements in his liver function was observed
and the patient recieved lactulose to treat any enchilitis that
may have been contributing to his depression.
.
#CHRONIC PAIN: From compression fractures s/p fusion. Will
continue home dilaudid at 8 mg BID.
.
#RESTLESS LEG SYNDROME: Stable, continued home gabapentin and
ropinirole.
.
#HTN: Good systolic pressures at this time, will continue
lisinopril.
.
#HYPOTHYROID: will continue synthroid per home dosing as TSH
was not elevated.
.
#COPD: Lungs clear on exam and CXR w/o no respiratory
complaints, will continue titropium and albuterol.
.
#DEPRESSION: Patient's depression was identified as a major
barrier to his longterm care needs, he was continued on his home
buproprion and clonazepam. Activating medications including
ritalin were entertained, but felt that his underlying cardiac
and liver disease percluded its use.
.
TRANSITIONAL ISSUES:
-Primary nephrologist raised issue of future neuro-cognative
testing
-patient is a full code, but should be reassed as his chronic
issues continue to evolve
-Palliative care consultation was placed to address future,
needs patient still wishes to persue treatment of chronic issues
at this time
-patinet's blood cultures were pending, but no growth at the
time of discharge.
Medications on Admission:
- albuterol 90mcg ___ puffs Q4hrs
- Renal Caps 1mg daily
- Betamethasone dipropionate 0.05% Cream daily
- bupropion Hcl 150mg daily
- clonazepam 1mg daily PRN
- Gabapentin 900mg QHS
- Hydromorphone 8mg BID
- levothyroxine 125mcg daily
- lisinopril 5mg daily
- metoprolol succinate 100mg daily
- mometasone 0.1% lotion BID
- ropinirole 0.25mg QHS
- sevelamer 2400mg TID
- tiotropium 18mcg 2 puffs daily
- trazodone 50mg QHS
- Vit C 500mg daily
- ASA 81mg daily
Discharge Medications:
1. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig:
One (1) Puff Inhalation Q4H (every 4 hours).
2. B complex-vitamin C-folic acid 1 mg Capsule Sig: One (1) Cap
PO DAILY (Daily).
3. betamethasone dipropionate 0.05 % Cream Sig: One (1) Appl
Topical BID (2 times a day).
4. bupropion HCl 150 mg Tablet Extended Release Sig: One (1)
Tablet Extended Release PO QAM (once a day (in the morning)).
5. clonazepam 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily)
as needed for anxiety.
6. gabapentin 300 mg Capsule Sig: Three (3) Capsule PO HS (at
bedtime).
7. hydromorphone 2 mg Tablet Sig: Four (4) Tablet PO BID (2
times a day).
8. levothyroxine 125 mcg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
9. lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
10. metoprolol succinate 100 mg Tablet Extended Release 24 hr
Sig: One (1) Tablet Extended Release 24 hr PO once a day.
11. mometasone 0.1 % Cream Sig: One (1) Topical BID (2 times a
day).
12. ropinirole 0.25 mg Tablet Sig: One (1) Tablet PO QHS (once a
day (at bedtime)).
13. sevelamer carbonate 800 mg Tablet Sig: Three (3) Tablet PO
TID W/MEALS (3 TIMES A DAY WITH MEALS).
14. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig:
One (1) Cap Inhalation DAILY (Daily).
15. trazodone 50 mg Tablet Sig: One (1) Tablet PO HS (at
bedtime).
16. ascorbic acid ___ mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
17. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable
PO DAILY (Daily).
18. ondansetron 4 mg Tablet, Rapid Dissolve Sig: One (1) Tablet,
Rapid Dissolve PO Q8H (every 8 hours) as needed for nausea.
19. lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO TID (3
times a day).
20. nicotine 7 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr
Transdermal DAILY (Daily).
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
PRIMARY
- End Stage Renal Disease on a TuThSa dialysis schedule
SECONDARY
- Systolic heart failure
- Anemia
- Chronic ascites and cirrhosis from congestive hepatopathy
- Compression fractures, s/p L2-4 fusion causing chronic pain
- Hypertension
- hypothyroidism
- restless leg syndrome
- psoriasis
- Chronic Obstructive Pulmonary Disease
- Depression
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
It was a pleasure taking care of you while you were in the
hospital. You were admitted for evaluation of your weakness and
difficulty standing. This was felt to be related to missing
your dialysis session and a result of your chronic liver, lung,
heart and kidney diseases. You were seen by our physical
therapists who felt that you would benefit from rehab, Dr.
___ Dr. ___ agreed as did your family.
The following changes were made to your medications:
-Start Lactulose 30 mL three times a day
Followup Instructions:
___
|
10808292-DS-11
| 10,808,292 | 29,980,567 |
DS
| 11 |
2188-04-25 00:00:00
|
2188-04-25 17:04:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Dyspnea
Major Surgical or Invasive Procedure:
EKOS catheter placement with tPA administration
History of Present Illness:
Mr. ___ is a ___ year-old male with PMH significant for HTN, HLD
who presents with 2 days of dyspnea and pre-syncope with imaging
showing extensive bilateral acute pulmonary embolism and TTE
with right heart strain.
Patient had recurrent fevers and fatigue and was admitted to
___ 1 week ago. During that hospitalization, he
underwent flu testing that was negative and was found to have
elevated troponin. He underwent a negative stress test and was
discharged after a 3 day hospitalization. After discharge, he
continued to have fevers up to ___. Patient awoke on ___ at
2AM to use the restroom and noted dyspnea and lightheadedness.
He felt pre-syncopal and lowered himself to the ground. He did
not lose consciousness and denied head strike or trauma. He
asked his tenant to call EMS and was taken to ___
with CTA findings of bilateral pulmonary emboli. He was started
on IV
heparin and transferred to ___ for further evaluation. Patient
denies any recent travel, immobility, or prior history of VTE.
Has had cramping of left calf over last few days and bilateral
lower extremity edema. Denies family history of VTE, history of
stroke, trauma, malignancy.
In the ED at ___, initial vitals were notable:
T 98.3 HR 116 BP 133/83 RR 18 SpO2 93%|2L O2
- Exam notable for:
Uncomfortably appearing, dyspneic. No lower extremity edema.
- Labs notable for:
14.7
15.9 >----< 208
43.8
137|100|14
----------< 127
5.3|21|0.9
Trop T < 0.01
BNP 2729
Lactate 2.2
- Studies notable for:
TTE: Dilated right ventricle with severe RV systolic dysfunction
c/w PE on chronic pHTN. Small underfilled LV with normal global
and regional LV systolic function. Moderate to severe functional
TR. Severe pHTN.
___:
DVT within posterior tibial veins of left upper calf.
ECG:
Sinus rhythm with PACs. Tachycardic. S1, Q3. Incomplete RBBB.
Borderline LAD. T wave inversions in V1-V4.
- Patient was given:
+ Heparin gtt
- Consults
Vascular medicine: Recommended catheter-directed thrombolysis
and admission to the CCU.
Patient was taken to ___ where EKOS catheters were placed and tPA
started w/o complication.
On arrival to the CCU, patient confirmed the above history. He
has had some intermittent L sided pleuritic chest pain and he
has had back pain secondary to lying in the hospital bed. He
does not currently feel short of breath.
ROS: Positive per HPI. Remaining 10 point ROS reviewed and
negative.
Past Medical History:
PAST MEDICAL HISTORY:
Cardiac History:
- HTN
- HLD
Other PMH:
- Anxiety
Social History:
___
Family History:
No known family history of VTE. Father with MI in his ___.
Physical Exam:
ADMISSION PHYSICAL EXAM:
==========================
VS: T98.7 HR 114 BP 135/84 RR 36 91% 3L NC
GENERAL: Well developed, well nourished in NAD. Oriented x3.
Mood, affect appropriate.
HEENT: Normocephalic, atraumatic. Sclera anicteric. PERRL. EOMI.
NECK: Supple. EKOS catheters in place through R IJ.
CARDIAC: Tachycardic. No murmurs, rubs, or gallops appreciated.
LUNGS: Tachypneic, CTAB
ABDOMEN: Soft, non-tender, non-distended. No palpable
hepatomegaly or splenomegaly.
EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or
peripheral edema.
SKIN: No significant lesions or rashes.
PULSES: Distal pulses palpable and symmetric.
DISCHARGE PHYSICAL EXAM:
==========================
VS: 24 HR Data (last updated ___ @ 710)
Temp: 97.7 (Tm 99.6), BP: 161/89 (145-175/73-99), HR: 75
(67-88), RR: 18, O2 sat: 98% (94-98), O2 delivery: Ra
Fluid Balance (last updated ___ @ 701)
Last 8 hours Total cumulative -2520ml
IN: Total 480ml, PO Amt 480ml
OUT: Total 3000ml, Urine Amt 3000ml
Last 24 hours Total cumulative -3002ml
IN: Total 2998ml, PO Amt 2020ml, IV Amt Infused 978ml
OUT: Total 6000ml, Urine Amt 6000ml
GENERAL: comfortable, well appearing, obese. in no acute
distress
HEENT: Normocephalic, atraumatic. Sclera anicteric. PERRL. EOMI.
CARDIAC: RRR, no murmurs/rubs/gallops
LUNGS: CTAB, normal work of breathing on RA
ABDOMEN: Soft, non-tender, non-distended. No palpable
hepatomegaly or splenomegaly.
EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or
peripheral edema.
SKIN: No significant lesions or rashes.
PULSES: Distal pulses palpable and symmetric.
Pertinent Results:
ADMISSION LABS:
=================
___ 10:35AM BLOOD WBC-15.9* RBC-5.26 Hgb-14.7 Hct-43.8
MCV-83 MCH-27.9 MCHC-33.6 RDW-14.2 RDWSD-42.5 Plt ___
___ 10:35AM BLOOD Neuts-73.0* ___ Monos-6.7
Eos-0.1* Baso-0.2 Im ___ AbsNeut-11.60* AbsLymp-3.02
AbsMono-1.06* AbsEos-0.01* AbsBaso-0.03
___ 10:35AM BLOOD ___ PTT-34.3 ___
___ 07:30PM BLOOD ___
___ 10:35AM BLOOD Glucose-127* UreaN-14 Creat-0.9 Na-137
K-5.3 Cl-100 HCO3-21* AnGap-16
___ 10:35AM BLOOD cTropnT-<0.01
___ 10:35AM BLOOD proBNP-2729*
___ 07:30PM BLOOD Calcium-8.3* Phos-3.3 Mg-2.1
___ 02:01PM BLOOD Lactate-2.2*
NOTABLE INTERVAL LABS:
========================
___ 09:56AM BLOOD ALT-41* AST-19 LD(LDH)-292* AlkPhos-80
TotBili-0.7
___ 06:03AM BLOOD %HbA1c-6.0 eAG-126
DISCHARGE LABS:
=====================
___ 05:50AM BLOOD WBC-8.0 RBC-4.57* Hgb-12.7* Hct-39.3*
MCV-86 MCH-27.8 MCHC-32.3 RDW-13.9 RDWSD-43.1 Plt ___
___ 05:50AM BLOOD ___ PTT-75.3* ___
___ 05:50AM BLOOD Glucose-136* UreaN-11 Creat-0.8 Na-141
K-5.0 Cl-100 HCO3-31 AnGap-10
___ 05:50AM BLOOD Calcium-9.0 Phos-5.6* Mg-2.2
IMAGING/STUDIES:
====================
BILAT LOWER EXT VEINS Study Date of ___ 11:50 AM
DVT suspected within the posterior tibial veins of the left
upper calf.
Otherwise negative
PULMONARY ARTERIOGRAM Study Date of ___ 1:58 ___
FINDINGS:
1. The access right basilic vein was patent and compressible.
2. Basilic Vein approach double-lumen right PICC with tips in
the distal SVC.
3. Placement of 6cm EKOS catheter into the left pulmonary
artery
4. Placement of 12cm EKOS catheter into the right pulmonary
artery
For reporting clarification, diagnostic arteriograms were
medically necessary to evaluate for anatomy, abnormal
vasculature, and the presence or absence of thrombus, active
bleeding, pseudoaneurysms, and or arteriovenous fistula.
IMPRESSION:
Successful placement of a right 41 cm basilic approach single
lumen PowerPICC with tip in the distal SVC. The line is ready
to use.
Technically successful placement of 6cm EKOS catheter into the
left pulmonary artery.
Technically successful placement of 12cm EKOS catheter into the
right
pulmonary artery.
Both catheters were infused each at a rate of 0.75
milligrams/hour of tPA for a total of 16 hours for a total doses
of 24 mg of tPA.
Improvement of bilateral mean pulmonary pressures from 56mmHg
pre-treatment to 27mmHg post-treatment.
CHEST (PORTABLE AP) Study Date of ___ 7:06 ___
Status post bilateral pulmonary artery catheter placements.
PICC line
terminating in the lower superior vena cava. Otherwise, no
significant
change.
Transthoracic Echocardiogram Report ___ 24:00
Dilated right ventricle with severe RV systolic dysfunction,
most c/w acute
pulmonary embolism on the background of chronic pulmonary
hypertension. Small, underfilled LV with normal global and
regional left ventricular systolic function. Moderate to severe
functional tricuspid regurgitation. Severe pulmonary
hypertension.
MICROBIOLOGY:
=================
___ 10:50 am URINE **FINAL REPORT ___
URINE CULTURE (Final ___: NO GROWTH.
Brief Hospital Course:
Mr. ___ is a ___ year-old male with PMH significant for HTN, HLD
who presented with 2 days of dyspnea and pre-syncope found to
have extensive bilateral acute submassive pulmonary embolism and
TTE with right heart strain. He underwent catheter-directed
thrombolysis with significant improvement in symptoms. He was
then bridged to warfarin with heparin gtt.
#CORONARIES: Unknown
#PUMP: EF 60-65%. Severe RV systolic dysfunction with dilated
RV.
#RHYTHM: sinus tachycardia
ACUTE ISSUES:
=============
# Acute submassive pulmonary embolism with RV systolic
dysfunction:
# Acute hypoxic respiratory failure:
Patient developed acute bilateral submassive pulmonary embolisms
w right heart strain. No recent travel, family history of VTE.
Given evidence of severe RV systolic dysfunction, he underwent
catheter-directed thrombolysis and initiation of heparin gtt
with bridge to warfarin. He was therapeutic on discharge with
INR 2.9. DOACs and lovenox avoided due to patient's obesity. He
will likely need at least 6 months of anticoagulation with
warfarin given BMI. He will be scheduled to follow up with Dr.
___ in vascular medicine. He will be set up with the
___ clinic for INR checks as he plans on
transitioning his primary care to ___ his next INR check
should be on ___.
# Severe pulmonary hypertension
# untreated OSA
# morbid obesity
Likely chronic underlying undiagnosed severe pulmonary
hypertension. Potential etiologies include Group 3 given
patient's untreated OSA, Group 4 due to possible chronic
thromboembolic disease. Should have outpatient follow up for
pulmonary hypertension workup and management of OSA. He was
care-connected with the sleep medicine clinic so that he can
undergo a sleep study and be initiated on CPAP treatment. He
also expressed desire to follow with a nutritionist to help him
with weight loss and should be referred to one as an outpatient
as appropriate.
# HTN
Had been hypertensive to 150-160s on home lisinopril 5mg.
Uptitrated home lisinopril to 20mg daily.
# HLD
Continued home pravastatin 40mg daily
#acute gout flare
Pt complaining of acute R MTP pain that he attributes to his
gout and for which he takes colchicine PRN. He was loaded with
colchicine 1.8mg on ___, with plan to complete 10 day course
of colchicine 0.6mg BID to end on ___.
#prediabetes
A1c 6.0% - he was counseled on exercise and diet for weight loss
and should be considered for metformin initiation as an
outpatient.
TRANSITIONAL ISSUES:
=====================
[ ] Discharged with warfarin 5mg daily, INR on ___ was 2.9. He
will be setup with the ___ clinic for INR
checks. He should have his next INR checked on ___.
[ ] He will be followed in vascular medicine clinic with Dr.
___ at ___ for bilateral pulmonary emboli.
[ ] Pt with severe underlying pulmonary hypertension. Should
undergo outpatient workup with pulmonology.
[ ] Pt likely has underlying and untreated OSA. Should have
sleep study and initiation.
[ ] Pt started on colchicine 0.6mg BID for acute gout flare.
Total 10 day course to end on ___.
[ ] A1c 6.0% - prediabetic. Recommend nutrition counseling as
outpatient for weight loss. Consider initiating metformin
[ ] Please continue to titrate antihypertensives, he was
discharged with lisinopril 20mg daily. He should have a BMP
check along with his INR check a week after discharge.
[ ] Patient takes clonazepam 1mg TID as needed for anxiety as
prescribed by his current PCP ___ in ___. He
last received 90 tabs of clonazepam on ___ per MassPMP
check.
[ ] Please continue to support smoking cessation efforts
#CODE: Full Code (confirmed)
#CONTACT/HCP: ___ (father) ___
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Lisinopril 5 mg PO DAILY
2. Pravastatin 40 mg PO QPM
3. Nicotine Patch 21 mg/day TD DAILY
4. ClonazePAM 1 mg PO TID:PRN anxiety
Discharge Medications:
1. Warfarin 5 mg PO DAILY16
RX *warfarin 5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet
Refills:*0
2. Colchicine 0.6 mg PO BID
RX *colchicine 0.6 mg 1 tablet(s) by mouth twice daily Disp #*16
Tablet Refills:*0
3. Lisinopril 20 mg PO DAILY
RX *lisinopril 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet
Refills:*0
4. ClonazePAM 1 mg PO TID:PRN anxiety
5. Nicotine Patch 21 mg/day TD DAILY
6. Pravastatin 40 mg PO QPM
Discharge Disposition:
Home
Discharge Diagnosis:
Submassive pulmonary embolism with right heart strain
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you during your stay at ___.
WHY WAS I HERE?
-You had pulmonary embolisms (blood clots) in both your lungs
which was straining your heart
WHAT WAS DONE WHILE I WAS HERE?
- You were given a powerful blood thinner through special
catheters directed to the blood clots in your heart to help
break them up
- You were started on a blood thinner called warfarin (Coumadin)
to help prevent any further clot from forming
- You were started on colchicine for your gout flare and will
need to continue taking this for another week
- You improved and were ready to go home.
WHAT SHOULD I DO WHEN I GO HOME?
- You should continue to take your blood thinner (warfarin) as
directed; you will need to have regular blood checks to help
direct the dosing of this medication. You will need to take this
for at least 6 months after leaving the hospital.
- You will be scheduled with an appointment with Dr. ___ in
the ___ Medicine Clinic.
- You should see a sleep medicine doctor and wear your CPAP
machine.
- You should see a ___ and work on weight loss.
- You should see a primary care doctor regularly and ___ set
you up with a new primary care physician at ___
Associates
- If you have any chest pain, shortness of breath, trouble
breathing when you are exerting yourself, or any other new or
worsening symptoms that concern you - please call your doctor
and go to an emergency room.
We wish you the best!
-Your ___ Care Team
Followup Instructions:
___
|
10808848-DS-12
| 10,808,848 | 25,986,133 |
DS
| 12 |
2165-10-28 00:00:00
|
2165-10-29 16:27:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: SURGERY
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Splenic cyst
Major Surgical or Invasive Procedure:
___: Laparoscopy-assisted splenectomy
History of Present Illness:
This is a ___ year old lady with left pleuritic chest pain x ___
weeks found on imaging to have 10.3 cm splenic cyst. She
originally presented to an OSH after having ___ left pleuritic
chest pain. An elevated D-dimer prompted a CTA chest which was
negative, but incidentally was found to have a splenic cyst. A
CT abdomen with contrast was performed and demonstrated a large
splenic cyst measuring 10.3 cm. Surgical consultation
recommended transfer to ___ for further management. She has
had associated nausea and NB/NB emesis x1.
Of note, she reports increased shortness of breath over the past
month and has been seen by a cardiologist at ___. Her
SOB was attributed to severe mitral regurgitation and she was
being planned for surgical repair in ___.
She was in ___ hiking about a month ago when her shortness of
breath was first noticed, but she was staying in hotels. She
has had no other recent travel. Denies fevers, chills,
diarrhea, BRBPR, hematemesis, dyspnea, rash, skin changes, or
jaundice.
Past Medical History:
Past Medical History:
-Mitral valve prolapse (on quinapril)
-Severe mitral regurgitation scheduled for repair in ___
-H. pylori treated ___
-Strongyloides with ivermectin x2 in ___
-Lyme ___
-IBS with chronic constipation since childhood
-H/o BRBPR s/p colonoscopy ___ (negative)
-Seasonal allergies
-Asthma
Past Surgical History:
-C-section x 1
-Umbilical hernia repair
-Ovarian cyst excision (benign per patient)
Social History:
___
Family History:
There is no celiac sprue, colitis or Crohn's. There is no
rheumatoid or lupus, diabetes or thyroid in the family. There is
no colon cancer. Her mother has hypertension and osteoarthritis
and her father has osteoarthritis.
Physical Exam:
VS: Temp 98.9, HR 101, BP 129/84, RR 16, SpO2 98% RA
GEN: AA&O x 3, NAD, calm, cooperative.
HEENT: (-) LAD, mucous membranes moist, trachea midline, EOMI,
PERRL.
CHEST: Clear to auscultation bilaterally, no increased work of
breathing noted.
ABDOMEN: Soft, mildly tender to palpation incisionally,
non-distended. Incisions: clean, dry and intact without
surrounding erythema or fluctuance, closed with staples.
EXTREMITIES: Warm, well perfused, pulses palpable, (-) edema.
Pertinent Results:
SPLENIC ULTRASOUND (___):
Complex cystic necrotic mass in the spleen. The differential
remains broad including tumor is as well as parasitic cysts.
CHEST X-RAY (___):
Lungs are grossly clear. There is minimal blunting of the right
CP angle, however this area appears unremarkable on the lateral
view. Heart size is normal. Bony structures are intact.
Brief Hospital Course:
Ms. ___ was initially admitted to the Medicine Service on
___ for workup of her left upper quadrant pain that was
associated with pleurisy. In her initial evaluation, a chest CTA
was performed at an outside hospital, which was negative for a
pulmonary embolism, but did show a 10.3 cm heterogeneous LUQ
(presumed splenic) mass with internal septation, displacing the
tail of pancreas anteriorly. A surgical consult was obtained and
the decision was made to transfer the patient to the Acute Care
Surgical service for further management. Cardiology and
Infectious Disease were also consulted, the former for surgical
planning in relation to the patient's severe mitral
regurgitation and the latter for question that this mass could
be an echinococcal cyst. She was started on albendazole on
hospital day 3. The patient was taken to the operating room on
___ for a laparoscopy-assisted splenectomy (please see the
Operative Report for further details). The splenic contents were
sent for pathology. At the time of discharge, the splenic
pathology had returned and was negative for echinococcus, so
albendazole was stopped. On the day of discharge, the patient
was given post-splenectomy vaccines (Prevnar 13, Menactra and
Hib conjugate) and discharged with appropriate follow-up
instructions.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Quinapril 10 mg PO DAILY
Discharge Medications:
1. Quinapril 10 mg PO DAILY
2. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain
You may not drive while taking Oxycodone pain medication.
RX *oxycodone 5 mg ___ tablet(s) by mouth every four hours Disp
#*30 Tablet Refills:*0
3. Docusate Sodium 100 mg PO BID
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day
Disp #*60 Capsule Refills:*0
4. Levofloxacin 750 mg PO Q24H Duration: 5 Days
Please take this medication only if you spike a fever (>100.4 F)
at home.
RX *levofloxacin [Levaquin] 750 mg 1 tablet(s) by mouth daily
Disp #*5 Tablet Refills:*0
Discharge Disposition:
Home
Discharge Diagnosis:
Splenic cyst s/p splenectomy
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Ms. ___,
You were admitted to ___ with a
cyst in your spleen. While you were here, we removed your spleen
and gave you the appropriate post-splenectomy vaccinations. You
have now recovered well from your procedure and are ready to
continue your recovery at home. Please follow the instructions
below to ensure a safe and speedy recovery:
Please call your doctor or nurse practitioner or return to the
Emergency Department for any of the following:
*You experience new chest pain, pressure, squeezing or
tightness.
*New or worsening cough, shortness of breath, or wheeze.
*If you are vomiting and cannot keep down fluids or your
medications.
*You are getting dehydrated due to continued vomiting, diarrhea,
or other reasons. Signs of dehydration include dry mouth, rapid
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a
bowel movement.
*You experience burning when you urinate, have blood in your
urine, or experience a discharge.
*Your pain in not improving within ___ hours or is not gone
within 24 hours. Call or return immediately if your pain is
getting worse or changes location or moving to your chest or
back.
*You have shaking chills, or fever greater than 101.5 degrees
Fahrenheit or 38 degrees Celsius.
*Any change in your symptoms, or any new symptoms that concern
you.
Please resume all regular home medications, unless specifically
advised not to take a particular medication. Also, please take
any new medications as prescribed.
Please get plenty of rest, continue to ambulate several times
per day, and drink adequate amounts of fluids. Avoid lifting
weights greater than ___ lbs until you follow-up with your
surgeon.
Avoid driving or operating heavy machinery while taking pain
medications.
Incision Care:
*Please call your doctor or nurse practitioner if you have
increased pain, swelling, redness, or drainage from the incision
site.
*Avoid swimming and baths until your follow-up appointment.
*You may shower, and wash surgical incisions with a mild soap
and warm water. Gently pat the area dry.
*If you have staples, they will be removed at your follow-up
appointment.
*If you have steri-strips, they will fall off on their own.
Please remove any remaining strips ___ days after surgery.
Additionally, please follow up with your primary care physician
within two weeks of discharge. We will send you with a
prescription for an antibiotic called levofloxacin. Please take
this only if you spike a fever with a temperature greater than
100.4 F.
Best wishes,
Your surgical team
Followup Instructions:
___
|
10808848-DS-14
| 10,808,848 | 27,124,577 |
DS
| 14 |
2169-12-29 00:00:00
|
2169-12-29 13:11:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: NEUROLOGY
Allergies:
gluten
Attending: ___
Chief Complaint:
vertigo, abnormal imaging
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ is a ___ year old right handed woman with a history of
metastatic angiosarcoma as well as mitral regurgitation for whom
a Neurology consultation is requested due to findings of an
acute
infarct on MRI.
Her history begins yesterday evening. She states she otherwise
had a normal day and was able to exercise, go to work, and drive
home without any difficulty. She returned home at about 6:30pm.
Shortly after walking into the house and putting down her
things,
she noticed the onset of room spinning vertigo. She describes
this as coming on gradually over about 5 minutes. She notes that
the vertigo was generally mild and at first she did not think
much of it but did feel generally unwell. Vertigo was made worse
by head movement, but only for a second or two, and she reports
a
constant level of mild vertigo. She also experienced a gradual
onset of a feeling of tightness in a band across her chest.
There
was no associated dyspnea. She thought she had not slept enough
over the past few days, so lied down on the couch. She asked her
husband to go any buy a blood pressure cuff, as she was worried
her blood pressure may be too high. When he returned, her
symptoms had not abated, so she presented to the ED around 8pm
last night.
In the ED, she notes that she experienced a few other symptoms,
including some nonrhythmic, asynchronous or alternating
movements of
her limbs, mostly her legs as well as a sensation as if the
lights were dimmed, a darkness sensation (she denies a loss of
vision), a feeling of tightness in her throat, and occasional
nausea without vomiting. She also noted that when undergoing a
neurologic exam by the ED team, she felt that the right side of
her body felt "colder" when touched compared to the left.
Finally
she does endorse occasional "difficulty speaking", though
clarifies that this was more due to her
Initial vital signs in the ED were notable for a BP of 172/103,
though subsequent blood pressures have been normal. She
underwent
a CTA of the chest/abdomen/pelvis, which showed numerous
pulmonary metastases, new from earlier this year. She also
underwent an MRI of the brain w/ and w/o contrast given concern
for metastatic disease. This showed a small acute ischemic
stroke in the left mesial temporal lobe, prompting Neurology
consult.
On my evaluation, she reports that her vertigo has essentially
resolved, and she has been able to walk around without any
difficulty. Throughout this episode she denies any headache,
neck
ache, fever, chills, slurred speech, difficulty comprehending or
producing speech, confusion, loss of consciousness, tinnitus,
hearing loss, dysarthria, dysphagia, facial droop, weakness, or
other sensory change.
Past Medical History:
Past Medical History:
-Splenic angiosarcoma
-Mitral valve prolapse (on quinapril, followed by Dr. ___
at ___
-Severe mitral regurgitation
-H. pylori treated ___
-Strongyloides with ivermectin x2 in ___
-IBS with chronic constipation since childhood
-Seasonal allergies
-Ovarian cyst (noted incidentally on PET)
Surgical History
Resection of angiosarcoma diaphragm recurrence
Splenectomy
Social History:
___
Family History:
Maternal grandfather had a stroke in his ___. Both parents have
hypertension.
Physical Exam:
ADMISSION PHYSICAL EXAM
=======================
Vitals: T: 98.7 BP: 126/86 HR: 78 RR: 17 SaO2: 97% RA
General: Awake, cooperative, NAD.
HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in
oropharynx.
Neck: Supple, no carotid bruits appreciated. No nuchal rigidity.
Pulmonary: Normal work of breathing.
Cardiac: warm, well-perfused.
Abdomen: Soft, non-distended.
Extremities: No ___ edema.
Skin: No rashes or lesions noted.
Neurologic:
-Mental Status: Alert, oriented x 3. Able to relate history
without difficulty. Attentive, able to name ___ backward without
difficulty. Language is fluent with intact repetition and
comprehension. Normal prosody. There were no paraphasic errors.
Able to name both high and low frequency objects. No dysarthria.
Able to follow both midline and appendicular commands. Able to
register 3 objects and recall ___ at 5 minutes. There was no
evidence of apraxia or neglect.
-Cranial Nerves:
II, III, IV, VI: PERRL 4 to 2mm and brisk. EOMI without
nystagmus. Normal saccades. VFF to confrontation. Funduscopic
exam revealed no papilledema, exudates, or hemorrhages.
V: Facial sensation intact to light touch.
VII: No facial droop, facial musculature symmetric.
VIII: Hearing intact to finger-rub bilaterally.
IX, X: Palate elevates symmetrically.
XI: ___ strength in trapezii bilaterally.
XII: Tongue protrudes in midline with good excursions. Strength
full with tongue-in-cheek testing.
-Motor: Normal bulk and tone throughout. No pronator drift. No
adventitious movements, such as tremor or asterixis noted.
[___]
L 5 5 5 5 5 5 5 5 5 5 5 5
R 5 5 5 5 5 5 5 5 5 5 5 5
-Sensory: No deficits to light touch, pinprick, temperature,
vibration, or proprioception throughout. No extinction to DSS.
Romberg absent.
-Reflexes:
[Bic] [Tri] [___] [Pat] [Ach]
L 2 2 2 2 2
R 2 2 2 2 2
She did occasional seem to "jump" when reflexes were tested, but
this seemed more of a voluntary movement. No pathologic reflexes
were present.
Plantar response was flexor bilaterally.
-Coordination: No intention tremor. Normal finger-tap
bilaterally. No dysmetria on FNF or HKS bilaterally.
-Gait: Good initiation. Narrow-based, normal stride and arm
swing. Able to walk in tandem without difficulty.
___ maneuver not attempted as she is no longer
complaining of vertigo.
DISCHARGE PHYSICAL EXAM
=======================
General: Awake, cooperative, NAD.
HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in
oropharynx.
Neck: Supple, no carotid bruits appreciated. No nuchal rigidity.
Pulmonary: Normal work of breathing.
Cardiac: warm, well-perfused.
Abdomen: Soft, non-distended.
Extremities: No ___ edema.
Skin: No rashes or lesions noted.
Neurologic:
-Mental Status: Alert, oriented x 3. Able to relate history
without difficulty. Attentive. Language fluent no paraphasic
errors.
Able to follow both midline and appendicular commands.
-Cranial Nerves:
II, III, IV, VI: PERRL 4 to 2mm and brisk. EOMI without
nystagmus. Normal saccades. VFF to confrontation. Funduscopic
exam revealed no papilledema, exudates, or hemorrhages.
V: Facial sensation intact to light touch.
VII: No facial droop, facial musculature symmetric.
VIII: Hearing intact to finger-rub bilaterally.
IX, X: Palate elevates symmetrically.
XI: ___ strength in trapezii bilaterally.
XII: Tongue protrudes in midline with good excursions. Strength
full with tongue-in-cheek testing.
-Motor: Normal bulk and tone throughout. No pronator drift. No
adventitious movements, such as tremor or asterixis noted.
[___]
L 5 5 5 5 5 5 5 5 5 5 5 5
R 5 5 5 5 5 5 5 5 5 5 5 5
-Sensory: No deficits to light touch throughout. No extinction
to DSS.
-Coordination: No intention tremor. Normal finger-tap
bilaterally. No dysmetria on FNF or HKS bilaterally.
Pertinent Results:
ADMISSION LABS
==============
___ 07:45PM BLOOD WBC-6.8 RBC-4.03 Hgb-11.9 Hct-35.4 MCV-88
MCH-29.5 MCHC-33.6 RDW-13.9 RDWSD-44.8 Plt ___
___ 07:45PM BLOOD Neuts-46.2 ___ Monos-12.7
Eos-7.4* Baso-1.2* Im ___ AbsNeut-3.14 AbsLymp-2.18
AbsMono-0.86* AbsEos-0.50 AbsBaso-0.08
___ 07:45PM BLOOD Plt ___
___ 07:45PM BLOOD ___ PTT-30.2 ___
___ 07:45PM BLOOD Glucose-120* UreaN-19 Creat-0.6 Na-138
K-4.2 Cl-99 HCO3-24 AnGap-15
___ 07:45PM BLOOD ALT-18 AST-33 AlkPhos-82 TotBili-0.3
___ 07:45PM BLOOD cTropnT-<0.01
___ 11:49PM BLOOD cTropnT-<0.01
___ 07:45PM BLOOD Albumin-4.4
DISCHARGE LABS
==============
___ 04:45AM BLOOD WBC-5.3 RBC-3.96 Hgb-11.6 Hct-35.2 MCV-89
MCH-29.3 MCHC-33.0 RDW-13.9 RDWSD-45.5 Plt ___
___ 04:45AM BLOOD Plt ___
___ 04:45AM BLOOD Glucose-94 UreaN-12 Creat-0.6 Na-140
K-4.7 Cl-102 HCO3-27 AnGap-11
___ 04:45AM BLOOD Calcium-9.9 Phos-4.6* Mg-1.9
IMAGING
=======
MR HEAD W & W/O CONTRAST Study Date of ___
IMPRESSION:
1. 5 mm diffusion-weighted hyperintense signal in the left
medial temporal
lobe without evidence of abnormal enhancement, suggesting acute
infarct. No findings to suggest intracranial metastatic disease
at this time.
2. Focal enlargement of the right trigeminal nerve expanding the
right
foramina ovale, in retrospect unchanged since examination of ___.
This may represent a nerve sheath tumor. Recommend follow-up
examination in ___ months to document stability.
3. Additional findings described above.
CTA HEAD AND CTA NECK Study Date of ___
IMPRESSION:
1. Known tiny left temporal lobe infarct is not appreciated.
2. Normal head and neck CTA.
3. Possible right trigeminal nerve schwannoma is better assessed
on preceding MRI.
4. Lung findings more fully characterized on same day chest CT.
CTA CHEST Study Date of ___
IMPRESSION:
1. No pulmonary embolism or acute aortic abnormality.
2. Numerous bilateral pulmonary metastases.
3. Prominent right periaortic lymph nodes, recommend attention
on follow-up.
___ TTE
IMPRESSION: Mild bileaflet mitral valve prolapse with moderate
late systolic mitral regurgitation. Mild symmetric left
ventricular hypertrophy with normal cavity size, and
regional/global systolic function. Mild tricuspid regurgitation.
Compared with the prior TTE ___ , the degree of tricuspid
regurgitation is now less.
Brief Hospital Course:
Ms ___ is a ___ year old woman with a past medical history of
splenic angiosarcoma and mitral regurgitation who presented to
the ED with vertigo, chest tightness. Found to have new ischemic
stroke and pulmonary metastases.
#Left medial temoral lobe ischemic stroke:
Initial NIHSS was 0. History notable for cycling-like movements
of her extremities which were suppressible and resolved prior to
Neuro evaluation. Exam remained normal throughout admission and
vertigo was resolved by the time of neurology assessment. MRI
was initially obtained to evaluate for metastatic disease, and
instead showed a small ischemic stroke in the left medial
temporal lobe. Vessels were patent with no atherosclerotic
burden on CTA imaging. TTE with no thrombus or PFO. Risk factors
notable for HbA1c of 5.6, LDL of 116. Etiology concerning for
hypercoagulability in setting of malignancy (potentially basilar
thrombus that resolved given transient symptoms of brainstem
ischemia such as vertigo/nausea, right-sided sensory problems,
bilateral leg movements, and odd visual sensations such as
dimming of the lights, possibly suggesting a bilateral PCA
problem) versus cardioembolic. In that context, it is important
that the small ischemic stroke in the left messiah temporal lobe
is suggestive of a small embolus that travelled into the left
PCA. Per discussion with outpatient oncologist (Dr. ___
___, decision made to initiate lovenox for secondary
stroke prophylaxis. Also initiated atorvastatin 40mg qhs. She
will be discharged with a zio patch to monitor for atrial
fibrillation.
#Splenic angiosarcoma with new pulmonary metastases:
Presented with chest tightness of unclear etiology. CTA chest
revealed multiple bilateral pulmonary metastases. Outpatient
oncologist aware, reviewing scans at sarcoma conference, will
see in clinic the next several days to discuss next steps for
management. Visited patient prior to her discharge.
#HTN:
Continued home quinapril.
#Hypothyroidism:
Continued home ___ thyroid.
TRANSITIONAL ISSUES
===================
[] initiated lovenox, atorvastatin for stroke management
[] f/u Zio patch to monitor for atrial fibrillation, consider
transition from lovenox to apixaban if afib identified
===============
AHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic
Attack
1. Dysphagia screening before any PO intake? (x) Yes, confirmed
done - () Not confirmed () No. If no, reason why:
2. DVT Prophylaxis administered? (x) Yes - () No. If no, why not
(I.e. bleeding risk, hemorrhage, etc.)
3. Antithrombotic therapy administered by end of hospital day 2?
(x) Yes - () No. If not, why not? (I.e. bleeding risk,
hemorrhage, etc.)
4. LDL documented? (x) Yes (LDL = 116 ) - () No
5. Intensive statin therapy administered? (simvastatin 80mg,
simvastatin 80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg,
rosuvastatin 20mg or 40mg, for LDL > 70) (x) Yes - () No [if LDL
>70, reason not given:
[ ] Statin medication allergy
[ ] Other reasons documented by physician/advanced practice
nurse/physician ___ (physician/APN/PA) or pharmacist
[ ] LDL-c less than 70 mg/dL
6. Smoking cessation counseling given? () Yes - (x) No [reason
(x) non-smoker - () unable to participate]
7. Stroke education (personal modifiable risk factors, how to
activate EMS for stroke, stroke warning signs and symptoms,
prescribed medications, need for followup) given (verbally or
written)? (x) Yes - () No
8. Assessment for rehabilitation or rehab services considered?
(x) Yes - () No. If no, why not? (I.e. patient at baseline
functional status)
9. Discharged on statin therapy? (x) Yes - () No [if LDL >70,
reason not given:
[ ] Statin medication allergy
[ ] Other reasons documented by physician/advanced practice
nurse/physician ___ (physician/APN/PA) or pharmacist
[ ] LDL-c less than 70 mg/dL
10. Discharged on antithrombotic therapy? (x) Yes [Type: ()
Antiplatelet - (x) Anticoagulation] - () No
11. Discharged on oral anticoagulation for patients with atrial
fibrillation/flutter? () Yes - (x) No - If no, why not (I.e.
bleeding risk, etc.) (x) N/A
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Quinapril 10 mg PO DAILY
2. Thyroid 60 mg PO QAM
3. Thyroid 30 mg PO QPM
Discharge Medications:
1. Atorvastatin 40 mg PO QPM
RX *atorvastatin 40 mg 1 tablet(s) by mouth at bedtime Disp #*30
Tablet Refills:*6
2. Enoxaparin Sodium 60 mg SC BID
RX *enoxaparin 60 mg/0.6 mL 1 twice a day Disp #*60 Syringe
Refills:*8
3. Quinapril 10 mg PO DAILY
4. Thyroid 60 mg PO QAM
5. Thyroid 30 mg PO QPM
Discharge Disposition:
Home
Discharge Diagnosis:
Ischemic stroke
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear ___,
___ were hospitalized due to symptoms of vertigo resulting from
an ACUTE ISCHEMIC STROKE, a condition where a blood vessel
providing oxygen and nutrients to the brain is blocked by a
clot. The brain is the part of your body that controls and
directs all the other parts of your body, so damage to the brain
from being deprived of its blood supply can result in a variety
of symptoms.
Stroke can have many different causes, so we assessed ___ for
medical conditions that might raise your risk of having stroke.
In order to prevent future strokes, we plan to modify those risk
factors. Your risk factors are:
-Hyperlipidemia
-malignancy
We are changing your medications as follows:
-Start Lovenox
-start atorvastatin
Please take your other medications as prescribed.
Please follow up with Neurology and your primary care physician
as listed below.
If ___ experience any of the symptoms below, please seek
emergency medical attention by calling Emergency Medical
Services (dialing 911). In particular, since stroke can recur,
please pay attention to the sudden onset and persistence of
these symptoms:
- Sudden partial or complete loss of vision
- Sudden loss of the ability to speak words from your mouth
- Sudden loss of the ability to understand others speaking to
___
- Sudden weakness of one side of the body
- Sudden drooping of one side of the face
- Sudden loss of sensation of one side of the body
Sincerely,
Your ___ Neurology Team
Followup Instructions:
___
|
10808848-DS-15
| 10,808,848 | 20,726,077 |
DS
| 15 |
2170-06-22 00:00:00
|
2170-06-23 07:36:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: NEUROLOGY
Allergies:
gluten
Attending: ___
Chief Complaint:
dizziness, buzzing sound in ears
Major Surgical or Invasive Procedure:
none
History of Present Illness:
___ female right-handed with a history of
metastatic angiosarcoma currently undergoing chemo for
metastatic
disease, MR, and recent ischemic stroke in ___ felt
due
to hypercoagulability of malignancy on Xarelto who presented
with
persistent dizziness since awaking in the morning.
Patient says that she was in her usual state of health on ___
other than mild right ear pain that was new. She awoke in the
morning with new disequilibrium sensation. She denies any room
spinning vertigo but says it feels like she is on a ship. She
also noticed a new buzzing in her ears that was not present
prior
in addition to the continued right ear pain. She feels like she
is a pressure behind her ears. Buzzing is constant and does not
fluctuate. Disequilibrium has wax and wane but has not
completely gone away since it started. It worsens when she
changes positions. She said a little bit of nausea but no
vomiting. She has been able to walk but just feels like she
needs to be more careful when she does. She has not had any
falls.
She denies any fever or upper respiratory infection symptoms
But she did use Afrin due to the ear pressure but without any
relief. She has been taking her Xarelto regularly and has not
missed any doses. She denies any palpitations.
Her chemotherapy was recently put on hold due to a nail
infection. She last received chemo about 7 weeks ago.
On neuro ROS, pertinent positives in HPI, currently the pt
denies
headache, loss of vision, blurred vision, diplopia, dysarthria,
dysphagia, or hearing difficulty. Denies difficulties producing
or comprehending speech. Denies focal weakness, numbness,
parasthesiae. No bowel or bladder incontinence or retention.
On general review of systems, positives in HPI, the pt denies
recent fever or chills. No night sweats or recent weight loss
or
gain. Denies cough, shortness of breath. Denies chest pain or
tightness, palpitations. Denies nausea, vomiting, diarrhea,
constipation or abdominal pain. No recent change in bowel or
bladder habits. No dysuria. Denies arthralgias or myalgias.
Denies rash.
Past Medical History:
-Splenic angiosarcoma, recent pulmonary metastatic disease
currently on chemotherapy though has been on hold for around 7
weeks
-Mitral valve prolapse (on quinapril, followed by Dr. ___
at ___
-Severe mitral regurgitation
-H. pylori treated ___
-Strongyloides with ivermectin x2 in ___
-IBS with chronic constipation since childhood
-Seasonal allergies
-Ovarian cyst (noted incidentally on PET)
Surgical HX
Resection of angiosarcoma diaphragm recurrence
Splenectomy
Social History:
___
Family History:
Maternal grandfather had a stroke in his ___. Both parents have
hypertension.
Physical Exam:
Admission Physical Exam: Vitals: 96.4, HR 87, BP 114/77, RR16,
98% RA
General: Awake, cooperative, NAD.
HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in
oropharynx, ___ with good light reflex, no injection or obvious
fluid
Neck: Supple, no carotid bruits appreciated. No nuchal rigidity
Pulmonary: Normal work of breathing
Cardiac: RRR, warm, well-perfused
Abdomen: soft, non-distended
Extremities: No ___ edema.
Skin: no rashes or lesions noted.
Neurologic:
-Mental Status: Alert, oriented x 3. Able to relate history
without difficulty. Attentive, able to name ___ backward without
difficulty. Language is fluent with intact repetition and
comprehension. Normal prosody. There were no paraphasic errors.
Pt was able to name both high and low frequency objects. Able
to
read without difficulty. Speech was not dysarthric. Able to
follow both midline and appendicular commands. Pt was able to
register 3 objects and recall ___ at 5 minutes. There was no
evidence of apraxia or neglect.
-Cranial Nerves:
II, III, IV, VI: PERRL 3 to 2mm and brisk. Coarse left beating
nystagmus with left gaze that does not extinguish, fine right
beating nystagmus with right gaze that does extinguish, normal
saccades. No skew with cover-uncover, has a corrective saccade
with head impulse to the left, VFF to confrontation. Fundoscopic
exam revealed no papilledema, exudates, or hemorrhages in right
eye was unable to view fundus in the left eye.
V: Facial sensation intact to light touch.
VII: No facial droop, facial musculature symmetric.
VIII: Hearing intact to finger-rub bilaterally.
IX, X: Palate elevates symmetrically.
XI: ___ strength in trapezii bilaterally.
XII: Tongue protrudes in midline with good excursions. Strength
full with tongue-in-cheek testing.
-Motor: Normal bulk, tone throughout. No pronator drift
bilaterally.
No adventitious movements, such as tremor, noted. No asterixis
noted.
Delt Bic Tri WrE FE IP Quad Ham TA ___ ___
L 5 ___ 5 5 5 5 5 5 5
R 5 ___ 5 5 5 5 5 5 5
-Sensory: No deficits to light touch, pinprick, cold sensation,
vibratory sense, proprioception throughout. No extinction to
DSS.
Romberg absent.
-DTRs:
Bi Tri ___ Pat Ach
L 2 2 2 3+ 1
R 2 2 2 3+ 1
Plantar response was flexor bilaterally.
-Coordination: No intention tremor. Normal finger-tap
bilaterally. No dysmetria on FNF or HKS bilaterally. Mild left
sided rebound, left overshoot with mirroring
-Gait: Good initiation. mildly wide based, mildly unsteady.
Negative Romberg, attempts tandem gait but has to grab on to the
wall
Discharge physical exam
General: Awake, cooperative, NAD.
HEENT: NC/AT, no scleral icterus noted
Pulmonary: Normal work of breathing
Cardiac: warm, well-perfused
Extremities: No ___ edema.
Skin: no rashes or lesions noted.
Neurologic:
-Mental Status: Alert, speaking fluently, answering questions
appropriately
-Cranial Nerves:
II, III, IV, VI: PERRL 3 to 2mm and brisk. EOMI without
nystagmus. VFF to confrontation.
V: Facial sensation intact to light touch.
VII: No facial droop, facial musculature symmetric.
VIII: Hearing intact to finger-rub bilaterally.
IX, X: Palate elevates symmetrically.
XI: ___ strength in trapezii bilaterally.
XII: Tongue protrudes in midline with good excursions. Strength
full with tongue-in-cheek testing.
-Motor: Normal bulk, tone throughout. No pronator drift
bilaterally. No adventitious movements, such as tremor, noted.
No asterixis
noted.
Delt Bic Tri WrE FE IP Quad Ham TA ___
L 5 ___ 5 5 5 5 5 5
R 5 ___ 5 5 5 5 5 5
-Sensory: No deficits to light touch.
Romberg absent.
-Coordination: No intention tremor. Normal finger-tap
bilaterally. No dysmetria on FNF.
-Gait: Good initiation. Some difficulty with tandem gait.
Pertinent Results:
ADMISSION LABS
___ 12:20AM BLOOD WBC-4.9 RBC-3.80* Hgb-10.7* Hct-33.8*
MCV-89 MCH-28.2 MCHC-31.7* RDW-15.9* RDWSD-52.2* Plt ___
___ 12:20AM BLOOD Glucose-117* UreaN-16 Creat-0.6 Na-139
K-4.2 Cl-100 HCO3-25 AnGap-14
___ 12:20AM BLOOD ALT-17 AST-23 AlkPhos-74 TotBili-0.2
___ 09:19AM BLOOD Albumin-4.1 Calcium-9.7 Phos-4.2 Mg-1.8
Cholest-127
___ 09:19AM BLOOD %HbA1c-5.1 eAG-100
___ 09:19AM BLOOD Triglyc-38 HDL-64 CHOL/HD-2.0 LDLcalc-55
___ 09:19AM BLOOD TSH-0.06*
___ 09:19AM BLOOD Free T4-0.9*
___ 12:20AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG
Tricycl-NEG
MRI BRAIN ___. No acute intracranial abnormality on contrast enhanced MRI
brain.
2. Unchanged focal enlargement of the right trigeminal nerve
within the
foramen ovale since ___, possibly representing a nerve
sheath tumor.
CTA HEAD AND NECK
1. Normal CTA of the head and neck.
2. No CT evidence of acute intracranial abnormality.
Brief Hospital Course:
___ with a history of angiosarcoma s/p splenectomy with
metastatic disease to the lungs currently on chemotherapy (last
dose ___, prior ischemic stroke in the L mesial temporal
region likely due to hypercoagulability of malignancy who
presented with new disequilibrium, 'buzzing' in both ears, and
ear pressure.
Initial concern for stroke given that her history of malignancy
and L mesial temporal stroke (that presentation was vertigo,
chest tightness, seeing darkness in her vision). Her initial
exam had concern for central nystagmus with pathologic gaze
evoked nystagmus on the left. However, this time her exam was
reassuring without focal findings. CT head and CTA head/neck
showed no acute findings. MRI brain showed no acute intracranial
abnormality.
Her symptoms were likely due to a peripheral process such as
vestibular neuritis. She was continued on home medications
including xarelto and atorvastatin. Her oncology team was
updated. She was ordered for outpatient ___ for peripheral
vestibulopathy and gait training.
Given the unchanged R CN V enlargement within the foramen ovale
seen on previous scans possibly representing nerve sheath tumor,
she was advised to f/u with Neurosurgery in clinic.
MRI BRAIN ___
1. No acute intracranial abnormality on contrast enhanced MRI
brain.
2. Unchanged focal enlargement of the right trigeminal nerve
within the foramen ovale since ___, possibly representing a
nerve sheath tumor
CT CTA HEAD ___
CT HEAD WITHOUT CONTRAST:
There is no evidence of infarction,hemorrhage or edema.
Previously seen
possible right trigeminal nerve enlargement possibly
representing a schwannoma is not well assessed on this study.
The ventricles and sulci are normal in size and configuration
for age. The visualized portion of the paranasal sinuses,
mastoid air cells,and middle ear cavities are clear. The
visualized portion of the orbits are unremarkable.
CTA HEAD:
The vessels of the circle of ___ and their principal
intracranial branches appear normal without stenosis, occlusion,
or aneurysm formation. The dural venous sinuses are patent.
CTA NECK:
The carotidandvertebral arteries and their major branches appear
normal with no evidence of stenosis or occlusion. There is no
evidence of internal carotid stenosis by NASCET criteria. Dental
amalgam limits assessment of the oropharynx.
OTHER:
Right chest port catheter noted in partially visualized. The
visualized portion of the lungs are essentially clear. The
visualized portion of the thyroid gland is within normal limits.
There is no lymphadenopathy by CT size criteria.
IMPRESSION:
1. Normal CTA of the head and neck.
2. No CT evidence of acute intracranial abnormality.
TRANSITIONAL ISSUES
-------------------
[]Given the unchanged R CN V enlargement within the foramen
ovale seen on previous scans possibly representing nerve sheath
tumor, she was advised to f/u with Neurosurgery in clinic.
[]Utox pending at time of discharge and needs to be followed up
[]TSH and free T4 were low during this hospitalization. Would
need outpatient follow up.
Medications on Admission:
Xarelto 20mg Qpm
Atorvastatin 40 mg nightly
Dexamethasone 4 mg with chemotherapy,
Zofran 8 mg p.o. every 8 hours as needed
Discharge Medications:
1. Atorvastatin 40 mg PO QPM
2. Rivaroxaban 20 mg PO/NG QPM with dinner
3.Outpatient Physical Therapy
H81.23 VESTIBULAR NEURITIS
Provider ___: ___
Discharge Disposition:
Home
Discharge Diagnosis:
vestibular neuritis
dizziness
history of angiosarcoma s/p splenectomy
history of ischemic stroke
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Dear Ms ___,
You presented to ___ because you were having
symptoms of dizziness and a buzzing sound in your ears.
While in the hospital, you had a CT scan of your head, which
showed no acute stroke. Imaging of your blood vessels was also
reassuring. You received a brain MRI which showed no acute
findings. It did show an enlargement of one of your nerves, and
for this we recommend that you follow up with neurosurgery in
clinic after discharge.
Overall, the cause for your symptoms is unclear, but is most
likely vestibular neuritis. This is an inflammation/viral
response in the inner ear which can cause dizziness, ringing in
the ears and ear pain. This should gradually improve over time
with supportive care. Please make sure you are well hydrated and
continue physical activity as tolerated.
We have placed an order for outpatient physical therapy. Please
try to get this done to make sure your walking is secure.
We will keep your medications the same. We also will update your
oncologist about this admission.
It was a pleasure taking care of you.
We wish you the best,
Your ___ team
Followup Instructions:
___
|
10808949-DS-8
| 10,808,949 | 25,233,419 |
DS
| 8 |
2150-02-11 00:00:00
|
2150-02-24 15:58:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
naproxen / Plavix / Rofecoxib / fluoxetine
Attending: ___.
Chief Complaint:
Somnolence, fluctuating mental status
Major Surgical or Invasive Procedure:
None
History of Present Illness:
The patient presented to ___ at ___ on ___ due to
SOB and audible wheezes. The patient has a h/o COPD and is on 2
L NC at home. During this episode of dyspnea, the patient was
96% on his baseline 2L. The patient also c/o slurred speech,
which he attributed to a swollen tongue. According to the notes,
the patient recently started a new medication, which he said was
Chantix three days prior. The patient was also recently
diagnosed with Parkinsonism and is on Sinemet at home. The
patient was also complaining of increased visual hallucinations
at home prior to presentation. At ___, the patient had an ABG
that was 7.36/47/142/26 on 4L NC. He was given 125mg Solumedrol,
Duoneb, Levaquin 750mg. His saturations remained in the high ___
on 2L NC. During the ED stay at ___, the patient took off all
of his EKG leads and wanted to leave, but was easily redirected.
By ___, it was reported that the patient's tongue swelling had
improved. The patient was transfered to ___ due to altered
mental status and neurology consult. During transport, the
patient continued to have visual hallucinations and was
repsonding to internal stimuli, which the patient says was
baseline for him. He was not distressed by these.
.
At ___, initial VS were 98.8, 112/71, 79, 20, 96% RA. He
triggered for 2 episodes of unresponsiveness even to sternal
rub. On exam, at first incredibly somnolent, slurred speech,
tongue fasciculations, otherwise CN II-XII intact; strength ___
throughout w/e/o L leg foot drop; lungs exp wheezing bilat. ?
myoclonic jerks. Awoke spontaneously after minutes. Lactate
normal, ABG 7.37/46/62/28. Normal head CT. Utox negative. Given
narcan with no change in mental status.
.
On arrival to the MICU, the patient was initially difficult to
arouse. Once awoken, the patient was appropriate, following
commands, and logical. The patient says that he doesn't remember
much of what happened today, but notes that it started this AM
with some SOB and then increasing visual hallucinations. He says
that he has had these hallucinations for ___ weeks, which he
describes as seeing people whom he knows and he has
conversations with. These are nonthreatening hallucinations. The
patient also notes some orthostasis, especially dizziness when
he arises from bed in the AM. He complains of tremor, both at
rest and with movement, which he says has gotten better since
starting Sinimet. He denies rigidity or gait disturbance. No
urinary symptoms. He notes dry mouth, but little tongue swelling
now.
.
Review of systems:
(+) Per HPI, otherwise unable to be elicited by patient
Past Medical History:
Past Medical History:
left foot drop s/p surgery in ___
chronic back pain
anxiety
depression
COPD on 2L NC at home
HTN
degenerative disk disease
Past Surgical History:
CABG with aneurysm repair ___
Appendectomy
Subclavian stenting
___ knee surgeries ___
Social History:
___
Family History:
Mother: ___ disease with ___ Body features
Father: killed by a drunk driver, but previously was healthy w/
thyroid disease
Sister: thyroid disease
Physical Exam:
ADMISSION EXAM:
Vitals: T: 97.9 BP: 113/61 P: 75 R: 18 O2: 99% RA
General: Once arousable, AOx2, no hallucinations now, able to
carry on logical conversation
HEENT: Sclera anicteric, dry MM, dry tongue, non-swollen, no
dysarthria, PERRLA
Neck: obese, JVP not elevated, no LAD
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,
gallops
Lungs: distant breath sounds, end-expiratory wheezes
Abdomen: soft, non-tender, non-distended, bowel sounds present,
no organomegaly
Ext: warm, well perfused, has brace on left foot due to foot
drop
Neuro: CNII-XII intact, ___ strength upper/lower extremities,
grossly normal sensation, 1+ biceps reflex, unable to elicit
other reflexes, gait deferred, finger-to-nose intact, some
resting arm and chin tremor, but normal cerebellar function
DISCHARGE EXAM:
On discharge he is awake and alert, oriented x3, denies
hallucinations. Neuro exam intact.
Pertinent Results:
ADMISSION LABS:
___ 04:27PM BLOOD WBC-7.2 RBC-4.41* Hgb-13.3* Hct-39.2*
MCV-89 MCH-30.2 MCHC-34.0 RDW-12.3 Plt ___
___ 04:27PM BLOOD Neuts-90.9* Lymphs-8.3* Monos-0.3*
Eos-0.3 Baso-0.2
___ 04:27PM BLOOD ___ PTT-32.7 ___
___ 04:27PM BLOOD Glucose-182* UreaN-24* Creat-1.4* Na-139
K-3.6 Cl-101 HCO3-24 AnGap-18
___ 04:27PM BLOOD ALT-12 AST-12 AlkPhos-114 TotBili-0.2
___ 04:27PM BLOOD Lipase-24
___ 04:27PM BLOOD Calcium-9.4 Phos-1.9* Mg-2.0
___ 04:27PM BLOOD VitB12-417
___ 04:27PM BLOOD TSH-0.82
___ 04:27PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 05:49PM BLOOD Type-ART pO2-62* pCO2-46* pH-7.37
calTCO2-28 Base XS-0 Intubat-NOT INTUBA
___ 04:25PM BLOOD Lactate-2.9*
___ 05:57PM BLOOD Lactate-3.0*
___ 04:23AM BLOOD Lactate-1.8
DISCHARGE LABS:
___ 08:05AM BLOOD WBC-13.2* RBC-4.35* Hgb-13.1* Hct-38.1*
MCV-88 MCH-30.2 MCHC-34.4 RDW-12.8 Plt ___
___ 08:05AM BLOOD Glucose-88 UreaN-23* Creat-1.2 Na-144
K-4.0 Cl-107 HCO3-29 AnGap-12
___ 08:05AM BLOOD Calcium-9.4 Phos-2.9 Mg-2.0
MICRO DATA:
___ RAPID PLASMA REAGIN TEST: Negative
___ BLOOD CULTURE: No growth
IMAGING:
___ CT HEAD W/O CONTRAST
No acute intracranial process.
___ CHEST (SINGLE VIEW)
Mild bibasilar atelectasis. Low lung volumes. Blunting of the
left costophrenic angle may be due to overlying soft tissue
although a small left pleural effusion cannot be excluded. No
definite focal consolidation.
Brief Hospital Course:
PRIMARY REASON FOR HOSPITALIZATION:
Mr. ___ is a ___ gentleman with COPD, CAD s/p distant
CABG, depression, anxiety, smoking, and recent dx of
Parkinsonism who presented from ___ for neurological
evaluation given increasing somnolence and visual
hallucinations.
ACTIVE ISSUES:
#. AMS with hallucinations: The etiology of his AMS and
hallucinations is not clear. His fluctuating consciousness on
admission with non-threatening hallucinations could be c/w a
neurologic process such as ___ Body dementia although he did
not have the characteristic motor findings. The neurology
service was consulted and felt his hallucinations were most
likely ___ polypharmacy vs hypoxia from his underlying lung
disease. His sinemet was discontinued as neurology felt he had
no s/sx ___ disease. His alprazolam, loratidine,
oxycodone, amitriptyline, and gabapentin were held. His
hallucinations resolved and mental status cleared. On
discharge, it was recommended that he continue to hold these
medications and follow up with his PCP and an outpatient
neurologist for further evaluation.
CHRONIC ISSUES:
# COPD: The patient has a long hx of COPD and is a chronic
smoker. He remained at his baseline O2 requirement of 2L
throughout hospitalization, and ABG was wnl. he was continued
on his home inhalers.
# CAD s/p CABG: He was continued on his home ASA and statin.
# HTN: He was continued on his home lisinopril and nifedipine.
TRANSITIONAL ISSUES
- The following medications were discontinued: Sinimet, chantix,
ropinirole, alprazolam, loratidine, oxycodone, amitriptyline,
and gabapentin.
- He was scheduled to follow up with his PCP after discharge.
It was recommended that he ask his PCP about referral to a
neurologist in his area.
Medications on Admission:
Aspirin 81mg Qday
Bisoprolol and HCTZ ___ Qday
Lisinopril 20mg Qday
Nifedipine ER 30mg Qday
Zocor 20mg QHS
Sinemet ___ 1 tab QID
Gabapentin 100mg TID
Celexa 10mg Qday
Amitriptyline 25mg QHS
Alprazolam 0.5mg BID
Oxycodone 5mg TID
Duoneb QID
Albuterol 2 puffs Q4hr PRN
Symbicort 2 puffs BID
Singulair 10mg QHS
Loratidine 10mg Qday
Fluticasone nasal spray 2 sprays Qday
Ropinirole 0.5mg TID
Pyridoxine 100mg BID
Vitamin B12 500mcg BID
Prilosec 20mg Qday
Nicotine patch
Chantix --> started 3 days ago
Discharge Medications:
1. aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1)
Tablet, Delayed Release (E.C.) PO once a day.
2. montelukast 10 mg Tablet Sig: One (1) Tablet PO once a day.
3. Claritin 10 mg Tablet Sig: One (1) Tablet PO once a day.
4. ProAir HFA 90 mcg/Actuation HFA Aerosol Inhaler Sig: Two (2)
puffs Inhalation every ___ hours as needed for shortness of
breath or wheezing.
5. Flonase 50 mcg/Actuation Spray, Suspension Sig: Two (2)
sprays Nasal once a day: 2 sprays each nostril once daily.
6. Vitamin B-6 100 mg Tablet Sig: One (1) Tablet PO twice a day.
7. Vitamin B-12 500 mcg Lozenge Sig: One (1) lozenge PO twice a
day.
8. DuoNeb 0.5 mg-3 mg(2.5 mg base)/3 mL Solution for
Nebulization Sig: One (1) neb Inhalation once a day.
9. Zocor 20 mg Tablet Sig: One (1) Tablet PO at bedtime.
10. bisoprolol-hydrochlorothiazide ___ mg Tablet Sig: One (1)
Tablet PO once a day.
11. Prilosec 20 mg Capsule, Delayed Release(E.C.) Sig: One (1)
Capsule, Delayed Release(E.C.) PO once a day.
12. Nifedical XL 30 mg Tablet Extended Rel 24 hr Sig: One (1)
Tablet Extended Rel 24 hr PO once a day.
13. Symbicort Inhalation
14. Neurontin 100 mg Capsule Sig: One (1) Capsule PO three times
a day.
15. lisinopril 20 mg Tablet Sig: One (1) Tablet PO once a day.
16. Nicoderm CQ 21 mg/24 hr Patch 24 hr Sig: One (1) patch
Transdermal once a day.
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
Altered mental status due to medication side effect
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
You were admitted to ___ because you were confused and having
hallucinations. We believe this happened as a side effect of
multiple medications you were taking, including Sinimet,
Chantix, Citalopram, ropinirole, and percocet. We stopped these
medications while you were in the hospital, and your confusion
improved.
You were also evaluated by our neurologists while you were in
the hospital. The neurologists do not feel that you have
___ disease and recommend that you stop taking Sinimet
as it could be contributing to your hallucinations. We
recommend that you follow up with a neurologist as an
outpatient. Please talk to your primary care provider about
setting up an appointment with a neurologist near you.
We recommend that you stop the following medications:
-STOP Sinimet
-STOP Chantix - we recommend you continue using your nicotine
patch for smoking cessation
-STOP Ropinirole
-STOP Citalopram
-STOP alprazolam
-STOP percocet
-STOP amitriptyline
We made no other changes to your medications while you were in
the hospital. Please continue taking the rest of your
medications as prescribed by your outpatient providers.
We have scheduled an appointment for you to follow up with your
primary care provider. Please see below for your appointment
time.
It has been a pleasure taking care of you at ___ and we wish
you a speedy recovery.
Followup Instructions:
___
|
10808966-DS-11
| 10,808,966 | 26,208,995 |
DS
| 11 |
2124-01-01 00:00:00
|
2124-01-01 20:50:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: NEUROLOGY
Allergies:
Cipro / doxycycline / clindamycin
Attending: ___.
Chief Complaint:
episode of aphasia
Major Surgical or Invasive Procedure:
none
History of Present Illness:
This was NOT a code stroke.
The NIHSS was performed:
Date: ___
Time: 00:25
___ Stroke Scale score was : 2
1a. Level of Consciousness: 0
1b. LOC Question: 0
1c. LOC Commands: 0
2. Best gaze: 0
3. Visual fields: 0
4. Facial palsy: 1
5a. Motor arm, left: 0
5b. Motor arm, right: 1
6a. Motor leg, left: 0
6b. Motor leg, right: 0
7. Limb Ataxia: 0
8. Sensory: 0
9. Language: 0
10. Dysarthria: 0
11. Extinction and Neglect: 0
REASON FOR CONSULTATION: TIA/Stroke
HISTORY OF THE PRESENTING ILLNESS:
==================================
Eu Critical ___ MRN ___ (AKA ___ MRN
___) is an ___ year old right-handed man with a history of
HTN, HLD, and recent PPM placement for symptomatic bradycardia
(___) who presents to the ED after an episode of vision
loss
and difficulty speaking.
History is provided by the patient and his wife.
Mr. ___ was sitting on the couch at home with his wife
earlier this evening (9:30 ___ on ___ watching a ___
when he developed sudden onset vision loss in the right
hemi-field. He states that the actor's left eye (but curiously
not the rest of his face) suddenly became absent. This lasted
for
a few seconds and then resolved. There was no diplopia, blurry
vision, or other associated symptoms. No headache.
He stood up from the couch and realized something "was wrong."
His speech was "completely garbled" and he was unable to make a
meaningful sentence. According to his wife, he had "trouble
getting the words out" but no issues comprehending what she was
saying. This lasted longer than the visual symptoms,
approximately ___ minutes. His wife called ___. Upon EMS
arrival, the patient states he "still felt off" but he was able
to speak in full sentences. He was brought to the ___ ED for
further evaluation.
On ROS, the patient notes 2 prior episodes of visual field loss
over the past month or so (since his PPM placement).
Interestingly, both of the prior episodes also involved the
"left
eye of the person on the screen." He has felt "weird" recently -
feeling "overall weak" today. This he felt could have been
related to a couple mile walk he went on yesterday - the first
exercise he has had since his PPM implantation.
On further neurological ROS, the patient denies headache,
blurred
vision, diplopia, dysphagia, lightheadedness, vertigo, tinnitus
or hearing difficulty. Denies focal weakness, numbness,
parasthesiae. No bowel or bladder incontinence or retention.
Chronic unsteadiness when walking which has overall improved
since his PPM was placed.
On general review of systems, the patient denies recent fever or
chills. No night sweats or recent weight loss or gain. Denies
cough, shortness of breath. Denies chest pain or tightness,
palpitations. Denies nausea, vomiting, diarrhea, constipation or
abdominal pain. No recent change in bowel or bladder habits. No
dysuria. Denies arthralgias or myalgias. Denies rash.
Past Medical History:
- Symptomatic bradycardia with 2:1 AV block s/p dcPPM ___
- Hypertension, BPs at home recently 120-130 mmHg systolic
- Prostate cancer s/p cyberknife and hormone therapy (last
injection several months ago)
- Hyperlipidemia
- Nephrolithiasis
Social History:
___
Family History:
Non-contributory
Physical Exam:
ADMISSION PHYSICAL EXAM
Vitals: Afebrile, HR 73, BP 150/78, RR 16, Sa 98% RA
General: Awake, cooperative, NAD, supine in ED bed
HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in
oropharynx
Neck: Supple, no carotid bruits appreciated. No nuchal rigidity
Pulmonary: Normal work of breathing
Cardiac: RRR, warm, well-perfused
Abdomen: soft, non-distended
Extremities: Trace ___ edema.
Skin: no rashes or lesions noted.
Neurologic Exam:
-Mental Status: Alert, oriented to ___, ___, and
president. States the date at the ___ not ___. Attentive.
Occasional word finding difficulties - "spy plane" instead of
"drone." Wife and patient state he would usually know the word
"drone." Language is fluent with intact repetition and
comprehension. Normal prosody. There were no paraphasic errors.
Able to read without difficulty. Able to follow both midline and
appendicular commands. Pt was able to register 3 objects and
recall ___ at 5 minutes. There was no evidence of apraxia or
neglect.
-Cranial Nerves:
II, III, IV, VI: PERRL 2.5 to 2mm and brisk. EOMI without
nystagmus. Normal saccades. VFF to confrontation.
V: Facial sensation intact to light touch.
VII: There is right NLFF and widening of the right palpebral
fissure (compared to photo from ___, this is stable).
VIII: Hearing intact to finger-rub bilaterally.
IX, X: Palate elevates symmetrically.
XI: ___ strength in trapezii bilaterally.
XII: Tongue protrudes in midline with good excursions. Strength
full with tongue-in-cheek testing.
-Motor: Normal bulk, tone throughout. Subtle right pronation but
no drift. No adventitious movements, such as tremor, noted. No
asterixis noted.
Delt Bic Tri WrE FE IP Quad Ham TA ___ ___
L 5 ___ 5 ___ 5 5 5
R 5- ___ 5 4+ 5 4+ 5 5 5
-Sensory: 50% decreased pin prick sensation over the right leg
compared to the left. Otherwise, no deficits to light touch,
cold sensation, vibratory sense, proprioception throughout. No
extinction to DSS. Romberg absent.
-DTRs: ___ brisk, 3+ with bilateral pectoral jerks and
crossed adductors. 2+ at the Achilles bilaterally. No clonus.
Plantar response was withdrawal bilaterally.
-Coordination: No intention tremor. Normal finger-tap
bilaterally, perhaps slightly irregular on the right compared to
the left. No dysmetria on FNF or HKS bilaterally.
-Gait/Station: Good initiation. Narrow-based, normal stride and
arm swing. Unable to walk on tip toes.
========
DISCHARGE PHYSICAL EXAM
Gen: awake, alert, comfortable, in no acute distress
HEENT: normocephalic atraumatic, no oropharyngeal lesions
CV: warm, well perfused
Pulm: breathing non labored on room air
Extremities: no cyanosis/clubbing or edema
Neurologic:
-MS: Awake, alert, oriented to self, place, time and situation.
Easily maintains attention to examiner. Able to say months of
the year backwards. Speech fluent, no dysarthria. No evidence
of hemineglect.
-CN: Gaze congjugate, ___, EOMI no nystagmus, face symmetric,
palate elevates symmetrically, tongue midline
-Motor: normal bulk and tone. No tremor or asterixis.
Delt Bic Tri ECR FEx FFl IO IP Quad Ham TA Gas
___
L 5 5 5 5 5 5 5 5 5 5 5 5 5
R 5 5 5 5 5 5 5 5 5 5 5 5 5
-Sensory: intact to LT in bilateral UE and ___, no extinction to
DSS
-Coordination: finger nose finger intact, no dysmetria
-Gait: narrow based, no ataxia or sway
Pertinent Results:
___ 08:00AM BLOOD WBC-5.0 RBC-3.89* Hgb-12.8* Hct-36.1*
MCV-93 MCH-32.9* MCHC-35.5 RDW-12.9 RDWSD-43.6 Plt Ct-90*
___ 08:00AM BLOOD ___ PTT-28.3 ___
___ 08:00AM BLOOD Glucose-95 UreaN-14 Creat-0.8 Na-141
K-4.8 Cl-102 HCO3-24 AnGap-15
___ 08:00AM BLOOD ALT-24 AST-24 LD(LDH)-197 CK(CPK)-42*
AlkPhos-71 TotBili-0.7
___ 08:00AM BLOOD GGT-20
___ 08:00AM BLOOD TotProt-6.5 Albumin-4.4 Globuln-2.1
Cholest-126
___ 08:00AM BLOOD %HbA1c-4.6 eAG-85
___ 08:00AM BLOOD Triglyc-176* HDL-29* CHOL/HD-4.3
LDLcalc-62
___ 08:00AM BLOOD TSH-2.9
___ 08:00AM BLOOD CRP-0.7
___ 10:50PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG
Tricycl-NEG
===========
IMAGING STUDIES
CTA Head/neck
1. No evidence of masses, hemorrhage or infarction.
2. 12 mm left upper lobe pulmonary nodule.
3. 8 mm calcified right thyroid nodule.
RECOMMENDATION(S): For incidentally detected single solid
pulmonary nodule
bigger than 8mm, a follow-up CT in 3 months, a PET-CT, or tissue
sampling is
recommended.
See the ___ ___ Society Guidelines for the Management
of Pulmonary
Nodules Incidentally Detected on CT" for comments and reference:
___
Thyroid nodule. No follow up recommended.
Absent suspicious imaging features, unless there is additional
clinical
concern, ___ College of Radiology guidelines do not
recommend further
evaluation for incidental thyroid nodules less than 1.0 cm in
patients under
age ___ or less than 1.5 cm in patients age ___ or ___.
Suspicious findings include: Abnormal lymph nodes (those
displaying
enlargement, calcification, cystic components and/or increased
enhancement) or
invasion of local tissues by the thyroid nodule.
___, et al, "Managing Incidental Thyroid Nodules Detected on
Imaging: White
Paper of the ACR Incidental Findings Committee". J ___
___ ___
12:143-150.
CXR- no acute cardiopulmonary process
Brief Hospital Course:
___ year old right-handed man with a history of HTN, HLD, and
recent PPM placement who presents to the ED after an episode of
vision loss and difficulty speaking concerning for TIA vs.
stroke.
#TIA: on exam initially patient was noted to have right sided
weakness in an UMN pattern and decreased pin prick sensation,
iso episode of aphasia was concerning for possible left MCA
syndrome. On re-assessment these findings were no longer
present. While in hospital vision changes and aphasia did not
recur. Given recent placement of pacemaker cardiology
interrogated the pacemaker and found it was functioning normally
without any episodes of a fib. MRI brain was cleared by
cardiology given pacemaker placement, but unfortunately unable
to be completed as inpatient due to inability for cardiology
coverage on weekend to complete MRI. TTE also unable to be
performed due to no weekend availability, and not felt to be
critical given prior TTE in ___ that was unrevealing. Risk
factors were notable for LDL 62 and HgbA1c of 4.6. He was
continued on atrova 20mg QHS and started on aspirin 81mg after
load of 325mg. He was discharged with Zio patch.
#Symptomatic bardycardia s/p pacemaker placement: Pacemaker
interrogated and found to be functioning normally without any
episodes of a fib or other arrhythmias. TTE also unable to be
performed due to no weekend availability, and not felt to be
critical given prior TTE in ___ that was unrevealing.
#Thrombocytopenia: plts were notably low to 100s on
presentation, looking at OSH records patient's platelets have
been in 120s-80s from ___.
Transitional issues
================
[]Discharged on Aspirin 81mg daily
[]Follow up with Neurology
[]Neurology: discharged with zio patch
[]PCP: consider referral to hematology for thrombocytopenia
AHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic
Attack
1. Dysphagia screening before any PO intake? (x) Yes, confirmed
done - () Not confirmed () No. If no, reason why
2. DVT Prophylaxis administered? (x) Yes - () No. If no, why not
(I.e. bleeding risk, hemorrhage, etc.)
3. Antithrombotic therapy administered by end of hospital day 2?
(x) Yes - () No. If not, why not? (I.e. bleeding risk,
hemorrhage, etc.)
4. LDL documented? (x) Yes (LDL =63 ) - () No
5. Intensive statin therapy administered? (simvastatin 80mg,
simvastatin 80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg,
rosuvastatin 20mg or 40mg, for LDL > 70) () Yes - (x) No [if LDL
>70, reason not given:
[ ] Statin medication allergy
[ ] Other reasons documented by physician/advanced practice
nurse/physician ___ (physician/APN/PA) or pharmacist
[x ] LDL-c less than 70 mg/dL
6. Smoking cessation counseling given? () Yes - (x) No [reason
(x) non-smoker - () unable to participate]
7. Stroke education (personal modifiable risk factors, how to
activate EMS for stroke, stroke warning signs and symptoms,
prescribed medications, need for followup) given in written
form? (x) Yes - () No
8. Assessment for rehabilitation or rehab services considered?
() Yes - (x) No. If no, why not? -> patient at baseline
functional status
9. Discharged on statin therapy? (x) Yes - () No [if LDL >70,
reason not given:
[ ] Statin medication allergy
[ ] Other reasons documented by physician/advanced practice
nurse/physician ___ (physician/APN/PA) or pharmacist
[ ] LDL-c less than 70 mg/dL
10. Discharged on antithrombotic therapy? (x) Yes [Type: (x)
Antiplatelet - () Anticoagulation] - () No
11. Discharged on oral anticoagulation for patients with atrial
fibrillation/flutter? () Yes - () No - If no, why not (I.e.
bleeding risk, etc.) (x) N/A
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Atorvastatin 20 mg PO QPM
2. LORazepam 1 mg PO QHS:PRN sleep
3. ___ (omega-3 acid ethyl esters) 2 caps oral BID
Discharge Medications:
1. Aspirin 81 mg PO DAILY
2. Atorvastatin 20 mg PO QPM
3. LORazepam 1 mg PO QHS:PRN sleep
4. Lovaza (omega-3 acid ethyl esters) 2 caps oral BID
Discharge Disposition:
Home
Discharge Diagnosis:
Transient Ischemic Attack (TIA)
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
You were hospitalized due to symptoms of vision loss and
difficulty speaking resulting from an Transient Ischemic Attack
(TIA) aka "mini stroke" , a condition where a blood vessel
providing oxygen and nutrients to the brain is blocked by a
clot. The brain is the part of your body that controls and
directs all the other parts of your body, so damage to the brain
from being deprived of its blood supply can result in a variety
of symptoms.
TIAs can have many different causes, so we assessed you for
medical conditions that might raise your risk of having stroke.
In order to prevent future strokes, we plan to modify those risk
factors. Your risk factors are:
-High blood pressure
-Hyperlipidemia
We are changing your medications as follows:
-Start taking aspirin 81mg daily
Please take your other medications as prescribed.
Please follow up with Neurology and your primary care physician
as listed below.
If you experience any of the symptoms below, please seek
emergency medical attention by calling Emergency Medical
Services (dialing 911). In particular, since stroke can recur,
please pay attention to the sudden onset and persistence of
these symptoms:
- Sudden partial or complete loss of vision
- Sudden loss of the ability to speak words from your mouth
- Sudden loss of the ability to understand others speaking to
you
- Sudden weakness of one side of the body
- Sudden drooping of one side of the face
- Sudden loss of sensation of one side of the body
Sincerely,
Your ___ Neurology Team
Followup Instructions:
___
|
10809510-DS-11
| 10,809,510 | 23,155,010 |
DS
| 11 |
2133-08-03 00:00:00
|
2133-08-03 15:18:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: NEUROSURGERY
Allergies:
Oxycodone
Attending: ___
Chief Complaint:
Bilateral lower extremity weakness, intradural mass
Major Surgical or Invasive Procedure:
___ (ORTHO/Dr. ___ L5-S1 laminectomy w/ interbody and
posterior fusion
___ C7-T1 laminectomies for intradural tumor resection
(Neurosurgery/Dr. ___
History of Present Illness:
This is a ___ female who has had 3 months of
progressively worsening neurological symptoms involving the
bilateral lower extremities. She first noticed a foot drop on
the
left approximately three months ago and has since had increasing
difficulty walking due to bilateral leg weakness, requiring the
use of a walker, and over the last 3 weeks she has been
wheelchair-bound. She has also had difficulty urinating and
urinary incontinence over the last two days. She has been
incontinent of small volumes and feels as if she has fullness in
her lower abdomen. No fecal incontinence however she has had to
manually disimpact herself in order to have bowel movements over
the past 2 weeks. She has progressive numbness in her legs and
torso. She was seen and evaluated in the ER and MRI Lumbar
spine
demonstrated L5-S1 stenosis. She underwent L5-S1 laminectomy
and
instrumented fusion with Orthopedics on ___. Postoperatively
the
patient had no improvement in her symptoms. MRI C and T Spine
were performed ___ that demonstrated a large intradural
mass posterior to the body of T1 displacing the spinal cord to
the left and causing significant spinal cord compression.
Neurosurgery was consulted for intradural mass.
Past Medical History:
Prior history of EtOH abuse, had a history of breast cancer
removed at "2 cells", denies chemo or active cancer. Previously
diagnosed with HTN and DM however pt feels these have resolved
and stopped taking medication.
Social History:
___
Family History:
Non-contributory
Physical Exam:
ON ADMISSION:
PHYSICAL EXAM:
O: T: 98.7 BP: 118/68 HR: 101 R: 18 O2Sats: 96% RA
Gen: WD/WN, comfortable, NAD.
HEENT: normocephalic, atraumatic. poor dentition
Neck: Supple.
Abd: Distended, firm, nontender
Extrem: Warm and well-perfused.
Neuro:
Mental status: Awake and alert, cooperative with exam, normal
affect.
Orientation: Oriented to person, place, and date.
Motor:
D B T WE WF IP Q H AT ___ G
R 5 5 5 5 5 3 3 2 0 0 0
L 5 5 5 5 5 3 4- 2 0 0 0
Sensation: decreased to light touch from the level of T3 down
and
absent from the mid thigh down. Decreased perianal sensation.
Reflexes: B T Br Pa Ac
Right 1+ 1+ 1+ 3+ 0
Left 1+ 1+ 1+ 3+ 0
Proprioception absent
Toes mute on the right and upgoing on the left
2 beats clonus on the left, no clonus on the right
No Hoffmans
Rectal exam normal sphincter control. There is stool in the
vault.
=======================================================
ON DISCHARGE:
Continued paresthesias in bilateral ___, worse below the knee.
Decreased sensation to light touch from the level of T3 down.
Small area of swelling L inferior incision. Staples. Soft
c-collar for comfort.
Motor:
IP Q H AT ___ G
R 4+ 5 4 5 5 5
L 5 5 4+ 5 5 5
Cervical incision is intact without erythema or drainage
Pertinent Results:
Please refer to OMR for pertinent imaging and lab results.
Brief Hospital Course:
Ms. ___ presented to the ED on ___ with complaints of
progressive lower extremity weakness and was initially admitted
to the Ortho Spine service for further management. During her
stay she was transitioned to the neurosurgery service for
findings of a T1 intradural extramedullary mass.
#Lumbar stenosis: On arrival to the ED the patient had bilateral
lower extremity weakness which she reported had been
progressive. MRI revealed stenosis and the patient was taken
urgently to the OR with orthopedic spine for L5-S1 laminectomy
and fusion with Dr. ___. A drain was left in place. On post-op
exam the patient's strength did not improve and an MRI of the
cervical and thoracic spine was obtained which demonstrated T1
intradural mass. Neurosurgery was consulted for management. The
patient self d/c'd her drain from her lumbar spine surgery and a
Lumbar wound vac was placed by orthopedics.
#T1 intradural extramedullary mass
Neurosurgery was consulted for MRI findings of T1 intradural
mass after she underwent an L5-S1 laminectomy and fusion without
improvement of her bilateral lower extremity weakness. She went
to the OR on ___ for tumor resection and tolerated the
procedure well. She was extubated in the OR and transferred to
the PACU for recovery. Neurologically her lower extremity
weakness had improved and she was transferred to the neuro
stepdown unit for ongoing evaluation. Post-operatively she
received a 1L fluid bolus for tachycardia to the 120's. A small
area of swelling on the left inferior aspect of her incision was
noted when the dressing was removed. There was no open areas or
active drainage from the site. Post-op MRI demonstrated full
resection of the mass and final pathology is pending. Her ___
weakness continued to improve.
#Anemia
Post-operatively her Hgb and Hct had dropped to 6.4 and 19.5 Se
was asymptomatic however she was given 1 unit of PRBCs for
downtrending labs. Her Hgb and Hct responded well and trended
up.
#ID
Blood cultures obtained on admission showed Gram positive rods
and final culture grew P. Acnes. Because the patient remained
afebrile with normal WBC throughout her hospital stay it was
felt that it was likely a contaminant. Repeat blood cultures
from ___ and ___ are negative to date. Urine Culture was
negative.
#Elder Services
Elder services was consulted for reported neglect at home.
Social work was also involved for additional support.
At the time of discharge she was voiding on her own, tolerating
a regular diet, ambulating with a walker, afebrile with stable
vital signs.
Medications on Admission:
ACETAMINOPHEN-CODEINE - acetaminophen 300 mg-codeine 30 mg
tablet. ___ tablet q6h PRN Pain
Discharge Medications:
1. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild
2. Bisacodyl 10 mg PO/PR DAILY
3. Calcium Carbonate 500 mg PO TID:PRN heartburn
4. Dexamethasone 4 mg PO Q12H Duration: 4 Doses
This is dose # 1 of 3 tapered doses
5. Dexamethasone 3 mg PO Q12H Duration: 4 Doses
This is dose # 2 of 3 tapered doses
6. Dexamethasone 2 mg PO Q12H Duration: 4 Doses
Start: After 3 mg Q12H tapered dose
This is dose # 3 of 3 tapered doses
7. Dextrose 50% 12.5 gm IV PRN hypoglycemia protocol
8. Diazepam 2 mg PO Q8H:PRN muscle spasm
9. Docusate Sodium 100 mg PO BID
10. Famotidine 20 mg PO BID
11. Glucagon 1 mg IM Q15MIN:PRN hypoglycemia protocol
12. Glucose Gel 15 g PO PRN hypoglycemia protocol
13. Heparin 5000 UNIT SC BID
14. Insulin SC
Sliding Scale
Fingerstick QACHS
Insulin SC Sliding Scale using REG Insulin
15. Senna 8.6 mg PO BID
16. TraMADol 50 mg PO Q6H:PRN pain
17. TraZODone 25 mg PO HS:PRN insomnia
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
T1 Intradural tumor
Lumbar stenosis
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Discharge Instructions
Spinal Fusion
Surgery
Your Cervical dressing may come off on the second day after
surgery.
** Your Lumbar wound is dressed with a Prevena Wound vac which
should stay in place for 7 days until ___. After that a dry
sterile dressing should stay in place until follow up with Dr.
___.
Your Cervical incision is closed with staples. You will need
staple removal. Your Lumbar incision is closed with Sutures and
you will need suture removal.
Do not apply any lotions or creams to the site.
Please keep your incision dry until removal of your
staples/sutures.
Please avoid swimming for two weeks after staple/suture
removal.
Call your surgeon if there are any signs of infection like
redness, fever, or drainage.
Activity
Soft cervical collar is for comfort only.
We recommend that you avoid heavy lifting, running, climbing,
or other strenuous exercise until your follow-up appointment.
You may take leisurely walks and slowly increase your activity
at your own pace. ___ try to do too much all at once.
No driving while taking any narcotic or sedating medication.
No contact sports until cleared by your neurosurgeon.
Do NOT smoke. Smoking can affect your healing and fusion.
Medications
Please do NOT take any blood thinning medication (Aspirin,
Ibuprofen, Plavix, Coumadin) until cleared by the neurosurgeon.
Do not take any anti-inflammatory medications such as Motrin,
Advil, Aspirin, and Ibuprofen etc
until cleared by your
neurosurgeon.
You may use Acetaminophen (Tylenol) for minor discomfort if
you are not otherwise restricted from taking this medication.
When to Call Your Doctor at ___ for:
Severe pain, swelling, redness or drainage from the incision
site.
Fever greater than 101.5 degrees Fahrenheit
New weakness or changes in sensation in your arms or legs.
Followup Instructions:
___
|
10809600-DS-21
| 10,809,600 | 23,636,380 |
DS
| 21 |
2118-04-09 00:00:00
|
2118-04-09 15:33:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: NEUROLOGY
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
CC: dysarthria, right facial weakness, and changes in vision
Major Surgical or Invasive Procedure:
PEG tube placement
History of Present Illness:
Mr. ___ is an ___ right-handed man with a history of
stroke which affected his left arm and leg, with no apparent
residual weakness, HTN, HLD, and DM, presenting with new onset
dysarthria, right arm weakness, and changes in his vision. Last
night at 2AM, Mr. ___ awoke to use the restroom. He tried to
walk to the bathroom, felt as though he was uncoordinated more
so
than feeling weak. He felt that "something was wrong," that he
was imbalanced and could fall to either side. He did not make
it
to the bathroom but used a chair as a walker to get to the
phone.
He called ___ and recognized that he had slurred speech, which
he
states is completely different from his baseline speech. He
denies any pain, dizziness, lightheadedness, weakness, numbness,
or tingling at that time. He states that he only felt like he
was
awakening from a deep sleep and noted something felt wrong when
trying to walk. EMS arrived shortly after. He was unable to walk
to the ambulance as he was worried he would fall.
Mr. ___ was brought to ___, where a head CT was
done and negative, and he was transferred to ___ for neuro
evaluation and workup. OSH states that he awoke with right
facial
weakness and dysarthria. Mr. ___ denied right facial weakness
when asked this AM at ___. He states at ___ he noticed that
people looked like they were moving up and down in his vision
which he had never experienced this before. He denied any frank
diplopia or blurry vision but describes it as objects in his
near
vision as bouncing up and down, he could not provide further
details.
Several years ago, Mr. ___ had what he was told was a minor
stroke, and he was seen at ___. In that
episode, he had arm and leg weakness on his left side. No
numbness and tingling, no facial involvement, and no speech
impairment. He has since been on Aggrenox ___ mg BID.
As of evaluation this morning, he continues to have vision
changes of seeing people and objects (now states that they are
moving "east and west"), and he says this happens when things
are
closer to him. He states that he has no trouble comprehending
speech, but he continues to have slurred speech. He is afraid to
walk due to fear of falls.
Mr. ___ denies headache, loss of vision, blurred vision,
diplopia, lightheadedness, vertigo, tinnitus or hearing
difficulty. Denies focal weakness, numbness, parasthesiae. He
denies any fever, recent illness, sick contacts, or recent
travel. He endorses neck pain from arthritis, as well as
arthritis in his left shoulder.
Past Medical History:
PMH:
-DM - states that it is controlled, not on insulin
-HTN
-HLD
-presumed ischemic stroke several years ago
- cervical arthritis
Social History:
___
Family History:
-Uncle with MI in his ___
- Unknown if family history of stroke or neurologic
disease
Physical Exam:
Admission
========
Physical Exam:
Vitals: T 99.3 BP 159/70 HR 64 RR 20
General: Awake at the beginning of exam. Drifting to sleep
toward
the last third of exam, but awakens quickly. Cooperative. Voided
urine in clothes. Appears frustrated when trying to state
history
and will slow down and exhibit much effort to pronounce words.
Volume of voice is normal.
HEENT: NC/AT, no scleral icterus noted, MMM. Hearing to speech
normal.
Neck: supple, no nuchal rigidity
Pulmonary: breathing comfortably on room air
Cardiac: RRR, nl
Abdomen: ND
Extremities: warm, well perfused
Skin: no rashes noted. Small, shallow lesion on left shin.
Multiple nevi on back.
Neurologic:
-Mental Status: Alert, when asked his name, would spell it out
but not state it directly, oriented to place, and date. Able to
relate history but spoke slowly due to difficulty with
pronounciation. Attentive, able to name ___ backward and spell
world backward without difficulty. Speech was dysarthric with
both lingual and labial difficulty (___, ___, ___, ta). Language is
fluent with intact repetition ("Today is a sunny day in ___,
"No ifs, ands, or buts") and comprehension. Normal prosody. Pt
was able to name both high and low frequency objects (Needed
some
prompting with hammock). Able to read. Able to follow both
midline and appendicular commands. No evidence of neglect.
-Cranial Nerves:
II, III, IV, VI: PERRL 4 to 2mm and brisk. EOMI. VFF. Drift of
right eye with corrective saccades back to center observed,
right
eye exotropia. Drift at baseline and when trying to focus on
something in front of him.
V: Facial sensation intact to light touch.
VII: No facial droop. Marginally weaker right eyelid. Facial
musculature otherwise symmetric.
VIII: Hearing to speech intact.
IX, X: Patient was able to swallow water without difficulty.
XI: strong
XII: Tongue protrudes in midline. could not assess tongue
strength in cheek, poor effort
-Motor: Normal bulk, tone throughout. Pronator drift of right
arm
observed.
No adventitious movements, such as tremor, noted. No asterixis
noted.
Delt Bic Tri WrE FE IP Quad Ham TA
L 5 ___ ___ 5 5
R 5* 5 5* ___ ___
Initially with R delt and R tricep, it was slightly weak at 4+
but with repeat testing, he was able to give full strength.
___
mild decreased strength compared to left. Did not test finger
tapping due to time limitations. could not test orbiting due to
multiple wires.
-Sensory: No deficits to light touch throughout.
-DTRs: ___ reflex 3 bl.
Bi Tri ___ Pat Ach
L ___ 3 0
R ___ 3 0
-Coordination: No intention tremor noted. Slight intention
tremor
on FNF, with more errors with R hand than L.
-Gait: Attempted, but patient unable to get out of bed. ___ up
but concerned about falling.
Discharge
===========
VS: T 98.3; BP 117 / 75; HR 74; RR 18; O2 sat 95% Ra
General Exam:
Gen: Lying in BED in NAD, awake and appropriately interactive
HEENT: NCAT, mucuous membranes moist
Lungs: Breathing comfortably on room air, lungs clear to
auscultation bilaterally
CV: well perfused, regular S1, S2
Abd: peg tube in place with clean/dry/intact dressing, abdomen
non-distended, +BS
Ext: non-edematous, warm to touch
Neuro Exam
MS: Speech is dysarthric w slurring. Oriented to self, place,
situation.
CN: Pupils: R 3.5>2, L 4>2; right NLFF; EOMI without nystagmus;
facial sensation intact; tongue deviated to right
Motor:
RUE: Delt 4; Bic 4+, Tric 4-, WE 3, FF 3
RLE: IP 4, HAM 4, Quad 4, TA 4, Gastroc 4
Left UE and ___: Full ___ throughout proximal and distal
Reflexes: UE 3+ bilaterally; patellar 3+ bilateraly, R toe
downgoing, L toe upgoing
Sensation: grossly intact to light touch
Coordination/Gait: Deferred
Pertinent Results:
Admission
========
___ 09:08AM BLOOD WBC-7.7 RBC-3.73* Hgb-11.8* Hct-35.1*
MCV-94# MCH-31.6 MCHC-33.6 RDW-12.7 RDWSD-43.8 Plt ___
___ 09:08AM BLOOD Neuts-76.5* Lymphs-13.5* Monos-5.5
Eos-3.4 Baso-0.7 Im ___ AbsNeut-5.86 AbsLymp-1.03*
AbsMono-0.42 AbsEos-0.26 AbsBaso-0.05
___ 09:08AM BLOOD ___ PTT-29.1 ___
___ 09:08AM BLOOD Plt ___
___ 09:08AM BLOOD Glucose-123* UreaN-29* Creat-1.2 Na-135
K-5.0 Cl-97 HCO3-25 AnGap-13
___ 09:08AM BLOOD ALT-13 AST-23 AlkPhos-70 TotBili-0.2
___ 09:08AM BLOOD Lipase-32
___ 09:08AM BLOOD cTropnT-<0.01
___ 09:08AM BLOOD Albumin-4.3 Calcium-9.5 Phos-3.3 Mg-1.9
___ 09:08AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 09:22AM BLOOD Lactate-1.7
Imaging
======
Chest (PA & LAT) ___: Bilateral calcified pleural plaques
suggest prior asbestos exposure. No
definite focal consolidation.
CTA Head and Neck w/wo ___:
1. No evidence for intracranial hemorrhage or vascular
territorial infarction.
2. Dominant left sided vertebrobasilar system with severe
calcifications in the distal left V4 segment, without occlusion
and with patency of the basilar artery and proximal V4 segment
3. Hypoplastic right vertebral artery with long segment smooth
narrowing of
the distal V4 segment prior to termination within the right
___.
No convincing evidence for dissection.
4. 30% stenosis of the proximal left ICA by NASCET criteria.
5. Moderate calcifications of the bilateral cavernous ICAs.
Otherwise, patent intracranial vasculature.
MRI HEAD ___
RESULTS:
There is moderate-sized acute infarct involving left paramedian
pons. Mild chronic small vessel ischemic changes. There is no
evidence of hemorrhage, edema, masses, mass effect, midline
shift. No hydrocephalus. Moderate generalized brain
parenchymal atrophy. Intracranial vascular flow voids are
preserved.
IMPRESSION:
Acute infarct left pons.
Brief Hospital Course:
Mr. ___ is a ___ RH man w/ h/o HTN, HLD, DM (HbA1C 5.9%),
and CAD s/p stent in ___ who presents with new onset
dysarthria, vision changes, gait unsteadiness, and R-sided arm
and leg weakness. Initial exam notable for bidirectional
horizontal
gaze-evoked nystagmus, R nasolabial fold flattening, R tongue
deviation, pronounced dysarthria in a pseudobulbar pattern, as
well as R UE and ___ weakness. Which has been slowly improving.
Imaging with CTA of the head and neck showed no evidence for
intracranial hemorrhage or vascular territory infarction. MRI
with acute LT pontine stroke. Stroke risk factors assess with
A1C 5.9% and LDL 64. Etiology of his infarct likely from small
vessel atherosclerosis. He was started on secondary prevention
measures with clopidogrel and atorvastatin 40mg daily. As he had
severe dysphagia and failed swallow study, he had a PEG tube
placed on ___ and feeds were starting through it prior to
discharge. Physical therapy worked with him throughout admission
and recommended he be discharged to acute rehab facility.
Transitional issues:
Stroke prevention: Continue to take clopidogrel
Hypertension: Discharged with metoprolol 100 BID and amlodipine
5 mg daily. Holding combination valsartan-hydrochlorothiazide
and Imdur to be resumed as outpatient as tolerated.
Hyperlipidemia: Previously on simvastatin, switched to
atorvastatin 40 mg daily to avoid interaction with amlodipine
Nutrition: PEG tube placed, will need re-evaluation for oral
feeds in future. Glucerna 1.5 at 45 ml/hour.
AHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic
Attack
1. Dysphagia screening before any PO intake? (x) Yes, confirmed
done - () Not confirmed () No
2. DVT Prophylaxis administered? (x) Yes - () No
3. Antithrombotic therapy administered by end of hospital day
2? (x) Yes - () No
4. LDL documented? (x) Yes (LDL = 64) - () No
5. Intensive statin therapy administered? (simvastatin 80mg,
simvastatin 80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg,
rosuvastatin 20mg or 40mg, for LDL > 70) (x) Yes - () No [if LDL
>70, reason not given:
[ ] Statin medication allergy
[ ] Other reasons documented by physician/advanced practice
nurse/physician ___ (physician/APN/PA) or pharmacist
[ ] LDL-c less than 70 mg/dL
]
6. Smoking cessation counseling given? () Yes - (x) No [reason
(x) non-smoker - () unable to participate]
7. Stroke education (personal modifiable risk factors, how to
activate EMS for stroke, stroke warning signs and symptoms,
prescribed medications, need for followup) given (verbally or
written)? (x) Yes - () No
8. Assessment for rehabilitation or rehab services considered?
(x) Yes - () No
9. Discharged on statin therapy? (x) Yes - () No [if LDL >70,
reason not given:
[ ] Statin medication allergy
[ ] Other reasons documented by physician/advanced practice
nurse/physician ___ (physician/APN/PA) or pharmacist
[ ] LDL-c less than 70 mg/dL
10. Discharged on antithrombotic therapy? (x) Yes [Type: (x)
Antiplatelet - () Anticoagulation] - () No
11. Discharged on oral anticoagulation for patients with atrial
fibrillation/flutter? () Yes - () No - (x) N/A
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY
2. Aspirin EC 325 mg PO DAILY
3. MetFORMIN (Glucophage) 1000 mg PO BID
4. Simvastatin 60 mg PO QPM
5. Dipyridamole-Aspirin 1 CAP PO BID
6. Omeprazole 20 mg PO DAILY
7. Metoprolol Tartrate 100 mg PO BID
8. valsartan-hydrochlorothiazide 160-12.5 mg oral unknown
9. amLODIPine 5 mg PO DAILY
Discharge Medications:
1. Atorvastatin 40 mg PO QPM
2. Clopidogrel 75 mg PO DAILY Stroke prevention
3. amLODIPine 5 mg PO DAILY
4. MetFORMIN (Glucophage) 1000 mg PO BID
5. Metoprolol Tartrate 100 mg PO BID
6. Omeprazole 20 mg PO DAILY
7. HELD- Isosorbide Mononitrate (Extended Release) 60 mg PO
DAILY This medication was held. Do not restart Isosorbide
Mononitrate (Extended Release) until you see your primary care
doctor
8. HELD- valsartan-hydrochlorothiazide 160-12.5 mg oral unknown
This medication was held. Do not restart
valsartan-hydrochlorothiazide until discussed with your ___
care doctor
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
Left pons stroke
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or
wheelchair.
Discharge Instructions:
Dear Mr. ___,
You were hospitalized here after you developed difficulty with
speech and right arm and leg speech and determined to have an
ACUTE ISCHEMIC STROKE, a condition where a blood vessel
providing oxygen and nutrients to the brain is blocked by a
clot. The brain is the part of your body that controls and
directs all the other parts of your body, so damage to the brain
from being deprived of its blood supply can result in a variety
of symptoms. Stroke can have many different causes, in your
case, the etiology is likely due to atherosclerotic disease in
the blood vessels that provide blood to your brain.
The goal will be to maximize your recovery from this stroke and
help to prevent you from having another stroke. You will be
discharged to acute rehabilitation and you will work with
physical therapists for hours a day to help increase your
strength. Previously, you were taking Aggrenox to help prevent
stroke, but we have changed management and you will no longer
take this medication. Instead, you will now take clopidogrel to
help reduce your risk of stroke. Also, you will no longer take
simvastatin and we have replaced it with atorvastatin as your
lipid lowering medication.
Please follow up with your primary care physician ___ days
after discharge from hospital to update her on your
hospitalization. We have scheduled you for a follow up
appointment with the stroke clinic with Dr. ___ the date
and time is listed below.
If you experience any of the symptoms below, please seek
emergency medical attention by calling Emergency Medical
Services dialing 911). In particular, since stroke can recur,
please pay attention to the sudden onset and persistence of
these symptoms:
- Sudden partial or complete loss of vision
- Sudden loss of the ability to speak words from your mouth
- Sudden loss of the ability to understand others speaking to
you
- Sudden weakness of one side of the body
- Sudden drooping of one side of the face
- Sudden loss of sensation of one side of the body
Sincerely,
Your ___ Neurology Team
Followup Instructions:
___
|
10809600-DS-22
| 10,809,600 | 25,103,522 |
DS
| 22 |
2118-04-22 00:00:00
|
2118-04-22 15:06:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: SURGERY
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
bleeding from PEG site
Major Surgical or Invasive Procedure:
PEG tube bolstered and released, one vicryl stitch placed
History of Present Illness:
___ year old male with history of stroke recently admitted for L.
pons infarct
c/b dysphagia s/p PEG tube ___ (Dr. ___ presenting with
bleeding around PEG tube. Per patient and living facility, he
has
been having painless bleeding around the PEG tube site over the
last ___ days. Today the amount of bleeding increasing and he
was
prompted to the ED.
The patient was started on Plavix on ___ for stroke
prevention.
He notes no associated pain with the bleeding. No symptoms of
fatigue, lightheadedness, blood in stool or urine, no dark or
tarry stools, no new aches or pain. Of note he had been
progressing in his swallowing rehab and was to start pureed
solids tomorrow.
Past Medical History:
PMH:
-DM - states that it is controlled, not on insulin
-HTN
-HLD
-presumed ischemic stroke several years ago
- cervical arthritis
Social History:
___
Family History:
-Uncle with MI in his ___
- Unknown if family history of stroke or neurologic
disease
Physical Exam:
Physical exam upon admission: ___:
T 97.7 HR 74 RR 16 BP 126/55 SatO2 99% RA
AAA
RRR
CTA bil
Abd: soft, non tender, non distended. PEG site surrounded with
dried blood, no active bleeding, no secreation.
Extremities: no edema
Physical exam upon discharge: ___
T 99.1 BP 138 / 61 HR 89 RR 19 ___ 96 RA
GEN: NAD
CV: RRR
RESP: CTA bil
ABD: soft, non tender, non distended. PEG site surrounded with
dried blood, no active bleeding, some oozing from site.
Extremities: no peripheral edema
Pertinent Results:
___ 07:35AM BLOOD WBC-9.4 RBC-3.47* Hgb-10.7* Hct-33.0*
MCV-95 MCH-30.8 MCHC-32.4 RDW-12.4 RDWSD-43.0 Plt ___
___ 05:00AM BLOOD WBC-13.9* RBC-3.51* Hgb-10.7* Hct-33.3*
MCV-95 MCH-30.5 MCHC-32.1 RDW-12.3 RDWSD-42.5 Plt ___
___ 10:10PM BLOOD WBC-14.9* RBC-3.70* Hgb-11.5* Hct-34.5*
MCV-93 MCH-31.1 MCHC-33.3 RDW-12.2 RDWSD-41.4 Plt ___
___ 07:35AM BLOOD Glucose-106* UreaN-24* Creat-1.0 Na-139
K-4.8 Cl-99 HCO3-23 AnGap-17
___ 05:00AM BLOOD Glucose-112* UreaN-38* Creat-1.1 Na-137
K-4.8 Cl-97 HCO3-28 AnGap-12
___ 07:35AM BLOOD Calcium-9.1 Phos-3.8 Mg-1.9
___ 05:04AM BLOOD Lactate-1.2
___: CXR:
No focal consolidation. Probable small bilateral pleural
effusions.
Brief Hospital Course:
___ year old male, s/p PEG tube on ___ placement for dysphagia,
presenting with
bleeding around PEG tube site. Patient reportedly had been
bleeding from the PEG site over the last ___ days. Because of
the increase in the bleeding, the patient was transferred here
for management. His hematocrit upon admission was 33. The
patient was made NPO and given intravenous fluids.
At bedside, the PEG was adjusted to tamponade bleeding, and no
further bleeding was observed for 24 hours. The patient's
hematocrit was monitored for 24 hours and remained stable.
However, after 24 hours bleeding was again noted and a stitch
was placed around a bleeding vessel. After another 24 hours of
observation, no vigorous bleeding was noted- only some residual
oozing that continues to decrease in quantity. Tube feeds were
held after the stitch was placed, but resumed on ___ and he
tolerated well without further evidence of bleeding.
The patient was discharged on HD #6. His vital signs were
stable and he was afebrile. His hematocrit remained stable. His
Plavix was held on ___ and should be held until ___ for
a total of 7 days. Discharge instructions were reviewed.
Medications on Admission:
1. Atorvastatin 40 mg PO QPM
2. Clopidogrel 75 mg PO DAILY Stroke prevention
3. amLODIPine 5 mg PO DAILY
4. MetFORMIN (Glucophage) 1000 mg PO BID
5. Metoprolol Tartrate 100 mg PO BID
6. Omeprazole 20 mg PO DAILY
7. HELD- Isosorbide Mononitrate (Extended Release) 60 mg PO
DAILY This medication was held. Do not restart Isosorbide
Mononitrate (Extended Release) until you see your primary care
doctor
8. HELD- valsartan-hydrochlorothiazide 160-12.5 mg oral unknown
This medication was held. Do not restart
valsartan-hydrochlorothiazide until discussed with your ___
care doctor
Discharge Medications:
1. Omeprazole 20 mg PO BID
2. valsartan-hydrochlorothiazide 160-12.5 mg oral DAILY
DO NOT RESUME UNTIL SEEN BY PRIMARY CARE PROVIDER
3. amLODIPine 5 mg PO DAILY
4. Atorvastatin 40 mg PO QPM
5. Clopidogrel 75 mg PO DAILY - HOLD UNTIL ___
6. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY
DO NOT RESUME UNTIL FOLLOW-UP WITH PCP
7. MetFORMIN (Glucophage) 1000 mg PO BID
please monitor blood sugar prior to meals and at bedtime
8. Metoprolol Tartrate 100 mg PO BID
hold for systolic blood pressure <100, hr <60
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
bleeding from PEG site
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or
wheelchair.
Discharge Instructions:
Dear Mr. ___
You were admitted to the hospital with bleeding from the PEG
site. The area around the PEG tube was pulled back and there has
been no further bleeding. There was one stitch placed around the
site of bleeding. You have resumed your tube feedings via the
PEG and there has been no further bleeding. You are being
dishcharged to your rehabilitation facility with the following
instructions:
You experience new chest pain, pressure, squeezing or tightness.
*New or worsening cough, shortness of breath, or wheeze.
*If you are vomiting and cannot keep down fluids or your
medications.
*You are getting dehydrated due to continued vomiting, diarrhea,
or other reasons. Signs of dehydration include dry mouth, rapid
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a
bowel movement.
*You experience burning when you urinate, have blood in your
urine, or experience a discharge.
*You have shaking chills, or fever greater than 101.5 degrees
Fahrenheit or 38 degrees Celsius.
*Any change in your symptoms, or any new symptoms that concern
you.
Followup Instructions:
___
|
10809663-DS-20
| 10,809,663 | 27,669,905 |
DS
| 20 |
2147-01-06 00:00:00
|
2147-01-08 17:22:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Headache for three days
Major Surgical or Invasive Procedure:
___: right craniectomy for IPH
___: Port placement
History of Present Illness:
___ year old female, 2-months post-partum, presented to ___
triage with chief complaint of headache with photophobia for
three days prior to presentation on ___. The patient was
transferred from triage to an ED room, and was found to be
obtunded when the ED resident entered the exam room. She was
alert in triage at 742am, but on evaluation by ED resident ~10
min later she was nonresponsive with fixed and dilated right
pupil. Neurosurgery was consulted. She was
intubated for airway protection and taken to STAT CT where she
was found to have large right IPH with IVH.
Past Medical History:
s/p normal vaginal delivery ___
s/p D&Cx3 for TABx3 (confidential)
Social History:
___
Family History:
unknown
Physical Exam:
ON ADMISSION:
Gen: unresponsive female,
HEENT: Pupils: R pupil 7mm NR, L pupil 4mm NR
Date and Time of evaluation: 8:02 am
___ Coma Scale:
[ ]Intubated [x]Not intubated
Eye Opening:
[x]1 Does not open eyes
[ ]2 Opens eyes to painful stimuli
[ ]3 Opens eyes to voice
[ ]4 Opens eyes spontaneously
Verbal:
[x]1 Makes no sounds
[ ]2 Incomprehensible sounds
[ ]3 Inappropriate words
[ ]4 Confused, disoriented
[ ]5 Oriented
Motor:
[ ]1 No movement
[ ]2 Extension to painful stimuli (decerebrate response)
[x]3 Abnormal flexion to painful stimuli (decorticate response)
[ ___ Flexion/ withdrawal to painful stimuli
[ ]5 Localizes to painful stimuli
[ ]6 Obeys commands
__5__ Total
ICH Score:
GCS
[ ]2 GCS ___
[x]1 GCS ___
[ ]0 GCS ___
ICH Volume
[x]1 30 mL or Greater
[ ]0 Less than 30 mL
Intraventricular Hemorrhage
[x]1 Present
[ ]0 Absent
Infratentorial ICH
[ ___ Yes
[x]0 No
Age
[ ]1 ___ years old or greater
[x]0 Less than ___ years old
Total Score: __3____
Neuro:
Mental status: unresponsive
Orientation/Language: nonverbal.
Right pupil 7mm NR, Left pupil 4mm NR
Right corneal present. Left corneal absent.
midline gaze
Right upper extremity extends to noxious
Left upper extremity abnormal flexion
Bilateral lower extremities extending
Sensation: response to noxious stimuli
AT DISCHARGE:
Vitals: ___ 0713 Temp: 98.1 PO BP: 128/78 Lying HR: 77 RR:
18 O2 sat: 98% O2 delivery: Ra
GENERAL: NAD, alert and oriented, depression over right side
with large surgical incision now with staples removed; looking
well-healed
EYES: ptosis/eyelid swelling on right close to symmetrical,
right
eye down and out w/ mild ptosis, EOMI but R eye limited on sup,
inf and lateral gaze. PERRL, cranial nerves otherwise intact
without deficits
HEENT: MMM. Ulcerations healing on lips. OP clear
NECK: supple
LUNGS: CTA b/l, no wheezes/rales/rhonchi
CV: RRR no m/r/g, normal distal perfusion,
ABD: soft, no TP, ND, normoactive
BS, no rebound or guarding
EXT: warm, normal muscle bulk, no edema
SKIN: warm/dry, large surgical incision well approximated on
right side of head, no erythema/drainage
NEURO: AOx3, fluent speech, ptosis on right w/ anisocoria;
otherwise normal cranial nerves
ACCESS: PIV, PICC, port
Pertinent Results:
Admit Labs
___ 08:07AM BLOOD WBC-9.7 RBC-3.35* Hgb-10.8* Hct-33.1*
MCV-99* MCH-32.2* MCHC-32.6 RDW-11.9 RDWSD-42.6 Plt ___
___ 08:07AM BLOOD Neuts-24.2* Lymphs-66.1* Monos-7.8
Eos-1.5 Baso-0.1 Im ___ AbsNeut-2.35 AbsLymp-6.43*
AbsMono-0.76 AbsEos-0.15 AbsBaso-0.01
___ 08:07AM BLOOD Hypochr-NORMAL Anisocy-1+* Poiklo-1+*
Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL Ovalocy-1+*
Burr-OCCASIONAL Tear Dr-OCCASIONAL
___ 08:07AM BLOOD ___ PTT-22.8* ___
___ 12:00PM BLOOD ___
___ 08:07AM BLOOD Glucose-173* UreaN-11 Creat-0.6 Na-141
K-3.2* Cl-104 HCO3-19* AnGap-18
___ 10:53AM BLOOD Calcium-8.8 Phos-2.1* Mg-1.5*
___ 11:10AM BLOOD ___
___ 11:10AM BLOOD CEA-1.6 CA125-8
___ 08:07AM BLOOD Digoxin-<0.4*
___ 08:07AM BLOOD Phenoba-<3* Phenyto-1.2* Lithium-<0.1*
Valproa-<3*
___ 08:07AM BLOOD ASA-NEG Ethanol-NEG Carbamz-<2*
Acetmnp-NEG Tricycl-NEG
___ 08:17AM BLOOD ___ pO2-50* pCO2-36 pH-7.39
calTCO2-23 Base XS--2
___ 08:17AM BLOOD O2 Sat-82 ___ MetHgb-0
Imaging
Radiology ReportED CODE STROKE ONLY CTStudy Date of ___
8:10 AM
1. Large right intraparenchymal hemorrhage with surrounding
edema,
intraventricular extension, and mass effect including effacement
of the
lateral ventricles, right greater than left, and leftward
midline shift
measuring up to 15 mm.
2. No underlying aneurysm or arteriovenous malformation
visualized.
3. Partially visualized soft tissue in the anterior mediastinum,
for which CT
chest is recommended for further evaluation, particularly given
a possible
pleural base mass seen on chest radiograph performed on same
day.
4. Right mainstem bronchus intubation.
Radiology ReportCT HEAD W/O CONTRASTStudy Date of ___
12:38 ___
1. Patient is status post right craniectomy and evacuation of
large right
frontotempooparietal intraparenchymal hemorrhage with expected
postoperative
findings. There has been interval decrease in overall mass
effect with
decrease in leftward midline shift, now measuring 8 mm
(previously 15 mm). No
suggestion of underlying acute, large territorial infarction.
2. Unchanged small amount of subarachnoid hemorrhage along the
posterolateral
right cerebral convexity.
Radiology ReportCT CHEST W/CONTRASTStudy Date of ___
5:40 AM
FINDINGS:
THORACIC INLET: The ET tube and NG tube are in acceptable
position.
BREAST AND AXILLA : There are no enlarged axillary lymph nodes.
MEDIASTINUM: There are no enlarged mediastinal or hilar lymph
nodes. The
aorta and pulmonary artery are normal in caliber. There is no
pleural or
pericardial effusion. Heart size is normal
PLEURA: There is no pleural effusion
LUNG: There is a large mass in the lingula measuring 3.1 x 3.1
cm (602, 96).
Multiple additional bilateral pulmonary nodules are seen ranging
in size from
16 mm to 18 mm. 2 smaller nodules are seen in the left lower
lobe. Some of
these the lesions have high-density material within them, which
could
represent enhancement or could represent calcification.
Difference aeration
due to presence of intravenous contrast is limited. There is
minimal
subsegmental atelectasis in the left lung base.
BONES AND CHEST WALL : Review of bones is unremarkable.
UPPER ABDOMEN: Limited sections through the upper abdomen shows
a hypodense
lesion in the right lobe of liver measuring 11 mm (2, 46), could
represent
evidence of calcification or enhancement.
IMPRESSION:
Multiple bilateral pulmonary masses the largest measuring 3 cm
in the lingula,
are concerning for metastasis. Some of these lesions have areas
of
high-density within them which could represent enhancement or
calcification.
Given the appearance and morphology of the nodules these could
represent
metastasis from a colon cancer or an ovarian cancer.
Small and high-density lesion in the right lobe of liver could
also represent
a metastasis.
The ET tube and the ET tube and NG tube are in appropriate
position
Radiology ReportMR HEAD W & W/O CONTRASTStudy Date of
___ 4:06 ___
FINDINGS:
The patient is status post large right-sided craniectomy.
Postsurgical
changes are noted including calvarial defect, relatively large
subgaleal
blood, fluid, and air-containing collection overlying the
craniectomy site,
and skin/scalp edema. There are intrinsically T1 hyperintense
subacute blood
products within the right temporal lobe associated with
scattered foci of
susceptibility-related artifact at the site of the known
intraparenchymal
hematoma. Serpiginous gyriform enhancement is within range for
expected
findings given involving hematoma. There is right-sided dural
thickening and
enhancement likely related to the recent surgery. There is no
evidence of
focal nodular or mass like enhancement at the site of the
hematomas to suggest
underlying mass, although note that the degree of postsurgical
change,
hematoma, and edema somewhat limits sensitivity.
Restricted diffusion seen peripheral to the site of the hematoma
likely
represents devitalized tissue secondary to bleed. There is a
separate acute
infarction in the medial right occipital lobe in the PCA
distribution (6 and 5
image 12).
Trace linear FLAIR hyperintense signal along the posterior
clivus, right
cerebellopontine angle, right anterior temporal pole, right
frontal convexity
and along the anterior falx may reflect enhancing dural
thickening primarily
ipsilateral to the hematoma and surgery.
There has been interval resolution of right frontal
pneumocephalus since prior
CT. There is unchanged 7 mm leftward shift of midline
structures. There is
slight right uncal herniation (13:67 and 100:65). There is mild
right
cerebral hemispheric sulcal and right lateral ventricular
effacement. No
ventricular entrapment.
IMPRESSION:
1. Status post evacuation of right-sided posterior temporal
hematoma with
postsurgical changes as described. Restricted diffusion at the
margin related
to surgery and postoperative change. No definite enhancing
nodular lesion is
seen no or abnormal vascular structures are identified.
2. Acute right posterior cerebral artery medial occipital
infarct likely
related to uncal herniation.
3. Mass effect as described above with other postsurgical
findings.
Radiology ReportCT ABD & PELVIS W & W/O CONTRAST, ADDL
SECTIONSStudy Date of ___ 11:02 AM
IMPRESSION:
1. No definite evidence of malignancy in the abdomen or pelvis.
2. 0.9 cm hyperenhancing lesion hepatic segment VIII is
nonspecific but could
represent a capillary hemangioma. Metastasis is unable to be
completely
excluded.
3. Mildly enlarged uterus with hyperenhancement of the
junctional zone, likely
secondary to recent postpartum state. No uterine or adnexal
mass.
4. Redemonstration of multiple pulmonary nodules and masses in
the visualized
lung bases. Please see dedicated chest CT performed on ___ for
more detailed evaluation.
adiology ReportPELVIS U.S., TRANSVAGINALStudy Date of
___ 8:19 AM
The postpartum uterus is anteverted and enlarged, measuring 8.7
cm x 5.5 cm x
5.2 cm. Atrium measures 6 mm, at the fundus the endometrium is
heterogeneous
without internal vascularity, this may represent retained
products of
conception, however no discrete mass is seen.
The ovaries are normal. There is a trace amount of free fluid.
IMPRESSION:
1. Enlarged postpartum uterus. Heterogeneous endometrium at the
fundus may
represent retained products of conception, however no discrete
mass is seen.
2. Normal ovaries.
CT HEAD ___. Status post right craniectomy with evacuation of right-sided
posterior
temporal hematoma, now with expected postoperative findings.
2. Interval decrease in left for midline shift, now measuring
4.6 mm
(previously 8 mm).
3. Interval decrease in frontal region pneumocephalus.
4. Interval resolution of the right cerebral convexity sub
arachnoid
hemorrhage.
5. Additional findings as described above.
MRI HEAD ___. Status post evacuation of right-sided temporal hematoma with
postsurgical changes as described.
2. Interval decrease of right temporal intraparenchymal
hemorrhage with
decreasing mass effect, now measuring 4 mm.
3. Possible new punctate acute/subacute infarct of the right
thalamic pulvinar region, correlate clinically.
CT HEAD ___. Status post right craniectomy and evacuation of a right-sided
temporoparietal intraparenchymal hematoma with expected
postoperative changes. Interval decrease in leftward midline
shift, now measuring 3 mm. No new intracranial hemorrhage.
MRI HEAD ___. Interval decrease and evolution of the right temporal
intraparenchymal
hemorrhage. Curvilinear areas of enhancement and restricted
diffusion likely relate to devitalized tissue/compressive
effects secondary to hemorrhage. Evaluation for underlying mass
and abnormal enhancement is limited. No discrete mass is
visualized.
2. Resolution of mass effect on the ventricular system. No
hydrocephalus. Patent basal cisterns.
3. Mildly increasing extra-axial fluid collection in the right
middle cranial fossa compatible with arachnoid cyst with mild
mass effect on the right temporal lobe.
4. Additional findings as described above.
CT HEAD ___. Status post right temporoparietal craniotomy with stable
postoperative
changes. No increase in cerebral edema in the parietal and
occipital lobes.
2. Unchanged 3 mm leftward midline shift. Stable
3. No new intracranial hemorrhage, large territorial infarction,
or mass.
RUQUS ___. Collapsed gallbladder, therefore inadequately assessed. If
there is
persistent clinical concern for cholelithiasis or acute
cholecystitis,
consider repeating the study after fasting for at least 4 hours.
2. Nonvisualization of the appendix.
CT ABDOMEN ___. No acute findings in the abdomen or pelvis.
2. 12 mm hyperenhancing lesion in the right hepatic lobe is
bigger, suspicious
for additional site of metastatic choriocarcinoma.
3. Masses in the imaged lung bases are similar or mildly
smaller.
CT HEAD ___. Status post right temporoparietal craniotomy with stable
postoperative
changes.
2. No new areas of hemorrhage or increased mass effect. No
evidence of new large territorial infarction.
3. Unchanged 3 mm leftward midline shift.
MICRO LABS
=================
___ 11:54 am BLOOD CULTURE Source: Line-PICC.
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
___ 12:36 pm URINE Source: ___.
**FINAL REPORT ___
URINE CULTURE (Final ___: < 10,000 CFU/mL.
ANAEROBIC CULTURE (Final ___:
TEST CANCELLED, PATIENT CREDITED.
Test performed only on suprapubic and kidney aspirates
received in a
syringe.
SPOKE WITH ___ ON ___ AT 1440.
___ 4:15 pm BLOOD CULTURE Source: Line-port ( 1 OF 3
).
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
___ 4:20 pm BLOOD CULTURE Source: Line-port ( 2 OF 3
).
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
___ 6:10 pm BLOOD CULTURE SET#3.
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
___ 12:48 pm URINE Source: ___.
**FINAL REPORT ___
URINE CULTURE (Final ___: NO GROWTH.
DISCHARGE LABS
===================
___ 04:25PM BLOOD WBC-1.0* RBC-3.17* Hgb-9.6* Hct-27.6*
MCV-87 MCH-30.3 MCHC-34.8 RDW-12.7 RDWSD-40.5 Plt Ct-48*
___ 04:36AM BLOOD Neuts-33.3* ___ Monos-17.5*
Eos-0.0* Baso-0.0 Im ___ AbsNeut-0.42* AbsLymp-0.57*
AbsMono-0.22 AbsEos-0.00* AbsBaso-0.00*
___ 04:25PM BLOOD Plt Ct-48*
___ 04:36AM BLOOD Plt Ct-47*
___ 04:36AM BLOOD ___ PTT-24.4* ___
___ 04:36AM BLOOD Glucose-105* UreaN-31* Creat-0.6 Na-139
K-4.6 Cl-105 HCO3-21* AnGap-13
___ 04:36AM BLOOD ALT-92* AST-26 LD(LDH)-223 AlkPhos-90
TotBili-0.3
___ 04:36AM BLOOD Calcium-8.5 Phos-4.0 Mg-1.9
___ 06:46PM BLOOD mthotrx-<0.04
Brief Hospital Course:
**PATIENT DISCHARGED WITH HOME SERVICES FOR ___ MEDICATION
MANAGEMENT**
___ F 3 months postpartum who initially presented to ED with
headache, found to have large right intraparenchymal and
intravascular hemorrhage (s/p craniectomy and clot evacuation),
was subsequently found to have liver/lung lesions and an
elevated HCG concerning for metastatic gestational trophoblastic
neoplasm, transferred to oncology service for chemotherapy.
# Metastatic gestational trophoblastic neoplasm w/
lung/brain/liver lesions:
Patient two months post partum with discovery of metastatic
choriocarcinoma iso intracranial and liver/lungs mets. Started
on etopo/MTX/cisplatin/dactinomycin with plan for at least 8
weeks following an HCG level of zero. HCG down from 150,000 to
2,000 post cycle 1. C2D1 initiated ___ with improvement in HCG
to 357. Will need to get readmitted every other week for MTX.
TLS labs have been stable. Her brain will likely either be
treated with whole brain radiation or CyberKnife and intrathecal
chemotherapy (likely post chemotherapy). Repeat MRI with
interval improvement, to determine neurosurgical plan in two
weeks. Cleared for home by ___ with 24 hour supervision at
home. Patient was at high risk for TLS given tumor burden but
stable labs on chemotherapy. Elevated LFTs likely attributed to
chemo drugs Etoposide vs. MTX, and now improving. Will need to
monitor weekly Hcg on ___. 14 day cycles of current
chemotherapy regimen to continue with at least two months
post-HCG level of zero so likely time course ___ months. Will
follow up with radiation oncology outpatient the to determine
future WBRT vs cyberknife, and will need repeat MRI at
outpatient follow up appointment. On discharge, patient and
family were given extensive teaching and a calendar outlining
which medications to take on what days. She received 3 cycles of
chemotherapy while in house and her methotrexate has been
cleared before discharge.
# Right intraparenchymal and intravascular hemorrhage (s/p
craniectomy and clot evacuation):
Improving headache and CN3 palsy with improved swelling. MRI
shows improvement in mass effect. Venous infarct in right
thalamic pulvinar region. Area is involved in attention/neglect.
Demonstrated left neglect and homonomyous hemianopsia. No
changes in neuro exam means no need for further work-up.
Continued keppra BID for seizure ppx. On ___ pt had one episode
of loss of consciousness, urinary incontinence and bilateral
upper extremity tremors, after which Keppra was uptitrated to
1000 BID with no further issues. On ___ patient started to c/o
headache and nausea/vomiting and increased right temporal
swelling was noted. MRI head showed mildly increasing
extra-axial fluid collection in the right middle cranial
fossa compatible with arachnoid cyst with mild mass effect on
the right
temporal lobe. Repeat CT head showed status post right
temporoparietal craniotomy with stable postoperative changes. No
increase in cerebral edema in the parietal and occipital lobes.
Unchanged 3 mm leftward midline shift and stable. No new
intracranial hemorrhage, large territorial infarction, or mass.
Patient received dexamethasone and symptom relief treatment and
patient's symptoms resolved. Her anticoagulation was held. On
Needs to continue to wear helmet whenever ambulating. Will
follow up with neurosurgery for repeat MRI and outpt appt with
___. Should discuss plan to replace skull bone at this
time. No platelet goal per neurosurgery.
# Unstable gait:
Likely secondary to intraparenchymal hemorrhage with subsequent
intracranial edema and deconditioning. As per ___, patient was at
high risk for deconditioning but with persistent ambulation and
working with ___ patient significantly improved. Discharged
with 24 hour supervision at home. Will need to continue to wear
the helmet whenever out of bed.
# Pupil-sparing CNIII palsy:
R eye down and out w/ ptosis. Failure to adduct past midline.
Pupils are equal and reactive to light, no afferent defect.
These findings support nuclear involvement vs chronic CNIII.
Neuroophtho endorsed CN III palsy OD and likely CN IV palsy with
L homonymous hemianopsia and ataxia. Improved on exam with time
and dexamethasone in the setting of resolving intracranial
edema. Will follow up with neuroopthalmology for a repeat
evaluation.
# Anemia:
Likely secondary to chemotherapy/malignancy rather than acute
blood loss. s/p 1U pRBC during time in ___ ICU and has received
transfusions after transferring to the floor. Upon discharge
hemolysis labs unremarkable, and with resolved vaginal spotting.
She received 1u RBC on the day of discharge.
RESOLVED ISSUES
================
# Dysphagia/nutrition
# Mucositis
Speech and swallow saw patient ___ and approved her for a
regular diet. Dysphagia previously secondary to acute insult
from IPH and intubation. NGT pulled out. No residual issues.
Patient developed mucositis which caused decreased oral intake
and TPN has been started. Patient's mucositis has improved and
she is able to eat and drink normally on discharge. We
discontinue her TPN on discharge.
# Neutropenic fever
Patient had 1 episode of fever on ___. She was started on
cefepime and pan-cultures were obtained. Unclear source and
patient had been afebrile since. Cefepime was discontinued on
___ and patient continues to be afebrile.
# S/p 3 month Post Partum
Patient's breast milk initially thought to be a hazard iso HD
MTX. With less frequent pumping and active chemotherapy, the
breast milk volume decreased and production eventually stopped.
# Orthostatic hypotension
Improved with IVF prn for orthostasis ___ poor PO intake, and
resolved after more persistent ambulation. It has been resolved.
# GERD
Hpylori negative. Improved symptoms with ranitidine 150 mg PO
BID and tums prn.
# Insomnia
Patient says pain was what was keeping her up instead of issues
with getting to sleep. Improved with pain improvement and able
to ambulate. Received ramelteon and trazodone PRN.
TRANSITIONAL ISSUES
==================
DISCHARGE WT: 51.62 kg (113.8 lb)
DISCHARGE HGB: 8.0
DISCHARGE WBC: 1.3 (___ 420)
[ ] Please check CBC/diff daily after discharge
[ ] Needs to wear helmet at all times while ambulating
[ ] Rad Onc outpatient follow up for radiation plans; they want
repeat imaging and follow up around the same time as
neurosurgery
[ ] Please check HCG once a week (next one ___
[ ] once HCG negative, will need at least 8 weeks of therapy as
per Dr ___ (2 week cycle with HD MTX and chemo)
[ ] On discharge, patient and family were given extensive
teaching and a calendar outlining which medications to take on
what days. Please ensure compliance as able.
[ ] Please ensure that an interpreter is booked for all
appointments
[ ] Please recheck CT abdomen to monitor hepatic mass as
outpatient.
Recommended Followup:
[ ] Please schedule f/u w/ NSGY first week of ___ (4 weeks
post craniectomy) for repeat MRI and outpt appt w/
___ plan for replacement of skull bone
[ ] follow up with neuro-optho Dr. ___ in ___ for
repeat exam and dilated fundus examination
[ ] Please schedule follow up outpatient with gyn Onc as needed
[ ] Neurosurgery follow up appointment pending
#HCP/Contact: Husband ___ ___
#Code: presumed FULL
This patient was prescribed, or continued on, an opioid pain
medication at the time of discharge (please see the attached
medication list for details). As part of our safe opioid
prescribing process, all patients are provided with an opioid
risks and treatment resource education sheet and encouraged to
discuss this therapy with their outpatient providers to
determine if opioid pain medication is still indicated.
Medications on Admission:
prenatal vitamin (unsure if still taking)
Discharge Medications:
1. Calcium Carbonate 1000 mg PO QID:PRN heartburn
2. Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID
3. Dexamethasone 4 mg PO BID
on days 2,3,9,10 of chemotherapy cycle
RX *dexamethasone [Decadron] 4 mg 1 tablet(s) by mouth twice a
day Disp #*8 Tablet Refills:*5
4. Docusate Sodium 100 mg PO BID
5. Filgrastim-sndz 300 mcg SC Q24H Duration: 5 Days
on days ___ and ___ of chemotherapy cycle
RX *filgrastim-sndz [Zarxio] 300 mcg/0.5 mL 300 mcg SC once a
day Disp #*11 Syringe Refills:*4
6. Heparin Flush (10 units/ml) 5 mL IV DAILY and PRN, line
flush
7. Leucovorin Calcium 15 mg PO Q6H Duration: 18 Doses
Start 24 hours after START of methotrexate infusion .
RX *leucovorin calcium 15 mg 1 tablet(s) by mouth every six (6)
hours Disp #*18 Tablet Refills:*0
8. LevETIRAcetam 1000 mg PO BID
RX *levetiracetam 1,000 mg 1 tablet(s) by mouth twice a day Disp
#*60 Tablet Refills:*0
9. LORazepam 0.5 mg PO Q8H:PRN nausea/insomnia
hold for sedation
RX *lorazepam [Ativan] 0.5 mg 1 tab by mouth every eight (8)
hours Disp #*30 Tablet Refills:*1
10. Maalox/Diphenhydramine/Lidocaine 15 mL PO QID
RX *alum-mag hydroxide-simeth [Maalox Maximum Strength] 400
mg-400 mg-40 mg/5 mL 5 mL by mouth four times a day Disp #*710
Milliliter Milliliter Refills:*0
11. Ondansetron 8 mg PO TID
on days 2,3,9,10 of chemotherapy cycle, then 8 hours prn
RX *ondansetron 8 mg 1 tablet(s) by mouth three times a day Disp
#*35 Tablet Refills:*3
12. OxycoDONE Liquid ___ mg PO Q6H:PRN Pain - Moderate
RX *oxycodone 5 mg ___ tabs by mouth every six (6) hours Disp
#*10 Tablet Refills:*0
13. Prochlorperazine 10 mg PO Q6H:PRN nausea/vomiting
RX *prochlorperazine maleate [Compazine] 10 mg 1 tablet(s) by
mouth every six (6) hours Disp #*30 Tablet Refills:*3
14. Ranitidine 150 mg PO BID
RX *ranitidine HCl 150 mg 1 capsule(s) by mouth twice a day Disp
#*60 Capsule Refills:*0
15. Senna 17.2 mg PO BID
RX *sennosides 8.6 mg 17.2 mg by mouth twice a day Disp #*60
Tablet Refills:*0
16. Sodium Bicarbonate 1300 mg PO TAKE 1 PRIOR TO MTX
CHEMOTHERAPY
Please take 1 tab prior to presenting for MTX chemo
RX *sodium bicarbonate 650 mg 2 tablet(s) by mouth Take one
prior to presenting for MTX chemotherapy Disp #*30 Tablet
Refills:*0
17. Sodium Bicarbonate 1300 mg PO ONCE Duration: 1 Dose
Take one prior to presenting for MTX chemotherapy.
RX *sodium bicarbonate 650 mg 2 tablet(s) by mouth once Disp #*2
Tablet Refills:*0
18.Rollator Walker
Dx: Choriocarcinoma ICD 10: C58
Length of need: 13 months
Prognosis: good
Discharge Disposition:
Home
Discharge Diagnosis:
Right intraparenchymal hemorrhage with intraventricular
hemorrhage
Cerebral compression
Metastatic gestational trophoblastic neoplasm with metastases to
the liver, lungs, and brain
Cranial nerve three palsy
Anemia
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane)(needs to wear helmet while ambulating)
Discharge Instructions:
Dear Ms ___,
WHY DID YOU COME TO THE HOSPITAL?
- You had a headache and were found to have bleeding in your
brain.
WHAT WE DID FOR YOU
- You had surgery to remove the blood from the brain which
involved removing a piece of the skull
- You were found to have a metastatic cancer from your pregnancy
that had spread to the brain, liver, and lungs that caused the
brain bleed
- You were started on chemotherapy and watched carefully to make
sure you tolerated it
- Your cancer numbers (HCG hormone) came down tremendously with
chemotherapy, which is good news
- You had an issue with moving your right eye and you saw
neuro-ophthalmology for this, but it improved significantly
- Your walking was unstable but the physical and occupational
therapists worked closely with you and your walking improved
- Your swallowing was initially impaired but improved to normal
so the feeding tube was removed
- You received a blood transfusion for dropping blood counts,
likely because of chemotherapy
- You were pumping your breast milk but it eventually stopped
coming
- You received a port placement for chemotherapy
- You underwent a CT abdomen which showed 12 mm hyperenhancing
lesion in the right hepatic lobe is bigger.
- You underwent MRI head and CT head which showed craniotomy
post-operative change.
WHAT YOU SHOULD DO WHEN YOU LEAVE
- Please make sure you are under 24 supervision at all times
with walking and with tasks. You are not completely healed yet
and cannot do your normal routine without supervision to prevent
injury to yourself!
- You NEED to wear your helmet every time you get out of bed or
are walking inside or outside. Your brain is still very tender
and there is risk for bleeding again if you fall or hit your
head
- You need to follow up regularly in clinic with Dr ___
chemotherapy as well as for inpatient methotrexate every other
week
- Please take all your medications as prescribed and follow up
with all the doctors below
It was a pleasure caring for you, we wish you the best!!
Sincerely,
Your ___ Care Team
Followup Instructions:
___
|
10809830-DS-28
| 10,809,830 | 28,710,771 |
DS
| 28 |
2170-03-13 00:00:00
|
2170-03-13 17:10:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Penicillins / Erythromycin Base / Gentamicin / Diltiazem /
Plavix / Sulfa (Sulfonamide Antibiotics) / IV Dye, Iodine
Containing / Vancomycin / Ativan / Clindamycin / ciprofloxacin
Attending: ___.
Chief Complaint:
Chest Pain
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ PMH CAD (with CABG in ___, multiple PCIs), Afib, HTN, DM,
who is presenting with chest pain. This has been occurring
intermittently over the last two days. He noticed the pain
immediately after getting into an argument with his daughter. He
reports substernal pain that radiates to the back. The pain is
pleuritic but nonexertional. He has noticed shortness of breath.
He denies fever, chills, cough, hemoptysis, abdominal pain,
nausea, vomiting. He has chronic history of left leg swelling
which is his baseline since he had vein stripping performed in
the past. No history of DVT, PE, but has prostate cancer in
past. He took aspirin prior to arrival.
In the ED initial vitals were: no temp 76 112/55 17 98% RA
EKG: SR 79, QTc 471, QRS 150, Qwaves II, III, AVF, AVR, V1-V3.
Labs/studies notable for: WBC 10.5, Hgb 11.1, K 5.2, Creat 1.5
INR 1.2, normal LFTS, trop 0.19->0.29, normal MB x2, lactate
1.4. UA showed large leuks, WBC 182, negative nitrate, many
bacteria. Exam with nontender prostate. Chest Xray with low lung
volume and persistent R hemidiaphragm elevation.
Patient was given: Ceftriaxone
Vitals on transfer: 98.2 62 120/50 17 97% RA
Consulted: Cards was consulted who recommended admit for rising
troponin.
On the floor the patient had no complaints.
ROS:
On review of systems, denies any prior history of stroke, TIA,
deep venous thrombosis, pulmonary embolism, bleeding at the time
of surgery, myalgias, joint pains, cough, hemoptysis, black
stools or red stools. Denies recent fevers, chills or rigors.
Denies exertional buttock or calf pain. All of the other review
of systems were negative. Cardiac review of systems is notable
for absence paroxysmal nocturnal dyspnea, orthopnea, ankle
edema, palpitations, syncope or presyncope.
Past Medical History:
1. Coronary artery disease with prior CABG in ___.
2. Abrupt occlusion of a vein graft to the OM in ___ in the
setting of brief aspirin discontinuation for prostate biopsy.
He
has had subsequent multiple PCIs.
3. Atrial fibrillation, currently managed with low-dose
amiodarone and dabigatran for thromboembolic prophylaxis.
4. Hypertension.
5. Diabetes mellitus.
6. PMR on chronic prednisone
Social History:
___
Family History:
No family history of early MI, arrhythmia, cardiomyopathies, or
sudden cardiac death; Family history is significant for father
who
died at age ___ of heart attack and coronary artery disease. His
mother died in her ___ of a heart attack and coronary artery
disease. He has a brother with lymphoma and sarcoma.
Physical Exam:
ADMISSION PHYSICAL EXAM
VS: 97 110/51 68 20 96%
GENERAL: NAD. Oriented x3. Mood, affect appropriate.
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were
pink, no pallor or cyanosis of the oral mucosa. No xanthelasma.
NECK: Supple with no elevated JVP.
CARDIAC: RR, normal S1, S2. No murmurs/rubs/gallops. No
thrills, lifts.
LUNGS: Resp were unlabored, no accessory muscle use. No
crackles, wheezes or rhonchi.
ABDOMEN: Soft, NTND. No HSM or tenderness.
EXTREMITIES: No c/c/e. No femoral bruits.
SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
PULSES: Distal pulses palpable and symmetric
DISCHARGE PHYSICAL EXAM
Vitals: 98.4 ___ 54-71 ___ 95-100%RA
I/O= ___ (8hrs), 480/780 (24hrs)
GENERAL: WDWN in NAD. Oriented x3. Mood, affect appropriate.
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were
pink, no pallor or cyanosis of the oral mucosa. No xanthelasma.
NECK: Supple with JVP not elevated.
CARDIAC: RRR, normal S1, S2. II/VI systolic murmur loudest at
RUSB. LUNGS: Very mild crackles at R base. Breathing comfortably
without accessory muscle use.
ABDOMEN: Soft, NTND. No HSM or tenderness.
EXTREMITIES: No c/c/e. B/l lower extremities thin. R knee with
non-tender swelling around patella. No overlying redness or
warmth.
SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
PULSES: b/l 2+ DP and ___
Pertinent Results:
ADMISSION LABS
___ 01:10PM WBC-10.5*# RBC-3.72* HGB-11.1* HCT-35.1*
MCV-94 MCH-29.8 MCHC-31.6* RDW-14.5 RDWSD-49.9*
___ 01:10PM NEUTS-83.3* LYMPHS-6.2* MONOS-9.0 EOS-0.7*
BASOS-0.3 IM ___ AbsNeut-8.75*# AbsLymp-0.65* AbsMono-0.95*
AbsEos-0.07 AbsBaso-0.03
___ 01:10PM PLT COUNT-178
___ 01:10PM cTropnT-0.19*
___ 01:10PM LIPASE-20
___ 01:10PM ALT(SGPT)-13 AST(SGOT)-21 CK(CPK)-84 ALK
PHOS-99 TOT BILI-0.4
___ 01:10PM GLUCOSE-215* UREA N-45* CREAT-1.5* SODIUM-138
POTASSIUM-5.2* CHLORIDE-104 TOTAL CO2-22 ANION GAP-17
___ 02:45PM URINE RBC-20* WBC->182* BACTERIA-MANY
YEAST-NONE EPI-1
___ 02:45PM URINE BLOOD-TR NITRITE-NEG PROTEIN-30
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0
LEUK-LG
___ 02:45PM URINE COLOR-Yellow APPEAR-Hazy SP ___
___ 04:37PM LACTATE-1.4
___ 06:28PM CK-MB-7 cTropnT-0.29* proBNP-8424*
___ 06:28PM CK(CPK)-69
PERTINENT LABS DURING ADMISSION
___ 01:10PM BLOOD cTropnT-0.19*
___ 06:28PM BLOOD CK-MB-7 cTropnT-0.29* proBNP-8424*
___ 03:11AM BLOOD CK-MB-6 cTropnT-0.19*
___ 06:20AM BLOOD CK-MB-5 cTropnT-0.15*
DISCHARGE LABS
___ 06:40AM BLOOD WBC-5.6 RBC-3.55* Hgb-10.4* Hct-34.0*
MCV-96 MCH-29.3 MCHC-30.6* RDW-14.4 RDWSD-50.2* Plt ___
___ 06:40AM BLOOD ___ PTT-30.3 ___
___ 06:40AM BLOOD Glucose-115* UreaN-44* Creat-1.3* Na-140
K-4.3 Cl-104 HCO3-27 AnGap-13
___ 06:40AM BLOOD Calcium-8.5 Phos-3.5 Mg-2.1
MICRO
URINE CULTURE (Final ___:
ESCHERICHIA COLI. >100,000 ORGANISMS/ML..
_________________________________________________________
ESCHERICHIA COLI
|
AMPICILLIN------------ =>32 R
AMPICILLIN/SULBACTAM-- =>32 R
CEFAZOLIN------------- =>64 R
CEFEPIME-------------- <=1 S
CEFTAZIDIME----------- <=1 S
CEFTRIAXONE----------- <=1 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------ <=1 S
MEROPENEM-------------<=0.25 S
NITROFURANTOIN-------- <=16 S
PIPERACILLIN/TAZO----- <=4 S
TOBRAMYCIN------------ <=1 S
TRIMETHOPRIM/SULFA---- <=1 S
STUDIES
CXR ___: Low lung volumes and persistent elevation of the
right hemidiaphragm. No
focal consolidation to suggest pneumonia. No pulmonary edema.
TTE ___: LVEF 40-45%
Mild symmetric left ventricular hypertrophy with mild regional
systolic dysfunction c/w CAD (PDA distribution). Severe mitral
regurgitation. Mild pulmonary artery systolic hypertension.
Compared with the prior study (images reviewed) of ___,
the severity of mitral regurgitation has increased and trivial
aortic valve stenosis is now present. Regional and global left
ventricular systolic function is similar. No aortic
regurgitation is seen on the current study.
CLINICAL IMPLICATIONS:
The patient has severe mitral regurgitation. Based on ___
ACC/AHA Valvular Heart Disease Guidelines, a follow-up
echocardiogram is suggested in ___ months.
Brief Hospital Course:
___ with ___ CAD s/p CABG and PCIs (10 total, last in ___,
Afib on amiodorone, DM, HTN who presents with atypical chest
pain admitted for rising troponins.
# Atypical Chest Pain. Troponin peaked at 0.29 while in the ED,
without recurrence of chest pain symptoms during
hospitalization. No significant EKG changes were noted. He was
not started on heparin. Repeat TTE showed mild symmetric left
ventricular hypertrophy with mild regional systolic dysfunction
consistent with CAD in PDA distribution. Also showed severe
mitral regurgitation and mild pulmonary artery systolic
hypertension. Given increase in severity of mitral
regurgitation, follow up echocardiogram recommended in ___
months. He was continued on his home medications ASA,
Lisinopril, Furosemide, Metoprolol and Simvistatin. Given his
extensive past PCI, in addition to his age, comorbidities and
atypical nature of his chest pain symptoms, he did not undergo
additional PCI. He was continued on medical management. Troponin
downtrended with treatment for UTI and patient remained chest
pain free at time of discharge.
# UTI. He was noted to have a UA positive for infection, with
symptoms of dysuria. Urine culture showed E. coli, resistent to
ampicillin, ampicillin/sulbactam, and cefazolin. He was treated
with Ceftriaxone IV and switched to cefpodoxime to complete a 10
day course of therapy for complicated UTI on ___.
Chronic Issues
# Atrial fibrillation. He remained in SR on telemetry during his
admission. He was continued on amiodorone and metoprolol. He
was taken off apixaban at some point prior to admission by his
outpatient cardiologist Dr. ___. This was not restarted
during admission.
# CKD. Cr remained near baseline 1.3. He was continued on home
lasix.
# Diabetes mellitus. Home glipizide was held and he was
continued on ISS.
**Transitional Issues ***
- Repeat TTE done ___ with read pending as of patient's
discharge. Given worsening of severe MR, patient will need
follow up TTE in ___ months.
- To complete 10 day course of cefpodoxime for UTI on ___.
- Please follow-up blood culture pending from ___.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Influenza Vaccine Quadrivalent 0.5 mL IM NOW X1
Start: ___, First Dose: Next Routine Administration Time
2. Amiodarone 100 mg PO DAILY
3. Aspirin 81 mg PO DAILY
4. Ferrous Sulfate 325 mg PO DAILY
5. Finasteride 5 mg PO DAILY
6. Furosemide 20 mg PO BID
7. Lisinopril 5 mg PO DAILY
8. Metoprolol Succinate XL 25 mg PO DAILY
9. Omeprazole 20 mg PO DAILY
10. Simvastatin 20 mg PO DAILY
11. flunisolide 25 mcg (0.025 %) nasal prn congestion
12. GlipiZIDE XL 1.25 mg PO DAILY
13. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY
14. Nitroglycerin SL 0.4 mg SL PRN chest pain
15. Vesicare (solifenacin) 10 mg oral daily
16. Vitamin D ___ UNIT PO 1X/WEEK (___)
17. Polyethylene Glycol 17 g PO DAILY:PRN constipation
18. Docusate Sodium 100 mg PO BID
Discharge Medications:
1. Amiodarone 100 mg PO DAILY
2. Aspirin 81 mg PO DAILY
3. Docusate Sodium 100 mg PO BID
4. Ferrous Sulfate 325 mg PO DAILY
5. Finasteride 5 mg PO DAILY
6. Furosemide 20 mg PO BID
7. Lisinopril 5 mg PO DAILY
8. Nitroglycerin SL 0.4 mg SL PRN chest pain
9. Omeprazole 20 mg PO DAILY
10. Polyethylene Glycol 17 g PO DAILY:PRN constipation
11. Simvastatin 20 mg PO DAILY
12. flunisolide 25 mcg (0.025 %) nasal prn congestion
13. GlipiZIDE XL 1.25 mg PO DAILY
14. Vesicare (solifenacin) 10 mg oral daily
15. Vitamin D ___ UNIT PO 1X/WEEK (___)
16. Cefpodoxime Proxetil 200 mg PO Q12H
RX *cefpodoxime 200 mg 1 tablet(s) by mouth twice a day Disp
#*15 Tablet Refills:*0
17. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY
18. Metoprolol Succinate XL 25 mg PO DAILY
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
Primary Diagnosis
- Atypical Angina
- Urinary Tract Infection
Secondary Diagnosis
- Atrial fibrillation
- Hypertension
- Hyperlipidemia
- Diabetes
- Prostate Cancer
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you during your hospitalization
at ___. Briefly, you were hospitalized with chest pain. You
were also found to have a UTI and you were started on IV
antibiotics. You will continue taking oral antibiotics
(Cefpodoxine) until ___.
Please weigh yourself every morning, call MD if weight goes up
more than 3 lbs.
We wish you the best,
Your ___ Treatment Team
Followup Instructions:
___
|
10809830-DS-29
| 10,809,830 | 27,831,894 |
DS
| 29 |
2170-03-29 00:00:00
|
2170-03-29 14:13:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: ORTHOPAEDICS
Allergies:
Penicillins / Erythromycin Base / Gentamicin / Diltiazem /
Plavix / Sulfa (Sulfonamide Antibiotics) / IV Dye, Iodine
Containing / Vancomycin / Ativan / Clindamycin / ciprofloxacin
Attending: ___.
Chief Complaint:
R hip fracture
Major Surgical or Invasive Procedure:
R hip ORIF with DHS
History of Present Illness:
___ M with CAD s/p CABG and PCI (on ASA) presents with R hip
fracture s/p mechanical fall. He tripped while ambulating with
his walker this morning and fell on his right side, with
immediate pain about the right hip and inability to ambulate.
He
denies numbness, tingling, or pain elsewhere. He was initially
taken to ___, then transferred to ___ in order to
undergo pre-operative evaluation by his established cardiac
team.
Past Medical History:
1. Coronary artery disease with prior CABG in ___.
2. Abrupt occlusion of a vein graft to the OM in ___ in the
setting of brief aspirin discontinuation for prostate biopsy.
He
has had subsequent multiple PCIs.
3. Atrial fibrillation, currently managed with low-dose
amiodarone and dabigatran for thromboembolic prophylaxis.
4. Hypertension.
5. Diabetes mellitus.
6. PMR on chronic prednisone
Social History:
___
Family History:
No family history of early MI, arrhythmia, cardiomyopathies, or
sudden cardiac death; Family history is significant for father
who
died at age ___ of heart attack and coronary artery disease. His
mother died in her ___ of a heart attack and coronary artery
disease. He has a brother with lymphoma and sarcoma.
Physical Exam:
Right lower extremity:
- Dsg cdi
- Fires ___
- SILT S/S/SP/DP/T distributions
- 1+ ___ pulses, WWP
Brief Hospital Course:
The patient presented to the emergency department and was
evaluated by the orthopedic surgery team. The patient was found
to have R intertrochanteric hip fracture and was admitted to the
orthopedic surgery service. The patient was taken to the
operating room on ___ for R hip DHS, which the patient
tolerated well. For full details of the procedure please see the
separately dictated operative report. The patient was taken from
the OR to the PACU in stable condition and after satisfactory
recovery from anesthesia was transferred to the floor. The
patient was initially given IV fluids and IV pain medications,
and progressed to a regular diet and oral medications by POD#1.
The patient was given ___ antibiotics and
anticoagulation per routine. The patient's home medications were
continued throughout this hospitalization. The patient worked
with ___ who determined that discharge to rehab was appropriate.
The ___ hospital course was otherwise unremarkable.
At the time of discharge the patient's pain was well controlled
with oral medications, incisions were clean/dry/intact, and the
patient was voiding/moving bowels spontaneously. The patient is
WBAT in the right lower extremity, and will be discharged on
lovenox for DVT prophylaxis. The patient will follow up with
___ trauma team per routine. A thorough discussion
was had with the patient regarding the diagnosis and expected
post-discharge course including reasons to call the office or
return to the hospital, and all questions were answered. The
patient was also given written instructions concerning
precautionary instructions and the appropriate follow-up care.
The patient expressed readiness for discharge.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Amiodarone 100 mg PO DAILY
2. Aspirin 81 mg PO DAILY
3. Ferrous Sulfate 325 mg PO DAILY
4. Finasteride 5 mg PO DAILY
5. Furosemide 10 mg PO DAILY
6. Lisinopril 5 mg PO DAILY
7. Omeprazole 20 mg PO DAILY
8. Simvastatin 20 mg PO QPM
9. Flunisolide Inhaler 80 mcg/actuation inhalation DAILY:PRN
congestion
10. GlipiZIDE XL 1.25 mg PO DAILY
11. Vesicare (solifenacin) 10 mg oral DAILY
12. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY
13. Metoprolol Succinate XL 25 mg PO DAILY
14. Vitamin D3 (cholecalciferol (vitamin D3)) 2,000 unit oral
DAILY
15. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain
16. Polyethylene Glycol 17 g PO DAILY
17. Docusate Sodium 100 mg PO DAILY
Discharge Medications:
1. Aspirin 81 mg PO DAILY
2. Ferrous Sulfate 325 mg PO DAILY
3. Finasteride 5 mg PO DAILY
4. Furosemide 20 mg PO BID
5. GlipiZIDE XL 1.25 mg PO DAILY
6. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY
7. Lisinopril 5 mg PO DAILY
8. Metoprolol Succinate XL 25 mg PO DAILY
9. Omeprazole 20 mg PO DAILY
10. Simvastatin 20 mg PO QPM
11. Acetaminophen 1000 mg PO Q8H
12. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation
13. Docusate Sodium 100 mg PO BID
14. Enoxaparin Sodium 40 mg SC Q24H
RX *enoxaparin [Lovenox] 40 mg/0.4 mL 1 syringe sq once a day
Disp #*24 Syringe Refills:*0
15. OxycoDONE (Immediate Release) 2.5-5 mg PO Q6H:PRN pain
RX *oxycodone 5 mg 1 tablet(s) by mouth every six (6) hours Disp
#*20 Tablet Refills:*0
16. Polyethylene Glycol 17 g PO DAILY:PRN constipation
17. Senna 8.6 mg PO BID
18. solifenacin 5 mg oral BID
19. Vitamin D 400 UNIT PO DAILY
20. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain
21. Flunisolide Inhaler 80 mcg/actuation inhalation DAILY:PRN
congestion
22. Vesicare (solifenacin) 10 mg ORAL DAILY
23. Amiodarone 100 mg PO DAILY
24. Vitamin D3 (cholecalciferol (vitamin D3)) 2,000 unit oral
DAILY
25. Ondansetron 4 mg PO Q8H:PRN nausea/vomiting
RX *ondansetron HCl 4 mg 1 tablet(s) by mouth every eight (8)
hours Disp #*20 Tablet Refills:*0
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
R hip intertrochanteric fracture
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY:
- You were in the hospital for orthopedic surgery. It is normal
to feel tired or "washed out" after surgery, and this feeling
should improve over the first few days to week.
- Resume your regular activities as tolerated, but please follow
your weight bearing precautions strictly at all times.
ACTIVITY AND WEIGHT BEARING:
- Weight bearing as tolerated in right lower extremity
MEDICATIONS:
- Please take all medications as prescribed by your physicians
at discharge.
- Continue all home medications unless specifically instructed
to stop by your surgeon.
- Do not drink alcohol, drive a motor vehicle, or operate
machinery while taking narcotic pain relievers.
- Narcotic pain relievers can cause constipation, so you should
drink eight 8oz glasses of water daily and take a stool softener
(colace) to prevent this side effect.
ANTICOAGULATION:
- Please take Lovenox 40mg daily for 4 weeks
WOUND CARE:
- You may shower. No baths or swimming for at least 4 weeks.
- Any stitches or staples that need to be removed will be taken
out at your 2-week follow up appointment.
- No dressing is needed if wound continues to be non-draining.
- If applicable, splint must be left on until follow up
appointment unless otherwise instructed
- Do NOT get splint wet
Weigh yourself every morning, call MD if weight goes up more
than 3 lbs.
Physical Therapy:
Activity: Activity: Out of bed w/ assist
Right lower extremity: Full weight bearing, can weight bear as
tolerated
Left lower extremity: Full weight bearing
Encourage turning, deep breathing and coughing qhour when awake.
Treatments Frequency:
Site: Incision
Type: Surgical
Dressing: Gauze - dry
Comment: on AM of POD 3 by ___, then daily by RN as needed;
please overwrap any dressing bleedthrough with ABD's and ACE.
Followup Instructions:
___
|
10809830-DS-30
| 10,809,830 | 24,153,916 |
DS
| 30 |
2170-06-15 00:00:00
|
2170-06-15 19:07:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Penicillins / Erythromycin Base / Gentamicin / Diltiazem /
Plavix / Sulfa (Sulfonamide Antibiotics) / IV Dye, Iodine
Containing / Vancomycin / Ativan / Clindamycin / ciprofloxacin
Attending: ___.
Chief Complaint:
Lower extremity swelling
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ year old male with history of coronary artery disease (s/p
CABG ___ and multiple PCIs, last NSTEMI ___ managed
medically), afib not on anticoagulation, and CHF with EF 40-45%
admitted with CHF exacerbation.
The patient's daughter, who is a ___, noticed
bilateral progressive lower extremity edema up to the thighs.
The patient's wife called his PCP who referred him to the
emergency room. The patient's daughter also feels as though he
is slightly confused.
The patient denies any recent chest pain or shortness of
breath. He states that he is complaint with taking 20mg Lasix
daily. He denies any change in diet.
- In the ED, initial vitals were: T 98.3 HR 82 BP 129/89 RR 18
O2 97%RA
- Exam notable for bilateral pitting edema to thighs
- Labs notable for mild, chronic anemia, Cr 1.4 at baseline, Na
141, K 5.2*, Cl 107, HCO3 23. Trop <0.01 at 1350, BNP 14771*
- Imaging notable for CXR with Mild to moderate interstitial
edema may be slightly exaggerated due to low lung volumes.
- Patient was given 20mg IV Lasix at 1600
- Patient was discussed with primary cardiologist Dr. ___
___ agrees with admission to CHF service
Vitals prior to transfer 97.4 94 134/72 18 96% RA
On the floor, patient was stable. Denies SOB. However agrees
his BLE look more swollen than usual, L>R (though chronically
has been L>R swelling to a lesser extent).
ROS: Full 10 pt review of systems negative except for above.
(-) Denies fever, chills, night sweats, Denies headache, sinus
tenderness, rhinorrhea or congestion. Denies cough, shortness of
breath. Denies chest pain or tightness, palpitations. Denies
nausea, vomiting, diarrhea, constipation or abdominal pain. No
recent change in bowel or bladder habits. No dysuria. Denies
arthralgias or myalgias.
Past Medical History:
1. Coronary artery disease: s/p CABG in ___, s/p multiple PCIs
(10 total, last in ___, Last NSTEMI ___ managed medically
2. Abrupt occlusion of a vein graft to the OM in ___ in the
setting of brief aspirin discontinuation for prostate biopsy.
3. Atrial fibrillation, currently managed with low-dose
amiodarone and dabigatran for thromboembolic prophylaxis.
4. Hypertension.
5. Diabetes mellitus.
6. PMR on chronic prednisone
7. CKD
8. CHF with EF 40-45%
9. Hip fracture s/p repair ___
10. Recurrent UTIs
Social History:
___
Family History:
No family history of early MI, arrhythmia, cardiomyopathies, or
sudden cardiac death; Family history is significant for father
who
died at age ___ of heart attack and coronary artery disease. His
mother died in her ___ of a heart attack and coronary artery
disease. He has a brother with lymphoma and sarcoma.
Physical Exam:
ADMISSION:
Vitals: T: 97.4 BP: 127/70 P: 93 R: 28 O2: 95% on RA
General: Alert, oriented, no acute distress
HEENT: Sclera anicteric, MMM, oropharynx clear
Neck: supple, JVP not elevated, no LAD
Lungs: Crackles at bases.Clear to auscultation bilaterally, no
wheezes, rales, rhonchi
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,
gallops
Abdomen: soft, non-tender, non-distended, bowel sounds present,
no rebound tenderness or guarding, no organomegaly
Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis.
Presence of significant edema upto knees. L>R
DISCHARGE EXAM
VS: 97.4 ___ 98-122/83-70 18 100% RA
Weight: 64.7 kg ___ yesterday)
I/O: ___ last 32 hr
General: alert and oriented, NAD, normal affect
HEENT: Sclera anicteric, MMM, conjunctivae noninjected
Neck: JVP 1 cm above clavicle
Lungs: Crackles midway up left lung, right basilar crackles,
otherwise no wheezes or rhonchi
CV: Regular rate and rhythm, systolic murmur best heard at apex,
otherwise no rubs or gallops
Abdomen: soft, non-tender, non-distended
Ext: Warm, well perfused, 1+ pitting edema in LLE, trace in
right
Pertinent Results:
ADMISSION:
___ 01:50PM BLOOD WBC-5.5 RBC-3.92* Hgb-11.9*# Hct-39.4*#
MCV-101*# MCH-30.4 MCHC-30.2* RDW-15.2 RDWSD-56.1* Plt ___
___ 01:50PM BLOOD Neuts-71.8* Lymphs-16.2* Monos-8.4
Eos-2.6 Baso-0.5 Im ___ AbsNeut-3.93# AbsLymp-0.89*
AbsMono-0.46 AbsEos-0.14 AbsBaso-0.03
___ 01:50PM BLOOD ___ PTT-30.9 ___
___ 01:50PM BLOOD Glucose-108* UreaN-50* Creat-1.4* Na-141
K-5.2* Cl-107 HCO3-23 AnGap-16
___ 01:50PM BLOOD Albumin-4.2 Calcium-9.4 Phos-3.9 Mg-2.4
___ 01:50PM BLOOD ___
___ 01:50PM BLOOD cTropnT-<0.01
___ 08:12PM BLOOD cTropnT-<0.01
PERTINENT LABS
___ 07:50AM BLOOD Glucose-90 UreaN-51* Creat-1.1 Na-144
K-4.6 Cl-108 HCO3-27 AnGap-14
___ 06:10AM BLOOD Glucose-77 UreaN-58* Creat-1.4* Na-145
K-4.2 Cl-106 HCO3-28 AnGap-15
___ 06:10AM BLOOD ___
___ 02:39PM URINE Blood-NEG Nitrite-NEG Protein-NEG
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG
___ 03:39PM URINE RBC-3* WBC-1 Bacteri-NONE Yeast-NONE
Epi-<1
DISCHARGE LABS
___ 07:00AM BLOOD WBC-8.1 RBC-3.72* Hgb-11.4* Hct-35.9*
MCV-97 MCH-30.6 MCHC-31.8* RDW-14.9 RDWSD-52.7* Plt ___
___ 07:00AM BLOOD Glucose-113* UreaN-61* Creat-1.5* Na-135
K-4.4 Cl-94* HCO3-29 AnGap-16
___ 08:10AM BLOOD proBNP-6448*
___ 07:00AM BLOOD Calcium-8.9 Phos-3.8 Mg-2.3
MICROBIOLOGY:
___ URINE CULTURES: NEGATIVE
___ BLOOD CULTURE: NEGATIVE
IMAGING:
___ CHEST X RAY:
Mild to moderate interstitial edema may be slightly exaggerated
due to low
lung volumes. Persistent elevation of the right hemidiaphragm.
___ LEFT ___:
No evidence of deep venous thrombosis in the left lower
extremity veins.
Biphasic respiratory variation within bilateral common femoral
veins
compatible with right-sided heart failure.
___ CHEST X RAY:
IN COMPARISON WITH THE STUDY OF ___, THERE AGAIN ARE VERY
LOW LUNG
VOLUMES. CONTINUED ENLARGEMENT OF THE CARDIAC SILHOUETTE, BUT
DRAMATIC
IMPROVEMENT IN THE DEGREE OF PULMONARY VASCULAR CONGESTION. NO
EVIDENCE OF
ACUTE FOCAL PNEUMONIA.
___ CT HEAD NON-CON:
No acute intracranial abnormality.
Brief Hospital Course:
BRIEF SUMMARY
=============
___ is an ___ year old man with a history of CAD (s/p
CABG ___ and multiple PCIs), afib not on anticoagulation, and
ischemic cardiomyopathy (EF 40-45%) who presented with bilateral
___ edema consistent with CHF exacerbation.
ACUTE ISSUES
============
# Acute on chronic systolic heart failure: Patient with known
ischemic cardiomyopathy with preserved EF. He was grossly volume
overloaded on clinical exam with pulmonary edema on chest X ray
and an elevated BNP. Decompensation likely occurred in the
setting of decreased home Lasix from 20 mg BID to 10 mg per day
with doses missed about once per week. Per the patient, these
changes had been made to avoid frequent urination after
consulting with Dr. ___. He was diuresed with bolus IV
Lasix to a dry weight of 64.7 kg. His Lasix was switched to
Torsemide 20 mg po daily
# Urinary retention: Patient developed urinary retention on ___
and also was noted to have clots in his urine. A Foley was
placed with return of clear urine. He had no history of recent
urinary trauma. The Foley was removed prior to discharge and Mr.
___ was able to void. He follows with urology (has seen
Dr. ___ in the past but primarily follows with Dr. ___ and
will follow up following discharge.
# Encephalopathy: Mr. ___ developed altered mental status
and agitation on ___. An infectious workup (blood/urine
cultures and chest X ray) was negative and a CT head was
unremarkable. His AMS was thought to be due to urinary retention
as it resolved subsequent to resolution of this. While agitated,
he was initially treated with Haldol but this had to be avoided
ultimately due to QTc prolongation (502 ms).
#CAD: s/p CABG in ___ with multiple PCIs. Mr. ___ was
chest-pain free and had two negative troponins in the ED. He was
continued on his home simvastatin, metoprolol, lisinopril, and
aspirin.
#Paroxysmal atrial fibrillation: Patient previously on warfarin
but now only on aspirin for anticoagulation given his age.
Aspirin and amiodarone continued.
#DM: Patient's home glipizide was held and he was treated with
SSI.
#GERD: Patient continued on his home omeprazole.
#BPH: Patient continues on his home finsteride 5 mg. He is not
on tamsulosin due to hypotension.
# Iron deficiency anemia: Patient continued on home ferrous
sulfate with bowel regimen.
Transitional issues:
===============================
-Home Lasix changed to Torsemide 20 mg po daily, home metoprolol
switched to carvedilol 6.25 bid for afterload reduction in
setting of worsening MR. ___ cardiac regimen unchanged; on
home ACE, statin, asa, amiodarone.
-Discharge weight 64.7 kg, d/c creatinine 1.5
-Will need follow up with urology after discharge. He has seen
Dr. ___ in the past but primarily follows with Dr. ___. Patient
had delirium in house ___ urinary obstruction, relieved with
foley placement, and had successful voiding trial with d/c of
foley prior to discharge
- CONTACT: ___ (wife and HCP)
___ Dr. ___ ___ ___
- CODE: Full code
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY
2. Ferrous Sulfate 325 mg PO DAILY
3. Finasteride 5 mg PO DAILY
4. Furosemide 10 mg PO DAILY
5. GlipiZIDE XL 1.25 mg PO DAILY
6. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY
7. Lisinopril 5 mg PO DAILY
8. Metoprolol Succinate XL 25 mg PO DAILY
9. Omeprazole 20 mg PO DAILY
10. Simvastatin 20 mg PO QPM
11. Acetaminophen 1000 mg PO Q8H
12. Bisacodyl 10 mg PO DAILY:PRN constipation
13. Docusate Sodium 100 mg PO BID
14. Polyethylene Glycol 17 g PO DAILY:PRN constipation
15. Senna 8.6 mg PO BID
16. Vitamin D ___ UNIT PO DAILY
17. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain
18. Flunisolide Inhaler 80 mcg/actuation inhalation DAILY:PRN
wheeze/sob
19. Amiodarone 100 mg PO DAILY
20. Tamsulosin 0.4 mg PO DAILY
21. Align (bifidobacterium infantis) 4 mg oral DAILY
Discharge Medications:
1. Acetaminophen 1000 mg PO Q8H
2. Amiodarone 100 mg PO DAILY
3. Aspirin 81 mg PO DAILY
4. Bisacodyl 10 mg PO DAILY:PRN constipation
5. Docusate Sodium 100 mg PO BID
6. Ferrous Sulfate 325 mg PO DAILY
7. Finasteride 5 mg PO DAILY
8. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY
9. Lisinopril 5 mg PO DAILY
10. Omeprazole 20 mg PO DAILY
11. Polyethylene Glycol 17 g PO DAILY:PRN constipation
12. Senna 8.6 mg PO BID
13. Simvastatin 20 mg PO QPM
14. Vitamin D ___ UNIT PO DAILY
15. Carvedilol 6.25 mg PO BID
16. Lidocaine 5% Patch 1 PTCH TD DAILY knee pain
17. Torsemide 20 mg PO DAILY
18. Align (bifidobacterium infantis) 4 mg oral DAILY
19. Flunisolide Inhaler 80 mcg/actuation inhalation DAILY:PRN
wheeze/sob
20. GlipiZIDE XL 1.25 mg PO DAILY
21. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain
22. Tamsulosin 0.4 mg PO DAILY
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
Primary diagnoses:
Acute on Chronic Diastolic heart failure
Urinary retention
Hematuria
Encephalopathy
Secondary diagnoses:
Coronary artery disease
Hypertension
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Dear Mr. ___,
You were hospitalized at ___
because you had developed worsening swelling in your legs. This
was due to your congestive heart failure, which causes excess
fluid to build up in your body. We treated you with a medication
through your IV to remove this fluid, called Lasix. We have
increased the amount of Lasix you should take at home to prevent
you from coming back to the hospital. You should weigh yourself
every morning, and call your doctor if your weight goes up more
than 3 lbs.
While you were in the hospital you also had difficult urinating
and had some blood in your urine, so a catheter was placed. You
should follow up with your urologist after you leave the
hospital. You became confused while you were in the hospital;
this was likely due to your inability to urinate.
It was a pleasure participating in your care. We wish you all
the best in the future.
Sincerely,
Your ___ team
Followup Instructions:
___
|
10809859-DS-10
| 10,809,859 | 28,177,364 |
DS
| 10 |
2133-04-29 00:00:00
|
2133-04-29 12:18:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: ORTHOPAEDICS
Allergies:
Amoxicillin
Attending: ___.
Chief Complaint:
R forearm abscesses
Major Surgical or Invasive Procedure:
___: Irrigation/debridement of right forearm abscesses
History of Present Illness:
___ F->M transgender w hx of IVDU and PCOS who presented to the
___ ED on ___ with multiple right forearm abscesses
located on the dorsal wrist and proximal volar forearm. He has
had pain his forearm for a week, which acutely worsened over the
past 48 hours. He has hx of abscess in his thigh. He states
these abscesses are at the site of prior IV injections.
Past Medical History:
PCOS
Iv drug abuse, last use 14 days prior
Social History:
___
Family History:
NC
Physical Exam:
PE
Easy work of breathing
RUE
erythematous, painful fluctuant mass over volar forearm just
distal to antecubital fossa. Also smaller mass of dorsal
radiocarpal joint.
decreased sensation to pinprick throughout hand, particularly
dorsally at first web space.
Fires EPL/FPL/ DIO/Wrist extensor
moderate pain with flexion and extension of digits.
2+ radial pulse
Pertinent Results:
___ 03:45AM WBC-11.7* RBC-3.51* HGB-11.3* HCT-32.8*
MCV-93 MCH-32.2* MCHC-34.5 RDW-12.3
___ 03:45AM NEUTS-70.4* ___ MONOS-5.9 EOS-1.6
BASOS-0.3
___ 03:45AM SED RATE-90*
___ 03:45AM CRP-113.8*
___ 03:45AM GLUCOSE-109* UREA N-8 CREAT-0.7 SODIUM-130*
POTASSIUM-3.4 CHLORIDE-96 TOTAL CO2-23 ANION GAP-14
___ 06:35AM ___ PTT-22.4* ___
Brief Hospital Course:
Patient was admitted from ___ ED on ___ with presentation
of multiple right forearm abscesses, one on right dorsal wrist
and one on proximal volar forearm. General Surgery was consulted
and recommended Hand Surgery consult. Evaluation by Hand Surgery
showed multiple abscesses requiring surgical I&D. While patient
was in the ED he was started on IV vancomycin and clindamycin.
He was taken to the OR on ___ for I&D of R forearm
abscesses. Cultures were sent from the OR.
Postoperatively he was extubated and taking the the PACU without
any complications. IV vancomycin and clindamycin were continued
pending OR cultures, which showed polymicrobial growth. The
clindamycin was changed to ciprofloxacin on POD#1 to cover gram
negatives. The patient was transitioned to oral bactrim and
ciprofloxacin prior to discharge with the plan to complete a
___ course. Pain was controlled with regional block performed
preoperatively by the Anesthesia team and ATC Tylenol, PO
oxycodone, and IV morphine for breakthrough. The RUE was kept
elevated and OT was consulted to fabricate a volar resting
orthoplast splint, which was placed on POD#1. ___ drains x
4 (2 in each incision) were removed on POD#3. DVT prophylaxis
with SC heparin was given while patient was in house. He was
advanced to a regular diet.
At the time of discharge, the right forearm incisions were clean
and healing with no evidence of further abscesses. Patient was
tolerating a diet, voiding, and afebrile. Pain was controlled.
The patient was discharged on PO antibiotics with follow-up in
Hand Clinic.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. This patient is not taking any preadmission medications
Discharge Medications:
1. Acetaminophen 650 mg PO Q6H
2. Ciprofloxacin HCl 500 mg PO Q12H
RX *ciprofloxacin 500 mg 1 tablet(s) by mouth twice a ___ Disp
#*20 Tablet Refills:*0
3. Sulfameth/Trimethoprim DS 1 TAB PO BID
RX *sulfamethoxazole-trimethoprim [Bactrim DS] 800 mg-160 mg 1
tablet(s) by mouth twice a ___ Disp #*20 Tablet Refills:*0
4. OxycoDONE (Immediate Release) ___ mg PO Q3H:PRN pain
RX *oxycodone 5 mg ___ tablet(s) by mouth Q3-4 Hours Disp #*60
Tablet Refills:*0
Discharge Disposition:
Home
Discharge Diagnosis:
Right forearm abscesses
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Wound Care:
- Keep Incision clean and dry.
- You can get the wound wet or take a shower starting from 7
days after surgery, but no baths or swimming for at least 4
weeks.
- Dry sterile dresssing may be changed daily. No dressing is
needed if wound continues to be non-draining.
- Any stitches or staples that need to be removed will be taken
out at your follow up appointment.
Activity:
- Elevate right arm to reduce swelling and pain.
- Keep splint/dressing clean/dry.
Other Instructions
- Resume your regular diet.
- Avoid nicotine products to optimize healing.
Medications
- Please complete all antibiotics as prescribed.
- Resume your home medications. Take all medications as
instructed.
- You have also been given Additional Medications to control
your pain. Please allow 72 hours for refill of narcotic
prescriptions, so plan ahead. You can either have them mailed
to your home or pick them up at the clinic located on ___.
We are not allowed to call in narcotic (oxycontin, oxycodone,
percocet) prescriptions to the pharmacy. In addition, we are
only allowed to write for pain medications for 90 days from the
date of surgery.
- Narcotic pain medication may cause drowsiness. Do not drink
alcohol while taking narcotic medications. Do not operate any
motor vehicle or machinery while taking narcotic pain
medications. Taking more than recommended may cause serious
breathing problems.
- If you have questions, concerns or experience any of the below
danger signs then please call your doctor at ___ or go
to your local emergency room.
Please follow-up on ___ at the Hand Clinic located
at ___, ___, ___
Center, ___ floor. To make an appointment, please call
___
Please follow-up with your primary care physician regarding this
admission.
Physical Therapy:
Keep right upper extremity elevated and splinted
OK to come out of splint for range of motion as tolerated
No weight bearing restrictions
Treatments Frequency:
Keep right arm elevated and splinted
Daily dressing changes with clean dry gauze
Continue antibiotics as prescribed
Followup Instructions:
___
|
10810206-DS-15
| 10,810,206 | 25,210,564 |
DS
| 15 |
2137-07-13 00:00:00
|
2137-07-14 08:48:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
naproxen / Ativan / Percocet / Detrol
Attending: ___
Chief Complaint:
nausea, dry heaving emesis
Major Surgical or Invasive Procedure:
None this hospitalization
History of Present Illness:
This is an ___ year-old Female with a PMH significant for CAD,
pulmonary emboli (s/p IVC filter), renal mass, prior TIAs, HTN,
HLD, and CHF (EF 40-45%) with recent admission for cholecystitis
(complicated by an NSTEMI and Klebsiella bacteremia) in ___
which resolved with antibiotics who now presents with confusion
and several days of nausea with dry heaving emesis. She is
accompanied by her daughter and son-in-law.
.
In ___, she presented to ___ with an episode of acute
cholecystitis with planned ___ percutaneous
cholecystostomy due to positive HIDA scan. On arrival to ___,
a repeat RUQ ultrasound showed no obstruction or cholecystitis,
so this was deferred and she was treated with IV Unasyn
transitioned to Levqauin PO (given documented Klebsiella
bacteremia at the time, presumed enteric source).
.
Her acute concerns revolve around 3-days prior to admission,
with the onset of nausea with multiple retching episodes daily -
there is little vomitus and she has not had diarrhea or loose
stools. She was iniitally concernd that this represented another
episode of cholecystitis, which prompted her ED evaluation. She
is very unclear of the details and looked to her family for help
answering questions. She denies abdominal pain. No recent sick
contacts.
.
During this period, some memory lapses have been more apparent.
There has been concern given her poor mental performance, which
started about ___ ago when her daughter described an episode
of acute delirium attributed to Detrol. Over the few ensuing
years, she has been hospitalized for a few fractures and prior
cholecystitis, and the family thinks she has become more
forgetful. She will sit on the bed at night and ask "how do I
get ready for bed?" She confuses her home with a nursing home or
hospital. Sometimes she gets lost in her home and mistakes one
room for another, asking how to navigate between them. She lives
with her daughter and son-in-law, and is dependent for all IADLs
- she is still able to wash, dress, and groom herself. Per her
family, she has had perhaps 5-episodes of TIAs in the past, some
unconfirmed. No major strokes or family history of Alzheimers or
dementia of note.
.
All of these symptoms of memory loss have become more common
recently. She is also noting significant fatigue - she
apparently had been sleeping from ___ to ___. She
otherwise denies recent fevers, chills, diarrhea, dyusuria,
hematuria, shortness of breath. She saw her PCP recently who was
planning on Neurology referral to work-up this memory loss.
.
In the ED, initial VS 100.6 88 141/50 18 99% RA. She had minimal
abdominal pain and her labs showed only a leukocytosis of 16 (N
84.6%, wihtout bandemia) and hyponatremia to 125. LFTs were
normal and RUQ ultrasound showed cholelithiasis without evidence
of cholecystitis. Her U/A was positive for 3000 glucose and 30
protein without infection. Lactate 1.4. TSH, vitamin-B12 and
folate were normal. Creatinine was 0.8. After 1L of NS x 1 her
sodium improved to 129. She was given Zofran 4 mg IV x 1 and
admitted to the Medicine service.
Past Medical History:
MEDICAL & SURGICAL HISTORY:
1. Coronary artery disease (s/p NSTEMI in ___
2. Diabetes mellitus, type 2
3. Hypertension
4. Klebsiella bacteremia in ___ with episode of acute
cholecystitis; improved with antibiotics - did not require
percutaneous cholecystostomy tube
5. E.coli bactermia (___) without identifiable source
6. Prior transient ischemic attacks (roughly 2 in the last
___
7. Left renal mass (4-cm)
8. History of right lower extremity osteomyelitis
9. Osteoarthritis
10. Acute rheumatic fever (age ___ years old)
___. s/p hip replacement in ___ (complicated by DVT/PE and IVC
filter)
12. s/p mechanical fall in ___ ___ removal of hardware in
her left hip
13. s/p partial hysterectomy (___)
14. s/p three spontaneous vaginal deliveries
Social History:
___
Family History:
Sister died of CAD. Grandfather and father died of MI. Brother
had MI (ages all unknown).
Physical Exam:
ADMISSION LABS:
.
VITALS: 100.3 99.7 122/64 92 18 100% RA BG: 309-421
mg/dL
I/Os: 1100 | 1000
GENERAL: Appears in no acute distress. Alert and interactive.
Elderly appearing female.
HEENT: Normocephalic, atraumatic. EOMI. PERRL. Nares clear.
Mucous membranes moist.
NECK: supple without lymphadenopathy. JVD not elevated.
___: Regular rate and rhythm, without murmurs, rubs or gallops.
S1 and S2 normal.
RESP: Clear to auscultation bilaterally without adventitious
sounds. No wheezing, rhonchi or crackles. Stable inspiratory
effort.
ABD: soft, non-tender, non-distended, with normoactive bowel
sounds. No palpable masses or peritoneal signs. Negative
___ sign.
EXTR: no cyanosis, clubbing or edema, 2+ peripheral pulses;
right knee osteoarthritic changes, deformity noted. Right leg
varicosities.
NEURO: awake, oriented to person, read day of month off wall but
thought it was ___ unknown year. Knows she is in the
hospital but not by name. Knows family members names. ___ of
year intact backwards ___, then lost interest. 5 minute
recall intact ___ objects. CNs II-XII grossly intact, muscle
strength ___ throughout, sensation grossly intact throughout,
DTRs 2+ and symmetric, cerebellar exam intact, steady gait.
.
DISCHARGE EXAM:
.
VITALS: 99.1 99.1 142/64 71 20 97% RA BG: 181-289 mg/dL
I/Os: 2220 | 2900
GENERAL: Appears in no acute distress. Alert and interactive.
Elderly appearing female.
HEENT: Normocephalic, atraumatic. EOMI. PERRL. Nares clear.
Mucous membranes moist.
NECK: supple without lymphadenopathy. JVD not elevated.
___: Regular rate and rhythm, without murmurs, rubs or gallops.
S1 and S2 normal.
RESP: Clear to auscultation bilaterally without adventitious
sounds. No wheezing, rhonchi or crackles. Stable inspiratory
effort.
ABD: soft, minimally tender to deep palpation in the RUQ,
non-distended, with normoactive bowel sounds. No palpable masses
or peritoneal signs. Negative ___ sign.
EXTR: no cyanosis, clubbing or edema, 2+ peripheral pulses;
right knee osteoarthritic changes, deformity noted. Right leg
varicosities.
NEURO: awake, oriented to person, read day of month off wall but
thought it was ___ unknown year. Knows she is in the
hospital but not by name. Knows family members names. ___ of
year intact backwards ___, then lost interest. 5 minute
recall intact ___ objects. CNs II-XII grossly intact, muscle
strength ___ throughout, sensation grossly intact throughout,
DTRs 2+ and symmetric, cerebellar exam intact, steady gait.
Pertinent Results:
ADMISSION LABS:
.
___ 05:40PM BLOOD WBC-16.0* RBC-3.86* Hgb-11.2* Hct-32.5*
MCV-84 MCH-29.1 MCHC-34.5 RDW-13.3 Plt ___
___ 05:40PM BLOOD Neuts-84.6* Lymphs-9.7* Monos-5.2 Eos-0.1
Baso-0.3
___ 05:40PM BLOOD ___ PTT-21.3* ___
___ 05:40PM BLOOD Glucose-298* UreaN-12 Creat-0.8 Na-125*
K-5.3* Cl-87* HCO3-24 AnGap-19
___ 05:40PM BLOOD CK-MB-2 cTropnT-<0.01
___ 05:40PM BLOOD Lipase-15
___ 05:40PM BLOOD ALT-12 AST-36 CK(CPK)-87 AlkPhos-89
TotBili-0.5
___ 05:40PM BLOOD Albumin-3.6 Calcium-9.9 Phos-2.8 Mg-1.4*
___ 05:40PM BLOOD VitB12-572 Folate-GREATER TH
___ 07:45AM BLOOD %HbA1c-9.3* eAG-220*
___ 05:40PM BLOOD TSH-1.0
.
DISCHARGE LABS:
.
___ 06:05AM BLOOD WBC-11.2* RBC-3.58* Hgb-10.2* Hct-30.9*
MCV-86 MCH-28.6 MCHC-33.1 RDW-13.5 Plt ___
___ 06:05AM BLOOD Glucose-164* UreaN-9 Creat-0.7 Na-131*
K-4.4 Cl-96 HCO3-27 AnGap-12
___ 06:05AM BLOOD Calcium-9.3 Phos-3.2 Mg-1.8
.
URINALYSIS: clear, negative for ___, negative for Nitr, protein
30, glucose 300
.
MICROBIOLOGY DATA:
___ Blood culture - E.coli (pan-sensitive)
___ Blood culture - pending
___ RPR serology - non-reactive
___ Urine culture - negative
___ Blood culture (x 2) - pending
___ Blood culture - pending
___ Blood culture - pending
___ Blood culture - pending
.
IMAGING:
___ LIVER OR GALLBLADDER US - Cholelithiasis without evidence
of cholecystitis. The liver echogenicity and echotexture are
normal. In the left hepatic lobe, there is a 6 x 4 x 6 mm simple
cyst, not significantly changed in size compared to CT from
___. No additional focal liver lesions are seen.
There is no intrahepatic biliary duct dilatation.
.
___ CHEST (PA & LAT) - No evidence of infection or
malignancy. Stable cardiomegaly with no evidence of heart
failure.
.
___ 2D-ECHO - The left atrium is mildly dilated. No atrial
septal defect is seen by 2D or color Doppler. There is moderate
symmetric left ventricular hypertrophy. The left ventricular
cavity is moderately dilated. There is moderate regional left
ventricular systolic dysfunction with inferior and
infero-lateral akinesis. The basal inferior wall appears near
dyskinetic. No masses or thrombi are seen in the left ventricle.
There is no ventricular septal defect. Right ventricular chamber
size and free wall motion are normal. The ascending aorta is
mildly dilated. The aortic valve leaflets (3) are mildly
thickened but aortic stenosis is not present. Mild (1+) aortic
regurgitation is seen. The mitral valve leaflets are mildly
thickened. There is no mitral valve prolapse. Moderate (2+)
mitral regurgitation is seen. The tricuspid valve leaflets are
mildly thickened. The pulmonary artery systolic pressure could
not be determined. There is no pericardial effusion. CAD with
prior inferior/infero-lateral MI and moderately reduced LVEF.
.
___ CT HEAD WITHOUT CONTRAST - No acute intracranial
process. Age-related atrophy, most significant in the midline
parasagittal frontal
lobes. Less likely this may be a chronic hygroma without mass
effect.
.
___ CT ABD & PELVIS WITH CO - Uncomplicated cholelithiasis.
No evidence for acute cholecystitis. Indeterminate left adrenal
lesion which can be further characterized with a wash-in and
wash-out CT or MRI when the patient's clinical status has
improved. No intra-abdominal abscess or collection identified to
correspond to
patient's symptom complex.
Brief Hospital Course:
IMPRESSION: ___ with a PMH significant for CAD, pulmonary emboli
(s/p IVC filter), renal mass, prior TIAs, HTN, HLD, and CHF (EF
40-45%) with recent admission for cholecystitis (complicated by
an NSTEMI and Klebsiella bacteremia) in ___ which resolved
with antibiotics who now presents with worsening confusion and a
few months of slow decline in cognitive function with several
days of nausea, dry heaving emesis without abdominal pain found
to have E.coli bacteremia and leukocytosis.
.
# E.COLI BACTEREMIA, LEUKOCYTOSIS - Patient presented with
non-specific GI complaints, specifically nausea and dry heaving
emesis without a biliary component for several days, which was
similar to her prior cholecytitis complaints from ___. Her
infectious work-up included a CXR, urine and blood cultures
which only revealed a positive blood culture (single bottle)
speciating pan-sensitive E.coli for which she was treated with
IV Unasyn initially and then discharged on IV Cefepime for
14-days, based off of the sensitivity report. The source of her
bacteremia was attributed to her biliary tree; likely she
develops episodic biliary colic with some inflammation that
results in hematogenous spreading of bacteria. Despite the
bacteremia, she remained afebrile, without leukocytosis and her
mental status appeared at baseline. Her RUQ ultrasound and
imaging showed no evidence of acute cholecystitis and her LFTs
were reassuring. She was referred to outpatient General Surgery
to consider cholecystectomy given her recurrent gram-negative
enteric bacteremia with the gall bladder being the likely
source.
.
# HYPONATREMIA - She presented with a sodium of 125, with normal
creatinine at 0.7. Baseline sodium 132-134 per our records. She
has baseline cognitive impairment, with slow decline over
several months without neurologic deficits on admission. Based
on her response to fluid administration in the setting of
infection, this was likely hypovolemic hyponatremia. She
returned to her baseline of 131-134 with fluid resuscitation.
.
# COGNITIVE DECLINE, PRESUMED DEMENTIA - The patient's baseline
mental status decline over several months has been notable, with
recent exacerbation per her daughter and son-in-law. Her family
offers a history of chronic decline in executive function over
the past few years, becoming more pronounced in the recent
months, consistent with a dementia. Vascular dementia would seem
likely given multiple TIAs in her history. A reversible dementia
work-up this admission was reassuring and her head CT imaging
was consistent with age-related atrophic changes. She is
encouraged to follow-up with Cognitive Neurology as an
outpatient.
.
# DIABETES MELLITUS, TYPE 2 - Patient has no history of
retinopathy, neuropathy or chronic kidney disease. Unknown
baseline HbA1c. Managed on Metformin therapy and Humilin 70-30
insulin regimen. Blood glucose in the 250-300 mg/dL range this
admission with marked glucosuria on admission. We continued her
home insulin regimen and resumed her Metformin on discharge. Her
HbA1c was 9.3% this admission.
.
# CORONARY ARTERY DISEASE - Documented coronary disease with
prior NSTEMI in ___ surrounding her cholecystitis issues. No
active chest pain this admission. EKG on admission reassuring.
Cardiac biomarker in the ED was flat. We continued her Aspirin
and statin.
.
# CONGESTIVE HEART FAILURE, DECREASED EF - Last 2D-Echo
demonstrated reported LVEF of 40-45% with systolic dysfunction
(although no TTE reports in our system). No evidence of volume
overload on exam and no CXR evidence of pulmonary congestion
this admission. We continued her ACEI, beta-blocker, and Lasix
this admission.
.
# HYPERTENSION, HYPERLIPIDEMIA - Home regimen includes ACEI,
beta-blocker and amlodipine, which were continued. Her
Pravastatin 80 mg PO daily was also continued.
.
TRANSITION OF CARE ISSUES:
1. Discharged with Cefepime 2g IV Q12 hours for a total of
14-days with the assistance of ___ and IV services given her
E.coli bacteremia.
2. She was scheduled to follow-up with General Surgery regarding
possible cholecystectomy given her recurrent bacteremia
episodes, likely from an enteric source in the setting of
biliary colic and inflammation.
3. She was scheduled with primary care follow-up; at the time of
discharge, her surveillance blood cultures were pending but
without notable growth.
4. She is encouraged to follow-up with Cognitive Neurology for
her chronic dementia concerns.
Medications on Admission:
HOME MEDICATIONS (confirmed with daughter and son-in-law)
1. Metoprolol succinate 50 mg ER PO daily
2. Lisinopril 20 mg PO daily
3. Potassium chloride 10 mEq PO BID
4. Vicodin ___ mg 2 tablets PO TID PRN pain
5. Pantroprazole 40 mg EC PO daily
6. Pravastatin 80 mg PO daily
7. Humulin 70/30 (30 units SC QAM and QPM)
8. Aspirin 81 mg PO daily
9. Furosemide 40 mg PO daily
10. Amlodipine 5 mg PO daily
11. Metformin 1000 mg PO BID
Discharge Medications:
1. cefepime 2 gram Recon Soln Sig: Two (2) grams Injection every
twelve (12) hours for 14 days: total of 14-days (started
___, ending ___.
Disp:*21 doses* Refills:*0*
2. metoprolol succinate 50 mg Tablet Extended Release 24 hr Sig:
One (1) Tablet Extended Release 24 hr PO DAILY (Daily).
3. lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
4. potassium chloride 10 mEq Capsule, Extended Release Sig: One
(1) Capsule, Extended Release PO twice a day.
5. pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One
(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).
6. pravastatin 20 mg Tablet Sig: Four (4) Tablet PO DAILY
(Daily).
7. Humulin R 100 unit/mL Solution Sig: Thirty (30) units
Injection twice a day.
8. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable
PO DAILY (Daily).
9. amlodipine 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
10. metformin 1,000 mg Tablet Sig: One (1) Tablet PO twice a
day.
11. Heparin Flush (10 units/ml) 2 mL IV PRN line flush
Mid-line, heparin dependent: Flush with 10 mL Normal Saline
followed by Heparin as above, daily and PRN per lumen.
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
Primary Diagnoses:
1. Escherichia coli bacteremia
.
Secondary Diagnoses:
1. Coronary artery disease
2. Diabetes mellitus, type 2
3. Hypertension
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Patient Discharge Instructions:
.
You were admitted to the Internal Medicine service at ___
___ on ___ regarding management of
your blood infection and abdominal complaints. You were found to
have a gram-negative enteric organisms in your blood which was
treated with IV antibiotics and will continue on these for a
total of 14-days. You were feeling well at the time of
discharge. You were also discharged with a follow-up appointment
with a general surgeon to discuss the possibiility of removing
your gallbladder in the near future.
.
Please call your doctor or go to the emergency department if:
* You experience new chest pain, pressure, squeezing or
tightness.
* You develop new or worsening cough, shortness of breath, or
wheezing.
* You are vomiting and cannot keep down fluids, or your
medications.
* If you are getting dehydrated due to continued vomiting,
diarrhea, or other reasons. Signs of dehydration include: dry
mouth, rapid heartbeat, or feeling dizzy or faint when standing.
* You see blood or dark/black material when you vomit, or have a
bowel movement.
* You experience burning when you urinate, have blood in your
urine, or experience an unusual discharge.
* Your pain is not improving within 12 hours or is not under
control within 24 hours.
* Your pain worsens or changes location.
* You have shaking chills, or fever greater than 101.5 degrees
Fahrenheit or 38 degrees Celsius.
* You develop any other concerning symptoms.
.
CHANGES IN YOUR MEDICATION RECONCILIATION:
.
* Upon admission, we ADDED:
START: Ceftriaxone 2 grams IV every 12-hours for 14-days total
(started ___, ending ___
.
* The following medications were DISCONTINUED on admission and
you should NOT resume:
DISCONTINUE: Lasix (stop this medication until discussing it
with your primary care physician)
DISCONTINUE: Vicodin
.
* You should continue all of your other home medications as
prescribed, unless otherwise directed above.
Followup Instructions:
___
|
10810607-DS-23
| 10,810,607 | 26,091,872 |
DS
| 23 |
2129-03-19 00:00:00
|
2129-03-19 15:09:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Prochlorperazine / Sulfa (Sulfonamide Antibiotics) / Meperidine
/ Indomethacin / Ampicillin
Attending: ___.
Chief Complaint:
Fevers
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ yo F with h/o advanced ___ Disease presenting from
her nursing facility due to concern that the patient had
increased lethargy and "change in mental status" over the last
24 hours. This was associated with "very poor" po intake and
reports that she was feeling weak and noted to be leaning to the
left. She had a fever 101.6 recorded at 1pm on the day of
admission and she was transferred to the ED for further
evaluation. The patient is confused at baseline but able to
verbalize her needs. She reportedly was noted to be leaning more
to her left. She is incontient of urine and stool.
.
In the ED, initial vitals 100.0, 85, 133/65, 20, 96%. Labs
notable for a white count of 6.7 with 12% bands, an increased
BUN, and increased alk phos. Her UA revealed >182 WBCs with
large ___ and negative nitrites. She received ceftriaxone 1 gm IV
and was admitted to medicine for further management. Vitals
prior to transfer: 99.6, 86, 130/87, 96% RA, 20
.
Currently, the patient reported feels "ok". She states multiple
times that she has ___ disease and appears somewhat
confused. She reports that she lives with her Daughter ___ in
___. When prompted, she reports that she has some pain in
her abdomen, and points to the b/l lower quadrants and increased
urinary frequency. She states that this has been going on for
"about a year". She denies burning on urination.
.
ROS: per HPI, denies fever, chills, night sweats, headache,
vision changes, sore throat, cough, shortness of breath, chest
pain, abdominal pain, nausea, vomiting, diarrhea, constipation,
dysuria, hematuria.
Past Medical History:
-Advanced Parkinsons Disease
-Dementia
-HTN
-HLD
-Spinal stenosis
-Depression
-s/p left hip replacement
Social History:
___
Family History:
Non-contributory.
Physical Exam:
Admission-
VS - 96.3, 143/82, 80, 18, 98%RA
GENERAL - well-appearing woman in NAD, comfortable, appropriate,
lethargic but arousable.
HEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, dry mucus
membranes, OP with dried orange coating in mouth.
NECK - supple, no JVD, no carotid bruits, no cervical LAD
LUNGS - CTA bilat anteriorly, no r/rh/wh, good air movement,
resp unlabored, no accessory muscle use
HEART - PMI non-displaced, RRR, ___ systolic murmur best heard
at that LUSB with mild radiation to the carotid, No other MRG,
nl S1-S2
ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no
rebound/guarding
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials,
DPs), toe nail changes c/w fungal infection
SKIN - no rashes or lesions
NEURO - lethargic but arousable, A&Ox2, CNs II-XII grossly
intact, +hypophonia, sensation grossly intact throughout,
+minimal cogwheel rigidity in wrist b/l, +clasp knife spasticity
in b/l UE.
Discharge-
VS - 98.2, 150/82, 84, 16, 98%RA
GENERAL - well-appearing woman in NAD, comfortable, appropriate,
sleeping but arousable.
HEENT - NC/AT, dry mucus membranes but significantly improving,
EOMI
NECK - supple, no JVD,
LUNGS - CTA bilat anteriorly, no r/rh/wh, good air movement,
resp unlabored, no accessory muscle use
HEART - PMI non-displaced, RRR, ___ systolic murmur best heard
at that LUSB with mild radiation to the carotid (unchanged), No
other MRG, nl S1-S2
ABDOMEN - NABS, soft/ND, mildly tender over suprapubic region
(similar to prior), no masses or HSM, no rebound/guarding
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials,
DPs), toe nail changes c/w fungal infection
NEURO - sleeping but arousable, opens eyes with less prompting
than yesterday. Continues to have difficulty with phonation, but
is able to mouth her responses.
Pertinent Results:
Admission-
___ 03:30PM BLOOD WBC-6.7 RBC-4.07* Hgb-12.8 Hct-36.2
MCV-89 MCH-31.4 MCHC-35.4* RDW-13.6 Plt ___
___ 03:30PM BLOOD Neuts-54 Bands-12* Lymphs-16* Monos-10
Eos-6* Baso-0 Atyps-1* Metas-1* Myelos-0
___ 03:30PM BLOOD Glucose-94 UreaN-23* Creat-0.7 Na-135
K-3.6 Cl-97 HCO3-27 AnGap-15
___ 03:30PM BLOOD ALT-10 AST-23 AlkPhos-149* TotBili-0.8
___ 06:30AM BLOOD Calcium-8.5 Phos-2.3* Mg-1.7
___ 04:24PM BLOOD Lactate-1.7
Discharge-
___ 05:40AM BLOOD WBC-6.8 RBC-3.96* Hgb-11.9* Hct-35.0*
MCV-88 MCH-30.1 MCHC-34.1 RDW-13.0 Plt ___
___ 05:40AM BLOOD Glucose-112* UreaN-7 Creat-0.5 Na-139
K-3.6 Cl-106 HCO3-28 AnGap-9
___ 05:40AM BLOOD AlkPhos-97
___ 05:40AM BLOOD Calcium-8.7 Phos-3.2 Mg-2.0
UA-
___ 04:33PM URINE Color-Yellow Appear-Hazy Sp ___
___ 04:33PM URINE Blood-TR Nitrite-NEG Protein-30
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-2* pH-6.5 Leuks-LG
___ 04:33PM URINE RBC-6* WBC->182* Bacteri-MOD Yeast-NONE
Epi-3
Urine Culture-
PROTEUS MIRABILIS. >100,000 ORGANISMS/ML..
AMPICILLIN------------ <=2 S
AMPICILLIN/SULBACTAM-- <=2 S
CEFEPIME-------------- <=1 S
CEFTAZIDIME----------- <=1 S
CEFTRIAXONE----------- <=1 S
CIPROFLOXACIN--------- =>4 R
GENTAMICIN------------ <=1 S
MEROPENEM-------------<=0.25 S
TOBRAMYCIN------------ <=1 S
TRIMETHOPRIM/SULFA---- <=1 S
Repeat UA-
___ 11:29AM URINE Color-Straw Appear-Clear Sp ___
___ 11:29AM URINE Blood-NEG Nitrite-NEG Protein-NEG
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG
Stool-
CLOSTRIDIUM DIFFICILE TOXIN A & B TEST (Final ___: FECES
POSITIVE FOR C. DIFFICILE TOXIN BY EIA.
Studies-
CXR (___)
Single erect AP portable view of the chest was obtained. No
focal consolidation, pleural effusion, or evidence of
pneumothorax is seen. Marked aortic tortuosity is stable. The
cardiac size remains upper limits of normal.
AXR (___)
A single supine image of the abdomen shows a nonspecific bowel
gas pattern without evidence of obstruction or ileus. There is
no evidence of toxic megacolon. There is no obvious free air,
although exam is somewhat limited due to supine positioning.
Hardware from a prior spinal fusion of L3 through L5 is present.
There are significant degenerative changes at those levels with
large osteophytes. A left total hip arthroplasty is in place.
There are multiple pelvic phleboliths.
Brief Hospital Course:
___ yo F with h/o advanced ___ Disease presenting with
fevers and lethargy; found to have UA c/w UTI.
# Severe sepsis secondary to UTI
Patient presented with AMS and reported suprapubic pain. She
was febrile on admission with 12% bands upon admission. The
following day, she was noted to be tachycardia and tachypneic.
Her UA was significant for >182 WBCs and large ___, and the
culture grew Proteus. She was initially treated with
ceftriaxone and when culture data returned she was transitioned
to cefpodoxime for a planned 10 day course. She has remained
hemodynamically stable throughout her admission and has been
afebrile for >48 hours prior to discharge.
# C diff
Patient has had multiple episodes of cdiff since this ___. She
has received both po vanco and iv/po flagyl and only recently
completed her vanco taper. She was noted to have having loose
stools, which were positive for Cdiff toxin. She was started on
po vanco and flagyl. Upon discharge, she is to continue po
vanco for two weeks following the completion of her cefpodoxime
course followed by an additional 2 weeks of Rifaximin.
# Atrial fibrillation with rapid ventricular response.
On ___, the patient was noted to be tachycardia with sustained
rates of 140-150s bpm. An EKG revealed that she was in atrial
fibrillation with RVR. Her home metoprolol had been held in the
setting of sepsis and the patient likely had high sympathetic
tone in the setting of her acute infections. She was given
metoprolol 15 mg IV push spread out over multiple doses while
her BP was closely monitored and remained stable. She remained
in afib with HR ranging from 100-110s for the next few hours and
later converted to normal sinus rhythm.
# Encephalopathy
The patient presented after her caretakers noted she was more
confused and less interactive, which was most likely secondary
to her acute infection. As her infection cleared, her mental
status did as well and she is back at her baseline upon
discharge.
# Acute Renal Failure
Her admission labs were significant for a BUN/Cr of ___
increased from a baseline of about ___. This was most likely
due to dehydration and possible poor forward flow in the setting
of sepsis, although she remained hemodynamically stable.
Following fluid resuscitation, her kidney function improved and
is back at her baseline.
# ___ Disease
Patient has reported h/o advanced ___ disease and has
findings c/w this on exam. She had difficulties speaking
particularly with phonation in the setting of her sepsis, but
this also improved as her infection cleared. She was continued
on her home sinemet dose which was confirmed with her outpatient
neurologist.
# Swallowing difficulties
Patient was evaluated by the speech and swallow team during her
prior admissions. Their recommendations were followed during
this hospitalization as well.
# Elevated alkaline phosphatase
The patient was noted to have an increased alkaline phosphatase
upon admission. Etiology was unclear, the patient did not
endorse signs of symptoms of biliary pathology. A GGT was sent
and was also elevated. Her alkaline phosphatase trended down
throughout her admission course.
# HTN
The patient's antihypertensives were held on admission in the
setting of sepsis. Her metoprolol was restarted after her
episode of afib with RVR and lisinopril was restarted when her
kidney function improved.
# HLD
Patient was continued on her home medication (simvastatin).
# Depression
Patient was continued on her home medication (cymbalta).
================================
Transition of Care
================================
# Antibiotics:
-Cefpodoxime 100 mg twice daily until ___.
-Vancomycin 125mg by mouth four times a day until ___.
-Rifaximin 400mg twice daily. Do not start this until ___
and then continue until ___.
# Pending Labs:
-Blood cultures from ___ and ___. Both currently have
no growth to date.
Medications on Admission:
-Amantadine 100 mg po qday
-Aspirin 325 mg po qday
-Calcium carbonate 1000 mg po qday
-Cymbalta 60 mg po qday
-Lisinopril 20 mg po qday
-Multivitamin daily
-Vitamin D3 daily (dose not noted)
-Simvastatin 20 mg po qpm
-Metoprolol 12.5 mg po BID
-Carbidopa/levodopa ___ mg po TID and 1 half tab 1hs.
-Enablex ___ mg po qday at 8pm
-Colace prn daily
Discharge Medications:
1. amantadine 100 mg Tablet Sig: One (1) Tablet PO once a day.
2. aspirin 325 mg Tablet Sig: One (1) Tablet PO once a day.
3. calcium carbonate 200 mg calcium (500 mg) Tablet, Chewable
Sig: Two (2) Tablet, Chewable PO DAILY (Daily).
4. duloxetine 30 mg Capsule, Delayed Release(E.C.) Sig: Two (2)
Capsule, Delayed Release(E.C.) PO DAILY (Daily).
5. lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
6. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily).
7. simvastatin 10 mg Tablet Sig: Two (2) Tablet PO qpm.
8. metoprolol tartrate 25 mg Tablet Sig: 0.5 Tablet PO twice a
day.
9. carbidopa-levodopa ___ mg Tablet Sig: ___ Tablet PO four
times a day: Please take 1 tab TID, and 0.5 tab qhs.
10. Enablex ___ mg Tablet Extended Release 24 hr Sig: One (1)
Tablet Extended Release 24 hr PO once a day.
11. docusate sodium 50 mg/5 mL Liquid Sig: One (1) dose PO prn
as needed for constipation.
12. cefpodoxime 100 mg Tablet Sig: One (1) Tablet PO Q12H (every
12 hours): Last dose: ___.
13. vancomycin 125 mg Capsule Sig: One (1) Capsule PO four times
a day: Last dose: ___.
14. rifaximin 200 mg Tablet Sig: Two (2) Tablet PO twice a day:
Please take from ___.
15. Vitamin D Oral
Discharge Disposition:
Extended Care
Facility:
___
___ Diagnosis:
Primary:
Severe sepsis secondary to acute cystitis
Secondary:
Atrial fibrillation with rapid ventricular response
Clostridium difficile infection
___ disease
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or
wheelchair.
Discharge Instructions:
Ms. ___,
It was a pleasure taking part in your care. We hope you
continue to feel well. You were admitted because you were
seeming more confused and tired at your nursing facility. You
were found to have both an infection in your urinary tract as
well as in your stool. You were given antibiotics.
We also found that your kidneys were slightly injured. This was
most likely due to dehydration and your blood worked showed that
they improved following IV fluids.
Please make the following changes to your medications:
-START: Cefpodoxime 100 mg twice daily until ___. This is
for the infection in your urinary tract.
-START: Vancomycin 125mg by mouth four times a day until
___. This is for the C. diff infection in your stool.
-START: Rifaximin 400mg twice daily. Do not start this until
___ and then continue until ___. This is also for the
C. diff infection in your stool.
Please continue all of your other medications as previously
directed.
Followup Instructions:
___
|
10810720-DS-13
| 10,810,720 | 21,027,678 |
DS
| 13 |
2176-03-20 00:00:00
|
2176-03-26 18:00:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: SURGERY
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
polytrauma s/p MVC
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ heroin user transferred from OSH s/p unrestrained passenger
in rear seat in MVC vs pole at 40-50 mph. GCS 15, HD stable at
scene and on arrival. Complaining of back pain and found to have
multiple spine fractures, left orbital floor fracture, nasal
bone fracture at OSH. Denies numbness or weakness. No saddle
anesthesia. No bowel or bladder incontinence.
Past Medical History:
PMHx: anxiety, osteomyelitis R thumb, chronic bronchitis
PSHx: R thumb distal phalanx resection
Social History:
___
Family History:
noncontributory
Physical Exam:
PE:
98.2 80 109/70 14 100
HEENT: Periorbital ecchymosis and swelling L>R.
L hand: Pain with ROM of the wrist, NVI.
Spine exam: TTP over mid thoracic and lumbar spine, no deformity
or stepoff.
PE on Discharge:
VS: 98.8, 75, 110/57, 18, 96%ra
HEENT: Left sided facial ecchymosis and swelling
CHEST: LS CTAB, TLSO brace on
CARD: HRR, normal s1/s2
ABD: soft, NT/ND
EXT: LLE in splint, ace wrap. +csm. No pedal edema
Pertinent Results:
___ 06:20AM BLOOD WBC-9.4 RBC-4.29 Hgb-11.6* Hct-34.4*
MCV-80* MCH-27.0 MCHC-33.7 RDW-16.4* Plt ___
___ 06:45PM BLOOD WBC-17.3* RBC-4.80 Hgb-13.2 Hct-39.1
MCV-82 MCH-27.6 MCHC-33.9 RDW-16.5* Plt ___
___ 06:20AM BLOOD Glucose-93 UreaN-13 Creat-0.7 Na-136
K-4.0 Cl-100 HCO3-25 AnGap-15
___ 06:45PM BLOOD Glucose-106* UreaN-12 Creat-0.8 Na-136
K-4.3 Cl-100 HCO3-23 AnGap-17
___ 06:20AM BLOOD ALT-168* AST-86* AlkPhos-85 TotBili-1.9*
___ 06:45PM BLOOD ALT-208* AST-108* AlkPhos-100 TotBili-1.4
___ 06:20AM BLOOD Calcium-9.1 Phos-3.7 Mg-1.7
___ 06:45PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
LEFT HAND XRAY
Isolated ulnar styloid fracture
CXR:
Metallic density projects in the right base of neck, correlate
for possible foreign body. Otherwise unremarkable.
Brief Hospital Course:
___ heroin user transferred from OSH s/p unrestrained passenger
in rear seat in MVC vs pole at 40-50 mph. GCS 15, HD stable at
scene and on arrival. CT showed compression fxs T7-T11; L2-L4
transverse process fxs, no evidence of listhesis or canal
narrowing. Spine consulted who recommended conservative
management with TLSO. Also found to have multiple facial fxs and
a distal left ulnar styloid fx, Plastics consulted and
recommended fractures be managed conservatively, sinus
precautions, outpatient follow-up. The patient was admitted for
pain management, Physical Therapy consult, social work, and to
be fitted for TLSO brace. The patient was hemodynamically
stable.
Pain was well controlled. Diet was progressively advanced as
tolerated to a regular diet with good tolerability. The patient
voided without problem. The TLSO brace was delivered on HD2 and
the patient worked with ___. She was cleared for home without
services. During this hospitalization, the patient ambulated
early and frequently, was adherent with respiratory toilet and
incentive spirometry, and actively participated in the plan of
care. The patient received subcutaneous heparin and venodyne
boots were used during this stay.
.
At the time of discharge, the patient was doing well, afebrile
with stable vital signs. The patient was tolerating a regular
diet, ambulating with the TLSO brace, voiding without
assistance, and pain was well controlled. The patient was
discharged home without services. The patient received discharge
teaching and follow-up instructions with understanding
verbalized and agreement with the discharge plan.
..
Medications on Admission:
none
Discharge Medications:
1. Acetaminophen 650 mg PO Q6H:PRN pain
RX *acetaminophen 325 mg 2 tablet(s) by mouth every six (6)
hours Disp #*60 Tablet Refills:*0
2. Docusate Sodium 100 mg PO BID
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day
Disp #*30 Capsule Refills:*0
3. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain
RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours
Disp #*20 Tablet Refills:*0
4. Ibuprofen 600 mg PO Q8H:PRN pain
RX *ibuprofen 600 mg 1 tablet(s) by mouth every eight (8) hours
Disp #*40 Tablet Refills:*0
Discharge Disposition:
Home
Discharge Diagnosis:
Polytrauma:
T7-11 compression fracture
L2-4 transverse process fracture
left orbit blow out fracture
left styloid ulnar fracture
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
You were admitted to ___ after sustaining injuries from a
motor vehicle collision. Your injuries included spine fractures,
facial fractures, and a left wrist fracture. You were seen by
the spine doctors and the plastic surgeons. Your spine injuries
were non-operative but require you wear the brace at all times
when out of bed. You will need to follow-up in the spine clinic,
to determine when the brace can be discontinued. Your facial and
wrist fracture may need surgical repair, and you will need to
follow-up in the Hand clinic and Plastics clinic for further
management of these injuries, once the swelling goes down.
Please note the following discharge instructions:
Please call your doctor or nurse practitioner or return to the
Emergency Department for any of the following:
*You experience new chest pain, pressure, squeezing or
tightness.
*New or worsening cough, shortness of breath, or wheeze.
*If you are vomiting and cannot keep down fluids or your
medications.
*You are getting dehydrated due to continued vomiting, diarrhea,
or other reasons. Signs of dehydration include dry mouth, rapid
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a
bowel movement.
*You experience burning when you urinate, have blood in your
urine, or experience a discharge.
*Your pain in not improving within ___ hours or is not gone
within 24 hours. Call or return immediately if your pain is
getting worse or changes location or moving to your chest or
back.
*You have shaking chills, or fever greater than 101.5 degrees
Fahrenheit or 38 degrees Celsius.
*Any change in your symptoms, or any new symptoms that concern
you.
Please resume all regular home medications, unless specifically
advised not to take a particular medication. Also, please take
any new medications as prescribed.
Please get plenty of rest, continue to ambulate several times
per day, and drink adequate amounts of fluids
SINUS PRECAUTIONS:
1. Take the prescribed medications as directed.
2. Do not forcefully spit for several days.
3. Do not smoke for several days.
4. Do not use straws for several days.
5. Do not forcefully blow your nose for at least 2 weeks, even
though your sinus may feel stuffy or there may be some nasal
drainage.
6. Try not to sneeze; it will cause undesired sinus pressure. If
you must sneeze, keep your mouth open.
7. Eat only soft foods for several days, always trying to chew
on the opposite side of your mouth.
8. Do not rinse vigorously for several days.
Followup Instructions:
___
|
10810971-DS-17
| 10,810,971 | 21,364,625 |
DS
| 17 |
2139-12-07 00:00:00
|
2139-12-07 12:42:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___
Chief Complaint:
abdominal pain
Major Surgical or Invasive Procedure:
Five palliative radiation treatments
History of Present Illness:
___ yo F with metastatic stage IV vulvar cancer (with pulmonary
mets) s/p radiation to the vulva presents with abdominal pain
and constipation. She was recently admitted to the oncology
service from ___ to ___ for vulvar pain, which was attributed
to painful inguinal lymphadenopathy. X-ray of her hip was
unremarkable. She was started on oxycontin 20mg BID for pain
control with improvement. During the admission she was seen by
Palliative Care, Social work and Physical Therapy. She was also
seen by radiation oncology, who began to plan for palliative
radiation to the area. On ___ she saw her oncologist as an
outpatient and they discussed starting palliative ___. She
was planning to start that on ___, after she completes 5
additional palliative raditation treatments that were due to
begin today (___). She and her family today report that her
pain has not been controlled since discharge. She was vomiting
on discharge and has severe pain with sitting in car and becomes
lightheaded and nauseated. At home she has been staying in bed,
getting out of bed for 10 min at a time to eat. She reports
___ pain from the vulvar mass that she has, worse with sitting
(putting pressure on it). She has not had a BM since ___, and
before that she had not had a BM in 7 days.
In the ED she was stable. She underwent a KUB that showed fecal
loading but not bowel obstruction. She had an enema that
produced a bowel movement. She was given morphine that she
reports was ineffective. She was admitted for pain control.
Review of systems:
(+) Per HPI
(-) Denies fever, chills, night sweats, recent weight loss or
gain. Denies headache, sinus tenderness, rhinorrhea or
congestion. Denies cough, shortness of breath. Denies chest pain
or tightness, palpitations. No dysuria. Denies arthralgias or
myalgias. Ten point review of systems is otherwise negative.
Past Medical History:
Per Prior notes:
Ms. ___ was initially diagnosed with vulvar patchy
lichen in ___ in ___, and recently confirmed as squamous vulvar
cancer in ___. She initially noticed white patches on the
left vulvar area with spots. She was started on clobetasol
without any responses.
- She was seen by a second GYN provider with ___ biopsy, which
showed chronic inflammation and she was continued on lichen's
treatment.
- She was seen then by a dermatologist and she was prescribed
mupirocin to help with the local erythema; however, her local
lesion continued to worsen and involved the other side of her
vulva.
- She was referred to ___. She was seen by Dr. ___ Dr.
___. She received a biopsy on ___, which showed
invasive squamous cell carcinoma of the vulva. Subsequently, a
staging PET-CT was performed. She was found to have FDG-avid
lymph nodes in the groin area as well as pulmonary nodules
concerning for pulmonary metastases. After seeing Dr. ___
___ GYN oncology, she was referred to our radiation oncologist,
Dr. ___.
- She received radiation therapy from ___ - ___
Other Past Medical History:
1. Hypertension.
2. Hyperlipidemia.
3. GERD.
Cardiac catheterization in ___ showed some stenosis, but no
need
for stenting.
Social History:
___
Family History:
Father had prostate cancer, but he died of heart attack. Mother
had MI. She is the only child. She has two children and five
grandchildren who are all healthy.
Physical Exam:
VSS
Gen: Appears comfortable, alert, awake
HEENT: EOMI, PERRLA, MMM
CV: RRR, no m/g/r
Pulm: CTAB, no w/r/r
Abd: Soft, LLQ ttp, +borborygmi, no rebound, minimal guarding
GU: + 0.5cm white firm nodule at vulvar meatus, also another 2cm
firm nodule over left inguinal canal, and a small red patch
which pt thinks is another nodule developing, no foley
Back: Left back tenderness, no spinal ttp, no buttock ttp
Skin: no rashes
Extrem: Warm, no edema
Neuro: A+Ox3, speech fluent, ___ strenght in bilat ___, affect
pleasant
Pertinent Results:
___ 10:12AM BLOOD Neuts-80.3* Lymphs-11.2* Monos-5.8
Eos-2.3 Baso-0.4
___ 10:12AM BLOOD Glucose-140* UreaN-12 Creat-0.9 Na-136
K-3.8 Cl-99 HCO3-30 AnGap-11
___ 10:12AM BLOOD ALT-40 AST-27 AlkPhos-108* TotBili-0.3
___ 10:12AM BLOOD Albumin-3.4*
___ 01:00PM BLOOD ___ pO2-31* pCO2-47* pH-7.41
calTCO2-31* Base XS-3
___ 10:20AM BLOOD Lactate-1.6
Abd xray
FINDINGS:
Gas and stool seen throughout the length of the colon which is
nondistended. There are no air-filled dilated loops of small
bowel. No abnormal air-fluid levels or free intraperitoneal air
identified on the decubitus film. Degenerative changes seen at
the lumbosacral junction. Calcifications in the pelvis
compatible with fibroids.
IMPRESSION:
Nonobstructive bowel gas pattern.
Brief Hospital Course:
___ yo F with metastatic stage IV vulvar carcinoma who was
admitted with refractory pain from vulvar mass and
lymphadenopathy.
# Pain: Pt reports that pain has been stable, with no change in
character, intensity, pattern. Working with palliative care
___ who met patient on the prior admission) PCA was
started, but she did not tolerate. She was switched to a
fentanyl patch at 50mcg. This was increased to 62mcg on ___.
Decadron was also added, initially at 6mg once, but this seemed
to make pt slightly giddy/agitated. This was down titrated to
once daily. Five palliative radiation treatments were scheduled
and the patient tolerated them well.
On discharge, she was much more comfortable. taking several
doses of oxycodone 10mg prn and able to sleep through the night.
# Constipation: An aggressive bowel regimen was started and she
was finally able to stool regularly.
# Strep bacteremia: After XRT was started she developed a fever.
___ blood cx grew strep bacteremia. The patient was vehemently
opposed to maintaining IV access, so after discussion with her
daughter and patient she was started on "palliative"
levofloxacin. Unclear source of bacteremia, but given palliative
goals this was not investigated further. She did well with no
further fevers and was sent home to finish a 10 day course.
# Metastatic vulvar cancer: Plan to start ___ once pt's
daughter obtains this prescription. Prior approval was being
pursued.
# Disposition: Upon family's request ___ was enrolled into a
hospice program and she will begin that after discharge.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. OxyCODONE SR (OxyconTIN) 20 mg PO Q12H
2. Aspirin 81 mg PO DAILY
3. Atenolol 100 mg PO DAILY
4. Zolpidem Tartrate 5 mg PO HS
5. Lisinopril 20 mg PO DAILY
Discharge Medications:
1. Atenolol 100 mg PO DAILY
2. Lisinopril 20 mg PO DAILY
3. Zolpidem Tartrate 5 mg PO HS
4. Aspirin 81 mg PO DAILY
5. Aquaphor Ointment 1 Appl TP TID:PRN apply to vulva
RX *white petrolatum [Advanced Healing (Petrolatum)] 41 % apply
to affected areas three times a day Disp #*396 Gram Gram
Refills:*3
6. Bisacodyl ___AILY
RX *bisacodyl 10 mg 1 suppository(s) rectally once a day Disp
#*30 Suppository Refills:*3
7. Dexamethasone 1 mg PO DAILY
RX *dexamethasone 1 mg 1 tablet(s) by mouth once a day Disp #*30
Tablet Refills:*3
8. Fentanyl Patch 62 mcg/h TD Q72H
RX *fentanyl 50 mcg/hour 1 patch q3d Disp #*10 Patch Refills:*1
RX *fentanyl [Duragesic] 12 mcg/hour 1 patch q3d Disp #*10 Patch
Refills:*1
9. Lactulose 15 mL PO BID:PRN Constipation
RX *lactulose 10 gram/15 mL 22.5 cc by mouth twice a day
Refills:*3
10. Levofloxacin 500 mg PO Q24H
RX *levofloxacin [Levaquin] 500 mg 1 tablet(s) by mouth once a
day Disp #*4 Tablet Refills:*0
11. OxycoDONE (Immediate Release) 10 mg PO Q2H:PRN pain
RX *oxycodone 10 mg 1 tablet(s) by mouth q2h Disp #*150 Tablet
Refills:*0
12. Polyethylene Glycol 17 g PO DAILY
RX *polyethylene glycol 3350 [Laxative PEG 3350] 17 gram/dose 1
powder(s) by mouth once a day Refills:*3
13. Prochlorperazine 5 mg PO Q6H:PRN nausea
RX *prochlorperazine maleate [Compazine] 5 mg 1 tablet(s) by
mouth every six (6) hours Disp #*40 Tablet Refills:*0
14. Senna 8.6 mg PO 4X/DAY
RX *sennosides [___] 8.6 mg 1 tab by mouth four times a
day Disp #*120 Tablet Refills:*3
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
Vulvar carcinoma
Constipation
Streptococcal bacteremia
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
You were admitted for pain and constipation. You were treated
with radiation treatments, pain medications and a bowel
regimen...
Followup Instructions:
___
|
10811085-DS-10
| 10,811,085 | 21,783,677 |
DS
| 10 |
2121-08-09 00:00:00
|
2121-08-30 15:33:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: SURGERY
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Abdominal pain
Major Surgical or Invasive Procedure:
None.
History of Present Illness:
___ with history of hysterectomy for uterine cancer and
appendectomy who presents with abdominal pain since last night.
The pain is periumbilical and was associated emesis last night.
She has not passed gas since, but did have a normal BM at the
onset of her symptoms. She initially presents to ___ where two
CT scans were performed with findings suggestive of SBO. An NGT
was placed and the patient transferred to ___ for further
evaluation.
Past Medical History:
Past Medical History: HTN, DM,
Past Surgical History: Hysterectomy, appendectomy
Social History:
___
Family History:
Family History: Non-contributory
Physical Exam:
Admission Physical Exam:
Vitals: 97.5 78 129/59 17 100RA
GEN: A&O, NAD
CV: RRR
PULM: non-labored on RA
ABD: obese. ventral hernias palpated. Difficult exam ___ to
habitus but the contents are soft and defects of moderate size.
She has discomfort to palpation of the hernias but is otherwise
soft and non-tender
Ext: No ___ edema, ___ warm and well perfused
Discharge Physical Exam:
97.9, 93/61, 73, 18, 96% 2L
Gen: [x] NAD, [x] AAOx3
CV: [x] RRR, [] murmur
Resp: [x] breaths unlabored, [] CTAB, [] wheezing, [] rales
Abdomen: [x] soft, [] distended, [] tender, [] rebound/guarding
Wound: [] incisions clean, dry, intact
Ext: [x] warm, [] tender, [] edema
Pertinent Results:
ABDOMEN (SUPINE ONLY) Study Date of ___
1. NG tube terminates within the proximal stomach.
2. Nonspecific nonobstructive bowel gas pattern. Enteric
contrast resides
within the right colon terminating at the hepatic flexure.
Large bowel
containing abdominal hernia was better assessed on preceding CT.
PORTABLE ABDOMEN Study Date of ___
1. No abnormally dilated loops of bowel, however no significant
change in
location of the enteric contrast from the mid transverse colon.
2. The enteric tube tip is not fully captured on this study and
the last
side-hole is not visualized.
PORTABLE ABDOMEN Study Date of ___
1. Compared to most recent abdominal radiograph dated 7 hours
prior, enteric contrast is still within the mid transverse
colon.
2. The enteric tube tips is below the level of the diaphragm,
however the
last side-hole is near the GE junction. Recommend advancement
at least 5 cm.
LAB DATA:
___ 07:00AM BLOOD WBC-6.0 RBC-4.10 Hgb-11.6 Hct-39.8 MCV-97
MCH-28.3 MCHC-29.1* RDW-19.1* RDWSD-67.9* Plt ___
___ 07:00AM BLOOD WBC-6.3 RBC-4.12 Hgb-11.5 Hct-40.4 MCV-98
MCH-27.9 MCHC-28.5* RDW-19.6* RDWSD-70.5* Plt ___
___ 07:08AM BLOOD WBC-7.2 RBC-4.26 Hgb-11.7 Hct-41.4 MCV-97
MCH-27.5 MCHC-28.3* RDW-20.0* RDWSD-71.2* Plt ___
___ 07:00AM BLOOD Glucose-118* UreaN-14 Creat-0.8 Na-143
K-4.3 Cl-101 HCO3-31 AnGap-11
___ 07:00AM BLOOD Glucose-96 UreaN-7 Creat-0.7 Na-145 K-3.7
Cl-99 HCO3-33* AnGap-13
___ 07:08AM BLOOD Glucose-105* UreaN-10 Creat-0.8 Na-144
K-4.0 Cl-100 HCO3-30 AnGap-14
___ 08:49PM BLOOD Glucose-91 UreaN-11 Creat-0.8 Na-142
K-4.0 Cl-97 HCO3-30 AnGap-15
___ 07:00AM BLOOD Calcium-10.0 Phos-2.6* Mg-1.9
___ 07:08AM BLOOD Calcium-10.2 Phos-2.8 Mg-1.9
Brief Hospital Course:
Ms. ___ is a ___ yo F history of abdominal hysterectomy who
presented to the emergency department from outside hospital on
___ with abdominal pain. She underwent CT scan that was
concerning for bowel obstruction. She was made NPO, NGT was
placed, and she was admitted to the surgical floor for further
management. Contrast was given via NGT and serial xrays were
obtained. Contrast transversed the colon and therefore
nasogastric tube was removed. She had return of bowel function
and diet was gradually advanced to regular. She then worked with
physical therapy and they determined she was safe to discharge
back home without need for home ___.
During this hospitalization, the patient voided without
difficulty and ambulated early and frequently. The patient was
adherent with respiratory toilet and incentive spirometry and
actively participated in the plan of care. The patient received
subcutaneous heparin and venodyne boots were used during this
stay.
At the time of discharge, the patient was doing well. She was
afebrile and her vital signs were stable. The patient was
tolerating a regular diet, ambulating, voiding without
assistance, and her pain was well controlled. The patient was
discharged home without services. Discharge teaching was
completed and follow-up instructions were reviewed with reported
understanding and agreement.
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires
further investigation.
1. Furosemide 20 mg PO DAILY
2. Metoprolol Succinate XL 25 mg PO DAILY
3. Januvia (SITagliptin) 15 mg oral DAILY
4. Tradjenta (linaGLIPtin) 5 mg oral DAILY
5. amLODIPine 5 mg PO DAILY
6. Aspirin 81 mg PO DAILY
7. Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation
inhalation ASDIR
Discharge Medications:
1. Bisacodyl ___AILY:PRN Constipation - Second Line
2. Polyethylene Glycol 17 g PO DAILY
may discontinue when bowel pattern normalizes
3. Senna 8.6 mg PO BID
may discontinue when bowel pattern normalizes
4. amLODIPine 5 mg PO DAILY
5. Aspirin 81 mg PO DAILY
6. Furosemide 20 mg PO DAILY
7. Januvia (SITagliptin) 15 mg oral DAILY
8. Metoprolol Succinate XL 25 mg PO DAILY
9. Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation
inhalation ASDIR
10. Tradjenta (linaGLIPtin) 5 mg oral DAILY
Discharge Disposition:
Home
Discharge Diagnosis:
Partial small bowel obstruction
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Ms. ___,
You were admitted to the Acute Care Surgery Service on ___
with abdominal pain and found to have a partial bowel
obstruction. You were given bowel rest, IV fluids, and had a
nasogastric tube placed to help decompress you bowels. You had
several xrays that showed the contrast you drank was able to
pass through your intestines. Your diet was gradually advanced
which you tolerated well. You are now ready to be discharged
home to continue your recovery.
Please note the following discharge instructions:
Please call your doctor or nurse practitioner or return to the
Emergency Department for any of the following:
*You experience new chest pain, pressure, squeezing or
tightness.
*New or worsening cough, shortness of breath, or wheeze.
*If you are vomiting and cannot keep down fluids or your
medications.
*You are getting dehydrated due to continued vomiting, diarrhea,
or other reasons. Signs of dehydration include dry mouth, rapid
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a
bowel movement.
*You experience burning when you urinate, have blood in your
urine, or experience a discharge.
*Your pain in not improving within ___ hours or is not gone
within 24 hours. Call or return immediately if your pain is
getting worse or changes location or moving to your chest or
back.
*You have shaking chills, or fever greater than 101.5 degrees
Fahrenheit or 38 degrees Celsius.
*Any change in your symptoms, or any new symptoms that concern
you.
Please resume all regular home medications, unless specifically
advised not to take a particular medication. Also, please take
any new medications as prescribed.
Please get plenty of rest, continue to ambulate several times
per day, and drink adequate amounts of fluids.
Followup Instructions:
___
|
10811369-DS-4
| 10,811,369 | 23,582,528 |
DS
| 4 |
2180-11-21 00:00:00
|
2180-11-21 18:50:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
acetylcysteine / tramadol
Attending: ___.
Chief Complaint:
Acute hepatitis
Major Surgical or Invasive Procedure:
none
History of Present Illness:
This is a ___ with a PMH of anxiety, migraines, and depression
c/b 2 previous APAP overdoses, most recently 1 month ago
presents with RUQ pain and vomiting.
GERD symptoms began this past ___ when she had 2 glasses of
wine at a coworkers event. Yesterday, she began feeling more
nauseated to the point she was unable to sleep. She had a
headache and took 2 tabs of extra-strength Tylenol. The patient
notes difficult family situation, but denies intentional
overdose.
She denies sick contacts or recent travel. She started birth
control 2 weeks ago. She has been taking sertraline and
trazodone as well, which were recently started.
She complains of RUQ/R flank pain with nausea and vomiting. The
nausea/vomiting is new. The R flank pain has come and gone since
her last discharge. She endorses increasing fatigue and
decreased appetite with weight loss. She denies fevers or
chills. She denied melena and hematochezia. She endorses acid
reflux symptoms, epigastric pain, and a band like pain around
her rib cage. She endorses non-productive cough.
At last admission, patient reported taking approximately 60-70
tablets of acetaminophen 500 mg over the course of the day
(30,000 to 35,000 mg) in addition to consuming alcohol. The day
prior to the overdose, she took 10 tablets of klonopin 0.5 mg.
AST/ALT peaked in 500s. She was given NAC x3 per guidelines w/
down-trending LFTs after 3 doses. Her INR was elevated to 1.3,
but downtrended to 1.1 prior to discharge. ALT 145 and AST 64 at
the time of discharge.
VS prior to transfer: 99.0 62 116/47 16 100% RA
In ED initial VS: 97.8 117 ___ 100% RA
Labs significant for: ALT: 1721->ALT: 2711 AST: 1706->AST: 2889
2711 Tbili: 1.5->1. INR 1.7 -> 1.8, APAP level negative
Patient was given:
___ 05:45 IV Ondansetron 4 mg
___ 05:51 IVF NS 1000 mL
___ 06:57 IV Ketorolac 30 mg
___ 07:47 IVF NS 1000 mL
___ 11:01 IV DiphenhydrAMINE 50 mg
___ 11:07 IV Ondansetron 4 mg
___ 11:07 IV DRIP Acetylcysteine (IV) ___ mg ordered)
___ 13:00 IV Ondansetron 4 mg
___ 13:01 IVF NS ___ Not Stopped
___ 13:58 IV DRIP Acetylcysteine (IV) (3750 mg ordered)
Started 62.5 mL/hr
___ 16:00 IVF NS 1000 mL
___ 16:07 IVF NS 150 mL/hr
___ 16:07 PO Omeprazole 40 mg
Imaging notable for: echogenic liver on RUQUS
Consults: Psych recommended ___ Hepatology recommended
hydration and NAC protocol, trend LFTs, chem 10, INR, lactate
q4, neuro exam and accuchecks q2 if LFTs rising quickly.
VS prior to transfer: 98.0 66 103/54 15 100% RA
REVIEW OF SYSTEMS: 11pt ROS negative unless noted above
Past Medical History:
PAST PSYCHIATRIC HISTORY:
History of symptoms as reported by patient are noted above.
Has one previous suicide attempt by Tylenol ingestion ___ years
ago, after which she was hospitalized. This was her only
psychiatric hospitalization.
___ provides medications and psychotherapy. She
currently takes sertraline when she notices premenstrual
symptoms
starting up until her period starts, as well as clonazepam as
needed for anxiety, and denies any other medication trials.
-Access to weapons: Denies
PAST MEDICAL HISTORY: Elevated LFTs following overdose
Depression - 2 previous suicide attempts, most recently with
Tylenol overdose.
Acute hepatitis ___ Tylenol ingestion
Migraines
Social History:
___
Family History:
FAMILY PSYCHIATRIC HISTORY: Denies known family history of
mental illness, substance abuse, suicide attempts
Physical Exam:
=================================
EXAM ON ADMISSION
=================================
VITALS: 99.5 66 126/68 13 100%RA
GENERAL: Alert, oriented, appears uncomfortable with dry heaves
HEENT: Sclera anicteric, MMM, oropharynx clear
NECK: supple, JVP not elevated, no LAD
LUNGS: Clear to auscultation bilaterally, no wheezes, rales,
rhonchi
CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs,
gallops
Chest: R side/rib cage TTP to palpation
ABD: soft, non-tender, non-distended, bowel sounds present, no
rebound tenderness or guarding, no organomegaly
EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
SKIN: no apparent rashes or jaundice
NEURO: II-XII intact, strength preserved ___ ___
=================================
EXAM ON DISCHARGE
=================================
VS: 98.6, HR 83, BP 97/65, RR 18, 100%RA
General: alert, oriented, no acute distress
Eyes: Sclera anicteric
Resp: clear to auscultation bilaterally, no wheezes, rales,
rhonchi
CV: regular rate and rhythm, normal S1 + S2, no murmurs, rubs,
gallops
GI: soft, mildly tender in RUQ, non-distended, bowel sounds
present, no rebound tenderness or guarding, no organomegaly
MSK: warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
Neuro: CNs2-12 intact, motor function grossly normal
Pertinent Results:
==============================
LABS ON ADMISSION
==============================
___ 05:45AM BLOOD WBC-8.5 RBC-4.06 Hgb-12.6 Hct-36.8 MCV-91
MCH-31.0 MCHC-34.2 RDW-13.9 RDWSD-45.8 Plt ___
___ 05:45AM BLOOD Neuts-75.4* Lymphs-14.4* Monos-6.5
Eos-2.7 Baso-0.6 Im ___ AbsNeut-6.39* AbsLymp-1.22
AbsMono-0.55 AbsEos-0.23 AbsBaso-0.05
___ 07:11AM BLOOD ___ PTT-24.9* ___
___ 05:45AM BLOOD Glucose-94 UreaN-10 Creat-0.8 Na-138
K-4.3 Cl-102 HCO3-19* AnGap-17
___ 05:45AM BLOOD ALT-1721* AST-1706* AlkPhos-82
TotBili-1.5
___ 05:45AM BLOOD Lipase-33
___ 07:43PM BLOOD Calcium-8.2* Phos-2.0* Mg-1.8 Iron-122
___ 07:43PM BLOOD calTIBC-246* ___ TRF-189*
___ 05:45AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
==============================
LFT TREND
==============================
___ 05:45AM BLOOD ALT-1721* AST-1706* AlkPhos-82
TotBili-1.5
___ 12:35PM BLOOD ALT-2711* AST-2889* AlkPhos-66
TotBili-1.0
___ 07:43PM BLOOD ALT-4851* AST-5679* AlkPhos-64
TotBili-0.9
___ 01:50AM BLOOD ALT-4806* AST-5193* AlkPhos-59
TotBili-0.8
___ 09:08AM BLOOD ALT-4472* AST-3937* LD(LDH)-2931*
AlkPhos-67
___ 04:30PM BLOOD ALT-4135* AST-2346* LD(LDH)-1263*
AlkPhos-66 TotBili-1.0
___ 10:20PM BLOOD ALT-3454* AST-1432* AlkPhos-65
TotBili-1.0
___ 05:50AM BLOOD ALT-2812* AST-800* LD(LDH)-350*
AlkPhos-59 TotBili-0.8
___ 04:26PM BLOOD ALT-2653* AST-501* AlkPhos-66 TotBili-0.8
___ 06:45AM BLOOD ALT-1682* AST-192* LD(LDH)-169 AlkPhos-60
TotBili-0.4
==============================
PERTINENT INTERVAL LABS
==============================
___ 07:43PM BLOOD calTIBC-246* ___ TRF-189*
___ 05:50AM BLOOD Ferritn-1469*
___ 10:20PM BLOOD Triglyc-108
___ 07:43PM BLOOD HBsAg-NEG HBsAb-POS HBcAb-NEG
___ 12:35PM BLOOD HAV Ab-POS* IgM HAV-NEG
___ 07:43PM BLOOD AMA-NEGATIVE
___ 12:35PM BLOOD Smooth-NEGATIVE
___ 12:35PM BLOOD ___
___ 07:43PM BLOOD IgG-1076 IgA-153 IgM-98
___ 04:30PM BLOOD HIV Ab-NEG
___ 04:30PM BLOOD HIV1 VL-NOT DETECT
___ 07:43PM BLOOD HCV Ab-NEG
==============================
LABS ON DISCHARGE
==============================
___ 06:45AM BLOOD WBC-5.4 RBC-3.24* Hgb-10.1* Hct-29.7*
MCV-92 MCH-31.2 MCHC-34.0 RDW-14.6 RDWSD-48.8* Plt ___
___ 06:45AM BLOOD Glucose-130* UreaN-3* Creat-0.5 Na-140
K-4.2 Cl-110* HCO3-20* AnGap-10
___ 06:45AM BLOOD ALT-1682* AST-192* LD(LDH)-169 AlkPhos-60
TotBili-0.4
==============================
MICROBIOLOGY:
==============================
- HSV negative
- EBV serologies - pending
- CMV serologies - IgM negative, IgG positive
- ___ blood culture - STAPHYLOCOCCUS, COAGULASE NEGATIVE. OF
TWO COLONIAL MORPHOLOGIES.
- ___ urine culture - pending
==============================
IMAGING
==============================
# ___ CXR FINDINGS:
Low bilateral lung volumes. There is no focal consolidation,
pleural effusion or pneumothorax identified. The size of the
cardiac silhouette is within normal limits.
IMPRESSION: No focal consolidation.
# ___: RUQ U/S IMPRESSION:
1. Echogenic liver with no focal lesions identified. Echogenic
liver is most likely from steatosis. More advanced liver disease
including hepatitis, hepatic fibrosis, and cirrhosis cannot be
excluded on this study. Please note that imaging findings
related to acute hepatitis related to drug overdose are
nonspecific.
2. No sonographic evidence of acute cholecystitis or
cholelithiasis.
3. No ascites.
Brief Hospital Course:
___ year old woman with a PMH of acetaminophen overdose,
depression, anxiety, migraines, who presented with 2 days of RUQ
pain, found to have acute hepatitis.
===========================
ACUTE ISSUES ADDRESSED
===========================
# Acute Hepatitis: Patient presenting with abdominal pain and
nausea, and found to have acute hepatitis with hepatocellular
pattern. ALT/AST peaked at ~5000, and also noted to have
synthetic dysfunction w/ INR up to 2.3. She was seen by
toxicology and hepatology. Patient only reported taking 2
Tylenol in past several weeks, and had recently started
sertraline, trazodone, and an OCP. Also with recent ingestion of
mushrooms (at restaurant), though after consultation, felt to be
unlikely to contribute given no reported cases of hepatitis from
mushroom ingestion from restaurants. Liver ultrasound with
Doppler with patent hepatic vasculature. CMV IgM negative
(positive IgG), hepatitis serologies with no signs of acute
infection, HSV negative. EBV serologies and urine copper pending
at time of discharge. Though cause was unclear, patient was
empirically treated with NAC for possible acetaminophen
toxicity, with improvement in her LFTs and INR. Her sertraline,
OCP, and trazodone were held on discharge, as possible that this
may have been a drug reaction.
# GPC Bacteremia - Patient found to have GPCs in blood cultures
from ___. She was started on vancomycin. These speciated to
coag negative staph, and felt very likely to be a contaminant.
Surveillance cultures no growth at time of discharge.
===========================
CHRONIC ISSUES ADDRESSED
===========================
#Depression/Anxiety:
Patient was followed by psychiatry given previous history of
Tylenol toxicity. She was felt to be stable, with no suicidal
ideation endorsed. Her sertraline and trazodone were held on
admission as some possibility that could be related to
hepatitis. Patient was discharged with therapy appointment
scheduled on ___ and to continue her clonazepam.
===========================
TRANSITIONAL ISSUES
===========================
[] Sertraline, trazodone, and OCP held at time of discharge
given unclear etiology of hepatitis. If restarted, should be
done with one medication at a time and LFT monitoring
[] Discharged with close ___ follow up and direct discussion with
outpatient provider
[] Should have repeat LFTs at PCP appointment next week
[] EBV serologies and 24 hour copper pending at time of
discharge, to be followed by inpatient team
[] Found to have mild anemia (discharge Hgb 10.1). Should have
recheck, and consider iron studies and further workup if
persists.
[] Hepatitis serologies show immunity to Hep A and Hep B
# Code - Full (presumed)
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Sertraline 50 mg PO DAILY
2. TraZODone 50 mg PO QHS:PRN insomnia
3. ClonazePAM 0.5 mg PO QHS
4. Sprintec (28) (norgestimate-ethinyl estradiol) 0.25-35 mg-mcg
oral DAILY
Discharge Medications:
1. ClonazePAM 0.5 mg PO QHS
Discharge Disposition:
Home
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
# Acute hepatitis
SECONDARY DIAGNOSIS
# Depression/anxiety
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Ms. ___,
It was a pleasure to be a part of your care team at ___
___. You were admitted to the hospital with
stomach pain, and we found that your liver tests were very high.
We do not know exactly what caused this to happen, but they
started to get better.
Please see below for your medications and follow up
appointments.
Again, it was very nice to meet you, and we wish you the best.
Sincerely,
Your ___ Care Team
Followup Instructions:
___
|
10811920-DS-24
| 10,811,920 | 27,645,791 |
DS
| 24 |
2161-09-08 00:00:00
|
2161-09-08 15:06:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Aspirin / Penicillins / Toradol
Attending: ___.
Chief Complaint:
right neck swelling and pain
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ female with chronic abdominal pain, N/V, diarrhea,
with self-diagnosis of acute intermittent porphyria (which was
dismissed by heme/onc) presenting with acute on chronic
abdominal pain as well as worsening of right neck swelling and
pain. Pt recently had thyroid ultrasound as outpatient ___
showing cyst in right thyroid. She notes increased swelling and
pain at right side of neck. Per pt, she is due for outpatient
biopsy of that cyst. Denies difficulties breathing.
.
Also reports acute on chronic abdominal pain, worse in LLQ,
associated with N/V and nonbloody diarrhea. States that this is
usual pattern for her pain. No recent sick contacts, recent
travel, or antibiotic use. She has a self-diagnosis of acute
intermittent porphyria which was never substantiated. She has
had previous hospitalizations ___ to ___ for similar
symptoms treated with IV dilaudied; heme/onc consult at that
time did not feel pt had AIP. She was also hospitalized
___ with abodminal pain with negative work-up.
Suspicion raised for drug-seeking behavior.
.
In the ED, initial VS: 99.2 94 140/90 16 100% ra. She underwent
bore scope that showed no vocal cord edema. Soft tissue x-rays
of neck that was largely unremarkable. She received 4mg iv
zofran, 10mg iv prochlorperazine, 10mg reglan, 4mg iv morphine,
12.5mg iv promethazine.
Past Medical History:
1. ? Porphyria- negative work-up in ___
2. Irritable bowel syndrome.
3. History of anemia.
4. Endometriosis status post SLAP.
5. Total abdominal hysterectomy and bilateral
salpingo-oophorectomy.
6. Allergic rhinitis.
7. History of abnormal gastric emptying.
8. Bronchitis.
Social History:
___
Family History:
Mother with ? porphyria
Physical Exam:
VS - 97.8 128/80 76 18 100%RA
GENERAL - Alert, interactive, well-appearing in NAD
HEENT - PERRL, EOMI, sclerae anicteric, dry MM, OP clear
NECK - Supple, right sided neck swelling and pain on palpation
HEART - PMI non-displaced, RRR, nl S1-S2, no MRG
LUNGS - CTAB, no r/rh/wh, good air movement, resp unlabored, no
accessory muscle use
ABDOMEN - NABS, soft, diffusely tender on palpation, voluntary
guarding
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses
SKIN - no rashes or lesions
NEURO - awake, A&Ox3, CNs II-XII grossly intact
.
VS - 98.7, 97.7, 132/78, 93, 16, 100% RA
GENERAL - Alert, interactive, well-appearing in NAD
HEENT - MMM, OP clear
NECK - Supple, right sided neck swelling and pain on palpation,
appears decreased from admission
HEART - RRR, nl S1-S2, no MRG
LUNGS - CTAB
ABDOMEN - Soft, nondistended, diffusely minimally TTP without
rebound, voluntary guarding, distractable
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses
SKIN - no rashes or lesions, port site without any surrounding
erythema
NEURO - awake, A&Ox3, no focal neuro defcitis
Pertinent Results:
___ 04:00AM BLOOD WBC-6.0 RBC-3.72* Hgb-10.2* Hct-31.6*
MCV-85 MCH-27.4 MCHC-32.2 RDW-15.0 Plt ___
___ 04:00AM BLOOD Plt ___
___ 04:00AM BLOOD Glucose-90 UreaN-6 Creat-0.7 Na-143 K-3.9
Cl-111* HCO3-26 AnGap-10
___ 04:00AM BLOOD ALT-7 AST-13 AlkPhos-68 TotBili-0.4
___ 04:00AM BLOOD TSH-0.46
.
.
.
.
DIAGNOSITIC STUDIES:
NECK SOFT TISSUES X-RAY ___: IMPRESSION: Mild leftward
deviation of the trachea above the thoracic inlet similar to
prior x-ray from ___. Otherwise, unremarkable examination
.
THYROID U/S ___: IMPRESSION:
1. Large 4.3 cm right thyroid cyst.
2. 1.8 and 1.7 cm partially cystic, partially solid left thyroid
gland
nodules with possible microcalficiation, recommend further
workup with FNA.
Brief Hospital Course:
# Acute on chronic abdominal pain: Pt with acute on chronic
abdominal pain, N/V, and diarrhea, which is exactly the same as
previous flares. Had recent one day admission for exact pain on
___. Has diagnosis of IBS but per pt, also reports question
of acute intermittent porphyria that has not been substantiated.
On percocet and fentanyl patch at home and per recent discharge
summary from Dr. ___ has narcotic contract with Dr. ___
PCP. Lab results were reassuring. Patient's pain was controlled
with IV morphine and IV zofran during her stay with improvement
in pain. She was able to eat and drink without difficulty and
was transitioned back to PO pain medications.
# Thyroid cyst: Pt with recent thyroid ultrasound showing right
sided cyst. Neck film showed mild leftward deviation of the
trachea above the thoracic inlet similar to prior x-ray from
___. Otherwise, unremarkable examination. Patient had no
difficulty speaking or breathing. TSH was normal at 0.46. On
hospital day 3, reported question of difficulty swallowing and a
repeat thyroid u/s was performed which showed essentially no
change from previous ultrasound the week prior for the right
cystic lesion, but did show evidence of two partially cystic,
partially solid left thyroid gland nodules with possible
microcalficiation. Patient will require outpatient follow-up for
FNA.
# Acute intermittent porphyria: Per heme/onc consult in ___, pt does not carry diagnosis of AIP. She has portacath that
was used previously for IV hematin infusions. Attempted to
reach Dr. ___ arranging for removal of portacath, but
Dr. ___ was not available. Patient will need to follow-up
removal of this portacath with the PCP.
TRANSITIONAL ISSUES:
# thyroid cyst - will require FNA for left small nodules with
microcalcifications
# portacath - please consider removal
Medications on Admission:
Percocet ___ 2 tabs q4-6h prn
Oxycodone 10mg 1tab q6H pain
Klonopin 2mg qhs
Folic acid 1mg daily
Nexium 40mg BID
Ca+2/vit D 600/400 daily
Fentanyl patch 100 mcg q72h
Zofran ODT q12H
Discharge Medications:
1. clonazepam 1 mg Tablet Sig: Two (2) Tablet PO QHS (once a day
(at bedtime)) as needed for Insomnia.
2. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
3. fentanyl 100 mcg/hr Patch 72 hr Sig: One (1) Patch 72 hr
Transdermal Q72H (every 72 hours).
4. Nexium 40 mg Capsule, Delayed Release(E.C.) Sig: One (1)
Capsule, Delayed Release(E.C.) PO twice a day.
5. ZOFRAN ODT 4 mg Tablet, Rapid Dissolve Sig: One (1) Tablet,
Rapid Dissolve PO every twelve (12) hours as needed for nausea.
6. Percocet ___ mg Tablet Sig: Two (2) Tablet PO every ___
hours as needed for pain.
7. oxycodone 10 mg Tablet Sig: One (1) Tablet PO every six (6)
hours as needed for pain.
8. Calcium 600 with Vitamin D3 600 mg(1,500mg) -400 unit Capsule
Sig: One (1) Capsule PO once a day.
Discharge Disposition:
Home
Discharge Diagnosis:
Acute on chronic abdominal pain
Complex thyroid cyst
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Ms. ___,
You were admitted to the ___
for acute on chronic abdominal pain. All of your lab tests were
reassuring. You were treated with IV pain medications and
anti-nausea medications and improved. Your diet was advanced
and you were able to tolerate a regular diet without difficulty.
Your neck swelling was monitored throughout your hospital stay.
It was likely due the cyst seen on ultrasound. A neck x-ray
showed no change from previous in ___. Your thyroid
stimulatory hormone was normal and a repeat ultrasound was
performed which showed a large right thyroid cyst essentially
unchanged from your previous ultrasound and a left sided complex
thyroid nodule that has concerning features and will likely
require a biopsy. Please follow-up with your endocrinologist as
planned on ___.
We have made no changes to your medications.
Followup Instructions:
___
|
10811920-DS-26
| 10,811,920 | 23,987,965 |
DS
| 26 |
2161-11-12 00:00:00
|
2161-11-13 10:40:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: ___
Allergies:
Aspirin / Penicillins / Toradol
Attending: ___.
Chief Complaint:
Abdominal Pain
Major Surgical or Invasive Procedure:
None
History of Present Illness:
Patient is a ___ year-old female with a history of chronic
abdominal pain of unknown etiology, narcotics dependence/abuse
on a narcotics contract, multiple readmissions for the same
abdominal pain presents with several days of abdominal pain. Of
note, she presented with similar abdominal pain on ___, was
admitted, and discharged on ___. Over the last ___ days, she has
had worsening of abdominal pain associated with nausea/vomiting,
fevers to 100, anorexia, diffuse myalgias, and rigors. Her
previous course was also complicated by a staph epidermis
bacteremia, presumed to be from her port-a-cath, which was
subsequently removed.
In the ED, initial vital signs were 97.9 104 143/95 16 100%.
She was given 2L NS, 4 mg IV dilaudid, zofran, reglan,
prochloperazine, and her normally prescribed fentanyl patch. CT
scan of the abdomen was normal and labs were unremarkable. On
transfer, vitals were HR 100, O2 sat 100, BP129/78, temp 98.0.
Of note, she has had previous hospitalizations ___ to
___ for similar symptoms treated with IV dilaudied; heme/onc
consult at that time did not feel pt had AIP. She was also
hospitalized ___ with abodminal pain with negative
work-up. Suspicion raised for drug-seeking behavior at that
time. She was also hospitalized on ___ with the same
symptoms.
Past Medical History:
1. Self -reported Porphyria- also carries diagnosis of porphyria
that has not been substantiated (see heme/onc note from ___ in ___). Evidence strongly suggests she does not have
porphyria.
2. Irritable bowel syndrome.
3. History of anemia.
4. Endometriosis status post SLAP.
5. Total abdominal hysterectomy and bilateral
salpingo-oophorectomy.
6. Allergic rhinitis.
7. History of abnormal gastric emptying.
8. Bronchitis.
9. Thyroid Cyst
10. GERD
11. Anxiety
12. Opioid abuse and dependence on narcotics Contract - HISTORY
OF DRUG SEEKING ___
Social History:
___
Family History:
Mother with ? porphyria
Physical Exam:
Discharge PE:
Vitals: 98.2 130/84 94 20 100% RA
General: Alert, oriented, no acute distress
HEENT: Sclera anicteric, MMM, oropharynx clear
Neck: supple,
Lungs: Clear to auscultation bilaterally, no wheezes, rales,
ronchi
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,
gallops
Abdomen: soft,non-distended, mildly tender to palpation, bowel
sounds present, no rebound tenderness
Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
Pertinent Results:
ADMISSION LABS:
___ 09:30AM BLOOD WBC-8.6 RBC-3.76* Hgb-9.9* Hct-31.6*
MCV-84 MCH-26.3* MCHC-31.3 RDW-15.1 Plt ___
___ 09:30AM BLOOD Glucose-91 UreaN-15 Creat-1.0# Na-141
K-4.2 Cl-104 HCO3-23 AnGap-18
___ 09:30AM BLOOD ALT-12 AST-19 AlkPhos-113* TotBili-0.3
___ 06:35AM BLOOD Calcium-8.4 Phos-3.0 Mg-1.5*
CT ABD/PELVIS
1. Mildly prominent fluid along the small bowel, but no evidence
for
dilatation, obstruction, or volvulus on this examination.
2. New mild pancreatic ductal dilatation of uncertain
significance
particularly given lack of pancreatic enzyme elevation; it is
possible that the ductal caliber fluctuates; if there are
recurrent or persistent symptoms, follow-up ultrasound could be
considered in the future.
Brief Hospital Course:
___ year-old female with chronic abdominal pain and narcotics
dependence with drug-seeking begavoir presenting with abdominal
pain.
# Abdominal Pain: Patient's abdominal pain similar to her
previous flares. Once she arrived on the floor, we stopped all
IV dilaudid and explained we would only give her the normal dose
of oxycodone ___ q4 PRN) per her narcotics contract with her
PCP (available through ___ records). Her nausea was
controlled with IV zofran PRN and PO hydroxyzine per her home
regimen. Her CT scan of the abdomen was negative for any acute
process, but did show mild pancreatic ductal dilation that may
be reactive. This finding is likely insignficiant, but should
be followed up by her PCP. She was admitted for 1.5 days until
she was able to tolerate full PO. No other pain medications
were given other than those stated in her narcotics contract.
# Drug Seeking Behavoir and Possible Withdrawl: Based on
patient's long history of repeated admissions and history of
receiving opiates from multiple providers around the city, she
has obvious drug seeking tendencies. Her repeated admissions
may be her withdrawing from opiates because she finished her
monthly allotment early. Our suspicions were raised to her PCP
___ letter and email. Patient has an appointment to
see Dr. ___ on ___. The team proposed that there should be
a care plan initiated when the patient presents to the Emergency
room in an attempt to break the patient's cycle of repeated
admissions. (i.e. bringing her pill bottles in with her).
# Anemia: Hct at baseline, which seems to be around 30. No
evidence of acute bleed. Iron studies on last admission showed
iron deficiency anemia; iron was written for, but patient not
taking.
# Anxiety: Continued clonazepam.
.
# History of staph bacteremia: Likely from portacath which has
since been removed. Patient treated with IV vancomycin and
subsequent negative blood cultures. Patient afebrile, and
suspicion for bacteremia was extremely low.
Transitional Issues:
Follow-up of pancreatic ductal findings on CT scan, could
consider endoscopic ultrasound.
Potential initiation of care plan for hospital admission and
narcotics administration.
Medications on Admission:
Preadmission medications listed are correct and complete.
Information was obtained from Atrius.
1. Clonazepam 2 mg PO QHS:PRN sleep
2. OxycoDONE (Immediate Release) ___ mg PO Q4-Q6 H PRN: pain
3. Fentanyl Patch 100 mcg/hr TP Q72H
4. HydrOXYzine 50 mg PO TID:PRN Nausea
5. NexIUM *NF* (esomeprazole magnesium) 40 mg Oral BID
6. fluticasone *NF* 50 mcg/actuation NU QD
7. phenobarb-hyoscy-atropine-scop *NF* 16.2-0.1037 -0.0194 mg
Oral TID
With meals
8. Calcarb 600 With Vitamin D *NF* (calcium carbonate-vitamin
D3) 600 mg(1,500mg) -200 unit Oral QD
9. Ondansetron 4 mg PO QD
Discharge Medications:
1. Clonazepam 2 mg PO QHS:PRN sleep
2. Fentanyl Patch 100 mcg/hr TP Q72H
3. OxycoDONE (Immediate Release) ___ mg PO Q4-Q6 H PRN: pain
4. Calcarb 600 With Vitamin D *NF* (calcium carbonate-vitamin
D3) 600 mg(1,500mg) -200 unit Oral QD
5. fluticasone *NF* 50 mcg/actuation NU QD
6. Ondansetron 4 mg PO QD
7. phenobarb-hyoscy-atropine-scop *NF* 16.2-0.1037 -0.0194 mg
Oral TID
With meals
8. *NF* (esomeprazole magnesium) 40 mg ORAL BID
9. HydrOXYzine 50 mg PO TID:PRN Nausea
Discharge Disposition:
Home
Discharge Diagnosis:
Abdominal Pain
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
You were seen in the hospital because of your chronic abdominal
pain. A CT scan of your abdomen did not show any acute process
and all of your labs were normal.
We made no changes to your medications.
Followup Instructions:
___
|
10811920-DS-28
| 10,811,920 | 25,103,682 |
DS
| 28 |
2162-01-04 00:00:00
|
2162-01-04 20:23:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Aspirin / Penicillins / Toradol
Attending: ___.
Chief Complaint:
Abdominal pain
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ year-old female with history of chronic abdominal pain of
unknown etiology, narcotics dependence/abuse on a narcotics
contract,and multiple readmissions for the same abdominal pain
who presents with worsening abdominal pain, nausea, and
vomiting.
Symptoms began ___ days ago when the pain woke her up in the
middle of the night. Pain is all over her entire abdomen but
worse in the LLQ. Pt reports pain as constant and crampy with a
"tightness." She compares it to past menstrual type pain (she is
post-menopausal). Also reports nonbloody emesis (yellow and
green) and nonbloody diarrhea--5 times a day, started green but
turned black. Per pt, has black diarrhea often. Also reports
subjective fevers (99.9), chills, dizziness, headache.
Denies chest pain, SOB, cough, dysuria, photophobia. She reports
her son and grandson having "cold symptoms" about 1 week ago.
Patient was admitted 1 month ago for this same type of pain and
workup was negative.
In the ED, initial VS were T 98.6, P 78, BP 132/91, RR 16, O2Sat
100%RA. Pain ___. Labs were significant for lipase 172 &
bicarb 18 with anion gap 14. Preliminary read of CT abd/pelvis
showed increasing common bile duct and main pancreatic duct
diameter and new intrahepatic biliary dilatation which per
radiology was sometimes present on prior CT imaging and
sometimes not. Patient was given dilaudid 1mg IV x 4, zofran &
metoclopramide. Vital signs on transfer were T 98.9, P 84, RR
16, BP 113/73, O2Sat 100%RA, Pain: ___.
Past Medical History:
She has had previous hospitalizations ___ to ___ for
similar abd pain symptoms treated with IV dilaudid; heme/onc
consult at that time did not feel pt had AIP. She was also
hospitalized ___ with abdominal pain with negative
work-up. Suspicion raised for drug-seeking behavior at that
time. She was also hospitalized ___,
___, and ___ with the same symptoms.
1. Self-reported porphyria - carries diagnosis of porphyria that
has not been substantiated (see heme/onc note from ___ in
___). Evidence strongly suggests she does not have porphyria.
2. Irritable bowel syndrome.
3. History of anemia.
4. Endometriosis status post SLAP.
5. Total abdominal hysterectomy and bilateral
salpingo-oophorectomy.
6. Allergic rhinitis.
7. History of abnormal gastric emptying.
8. Bronchitis.
9. Thyroid Cyst
10. GERD
11. Anxiety
12. Opioid abuse and dependence on narcotics Contract - HISTORY
OF DRUG SEEKING ___
Social History:
___
Family History:
Mother with ? porphyria.
Physical Exam:
Admission:
VS: 98.3 121/74 79 18 100RA
GEN: A+Ox3, NAD, was laying in bed flat not in acute distress,
discomfort or pain. Reported ___ pain only when asked about
otherwise looked very comfortable
HEENT: NCAT. EOMI. PERRL. MMM. Reported neck tenderness because
of enlarged thyroid and lymph node assessment was limited. no
JVD. neck supple. visible and palpable right thyroid enlargement
CV: RRR, normal S1/S2, no murmurs, rubs or gallops.
LUNG: CTAB, no wheezes, rales or rhonchi
ABD: soft, not distended, no rebound or guarding, reported
tenderness overall the abdomen more prominent at LLQ though when
pressed with same intensity with the stethoscope she did not
report pain and did not grimace, +BS. negative for HSM.
EXT: W/WP, no edema, no C/C. 2+ ___ pulses bilaterally.
SKIN: W/D/I
NEURO: CNs II-XII intact. ___ strength in U/L extremities.
sensation intact to LT. cerebellar fxn intact (FTN, HTS). gait
WNL.
PSYCH: appropriate affect
Discharge:
VS: 98.8 ___ 18 100RA
GEN: A+Ox3, NAD, was laying in bed flat not in acute distress,
discomfort or pain. Reported ___ pain only when asked about
otherwise looked very comfortable
HEENT: NCAT. EOMI. PERRL. MMM. Reported neck tenderness because
of enlarged thyroid and lymph node assessment was limited. no
JVD. neck supple. visible and palpable right thyroid enlargement
CV: RRR, normal S1/S2, no murmurs, rubs or gallops.
LUNG: CTAB, no wheezes, rales or rhonchi
ABD: soft, not distended, no rebound or guarding, reported
tenderness overall the abdomen more prominent at LLQ though when
pressed with same intensity with the stethoscope she did not
report pain and did not grimace, +BS. negative for HSM.
EXT: W/WP, no edema, no C/C. 2+ ___ pulses bilaterally.
SKIN: W/D/I
NEURO: CNs II-XII intact. ___ strength in U/L extremities.
sensation intact to LT. cerebellar fxn intact (FTN, HTS). gait
WNL.
PSYCH: appropriate affect
Pertinent Results:
Admission labs:
===============
___ 01:50AM BLOOD WBC-8.1 RBC-4.71 Hgb-12.3 Hct-39.4 MCV-84
MCH-26.1* MCHC-31.2 RDW-15.6* Plt ___
___ 01:50AM BLOOD Neuts-63.1 ___ Monos-3.4 Eos-3.2
Baso-0.5
___ 01:50AM BLOOD Plt ___
___ 01:50AM BLOOD Glucose-106* UreaN-12 Creat-1.1 Na-138
K-4.1 Cl-106 HCO3-18* AnGap-18
___ 01:50AM BLOOD ALT-7 AST-16 AlkPhos-101 TotBili-0.5
___ 01:50AM BLOOD Lipase-172*
___ 01:50AM BLOOD Albumin-4.6 Calcium-9.5 Phos-3.7 Mg-2.0
Discharge labs:
===============
___ 05:45AM BLOOD WBC-7.8 RBC-3.86* Hgb-10.1* Hct-32.4*
MCV-84 MCH-26.2* MCHC-31.2 RDW-15.6* Plt ___
___ 01:50AM BLOOD Neuts-63.1 ___ Monos-3.4 Eos-3.2
Baso-0.5
___ 05:45AM BLOOD Glucose-73 UreaN-9 Creat-1.0 Na-140 K-4.2
Cl-107 HCO3-24 AnGap-13
___ 01:50AM BLOOD ALT-7 AST-16 AlkPhos-101 TotBili-0.5
___ 01:50AM BLOOD Lipase-172*
___ 05:45AM BLOOD Calcium-8.5 Phos-3.7 Mg-1.6
Imaging:
========
IMPRESSION:
1. Increasing mild common bile duct and main pancreatic duct
dilation. Note is made of normal LFTs and mild lipase
elevation. Given the that the CBD has waxed and waned over the
past few CTs from this year and the pancreatic duct has
increased, potential etiologies include intermittently
obstructing stone, papillary stenosis, or sphincter of Oddi
dysfunction. An MRCP should be performed soon if acute symptoms
persist. If symptoms are intermittent, consider a non-emergent
MRCP with secretin.
2. RLQ fluid mentioned on preliminary report is likely within
the cecal tip.
3. Moderate to severe multilevel lumbar spine disc herniations
and canal
stenosis.
Brief Hospital Course:
___ year-old female with history of chronic abdominal pain and
narcotics dependence presenting with abdominal pain and
nausea/vomiting, similar to prior episodes, dramatically
improved overnight with dramatic improvement in oral intake.
# Abdominal Pain/Nausea: Unclear etiology but does not appear to
have acute pathology as CT abd/pelvis is without appendicitis,
colitis, diverticulitis. Given symptoms, elevated lipase and CT
findings, most concerning for possible pancreatitis. Due to
diffuse nature of abdominal pain and particularly LLW and how it
can often represent severe and potentially life-threatening
disease, we considered mesenteric ischemia and infarction,
ruptured abdominal aortic aneurysm, diffuse peritonitis, and
intestion obstruction. However, due to her presentation, labs,
and imaging, we were not concerned about these pathologies
except mesenteric ischemic/infarction which is discussed below.
Also, because she is a woman, we considered OB/GYN pathologies
however, pt is s/p hysterectomy and bilateral
salpingo-oophorectomy so unlikely. Given her nausea, vomiting,
and report of loose stools, viral gastroenteritis is possible.
Cannaboid hyperemesis syndrome is also possible, though patient
reports only using marijuana every week and not at heavy doses.
Cocaine induced abdominal vasospasm is another consideration,
though unclear when she last used cocaine per patient and Utox
in ___. Overall, her abdominal pain similar to her previous
flares. For the pain, she was on oxycodone ___ q4 PRN) per
her narcotics contract with her PCP (available through Atrius
records). For nausea, she was on zofran and PO hydroxyzine per
her home regimen. Of note, a prior CT scan has shown mild
pancreatic ductal dilation that may be reactive which is also
seen on this admission's CT. Per radiology, this is sometimes
seen and sometimes not. Consider MRCP with secretin as
outpatient since symptoms are intermittent (please see results
section)
# Elevated Lipase: Elevated lipase to 172. This is new and in
prior admissions for similar presentations (abdominal pain), it
has been low in the ___ and ___. First thought was toward
pancreatitis especially w/ mild pancreatic ductal dilation,
unsure if new however per radiology this has been find
intermittently on prior CT's. Her signs and symptoms did not fit
the classical picture of pancreatitis however Of note, older
studies have shown that CTs can miss acute pancreatitis up to
30% of the time. That being said, etiology is unclear. Lipase
can be elevated for a large number of reasons other than
pancreatitis. About 12% percent of patients admitted to the
hospital with non-pancreatic abdominal pain have an elevated
serum lipase. Other conditions associated with an elevated
lipase include renal failure, acute cholecystitis, bowel
obstruction or infarction, duodenal ulceration, pancreatic
tumor, DKA, HIV, macrolipasemia, celiac, trauma, idiopathic,
drugs. Her Cr is slightly up but likely secondary to volume
depletion. As above, bowel obstruction/infarction possible but
unlikely.
# Drug seeing behavior: During prior admission, question was
raised as to whether her repeated admissions may be her
withdrawing from opiates. She has a narcotic contract in Atrius
records. During admission, we avoided IV opioids as much as
possible (was given in the ED, none while on the medical floor
as she received only the opioid medications per her narcotic
contract while on the floor).
# Reported seizure: Patient reported seizure about 6 weeks prior
to admission. Reportedly witnessed by boyfriend and son and
being found "lying on the floor" wetting herself with minimal
tongue bite along with jerky body movements which lasted about
___ minutes. No recall of event. On exam, she has a non-focal
neuro exam and was neurologically stable throughout her hospital
stay. We continued her home anti-seizure medication as
inpatient.
# Neck fullness: Has an anterolateral neck nodule. Most likely
thyroid given movement with swallowing and lcoation. Patient
reports she is being evaluated by endocrinology. She reports
that she will have a biopsy done on ___.
Transitional issues:
- She was not provided with any narcotics on discharge
- F/U right anterolateral neck nodule work up
- If abd pain persists please order a MRCP with secretin test
Medications on Admission:
1. clonazepam 1 mg Tablet Sig: Two (2) Tablet PO QHS (once a day
(at bedtime)) as needed for sleep.
2. fentanyl 100 mcg/hr Patch 72 hr Sig: One (1) Transdermal
every ___ (72) hours.
3. oxycodone 10 mg Tablet Sig: ___ Tablets PO every ___ hours as
needed for pain: please do not drive or operate heavy machinery
while taking this medication; avoid alcohol.
4. fluticasone 50 mcg/actuation Spray, Suspension Sig: One (1)
Nasal once a day.
5. Zofran 4 mg Tablet Sig: One (1) Tablet PO once a day.
6. esomeprazole magnesium 40 mg Capsule, Delayed Release(E.C.)
Sig: One (1) Capsule, Delayed Release(E.C.) PO twice a day.
7. hydroxyzine HCl 50 mg Tablet Sig: One (1) Tablet PO three
times a day as needed for nausea.
8. Calcarb 600 With Vitamin D 600 mg(1,500mg) -200 unit Tablet
Sig: One (1) Tablet PO once a day.
9. phenobarb-hyoscy-atropine-scop 16.2-0.1037 -0.0194 mg Tablet
Sig: One (1) Tablet PO three times a day as needed for pain:
with meals.
10. levetiracetam 500 mg Tablet Sig: One (1) Tablet PO BID (2
times a day).
Discharge Medications:
1. Clonazepam ___ mg PO QHS:PRN insomnia or anxiety
2. Fentanyl Patch 100 mcg/hr TP Q72H
hold for sedation
3. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain
please hold if sedated or RR < 10
4. Fluticasone Propionate NASAL 1 SPRY NU DAILY
5. Ondansetron 4 mg PO DAILY:PRN nausea/vomiting
6. esomeprazole magnesium *NF* 40 mg Oral twice a day
7. HydrOXYzine 50 mg PO TID:PRN nausea
8. Calcarb 600 With Vitamin D *NF* (calcium carbonate-vitamin
D3) 600 mg(1,500mg) -200 unit Oral once daily
9. phenobarb-hyoscy-atropine-scop *NF* 16.2-0.1037 -0.0194 mg
Oral three times a day pain: with meals
10. LeVETiracetam 500 mg PO BID
Discharge Disposition:
Home
Discharge Diagnosis:
Primary diagnoses:
abdominal pain
Reported Seizure
Thyromegaly
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Ms. ___,
It was a great pleasure taking care of you. As you know you were
admitted for abdominal pain, nausea and vomiting. This was
managed by pain control based on your narcotic contract in
addition to IV anti-emetics that were transitioned to your oral
regimen. You also received IV fluids.
We did not make changes in your medication list. Please continue
taking them the way you were taking prior to admission.
Please follow with your appointment as illustrated below with
your primary care physician ___ ___.
Please make sure to follow-up regarding neck swelling with your
doctor as well.
Followup Instructions:
___
|
10812035-DS-5
| 10,812,035 | 23,931,867 |
DS
| 5 |
2159-07-07 00:00:00
|
2159-07-08 22:24:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
adhesive tape / Shellfish / fish / Vancomycin / Penicillins
Attending: ___.
Chief Complaint:
abdominal pain
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ w/Crohn's presents with abdominal pain. Pt reports that she
has been having abd pain and diarrhea for 1 month. She was seen
in GI clinic ___ and prescribed Humiria but her insurance has
not approved it yet. Her pain increased over the last week. Pain
is now constant located over her entire abdomen, worse in
epigastric and RLQ. She also has loose stool with small amounts
of blood in it, although this has been attributed to internal
hemorrhoids recently seen on sigmoidoscopy on ___.
Sigmoidoscopy was c/w mildly active colitis, with path showing
cryptitis, but no granulomas.
.
In ED pt given morphine and zofran. CT scan showed inflammation,
unchanged from prior.
On arrival to floor pt reports epigastric and RLQ pain. She was
concerned that pain was not just related to food, but constant.
And epigastric pain is similar to when she developed severe
gastritis and ulcers from steroids. She attempted to increased
PPI to BID with only short term relief. No nausea currently.
Last antibiotic course was approximately 1 month ago with a 2
week course of PO Bactrim for hidradenitis.
.
She inquires about being discharged to home today if it is safe.
It is her ___ year anniversary today, and she would like to spend
it with her husband outside of the hospital. She also reports
that she is concerned that we will need to start steroids, as
she has had significant side effects in the past, with severe
weight gain and steroid psychosis.
.
ROS: +as above, otherwise reviewed and negative
Past Medical History:
Crohn's Disease dx ___
Ankylosing Spondylitis
Fibromylagia
Social History:
___
Family History:
no history of IBD
Physical Exam:
Admit Exam:
Vitals: T:98.9 BP:121/77 P:88 R:18 O2:98%ra
PAIN: 5
General: nad
Lungs: clear
CV: rrr no m/r/g
Abdomen: bowel sounds present, soft, tender epigastrium and RLQ
Ext: no e/c/c
Skin: no rash
Neuro: alert, follows commands
.
Discharge Exam:
Similar to above, without major change, except pain improved
with PO pain control. Rated ___.
Otherwise AVSS and benign abd exam with mild TTP as above.
.
Pertinent Results:
Recent Imaging
=====================
CT Abd/Pelvis ___
IMPRESSION:
1. Wall thickening and surrounding inflammatory changes
involving the terminal ileum and cecum. increased since the
prior study, with prominence of adjacent lymph nodes, suggesting
acute Crohn's flair. Mucosal enhancement can not be assessed
given lack of IV contrast. No drainable collection seen at this
time. No free air.
.
.
PA/lat CXR ___
FINDINGS: Frontal and lateral views of the chest were obtained.
There is minimal right basilar atelectasis without frank focal
consolidation. No pleural effusion or pneumothorax is seen.
There is continued slight prominence of the interstitial
markings, stable since the prior study, most likely chronic.
Cardiac and mediastinal silhouettes are stable. The hilar
contours are stable.
IMPRESSION: No acute cardiopulmonary process.
.
.
Flex Sig ___
Impression:
Grade 1 internal hemorrhoids
Petechiae and erythema in the rectum, sigmoid colon and distal
descending colon compatible with mild inflamatory bowel disease
(biopsy)
Otherwise normal sigmoidoscopy to splenic flexure
.
Biopsy Pathology ___
Focal active cryptitis. No well developed changes of chronic
colitis are seen. The differential diagnosis includes
infection, drug effect, early inflammatory bowel disease, etc.
No granulomas seen. Clinical correlation is needed.
.
.
Admission Bloodwork:
=====================
___ 03:25PM BLOOD WBC-15.8* RBC-4.16* Hgb-12.1 Hct-38.3
MCV-92 MCH-29.2 MCHC-31.7 RDW-13.1 Plt ___
___ 03:25PM BLOOD Neuts-77.7* Lymphs-17.5* Monos-2.7
Eos-1.3 Baso-0.8
___ 03:25PM BLOOD Glucose-87 UreaN-7 Creat-0.6 Na-140 K-4.1
Cl-104 HCO3-24 AnGap-16
___ 03:25PM BLOOD ALT-17 AST-16 AlkPhos-81 TotBili-0.3
___ 03:25PM BLOOD Albumin-3.8
___ 03:25PM BLOOD Lipase-31
___ 03:25PM BLOOD CRP-85.6*
___ 03:25PM BLOOD ESR-49*
.
Discharge Bloodwork
=====================
___ 06:25AM BLOOD WBC-12.7* RBC-3.66* Hgb-10.7* Hct-33.7*
MCV-92 MCH-29.3 MCHC-31.9 RDW-13.2 Plt ___
___ 06:25AM BLOOD Glucose-89 UreaN-5* Creat-0.6 Na-139
K-3.9 Cl-108 HCO3-24 AnGap-11
.
Urine Studies
=====================
___ 03:30PM URINE Color-Yellow Appear-Hazy Sp ___
___ 03:30PM URINE Blood-NEG Nitrite-NEG Protein-30
Glucose-NEG Ketone-10 Bilirub-NEG Urobiln-2* pH-6.0 Leuks-NEG
___ 03:30PM URINE RBC-3* WBC-2 Bacteri-FEW Yeast-NONE Epi-3
___ 03:30PM URINE UCG-NEGATIVE
.
Brief Hospital Course:
___ w/Crohn's presents with abdominal pain concerning for
Crohn's flare.
.
ACTIVE ISSUES:
======================
# Abdominal pain: Pt had noted worsening upper abdominal pain
and had doubled her home PPI dose under instruction by her outpt
GI physician. However, her pain then continued to worsen.
Although she does not have evidence of upper GIB by sx's or lab
values, her symptoms warrant an EGD. She was seen by GI
consult, and they recommended expedited outpt EGD, increased PPI
to high-dose BID, and PO PRN opiates for pain control.
.
# Crohn's Disease: Although pt presents with worsening abdominal
pain, the location of the pain is more c/w upper abdomen, and
possibly unrelated to her Crohn's disease. She has recent
sigmoidoscopy (___) with biopsy, confirming active colitis.
She has leukocytosis. She also has elevated ESR and CRP vs
baseline, and her CT scan is c/w active Crohn's inflammation.
However, she does not endorse worsening diarrhea, bloody stools,
cramping lower abdominal pain, or fevers/chills. Her elevated
ESR/CRP may also be explained by exacerbation of her other
autoimmune diseases. As such, while she may certainly be having
active Crohn's flare, it may not be worsening. She is on
mesalamine as outpatient and is awaiting Humira approval. She
does not want to be on systemic steroids due to previous side
effects. She was seen by GI consult, and they recommended
continuing mesalamine, adding 2 weeks of Cipro/Flagyl, and to
obtain Humira ASAP. PACT Pharmacist was able to assist in
obtaining more information re: Humira script, and prior
authorization will be obtained by outpt GI office.
.
.
CHRONIC ISSUES:
=====================
# Fibromyalgia: continued home meds
.
.
TRANSITIONAL ISSUES:
=====================
1. trial of high dose PPI and outpt EGD to w/u abdominal pain
2. awaiting prior authorization approval of Humira. Outpt GI
Dr. ___ to complete.
3. complete 2 weeks of antibiotics
4. PENDING STUDIES AT TIME OF DISCHARGE: NONE
.
.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Mesalamine ___ 4800 mg PO DAILY
2. clindamycin phosphate 1 % topical BID
3. Diphenoxylate-Atropine 2 TAB PO Q6H:PRN diarrhea
4. Cyanocobalamin 1000 mcg IM/SC Q1MO
5. Apri (desogestrel-ethinyl estradiol) 0.15-30 mg-mcg oral
daily
6. Diazepam 10 mg PO HS:PRN restless legs
7. Omeprazole 20 mg PO BID
8. Cyclobenzaprine 10 mg PO HS:PRN muscle spasms
Discharge Medications:
1. Cyclobenzaprine 10 mg PO HS:PRN muscle spasms
2. Diazepam 10 mg PO HS:PRN restless legs
3. Diphenoxylate-Atropine 2 TAB PO Q6H:PRN diarrhea
4. Mesalamine ___ 4800 mg PO DAILY
5. Apri (desogestrel-ethinyl estradiol) 0.15-30 mg-mcg oral
daily
6. clindamycin phosphate 1 % topical BID
7. Cyanocobalamin 1000 mcg IM/SC Q1MO
8. Diazepam ___ mg PO PRN per psychiatrist
9. EpiPen (EPINEPHrine) 0.3 mg/0.3 mL (1:1,000) injection PRN
allergic reaction
10. Ranitidine 75 mg PO PRN heartburn
11. Omeprazole 40 mg PO BID
RX *omeprazole 40 mg 1 capsule,delayed ___ by
mouth twice daily Disp #*60 Capsule Refills:*0
12. Ciprofloxacin HCl 500 mg PO Q12H Duration: 2 Weeks
RX *ciprofloxacin 500 mg 1 tablet(s) by mouth every 12 hours
Disp #*28 Tablet Refills:*0
13. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H Duration: 2 Weeks
RX *metronidazole 500 mg 1 tablet(s) by mouth every 8 hours Disp
#*42 Tablet Refills:*0
14. HYDROmorphone (Dilaudid) 2 mg PO Q6H:PRN pain
RX *hydromorphone 2 mg 1 tablet(s) by mouth every 6 hours Disp
#*40 Tablet Refills:*0
15. Ondansetron 4 mg PO Q8H:PRN nausea
RX *ondansetron HCl 4 mg 1 tablet(s) by mouth every 8 hours Disp
#*42 Tablet Refills:*0
Discharge Disposition:
Home
Discharge Diagnosis:
abdominal pain
Crohn's Disease
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
You were admitted to the hospital with abdominal pain. Your CT
scan did show signs concerning for acute Crohn's flare. ___
d/w the GI consult service, you were felt to be stable for
discharge to home. Some medication adjustments were made. You
will need an outpatient EGD (upper endoscopy) which Dr. ___
___ will schedule for you.
.
Please take your medications as listed.
.
Please see your physicians as listed.
.
Followup Instructions:
___
|
10812219-DS-12
| 10,812,219 | 29,229,484 |
DS
| 12 |
2115-01-20 00:00:00
|
2115-01-21 20:20:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
codeine
Attending: ___.
Chief Complaint:
Fever
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ with hx of acquired TTP with severe ADAMTS13 deficiency,
recent MICU course s/p pheresis (last session ___, low dose
Rituximab therapy (final dose ___, on steroid taper, who is
presenting with fevers (as high as 104 with home oral
thermometer), headache, myalgias, nausea, and a "red jelly"
diarrhea for 2 days. All symptoms started with a headache. This
morning she also noted left sided groin pain, and had a very
dark
soft stool. She has a new cough for one day which is
non-productive, described as a tickle in her throat. She also
reports night sweats for about a month which she attributes to
her steroids. She denies urinary symptoms. She also endorses
memory issues since her hospitalization last month, as well as
some visual hallucinations (spiders crawling), which she thinks
are all due to steroids. She denies vomiting. She states that
four people at work have called out sick in the past week for
similar symptoms.
She was discharged on ___ after seizure induced by TTP, she
required pRBC transfusion and exchange pheresis, no head bleed
at
that time. Last dose Rituximab on ___, last pheresis ___. She
has been on steroids since her ___ admission, and is currently
tapering at 30mg prednisone daily.
In the ED, initial VS were 102.5, 115, 115/59, 20, 98% RA
Exam notable for
Tachycardia, regular rhythm, rate 110. CTAB. Diffuse tenderness
to abdominal palpation, worse in suprapubic and RUQ, no
peritoneal signs. Tender to both groins bilaterally without
masses, erythema or drainage.
Labs showed WBC 8.6, Hb 12.7, Plt 237, K 4.2 Cr. 0.8. lactate
1.8, UA trace leuk, neg nitrites, 1WBC, tr bld w/ 2RBC
Imaging showed
Liver Or Gallbladder Us
1. Echogenic liver consistent with steatosis. Other forms of
liver disease
including steatohepatitis, hepatic fibrosis, or cirrhosis cannot
be excluded
on the basis of this examination.
2. No cholelithiasis.
CXR PA/LAT
No acute cardiopulmonary abnormality
Received Vanc IV, cefepime 2gm IV, Zofran 4mg IV, Tylenol IV
1000mg, NS 1L bolus
Patient's oncologist (Dr. ___ was contacted, no signs of TTP
per labs or reason for OMED/BMT service, likely viral infection,
but wants to cover with IV antibiotics and admit to medicine
while awaiting blood culture results.
Transfer VS were 98.3, 99, 110/70, 20, 98% RA
On arrival to the floor, patient reports minimal improvement in
her symptoms. Says her Tylenol is wearing off and feels like she
has a fever again. Other notable HPI/ROS discussed above.
Past Medical History:
PAST MEDICAL HISTORY:
- TTP (treated in ___ in ___ -- plasmapheresis for
several months
- HTN
- Left leg surgery
Social History:
___
Family History:
Unknown
Physical Exam:
ADMISSION PHYSICAL
=================
VS: 102.6, 91/60, 109, 18, 99 Ra
GENERAL: NAD
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva,
MMM
NECK: supple, no LAD, no JVD
HEART: Tachycardic, S1/S2, no murmurs, gallops, or rubs
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably
without use of accessory muscles
ABDOMEN: nondistended, tender in all quadrants, moreso in LLQ,
no rebound/guarding, no hepatosplenomegaly. Groin tender
bilaterally, no notable lymphadenopathy. Mild tenderness to
percussion of CVA bilaterally.
EXTREMITIES: no cyanosis, clubbing, or edema
PULSES: 2+ DP pulses bilaterally
NEURO: A&Ox3, CN II-XII intact, moving all 4 extremities with
purpose
SKIN: warm and well perfused, no excoriations or lesions, no
rashes
Rectal: Chaperoned by RN. No hemorrhoids, minimal stool in
rectal vault, no blood.
DISCHARGE PHYSICAL
================
VITALS: 97.5 94 / 60 78 18 98 ra
GENERAL: well developed female resting in bed. NAD.
HEENT: normocephalic atraumatic. PERRL. Sclera anicteric. No
cervical LAD.
CV: RRR. Normal S1 and S2. No MGR.
RESP: nonlabored respirations. no adventitious sounds.
GI: soft, nondistended, nontender to palpation
MSK: moving all four extremities spontaneously, no lower
extremity edema
SKIN: no rashes
Pertinent Results:
ADMISSION LABS:
==============
___ 10:42AM BLOOD WBC-8.6 RBC-3.90 Hgb-12.7 Hct-38.3 MCV-98
MCH-32.6* MCHC-33.2 RDW-13.2 RDWSD-47.3* Plt ___
___ 10:42AM BLOOD Neuts-77.1* Lymphs-9.8* Monos-8.1 Eos-3.5
Baso-0.6 Im ___ AbsNeut-6.62* AbsLymp-0.84* AbsMono-0.70
AbsEos-0.30 AbsBaso-0.05
___ 01:01AM BLOOD Hypochr-1+* Anisocy-1+* Poiklo-NORMAL
Macrocy-1+* Microcy-NORMAL Polychr-NORMAL
___ 01:01AM BLOOD Ret Aut-1.4 Abs Ret-0.05
___ 10:42AM BLOOD Glucose-89 UreaN-12 Creat-0.8 Na-137
K-5.5* Cl-96 HCO3-23 AnGap-18*
___ 01:01AM BLOOD ALT-350* AST-297* LD(___)-490*
AlkPhos-202* DirBili-0.8*
___ 10:42AM BLOOD Calcium-8.6 Phos-4.2 Mg-2.1
___ 01:01AM BLOOD Hapto-235*
___ 10:49AM BLOOD Lactate-1.8 K-4.2
PERTINENT LABS:
==============
___ 10:42AM BLOOD ALT-224* AST-302* LD(___)-1019*
AlkPhos-119* TotBili-0.8
___ 08:00AM BLOOD ALT-340* AST-193* LD(___)-425*
AlkPhos-214* TotBili-2.3*
___ 07:58AM BLOOD ALT-257* AST-109* LD(___)-297*
AlkPhos-211* TotBili-2.0*
___ 03:15PM BLOOD ALT-269* AST-107* LD(___)-240
AlkPhos-206* TotBili-1.1
___ 10:42AM BLOOD Hapto-218*
DISCHARGE LABS:
==============
___ 07:40AM BLOOD WBC-9.8 RBC-4.15 Hgb-13.4 Hct-41.3
MCV-100* MCH-32.3* MCHC-32.4 RDW-13.1 RDWSD-48.1* Plt ___
___ 07:40AM BLOOD Glucose-77 UreaN-11 Creat-0.5 Na-143
K-4.5 Cl-103 HCO3-23 AnGap-17*
___ 07:40AM BLOOD ALT-212* AST-51* LD(___)-244 AlkPhos-214*
TotBili-0.5
___ 07:40AM BLOOD Calcium-9.3 Phos-4.4 Mg-2.3
MICROBIOLOGY:
==============
Time Taken Not Noted Log-In Date/Time: ___ 10:57 pm
URINE
**FINAL REPORT ___
Legionella Urinary Antigen (Final ___:
NEGATIVE FOR LEGIONELLA SEROGROUP 1 ANTIGEN.
(Reference Range-Negative).
Performed by Immunochromogenic assay.
A negative result does not rule out infection due to other
L.
pneumophila serogroups or other Legionella species.
Furthermore, in
infected patients the excretion of antigen in urine may
vary.
___ 10:50 am BLOOD CULTURE SET#2.
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
___ 10:42 am BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
___ 10:29 am URINE
**FINAL REPORT ___
URINE CULTURE (Final ___:
MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT
WITH SKIN
AND/OR GENITAL CONTAMINATION.
IMAGING/STUDIES:
==============
___
RUQUS
IMPRESSION:
1. Echogenic liver consistent with steatosis. Other forms of
liver disease
including steatohepatitis, hepatic fibrosis, or cirrhosis cannot
be excluded
on the basis of this examination.
2. No cholelithiasis.
___
CXR
IMPRESSION:
No acute cardiopulmonary abnormality.
Brief Hospital Course:
Patient summary statement for admission
___ year old female with past medical history of acquired TTP
severe ADAMTS13 deficiency, recent admission ___ with TTP
flare requiring pheresis, Rituximab and steroids, admitted
___ with diarrhea and fever of unclear etiology, workup
negative for cause, off antibiotics and afebrile for 72 hours,
able to be discharged home
# Sepsis secondary viral enteritis NOS
# Diarrhea
Patient presented with 2 days of fever, myalgias, diarrhea and
was found to be tachycardic and hypotensive in the emergency
department. Given her immunosuppressed state she was felt to
be at high risk for serious infection and was started on
empiric antibiotics for infection of unknown source and volume
resuscitated. Given diarrhea and recent sick contacts at work,
there was suspicion for a viral enteritis. Remainder of workup
including chest xray and RUQ ultrasound were negative for acute
processes. Urine culture was negative and blood cultures
remained without growth. She had one episode of nausea and
vomiting after admission, but otherwise had a rapid return to
her baseline health. Antibiotics were discontinued and patient
remained stable and without issue. At time of discharge
infectious stool studies were pending.
# Elevated LFTs
# Hepatic Steatosis
Patient with previously noted LFTs that were attributed to drug
effect from keppra, who was admitted with elevated LFTs
including AST, ALT, alk phos and tbili, all elevated from
recent baseline. RUQ ultrasound was only notable for echogenic
liver consistant with steatosis but unable to exclude
steatohepatitis, hepatofibrosis, or cirrhosis. LFTs rapidly
improved with her clinical condition and were felt to have
related to her acute illness / viral enteritis, with underlying
chronic abnormal liver parenchyma secondary to likely
steatosis. At discharge ALT 212 AST 51, AP 214 Tbili 0.5.
Would consider rechecking LFTs to ensure normalization as an
outpatient. If remain at recent baseline (elevated from
normal) would consider additional workup and/or referral to a
hepatologist given ultrasound abnormalities described above
that were unable to exclude a more serious chronic process.
# TTP
# Chronic steroids
Patient with history of TTP with recent admission and ICU stay
in ___ for recurrent TTP episode that required pheresis,
rituximab and prednisone. She had been prednisone 30mg prior
to admission. Hospital course was notable for patient
reporting that secondary to steroid side effects (anxiety,
hallucinations) she planned to "stop all steroids immediately"
after discharge. Per discussion with Dr. ___
managing her TTP as outpatient) we proposed a taper to the
patient as a less risky alternative (although one that still
carried risks of TTP recurrence). Patient was able to verbalize
understanding of risks, including TTP and death, and agreed to
a taper--team tapered her dose to 20mg on ___, to take until
___, then 10mg ___ and ___, then can stop. Platelets
remained stable. Admission otherwise notable for initiation of
PCP ppx with ___ given her prolonged steroid course, which
was stopped when above taper plan was devised. Patient
discharged with close PCP and hematology ___.
Would recheck CBC at ___ to ensure stability--patient is
high risk for complications.
# Hallucinations and Insomnia
During recent admission, patient ahd been started on zyprexa
for these symptoms, which were thought to relate to prednisone
side effects. Given plan to taper and stop steroids as
outpatient, would ___ with patient after taper to
discontinue zyprexa.
#HTN
Patient endorsed not taking Hctz since her discharge last
month. Held this admission and blood pressures remained
appropriate. Can reassess restarting at ___.
# ADD
Held Adderall during admission.
TRANSITIONAL ISSUES
[] Prednisone taper: 10mg ___, then stop
[] F/u CBC, LFTs within 1 week after discharge
Code Status: Full
___ (Mother) ___
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. PredniSONE 30 mg PO DAILY
2. OLANZapine 5 mg PO DAILY
3. Glucosamine (glucosamine sulfate) 500 mg oral DAILY
4. FoLIC Acid 5 mg PO DAILY
5. cranberry 400 mg oral DAILY
6. garlic extract ___ mg oral DAILY
7. Hydrochlorothiazide 25 mg PO DAILY
8. Amphetamine-Dextroamphetamine XR 20 mg PO DAILY
Discharge Medications:
1. PredniSONE 10 mg PO ONCE Duration: 1 Dose
2. cranberry 400 mg oral DAILY
3. FoLIC Acid 5 mg PO DAILY
4. garlic extract ___ mg oral DAILY
5. Glucosamine (glucosamine sulfate) 500 mg oral DAILY
6. OLANZapine 5 mg PO DAILY
7. HELD- Amphetamine-Dextroamphetamine XR 20 mg PO DAILY This
medication was held. Do not restart
Amphetamine-Dextroamphetamine XR until you see your PCP
8. HELD- Hydrochlorothiazide 25 mg PO DAILY This medication was
held because your blood pressure was low. Do not restart
Hydrochlorothiazide until you see your PCP
___:
Home
Discharge Diagnosis:
# Sepsis secondary viral enteritis NOS
# Diarrhea
# TTP
# Chronic steroids
# Elevated LFTs
# Hepatic Steatosis
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Ms. ___,
It was a pleasure to take care of you at ___.
WHY WAS I HERE?
You were admitted to the hospital because you had a fever and
you are taking medications that suppress your immune system.
WHAT WAS DONE WHILE YOU WERE IN THE HOSPITAL
- You were treated with antibiotics.
- Blood cultures and urine cultures were drawn and showed no
signs of a bacterial infection. We think you likely had a viral
infection that got better on its own.
- Your blood pressure was low when you presented and you were
given fluids through your IV.
- Your prednisone dose was weaned.
WHAT SHOULD I DO WHEN I GET HOME?
1) Follow up with your Primary Care Doctor.
2) Follow up with a Hematologist (Blood Doctor)
3) Take your medications as prescribed.
4) Your last dose of prednisone is tomorrow. Please take 10mg
once tomorrow, then follow up with your doctors.
We wish you the best!
Your ___ Care Team
Followup Instructions:
___
|
10812396-DS-4
| 10,812,396 | 25,312,759 |
DS
| 4 |
2173-10-06 00:00:00
|
2173-10-07 11:02:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
lisinopril
Attending: ___.
Chief Complaint:
Sore throat, hoarse voice
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ history of daily alcohol use, HTN who presents with two
weeks of sore throat and hoarse voice.
He has been experiencing a change in his voice ("lost his
voice") for approximately two weeks. He acutely presented after
having an episode of choking when laying flat.
In terms of his bowel movements, he does have a history of
hemorrhoids but in past has only had blood on toilet paper. Had
two episodes of BRBPR with significant amount (~200cc) of blood
in toilet bowel, first time this has happened. Has been having
diarrhea x ___ weeks.
In the ED, initial vitals were:
98.9 116 150/90 18 96% RA
- Exam notable for: Lungs CTAB, heart RRR, no throat pain, white
coating on the tongue.
- Labs notable for: Stable Hb/Hct at 15.4/43.5. K initially low
and then repleted.
- Imaging was notable for: none
- Consults: ENT consulted, thought bacterial vs fungal
pharyngitis, recommended fluconazole and levofloxacin x 14 days
with PPI. GI curbsided, no plans to scope at this point.
- Events: patient had two episodes of BRBPR, stable Hb/Hct,
tachycardic to 160s with ambulation.
- Patient was given: IV thiamine, LR, potassium/magnesium
repletion, diazepam for CIWA, fluconazole 200mg per ENT recs,
levofloxacin 750mg.
Upon arrival to the floor, patient reports that his two main
complaints are:
- Change in voice, hoarse voice that occurred abruptly ~13 days
ago associated with minor soreness of throat.
- Bloody bowel movements. Has a history of hemorrhoids but in
past only had blood on toilet paper; significantly more blood on
this occasion.
- He also notes that for weeks he has been having night sweats,
where he wakes up with varying degrees of sweat soaking in his
shirt in the AM.
Otherwise has intermittent chills, denies fevers, nausea,
vomiting, shortness of breath, chest pain.
Past Medical History:
- Hypertension
- Alcohol use disorder
Social History:
___
Family History:
Mother has DM, father has HTN.
Physical Exam:
ADMISSION EXAM:
Vitals: 98.5 156 / 84 92 18 98 RA
General: alert, oriented, no acute distress
HEENT: sclera anicteric, MMs slightly dry. Large amount of white
plaque covering the tongue and in the oropharynx.
Neck: supple, JVP not elevated, no LAD
Lungs: clear to auscultation bilaterally, no wheezes, rales,
ronchi
CV: regular rate and rhythm, normal S1 + S2, no murmurs, rubs,
gallops
Abdomen: soft, non-tender, non-distended, bowel sounds present,
no rebound tenderness or guarding, no organomegaly
GU: no foley
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
DISCHARGE EXAM:
98.2 PO 148 / 82 83 20 98 ra
General: alert, oriented, no acute distress
HEENT: sclera anicteric, MMs slightly dry. Large amount of
white plaque covering the tongue and in the oropharynx.
Neck: supple, no LAD
Lungs: clear to auscultation bilaterally, no wheezes, rales,
ronchi
CV: regular rate and rhythm, normal S1 + S2, no murmurs, rubs,
gallops
Abdomen: soft, non-tender, non-distended, no rebound tenderness
or guarding, no organomegaly
GU: no foley
Ext: warm, well perfused, no edema
Pertinent Results:
================
ADMISSION LABS
================
___ 09:27PM BLOOD WBC-8.8 RBC-4.58* Hgb-15.5 Hct-44.3
MCV-97 MCH-33.8* MCHC-35.0 RDW-13.0 RDWSD-46.6* Plt ___
___ 09:27PM BLOOD Neuts-72.8* Lymphs-14.9* Monos-10.6
Eos-0.5* Baso-0.7 Im ___ AbsNeut-6.39* AbsLymp-1.31
AbsMono-0.93* AbsEos-0.04 AbsBaso-0.06
___ 09:27PM BLOOD Plt ___
___ 07:55AM BLOOD ___ PTT-27.4 ___
___ 09:27PM BLOOD Glucose-126* UreaN-10 Creat-0.7 Na-138
K-3.0* Cl-96 HCO3-24 AnGap-21*
___ 03:20PM BLOOD ALT-88* AST-155* AlkPhos-115 TotBili-1.7*
DirBili-PND
___ 09:27PM BLOOD Mg-1.8
=================
DISCHARGE LABS
=================
___ 06:50AM BLOOD WBC-6.8 RBC-4.47* Hgb-15.5 Hct-43.7
MCV-98 MCH-34.7* MCHC-35.5 RDW-12.5 RDWSD-45.3 Plt ___
___ 07:55AM BLOOD Neuts-68.1 ___ Monos-10.2
Eos-0.9* Baso-0.6 NRBC-0.2* Im ___ AbsNeut-5.49
AbsLymp-1.55 AbsMono-0.82* AbsEos-0.07 AbsBaso-0.05
___ 06:50AM BLOOD Plt ___
___ 07:55AM BLOOD ___ PTT-27.4 ___
___ 06:50AM BLOOD Glucose-87 UreaN-10 Creat-0.6 Na-136
K-3.8 Cl-96 HCO3-25 AnGap-19
___ 06:50AM BLOOD ALT-73* AST-87* AlkPhos-110 TotBili-1.4
==================
IMAGING
==================
RUQ Ultrasound ___: Echogenic liver consistent with
steatosis. Other forms of liver disease including
steatohepatitis, hepatic fibrosis, or cirrhosis cannot be
excluded on the basis of this examination.
Brief Hospital Course:
SUMMARY: ___ history of daily alcohol use, HTN who presents with
pharyngitis and BRBPR.
ACUTE ISSUES:
# Pharyngitis: Patient presents with white plaque on tongue and
in mouth consistent with pharyngitis, fungal vs bacterial.
Underlying malignancy cannot be excluded and patient does have a
significant smoking history. Likely source of patient's symptoms
including sore throat and hoarse voice. Will assess for HIV
given findings of pharyngitis, night sweats, and diarrhea. ENT
was consulted and recommended levofloxacin 750mg, fluconazole
200mg daily x 14 days (d1 = ___. HIV testing was negative.
Patient will f/u with ENT as outpatient.
# BRBPR: History of hemorrhoids, has not bled for months. In ED
had two episodes of BRBPR (200cc in toilet bowl) with
tachycardia on ambulation to the 160s. Patient was admitted and
subsequently hemodynamically stable with stable Hb/Hct. He was
discharged with plan to f/u as outpatient.
# Transaminitis: Patient was found to have elevated ALT/AST with
elevated Tbili in the setting of extensive alcohol use. RUQ
ultrasound showed steatisus. Hepatitis serologies were sent and
showed negative HepC and HBs-Ab positive with HBs-Ag negative.
# Alcohol use: Daily EtOH use with ___ drinks per day.
Connected in the ED with social work who provided with
outpatient resources. Patient was kept on CIWA scale with
diazepam PRN
CHRONIC ISSUES:
# HTN: Continue home amlodipine
TRANSITIONAL ISSUES:
- Will complete 14-day course of fluconazole 200mg daily and
levofloxacin 750mg daily (last day ___
- F/u with ENT in clinic for scope to assess for malignancy
- Consider referral to GI for scope to assess cause of BRBPR
- HIV and hepatitis serologies pending, consider referral to
hepatology
- Patient counseled on importance of alcohol cessation
# Code status: Full
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. amLODIPine 10 mg PO DAILY
2. TraZODone 50 mg PO QHS
3. Tretinoin 0.025% Cream 1 Appl TP QHS
Discharge Medications:
1. Fluconazole 200 mg PO Q24H Duration: 13 Days
RX *fluconazole 200 mg 1 tablet(s) by mouth daily Disp #*11
Tablet Refills:*0
2. Levofloxacin 750 mg PO Q24H Duration: 13 Days
RX *levofloxacin 750 mg 1 tablet(s) by mouth daily Disp #*11
Tablet Refills:*0
3. amLODIPine 10 mg PO DAILY
4. TraZODone 50 mg PO QHS
5. Tretinoin 0.025% Cream 1 Appl TP QHS
Discharge Disposition:
Home
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
Pharyngitis
Gastrointestinal bleed
Alcohol use disorder
SECONDARY DIAGNOSIS:
Hypertension
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
You were admitted to ___ due to a change in your voice. You
were found to have an infection in your throat with either
bacteria or fungus. You were seen by our ENT doctors and started
on both antifungal and antibiotic medications.
After you leave the hospital:
- Please take all your doses of the new medications as
prescribed
- It is very important that you follow up with your PCP and with
the ENT doctors in ___. Appointments are listed below.
- You will need further testing for your liver, throat, and for
your GI tract. Please work with your outpatient doctors to get
these tests
We wish you all the best!
- Your ___ care team
Followup Instructions:
___
|
10812790-DS-7
| 10,812,790 | 22,767,916 |
DS
| 7 |
2117-04-28 00:00:00
|
2117-04-29 20:36:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Bactrim
Attending: ___.
Chief Complaint:
Fever, Shortness of Breath
Major Surgical or Invasive Procedure:
None
History of Present Illness:
Mr. ___ is a ___ year old gentleman with history of HIV on ART
and warm autoimmune hemolytic anemia who presents as transfer
from OSH with dyspnea and anemia.
Patient has had headache, shortness of breath with exertion, and
productive cough for the last week. His SOB is worsened by
exertion. Reports fever for last 3 days (up to ___ at home).
Denies chest pain. Patient feels symptoms are similar to those
prompting admission in ___ however less severe. He has not had
chills, abdominal pain, n/v/d, no dysuria. No recent sick
contacts. No travel.
Given his symptoms he presented to ___ for evaluation. There he
was found to have hct 18.4. Given fever and cough he was treated
with CTX and clinda. CXR reportedly without consolidation or
acute process.
In the ED, initial vitals were: 98.9 94 107/67 16 97% RA
Labs notable for: hgb 6.3 hct 20.3 MCV 112, normal WBC and plts,
elevated retic count 8.3, LDH 460, hapto <10, UA bacteria, large
leuks, neg nitrate, neg , trop <0.01
ECG sinus 90, NA, NI, sub mm st depressions in V4-v5
Patient was given: 1LNS, difficult crossmatch, awaiting blood
transfusion.
heme onc consulted and recommended: add on peripheral smear,
likely rituxan not taking effect yet and warm hemolytic anemia,
start steroids at 1mg/kg.
Vitals prior to transfer:
81 98/54 19 96% RA
On the floor, patient is feeling better. He is not currently
experiencing fevers. No SOB at rest. He feels overall better
than he did when admitted in ___. No other new medication
changes. ROS as above, otherwise negative.
Past Medical History:
- CKD
- T2DM
- HIV
- calcium phosphate renal stones
- OSA
Social History:
___
Family History:
No known history of kidney disease. His mother had diabetes.
His father died at a young age from an accident.
Physical Exam:
================================
ADMISSION PHYSICAL EXAM
================================
99.8 PO 107 / 52 91 20 96 ra
General: Alert, oriented, very pleasant gentleman in NAD
HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL,
neck supple, JVP not elevated, no LAD
CV: Regular rate and rhythm, normal S1 + S2, holosystolic flow
murmur, no rubs, gallops
Lungs: Clear to auscultation bilaterally, no wheezes, rales,
rhonchi
Abdomen: Soft, non-tender, non-distended, bowel sounds present,
no organomegaly, no rebound or guarding
GU: No foley , no CVA tenderness
Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
Neuro: CNII-XII intact, ___ strength upper/lower extremities,
grossly normal sensation, 2+ reflexes bilaterally, gait
deferred.
================================
DISCHARGE PHYSICAL EXAM
================================
Vitals: T 98.6, BP 109-115/74-82, P 74-82, RR 20, O2:98-100%
General: Alert and oriented x 3, NAD
HEENT: Sclera anicteric, MMM, oropharynx clear
Neck: supple, JVP not elevated, no cervical LAD
Lungs: Good air movement. Decreased bibasilar rales, no
wheezing.
CV: RRR normal S1 + S2, Holosystolic flow murmur, no rubs or
gallops
Abdomen: Soft, NT, ND, BS+, no rebound or guarding
Ext: WWP, 2+ pulses, No CCE.
Neuro: CNII-XII intact, Normal strength and sensation.
Pertinent Results:
===========================
LABS
===========================
ADMISSION LABS
===========================
___ 11:00PM BLOOD WBC-9.3# RBC-1.82* Hgb-6.3* Hct-20.3*
MCV-112* MCH-34.6* MCHC-31.0* RDW-15.9* RDWSD-62.7* Plt ___
___ 11:00PM BLOOD Neuts-61.6 ___ Monos-6.7 Eos-2.5
Baso-0.2 Im ___ AbsNeut-5.75# AbsLymp-2.60 AbsMono-0.62
AbsEos-0.23 AbsBaso-0.02
___ 11:00PM BLOOD ___ PTT-40.6* ___
___ 11:00PM BLOOD Glucose-120* UreaN-43* Creat-2.9*# Na-138
K-5.1 Cl-104 HCO3-22 AnGap-17
___ 11:00PM BLOOD ALT-16 AST-39 LD(LDH)-460* AlkPhos-52
TotBili-1.2
___ 11:00PM BLOOD cTropnT-<0.01
___ 11:00PM BLOOD Albumin-3.9 Iron-26*
DISCHARGE LABS
===========================
___ 11:00PM BLOOD calTIBC-208* Hapto-<10* Ferritn-460*
TRF-160*
___ 05:38AM BLOOD WBC-7.6 RBC-2.69* Hgb-9.0* Hct-29.6*
MCV-110* MCH-33.5* MCHC-30.4* RDW-16.2* RDWSD-65.3* Plt ___
___ 04:53PM BLOOD ___ PTT-35.0 ___
___ 05:38AM BLOOD Ret Aut-8.6* Abs Ret-0.23*
___ 05:38AM BLOOD Glucose-104* UreaN-30* Creat-1.7* Na-141
K-4.1 Cl-105 HCO3-24 AnGap-16
___ 05:38AM BLOOD LD(LDH)-310*
___ 05:38AM BLOOD Hapto-38
===========================
IMAGING
===========================
CXR ___:
FINDINGS:
The cardiomediastinal silhouette is normal. The hila and
bilateral pulmonary
vasculatures are normal. There is a right lower lobe
ill-defined hazy
opacities with air bronchogram. No pneumothorax. No fractures.
IMPRESSION:
Right lower lobe pneumonia.
Brief Hospital Course:
___ year-old male with a history of HIV, CKD, T2DM,
nephrolithiasis, and warm autoimmune hemolytic anemia s/p recent
steroid burst and 4 wks of rituxan who presents from an OSH with
dyspnea, headache, fevers for the last week, found to have a
hemolytic anemia (Hgb 6.3, haptoglobin <10, LDH 450) and CXR
findings c/f RLL PNA. He was given one unit of PRBCs and one
dose of Prednisone 70 mg with improvement in his symptoms and
appropriate increase in Hgb. Heme/onc saw him and felt the
hemolysis was likely related to the infection and Dapsone he was
taking for PCP ppx, rather than recurrence of his warm AIHA. His
dapsone was changed to Atovaquone for PCP ppx, and he was
treated with ceftriaxone and azithromycin for CAP per ID team.
On admission he also had a positive UA with WBC >182, but the
patient was asymptomatic, and would be covered by ceftriaxone.
Also on admission patient had a mild ___ with Cr of 2.9 from
baseline 1.6-1.8. His respiratory symptoms improved over the
next couple days and his labs improved with an increase in Hgb
and decrease in Cr back to baseline. He was discharged with CAP
coverage per ID: Cefpodoxime for remaining 7-day abx course (Day
___ finishing ___ and Azithromycin x 5 days (Day ___
finishing ___ and with plans for follow up with PCP and
hematologist within 1 week to check a CBC.
Discharge diagnoses:
Community acquired pneumonia, complicated by worsened hemolytic
anemia
HIV, complicated with autoimmune hemolytic anemia
type II diabetes
Hypertension
Acute on chronic renal disease
# Hemolytic anemia: Warm autoimmune hemolytic anemia recently
diagnosed during ___ admission (s/p rituxan x4), presented
with hemolytic anemia with Hgb 6.3, retic count 8.3. Given early
on in course of rituxan, heme/onc favored hemolysis in setting
of infection (UTI vs PNA) vs dapsone, less likely refractory
WAHA, rec'd d/c dapsone and start on atovaquone, consider TCR
rearrangement study. Hgb/Hct responded appropriately to 1u pRBC
transfusion on ___. Peripheral smear findings c/f spherocytes
and reticulocytes c/w hemolysis. Hgb remained stable.
# Pneumonia: Patient presented with fevers, shortness of breath,
and with RLL opacity on CXR. As patient immunocompromised ___
HIV and tx, with recent 4-week course of rituximab and ___
hospital stay, differential included CAP and HCAP. Given mild
symptoms, ID favored CAP coverage w/7-days of ceftriaxone (may
switch to cefpodoxime on discharge) plus 5-days of azithromycin.
Improved clinically.
# Acute on chronic kidney disease: Cr 2.9 on admission from
baseline 1.6-1.8, likely secondary to pre-renal azotemia and
hemolytic anemia. Patient also thought to have post obstructive
uropathy secondary to BPH during last admission, started on
finasteride. Imaging showed enlarged left kidney with
persistent, severe left calyceal dilation with layering
echogenic debris and new debris in the bladder concerning for
infection. Atrophic and echogenic right kidney. He is scheduled
to f/u with urology on ___ needs bladder cancer eval per ID.
Will give additional IVF, ensure all meds renally dosed. Cr
improved to 1.7 back to baseline.
# T2DM: last HgbA1c was 5.0 on ___, but patient has poorly
controlled glycemia in setting of steroids. He is s/p one dose
of 70 mg prednisone on ___. Will need close follow up with PCP
for blood glucose monitoring.
# HIV: CD4 count 102, HIV PCR undetected. Pt reports adherence
to HAART regimen. EBV viral load <200 on ___. Continued home
HAART regimen and switched PCP prophylaxis from ___ to
Atavaquone as above.
=======================
TRANSITIONAL ISSUES
=======================
-MUST HAVE CBC within 1 week (heme/onc to arrange follow up next
week)
-Cefpodixime until ___
-Azithromycin until ___
-Changed HIV medications per ID recs
-Needs follow up with hematology/oncology for further anemia
management
-Needs follow up with nephrology and urology for further work-up
of obstructive uropathy.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Darunavir 800 mg PO DAILY
2. Etravirine 200 mg PO DAILY
3. RiTONAvir 100 mg PO DAILY
4. Dapsone 100 mg PO DAILY
5. Finasteride 5 mg PO DAILY
6. FoLIC Acid 5 mg PO DAILY
7. Acetaminophen 500 mg PO Q4H:PRN pain
8. Aspirin 81 mg PO DAILY
9. DiphenhydrAMINE 25 mg PO Q8H:PRN allergies
10. Loratadine 10 mg PO DAILY
11. Vitamin D ___ UNIT PO 1X/WEEK (___)
12. LaMIVudine 150 mg PO DAILY
13. Repaglinide 0.5 mg PO TIDAC
Discharge Medications:
1. Atovaquone Suspension 1500 mg PO DAILY
RX *atovaquone 750 mg/5 mL 10 mL by mouth daily Refills:*0
2. Azithromycin 250 mg PO Q24H
RX *azithromycin 250 mg 1 tablet(s) by mouth daily Disp #*2
Tablet Refills:*0
3. Cefpodoxime Proxetil 400 mg PO Q12H
RX *cefpodoxime 200 mg 2 tablet(s) by mouth twice a day Disp
#*18 Tablet Refills:*0
4. Etravirine 200 mg PO BID
5. FoLIC Acid 1 mg PO DAILY
RX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet
Refills:*0
6. Acetaminophen 500 mg PO Q4H:PRN pain
7. Aspirin 81 mg PO DAILY
8. Darunavir 800 mg PO DAILY
9. DiphenhydrAMINE 25 mg PO Q8H:PRN allergies
10. Finasteride 5 mg PO DAILY
11. LaMIVudine 150 mg PO DAILY
12. Loratadine 10 mg PO DAILY
13. RiTONAvir 100 mg PO DAILY
14. Vitamin D ___ UNIT PO 1X/WEEK (___)
Discharge Disposition:
Home
Discharge Diagnosis:
PRIMARY DIAGNOSIS
================
Hemolytic anemia
SECONDARY DIAGNOSIS
=================
Pneumonia
Type 2 Diabetes Mellitus
Chronic Kidney Disease
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
You were admitted to ___ with difficulty breathing and fevers
for the last week. It as found that you had low red blood cell
counts (anemia) as well as a picture of your chest that showed a
lung infection (pneumonia). You were given a unit of blood with
improvement in your symptoms and blood counts. The blood doctors
saw ___ and ___ that the anemia was a result of the infection
and possibly one of the medications you were taking and not
because you had a recurrence of the blood disease you have been
being treated for (warm autoimmune hemolytic anemia). Therefore
the steroids that you were given in the emergency room were not
continued. The infection doctors saw ___ and agreed with
treatment for the pneumonia with antibiotics through the arm at
first, then with pills. You improved significantly and were
discharged with pills to continue treating the infection. You
will need to take these pills for the next several days as
prescribed. You will also need to follow up with 2 doctors: your
primary care doctor ___, ___ and the
hematologist that you have been seeing for your anemia (Dr.
___, ___. Since it's the weekend, we cannot
schedule these for you, but we have contacted them. Please
follow up with them to schedule an appointment. You should also
follow up with your kidney and urinary tract doctors as
___.
It was a pleasure taking care of you and we wish you all the
best!
-Your ___ Care Team
***Please call to schedule an appointment with your primary care
doctor, ___, ___
***You should be getting a call from your hematologist's office,
but if you do not hear from them by ___, please
call them: Dr. ___ ___
Followup Instructions:
___
|
10812790-DS-8
| 10,812,790 | 29,409,645 |
DS
| 8 |
2118-05-30 00:00:00
|
2118-05-30 14:49:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Bactrim
Attending: ___.
Chief Complaint:
fevers, shortness of breath, diarrhea
Major Surgical or Invasive Procedure:
Lumbar puncture on ___
History of Present Illness:
___ y/o M with complex PMHx of HIV (last CD4 of 100 in ___ on
ART, SLE complicated by AIHA s/p rituximab, CKD stage III with
chronic left hydronephrosis and not felt to have SLE nephritis
who p/w ___ weeks of fevers and worsening left posterior chest
pain with SOB. Pt was seen with
son at bedside who provided additional history and translation
as
needed. Pt has been feeling unwell for the last ___ weeks with
dry cough, progressive SOB, fevers and intermittent HAs. He was
seen by PCP who recommended supportive care. Pt developed
worsening SOB and DOE with poor appetite, diarrhea and was
brought in by family to the ED. Pt denies any confusion or
visual challenges, he often gets HA with fevers and denies any
HA
at the time of my exam. Denies any abd pain but has had
intermittent dysuria without hematuria. No BRBPR and no ___
edema. Pt has chronic bilateral hand rash that is stable for
some years and is followed by rheum for SLE. Pt reports that
chest pain is over left posterior chest wall, worse with
inspiration though present at all times for the last few days.
Denies any sick contacts, no recent Abx exposures and denies any
sputum or hemoptysis with cough. Denies any falls, weakness or
LH but does report intermittent "beating" in ears bilaterally
Past Medical History:
HIV on ART, last CD4 ~100 in ___
SLE on hydroxychloroquine
Warm autoimmune hemolytic anemia s/p steroids, rituxan
CKD stage III, hx of atrophic right kidney and chronic left
hydronephrosis
Diet controlled DM
Nephrolithiasis
OSA on CPAP (poor compliance)
Social History:
___
Family History:
No known history of kidney disease. + DM and colon cancer
Physical Exam:
ADMIT Physical Exam
VS Tm 100.9 BP 118/68 HR 74 RR 18 Sats 96% RA
GENERAL: Alert and in no apparent distress, warm
EYES: Anicteric
ENT: small ulcerated lesion on base of right tongue, otherwise
clear and dry MM
CV: Heart regular, no murmur
RESP: Crackles noted on inspiration over LLL > RLL
GI: Abdomen soft, non-distended, non-tender to palpation. Bowel
sounds present.
GU: No suprapubic fullness or tenderness to palpation
MSK: Neck supple, moves all extremities, strength grossly intact
SKIN: dry scaling rash with scale over bilateral hands
NEURO: Alert, oriented, face symmetric, gaze conjugate with
EOMI,
FNF intact bilaterally
PSYCH: pleasant, appropriate affect
Discharge exam
VITALS: T 98.6 BP 133/80 HR 70 RR 18 97% RA
GENERAL: Alert and in no apparent distress
EYES: Anicteric, pupils equally round
CV: Heart regular, no murmur
RESP: CTAB
GI: Abdomen soft, obese, non-distended, non-tender to palpation.
Bowel sounds present. No HSM
NEURO: moving all four extremities, no asymmetry
PSYCH: pleasant, appropriate affect
Pertinent Results:
___ 08:20AM BLOOD WBC-6.7 RBC-2.93* Hgb-8.6* Hct-27.7*
MCV-95 MCH-29.4 MCHC-31.0* RDW-14.2 RDWSD-49.3* Plt ___
___ 05:40PM BLOOD WBC-12.5*# Abs CD4-201*
___ 12:00AM BLOOD Glucose-102* UreaN-48* Creat-2.9* Na-135
K-4.7 Cl-98 HCO3-22 AnGap-15
___ 08:00AM BLOOD Glucose-98 UreaN-37* Creat-1.8* Na-146*
K-4.5 Cl-107 HCO3-18* AnGap-21*
___ 12:00AM BLOOD LD(LDH)-264*
___ 08:05PM CEREBROSPINAL FLUID (CSF) TNC-2 RBC-39* Polys-0
___ ___ 07:25PM CEREBROSPINAL FLUID (CSF) TNC-1 RBC-78* Polys-3
___ Mesothe-3
___ 07:25PM CEREBROSPINAL FLUID (CSF) TotProt-37 Glucose-82
___ 7:25 pm CSF;SPINAL FLUID Source: LP.
**FINAL REPORT ___
CRYPTOCOCCAL ANTIGEN (Final ___:
CRYPTOCOCCAL ANTIGEN NOT DETECTED.
(Reference Range-Negative).
Test performed by Lateral Flow Assay.
Results should be evaluated in light of culture results
and clinical
presentation.
Renal U/S IMPRESSION:
1. Interval progression of severe left renal caliceal dilation,
which contain debris, concerning for worsening obstruction at
the level of the left renal pelvis.
2. Stable left lower pole renal stone.
3. Bladder containing echogenic debris.
4. Atrophic right kidney with echogenic parenchyma, unchanged.
CT Chest IMPRESSION:
1. Confluent left lower lobe opacity compatible with bacterial
pneumonia.
2. Nodular opacity in the right upper lobe may represent
infection or focal atelectasis.
3. Hepatic steatosis.
Brief Hospital Course:
___ complex PMhx including HIV (last CD4 100, VL undetectable
per PCP), CKD stage III, SLE and warm AIHA who p/w ___ weeks off
fevers, HA, worsening SOB and acute onset diarrhea, found to
have new LLL PNA and acute on chronic renal failure.
Acute LLL PNA, immunocompromised host with CD4 201: Pt presented
with fevers, pleuritic chest pain and cough. CT chest revealed
LLL PNA and pt was treated empirically with
Ceftriaxone/Doxycycline for presume CAP. Fevers/HA resolved and
symptoms improved rapidly on CAP coverage. Pt was seen by ID
who recommended resp isolation for TB ruleout though it was felt
to be unlikely. Pt had significant difficulty providing sputums
and ultimately, pt was ruled out with a single negative sputum
and TB nucleic acid...?
Pt was transitioned to Cefpodoxime & Doxycycline to complete a 7
day course.
HIV on ARVs: Pt is followed by ___ for his HIC and
has had undetectable VL though CD4 of 201. He had a serum
Crypto Ag sent during admission that returned weakly positive at
1:2. He denied any prior history of Crypto infection and PCP
was unaware of prior serum Crypto Ag. Pt had a underwent LP on
___ that was negative of PMNs and CSF Crypto PCR was negative.
- Per ID recommendations, he was started on fluconazole 400 mg
daily x 12 months
Pt was continued on his home ARV regimen and is scheduled for
close follow up with his PCP.
Acute on chronic renal failure: Pt presented with ___ in setting
of diarrhea and fevers. He was seen by renal and underwent
additional work up including Renal u/s that showed acute on
chronic dilation of the left kidney. This has been evaluated
by urology in the past and felt to be draining appropriately.
There was no evidence of acute GN and pt was treated with
aggressive IVF resuscitation. Fortunately, his renal function
returned to baseline and he is scheduled for close urology
follow up given his acute on chronic left kidney calyx dilation.
Acute diarrhea: resolved, all stool Cx were negative for growth
Hx of AIHA: hgb stable at baseline, no acute issues while
admitted.
Hx of SLE: continued home hydroxychloroquine, no evidence of
acute glomerulonephritis.
>30 minutes were spent providing and coordinating care for this
patient on day of discharge.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. RiTONAvir 100 mg PO DAILY
2. Darunavir 800 mg PO DAILY
3. Dapsone 100 mg PO DAILY
4. Hydroxychloroquine Sulfate 200 mg PO DAILY
5. Tamsulosin 0.4 mg PO QHS
6. LaMIVudine 150 mg PO DAILY
7. Etravirine 200 mg PO BID
8. Loratadine 10 mg PO DAILY
9. Aspirin 81 mg PO DAILY
10. Multivitamins 1 TAB PO DAILY
Discharge Medications:
1. Acyclovir 800 mg PO Q12H
2. Cefpodoxime Proxetil 400 mg PO Q12H
RX *cefpodoxime 200 mg 2 tablet(s) by mouth every 12 hours Disp
#*6 Tablet Refills:*0
3. Doxycycline Hyclate 100 mg PO Q12H
RX *doxycycline hyclate 100 mg 1 capsule(s) by mouth every 12
hours Disp #*3 Capsule Refills:*0
4. Fluconazole 400 mg PO DAILY
RX *fluconazole 200 mg 2 tablet(s) by mouth daily Disp #*30
Tablet Refills:*0
5. Aspirin 81 mg PO DAILY
6. Dapsone 100 mg PO DAILY
7. Darunavir 800 mg PO DAILY
8. Etravirine 200 mg PO BID
9. Hydroxychloroquine Sulfate 200 mg PO DAILY
10. LaMIVudine 150 mg PO DAILY
11. Loratadine 10 mg PO DAILY
12. Multivitamins 1 TAB PO DAILY
13. RiTONAvir 100 mg PO DAILY
14. Tamsulosin 0.4 mg PO QHS
Discharge Disposition:
Home
Discharge Diagnosis:
Community acquired pneumonia
cryptococcal infection
Acute on chronic renal failure
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
You were admitted for fevers, shortness of breath and diarrhea.
You were found to have worsening renal function which improved
with IV fluids and a pneumonia. Your fevers improved with
antibiotics. One of your blood tests was mildly positive for a
fungal infection therefore you were also started on antifungal
medication.
Thank you for allowing us to participate in your care
Your ___ team
Followup Instructions:
___
|
10812798-DS-15
| 10,812,798 | 23,131,167 |
DS
| 15 |
2121-05-28 00:00:00
|
2121-05-29 18:44:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Penicillin G / Lithium / dicloxacillin / escitalopram
Attending: ___.
Chief Complaint:
Anemia
Major Surgical or Invasive Procedure:
None
History of Present Illness:
Ms. ___ is a ___ y/o woman with h/o CVA and vascular dementia
(has lived in ___ since ___, GI bleed in ___ in setting of
warfarin use, chronic iron deficiency anemia, presenting from
___ with worsening anemia and guaiac-positive stool.
History was obtained from ___ notes; patient unable to
confirm due to dementia.
Per records, patient's Hgb has been down-trending since at least
___ (9.1 ___ -> 7.4 ___ -> 6.4 ___. She has not
had any overt bleeding but stool was guaiac positive. She was
started on ferrous sulfate and omeprazole was increased to 20
BID. However, Hgb continued to drop and decision was made to
transfer patient to ___ for GI evaluation, with agreement from
patient's daughter/HCP.
In the ED, initial VS were: 98.5 84 121/49 17 99% RA
Exam notable for: pallor, looks ill, NAD, obese abdomen,
increased BS, no tenderness, + occult blood test (stool)
Labs showed: Hgb 6.8, WBC 12.4, lactate 1.3
Consults: GI - PPI BID, clears, NPO at MN for possible EGD
pending discussion with family
20:35 verbal consent was received from her daughter (___)
to give PRBC (1 unit), daughter could not recall if her mother
had colonoscopy or EGD before.
Patient received: IVF, IV pantoprazole 40, 1u RBC
Transfer VS were: 97.7 82 138/67 24 98% RA
On arrival to the floor, patient reports she feels well. No
pain,
nausea, lightheadedness, or dyspnea.
Past Medical History:
Vascular dementia c/b mood and behavior disturbances
CVA ___ L-sided hemiparesis
DVT ___, warfarin discontinued to GI bleed in ___
Iron deficiency anemia
CAD
HTN
Hypothyroidism
Hyperlipidemia
DJD
Depression
Idiopathic peripheral neuropathy
Slow transit constipation
Social History:
___
Family History:
non-contributory
Physical Exam:
ADMISSION PHYSICAL EXAM
VS: reviewed, afebrile and hemodynamically stable
General: elderly woman lying comfortably in bed in NAD.
HEENT: NC/AT. No icterus or injection. MMM.
CV: ___. ___ mid-systolic murmur heard best at ___ c/w AS.
Resp: Non-labored, CTAB.
Abd: Soft, NDNT, no palpable HSM or masses.
GU: No suprapubic tenderness.
Extr: Warm. LLE larger than RLE, no erythema or edema.
Neuro: Alert, interactive, oriented to self and "doctor" but
otherwise confused.
DISCHARGE PHYSICAL EXAM
General: Pleasant, elderly woman lying comfortably in bed in
NAD.
HEENT: NC/AT. No icterus or injection. MMM.
CV: Irregularly irregular rhythm. III/VI mid-systolic murmur
heard best at ___ c/w AS.
Resp: Non-labored, CTAB.
Abd: Soft, mildly tender RUQ, nondistended, no palpable HSM or
masses.
Pertinent Results:
ADMISSION LABS
==============
___ 04:00PM BLOOD WBC-12.4* RBC-2.98* Hgb-6.8* Hct-22.8*
MCV-77*# MCH-22.8* MCHC-29.8* RDW-17.2* RDWSD-47.5* Plt ___
___ 04:00PM BLOOD Neuts-75.4* Lymphs-17.1* Monos-5.7
Eos-0.8* Baso-0.4 Im ___ AbsNeut-9.36* AbsLymp-2.13
AbsMono-0.71 AbsEos-0.10 AbsBaso-0.05
___ 09:34AM BLOOD ___ PTT-26.1 ___
___ 04:00PM BLOOD Glucose-141* UreaN-30* Creat-0.6 Na-143
K-4.8 Cl-106 HCO3-25 AnGap-12
___ 04:00PM BLOOD ALT-6 AST-9 LD(LDH)-143 AlkPhos-167*
TotBili-<0.2
___ 04:00PM BLOOD Albumin-2.8* Iron-15*
___ 09:34AM BLOOD Calcium-8.9 Phos-3.3 Mg-2.3
___ 04:00PM BLOOD calTIBC-280 VitB12-744 Hapto-276*
Ferritn-37 TRF-215
___ 04:00PM BLOOD TSH-3.3
___ 06:10PM BLOOD Lactate-1.3
STUDIES
=======
CT A/P ___
1. Large right pleural effusion with compressive atelectasis.
2. No evidence of active extravasation.
3. Heterogeneous enhancement and mural thickening with nodular
mucosa of the
ascending colon from the ileocecal valve is concerning for
underlying mass
with possible ulceration.
4. Suspected acute non-occlusive thrombus within the splenic
vein. Evidence
for chronic splenic infarcts. Patent SMV and portal
vasculature.
5. Heterogeneous thickened endometrium measuring 15 mm in
thickness is
concerning for malignancy. Correlate with pelvic ultrasound.
6. Chronic occlusion of the right internal iliac artery.
Moderate narrowing
just distal to the origin of the right common iliac artery.
7. Paget's disease in the pelvic bones
8. Gallbladder fundal adenomyomatosis.
Brief Hospital Course:
Ms. ___ is a ___ year-old female with advanced vascular
dementia, h/o GIB on warfarin in ___, presenting with
subacute/chronic anemia and guaiac-positive stool
concerning for slow GI bleeding, found to have colonic mass on
CT of abdomen, with decision made to focus on palliation.
ACUTE ISSUES
============
# Subacute GI Bleed with Microcytic Anemia
# Weight Loss
# Colonic Mass
Admitted from ___ with guaiac positive stools and Hb drop since
___. Per our records and ___ ~50 pound weight loss
in past ___ years. Started on pantoprazole. Maroon and black
stools here. No known h/o EGD or colonoscopy. s/p 1U pRBC this
admission. Attempted to prep for colonoscopy, but unsuccessful.
CT A/P showed mass of ascending colon/cecum and multiple sites
of thrombosis in abdomen. Decision made to focus on palliation.
Chronic Issues
==============
# Atrial Fibrillation
Rate controlled. Poor candidate for anticoagulation given prior
GIB, current c/f GIB. Monitored on telemetry.
# Vascular dementia
H/o significant mood & behavioral disturbances. Continued on
home trazodone, ramelteon and delirium precautions.
# History of CVA
Discontinued home lisinopril given stable blood pressures and
desire to minimize unnecessary medications.
# Hypothyroidism
TSH stable. Continued home levothyroxine at same dose.
# Idiopathic peripheral neuropathy
Continued home gabapentin 100mg BID + 200mg QHS.
#Chronic left heel ulcer
Continued home collagenase ointment.
TRANSITIONAL ISSUES
===================
[ ] MOLST filled out indicating DNR/DNI/DN transfer except for
comfort.
[ ] Palliative care per primary team at ___.
[ ] Discharged on morphine 5mg q1h prn for
pain/dyspnea/distress.
[ ] Discontinued all non-symptomatic medications given focus on
palliation.
#CODE: DNR/DNI (confirmed by MOLST)
#CONTACTS: Daughters:
___ - ___
___ - ___
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO BID
2. Collagenase Ointment 1 Appl TP DAILY
3. Ferrous Sulfate 325 mg PO DAILY
4. Gabapentin 100 mg PO BID
5. Levothyroxine Sodium 100 mcg PO DAILY
6. Lisinopril 5 mg PO DAILY
7. melatonin 3 mg oral QHS
8. Bengay Cream 1 Appl TP BID
9. Omeprazole 20 mg PO BID
10. Polyethylene Glycol 17 g PO DAILY
11. TraZODone 100 mg PO QHS
12. Bisacodyl ___AILY:PRN constipation
13. Aluminum-Magnesium Hydrox.-Simethicone ___ mL PO BID:PRN
heartburn
14. Ondansetron ODT 4 mg PO Q8H:PRN nausea
15. TraZODone 25 mg PO Q6H:PRN agitation
16. Gabapentin 200 mg PO QHS
Discharge Medications:
1. Benzonatate 100 mg PO TID:PRN cough
2. Cepacol (Sore Throat Lozenge) 1 LOZ PO Q4H:PRN cough, sore
throat
3. GuaiFENesin ___ mL PO Q6H:PRN cough
4. Morphine Sulfate (Concentrated Oral Solution) 20 mg/mL 5 mg
PO Q1H:PRN Pain or respiratory
RX *morphine concentrate 100 mg/5 mL (20 mg/mL) 5 mg by mouth
q1h Refills:*0
5. Sodium Chloride Nasal ___ SPRY NU QID:PRN dryness
6. Acetaminophen 650 mg PO BID
7. Aluminum-Magnesium Hydrox.-Simethicone ___ mL PO BID:PRN
heartburn
8. Bengay Cream 1 Appl TP BID
9. Bisacodyl ___AILY:PRN constipation
10. Collagenase Ointment 1 Appl TP DAILY
11. Gabapentin 100 mg PO BID
12. Gabapentin 200 mg PO QHS
13. Levothyroxine Sodium 100 mcg PO DAILY
14. melatonin 3 mg oral QHS
15. Omeprazole 20 mg PO BID
16. Ondansetron ODT 4 mg PO Q8H:PRN nausea
17. Polyethylene Glycol 17 g PO DAILY
18. TraZODone 25 mg PO Q6H:PRN agitation
19. TraZODone 100 mg PO QHS
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
PRIMARY DIAGNOSES
=================
GI Bleed, Presumed Due to Colonic Mass
Acute Blood Loss Anemia
Severe Malnutrition
SECONDARY DIAGNOSES
===================
Atrial Fibrillation
Thrombocytosis
Vascular Dementia
H/o Stroke
Hypothyroidism
Idiopathic Peripheral Neuropathy
Chronic Left Heel Ulcer
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Dear Ms. ___,
It was a pleasure caring for you at ___.
WHY WAS I IN THE HOSPITAL?
- You came to the hospital because you were having bleeding with
your bowel movements.
WHAT HAPPENED TO ME IN THE HOSPITAL?
- We gave you a unit of blood.
- We watched your blood counts.
- We did a CT scan of your abdomen which showed the source of
your bleeding in your colon, but that it wasn't something we
could fix with a colonoscopy.
- We decided not to do a colonoscopy.
- We cleaned up your medication list to make sure everything we
were giving you was helping you feel better.
WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?
- Continue to take all your medicines. Your doctors at your ___
___ continue to care for you and address your concerns.
We wish you the best!
Sincerely,
Your ___ Team
Followup Instructions:
___
|
10813295-DS-8
| 10,813,295 | 22,053,636 |
DS
| 8 |
2124-11-22 00:00:00
|
2124-11-22 17:54:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Codeine / morphine
Attending: ___.
Chief Complaint:
Abdominal pain, nausea, vomiting
Major Surgical or Invasive Procedure:
___: Intubation (extubated later that day)
History of Present Illness:
___ is an ___ PMH Afib, uterine CA s/p radical
hysterectomy and radiation, recurrent SBOs s/p ex lap for lysis
of adhesions and small bowel resection in ___, cholecystectomy
w subsequent RNY hepaticojejunostomy, who presented to OSH for
abdominal pain and was found to have an obstructive bile duct
concerning for cholangiocarcinoma.
Initial vitals at ___ with BP 168/87, 100% room air.
Physician ___: ___ presents with severe epigastric pain
radiating toward her back x ___ hours. She reports that the pain
is tearing in character and accompanied by intense nausea. She
has had prior SBOs, but this feels much more severe. Per EMS she
had a differential in blood pressure between her arms...
Increasing somnolence and continued nausea. Concern for airway
risk... Placing OGT (NGT placed by nursing with minimal return
after initial placement."
She was acutely vomiting and was intubated for airway
protection. Was given Zosyn at 2204 (preventative, was afebrile)
and 2L NS. Labs with Cr 1.1, CO2 24, WBC 8.9, Hb 11.6, lactate
0.9. Arrived to ___ intubated and sedated on fentanyl and
midazolam, CMV FiO2:40% PEEP:5 RR:20 Vt:450. She was extubated
on ___ without complications. The ___ team discussed the case
with the ERCP team. They felt the the lesion would not be
amenable to stenting due to its location. They recommended
consulting ___, who recommended against acute intervention.
Hepatology recommended further evaluation of the lesion with
MRCP. Her symptoms resolved with NGT decompression. She was
stable and transferred to the Medicine floor on ___.
Past Medical History:
PMH:
1. Uterine cancer s/p surgery and radiation
2. Radiation enteritis
3. Chronic diarrhea of unknown etiology
4. Recurrent SBO
5. Anemia
6. Asthma
7. Generalized anxiety disorder
.
PSH:
1. TAH
2. Lap ccy c/b CBD injury
3. Hepatectomy/RNY hepaticoJ
4. SBO/LOA in distant past
Social History:
___
Family History:
Diabetes mellitus
Crohn's disease
squamous cell cancer in mouth -> father
cancer (unknown location) -> mother
cancer (unknown location) -> siblings
Physical Exam:
ADMISSION EXAM (FICU):
VITALS: 73 137/86 14 100% intubated
GENERAL: intubated, awake, responding appropriately to
commands, answers yes/no questions
HEENT: Sclerae anicteric, OGT and ETT in place, +oral secretions
NECK: supple
LUNGS: Ventilator breath sounds
CV: Distant heart sounds, Regular rate and rhythm, normal S1 S2,
no murmurs, rubs, gallops
ABD: soft, non-tender, non-distended, bowel sounds present, no
rebound tenderness or guarding, no organomegaly
EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
SKIN: no significant rashes
NEURO: following commands, moving all extremities spontaneously
ACCESS: PIVs
DISCHARGE EXAM:
Vitals: T: 97.8, BP: 154/84, HR: 72, RR: 18, O2: 94% RA; I/O:
1252/1050
GENERAL: Alert, appears uncomfortable
EYES: Anicteric, pupils equally round
ENT: Oropharynx without visible lesion, erythema or exudate
CV: NS1/S2, RRR
RESP: Lungs clear to auscultation with good air movement
bilaterally. Breathing is non-labored
GI: Abdomen soft, non-distended, non-tender to palpation. Bowel
sounds present.
MSK: Neck supple, moves all extremities, strength grossly full
and symmetric bilaterally in all limbs
SKIN: No rashes or ulcerations noted
NEURO: Alert, oriented, face symmetric, gaze conjugate with
EOMI,
speech fluent, moves all limbs, sensation to light touch grossly
intact throughout
PSYCH: pleasant, appropriate affect
Pertinent Results:
ADMISSION LABS:
___ 07:55PM TYPE-ART TEMP-37 RATES-16/ TIDAL VOL-400
PEEP-5 O2-40 PO2-130* PCO2-33* PH-7.43 TOTAL CO2-23 BASE XS-0
AS/CTRL-ASSIST/CON INTUBATED-INTUBATED
___ 03:07PM GLUCOSE-97 UREA N-19 CREAT-0.9 SODIUM-137
POTASSIUM-4.0 CHLORIDE-104 TOTAL CO2-22 ANION GAP-11
___ 03:07PM estGFR-Using this
___ 03:07PM ALT(SGPT)-37 AST(SGOT)-60* LD(LDH)-202 ALK
PHOS-86 TOT BILI-1.1
___ 03:07PM ALBUMIN-3.4* CALCIUM-7.9* PHOSPHATE-3.3
MAGNESIUM-1.8
___ 03:07PM WBC-7.0 RBC-3.49* HGB-10.8* HCT-32.3* MCV-93
MCH-30.9 MCHC-33.4 RDW-14.5 RDWSD-49.1*
___ 03:07PM PLT COUNT-138*
___ 03:07PM ___ PTT-29.4 ___
___ 06:58AM cTropnT-0.02*
___ 01:54AM URINE HOURS-RANDOM
___ 01:54AM URINE UHOLD-HOLD
___ 01:54AM URINE COLOR-Straw APPEAR-Clear SP ___
___ 01:54AM URINE BLOOD-TR* NITRITE-NEG PROTEIN-NEG
GLUCOSE-NEG KETONE-10* BILIRUBIN-NEG UROBILNGN-NEG PH-7.0
LEUK-NEG
___ 01:54AM URINE RBC-1 WBC-0 BACTERIA-NONE YEAST-NONE
EPI-<1
___ 01:54AM URINE MUCOUS-RARE*
___ 01:49AM ___ PO2-32* PCO2-39 PH-7.37 TOTAL CO2-23
BASE XS--3
___ 01:49AM LACTATE-1.6
___ 01:41AM GLUCOSE-129* UREA N-19 CREAT-0.9 SODIUM-138
POTASSIUM-4.2 CHLORIDE-105 TOTAL CO2-19* ANION GAP-14
___ 01:41AM estGFR-Using this
___ 01:41AM ALT(SGPT)-26 AST(SGOT)-56* CK(CPK)-99 ALK
PHOS-99 TOT BILI-1.2
___ 01:41AM LIPASE-26
___ 01:41AM CK-MB-2 cTropnT-0.04*
___ 01:41AM ALBUMIN-3.6 CALCIUM-7.9* PHOSPHATE-2.3*
MAGNESIUM-1.7
___ 01:41AM WBC-9.0 RBC-3.37* HGB-10.5* HCT-31.7* MCV-94
MCH-31.2 MCHC-33.1 RDW-14.2 RDWSD-48.6*
___ 01:41AM NEUTS-84.6* LYMPHS-7.0* MONOS-7.2 EOS-0.0*
BASOS-0.4 IM ___ AbsNeut-7.62* AbsLymp-0.63* AbsMono-0.65
AbsEos-0.00* AbsBaso-0.04
___ 01:41AM ___ PTT-26.1 ___
___ 01:41AM PLT COUNT-125*
___ 06:58AM BLOOD cTropnT-0.___ 01:41AM BLOOD CK-MB-2 cTropnT-0.04*
MICROBIOLOGY:
- ___ Blood cx: STAPHYLOCOCCUS, COAGULASE NEGATIVE. Isolated
from only one set in the previous five days.
- ___ Urine cx: Negative
- ___ Urine cx: Negative
- ___ Blood cx: pending
- ___ Blood cx: pending
- ___ Blood cx: pending
IMAGING:
- ___ CXR:
IMPRESSION:
1. There is volume loss/infiltrate at the bases
2. Endotracheal tube tip is approximately 4.5 cm above the
carina.
___ CXR:
IMPRESSION:
Upper enteric tube tip terminates in the distal gastric body.
___ CXR:
IMPRESSION:
Compared to chest radiographs ___ and ___.
Regions of peribronchial opacification in the lower lobes,
stable on the left, increased on the right could be due to acute
aspiration, atelectasis and/or pneumonia. Upper lungs clear.
No pulmonary edema. Heart size top-normal. Pleural effusions
small if any.
Nasogastric drainage tube passes into a nondistended stomach and
out of view.
___ MRCP:
IMPRESSION:
1. 0.8 cm intraductal stone just proximal to the
hepaticojejunostomy, with
upstream biliary duct dilatation, likely due to stricture at the
anastomosis.
2. Left-sided cholangitis.
3. Persistent severe attenuation of the left portal vein with
associated
hepatic perfusional abnormalities
DISCHARGE LABS:
___ 07:50AM BLOOD WBC-3.8* RBC-3.05* Hgb-9.6* Hct-28.5*
MCV-93 MCH-31.5 MCHC-33.7 RDW-14.1 RDWSD-47.9* Plt ___
___ 07:45AM BLOOD Neuts-46.1 ___ Monos-9.9 Eos-5.9
Baso-0.7 Im ___ AbsNeut-1.26*# AbsLymp-1.01* AbsMono-0.27
AbsEos-0.16 AbsBaso-0.02
___ 07:50AM BLOOD Plt ___
___ 07:50AM BLOOD Glucose-94 UreaN-6 Creat-0.7 Na-144 K-4.0
Cl-106 HCO3-26 AnGap-12
___ 07:50AM BLOOD ALT-25 AST-36 AlkPhos-137* TotBili-0.3
___ 07:45AM BLOOD ALT-20 AST-32 AlkPhos-136* TotBili-0.4
___ 07:10AM BLOOD ALT-19 AlkPhos-107* TotBili-0.4
___ 01:41AM BLOOD Lipase-26
___ 07:50AM BLOOD Calcium-8.3* Phos-3.1 Mg-1.7
___ 02:40AM BLOOD HBsAg-NEG HBsAb-NEG HBcAb-NEG
___ 02:40AM BLOOD AFP-5.3
___ 02:40AM BLOOD HCV Ab-NEG
Brief Hospital Course:
# Cholangitis with intraductal stone
# Intrahepatic Biliary Dilatation
# Transaminitis
# Elevated alk phos
Patient presented to OSH with abdominal pain and nausea and was
intubated for airway protection in the setting of nausea and
somnolence. She was started on zosyn due to evidence of an
intrahepatic biliary ductal dilatation with concern for
obstruction vs. malignancy. Upon arrival to ___, ERCP reviewed
her outside imaging and did not think ERCP would be helpful
given how central the mass was in the left lobe. They believed
there were limited options for stenting (could only use plastic
stent). They recommended ___ consult for drainage given that
there was a risk for infection to develop. ___ was consulted and
did not believe there was immediate need for intervention. The
patient was continued on zosyn and transferred to Medicine.
Hepatology recommended an MCRP for better characterization of
the mass/stricture.
MCRP showed abnormal enhancement of left lobe of liver and
cholangitis with 0.8 cm intraductalstone. Given her lack of
ongoing symptoms and fevers, the cholangitis was may be a
chronic issue - it may be due to
secondary biliary cirrhosis from multiple bouts of cholangitis.
She has chronically elevated alk phos and mild transaminitis and
chronic radiographic changes of her liver. ___ recommended
against any acute intervention due to her lack of
symptoms/significant lab abnormalities. Hepatology recommended
continuing treatment for acute cholangitis with a 14-day course
of antibiotics, she was discharged on Augmentin to complete 14
day course of antibiotics. They also recommended starting
ursodiol. She will be presented at Liver Tumor Conference to
discuss the possibility of future interventions.
# Recurrent small bowel obstruction
The patient has a history of recurrent SBOs, with presentation
of abdominal pain, nausea, vomiting, that has improved with
decompression. Initially, given CT imaging findings concerning
for biliary duct dilatation, there
was a concern for ongoing cholangitis or biliary obstruction
contributing to her clinical picture. Given significant
improvement with decompression alone, it is likely that some
part of her symptoms were related to small bowel obstruction.
# Intubated for airway protection
Patient was noted to be more somnolent and nauseated per OSH
note and was intubated for airway protection. ED report differs
somewhat ("acutely vomiting"). Given that ERCP and ___ were not
able to intervene immediately and the patient's respiratory
status was stable, the patient was extubated on ___.
# Troponinemia
Patient presented with positive troponins in setting of normal
renal function. She has a history of atrial fibrillation and is
not on anticoagulation, but has no known history of heart
failure. Troponemia thought to be secondary to demand ischemia
and down-trended from 0.04 to 0.02.
# Blood culture contaminant
She was initially treated with vancomycin when a blood culture
returned with GPCs. Vancomycin was stopped when the culture
resulted as coagulase negative Staph (___).
# Thrombocytopenia
Platelets were consistently in the 120s-130s, with prior labs at
___ showing a baseline in the 180s-200s. She had no
evidence of active bleeding. This was thought to be due to
underlying infection (possible cholangitis).
# Atrial fibrillation
Per the FICU team, she had an episode of afib with RVR in the
130s. Not on anticoagulation. CHADS VASC score elevated in the
setting of age, sex, gender. ___ lists atrial fibrillation
as a known problem, but it is unknown what workup and options
have been discussed in the past. Afib with RVR resolved with
treatment of SBO and cholangitis. She was monitored on telemetry
for 48 hours after transfer to medicine and maintained in normal
sinus rhythm.
# Anxiety
- Continue buspirone 20 mg PO BID
- Continue sertraline 25 mg PO daily
Transitional issues:
Pending future decisions re: interventions, anticoagulation
should be discussed with the patient as outpatient with PCP.
Will need to discuss with liver team as outpatient regarding
future procedures planned.
-Repeat CBC, chemistries as outpatient
-Follow-up appointment with liver clinic and PCP
___ on ___:
The Preadmission Medication list is accurate and complete.
1. BusPIRone 20 mg PO BID
2. Famotidine 40 mg PO DAILY
3. Vitamin D 1000 UNIT PO DAILY
4. Sertraline 25 mg PO DAILY
5. Aspirin 81 mg PO DAILY
6. Thera-M
(
m
u
l
t
i
v
i
t
-
i
r
o
n
-
F
A
-
c
a
l
c
i
u
m
-
m
i
n
s
;
<
b
r
>
m
ultivitamin,tx-iron-Ca-FA-min;<br>multivitamin,tx-iron-minerals)
___ mg oral DAILY
7. magnesium 250 mg oral BID
8. Cyanocobalamin Dose is Unknown PO 3X/WEEK (___)
Discharge Medications:
1. Amoxicillin-Clavulanic Acid ___ mg PO Q12H cholangitis
RX *amoxicillin-pot clavulanate [Augmentin] 875 mg-125 mg 1
tablet(s) by mouth twice daily Disp #*18 Tablet Refills:*0
2. Ursodiol 300 mg PO BID
RX *ursodiol 300 mg 1 capsule(s) by mouth twice daily Disp #*30
Capsule Refills:*0
3. Cyanocobalamin 100 mcg PO 3X/WEEK (___)
4. Aspirin 81 mg PO DAILY
5. BusPIRone 20 mg PO BID
6. Famotidine 40 mg PO DAILY
7. magnesium 250 mg oral BID
8. Sertraline 25 mg PO DAILY
9. Thera-M
(
m
u
l
t
i
v
i
t
-
i
r
o
n
-
F
A
-
c
a
l
c
i
u
m
-
m
i
n
s
;
<
b
r
>
m
ultivitamin,tx-iron-Ca-FA-min;<br>multivitamin,tx-iron-minerals)
___ mg oral DAILY
10. Vitamin D 1000 UNIT PO DAILY
Discharge Disposition:
Home
Discharge Diagnosis:
Cholangitis with intraductal stone
Intrahepatic biliary ductal dilatation
Small bowel obstruction
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Ms. ___,
You were admitted to the hospital for severe abdominal pain,
nausea, and vomiting with concern for acute cholangitis. At ___
___, you were intubated for airway protection. A CT of your
abdomen showed dilatation of the ducts in your liver and you
were transferred to ___ to have an MRCP and to be evaluated by
the Liver and Interventional Radiology teams for a potential
intervention.
Your abdominal pain, nausea, and vomiting resolved with
decompression by an NG tube, so this was likely due to a small
bowel obstruction. It is possible there was some contribution
from cholangitis. You were treated with antibiotics for possible
cholangitis, which you should continue as an outpatient. The
MRCP showed abnormal enhancement of left lobe of liver, enlarged
ducts in the liver, and a stone at the junction of the main
liver duct and the small intestine. The enlarged ducts and
abnormal liver function tests may be due to chronic recurrent
bouts of cholangitis. Due to your lack of symptoms and
relatively stable lab results, the Liver and Interventional
Radiology teams decided against any acute intervention. However,
they would like to discuss you further at the Liver Tumor
Conference next week and decide on a plan to try to prevent
recurrences of cholangitis.
Take care,
Your ___ medical team
Followup Instructions:
___
|
10813365-DS-18
| 10,813,365 | 22,345,559 |
DS
| 18 |
2129-01-29 00:00:00
|
2129-01-30 14:19:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Rash, hearing loss
Major Surgical or Invasive Procedure:
Lumbar puncture
History of Present Illness:
Mr. ___ is a ___ year-old man with a history of HIV
presenting with a 4 month history of a peeling rash on his palms
and soles and difficulty hearing. He reports that he presented
to his PCP 4 months prior to admission with peeling rashes on
his hands and feet along with a headache, and his PCP advised
him to use a lotion and a salt rub. Over the course of the 4
months, his rashes have worsened, and he identifies nothing that
has helped reduce them. The rash is mildly tender to touch, but
not exquisitely so. Advil has helped to alleviate his headache,
which he describes as intermittent and pressure-like, with
radiation down his neck and into his shoulders. He also has
experienced increased difficulty hearing, as voices now sound
muffled and he has a constant ringing sensation in both ears. He
denies any exposures to new substances. He denies penile
discharge, dysuria, or rashes on other bodily locations.
He mentions that he presented to his ID doctor 1 week PTA who
was quite concerned that he may have syphilis. Although the
history is unclear, it seems that his ID doctor ordered an RPR
which was highly reactive at 1:256, but was unable to perform an
LP for CSF VDRL to confirm the diagnosis of neurosyphilis. He
was then referred to the ED by either his PCP or ID doctor for
further workup.
In the ED, initial vitals were T 97.2, HR 116, BP 154/94, RR 19,
O2Sat 100% RA. Exam notable for desquamating red rash on palms
and soles, neurologically intact. Labs notable for RPR highly
reactive at 1:256, CSF with 300-475 WBCs and elevated protein to
170. Chemistries, CBC, and UA were unremarkable. CT head
demonstrated no definite evidence of mass effect or abscess. The
patient was given fioricet x2, penicillin G x2, ceftriaxone 2g,
vancomycin 1 g, 2L NS, and 1mg Ativan. Decision was made to
admit for further treatment for likely neurosyphilis.
Pre-transfer vitals were T 98.4, HR 90, BP 158/80, RR 16, O2Sat
100% RA.
On the floor, he is lying comfortably on his bed waiting for his
dinner. He complains of a headache but has no other issues.
Review of systems:
(+) Per HPI
(-) Denies fever, chills, night sweats. Denies cough or
shortness of breath. Denies chest pain. Denies nausea, vomiting,
diarrhea, or abdominal pain. No recent change in bowel or
bladder habits. No dysuria or penile discharge.
Past Medical History:
- HIV (___): He previously took Truvada and another
antiretroviral drug but discontinued these ___ years ago due to
an insurance issue. He is planning to restart HAART with his ID
doctor soon after discharge.
- MRSA cellulitis (___)
- Questionable gamma-globulin deficiency as a child, was born
with PNA and scarlet fever, remembers getting "shots" for it.
After the age of ___ years, he does not remember it being an
issue.
Social History:
___
Family History:
Parents and siblings alive and healthy. No h/o malignancies,
HTN, DM that he is aware of.
Physical Exam:
Admission Physical Exam:
========================
VS: 98.2 131/76 84 19 100%RA
Gen: Middle-aged man sitting comfortably on his bed in NAD
HEENT: NCAT. EOMI.
Neck: supple, 1cm palpable and rubbery anterior chain nodes
bilaterally. No pain on neck flexion
CV: RRR, no murmurs/rubs/gallops
Pulm: CTAB, no crackles or wheezes
Abd: soft, non-tender, non-distended. No rebound or guarding
Ext: WWP, no ___ edema
Skin: Blotchy, mildly erythematous rash over abdomen.
Erythematous, scaling rash on bilateral palms and soles
Neuro: A/Ox3. Hearing intact to finger rub bilaterally. Normal
gait.
Discharge Physical Exam:
========================
VS: 98.3 116/69 81 20 98% RA
Gen: Middle-aged man sitting comfortably on his bed in NAD
HEENT: NCAT. EOMI.
Neck: supple, 1cm palpable and rubbery anterior chain nodes
bilaterally. No pain on neck flexion
CV: RRR, no murmurs/rubs/gallops
Pulm: CTAB, no crackles or wheezes
Abd: soft, non-tender, non-distended. No rebound or guarding
Ext: WWP, no ___ edema
Skin: Blotchy, mildly erythematous rash over abdomen.
Erythematous, scaling rash on bilateral palms and soles
Neuro: A/Ox3. Hearing intact to finger rub bilaterally but
softer on left. Normal gait.
Pertinent Results:
Admission Labs:
===============
___ 02:50AM BLOOD WBC-5.2 RBC-4.87 Hgb-13.7 Hct-41.2 MCV-85
MCH-28.1 MCHC-33.3 RDW-13.2 RDWSD-41.2 Plt ___
___ 02:50AM BLOOD Neuts-57.1 ___ Monos-8.4 Eos-2.5
Baso-0.8 Im ___ AbsNeut-2.99 AbsLymp-1.61 AbsMono-0.44
AbsEos-0.13 AbsBaso-0.04
___ 02:50AM BLOOD ___ PTT-28.6 ___
___ 02:50AM BLOOD WBC-5.2 Lymph-31 Abs ___ CD3%-82
Abs CD3-1314 CD4%-23 Abs CD4-375 CD8%-55 Abs CD8-891*
CD4/CD8-0.42*
___ 02:50AM BLOOD Glucose-134* UreaN-15 Creat-0.9 Na-136
K-3.6 Cl-99 HCO3-27 AnGap-14
___ 06:45AM BLOOD ALT-8 AST-14 LD(LDH)-127 AlkPhos-76
TotBili-0.2
___ 06:45AM BLOOD Albumin-3.8 Calcium-9.1 Phos-4.1 Mg-2.1
Discharge Labs:
===============
___ 06:03AM BLOOD WBC-6.2 RBC-4.99 Hgb-14.1 Hct-42.5 MCV-85
MCH-28.3 MCHC-33.2 RDW-13.6 RDWSD-42.0 Plt ___
___ 06:03AM BLOOD Glucose-89 UreaN-10 Creat-0.7 Na-141
K-4.1 Cl-103 HCO3-32 AnGap-10
___ 06:03AM BLOOD Calcium-9.3 Phos-4.0 Mg-2.2
Micro:
======
Serum HIV Viral Load ___: Pending
RPR ___: Nonreactive
CSF Viral Culture ___: No enterovirus isolated
CSF Culture ___: ___ no PMNs and no organisms; bacterial and
fungal cultures NG; AFB cultures pending
CSF HIV Viral Load ___: Pending
CSF Cryptococcal Antigen ___: Negative
CSF VDRL: Reactive 1:64
Blood Cultures x2 ___: Pending, NGTD
Studies:
========
CT Head w/ contrast:
1. No definite evidence of mass effect or abscess. Please note
contrast MRI of the brain is more sensitive for the evaluation
of intracranial mass or abscess.
2. Paranasal sinus disease as described.
Brief Hospital Course:
___ year-old man with a history of HIV (not on HAART) presenting
with a 4-week history of scaling, erythematous rash on his
bilateral palms and soles along with bilateral tinnitus and
difficulty hearing in the setting of a reactive RPR, most
concerning for tertiary syphilis.
# Syphilis: Tertiary syphilis is the most likely cause for the
scaling rash on his palms and soles along with headache and
tinnitus (auditory nerve involvement). RPR was reactive at his
PCP's office and reactive 1:256 in-house, and CSF VDRL was
reactive 1:64. HSV meningitis ruled out with negative CSF HSV
PCR, so empiric acyclovir d/c'ed on HD2. Bacterial meningitis
unlikely given ___ut initially treated with
vanc/ceftriaxone, which were d/c'ed on HD2 when CSF cell counts
and ___ were not c/w bacterial meningitis (473 WBCs with
lymphocytic predominance, no organisms or PMNs on ___. PICC
inserted on ___ for two-week antibiotic course. Neurosyphilis
treated with IV Penicillin G 4 million units q4h x14 days
(___), and pt was discharged to a SNF to finish antibiotic
course. Pt will require neuro exams and LP with CSF-VDRL q3
months to assess response to treatment. Pt was informed to tell
all close contacts that they need to be treated for syphilis
with a single dose of benzathine penicillin G 2.4 million units
IM. If penicillin allergic, doxycycline 100mg BID x14 days is an
alternative regimen.
# HIV: Not currently on HAART, but has plan to initiate HAART as
outpatient with ID. CD4 count currently 375, viral load pending
on discharge. Was seen by SW consult due to concerns about
patient having trouble affording medications. Pt said that when
he was at risk for losing his job as well as his medication
coverage, he stopped taking antiretrovirals because he knew that
taking them intermittently would be risky. His insurance
situation is now stable, and he will be able to take his
medication consistently.
# Tobacco Abuse:
Pt given tobacco cessation counseling and a nicotine patch while
in-house and upon discharge.
Transitional Issues:
- Penicillin G Potassium 4 Million Units IV Q4H, Duration: 14
Days (___). Will only need 4am, 8am, and 12pm doses on ___.
- Will require neuro exam and LP with CSF-VDRL q3 months to
assess response to treatment.
- F/u HIV viral load and consider restarting HAART.
- Consider further STD workup, including urine GC and chlamydia.
- Please ensure regular STD screening.
- Patient informed to tell all close contacts that they need to
be treated for syphilis with a single dose of benzathine
penicillin G 2.4 million units IM. If penicillin allergic,
doxycycline 100mg BID x14 days is an alternative regimen.
- ___ stay anticipated to be <30 days
# Code status: Full
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Ibuprofen Dose is Unknown PO Frequency is Unknown
Discharge Medications:
1. Ibuprofen 400 mg PO Q6H:PRN pain
2. Acetaminophen 650 mg PO Q4H:PRN headache
3. Nicotine Patch 21 mg TD DAILY
4. Penicillin G Potassium 4 Million Units IV Q4H Duration: 14
Days
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
Primary:
Tertiary syphilis
Secondary:
HIV
Tobacco abuse
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
You presented to ___ with
several months of rash on your hands, headaches, and hearing
loss. You were found to have neurosyphilis and were started on a
two-week course of IV penicillin. You were discharged to a
facility that can help you complete your IV antibiotics.
You should follow up with your PCP after discharge from the
skilled nursing facility to restart HAART for your HIV.
Thank you for allowing us to participate in your care.
Sincerely,
Your ___ Care Team
Followup Instructions:
___
|
10813632-DS-20
| 10,813,632 | 28,201,230 |
DS
| 20 |
2151-11-11 00:00:00
|
2151-11-11 11:58:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: NEUROSURGERY
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Subarachnoid Hemorrhage
Major Surgical or Invasive Procedure:
___ Diagnostic cerebral angiogram
___ Right frontal EVD
___ Diagnostic cerebral angiogram
History of Present Illness:
___ y/o male with PMH significant for HTN, Hyperlipidemia,
and DM who was transferred from ___ with a
subarachnoid
hemorrhage. Per his daughter, the patient developed sudden onset
nausea and vomiting yesterday around 11AM. He then took a nap.
He
awoke this morning and was extremely confused. He complained of
a
headache and continued with nausea with possible vomiting. He
was
brought to ___ and underwent a non-contrast head CT
which showed a subarachnoid hemorrhage. He was transferred to
___ for further evaluation.
Past Medical History:
Hypertension; Hyperlipidemia; DM
Social History:
___
Family History:
No family history of aneurysm.
Physical Exam:
Exam on Admit:
T: 97.8 BP: 148/66 HR: 95 RR: 20 O2Sats 96% RA
Gen: Lying in bed, drowsy. Awakens and opens eyes to name.
___: 3-2mm bilaterally.
Extrem: Warm and well-perfused.
Neuro:
Mental status: Drowsy but awakens to name.
___ to person, place, but stating it is
___.
Language: Speech fluent with good comprehension and repetition.
No dysarthria or paraphasic errors.
Motor: Normal bulk and tone bilaterally. No abnormal movements,
tremors. Strength full power ___ throughout. No pronator drift.
Sensation: Intact to light touch bilaterally.
Toes downgoing bilaterally.
On Discharge:
alert and oriented to person, place and time.
MAE ___
no prontator drift
Incision is clean, dry and intact.
Pertinent Results:
___ 10:44PM BLOOD WBC-10.1 RBC-4.13* Hgb-12.7* Hct-36.9*
MCV-89 MCH-30.7 MCHC-34.4 RDW-13.2 Plt ___
___ 03:57AM BLOOD WBC-12.0* RBC-4.13* Hgb-12.6* Hct-36.9*
MCV-89 MCH-30.6 MCHC-34.3 RDW-13.3 Plt ___
___ 03:57AM BLOOD ___ PTT-24.3* ___
___ 10:44PM BLOOD Glucose-207* UreaN-18 Creat-1.0 Na-143
K-4.8 Cl-111* HCO3-23 AnGap-14
___ 03:57AM BLOOD Glucose-161* UreaN-18 Creat-1.0 Na-144
K-4.3 Cl-112* HCO3-23 AnGap-13
___ 10:44PM BLOOD Calcium-8.3* Phos-3.8 Mg-1.7
___ 03:57AM BLOOD Calcium-8.3* Phos-2.8 Mg-2.3
CTA NECK W&W/OC & RECONS ___
CT HEAD W/O CONTRAST ___
1. Improved ventriculomegaly and slightly increased blood within
the left
lateral ventricle related to ventriculostomy placement. No
evidence of new hemorrhage.
2. Mild mucosal thickening of the left maxillary and paranasal
sinuses.
CXR ___:
As compared to the previous radiograph, the monitoring and
support devices
have been removed. The lung volumes have returned to normal.
Borderline size of the cardiac silhouette without pulmonary
edema. No pneumonia. No pleural effusions.
MRI C-Spine ___:
1. Right paracentral disc protrusion at C5-C6 level, causing
slightly
flattening the right ventral aspect of the cervical spinal cord,
without
causing abnormal cord signal.
2. Other mild multilevel degenerative changes as detailed above.
MRI Brain ___:
1. No significant interval change in subarachnoid hemorrhage and
intraventricular hemorrhage accounting for differences in
technique. No new hemorrhage.
2. Interval decrease in ventricular size with resolution of
previously noted hydrocephalus.
3. Scattered foci of T2/FLAIR signal hyperintensity in the
periventricular, subcortical, and deep white matter which are
nonspecific but a patient of this age most likely reflects the
sequela of chronic small vessel ischemic disease.
CT Head ___:
1. Interval decrease in previously seen subarachnoid and
intraventricular
hemorrhage.
2. Right ventriculostomy tube was partially withdrawn between
___ and ___, with its tip still within the lateral
aspect of the right lateral ventricle. No hydrocephalus.
3. Moderate chronic small vessel ischemic changes.
CT Head: ___:
IMPRESSION:
1. No significant change in the size of the lateral and third
ventricles
following clamping of the EVD.
2. Tip of the EVD has been further withdrawn, now terminating
immediately
lateral to the right lateral ventricle
Brief Hospital Course:
___ year-old male presented to OSH with N/V, HA, confusion and
found on CT scan to have diffuse subarachnoid hemorrhage with
intraventricular extension. Mr. ___ was transfered to
___ for further evaluation. While in the ED, Mr. ___
became sommulent and was intubated at that time. An external
ventriculostomy drain was placed without difficulty and
maintained at 15cm H2O. Mr. ___ was loaded with Keppra
1gm and continued on Keppra BID. Mr. ___ was admitted to
the ICU on the Neurosurgery Service for further care and
management. On ___ Mr. ___ underwent a diagnostic
angiogram which was negative for aneurysm. Mr. ___ was
started on Nimodipine 60mg Q4H and Simvastatin 80mg daily
prophylactically for vasospasm. Mr. ___ blood pressure
was strictly maintained SBP <130 preangiography, but was
liberalized post-angiography to SBP 100-160.
On ___ Mr. ___ neurologic exam was intact and he was
successfully extubated. A preliminary report of the CSF
specimen collected on ___ showed no mincroorganism growth. A
repeat NCHCT was performed on ___ which revealed edistribution
and slight increase in subarachnoid hemorrhage, with increased
blood in the left lateral ventricle in the sellar cistern.
Transcranial dopplers were completed.
On ___, patient remained intact. His EVD remained open at 15.
TCDs were also completed.
On ___ Patient remained neurologically stable. CSF culture has
shown no growth to date. TCS were completed and no vasospasm was
appreciated.
On ___, patient was febrile overnight to 101.3. Cultures were
sent and he was started on vanc/zoysn empirically. TCDs showed
slightly high L ACA, but no vasospasm. CSF was sent and CXR was
negative.
On ___ he remained stbale clinically. His Tmax was 102.2
On ___ patient remained stable, he recieved intermittent IVF
boluses to keep I/Os equal to positive.
On ___ the patient the patient c/o headache and pain meds were
changed. He received a 500cc IVF bolus.
On ___ he underwent an angiogram that was negative and his left
groin was angiosealed.
On ___ he had a Head CT which was stable and then his EVD was
clamped. He toelrated the clamping well into the evening of
___.
On ___, the patient's EVD was removed. Physical therapy and
occupational therapy were consulted.
On ___, The intravenous fluid was discontinued. The arterial
line was discontinued. The patient was deemed ready for
transfer to the floor when a bed was available.
___, the patient continued to be stable. His nimodipine was
discontinued and he was discharged home.
Medications on Admission:
Metformin 1000mg BID; Glipizide ER 10mg BID; Simvastatin 80mg
QD; Lisinopril 20mg PO daily; ASA 325mg PO daily; Vitamin D3
2,000 unit tablet daily
Discharge Medications:
1. Acetaminophen-Caff-Butalbital ___ TAB PO Q4H:PRN pain
RX *butalbital-acetaminophen-caff 50 mg-325 mg-40 mg ___
tablet(s) by mouth every four (4) hours Disp #*30 Tablet
Refills:*0
2. Bisacodyl 10 mg PO/PR DAILY constipation
3. Docusate Sodium 100 mg PO BID constipation
4. Famotidine 20 mg PO BID
5. Lisinopril 20 mg PO DAILY
6. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain
RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours
Disp #*40 Tablet Refills:*0
7. Senna 8.6 mg PO BID constipation
8. Simvastatin 80 mg PO QPM
9. MetFORMIN (Glucophage) 1000 mg PO BID
10. GlipiZIDE XL 10 mg PO DAILY
Discharge Disposition:
Home
Discharge Diagnosis:
SAH (aneurysmal negative)
Cerebral vasospasm
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Discharge Instructions
Subarachnoid Hemorrhage
Surgery/ Procedures:
You had a diagnostic cerebral angiogram to coil the aneurysm.
You may experience some mild tenderness and bruising at the
puncture site (groin).
Activity
We recommend that you avoid heavy lifting, running, climbing,
or other strenuous exercise until your follow-up appointment.
You make take leisurely walks and slowly increase your
activity at your own pace. ___ try to do too much all at once.
You make take a shower.
No driving while taking any narcotic or sedating medication.
If you experienced a seizure while admitted, you must refrain
from driving.
Medications
Resume your normal medications and begin new medications as
directed.
Please do NOT take any blood thinning medication (Aspirin,
Plavix, Coumadin) until cleared by the neurosurgeon.
You have been discharged on a medication to lower your
cholesterol levels. We recommend that you continue this
medication indefinitely.
You may use Acetaminophen (Tylenol) for minor discomfort if
you are not otherwise restricted from taking this medication.
What You ___ Experience:
Mild to moderate headaches that last several days to a few
weeks.
Difficulty with short term memory.
Fatigue is very normal
Constipation is common. Be sure to drink plenty of fluids and
eat a high-fiber diet. If you are taking narcotics (prescription
pain medications), try an over-the-counter stool softener.
When to Call Your Doctor at ___ for:
Severe pain, swelling, redness or drainage from the incision
site or puncture site.
Fever greater than 101.5 degrees Fahrenheit
Constipation
Blood in your stool or urine
Nausea and/or vomiting
Extreme sleepiness and not being able to stay awake
Severe headaches not relieved by pain relievers
Seizures
Any new problems with your vision or ability to speak
Weakness or changes in sensation in your face, arms, or leg
Call ___ and go to the nearest Emergency Room if you experience
any of the following:
Sudden numbness or weakness in the face, arm, or leg
Sudden confusion or trouble speaking or understanding
Sudden trouble walking, dizziness, or loss of balance or
coordination
Sudden severe headaches with no known reason
Followup Instructions:
___
|
10814338-DS-20
| 10,814,338 | 26,420,995 |
DS
| 20 |
2184-02-05 00:00:00
|
2184-02-05 19:12:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Penicillins / Hickory
Attending: ___.
Chief Complaint:
Acute liver failure, alcoholic hepatitis
Major Surgical or Invasive Procedure:
___ - EGD
History of Present Illness:
___ is a ___ year-old woman with a history of alcohol use
disorder, fatty liver disease (MELD-Na 35, DF 106.6, drinks 1
pint vodka per day ), depression, hypertension, who presents
with worsening RUQ pain and found to be in acute liver failure.
She initially presented to and was transferred from ___
___ for abnormal liver tests. Patient states that since
___ she has had increasing RUQ pain radiating to the right
flank. She states it is sharp ___ pain, worse with movement
but continues at rest. She has had multiple episodes of
vomiting, but no hematemesis or coffee ground. no change in
stools, no f/c/cp/sob and she denies any abdominal distention.
In the ED initial vitals: 98.3 102 125/57 18 100% RA
Patient was given: diazepam per CIWA protocol, IV morphine, home
gabapentin, albumin, lactulose, vitamin K, 40 mEq IV potassium,
MVI, thiamine.
Hepatology was consulted and noted that the patient had a
distended abdomen but not fluid that they could tap.
Upon arrival to the floor, the patient reports that she has
right shoulder and back pain. She adds that she also has
suprapubic tenderness. Notes that she takes all of her psych
meds because she is a "psycho" and that if she doesn't take
them, she hears voices and has anxiety. Last drink ___. Was
constipated but had a large BM just before I met her.
REVIEW OF SYSTEMS:
(+) Exertional dyspnea (but not active chest pain), light
headedness
(-) Fever, chills, night sweats, headache, vision changes,
rhinorrhea, congestion, sore throat, cough, shortness of breath,
chest pain, abdominal pain, nausea, vomiting, diarrhea,
constipation, BRBPR, melena, hematochezia, dysuria, hematuria.
All other 10-system review negative in detail.
Past Medical History:
- HTN
- GERD
- Depression & anxiety
- Bipolar disorder
- Schizophrenia
- Alcohol use disorder
- Gastric bypass surgery ___ years ago
Social History:
___
Family History:
- Mother with ovarian tumor
- Father with prostate cancer
Physical Exam:
ADMISSION PHYSICAL EXAM
======================
VS: 98.2 PO 160 / 93 103 18 96 RA
GENERAL: NAD, AOx3 but falling asleep during exam but easy to
redirect and wake up. Pleasant.
HEENT: AT/NC, EOMI, PERRL, sclera icteric, pink conjunctiva,
MMM, poor dentition
NECK: Tender but supple neck, no LAD, no JVD
HEART: Tachycardia, S1/S2, no murmurs, gallops, or rubs
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably
without use of accessory muscles
ABDOMEN: nondistended, +BS, epigastric and RUQ tenderness,
suprapubic tenderness, no rebound/guarding, +hepatomegaly with
nodularity
EXTREMITIES: no cyanosis, clubbing or edema, moving all 4
extremities with purpose
PULSES: 2+ DP pulses bilaterally
NEURO: CN II-XII intact, no asterixis
SKIN: warm and well perfused, jaundiced, palmar erythema, no
spider angiomas, scattered ecchymosis
DISCHARGE PHYSICAL EXAM
======================
PHYSICAL EXAM:
VS: T 97.5, BP 122/75 HR 91 RR 18 O2 94% RA
GENERAL: NAD, AOx3. Pleasant.
HEENT: AT/NC, EOMI, PERRL, sclera icteric, MM
NECK: supple neck, no LAD, no JVD
HEART: Regular rate and rhythm, nl S1/S2, no m/r/g
LUNGS: CTAB, no wheezes/rales/rhonchi
ABDOMEN: +BS, mildly distended without fluid wave, soft, no
tenderness to palpation.
EXTREMITIES: no cyanosis, clubbing or edema, moving all 4
extremities. Soft, tender 1x1 superficial mass inferior to R
deltoid smaller, no ecchymoses, erythema.
PULSES: 2+ DP pulses bilaterally
SKIN: warm and well perfused, no spider angiomas, scattered
ecchymosis, jaundiced.
Pertinent Results:
_______________________
ADMISSION LABS:
___ 01:20AM BLOOD WBC-5.3 RBC-3.25* Hgb-9.3* Hct-25.5*
MCV-79* MCH-28.6 MCHC-36.5 RDW-23.8* RDWSD-58.3* Plt ___
___ 01:20AM BLOOD Neuts-62.6 ___ Monos-11.2
Eos-0.9* Baso-0.4 NRBC-0.6* Im ___ AbsNeut-3.34
AbsLymp-1.31 AbsMono-0.60 AbsEos-0.05 AbsBaso-0.02
___ 01:20AM BLOOD ___ PTT-37.6* ___
___ 07:11PM BLOOD ___ 02:50AM BLOOD Glucose-82 UreaN-9 Creat-1.1 Na-126*
K-3.2* Cl-87* HCO3-24 AnGap-18
___ 02:50AM BLOOD ALT-110* AST-564* AlkPhos-398*
TotBili-10.8* DirBili-6.6* IndBili-4.2
___ 02:50AM BLOOD Lipase-37
___ 03:38PM BLOOD CK-MB-<1 cTropnT-<0.01
___ 11:55AM BLOOD Albumin-4.0 Calcium-9.1 Phos-1.1* Mg-1.5*
___ 11:45AM BLOOD calTIBC-198* Ferritn-635* TRF-152*
___ 11:55AM BLOOD PTH-159*
_______________________
PERTINENT LABS:
___ 11:45AM BLOOD calTIBC-198* Ferritn-635* TRF-152*
___ 07:20AM BLOOD PTH-241*
___ 11:45AM BLOOD HBsAg-Negative HBsAb-Positive
HBcAb-Negative HAV Ab-Positive IgM HAV-Negative
___ 11:45AM BLOOD AMA-NEGATIVE Smooth-NEGATIVE
___ 02:48PM BLOOD CRP-56.0*
___ 11:45AM BLOOD ___
___ 11:45AM BLOOD IgG-2330* IgA-428* IgM-436*
___ 02:50AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 11:45AM BLOOD HCV Ab-Negative
___ 01:27AM BLOOD Lactate-4.9* K-3.2*
___ 11:58AM BLOOD Lactate-2.9*
___ 05:34PM BLOOD Lactate-2.1*
___ 02:50AM BLOOD ALT-110* AST-564* AlkPhos-398*
TotBili-10.8* DirBili-6.6* IndBili-4.2
___ 11:55AM BLOOD ALT-116* AST-562* AlkPhos-385*
TotBili-11.8*
___ 07:11PM BLOOD ALT-106* AST-540* LD(LDH)-442*
AlkPhos-341* TotBili-12.8*
___ 07:20AM BLOOD ALT-98* AST-470* AlkPhos-320*
TotBili-12.8*
___ 07:50AM BLOOD ALT-82* AST-360* AlkPhos-284*
TotBili-14.7*
___ 12:45AM BLOOD ALT-77* AST-297* LD(___)-373*
AlkPhos-270* TotBili-16.3*
___ 07:30AM BLOOD ALT-77* AST-289* AlkPhos-270*
TotBili-17.0*
___ 08:25AM BLOOD ALT-69* AST-221* AlkPhos-257*
TotBili-18.3*
___ 08:05AM BLOOD ALT-67* AST-208* AlkPhos-260*
TotBili-20.6*
___ 07:40AM BLOOD ALT-54* AST-163* LD(LDH)-319*
AlkPhos-223* TotBili-23.7*
___ 08:00AM BLOOD ALT-42* AST-123* AlkPhos-166*
TotBili-20.4*
___ 07:50AM BLOOD ALT-42* AST-131* AlkPhos-161*
TotBili-20.2*
___ 07:50AM BLOOD ALT-41* AST-132* AlkPhos-148*
TotBili-23.9*
___ 07:20AM BLOOD ALT-43* AST-142* AlkPhos-148*
TotBili-26.2*
___ 08:30AM BLOOD AST-147* AlkPhos-161* TotBili-28.9*
___ 08:05AM BLOOD ALT-53* AST-150* LD(___)-271*
AlkPhos-169* TotBili-28.7*
___ 07:45AM BLOOD ALT-50* AST-140* AlkPhos-146*
TotBili-25.0*
___ 08:00AM BLOOD ALT-58* AST-140* AlkPhos-147*
TotBili-22.1*
___ 07:40AM BLOOD ALT-67* AST-147* AlkPhos-151*
TotBili-20.5*
_______________________
DISCHARGE LABS:
___ 07:40AM BLOOD WBC-9.3 RBC-3.10* Hgb-9.3* Hct-28.2*
MCV-91 MCH-30.0 MCHC-33.0 RDW-31.5* RDWSD-99.1* Plt ___
___ 07:40AM BLOOD Plt ___
___ 07:40AM BLOOD Glucose-127* UreaN-15 Creat-0.6 Na-133
K-4.4 Cl-98 HCO3-21* AnGap-18
___ 07:40AM BLOOD ALT-67* AST-147* AlkPhos-151*
TotBili-20.5*
___ 07:20AM BLOOD ALT-83* AST-168* AlkPhos-156*
TotBili-18.8*
_______________________
IMAGING/STUDIES:
___ LIVER OR GALLBLADDER US W/ DUPLEX:
1. Markedly limited evaluation by poor sonographic penetration,
particularly of the liver.
2. Markedly echogenic and heterogeneous liver compatible with
steatosis and/or hepatitis.
3. Patent main portal vein with to and fro flow. Impending
thrombosis is a concern.
4. Right lower quadrant ascites with echogenic debris raising
the possibility peritonitis.
___ Imaging US ABD LIMIT, SINGLE ORGAN:
Limited grayscale ultrasound images of the abdomen were
obtained. Images
demonstrate only a trace volume of fluid in the right lower
quadrant. No
adequately sized pockets of ascites fluid were identified
suitable for
percutaneous drainage.
___ Imaging CTA CHEST:
1. No evidence of pulmonary embolism or aortic abnormality.
2. Diffuse bilateral ground-glass opacities associated with
airspace nodules could be due to atypical infection or pulmonary
edema. Please correlate clinically.
3. Trace right-sided pleural effusion.
4. Mildly enlarged main pulmonary artery could be related to
pulmonary artery hypertension.
5. Limited evaluation of the upper abdomen shows diffuse severe
hepatic
steatosis.
___ EGD
No esophageal varices
___ RUQ US
No evidence of ascites.
___ CXR
No new regions of airspace disease as described.
___ US MSK SHOULDER RIGHT
1.9 x 0.8 x 2.2 cm fluid collection is identified in the
subcutaneous fat of left lateral arm, possibly an old hematoma
given the low level internal echoes.
Brief Hospital Course:
Ms. ___ is a ___ year-old woman with a history of alcohol use
disorder, fatty liver disease (admission MELD-Na 35, DF 106.6,
Child's Class C), depression and hypertension who presented as
transfer from ___ with abdominal pain and elevated
liver enzymes, found to be in acute liver failure secondary to
alcoholic hepatitis.
ACUTE ISSUES:
====================================================
#Alcoholic hepatitis:
#Hyperbilirubinemia:
#Coagulopathy:
Patient has history of heavy alcohol consumption. She also had a
history of fatty liver disease. ___ tried to tap ascites but
could not find a fluid pocket (RUQ US x 2 without fluid). All
infectious and autoimmune work up were negative. RUQ ultrasound
with Doppler was without evidence of portal vein thrombosis. An
EGD on ___ was without evidence of esophageal varices. She was
given one dose of steroids, but then developed pneumonia (which
was treated), so the steroids were stopped. Her total bilirubin
and DF began to increase on ___ (peak Tbili = 28.9 on ___ and
so patient was restarted on steroid trial on ___ with
significant clinical improvement and decrease in Tbili. Patient
was discharged with plan for alcohol abstinence and total 28-day
course of prednisone (discharged on D5 of steroids) and will
follow up with liver clinic on ___.
#Healthcare Associated Pneumonia:
Patient became hypoxic on ___. CTA negative for PE but did show
bilateral pulmonary edema, likely volume overload in setting of
large amount of IV albumin that patient received. Her first
fever of the admission was on ___, at which time she was
started on ceftriaxone and azithromycin. MRSA screen positive.
She was broadened to vanc/cefepime/azithromycin for healthcare
associated pneumonia on ___. She was narrowed to levofloxacin
on ___ and completed 7-day course on ___ without issue.
___:
Patient presented with Cr of 1.7. It improved to Cr 0.6 after
albumin challenge.
#Severe Malnutrition:
Albumin on presentation <3. Secondary to alcohol use disorder.
She was given Ensure shakes to supplement meals. She was also
given thiamine and multivitamin supplementation. She had good
nutrition for duration of stay.
#Hepatic Encephalopathy.
The patient presented altered with asterixis. Significant
improvement with lactulose and rifaximin.
# CHRONIC ISSUES:
=======================================================
#Anemia of chronic inflammation:
The patient presented with Hb of 9.3, which has been stable
throughout admission. Iron studies showed normal iron, low TIBC
and transferrin, very elevated ferritin.
#Hypertension:
Her home valsartan was held initially because of low blood
pressures, but it was restarted on ___ when the patient became
hypertensive.
#Psych:
The patient was seeing psych at ___. She was
continued on her home aripiprazole 5 mg daily and prn clonidine
(with bp holding parameters). Mirtazapine 30 mg QHS was held per
psych recommendation given that patient only takes
intermittently at home and had no issues during hospitalization.
#GERD:
Continued home omeprazole.
====================================================
TRANSITIONAL ISSUES
====================================================
[ ] Please follow up CBC, Chem7, LFTs, and INR at next liver
appointment
[ ] Will be discharged with 40mg daily until ___ and will be on
day 11 of steroids on ___. Plan to prescribe refills at that
time for completion of 28-day trial on ___.
Discharge Tbili: 18.8
Discharge Cr: 0.6
Discharge weight: 87 kg
#CODE STATUS: FULL CODE
#CONTACT/HCP: ___ ___, friend/proxy
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Valsartan 80 mg PO DAILY
2. Omeprazole 20 mg PO DAILY
3. Gabapentin 800 mg PO QID
4. Daily-Vite (multivitamin) 1 tablet oral DAILY
5. Sucralfate 1 gm PO QID
6. ARIPiprazole 5 mg PO DAILY
7. CloNIDine 0.2 mg PO TID as needed for anxiety and auditory
hallucinations
8. Vitamin D ___ UNIT PO DAILY
9. Mirtazapine 30 mg PO QHS
10. Ferrous Sulfate 325 mg PO DAILY
Discharge Medications:
1. FoLIC Acid 1 mg PO DAILY
RX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet
Refills:*3
2. HydrOXYzine 25 mg PO Q6H:PRN Itching
RX *hydroxyzine HCl 25 mg 1 tablet by mouth Up to 4 times a day
every 6 hours Disp #*120 Tablet Refills:*3
3. Lactulose 30 mL PO BID
RX *lactulose 20 gram/30 mL 30 mL by mouth Twice daily
Refills:*3
4. Miconazole Powder 2% 1 Appl TP TID:PRN rash
RX *miconazole nitrate 2 % For rash Three times daily as needed
Disp #*30 Spray Refills:*3
5. PredniSONE 40 mg PO DAILY
RX *prednisone 20 mg 2 tablet(s) by mouth daily Disp #*6 Tablet
Refills:*0
6. Rifaximin 550 mg PO BID
RX *rifaximin [Xifaxan] 550 mg 1 tablet(s) by mouth Twice a day
Disp #*30 Tablet Refills:*3
7. Sarna Lotion 1 Appl TP QID:PRN Itching (hyperbilirubinemia)
RX *camphor-menthol [Sarna Anti-Itch] 0.5 %-0.5 % For itching As
needed Refills:*0
8. Simethicone 40-80 mg PO QID:PRN gas pain
RX *simethicone [Gas Relief] 80 mg 1 tablet by mouth Take up to
4 times daily as needed Disp #*120 Tablet Refills:*3
9. TraMADol 25 mg PO Q6H:PRN Pain - Moderate
RX *tramadol 50 mg 0.5 (One half) tablet(s) by mouth every six
(6) hours Disp #*10 Tablet Refills:*0
10. Zinc Sulfate 220 mg PO DAILY Duration: 14 Days
stop date: ___
RX *zinc sulfate 220 mg (50 mg zinc) 1 capsule(s) by mouth daily
Disp #*4 Capsule Refills:*0
11. ARIPiprazole 5 mg PO DAILY
12. CloNIDine 0.2 mg PO TID as needed for anxiety and auditory
hallucinations
13. Daily-Vite (multivitamin) 1 tablet oral DAILY
14. Ferrous Sulfate 325 mg PO DAILY
15. Gabapentin 800 mg PO QID
16. Mirtazapine 30 mg PO QHS
17. Omeprazole 20 mg PO DAILY
18. Sucralfate 1 gm PO QID
19. Valsartan 80 mg PO DAILY
20. Vitamin D ___ UNIT PO DAILY
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
Primary Diagnosis:
- Alcoholic hepatitis, complicated by Hyperbilirubinemia and
Coagulopathy
Secondary Diagnosis:
- Healthcare Associated Pneumonia
- Severe malnutrition
- Acute Kidney Injury (resolved)
- Hepatic encephalopathy (resolved)
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Ms. ___,
You were hospitalized at ___.
Why were you admitted?
=================================================
- You were transferred here from ___ because you
had belly pain and your liver tests were abnormal.
- These problems are due to your history of alcohol use, which
has severely damaged your liver.
What was done in the hospital?
===================================================
- You had an ultrasound of your liver, which showed that there
was no fluid around your liver.
- You had a fever while hospitalized and so we gave you IV
antibiotics to treat an infection in your lungs (pneumonia).
- We also started you on a 28-day course of steroids, which has
improved your liver function.
What do you need to do?
===============================================
- You will be discharged to a nursing home.
- It is very important that you NEVER drink alcohol again.
- Please follow up with your liver doctor as shown below. Please
also follow up with your primary care provider.
- Please take your medications as prescribed.
Sincerely,
Your ___ Care Team
Followup Instructions:
___
|
10814412-DS-9
| 10,814,412 | 28,253,758 |
DS
| 9 |
2146-08-06 00:00:00
|
2146-08-09 18:36:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: ORTHOPAEDICS
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Right ankle fracture
Major Surgical or Invasive Procedure:
ORIF ___ ___
History of Present Illness:
___ with right ankle fracture. Patient slipped two days ago and
presented to an outside hospital. She was found to have a bimal
ankle fracture there. Surgery was offered but patient refused.
Went to PCP today who referred to an orthopaedic surgeon. She
saw him in clinic and was referred to the ED for ortho
evaluation for surgery. Patient denies any numbness/tingling.
Does take any medications.
Past Medical History:
none
Social History:
___
Family History:
nc
Physical Exam:
___ fire
+SILT SPN/DPN distributions
+foot warm and well-perfused
Brief Hospital Course:
The patient presented to the emergency department and was
evaluated by the orthopedic surgery team. The patient was found
to have R ankle fx and was admitted to the orthopedic surgery
service. The patient was taken to the operating room on ___
for R ankle orif, which the patient tolerated well. For full
details of the procedure please see the separately dictated
operative report. The patient was taken from the OR to the PACU
in stable condition and after satisfactory recovery from
anesthesia was transferred to the floor. The patient was
initially given IV fluids and IV pain medications, and
progressed to a regular diet and oral medications by POD#1. The
patient was given perioperative antibiotics and anticoagulation
per routine. The patient's home medications were continued
throughout this hospitalization. The patient worked with ___ who
determined that discharge to home was appropriate. The ___
hospital course was otherwise unremarkable.
At the time of discharge the patient's pain was well controlled
with oral medications, incisions were clean/dry/intact, and the
patient was voiding/moving bowels spontaneously. The patient is
tdwb in RLE, and will be discharged on Lovenox for DVT
prophylaxis. The patient will follow up in two weeks with Dr.
___ routine. A thorough discussion was had with the
patient regarding the diagnosis and expected post-discharge
course including reasons to call the office or return to the
hospital, and all questions were answered. The patient was also
given written instructions concerning precautionary instructions
and the appropriate follow-up care. The patient expressed
readiness for discharge.
Medications on Admission:
oxycodone
Discharge Medications:
1. Acetaminophen 650 mg PO Q6H pain
2. Docusate Sodium 100 mg PO BID
RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp
#*60 Tablet Refills:*0
3. Enoxaparin Sodium 40 mg SC QHS Duration: 14 Days
Start: Today - ___, First Dose: Next Routine Administration
Time
RX *enoxaparin 40 mg/0.4 mL 40 mg sc at bedtime Disp #*14
Syringe Refills:*0
4. OxycoDONE (Immediate Release) ___ mg PO Q3H:PRN Pain
RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours
Disp #*75 Tablet Refills:*0
5. Vitamin D 400 UNIT PO DAILY
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
R ankle fracture
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Instructions After Orthopedic Surgery
- You were in the hospital for orthopedic surgery. It is normal
to feel tired or "washed out" after surgery, and this feeling
should improve over the first few days to week.
- Resume your regular activities as tolerated, but please follow
your weight bearing precautions strictly at all times.
Medicines
- Resume taking your home medications unless specifically
instructed to stop by your surgeon. Please talk to your primary
care doctor within the next ___ weeks regarding this
hospitalization and any changes to your home medications that
may be necessary.
- Do not drink alcohol, drive, or operate machinery while you
are taking narcotic pain relievers (oxycodone/dilaudid).
- As your pain lessens, decrease the amount of narcotic pain
relievers you are taking. Instead, take acetaminophen (also
called tylenol). Follow all instructions on the medication
bottle and never take more than 4,000mg of tylenol in a single
day.
- If you need medication refills, call your surgeon's office
3-to-4 days before you need the refill. Your prescriptions will
be mailed to your home.
- Please take Lovenox for 2 weeks to help prevent the formation
of blood clots.
Constipation
- Both surgery and narcotic pain relievers can cause
constipation. Please follow the advice below to help prevent
constipation.
- Drink 8 glasses of water and/or other fluids like juice, tea,
and broth to stay well hydrated.
- Eat foods that are high in fiber like fruits and vegetables.
- Please take a stool softener like docusate (also called
colace) to help prevent constipation while you are taking
narcotic pain relievers.
- You may also take a laxative such as senna (also called
Senokot) to help promote regular bowel movements.
- You can buy senna or colace over the counter. Stop taking them
if your bowel movements become loose. If your bowel movements
continue to stay loose after stopping these medications, please
call your doctor.
Incision
- Please return to the emergency department or notify your
surgeon if you experience severe pain, increased swelling,
decreased sensation, difficulty with movement, redness or
drainage at the incision site.
- You can get the wound wet/take a shower starting 3 days after
surgery. Let water run over the incision and do not vigorously
scrub the surgical site. Pat the area dry after showering.
- No baths or swimming for at least 4 weeks after surgery.
- Your staples/sutures will be taken out at your 2-week follow
up appointment. No dressing is needed if your wound is
non-draining.
- You may put an ice pack on your surgical site, but do not put
the ice pack directly on your skin (place a towel between your
skin and the ice pack), and do not leave it in place for more
than 20 minutes at a time.
Activity
TDWB RLE
Followup Instructions:
___
|
10814670-DS-21
| 10,814,670 | 20,879,907 |
DS
| 21 |
2143-10-21 00:00:00
|
2143-10-21 11:23:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: ORTHOPAEDICS
Allergies:
lisinopril
Attending: ___.
Chief Complaint:
R hip pain
Major Surgical or Invasive Procedure:
___: Right hip hemiarthroplasty.
History of Present Illness:
___ w/ hx as below including L hip fx s/p ORIF in ___ s/p fall
w/ R hip fracture. Patient tripped while using his walker and
landed on his right side. He complains of pain in his R hip with
a shortened and externally rotated RLE. He denies any head
strike
or LOC.
Past Medical History:
Coronary Artery Disease
s/p Coronary Artery Bypass Graft x 4 ___
Diabetes
Hyperlipidemia
Hypertension
Seborrheic dermatitis
Cataracts
Social History:
___
Family History:
NC
Physical Exam:
Physical Exam:
98.1 65 134/80 18 100%
Gen: alert, no distress
ENT: EOMI, OP clear
CV: regular rate
Resp: non-labored breathing
Abd: soft, nontender, nondistended
Ext: nontender over midline c-spine, nontender chest wall,
stable
pelvis, TTP R groin but otherwise nontender in RLE with no
crepitus or deformity, RLE is shortened and rotated externally,
well perfused with 2+ DP pulse, other extremities atraumatic and
nontender except for distal radius and thenar eminance of R hand
although intrinsic hand movements are all fully intact and the
hand is well perfused
Neuro: ___ strength throughout except for R hip and knee which
were not tested ___ pain, sensation intact
Skin: warm and dry, no open lesions, multiple areas of
ecchymosis
Pertinent Results:
___ 12:15PM GLUCOSE-193* UREA N-15 CREAT-1.0 SODIUM-140
POTASSIUM-4.4 CHLORIDE-104 TOTAL CO2-25 ANION GAP-15
___ 12:15PM estGFR-Using this
___ 12:15PM WBC-8.1 RBC-4.02* HGB-12.7* HCT-38.4* MCV-96
MCH-31.7 MCHC-33.1 RDW-12.6
___ 12:15PM NEUTS-74.5* LYMPHS-15.6* MONOS-6.3 EOS-2.8
BASOS-0.8
___ 12:15PM PLT COUNT-206
___ 12:15PM ___ PTT-27.4 ___
Brief Hospital Course:
The patient presented to the emergency department and was
evaluated by the orthopedic surgery team. The patient was found
to have right hip fracture and was admitted to the orthopedic
surgery service. The patient was taken to the operating room on
___ for right hip hemiarthroplasty which the patient
tolerated well (for full details please see the separately
dictated operative report). The patient was taken from the OR to
the PACU in stable condition and after recovery from anesthesia
was transferred to the floor. The patient was initially given
IV fluids and IV pain medications, and progressed to a regular
diet and oral medications by POD#1. The patient was given
perioperative antibiotics and anticoagulation per routine. The
patients home medications were continued throughout this
hospitalization. The patient worked with ___ who determined that
discharge to rehab was appropriate. The ___ hospital
course was otherwise unremarkable.
At the time of discharge the patient was afebrile with stable
vital signs that were within normal limits, pain was well
controlled with oral medications, incisions were
clean/dry/intact, and the patient was voiding/moving bowels
spontaneously. The patient is WBAT in the right lower extremity,
and will be discharged on lovenox for DVT prophylaxis. The
patient will follow up in two weeks per routine. A thorough
discussion was had with the patient regarding the diagnosis and
expected post-discharge course, and all questions were answered
prior to discharge.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Amlodipine 10 mg PO DAILY
2. Lovastatin *NF* 40 mg Oral daily
3. MetFORMIN (Glucophage) 1000 mg PO BID
4. Metoprolol Tartrate 50 mg PO BID
5. Tamsulosin 0.4 mg PO HS
6. Aspirin EC 81 mg PO DAILY
Discharge Medications:
1. Amlodipine 10 mg PO DAILY
2. Aspirin EC 81 mg PO DAILY
3. Lovastatin *NF* 40 mg Oral daily
4. Metoprolol Tartrate 50 mg PO BID
5. Tamsulosin 0.4 mg PO HS
6. Acetaminophen 650 mg PO TID
7. Enoxaparin Sodium 40 mg SC DAILY
8. Insulin SC
Sliding Scale
Fingerstick QACHS
Insulin SC Sliding Scale using REG Insulin
9. Multivitamins 1 CAP PO DAILY
10. Vitamin D 400 UNIT PO DAILY
11. OxycoDONE (Immediate Release) 2.5 mg PO Q4H:PRN pain
RX *oxycodone 5 mg 2.5 tablet(s) by mouth q4 hours Disp #*40
Tablet Refills:*0
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
R hip fracture
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
MEDICATIONS:
- Please take all medications as prescribed by your physicians
at discharge.
- Continue all home medications unless specifically instructed
to stop by your surgeon.
- Do not drink alcohol, drive a motor vehicle, or operate
machinery while taking narcotic pain relievers.
- Narcotic pain relievers can cause constipation, so you should
drink eight 8oz glasses of water daily and take a stool softener
(colace) to prevent this side effect.
ANTICOAGULATION:
- Please take lovenox 40mg daily for 2 weeks
WOUND CARE:
- You can get the wound wet/take a shower starting 3 days after
your surgery. You may wash gently with soap and water, and pat
the incision dry after showering.
- No baths or swimming for at least 4 weeks.
- Any stitches or staples that need to be removed will be taken
out at your 2-week follow up appointment.
- No dressing is needed if wound continues to be non-draining.
ACTIVITY AND WEIGHT BEARING:
- Weight Bearing as tolerated
Physical Therapy:
Weight Bearing as tolerated
Treatments Frequency:
Dry sterile dressing to wound daily.
Followup Instructions:
___
|
10814713-DS-7
| 10,814,713 | 23,020,238 |
DS
| 7 |
2141-01-08 00:00:00
|
2141-01-18 09:28:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
vitamin C / Compazine
Attending: ___
Chief Complaint:
weakness
Major Surgical or Invasive Procedure:
none
History of Present Illness:
___ year-old ___ speaking woman with dementia, h/o CAD s/p
PCI ___ yrs ago on plavix, and recently hospitalized at ___.
___ with new diagnosis of afib now presents with 3 days
of generalized weakness.
Her daughter reports that for the last 3 days she has been weak
with poor po intake. She has been complaining of full body pain.
On the day of presentation, she also had 1 episode of nonbloody
nonbilious vomiting and one episode of nonbloody diarrhea. They
were monitoring her vital signs at home, and her heart rates
were within normal limits. No fevers. She became more agitated
yesterday, for which they gave her remeron. She subsequently
slept all day but then refused to move. This concerned her
daughter, who then brought her to the ED.
In the ED, initial vitals: 98.8 88 120/60 24 97%. On exam she
was moaning frequently and unable to provide much history. Labs
were notable for leukocytosis to 15, ___ with Cr 3.4 (unknown
baseline), Na 128, lactate 2.6, bicarb 19. UA was positive for
large ___ and ___ bacteria, 4 WBC. CXR showed gross volume
overload. A BNP was checked which was 11,000. Given a tender
abdominal exam, she underwent CT A/P which showed no acute
process. During her ED stay, she converted to afib with RVR in
the 160s. Her BPs dropped to the ___ systolic with MAPs in
the 60-65 range. She was loaded with 0.5mg IV digoxin. Her rates
were in the 140s upon transfer. During her stay she desatted to
the ___ on RA and was on NRB for a few hours, then back on 4L NC
prior to transfer. She was also given zofran and droperidol for
nausea, and vanc and zosyn for presumed UTI.
On transfer, vitals were: 128 118/64 18 94% 4L Nasal ___
On arrival to the MICU, the patient is complaining of full body
pain. She did not know why she was in the hospital.
Her daughter reports that she was hospitalized at ___ E___ 1.5
months ago for afib with RVR. They treated her with amio and
then digoxin, however, she did not tolerate these medications
due to nausea and sedation. She is apparently very sensitive to
any medications. Since then, she has not been taking medications
for afib. She has a new cardiologist named Dr. ___ at ___.
The daughter reports that they were told her echo at ___
looked okay.
Past Medical History:
Dementia
CAD s/p stent ___ years ago, on ASA and plavix
Afib with RVR diagnosed ___, not on meds
? diabetes (on glipizide)
Social History:
___
Family History:
No heart disease, cancer, or DM
Physical Exam:
Admission Exam:
General- elderly ___ woman moaning in pain, grabbing at
lines and tubes
HEENT- PERRL, EOMI, MMM
Neck- unable to assess due to pt movement
CV- tachycardic, irregular, no m/g/r appreciated
Lungs- CTAB, however lung exam limited due to lack of
cooperation with exam
Abdomen- does not appear to withdraw to pain
GU- no foley
Ext- warm, well perfused, trace ___ pitting edema b/l
Neuro- AAOx1, MAEE, unable to cooperate with neuro exam however
no lateralizing signs, good strength
Patient expired
Pertinent Results:
Admission labs:
___ 08:00PM BLOOD WBC-15.6* RBC-4.14* Hgb-11.8* Hct-37.1
MCV-90 MCH-28.5 MCHC-31.9 RDW-16.8* Plt ___
___ 08:00PM BLOOD Neuts-52 Bands-3 Lymphs-13* Monos-9 Eos-0
Baso-0 Atyps-22* ___ Myelos-0 Promyel-1*
___ 08:00PM BLOOD Hypochr-1+ Anisocy-1+ Poiklo-1+
Macrocy-1+ Microcy-1+ Polychr-NORMAL Ovalocy-1+ Acantho-1+
___ 03:07AM BLOOD ___ PTT-33.8 ___
___ 08:00PM BLOOD Glucose-58* UreaN-62* Creat-3.4* Na-128*
K-4.8 Cl-102 HCO3-19* AnGap-12
___ 08:00PM BLOOD ALT-16 AST-24 CK(CPK)-16* AlkPhos-133*
TotBili-1.2
___ 03:07AM BLOOD Calcium-8.4 Phos-3.8 Mg-1.9
___ 08:00PM BLOOD Albumin-2.3*
___ 04:13AM BLOOD %HbA1c-PND
___ 08:09PM BLOOD Lactate-2.6*
Micro:
___ 2:55 am Rapid Respiratory Viral Screen & Culture
Source: Nasopharyngeal swab.
Respiratory Viral Culture (Pending):
Respiratory Viral Antigen Screen (Final ___:
Negative for Respiratory Viral Antigen.
Specimen screened for: Adeno, Parainfluenza 1, 2, 3,
Influenza A, B,
and RSV by immunofluorescence.
Refer to respiratory viral culture for further
information.
___ 10:15 pm URINE
URINE CULTURE (Preliminary):
GRAM NEGATIVE ROD(S). >100,000 ORGANISMS/ML..
___ BLOOD CULTURE Blood Culture, Routine-PENDING
EMERGENCY WARD
___ BLOOD CULTURE Blood Culture, Routine-PENDING
EMERGENCY WARD
Imaging:
CXR:
Pulmonary edema with possible superimposed pneumonia at the
right
lung base. Followup post-diuresis is advised to further assess.
CT A/P:
1. Mildly dilated gallbladder with gallstones, but no other
signs of
cholecystitis such as gallbladder wall thickening or
pericholecystic fluid.
2. Moderate right and small left pleural effusions with
adjacent atelectasis.
3. Multiple small peripheral hypodensities in the spleen
consistent with
infarcts.
Brief Hospital Course:
___ with h/o dementia, CAD, afib presents with 3 days of
weakness and full body pain, found to have afib with RVR,
hypoxia, and UTI.
# Hypoxia:
Briefly on NRB in the ED, so was admitted to MICU. In MICU, was
94% on 4LNC and no longer required NRB. CXR findings most c/w
pulmonary edema, possibly exacerbated by RVR. Does have h/o CAD
and cardiomegaly on CXR which make heart failure more likely.
However, with leukocytosis, AMS, and body aches, it was
difficult to rule out pneumonia or a viral process. Other
etiologies include PE but no obvious risk factors. Received vanc
and zosyn in ED. Flu swab was negative. Pt was started on a
lasix drip for pulmonary edema. She was called out to the
regular cardiology floor. She was treated empirically with
antibiotics for PNA and diuresed, with resolution of her
hypoxia, but with no improvement in her overall condition, and
decline in her mental status and with continued pauses on
telemetry (see below).
# Afib with RVR:
She was hospitalized in ___ with afib and has been off
rhythm control since then due to not tolerating side effects.
Difficult to say if afib was triggered by hypoxia or if RVR
precipitated fluid overload, thus leading to hypoxia. On
metoprolol 25 BID at home. She was dig loaded in ED, and this
was continued in the MICU. She remained in RVR in the 140s, so
metoprolol was added. However, following this, the pt began
having sinus conversion pauses up to 6 seconds long with likely
tachy brady syndrome. EP was consulted, who recommended
monitoring for now and starting low dose metoprolol to control
tachycardia. Pt was transferred to the ___ team where she
continued to have tachy/bradycardia. Her condition continued to
decline.
# Leukocytosis:
UTI is positive. Cannot exclude pneumonia based on CXR. s/p vanc
and zosyn in ED. Pt received one dose of cefepime in unit, then
changed to CTX. Antibiotics were later discontinued as her
condition deteriorated, and as she was comfort measures only
(see above).
# ___:
Given RVR and fluid overload on CXR this was likely ___ due to
poor forward flow, i.e. cardiorenal injury. She was diuresed
with lasix, but continued to decline.
# Hyponatremia:
Resolved. Most likely hypervolemic due to congestive heart
failure versus hypovolemic with poor po intake, vomiting, and
diarrhea.
# AMS:
This appeared to be a subacute process per the pt's daughter
with gradual worsening since her recent hospitalization in ___. Multiple potential sources including infection (UTI vs
PNA), hypoxia, uremia from ___, hyponatremia, hypoglycemia. In
the unit, she remained confused and agitated, improved with
zyprexa. On the floor, she was initially delerious, and then
became increasingly less responsive.
# Thrombocytopenia:
Given patient's age, anemia, and atypical cells, we suspect she
may have a component of myelodysplastic syndrome, undiagnosed.
Baseline platelet count unknown. No active bleeding.
# CAD/dCHF:
Troponins negative. Continued home atorvastatin, asa, plavix.
Metoprolol was restarted at half home dose due to sinus pauses.
Echo showed hyperdynamic global systolic function; dilated right
ventricle with preserved systolic function; septal flattening
consistent with RV volume overload; at least moderate pulmonary
artery hypertension.
After extensive discussion with the Patient's family, Palliative
Care and the Cardiology team, Patient was made CMO, was seen by
Hospice, and expired peacefully on ___.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY
2. Metoprolol Tartrate 50 mg PO BID
3. GlipiZIDE XL 2.5 mg PO DAILY
4. Pantoprazole 20 mg PO Q12H
5. Docusate Sodium 100 mg PO DAILY:PRN constipation
6. Clopidogrel 75 mg PO DAILY
7. Atorvastatin 80 mg PO DAILY
8. DiphenhydrAMINE 25 mg PO HS:PRN insomnia
9. Fluoxetine 10 mg PO DAILY
Discharge Medications:
Patient expired
Discharge Disposition:
Expired
Discharge Diagnosis:
Atrial fibrillation
Acute Kidney Injury
Discharge Condition:
Deceased
Discharge Instructions:
Dear Ms. ___ family,
Your mother presented with a fast heart rate, kidney
failure, and volume overload (fluid in the heart, lungs, and
tissues). Unfortunately we were not able to reverse this with
medical therapy and she passed away comfortably on hospice.
Unfortuantely, it is unclear what caused this initially.
Followup Instructions:
___
|
10814901-DS-21
| 10,814,901 | 29,757,019 |
DS
| 21 |
2174-09-30 00:00:00
|
2174-10-12 05:45:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: NEUROLOGY
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Dizziness
Major Surgical or Invasive Procedure:
None
History of Present Illness:
The patient is a ___ year old man with hypertension referred to
the ED from his outpatient neurologist due to uncontrolled
hypertension and episodic dizziness.
Mr. ___ states that he has had approximately 4 episodes of
dizziness over the past 2 weeks.
The first episode occurred while visiting someone in a hospital.
He was riding the elevator down towards the lobby when he noted
the sudden-onset of a sensation that "everything started
shaking." The doors of the elevator opened and the "room felt
like it was shaking." He held on to a gurney outside of the
elevator while waiting for the episode to subside. It lasted
approximately 1 minute.
He was "fine" for the next week without any additional episodes.
Then, last week, while he was delivering mail for work, he
noticed that he was "veering towards the left." He was pushing a
hand cart full of mail and felt as though he had "no control"
over the cart. He would pause, and try again to push the cart
straight, but it would repeatedly veer towards the left. He kept
hitting the wall on his left hand side. This persisted for
roughly 1 hour and then resolved. There was no associated double
vision, voice changes, or weakness.
He has had 2 additional episodes of "dizziness" over this time
period though he does not recall the precise details of these
other events. He has felt a "fog" - like "when you're hung over"
- upon wakening in the morning. He has had a "tinge" of a
bitemporal headache over this time period but no thunderclap
headache and no nausea, vomiting, or blurred vision. It was the
incident with the hand cart that prompted him to see his PCP.
He was evaluated by his PCP in ___ yesterday afternoon. BP
there was 140/90 according to the patient. BP at home is usually
140 - 160/80 - 90. He was referred to Dr. ___
neurological evaluation given his episodic unsteadiness. At Dr.
___, his SBP was > 200 mmHg. Dr. ___
referred the patient to the ED for further neurological
evaluation, including MRI.
Past Medical History:
Hypertension
Cervical spine surgery (possibly discectomy) C5-C7 ___
Social History:
___
Family History:
Father had throat and colon cancer. One brother had kidney
cancer, the other brother with prostate cancer. No family
history
of stroke.
Physical Exam:
ADMISSION PHYSICAL EXAM
========================
Vitals: T 96.5, HR 66, BP 171/120, RR 18, Sa 95% RA (initial BP
204/117, peak 230/130)
General: Awake, cooperative, NAD.
HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in
oropharynx
Neck: Supple, no carotid bruits appreciated. No nuchal rigidity
Pulmonary: CTAB
Cardiac: RRR, warm, well-perfused
Abdomen: soft, non-distended
Extremities: Left > right pitting edema, 2+
Skin: no rashes or lesions noted.
Neurologic Exam:
-Mental Status: Alert, oriented. Able to relate history without
difficulty. Language is fluent with intact repetition and
comprehension. Normal prosody. There were no paraphasic errors.
Pt was able to name both high and low frequency objects. Able
to
read without difficulty. Able to follow both midline and
appendicular commands. There was no evidence of apraxia or
neglect.
-Cranial Nerves:
II, III, IV, VI: PERRL 3 to 2 mm and brisk. EOMI without
nystagmus. Normal saccades. VFF to confrontation. Fundoscopic
exam revealed no papilledema, exudates, or hemorrhages.
V: Facial sensation intact to light touch.
VII: Very mild facial asymmetry limited to the mouth. Facial
musculature activates symmetrically.
VIII: Hearing intact to finger-rub bilaterally.
IX, X: Palate elevates symmetrically.
XI: ___ strength in trapezii bilaterally.
XII: Tongue protrudes in midline with good excursions. Strength
full with tongue-in-cheek testing.
-Motor: Normal bulk, tone throughout. No pronator drift
bilaterally. No adventitious movements, such as tremor, noted.
No
asterixis noted.
Delt Bic Tri WrE FE IP Quad Ham TA ___ ___
L 5 ___ 5 ___ 5 5 5
R 5- ___ 5 ___ 5 5 5
-Sensory: Decreased sensation to pin prick in C 5 - 7
dermatomes,
left more than right. No deficits to light touch, pinprick, cold
sensation, vibratory sense, proprioception throughout otherwise.
No extinction to DSS. Romberg absent.
-DTRs:
Bi Tri ___ Pat Ach
L 2 2 2 2 2
R 2 2 2 2 2
Plantar response was flexor bilaterally.
-Coordination: No intention tremor. Normal finger-tap
bilaterally. No dysmetria on FNF or HKS bilaterally. No
overshoot
with mirroring. Unterberger negative.
-Gait/Station: Good initiation. Narrow-based, normal stride and
arm swing. Slightly antalgic. Able to walk tandem for a few
steps, albeit with difficulty.
DISCHARGE PHYSICAL EXAM
======================
Gen - well appearing gentleman in NAD
Resp - breathing comfortable on room air
CV - RRR
-Mental Status: Alert, oriented. Able to relate history without
difficulty. Language is fluent with intact repetition and
comprehension. Normal prosody. There were no paraphasic errors.
Pt was able to name both high and low frequency objects. Able
to
read without difficulty. Able to follow both midline and
appendicular commands. There was no evidence of apraxia or
neglect.
-Cranial Nerves:
II, III, IV, VI: PERRL 3 to 2 mm and brisk. EOMI without
nystagmus. Normal saccades. VFF to confrontation. Fundoscopic
exam revealed no papilledema, exudates, or hemorrhages.
V: Facial sensation intact to light touch.
VII: Very mild facial asymmetry limited to the mouth. Facial
musculature activates symmetrically.
VIII: Hearing intact to finger-rub bilaterally.
IX, X: Palate elevates symmetrically.
XI: ___ strength in trapezii bilaterally.
XII: Tongue protrudes in midline with good excursions. Strength
full with tongue-in-cheek testing.
-Motor: Normal bulk, tone throughout. No pronator drift
bilaterally. No adventitious movements, such as tremor, noted.
No
asterixis noted.
Delt Bic Tri WrE FE IP Quad Ham TA ___ ___
L 5 ___ 5 ___ 5 5 5
R 5- ___ 5 ___ 5 5 5
-Sensory: Decreased sensation to pin prick in C 5 - 7
dermatomes,
left more than right. No deficits to light touch, pinprick, cold
sensation, vibratory sense, proprioception throughout otherwise.
No extinction to DSS. Romberg absent.
-DTRs:
Bi Tri ___ Pat Ach
L 2 2 2 2 2
R 2 2 2 2 2
Plantar response was flexor bilaterally.
-Coordination: No intention tremor. Normal finger-tap
bilaterally. No dysmetria on FNF or HKS bilaterally. No
overshoot
with mirroring. Unterberger negative.
-Gait/Station: Good initiation. Narrow-based, normal stride and
arm swing. Slightly antalgic. Able to walk tandem for a few
steps, albeit with difficulty.
Pertinent Results:
___ 02:03PM BLOOD WBC-6.8 RBC-4.85 Hgb-14.9 Hct-44.3 MCV-91
MCH-30.7 MCHC-33.6 RDW-12.6 RDWSD-41.4 Plt ___
___ 02:03PM BLOOD Glucose-104* UreaN-15 Creat-0.9 Na-144
K-3.7 Cl-102 HCO3-27 AnGap-15
___ 02:03PM BLOOD ALT-26 AST-25 AlkPhos-72 TotBili-0.6
___ 02:13PM BLOOD Calcium-9.2 Phos-3.3 Mg-2.2 Cholest-207*
___ 02:13PM BLOOD %HbA1c-6.0 eAG-126
___ 02:13PM BLOOD Triglyc-809* HDL-25* CHOL/HD-8.3
LDLmeas-84
IMAGING
=======
MRI
There are multiple areas of slow diffusion with associated FLAIR
hyperintensity in the right splenium of the corpus callosum,
left parietal
white matter and in the left external capsule. Findings
suggestive of
subacute infarction.
There is a small hyperintense focus in the right frontal lobe on
diffusion
weighted image without corresponding definite hypointensity on
ADC map and
FLAIR hyperintensity, likely representing subacute to chronic
infarct.
There are multiple chronic lacunar infarction in the bilateral
corona radiata.
There is chronic infarction in the right cerebellum.
There is no evidence of hemorrhage, edema, masses, mass effect,
or midline
shift. The ventricles and sulci are normal in caliber and
configuration.
There is minimal mucosal thickening of the ethmoid air cells,
otherwise the
paranasal sinuses are clear. The mastoid air cells are clear.
The orbits and
globes appear normal. No abnormal marrow signal.
IMPRESSION:
1. Multiple areas of subacute infarction in the right splenium
of the corpus
callosum, left parietal white matter, and in the left external
capsule. No
large vascular distribution infarct is identified.
2. Small subacute to chronic infarction in the right frontal
white matter.
3. Scattered chronic infa infarction rct in the bilateral corona
radiata, and
in the right cerebellum.
4. No hemorrhage or mass.
TTE
IMPRESSION: Mild to moderate symmetric left ventricular
hypertrophy with normal cavity size and
regional/global biventricular systolic function. Mildly dilated
thoracic aorta. No significant valvular
disease detected. No structural cardiac source of embolism
(e.g.patent foramen ovale/atrial septal
defect, intracardiac thrombus, or vegetation) seen.
Brief Hospital Course:
Summary Statement
===================
This is a ___ year old man with poorly controlled hypertension
referred to the ED after multiple episodes of unsteadiness,
including a 60 minute period during which he was repeatedly
veering towards the left. Pt was found to be quite hypertensive
with systolic blood pressures > 200 and MRI revealed multiple
chronic lacunar strokes w/o new acute infarct to explain his
symptoms.
Transitional Issues
=====================
[ ] Please continue to uptitrate patients blood pressure
medications, we did not want to increase too drastically given
report that patient has had systolic blood pressures 140s-160s
at home. We did increase the carvedilol to 25mg BID.
[ ] Please make sure pt has a neurology appointment set up (pt
is atrius pt and cannot be arranged for him)
[ ] Pt encouraged this admission to reconsider using CPAP for
his OSA
[ ] Of note patient has evidence of bilateral ventricular
hypertrophy on a TTE
[ ] Pt's LDL and A1c were pending at discharge, please follow-up
[ ] Pt was discharged with a Ziopatch to look for evidence of
atrial fibrillation
Pt presented w/ multiple episodes of unsteadiness, room shaking
and one episode where he noted veering to the left for ~ 1 hour.
Pt was admitted for blood pressure control and MRI. MRI revealed
multiple chronic lacunar infarcts, likely due to his
uncontrolled hypertension, but no acute infarcts that would have
explained his symptoms. Overall impression is that his transient
symptoms are likely in the setting of uncontrolled hypertension
as well given slightly vague non-stereotyped features. He had an
TTE which was notable for ventricular hypertrophy but otherwise
without concerning features. Pt will be discharged with a Zio
patch to investigate for atrial fibrillation. Blood pressure
this admission was labile but SBP range was between SBP 160-190
even after increase in carvedilol. Elected not to increase
medications further given pt notes that he normally has SBPs in
140s-160s. However, he will most certainly require further
titration of his medications as an outpatient.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. CARVedilol 12.5 mg PO QAM
2. CARVedilol 6.25 mg PO QPM
3. Gabapentin 100 mg PO TID
4. Hydrochlorothiazide 25 mg PO DAILY
5. Losartan Potassium 50 mg PO DAILY
6. TraMADol 50 mg PO ___ WEEKLY
Discharge Medications:
1. Aspirin 81 mg PO DAILY
RX *aspirin 81 mg 1 tablet(s) by mouth once a day Disp #*30
Tablet Refills:*3
2. Atorvastatin 40 mg PO QPM
RX *atorvastatin 40 mg 1 tablet(s) by mouth QPM Disp #*30 Tablet
Refills:*3
3. CARVedilol 25 mg PO BID
RX *carvedilol 25 mg 1 tablet(s) by mouth twice a day Disp #*30
Tablet Refills:*3
4. Gabapentin 100 mg PO TID
5. Hydrochlorothiazide 25 mg PO DAILY
6. Losartan Potassium 50 mg PO DAILY
7. TraMADol 50 mg PO ___ WEEKLY
Discharge Disposition:
Home
Discharge Diagnosis:
Primary Diagnosis
===================
Hypertensive Urgency
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
You were admitted to the hospital due to transient episodes of
dizziness and unsteadiness as well as your high blood pressure.
There was some concern that you had a stroke. You had an MRI
which showed evidence of previous small strokes likely due to
your high blood pressure. However there was not any evidence of
a new stroke to explain your symptoms.
We think this is all likely due to your high blood pressure and
it will be important to continue to work on this with your
primary care physician. We also recommend that you reconsider
have your obstructive sleep apnea treated, as this will be
important to help control your blood pressure as well. You also
had an echocardiogram (ultrasound) of your heart which was
largely normal, though shows some evidence of hypertension and
enlarged heart muscles (called ventricular hypertrophy).
We increased one of your blood pressure medications called
Carvedilol to 25mg two times per day, started you on an aspirin,
as well as a statin medication for cholesterol.
Please take your blood pressure at least ___ daily if possible
and record in a notebook to bring to your primary care
appointment. Please continue to take all of your medications and
go to all of your appointments.
- Your ___ neurology team
Followup Instructions:
___
|
10814905-DS-7
| 10,814,905 | 26,021,073 |
DS
| 7 |
2123-04-10 00:00:00
|
2123-04-10 12:15:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
IV Contrast
Attending: ___.
Chief Complaint:
right flank pain
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ hx of stage IIB pancreatic CA treated with FOLFOX then
gem/abraxane for PD in LN, recently completed ___ cycle, also
underwent cyberknife ___.
She presents to BI with rt flank pain for the past two days. Is
intermittent, when having episode of pain is sever, ___ feels
like wrenching/twisting inside. sometimes also having dull pain
at R ant subcostal margin. She also had some nausea w/ emesis x
2
of stomach contents. No hematemsis or bilious contents. no other
pain. states she did not take MSIR at home because it causes bad
constipation. Currently BM are regualr. No fever/chills. No
cough, SOB. No back pain. No numbness/focal weakness or HA.
In ___ she underwent CT abdomen that was concerning for
progressive disease now with fat stranding of pancreas,
vasculature involvement as well as questionable liver met.
Also had UA with gross hematuria but pt currently has menses.
Pt referred to BI for heme/onc eval and pain treatment and
planning.
In ___ ___ intiial VS 17:48 3 98.7 94 121/76 16 97% RA
she was given 4mg morphine w/ significant improvement in pain
and
IV zofran and 1L NS
REVIEW OF SYSTEMS:
GENERAL: No fever, chills, night sweats, recent weight changes.
HEENT: No mouth sores, odynophagia, sinus tenderness,
rhinorrhea,
or congestion.
CARDS: No chest pain, chest pressure, exertional symptoms, or
palpitations.
PULM: No cough, shortness of breath, hemoptysis, or wheezing.
GI: as above.
GU: No dysuria, hematuruia or frequency.
MSK: No arthritis, arthralgias, myalgias, or bone pain.
DERM: Denies rashes, itching, or skin breakdown.
NEURO: No headache, visual changes, numbness, paresthesias,
focal
weakness, or neurologic symptoms.
HEME: No bleeding or clotting
Past Medical History:
PAST ONCOLOGIC HISTORY: per OMR
Pancreatic cancer stage IIB (T3N1M0)
- ___ Initially presented about three weeks ago with upper
back pain and was prescribed naproxen and flexeril. Shortly
after
starting the new medications she developed jaundice and pruritus
and was found to have abnormal liver function tests and was sent
to the ___ emergency room and then transferred to ___.
- ___ Admission to ___
- ___ ERCP showed a 2 cm stricture in the mid-common bile
duct for which a plastic biliary stent was placed. Brushings
were
taken which returned negative.
- ___ Underwent CTA abdomen, which show a partially necrotic
pancreatic head/neck mass, abnormal appearing peripancreatic
lymph nodes measuring up to 1.5 cm, tumor abutment of the portal
splenic confluence and SMV involvement over a 180 degree
circumference with encasement/narrowing of the GDA. CA ___ on
___ was 438. Her bilirubin on admission was 9.6 but after stent
placement has trended down to 1.7.
- ___ Initial Pancreatic MDC visit
- ___ ERCP cytology revealed pancreatic adenocarcinoma
- ___ ERCP exchange of plastic stent for metal. EUS
report
says, "A 2.5cm ill-defined mass was again noted in the head/neck
of the pancreas. The mass was hypoechoic and heterogenous in
echotexture. The borders of the mass were irregular and poorly
defined. The mass was seen abutting the portal vein,
porto-splenic confluence and the superior mesenteric vein. This
was suspicious for vascular invasion by the mass. CBD stent was
seen in situ. Successful placement of fiducials were placed."
- ___ FOLFIRINOX C1D1 at full dose. Complicated by
febrile
neutropenia and colitis. Admitted to ___. D15 dose not given.
- ___ C1D1 FOLFOX6 + Neulasta
- ___ C2D1 FOLFOX6 + Neulasta
- ___ CT torso showed no metastatic disease and stable
disease to response in the pancreatic mass, but possible
progression in the LNs.
- ___ C1D1 gemcitabine 1000 mg/m2 Abraxane 125 mg/m2 D1,8.
D15 held for low counts
- ___ Start CK
- ___ Complete CK with 2400 cGy
- ___ C2D1 gemcitabine 1000 mg/m2 Abraxane 125 mg/m2
D1,8,15
- ___ PLT 83. Reduce gemcitabine to 750 mg/m2 starting D8
of this cycle.
- ___ C2D15 chemo held for pancytopenia.
- ___ C3D1 gemcitabine 1000 mg/m2 Abraxane 125 mg/m2
D1,8,15
- ___ C3D15 chemo held for cytopenias
- ___ C4D1 gemcitabine 750 mg/m2 Abraxane 100 mg/m2
D1,8,15, delayed for patient preference
- ___ C4D15 dose of gem/Abraxane given, pt unable to make
her D8 visit
PAST MEDICAL HISTORY:
Obesity, depression/anxiety, status post C-section ___
Social History:
___
Family History:
Paternal GM with urinary CA. Maternal GF with melanoma. No FHx
of GI or pancreatic malignancies.
Physical Exam:
ADMISSIOn PHYSICAL EXAM:
General: NAD
VITAL SIGNS: 97.6 124/78 99 18 100%RA
HEENT: MMM, no OP lesions
Neck: supple, no JVD
CV: RR, NL S1S2 no S3S4 or MRG
PULM: CTAB
ABD: BS+, soft, mild ttp R lat subcostal margin, no masses or
hepatosplenomegaly
EXT: warm well perfused, no edema, no CVA tenderness, no spinal
tenderness
SKIN: No rashes or skin breakdown
NEURO: alert and oriented x 4, ___, EOMI, no nystagmus, face
symmetric, no tongue deviation, full hand grip, shoulder shrug
and bicep flexion, full toe dorsiflexion and hip flexion against
resistance bilateral, sensation intact to light touch, no clonus
DISCHARGE PHYSICAL EXAM:
General: NAD
VITAL SIGNS: 98.1 120s/60s ___ 100s 18 98% RA
HEENT: MMM, no OP lesions
Neck: supple, no JVD
CV: RR, NL S1S2 no S3S4 or MRG
PULM: CTAB
ABD: BS+, soft, no tendereness of abdomen or spine/flanks on
exam, no masses or hepatosplenomegaly
EXT: warm well perfused, no edema, no CVA tenderness, no spinal
tenderness
SKIN: No rashes or skin breakdown
NEURO: alert and oriented x 4, ___, EOMI, no asterixis, ___
strength throughout
Pelvic: no signs of rectal bleeding but red blood is coming from
the vagina
Pertinent Results:
IMAGING:
CT abdomen/pelvis - ___ ___
Pneumobilia is present in association with a stent across the
metallic common bile duct, which is unchanged in position. The
liver demonstrates fatty infiltration. There is a new hypodense
lesion measuring low attenuation adjacent to the gallbladder
fossa
within segment V of the liver measuring overall 37 x 18 mm in
axial
___, suggestive of focal fatty infiltration although a
metastasis is hard to exclude . A right adrenal nodule which
previously measured 22 x 19 mm in axial ___ and now
measures
up to 22 x 18 mm , very similar in size. The left adrenal is
unremarkable. A few small hypodense foci in the each at kidney
are
too small to characterize but unchanged and doubtful in
clinical significance. No stones are identified. There has
very mild bilateral hydronephrosis, greater on the right than
left, but unchanged and not necessarily pathological; there is
no indication of an obstructing lesion. The spleen appears
mildly enlarged, measuring up to 15.0 cm in length; p reviously
it measured 13.1 cm.
An ill-defined pancreatic mass in the head narrows the
main
portal vein to a greater than degree before, although probably
still slightly patent, suggesting underlying progression of
tumor. The tumor is infilrative and irregular in shape, and
accordingly difficult to measure precisely, but appears
slightly increased; it now contains a small amount of gas which
may be associated with necrosis but likely from the stent lumen.
There is also new stranding about the pancreas as well as
ill-defined fluid or infiltration of the right anterior
pararenal space. The body and tail of the pancreas show similar
ductal dilatation. The pancreatic duct again measures 6 mm in
diameter. Tumor
invo lvement of the celiac axis and common hepatic artery
hasincreased and it may be that the artery is now occluded with
collaterals, although not optimally delineated non-angiographic
technique. Central mesenteric lymph nodes appear mildly more
prominent particularly with regard to number but not enlarged by
size criteria.
The duodenum appears partly encased but there is
noobstruction. The colon is unremarkable. Pelvis: A small
quantity of ascites is present in the pelvic cul-de-sac.
The uterus is mildly enlarged with minimally uneven
outer cont our, particularly posteriorly, possibly
reflectingf
ibroids. There is a a left-sided involve are cyst measuring
up to 26 x 17 mm in axial ___, respectively. In the right
lower quadrant, there is a small nodule, probably a lymph node
measuring 10 mm in length, previously 7 mm. An additional
tiny nodule measures 4 mm, not apparent before but quite
small.Mild
atherosclerotic calcification is present.
Bones: There are no suspicious lytic or blastic bone
lesions. The bones appear de mineralized.
MRI ___ liver at BID
IMPRESSION:
1. Segment V hepatic lesion seen on prior CT is compatible
with increased focal fat deposition on a background of diffuse
hepatic steatosis. No suspicious liver lesion detected.
2. 2.7 cm pancreatic head mass with worsening moderate
compression of the proximal main portal vein and a small
nonocclusive thrombus in the narrowed segment, new since
___.
3. Mild splenomegaly and trace perihepatic ascites suggest
portal hypertension.
3. 1.7 cm right adrenal adenoma.
4. Gallbladder sludge.
Brief Hospital Course:
Ms ___ is a ___ yr old female with hx stage IIB pancreatic
cancer s/p cyberknife and most recently ___ C4D1 abraxane who
presents with acute R flank pain and imaging concerning for
progressive disease w/ worsening vascular involvement (portal
vein narrowing further, possibly complete celiac artery
occlusion) found also to have Hct drop in the setting of menses.
Anemia - Hct drop initially likely ___ hemodilution as no reason
clinically to suspect internal bleeding at that time (and
subsequently no evidence of such on MRI) however drop was
noteworthy. Underlying baseline anemia likely ___ chemo, though
recent clinic visit had noted worsening anemia and considered
etiologies; at that time iron 14 (ferritin 54 and TIBC 342
suggests possibly superimposed iron deficiency). Pt also
currently menstruating during this admission with heavy flow.
She stated her last period was ___ months ago and she has a
history of heavy periods. She may just be perimenopausal and
having irregular periods however she noted being told she had a
history of fibroids at one point (s/p Csection in ___ but
subsequently told she did not have them. Pelvic ultrasound was
done which showed only one small fibroid and nothing else
unusual. Overall Hct stable with slight further downtrend which
stabilized. Hemolysis labs and smear were unremarkable. There
was no evidence of GI bleeding (in fact the patient had
constipation) and on pelvic exam it was clear the blood was
coming from the vagina rather than the rectum. Given the iron
studies suggestive of iron deficiency along with the evidence of
active blood loss she was started on iron supplementation. By
the time of discharge her menstrual flow had subsided. She was
instructed to see her OB/gyn the week after discharge for
complete speculum exam.
Heavy/abnormal menstrual bleeding - see anemia above. ultrasound
showed no evidence of cancer or thickened endometrial stripe or
sizeable fibroid. After brief discussion with OB/gyn, it was
felt that she should return on an outpatient basis to have an
endometrial biopsy or at least consideration of such by a
gynecologist. The gyn team said it is sometimes the case that a
sizeable Hct drop can occur simply from abnormal menstrual
bleeding, as above. Her TSH was normal at 1.3.
Pancreatic cancer - clinical picture and imaging as above
concerning for progressive disease and possible new liver met
(fatty infiltration on read but met hard to exclude, however MRI
done at ___ showed fatty focus rather than metastatic
disease), ___ slowly rising. worsening vascular involvement
of tumor on imaging as well - specifically portal vein narrowing
and almost complete occlusion of celiac artery. Poor prognosis
as she has completed 6mo chemo (FOLFOX +
gem/abraxane) and has had cyberknife w/ steadily progressive
disease. As noted, liver lesion however appears to be fatty and
nonmalignant per MRI.
Abd pain - likely ___ pancreatic cancer, possibly compressing
celiac plexus.She was started on MS contin 15mg BID with
excellent effect and went home with this and with prn MSIR 7.5mg
po as needed. She can follow up in the pain clinic if she wishes
to puruse a celiac plexus block in the future if her pain is
poorly controlled.
Portal vein thrombus - new, small, nonocclusive thrombus noted
on MRI noted compared to ___. Pt likely warrants
anticoagulation but given the sizeable Hct drop and heavy
menstrual flow, this was not initiated at this time. Her
outpatient oncologist is aware of this and can start
anticoagulation if Hct stabilizes or at his discretion.
Constipation - significant issue during this hospital stay but
finally had BM before discharge. sent home on standing colase,
senna, dulcolax, miralax, with mg citrate and suppositories prn.
Likely exacerbated by the uptitration of pain meds and addition
of PO iron.
TRANSITIONAL ISSUES:
- Portal vein thrombus, though small/nonocclusive as above
- needs f/u with gynecology for consideration of endometrial
biopsy, pt aware
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Lorazepam 0.5 mg PO Q6H:PRN nausea, vomiting
2. Docusate Sodium 100 mg PO BID
3. Magnesium Citrate 150 mL PO BID PRN constipation
4. Senna 8.6 mg PO BID:PRN constipation
5. Morphine Sulfate 7.5 mg IM Q6H:PRN pain
Discharge Medications:
1. Docusate Sodium 200 mg PO BID
RX *docusate sodium [Colace] 100 mg 2 capsule(s) by mouth twice
a day Disp #*80 Capsule Refills:*0
2. Lorazepam 0.5 mg PO Q6H:PRN nausea, vomiting
3. Magnesium Citrate 150 mL PO BID PRN constipation
4. Senna 17.2 mg PO BID constipation
RX *sennosides [senna] 8.6 mg 2 capsules by mouth twice a day
Disp #*80 Capsule Refills:*0
5. Bisacodyl 10 mg PO DAILY
RX *bisacodyl 5 mg 2 tablet(s) by mouth daily Disp #*60 Tablet
Refills:*0
6. Ferrous Sulfate 325 mg PO BID
RX *ferrous sulfate 325 mg (65 mg iron) 1 tablet(s) by mouth
twice a day Disp #*60 Tablet Refills:*0
7. Ondansetron 4 mg PO Q8H:PRN nausea
RX *ondansetron 4 mg ___ tablet(s) by mouth every 8 hours as
needed Disp #*45 Tablet Refills:*0
8. Polyethylene Glycol 17 g PO DAILY:PRN constipation
RX *polyethylene glycol 3350 [Miralax] 17 gram 1 powder(s) by
mouth daily prn Disp #*30 Packet Refills:*0
9. Prochlorperazine 10 mg PO Q6H:PRN nausea
RX *prochlorperazine maleate [Compazine] 10 mg 1 tablet(s) by
mouth every 6 hours as needed Disp #*45 Tablet Refills:*0
10. Morphine Sulfate ___ 7.5-15 mg PO Q4H:PRN pain
RX *morphine 15 mg ___ tablet(s) by mouth every 4 hours as
needed Disp #*60 Tablet Refills:*0
11. Morphine SR (MS ___ 15 mg PO Q12H
dont drive or use alcohol with this
RX *morphine 15 mg 1 tablet(s) by mouth twice a day Disp #*60
Tablet Refills:*0
12. Lactulose 30 mL PO DAILY:PRN constipation
RX *lactulose 20 gram/30 mL 30 mL by mouth daily if needed
Refills:*0
Discharge Disposition:
Home
Discharge Diagnosis:
Pancreatic cancer
Iron Deficiency Anemia
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
You were admitted with abdominal pain. We did a CT scan which
showed question of a liver lesion concerning for cancer but our
MRI suggested it was just an area of focal fat deposit. We
started you on long acting morphine for pain, to be taken twice
a day, with short acting morphine pills to be used in addition
to this throughout the day.
Your blood counts were dropping and this was likely due to heavy
vaginal bleeding from your period. However given the degree of
bleeding we did an ultrasound which actually didn't show any
significant fibroids. We started you on iron supplementation.
make sure to take the iron with food and use the medications to
prevent constipation (take colase and senna and dulcolax every
day) and if you develop constipation you should ALSO use miralax
that day. it is ok if you need to use the miralax every day.
Actually I would recommend you just use the miralax daily to
prevent a bad situation with constipation and use a SECOND dose
if you are constipated.
It is important that you see a gynecologist within ___ weeks
after discharge. Your bleeding was signficant and given your
age, you will need a biopsy of the inside lining of the uterus
at some point to make sure there is no evidence of cancer. Our
ultrasound didn't suggest cancer, but anyone over ___ with
abnormal bleeding like this should have it investigated further
just to be safe. I know you don't have a gynecologist so if your
primary care doctor cannot get you in to see a gynecologist in
the next ___ weeks please call OUR gynecologists (information is
below) and make an appointment to come to ___. It is important to
follow up on this. If you bleeding gets worse again please call
your doctor immediately.
In the future if you have worsening pain, talk to Dr. ___
___ You should make an appointment to be seen in our pain clinic
to consider a nerve block near your tumor which would numb some
of the nerves affected by the tumor likely responsible for
causing the pain. You can call ___ and ask for the next
available appointment with Dr. ___.
For pain, use the long acting morphine twice a day (it is called
MS CONTIN) and use the short acting morphine (MS ___, ___
sulfate) during the day if you have extra pain. These meds have
similar names so it can be confusing so pay attention to this on
the bottle.
Followup Instructions:
___
|
10815292-DS-2
| 10,815,292 | 29,052,052 |
DS
| 2 |
2166-06-26 00:00:00
|
2166-06-27 10:25:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: NEUROLOGY
Allergies:
Penicillins / Iodinated Contrast Media - IV Dye
Attending: ___.
Chief Complaint:
expedited workup of progressive dysarthria and ataxia
Major Surgical or Invasive Procedure:
Lumbar puncture
History of Present Illness:
___ is a ___ year-old right-handed woman with
history of anxiety, HTN, HLD, DM, COPD (chronic smoker) followed
by ___ at ___ Neuro since ___ who presents with
worsening ataxia and dysarthria.
In ___ her son remarked on her dysarthria and left
facial droop, and wondered if she had had a stroke. However, in
retrospect she and her family agree that these symptoms came on
gradually. Due to ongoing family turmoil, she was not evaluated
until several months later, at which point her most bothersome
symptoms were left-sided weakness and dysarthria. She had an MRI
of the brain which was negative for stroke and an EMG which
reportedly showed myotonia, and was referred to ___ in
___. At that clinic visit, she was noted to have
dysarthria, mild appendicular ataxia and inability to walk in
tandem. An initial workup consisting of a myelopathy evaluation
and paraneoplastic panel in the serum was sent and reportedly
notable only for low B12, for which she was started on
cyanocobalamin. She returned today for a swallowing evaluation
and was found to have significant progression of her deficits,
with more pronounced dysarthria, appendicular ataxia, and left
sided weakness. Her video swallow showed penetration of thin
liquids but she was cleared for an unrestricted diet.
Since her prior clinic visit, she has fallen twice. Once was a
fall after making a turn too briskly at the bank; the other was
when kicking laundry down the stairs and becoming tangled up
with it. She denies loss of consciousness. She has also had some
episodes of coughing on thin liquids but no frank choking. Her
dysarthria is worse. She has noticed weakness of her left arm
and has dropped things a couple times. She has been having
progressive difficulty performing her activities of daily
living.
On arrival in the ED she was noted to have sinus tachycardia and
received a bolus of 500 cc of normal saline.
She also has a history of childhood/familial muscle cramps
(unclear formal diagnosis) that is likely unrelated to the
current presentation. She complains of stiffness and muscle
cramps since birth which worsen in the cold, with delayed muscle
relaxation. She admits to balance issues and clumsiness in her
teenage years.
Past Medical History:
- HTN
- HLD
- DM
- COPD
- anxiety
- spastic dysarthria
- hereditary myotonic syndrome
Social History:
___
Family History:
Mother: deceased age ___ heart, COPD, diabetes,
Father: deceased age ___ diabetes mellitus, bladder cancer with
mets to liver
She has 7 brother and sisters who are healthy.
Paternal family history of myotonia: She has a pertinent family
history of similar muscle cramping problems in multiple
relatives. For example her father, brother, son, niece and
sister get cramping of their eyes when they rubbed her eyes and
are unable to open them. In addition, she has a great nephew,
which is her sister's daughter's son who has been diagnosed with
a sodium channel genetic abnormality (sodium channel gene
problem in the SCN4A.) Pedigree appears consistent with AD
disorder.
Physical Exam:
General: Overweight woman who appears stated age, sitting in
chair, NAD. Obese trunk with minimal cutaneous fat on arms and
legs.
HEENT: No scleral icterus or injection. Moist mucus membranes.
Neck: Supple, multiple subcentimeter lymph nodes noted in
posterior cervical chain with one 1.5 cm lymph node in left
supraclavicular area. There is a left-sided, asymmetric
non-tender soft tissue mass at the nape of the neck.
Pulmonary: Normal work of breathing. Vesicular breath sounds
bilaterally, no wheezes or crackles appreciated.
Cardiac: S1/S2 appreciated, RRR.
Abdomen: Obese, soft, nontender, nondistended
Extremities: no lower extremity edema
Skin: no rashes or lesions noted.
Neurologic:
-Mental Status: Alert, oriented x 3. Able to relate history
without difficulty and recite pedigree across multiple
generations without difficulty. Attentive to ___ backwards.
Language is fluent and intact to naming of high and low
frequency objects, repetition long and complex phrases, and
comprehension. There were no paraphasic errors. Encoded 3
objects and recalled ___ at 5 minutes. The pt. had good
knowledge of current events. There was no evidence of neglect.
There is dysarthria, spastic speech with lingual > labial >
palatal dysarthria and slowing of all phonemes.
-Cranial Nerves:
I: Olfaction not tested.
II: Pupils round and reactive to light with physiologic
anisocoria, R ___ and L 4.5-2.5. VFF to confrontation with
finger counting.
III, IV, VI: EOMI. There is saccadic breakdown in horizontal
gaze, more prominent on leftward gaze. There are several beats
of low amplitude right rotary nystagmus on rightward gaze and
left rotary nystagmus on leftward gaze but none in primary
position. Saccades are hypometric in all directions of gaze.
V: Facial sensation intact to light touch, pinprick in all
distributions.
VII: Left nasolabial fold flattening, slow to activate and
excursion is not as full. There is intermittent widening of the
left palpebral fissure, but frontalis is not involved.
VIII: Hearing intact to finger-rub bilaterally.
IX, X: Palate elevates symmetrically. Gag is present bilaterally
XI: ___ strength in trapezii and SCM bilaterally.
XII: Tongue protrudes in midline, and is equal ___ strength
bilaterally as evidenced by tongue-in-cheek testing.
-Motor: Increased bulk symmetrically throughout. Spastic catch
in legs bilaterally. Left pronation without drift. No tremor or
asterixis.
Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___
L 4+ 5 4+ ___ 5 4+ 5 4+ 5 5 5 5
R ___ ___ ___ 5 5 5 5 5
- DTRs:
Bi Tri ___ Pat Ach
L 3 2 3 3 2
R 3 2 3 3 2
- Plantar response was flexor bilaterally.
- Jaw jerk present. No grasp.
- Sensory: No deficits to light touch, pinprick in upper
extremities. There is hyperesthesia to pinprick in bilateral
lower extremities from mid-thigh. Vibration and proprioception
are intact in great toes bilaterally. No extinction to DSS.
- Coordination: There is dysmetria on L>R FNF. Finger tapping is
markedly slowed and inaccurate on the L>R. L HKS is
significantly dysmetric, R relatively preserved. L toe tapping
is slow with irregular cadence.
- Gait: Able to rise to a standing position without pushing off.
Good initiation. Gait is wide based but steady. Turn is slow
with multiple steps, but is off balance. Cannot walk in tandem.
On Romberg testing she has difficulty standing with feet
together and eyes open.
Pertinent Results:
LABS
___ 03:00PM BLOOD WBC-9.4 RBC-4.36 Hgb-13.0 Hct-38.5 MCV-88
MCH-29.8 MCHC-33.8 RDW-12.1 RDWSD-38.7 Plt ___
___ 03:00PM BLOOD Neuts-67.8 ___ Monos-6.9 Eos-1.7
Baso-0.4 Im ___ AbsNeut-6.35* AbsLymp-2.14 AbsMono-0.65
AbsEos-0.16 AbsBaso-0.04
___ 03:00PM BLOOD Glucose-211* UreaN-12 Creat-0.9 Na-143
K-3.6 Cl-103 HCO3-26 AnGap-18
___ 03:00PM BLOOD Glucose-211* UreaN-12 Creat-0.9 Na-143
K-3.6 Cl-103 HCO3-26 AnGap-18
___ 03:00PM BLOOD Albumin-4.5 Calcium-9.9 Phos-2.8 Mg-2.5
___ 03:00PM BLOOD ALT-17 AST-19 AlkPhos-119* TotBili-0.3
___ 03:00PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 05:20AM BLOOD SPINOCEREBELLAR ATAXIA TYPE 3-PND
___ 07:00PM CEREBROSPINAL FLUID (CSF) WBC-0 RBC-0 Polys-1
___ ___ 07:00PM CEREBROSPINAL FLUID (CSF) TotProt-42 Glucose-72
___ 07:00PM CEREBROSPINAL FLUID (CSF) PARANEOPLASTIC
AUTOANTIBODY EVALUATION, CSF-PND
************
IMAGING
MR head w/wo contrast ___
IMPRESSION:
1. Somewhat motion limited exam. Within that limitation, no
acute
intracranial process.
2. There is atrophy of the cerebellum, slightly disproportionate
to the degree of age related mild cerebral atrophy.
CT chest ___
IMPRESSION:
1. No evidence of malignancy in the chest.
2. Moderate atelectasis bilaterally.
CT abdomen/pelvis ___
IMPRESSION:
1. No acute intra-abdominal process. No evidence of malignancy
in the abdomen or pelvis.
Brief Hospital Course:
Patient was admitted from clinic for expedited workup of
worsening dysarthria and ataxia as well as spastic hemiparesis
of the left concerning for a progressive cerebellar degenerative
process. Of note, she also has a personal and family history of
myotonia and cramps in the extremities and eyelids. She
underwent MRI brain with/without contrast which showed marked
cerebellar atrophy, left worse than right, but no abnormal
enhancement. She underwent lumbar puncture; cell count and
protein were bland. Numerous studies were sent including CSF
cytology, CSF and serum paraneoplastic panel, as well as genetic
testing for spinocerebellar ataxia type 3. She will be followed
up in clinic to review final results of these studies.
She was found to have a pan-sensitive E coli UTI which was
treated with 3 days of Bactrim DS. She was evaluated by Physical
Therapy who felt she was safe to discharge home with home ___ and
a cane. She was encouraged to enroll in DriveWise or similar
service to assess driving capability if needed.
Transitional issues:
[ ] F/U CSF paraneoplastic panel and serum spinocerebellar
ataxia type 3 analysis.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY
2. Simvastatin 40 mg PO QPM
3. bisoprolol-hydrochlorothiazide ___ mg oral DAILY
4. Imipramine 100 mg PO BID
5. Imipramine 25 mg PO QHS
6. MetFORMIN (Glucophage) 500 mg PO QAM
7. MetFORMIN (Glucophage) 1000 mg PO QHS
8. Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation
inhalation BID
9. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing, sob
10. TRIAzolam 0.25 mg PO QHS:PRN anxiety
11. Cyanocobalamin 500 mcg PO DAILY
12. GlipiZIDE XL 5 mg PO DAILY
Discharge Medications:
1. Striaght cane
Diagnosis: progressive ataxia of unclear etiology
Prognosis: good
Level of need: 13 months
2. Aspirin 81 mg PO DAILY
3. bisoprolol-hydrochlorothiazide ___ mg oral DAILY
4. Imipramine 100 mg PO BID
5. Imipramine 25 mg PO QHS
6. Simvastatin 40 mg PO QPM
7. TRIAzolam 0.25 mg PO QHS:PRN anxiety
8. Cyanocobalamin 500 mcg PO DAILY
9. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing, sob
10. MetFORMIN (Glucophage) 500 mg PO QAM
11. MetFORMIN (Glucophage) 1000 mg PO QHS
12. Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation
INHALATION BID
13. GlipiZIDE XL 5 mg PO DAILY
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
Progressive dysarthria and ataxia of unclear etiology
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Dear Ms. ___,
You were admitted from clinic for symptoms of progressive
worsening slurred speech and gait instability. We performed an
extensive evaluation including an MRI of your brain, which
showed a degenerative process of your cerebellum (the
"cauliflower" of the brain which controls the coordination of
your body) and a lumbar puncture, which is a test in which we
sampled a small amount of cerebrospinal fluid. The preliminary
results of that showed no evidence of acute infection. The final
results will take some time to return; you will follow up with
Dr. ___ in her office to review the final results.
You were also found to have a urinary tract infection while you
were here. We treated you with a 3 day course of an antibiotic
called Bactrim. You do not need further treatment for this.
While you were here, we also had our physical therapist perform
an evaluation. They felt that you were able to safely ambulate
with the help of an assistive device (cane) as well as climb
stairs. We will arrange for a home therapist to visit and work
with you in your home environment to provide specific strategies
and tips to remain safe at home. If there is a concern for
driving, we recommend you participate in DriveWise, which is a
program at ___ that offers an evaluation of your ability to
continue driving.
It was a pleasure taking care of you. We wish you the best.
Sincerely,
Your ___ Care Team
Followup Instructions:
___
|
10815532-DS-13
| 10,815,532 | 22,723,348 |
DS
| 13 |
2184-04-07 00:00:00
|
2184-04-08 10:15:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Statins-Hmg-Coa Reductase Inhibitors
Attending: ___.
Chief Complaint:
Blood in urine
Major Surgical or Invasive Procedure:
R sided thoracentesis.
History of Present Illness:
Mr. ___ is a ___ male with history of metastatic
prostate cancer s/p left PCNU placement on ___ for left-sided
hydronephrosis secondary to bulky lymphadenopathy who presents
for hematuria.
He underwent PCNU placement on ___ and had been doing well at
home. His output from the PCNU slowly cleared and was a normal
clear yellow for several days. However, the day prior to
admission his urine output changed from clear yellow to dark
red.
He denies any trauma or dislodgement of the PCNU. His ___
noticed
the change and his vitals were notable for BP 100/62 and HR 110.
His ___ recommended him to go the ED for further evaluation.
On arrival to the ED, initial vitals were 97.8 105 120/80 18 98%
RA. Labs were notable for WBC 7.2, H/H 11.837.9, Plt 337, Na
132,
Cl 91, BUN/Cr ___, lactate 1.6, and UA with large blood,
large
lueks, negative nitrite, WBC > 182, RBC > 182, and bacteruria.
___
was consulted who recommended CTA abdomen for further evaluation
which showed correct position of PCNU with possible blood
products in the bladder. Patient was given ceftriaxone 1g IV,
morphine 4mg IV x 2, and 2L NS. Prior to transfer, vitals were
98.7 114 113/60 18 96% RA.
On arrival to the floor, the patient reports a poor appetite
which is chronic. He notes generalized fatigue for several
months. Also reports pain in his pelvis/groin on the left. He
reports that since the PCNU he has not had any urine output via
his urethra however today had a small amount of leakage He
denies
fevers/chills, headache, dizzinesss/lightheadedness, shortness
of
breath, cough, chest pain, flank pain, nausea/vomiting,
diarrhea,
and dysuria.
Past Medical History:
Arthritis
Coronary Artery Disease
Diabetes Mellitus Type II
Diabetic Neuropathy
Gout
Hypertension
Metastatic Prostate Cancer s/p Lupron, Bicalutamide, and
radiation
Mitral Regurgitation
Mitral Valve Prolapse
Social History:
___
Family History:
Father ___ in ___
Physical Exam:
Discharge exam
VS 97.5 90-100s/60-70 90-100 18 91% RA
In 660 out ___ yesterday
Heart- RRR S1 and S2 normal. No MRG
Lungs- CTAB, no crackles or wheezes
Abdomen-Soft NT ND
Extremities-No edema.
Neuro: ___ strength throughout, though notably weaker in LLE
(per
pt chronic). Pt with difficulty fully closing left eyelid
dysconjugate extraocular gaze though movements are
coordinated, PERRLA, no tremor/asterixis, left facial droop
left TM with fullness, dullness
Pertinent Results:
___ 02:20PM BLOOD WBC-7.2 RBC-4.69 Hgb-11.8* Hct-37.9*
MCV-81* MCH-25.2* MCHC-31.1* RDW-14.9 RDWSD-43.1 Plt ___
___ 07:20AM BLOOD WBC-5.9 RBC-4.29* Hgb-10.5* Hct-34.3*
MCV-80* MCH-24.5* MCHC-30.6* RDW-16.0* RDWSD-45.1 Plt ___
___ 02:20PM BLOOD Glucose-128* UreaN-16 Creat-1.0 Na-132*
K-4.1 Cl-91* HCO3-25 AnGap-20
___ 07:20AM BLOOD UreaN-15 Creat-0.8 Na-138 K-4.2 Cl-100
HCO3-28 AnGap-14
___ 08:09AM BLOOD ALT-8 AST-15 AlkPhos-106 TotBili-0.2
___ 10:50AM BLOOD proBNP-712*
___ 07:57AM BLOOD PSA-72*
___ 02:33PM BLOOD Lactate-1.___hest
IMPRESSION:
1. Right middle and lower lobe pneumonia.
2. Mild focal interstitial pulmonary edema in the medial
lingula.
3. Bilateral layering nonhemorrhagic moderate-to-large pleural
effusions.
4. Unchanged multifocal sclerotic osseous metastases.
5. Unchanged fusiform ascending thoracic aortic dilation
measuring 4.1 cm. In
the absence of imaging prior to this, ___ year follow-up chest CT
is recommended
to ensure stability.
6. New mediastinal lymphadenopathy is likely reactive.
7. Unchanged 16 mm left adrenal nodule.
RECOMMENDATION(S): In the absence of imaging prior to this, ___
year follow-up
chest CT is recommended to ensure stability of a 4.1 cm
ascending thoracic
aortic aneurysm.
MRI head
IMPRESSION:
1. Postcontrast examination is severely limited secondary to
patient motion.
Within this confine:
2. Apparent 8 mm lesion in the left internal auditory canal with
likely
postcontrast enhancement. Possible asymmetric enhancement of
the left
tympanic and mastoid segments of the facial nerve. There is new
T2
hyperintense signal/opacification of pneumatized left petrous
apex and the
mastoid air cells. It is uncertain whether this lesion
represents
leptomeningeal disease or extension of from an osseous lesion.
No abnormality
is noted in the internal auditory canal on nondedicated
sequences on prior MRI
of ___.
3. Recommend dedicated temporal bone CT for further evaluation
of the osseous
structures.
4. Numerous scattered calvarial lesions consistent with
metastatic disease.
The occipital lesion has a soft tissue component that extends
to the dura and
the scalp. There is also suspicion for extension of the right
orbital roof
lesion into the anterior cranial fossa.
RECOMMENDATION(S): Temporal bone CT is recommended for further
evaluation of
the left temporal bone.
Brief Hospital Course:
___ M with metastatic prostate cancer and PCNU presented with
hematuria, now resolved, found to have Klebsiella UTI, pleural
effusions, and multiple skull based mets with new finding of
auditory canal lesion of unclear etiology.
# Bells palsy/peripheral L ___ nerve palsy
# auditory canal lesion
# numerous osseous/skull mets
___ nerve palsy somewhat chronic (present last 4 months),
overall MRI with finding of new auditory canal lesion w/
enhancement c/f possible extension of osseous lesion vs
leptomeningeal disease. Ct temporal bone however now suggests
possibly cholesteatoma as appears to be soft tissue lesion
rather than osseous lesion, with
extension into the auditory canal effacing the bone covering the
facial nerve, so seems possible explanation for facial palsy,
and further likely to explain his more recent left ear fullness
and reported hearing loss. ENT evaluated and felt very unlikely
cholesteatoma, more likely metastatic lesion. Per Dr. ___,
___ for ___ sessions of CK to the lesion. He also suggested
starting steroids, so 4mg dex daily was started on ___, with
plan to taper or continue per direction of radiation oncology,
and he has follow up with Dr. ___ ___ at which time they
can also be stopped. Note that brain MRI showed numerous
scattered calvarial lesions consistent with metastatic disease.
Of great importance, he must continue supportive care for facial
nerve palsy - artificial tears and ointment nightly, and at
night needs to tape the eye shut. The radiation oncology
department in ___ (Dr. ___, should contact
the patient about scheduling/timing of radiation)
# New large bilateral non-hemorrhagic pleural effusions -
cytology positive for malignant cells per pathologist. There was
nothing clinically or initially radiographically (serial CXR) to
suggest infectious process - pt without fever, cough,
leukocytosis, and pleural fluid cultures not convincing for
infectious process. However ultimately because pleural fluid
cytology was not completely consistent with prostate cancer, we
did a chest CT to evaluate for a possible other malignancy, such
as lung cancer for example, which did not reveal other malignant
process but did suggest pt had right sided pneumonia, therefore
he was treated with a course of 5 days of levoflox ___ - ___
given noteworthy radiographic appearance, however clinically not
consistent with infection. His pleural effusion may also be CHF
related though more likely malignant driver given positive
cytology. Pt with history of CHF but no recent echo in our
system, BNP 700s but no prior for comparison. Clinically
otherwise he did not seem to be in heart failure, no ___ edema.
Very possible that with time his cardiac function is worsening,
however given low BPs in the 80-90 range systolic (back to ___
every time we initiated low dose metop or resumed home Lasix) we
had to hold Lasix/metop regardless, could consider re-eval with
ECHO but likely would not change management given overall
prognosis and hypotension limiting reintroduction of cardiac
meds. ___ for 1.1 L out via ___ on ___ with
reaccumulation on CXR and more dyspnea though comfortable, IP
repeated tap on ___, for 1.7L out with sx improvement. Has f/u
with IP for consideration of pleurex on ___, ctyo from both
taps pending at ___. Holding Lasix due to low blood pressures and
generally low appetite/poor PO intake.
# Gross Hematuria - Resolved. Source of hematuria likely from
invasion of bladder by prostate ca.
# Metastatic Prostate Cancer: Continue Tamoxifen.
Plans for ongoing Enzalutamide treatment as outpatient, has f/u
with Dr. ___ ___. Dr. ___ was able to
secure enzalutamide for him from specialty pharmacy and it will
be delivered to his house, should be started right away at
rehab.
# Hypotension - borderline, overall running low during this
admission, pt with history of heart failure, no recent echo in
our system, s/p MVR with annular ring, last echo ___ with EF
55%. Pt asymptomatic. Suspect that decr po intake also
contributed to BP in ___ range at times, compounded by Lasix
use. Improved somewhat after small amt albumin on ___ post
___. No e/o bleeding or systemic infection (UTI on cipro well
treated it seemed, and clinical picture not consistent with true
pneumonia). Held Lasix as BPs in low ___ and went to ___ when
tried to reintroduce. Also held metoprolol for similar reason -
tried dose reduction to 12.5mg BID but again SBP went to low
___. At rehab, he should weigh himself daily (DC weight 161 lbs)
and if weight goes up more than 3 pounds consider 10mg po Lasix.
# Klebsiella UTI - CTX started on admit ___, changed to cipro
as pan sensitive.
Completed 10d course ___.
# Constipation - addressed ultimately w miralax, Colace, senna.
# Type II Diabetes: Per patient, no longer taking Janumet.
Humalog ISS while admitted but did not require much even after
steroids initiated so stopped insulin sliding scale.
# CAD/Hypertension:
- Continued aspirin
- holding metop as above due to hypotension
# Depression
- Continued citalopram
# Weakness - likely due to progressive cancer, deconditioning w/
hospitalizations, no back pain or particularly pronounced
bilateral lower ext issues to suggest cord compression. Will
optimize nutrition, ___ recommending rehab, pt agrees to rehab.
# Severe protein calorie malnutrition - poor appetite likely due
to malignancy, deconditioning, comorbidities. Initiating
steroids as above seemed somewhat helpful. Nutrition followed,
pt declined offer for dobhoff with enteral feeds.
EMERGENCY CONTACT HCP: ___ (friend) ___
TRANSITIONAL ISSUES:
- continue dexamethasone until sees Dr. ___ on ___ but
likely should stop at that point
- Of great importance, he must continue supportive care for
facial nerve palsy - artificial tears and ointment nightly, and
at night needs to tape the eye shut.
- When enzalutamide arrives to his house (friend will deliver to
rehab) pt should start this right away.
- please weigh patient daily and if weight goes up more than ___
pounds would give ___ Lasix po. discharge weight was 73.4
kg/161.9 lbs
- Pt needs to go to interventional pulm apt ___ for pleural
effusion follow up
- pt needs radiation therapy ___, Dr. ___
___ to the auditory canal lesion
Greater than 30 minutes were spent on planning and execution of
this discharge.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Citalopram 20 mg PO DAILY
2. Colchicine 0.6 mg PO DAILY:PRN gout
3. Furosemide 20 mg PO DAILY
4. Metoprolol Succinate XL 50 mg PO DAILY
5. Tamoxifen Citrate 10 mg PO DAILY
6. TraMADol 50 mg PO Q6H:PRN Pain - Moderate
7. Aspirin 81 mg PO DAILY
8. Vitamin D 5000 UNIT PO DAILY
9. Multivitamins 1 TAB PO DAILY
10. Vitamin B Complex 1 CAP PO DAILY
Discharge Medications:
1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild
2. Artificial Tear Ointment 1 Appl LEFT EYE QHS
3. Artificial Tears ___ DROP BOTH EYES Q6H dry eyes
4. Dexamethasone 4 mg PO DAILY
5. Docusate Sodium 100 mg PO BID
6. Levofloxacin 750 mg PO DAILY Duration: 2 Days
7. OxyCODONE (Immediate Release) 5 mg PO Q3H:PRN Pain -
Moderate
RX *oxycodone 5 mg 1 tablet(s) by mouth every 3 hours as needed
Disp #*5 Tablet Refills:*0
8. Polyethylene Glycol 17 g PO DAILY
9. Senna 8.6 mg PO BID
10. Aspirin 81 mg PO DAILY
11. Citalopram 20 mg PO DAILY
12. Colchicine 0.6 mg PO DAILY:PRN gout
13. Multivitamins 1 TAB PO DAILY
14. Tamoxifen Citrate 10 mg PO DAILY
15. Vitamin B Complex 1 CAP PO DAILY
16. Vitamin D 5000 UNIT PO DAILY
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
Hematuria-likely from bladder invasion
Bilateral pleural effusion
Klebsiella Urinary infection.
Calvareal(skull) Lesions-likely from malignancy
Discharge Condition:
Stable
Alert oriented
Needs help with transfer, able to ambulate with walker
Discharge Instructions:
Dear ___,
IT was a pleasure taking care of you at ___.
You were admitted as you had blood in your urine. This is most
likely from the invasion of your urinary bladder by prostate
cancer. We discussed with urology and although it may appear
alarming, it does not cause your body's blood counts to drop
significantly and will continue for a while.
You also had your R sided lung drained. You still have some
fluid left and at this time, we are waiting on the lab results
as to the cause of this fluid accummulation. You may need to get
his done again in the future.
During this admission we found several brain lesions in the
skull and your brain which required help from Neurology and
Neuro-oncologists.
Followup Instructions:
___
|
10815532-DS-14
| 10,815,532 | 23,088,000 |
DS
| 14 |
2184-05-04 00:00:00
|
2184-05-05 07:06:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Statins-Hmg-Coa Reductase Inhibitors
Attending: ___.
Chief Complaint:
Left lower extremity weakness
Major Surgical or Invasive Procedure:
None
History of Present Illness:
Mr. ___ is a ___ male with history of metastatic
prostate cancer s/p left PCNU placement on ___ for left-sided
hydronephrosis secondary to bulky lymphadenopathy who presents
from clinic with chief complaint of lower extremity weakness for
evaluation of cord compression.
Patient recently admitted to OMED ___ to ___ with
heamturia which was likely from invasion of bladder by prostate
cancer and was resolved at time of discharge. He had brain
imaging due to chronic seventh nerve palsy which showed concern
for auditory canal lesion as well as multiple calvarial lesions
consistent with metastatic disease. Radiation Oncology was
consulted with plan for CK to the lesion. He also had large
bilateral pleural effusions which were tapped several times with
cytology positive for malignant cells. He was discharged to
___.
Since discharge he was seen by IP on ___ where her
underwent
therapeutic right thoracentesis with removal of 1250cc. On
___, the patient presented to radiation simulation for
planned SRT mapping for left IAC lesion but refused to have
follow-up MRI brain. He was noted at that time to have profound
lower extremity weakness that had progressively worsened in the
last 2 weeks. An MRI Spine was ordered for ___ to accompany
the
MRI brain needed for RT planning. Unfortunately, on ___,
the
patient refused the scan. Dr. ___ requested that he be
admitted directly for inpatient imaging following previously
scheduled thoracentesis on ___. This morning, the
thoracentesis
was ultimately deferred (to allow re-accumulation for planned
TPC
placement). He had a CXR which showed increased moderate to
large
right pleural effusion and moderate left pleural effusion. He
was
referred directly to the ER.
Patient reports bilateral lower extremity weakness (left worse
than right) for the past five to seven days. Has been using a
walker but for the past two days has felt too weak to get out of
bed. Has been trying to participate in ___ at rehab but found
difficult. Also notes pain across lower back. He denies lower
extremity numbness and urine/stool incontinence. He also
endorses
poor PO intake due to poor appetite and dislike of the food at
rehab. He reports 40 pound weight loss over the past ___ months.
On arrival to the ED, initial vitals were 97.4 110 ___ 95%
on 6L. Exam notable for normal strength/sensation in lower
extremities and intact rectal tone. Labs were notable for WBC
6.8, H/H 9.7/35.1, Plt 373, Na 136, Cl 95, CO2 17, BUN/Cr 95/17,
and lactate 3.5. No imaging obtained. Patient was given
oxycodone
5mg PO and 1L NS. Vitals prior to transfer were 113 115/76 26
89%
2.5L.
On arrival to the floor, the patient reports ___ lower
abdominal
pain which is chronic. He notes constipation but just had a
bowel
movement. He notes intermittent dizziness and mild shortness of
breath. Patient denies fevers/chills, headache, vision changes,
cough, chest pain, palpitations, abdominal pain,
nausea/vomiting,
diarrhea, hematemesis, hematochezia/melena, dysuria, hematuria,
and new rashes.
REVIEW OF SYSTEMS: A complete 10-point review of systems was
performed and was negative unless otherwise noted in the HPI.
Past Medical History:
PAST ONCOLOGIC HISTORY:
- Abnormal rectal exam in ___. The PSA obtained at that
time was 32.
- ___ the patient underwent prostate biopsy, which showed
___ cores positive for adenocarcinoma, highest ___ score
4+5. The transrectal US showed a mass in the left pelvic area
and
the patient was referred for MRI.
- ___ MRI showed tumor extending through the prostatic
base
into the seminal vesicles greater to the left where there was
extension beyond the seminal vesicles into the pelvic sidewall.
The left pelvic mass measured approximately 5.8x4.5x4cm. The
prostate was described as rotated and deviated to the left.
Invasion of the hypogastric neurovascular bundle was described
with encasement of the sciatic nerve. The distal ureter resulted
dilated with left hydronephrosis. Left pelvic lymphadenopathy up
to 2.3 was also described, as well as 1.4 retroperitoneal
lymphadenopathy to the left of the aortic bifurcation.
- ___ patient was started on Casodex
- ___ CT guided biopsy of the L pelvic sidewall mass.
Pathology examination consistent with metastatic prostate
cancer.
- ___ start Lupron
- ___ to ___ XRT
- Lupron # 4 ___
- Lupron # 5 ___
- Discontinued Lupron ___
- PSA rose from <0.1 in ___ to 6.4 in ___, started
Bicalutamide
- ___: PSA started to rise again, 1.9 in ___ in ___
- ___: Bone scan without mets, CT Torso with some
retroperitoneal lymphadenopathy (stable). PSA up to 2.8.
- ___: Switch to nilutamide 150mg daily
- ___: Rise in PSA, started on Lupron monthly
- ___: L-sided PCNU for hydronephrosis ___ lymphadenopathy
- ___ to ___ admitted to OMED with heamturia which was
likely from invasion of bladder by prostate cancer and was
resolved at time of discharge. MRI Brain showed numerous
scattered calvarial lesions, known occipital lesion with soft
tissue component that extended to dura and scalp, right orbital
roof lesion, and a 8 mm lesion in the left IAC with some
enhancement. There was associated asymmetric enhancement of the
left tympanic and mastoid segments of the facial nerve. There
was
a question of whether this represented the cause of the
patient's
known left facial palsy. He was evaluated by radiation oncology,
who recommended stereotactic hypofractionated radiotherapy to
the
IAC lesion with a palliative intent. He also had large bilateral
pleural effusions which were tapped several times with cytology
positive for malignant cells. He was discharged to ___.
- ___, the patient presented to radiation simulation for
planned SRT mapping for left IAC lesion (with the hope it would
provide palliative improvement in facial palsy). He was noted at
that time to have profound lower extremity weakness that had
progressively worsened in the last 2 weeks. An MRI Spine was
ordered for ___ to accompany the MRI Brain needed for RT
planning. Unfortunately, on ___, the patient refused the
scan despite calls from his radiation oncologist and medical
oncologist. Dr. ___ requested that he be admitted
directly for inpatient imaging following previously scheduled
thoracentesis on ___. This morning, the thoracentesis was
ultimately deferred (to allow re-accumulation for planned TPC
placement). He was referred directly to the ER.
PAST MEDICAL HISTORY:
- Arthritis
- Coronary Artery Disease s/p CABG x 2(LIMA to LAD, SVG to OM)
in
___
- Diabetes Mellitus Type II c/b neuropathy
- Gout
- Hypertension
- Hyperlipidemia
- Metastatic Prostate Cancer s/p Lupron, Bicalutamide, and
radiation
- Mitral Regurgitation s/p MVR with ___ II
annuloplasty ring in ___
- Mitral Valve Prolapse
- Bell's Palsy
- Thoracic Aneurysm
Social History:
___
Family History:
His mother had CHF. His father is deceased and had coronary
artery disease.
Physical Exam:
ADMISSION PHYSICAL EXAM:
VS: Temp 97.5, BP 98/64, HR 113, RR 16, O2 sat 96% on 2.5L.
GENERAL: Pleasant man, in no distress, lying in bed comfortably.
HEENT: Anicteric, PERLL, OP clear.
CARDIAC: Tachycardic, regular rhythm, normal s1/s2, no m/r/g.
LUNG: Appears in no respiratory distress, decreased breath
sounds
at bases bilaterally.
ABD: Normal bowel sounds, soft, mild LLQ tenderness to
palpation,
nondistended, no hepatomegaly, no splenomegaly.
EXT: Warm, well perfused, trace bilateral lower extremity edema,
no erythema or tenderness.
BACK: Left nephrostomy tube draining brown urine. Diffuse lower
back mild tenderness to palpation.
NEURO: Alert, oriented, good attention and linear thought, left
facial droop and left ear with fullness. ___ ___ strength (L>R).
SKIN: No significant rashes.
DISCHARGE PHYSICAL EXAM:
VS: T 97.5 BP 102/68 HR 110 RR 20 O2 4LNC
GENERAL: Chronically ill appearing; tired. No acute distress.
HEENT: Anciteric. Dense left facial palsy. OP clear.
CARDIOVASCULAR: RRR. No MRG.
PULMONARY: Mildly increased WOB. Absent breathsounds over
halfway up both lung bases. No crackles or wheeze.
GASTROINTESTINAL: Nondistended, soft, NT. No HSM. No rebound or
guarding.
NEURO: Alert, oriented x3. Dense left sided facial palsy. Tracks
in all four quadrants. PERLL. Symmetric palate. Normal
sensation
in all 4 extremities. Normal Bilateral upper extremity strength.
RLE- ___ proximal strength. LLE ___ proximal strength. Preserved
distal strength.
MSK: No edema. Diminished bulk.
SKIN: No significant rashes
Pertinent Results:
ADMISSION LABS:
===============
___ 04:50PM BLOOD WBC-6.8 RBC-4.09* Hgb-9.7* Hct-35.1*
MCV-86 MCH-23.7* MCHC-27.6* RDW-17.7* RDWSD-55.3* Plt ___
___ 01:11PM BLOOD Glucose-96 UreaN-17 Creat-0.8 Na-134
K-4.5 Cl-95* HCO3-17* AnGap-27*
___ 01:11PM BLOOD Calcium-9.6 Phos-4.4 Mg-1.9
___ 07:59AM BLOOD PSA-333*
___ 01:22PM BLOOD Lactate-3.5*
DISCHARGE LABS:
===============
___ 08:00AM BLOOD WBC-4.9 RBC-4.28* Hgb-10.0* Hct-33.4*
MCV-78* MCH-23.4* MCHC-29.9* RDW-17.1* RDWSD-47.7* Plt ___
___ 09:15AM BLOOD ___ PTT-43.7* ___
___ 08:00AM BLOOD Glucose-152* UreaN-25* Creat-0.6 Na-137
K-4.2 Cl-100 HCO3-28 AnGap-13
___ 08:00AM BLOOD PSA-353*
___ 07:59AM BLOOD Lactate-1.0
IMAGING:
========
___ Imaging CHEST (PORTABLE AP)
In comparison with the study of ___, there again are
layering bilateral pleural effusions, more prominent on the
right, with associated compressive basilar atelectasis. Known
osseous metastatic disease is again seen.
___ Imaging CT ___ W/O CONTRAST
1. Diffuse extensive metastases involving essentially all imaged
bones.
2. No evidence of compression fractures.
3. The epidural soft tissue encroaching on the spinal canal at
T12 and L3 are best evaluated by prior MRI, however within the
limitations of CT do not appear worse.
4. Degenerative disc disease with disc bulging at L4-5
encroaching on the right L5 nerve root.
___ Imaging CHEST (PORTABLE AP)
1. Layering moderate to large bilateral pleural effusions, right
greater than left. More accurate quantification could be
performed with upright lateral radiograph or CT chest.
2. Known osseous metastatic disease.
___ Imaging MR HEAD W & W/O CONTRAS
1. Progression of osseous metastatic disease with enlargement of
a mass encroaching on the right frontal bone and medial right
orbit.
2. Progression of an osseous lesion involving the sphenoid bone
and lateral portion of the clivus with extension into the
posterior nasopharynx on the right and into the right cavernous
sinus.
3. Definite progression of multiple calvarial metastases since
___. These lesions appear new since the study of ___.
4. Unchanged enhancement in the left internal auditory canal
suggesting leptomeningeal disease.
___ Imaging MR ___ & W/O CONT
1. Diffuse extensive metastases involving essentially all imaged
bones.
2. Wedging of the T12 vertebral body with epidural soft tissue
extending into the spinal canal and deforming at the distal
spinal cord.
3. Expansion of the left pedicle at L3 with intraspinal epidural
soft tissue arising from the pedicle and the posterior margin of
the vertebral body. This encroaches on the left L3 nerve root.
___ Imaging CHEST (PA & LAT)
Increased moderate to large right pleural effusion and moderate
left pleural effusion and increased bibasilar atelectasis when
compared to ___ study.
Brief Hospital Course:
PRINCIPLE REASON FOR ADMISSION
___ year old man with metastatic prostate cancer with widespread
bony involvement and malignant effusions who is admitted with
increasing lower extremity weakness, found to have T12 disease
approaching spinal cord. Now undergoing XRT.
ACTIVE PROBLEMS:
# Lower Extremity Weakness
# Back pain: Weakness likely from extensive metastatic prostate
cancer burden including expansion L3 pedical with encroaching of
the nerve root. He deferred further orthopedic evaluation or
intervention and declinced prophylactic TLSO brace. Planned to
under 5 fractions XRT to T11-S1. First of five fractions
received on ___. Patient had progressive weakness and given
rising PSA, it was felt he was not responding to his therapy for
prostate cancer. We deferred his last XRT session on ___ due to
patient preference. He was started on dexamethasone 4mg po q6
hours. Tapering down every few days to 4mg poq12 hours on
discharge. ___ continue taper dose by half every 5 days per
patient comfort if needed.
# Metastatic Prostate Cancer: Recently found to have recurrence
with retroeritoneal disease causing urinary outflow obstruction
requiring PCN. Also with malignant effusions and widespread bony
metastatic burden. PSA on admission elevated to 333 from 72 on
___. Continued to rise inhouse. He was recently started
enzalutamide early ___. However, cancer continued to
progress, and it is felt he is unlikely to have good response to
enzalutamide at this point. Therefore, he was made DNR/DNI and
we decided to pursue hospice. We did continue the enzalutamide
and tamoxifen, however, as he had the medication already and he
seemingly tolerated it well. Follow up with Dr. ___ as
needed.
# Peripheral Left ___ Nerve Palsy
# Auditory Canal Lesion
# Numerous Calvarial Mets: Patient with several month history of
seventh nerve palsy. MRI recently found new auditory canal
lesion with enhancement c/f possible extension of osseous lesion
vs. leptomeningeal disease. Plan had been for SBRT but deferred
given recent developments. We used artificial tears as needed
and ensured to maintain left eye shut while sleeping
# Bilateral Malignant Pleural Effusions/Respiratory Distress:
Patient with bilateral pleural effusions. Right effusion tapped
x
3 with malignant cells prior to admission. He remained mildly
symptomatic with stable O2 requirement. Plan had been to defer
tunneled pleural catheter
placement as outpatient. Given increasing symptoms and goals of
___, we asked IP to evaluate for TPC placement in house.
Unfortunately, his INR was too eleveted to safely undergo
procedure. He does have a follow up appointment in ___ clinic IF
he wishes to attempt repeat procedure after repletion with
vitamin K.
# Coagulaopathy: Developed marked coagulopathy during admission.
Possibly from nutritional deficit vs possible liver metastatic
involvement (no documented liver disease, however). We started
him on vitamin K 5mg po daily x3 days prior to discharge.
# Anion-Gap Metabolic Acidosis: Elevated lactate to 3.5 on
admission. Resolved.
# Hypotension: Hypotensive of admission. Lasix and metoprolol
were held and it resolved. Likely from poor PO intake.
# Enterococcus UTI: Patient with positive urine culture from
rehab prior to admission. Finished 10 day course of augmentin
___. Repeat urine culture negative, persistent pyuria
likely related to PCN.
# Constipation: Continued bowel reigmen
# CAD/Hypertension
- Continued aspirin
- Holding anti-hypertensives
# Depression: Continued citalopram
# Severe Protein Calorie Malnutrition: Poor appetite likely due
to malignancy, deconditioning, comorbidities.
# Mitral Regurgitation s/p MVR with ___ II
annuloplasty ring in ___
FEN: Regular, Encourage PO, Replete Electrolytes PRN scales
PPX: Heparin SC BID
ACCESS: PIV
CODE: Full Code
COMMUNICATION: Patient
EMERGENCY CONTACT HCP: ___ (friend) ___
DISPO: Inpatient Hospice
TRANSITIONAL ISSUES:
- Continue vitamin K 5mg po x2 more doses
- ___ with IP *IF* feasible and appropriate for patient to pursue
tunneled pleural catheter
- ___ complete his current enzalutamide and/or tamoxifen if
feasible. However, unlikely to have positive result at this
point
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild
2. Artificial Tear Ointment 1 Appl LEFT EYE QHS
3. Artificial Tears ___ DROP BOTH EYES Q6H:PRN dry eyes
4. Docusate Sodium 100 mg PO BID
5. OxyCODONE (Immediate Release) 5 mg PO Q3H:PRN Pain - Moderate
6. Polyethylene Glycol 17 g PO DAILY
7. Aspirin 81 mg PO DAILY
8. Citalopram 20 mg PO DAILY
9. Colchicine 0.6 mg PO DAILY:PRN gout
10. Multivitamins 1 TAB PO DAILY
11. Vitamin B Complex 1 CAP PO DAILY
12. Vitamin D 5000 UNIT PO DAILY
13. Tamoxifen Citrate 10 mg PO DAILY
14. Bisacodyl ___AILY:PRN constipation
15. Milk of Magnesia 30 mL PO DAILY:PRN constipation
16. Calcium Carbonate 1250 mg PO QPM
17. Xtandi (enzalutamide) 160 mg oral DAILY
18. Amoxicillin-Clavulanic Acid ___ mg PO BID
19. OxyCODONE SR (OxyconTIN) 20 mg PO QAM
20. OxyCODONE SR (OxyconTIN) 10 mg PO QPM
21. Saccharomyces boulardii 250 mg oral BID
22. Senna 17.2 mg PO BID
23. Acetaminophen 650 mg PO QHS
24. Enoxaparin Sodium 40 mg SC DAILY
Discharge Medications:
1. Dexamethasone 4 mg PO Q8H
RX *dexamethasone 2 mg 2 tablet(s) by mouth q8 hours Disp #*180
Tablet Refills:*0
2. Pantoprazole 40 mg PO Q24H
3. Phytonadione 5 mg PO DAILY Duration: 2 Doses
RX *phytonadione (vitamin K1) [Mephyton] 5 mg 1 tablet(s) by
mouth daily Disp #*2 Tablet Refills:*0
4. OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain -
Moderate
5. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild
6. Acetaminophen 650 mg PO QHS
7. Artificial Tear Ointment 1 Appl LEFT EYE QHS
8. Artificial Tears ___ DROP BOTH EYES Q6H:PRN dry eyes
9. Aspirin 81 mg PO DAILY
10. Bisacodyl ___AILY:PRN constipation
11. Calcium Carbonate 1250 mg PO QPM
12. Citalopram 20 mg PO DAILY
RX *citalopram 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet
Refills:*0
13. Colchicine 0.6 mg PO DAILY:PRN gout
14. Docusate Sodium 100 mg PO BID
15. Milk of Magnesia 30 mL PO DAILY:PRN constipation
16. Multivitamins 1 TAB PO DAILY
17. OxyCODONE SR (OxyconTIN) 20 mg PO QAM
RX *oxycodone 10 mg 1 tablet(s) by mouth qam Disp #*30 Tablet
Refills:*0
RX *oxycodone 20 mg 1 tablet(s) by mouth qpm Disp #*30 Tablet
Refills:*0
18. OxyCODONE SR (OxyconTIN) 10 mg PO QPM
19. Polyethylene Glycol 17 g PO DAILY
20. Saccharomyces ___ 250 mg oral BID
21. Senna 17.2 mg PO BID
22. Tamoxifen Citrate 10 mg PO DAILY
23. Vitamin B Complex 1 CAP PO DAILY
24. Vitamin D 5000 UNIT PO DAILY
25. Xtandi (enzalutamide) 160 mg oral DAILY
Discharge Disposition:
Extended ___
Facility:
___
Discharge Diagnosis:
- Metastatic prostate cancer
- Lumbar metastatic disease with associated leg weakness
- Calvarial/Intra-auditory canal metastatic disease with left
facial never paralysis
- Likely malignant bilateral pleural effusions.
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Lethargic but arousable.
Activity Status: Out of Bed with assistance to chair or
wheelchair.
Discharge Instructions:
Dear Mr. ___,
It has been a pleasure taking ___ of you at ___
___. You were admitted for increasing
weakness in your legs. You were found to have progression of
your prostate cancer in your lower spine, likely causing your
weakness. You also have some fluid building around your lung, as
well. We were hoping to drain the fluid off your lung,
unfortunately your blood is too think for this procedure to be
done safely. Given the progression of your cancer, we talked
with you and Dr. ___ we all decided that transitioning
to an inpatient hospice ___ would help meet your needs best in
the coming days. We wish you all the best,
Your ___ Team
Followup Instructions:
___
|
10816667-DS-21
| 10,816,667 | 25,407,448 |
DS
| 21 |
2148-11-08 00:00:00
|
2148-11-08 20:25:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
-shortness of breath
- leg swelling
Major Surgical or Invasive Procedure:
none
History of Present Illness:
___ with history of HTN, T2DM c/b Stage V CKD with nephrotic
range proteinuria (planning to start dialysis soon),
dyslipidemia, legal blindness with hx of acute angle closure
glaucoma and diabetic retinopathy, and anemia, who presents with
2 days of worsening dyspnea superimposed on several months of
worsening ___ swelling and ascending anasarca.
She was admitted to ___ back on ___ with worsening b/l
lower extremity swelling presumably due to worsening CKD ___
T2DM. She was diuresed in the hopsital and discharged home on
Torsemide 20 mg daily. Since then she has still developed
worsening lower extremity edema b/l and diffuse anasarca
throughout the abdomen. She notes that she is currently ___
pounds above her normal weight. She has also had progressive
dyspnea on exertion, having to pause to catch her breath after
climbing ___ stairs. A contributing factor is also the
heaviness and weakness she experiences in her lower extremities
due to the swelling. In the past two days, she has developed
dyspnea at night while lying down in bed which has prevented her
from sleeping at night. She has two-pillow orthopnea, and has
occasional dyspnea at rest as well. She has an occasional dry
cough, but no sputum production or recent fevers, no sick
contacts. Given her inability to sleep at night ___ SOB she came
to the ED.
- In the ED, initial vitals were:
T 98.8 HR 92 BP 206/110 RR 18 O2 100% RA
- Exam was notable for:
"Coarse breath sounds bilaterally, no crackles or wheezing.
Bilateral pitting edema with some non-purulent blistering and
chronic skin changes"
- Labs were notable for:
WBC 7.2 Hgb 7.4 Plt 387
Cr 5.3 BUN 58 Ca 7.3
pro-BNP 10,000
- Studies were notable for:
CXR
1. Small right pleural effusion.
2. No evidence of pulmonary edema or focal consolidation.
- The patient was given: Lasix 100 mg
On arrival to the floor, she feels comfortable lying in bed,
with
minimal shortness of breath. SBP in the 190s, but denies any
headaches. She denies any current nausea, vomiting, decreased
appetite, or diffuse pruritis. However, she has had uremic
symptoms in the past. She has been feeling more fatigued
recently
but also attributes this to the shortness of breath and feeling
of heaviness from her diffuse swelling. She describes a pressure
and tightness around her chest that is also new. Denies
palpitations or lightheadedness. Her EF is 59% (last TTE
___. She has no hx of cirrhosis or impaired liver function.
In terms of her CKD history, she first developed albuminuria in
___, with progression to nephrotic range in ___. Creatinine
has
been rising since ___, most notably from 2.3 in ___ to ~4s
in
___. She met with nephrology on ___, with whom she
discussed dialysis and kidney transplant options.
Past Medical History:
DMII, complicated by retinopathy, neuropathy, nephropathy
CKDV
Hypertension
Dyslipidemia
Acute angle glaucoma
multiple eye surgeries
Social History:
___
Family History:
Mother Living ___ DIABETES TYPE II
Father ___ ___ HYPERTENSION, PERIPHERAL ARTERY DISEASE
MGM Deceased DIABETES TYPE II
Physical Exam:
=========================
ADMISSION PHYSICAL EXAM:
=========================
VITALS: Temp: 98.8 (Tm 98.8), BP: 196/89, HR: 84, RR: 17, O2
sat: 98%, O2 delivery: RA
GENERAL: Alert and interactive. In no acute distress.
HEENT: R pupil 3mm, L pupil 2mm. Sclera anicteric and without
injection. MMM.
NECK: No cervical lymphadenopathy. No JVD.
CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No
murmurs/rubs/gallops.
LUNGS: Soft inspiratory crackles in the L lower lung base. No
wheezes, rhonchi or rales. No increased work of breathing.
BACK: No CVA tenderness.
ABDOMEN: Normal bowels sounds. Distended abdomen. Non-tender to
deep palpation in all four quadrants. No organomegaly.
EXTREMITIES: No clubbing, cyanosis. 2+ pitting edema b/l.
Non-bleeding ulcerations b/l in the lower legs.
SKIN: Warm. Cap refill <2s.
NEUROLOGIC: AOx3. CN2-12 intact. Moving all 4 limbs
spontaneously. ___ strength throughout. Normal sensation.
========================
DISCHARGE PHSYICAL EXAM
========================
GENERAL: Alert and interactive. In no acute distress. Wearing
sunglasses at baseline (legally blind).
HEENT: R pupil 3mm, L pupil 2mm. Sclera anicteric and without
injection. MMM.
NECK: No cervical lymphadenopathy. No JVD.
CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No
murmurs/rubs/gallops.
LUNGS: CTAB. No wheezes, rhonchi or rales. No increased work
of breathing.
BACK: No CVA tenderness.
ABDOMEN: Normal bowels sounds. Mildly distended abdomen.
Non-tender to deep palpation in all four quadrants. No
organomegaly.
EXTREMITIES: No clubbing, cyanosis. 1+ pitting edema b/l.
Non-bleeding ulcerations b/l in the lower legs.
SKIN: Warm and well-perfused.
NEUROLOGIC: AOx3. Face symmetric except changes noted above.
Moving all 4 limbs spontaneously. Normal sensation.
Pertinent Results:
ADMISSION LABS:
================
___ 04:34AM BLOOD WBC-7.2 RBC-2.65* Hgb-7.4* Hct-23.4*
MCV-88 MCH-27.9 MCHC-31.6* RDW-13.2 RDWSD-43.1 Plt ___
___ 04:34AM BLOOD ___ PTT-30.8 ___
___ 08:15AM BLOOD ___
___ 08:15AM BLOOD Ret Aut-1.4 Abs Ret-0.04
___ 04:34AM BLOOD Glucose-273* UreaN-58* Creat-5.3* Na-139
K-3.9 Cl-104 HCO3-24 AnGap-11
___ 08:15AM BLOOD ALT-17 AST-20 LD(LDH)-350* CK(CPK)-851*
AlkPhos-131* TotBili-<0.2
___ 08:15AM BLOOD CK-MB-5 cTropnT-0.08*
___ 04:34AM BLOOD ___
___ 04:34AM BLOOD Calcium-7.3* Phos-4.5 Mg-1.9
___ 08:15AM BLOOD Hapto-282*
PERTINENT INTERVAL LABS:
========================
___ 06:24AM BLOOD calTIBC-198* Ferritn-66 TRF-152*
___ 06:43AM BLOOD WBC-6.9 RBC-2.34* Hgb-6.6* Hct-20.5*
MCV-88 MCH-28.2 MCHC-32.2 RDW-13.4 RDWSD-42.7 Plt ___
___ 08:40PM BLOOD Hgb-8.8*
___ 06:43AM BLOOD cTropnT-0.09*
IMAGING:
=========
___ CXR PA/LAT:
IMPRESSION:
1. Small right pleural effusion.
2. No evidence of pulmonary edema or focal consolidation.
MICRO:
=======
none
DISCHARGE LABS:
================
___ 06:23AM BLOOD WBC-7.6 RBC-2.95* Hgb-8.3* Hct-25.5*
MCV-86 MCH-28.1 MCHC-32.5 RDW-13.4 RDWSD-41.5 Plt ___
___ 06:53AM BLOOD Glucose-83 UreaN-82* Creat-7.2* Na-140
K-4.2 Cl-99 HCO3-26 AnGap-15
___ 06:53AM BLOOD Calcium-7.8* Phos-6.2* Mg-2.1
Brief Hospital Course:
==================
PATIENT SUMMARY
==================
___ with history of HTN, T2DM c/b Stage V CKD with nephrotic
range proteinuria (planning to start dialysis soon),
dyslipidemia, legal blindness with hx of acute angle closure
glaucoma and diabetic retinopathy, and anemia, who presented
with
2 days of worsening dyspnea superimposed on several months of
worsening ___ swelling and ascending anasarca. She was diuresed
with IV Lasix to good effect, with neg -12 L fluid balance and
15 lb weight loss, accompanied by resolution of her shortness of
breath and improvement ___ swelling. She was discharged on her
home dose of PO torsemide 30 mg.
====================
ACUTE/ACTIVE ISSUES
====================
# Dyspnea, resolved
# Volume overload
# Lower extremity edema
# CKDV
Most likely secondary to CKDV. Sx of chronic volume overload
with
progression to lungs now, despite being on torsemide 30 mg PO
daily at baseline. Myocardial ischemia was ruled out, given
normal ECG, nl
CK-MB, and Trop 0.08 (not concerning I/s/o CKD). On
presentation, she had no symptoms
of uremia, and labs did not show acidemia or hyperkalemia. She
had
discussed the options of dialysis and transplant with ___
nephrology recently. However, given that volume overload was her
primary
symptom, the decision was made to diurese her and defer dialysis
until AV fistula placement could be arranged. She was diuresed
with 100 mg IV Lasix BID and 5 mg
metalozone daily with resolution of SOB and improvement of
anasarca. On her date of discharge on ___, her fluid balance
was net -12 L and her weight was 198.19 lbs, down 15 lbs from
admission. Given her brisk diuresis, she was discharged on her
home dose of PO torsemide 30 mg with instructions for close
follow up if her swelling worsens.
# Hypertensive urgency
# Long-term hypertension management
On presentation, initial BPs in the ED were concerning for
hypertensive urgency with
SBP to 200s, likely worsened from volume overload. She denied
any
headaches. She was started on PO labetalol, which was gradually
uptitrated to 400 mg
TID. Before her discharge, she was transitioned to carvedilol
12.5 mg BID to reduce medication frequency (legally blind and
receives meds in blisterpacks).
# Renal osteodystrophy
She has secondary hyperparathyroidism related to her kidney
disease. Phosphate was elevated throughout admission, max 6.3.
She was placed on Sevelamer 1600 mg TID with meals and her diet
was phosphorus-restricted. Her home calcitriol and Vitamin D
supplements were held, and nephrology recommended that she not
restart them until P < 5.5
# Anemia
Initially thought to be secondary to renal disease I/s/o dec
EPO.
She had started iron as an outpatient. However, given her
subsequent Hb drop (8.3 on ___ to 6.6 on ___, other
etiologies
were considered: occult bleed (GI) vs hemolytic process. Her
Iron studies were consistent with
iron-deficiency anemia, guaiac was negative, and hemolysis labs
unremarkable. Unclear etiology, but Hb improved after
transfusion and remained stable >7.9 throughout the rest of
admission.
# DMII
Most recent A1c 8.8%. Home regimen is insulin glargine 30 U
daily with a sliding scale. She notes her glucose levels have
been higher lately, in the 200s. Was initially hypoglycemic at
night on her home regimen, which was subsequently adjusted to 10
u glargine nightly, with 3 u Humalog +
sliding scale each meal. Her glucose levels were well controlled
and she was discharged on this regimen.
# Transplant surgery consultation
Transplant surgery was consulted, and the decision was made to
preserve R arm for future fistula placement for dialysis. She
will follow up with them outpatient.
=======================
CHRONIC/STABLE ISSUES
=======================
# Nutrition
Pt noted confusion over balancing diet requirements and
restrictions for both diabetes and chronic kidney disease.
Nutrition consulted and provided education to patient. She will
be set up with a dietician from the ___ Diabetes team for
outpatient followup
# Wound care
Pt with likely venous stasis ulcers, but has been treating them
with alcohol wipes daily. Wound care consulted, and recommended
washing LEs with disposable wash clothes and foam cleanser, with
application of Soothe and ___ moisturizers to bilat LLE & feet
BID
# Glaucoma
Her home medications were continued, as below:
- brimonidine 0.2% eye drops 1 drop each eye TID
- dorzolamide-timolol
====================
TRANSITIONAL ISSUES
====================
MEDICATION CHANGES:
[] Carvedilol 12.5 mg BID was added to her antihypertensive
regimen, as her SBP was initially in the 160-180s
[] Calcitriol and Vitamin D were stopped given her high
phosphorus. We recommend holding these until phosphorus is < 5.5
[] Her insulin regimen is now 10 units Lantus nightly, with 3
units Humalog + Humalog sliding scale with each meal
[] She was started on Sevelamer 1600 mg TID with meals to help
control her phosphate levels.
MONITORING:
[] Repeat electrolytes and CBC (last Hb 8.3) within 5 days of
discharge
[] Please follow up on blood pressures within 1 week of
discharge. Nephrology recommends to continue amlodipine 10 mg
daily and titrate her new carvedilol for goal average BP 140/90
[] Please follow up her blood glucose levels within 1 week of
discharge
[] Please ensure that the patient is weighing herself daily.
Nephrology wants her to contact them if she experiences weight
gain or loss exceeding 3 lbs in one day, or 5 lbs over one week.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. amLODIPine 10 mg PO QPM
2. Torsemide 30 mg PO DAILY
3. Glargine 30 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
4. Atorvastatin 40 mg PO QPM
5. brimonidine 0.2 % ophthalmic (eye) TID
6. Calcitriol 0.25 mcg PO 3X/WEEK (___)
7. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP RIGHT EYE BID
8. Aspirin 81 mg PO QPM
9. Vitamin D 1000 UNIT PO DAILY
10. Multivitamins 1 TAB PO DAILY
11. Ferrous Sulfate 325 mg PO DAILY
Discharge Medications:
1. CARVedilol 12.5 mg PO BID Hypertension
RX *carvedilol 12.5 mg 1 tablet(s) by mouth twice a day Disp
#*60 Tablet Refills:*2
2. sevelamer CARBONATE 1600 mg PO TID W/MEALS
RX *sevelamer carbonate 800 mg 2 tablet(s) by mouth three times
a day with meals Disp #*180 Tablet Refills:*2
3. Torsemide 30 mg PO/NG DAILY
Start: Upon Arrival
RX *torsemide 20 mg 1.5 (One and a half) tablet(s) by mouth once
a day Disp #*45 Tablet Refills:*2
4. Ferrous Sulfate 325 mg PO EVERY OTHER DAY
RX *ferrous sulfate 325 mg (65 mg iron) 1 tablet(s) by mouth
every other day Disp #*15 Tablet Refills:*2
5. Glargine 10 Units Bedtime
Humalog 3 Units Breakfast
Humalog 3 Units Lunch
Humalog 3 Units Dinner
RX *insulin glargine [Lantus Solostar U-100 Insulin] 100 unit/mL
(3 mL) AS DIR 10 Units before BED; Disp #*1 Syringe Refills:*2
RX *insulin lispro [Humalog KwikPen Insulin] 100 unit/mL AS DIR
3 Units before BKFT; 3 Units before LNCH; 3 Units before DINR;
Disp #*1 Syringe Refills:*2
6. amLODIPine 10 mg PO QPM
RX *amlodipine 10 mg 1 tablet(s) by mouth once a day Disp #*30
Tablet Refills:*2
7. Aspirin 81 mg PO QPM
RX *aspirin 81 mg 1 tablet(s) by mouth once a day Disp #*30
Tablet Refills:*2
8. Atorvastatin 40 mg PO QPM
RX *atorvastatin 40 mg 1 tablet(s) by mouth once a day Disp #*30
Tablet Refills:*2
9. brimonidine 0.2 % ophthalmic (eye) TID
10. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP RIGHT EYE BID
11. Multivitamins 1 TAB PO DAILY
RX *multivitamin 1 capsule(s) by mouth once a day Disp #*30
Tablet Refills:*2
12. HELD- Calcitriol 0.25 mcg PO 3X/WEEK (___) This
medication was held. Do not restart Calcitriol until your renal
doctor tells you it is safe to restart.
13. HELD- Vitamin D 1000 UNIT PO DAILY This medication was
held. Do not restart Vitamin D until your renal doctor tells you
it is safe to restart.
Discharge Disposition:
Home
Discharge Diagnosis:
- volume overload secondary to chronic kidney disease
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear ___,
___ was a pleasure taking part in your care here at ___!
Why was I admitted to the hospital?
- You were admitted for shortness of breath and increased
swelling in your legs and belly.
What was done for me while I was in the hospital?
- We gave you diuretics (water pills) to help you release the
extra fluid in your body which was causing your shortness of
breath and swelling. We also noticed your blood pressures were
high and gave you a new medication to help keep your blood
pressure under control. By the end of your hospital stay, you
were no longer short of breath and the swelling had improved.
What should I do when I leave the hospital?
The Nephrology team recommends the following:
- Please weigh yourself every day
- Contact the ___ clinic if you notice a weight gain of over 3
pounds over a 24 hour period, or a weight loss of over 3 pounds
in a 24 hour period. Please also contact them if, over the
course of a whole week, you lose or gain more than 5 pounds
- Drink water and other liquids when you are thirsty, but try
not to drink too much more than 1 liter per day (about two
regular sized water bottles).
We also have the following recommendations:
-Please go to your follow up appointments as scheduled in the
discharge papers. Most of them already have a specific date &
time set. If there is no specific time specified, and you do not
hear from their office in ___ business days, please contact the
office to schedule an appointment.
- Please monitor for new/or worsening symptoms (worsening
swelling, shortness of breath, uncontrollable itching,
nausea/vomiting, or confusion). If you do not feel like you are
getting better or have any other concerns, please call your
doctor to discuss or return to the emergency room.
-Please note any new medications in your discharge worksheet
-Your appointments are as below
Sincerely,
Your ___ Care Team
Followup Instructions:
___
|
10816667-DS-23
| 10,816,667 | 24,119,839 |
DS
| 23 |
2149-02-12 00:00:00
|
2149-02-13 16:46:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
lower extremity wounds
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ female with hypertension, hyperlipidemia, type 2
diabetes complicated by diabetic retinopathy and stage V CKD who
presents with 10 days of foul smelling lesions on her bilateral
lower extremities. She recently had an AV fistula placed but has
not started dialysis. She was recently seen in ___
clinic and was diagnosed with elephantiasis nostra verrucosa
from
chronic venous stasis and was recommended to wear compression
stockings and elevation. The lesions became more diffuse and
foul-smelling starting on the ___, and have progressed since
then. No redness, pain, or fevers. She has been dressing them by
herself with paper towels at home. She denies chest pain,
shortness of breath, orthopnea, PND, and notes that her weight
has actually decreased.
In the ED, initial vital signs notable for blood pressure 158/77
and she was satting 98% on room air. Physical exam notable for
wartlike lesions on the bilateral lower calves that are
tan-colored. Legs were not noted to be swollen or tense and she
had strong ___ pulses. Labs were notable for BUN of 99 and
creatinine 7.0. Hemoglobin was 7.2 with normal platelets and
white count. proBNP was 26,578. She received torsemide 100 mg,
carvedilol 25 mg, insulin 4 units, potassium chloride ___ M EQ
and
insulin 6 units. Chest x-ray showed mild pulmonary vascular
congestion without frank edema. Dermatology consult was
requested, as well as renal consult who stated she was stable
from a renal standpoint.
Vitals on transfer notable for blood pressure of 165/74. On the
floor, she states she is feeling well and has been able to
perform most tasks at home. She is most bothered by the smell
and
increase in blisters that suddenly appeared on her lower legs.
Past Medical History:
Diabetes mellitus type 2 complicated by retinopathy, neuropathy,
nephropathy
Chronic kidney disease stage V
Hypertension
Dyslipidemia
Acute angle glaucoma
Multiple eye surgeries
Social History:
___
Family History:
Mother Living ___ DIABETES TYPE II
Father ___ ___ HYPERTENSION, PERIPHERAL ARTERY DISEASE
MGM Deceased DIABETES TYPE II
Physical Exam:
ADMISSION PHYSICAL
==================
VITALS: T 98.4 BP 165/74 HR 78 RR 18 O2 sat 97 RA
GENERAL: Alert and interactive. In no acute distress.
EYES: NCAT. Wearing sunglasses. Sclera anicteric and without
injection.
ENT: MMM. Thyroid is normal in size and texture, no nodules. No
cervical lymphadenopathy. JVP 7cm.
CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No
murmurs/rubs/gallops.
RESP: Clear to auscultation bilaterally. No wheezes, rhonchi or
rales. No increased work of breathing.
ABDOMEN: Normal bowels sounds, non distended, non-tender to deep
palpation in all four quadrants. No organomegaly.
MSK: Lower extremities with signs of chronic venous ulceration
with diffuse tissue edema and swelling.
SKIN: Warm. Skin findings as above.
PSYCH: appropriate mood and affect
DISCHARGE PHYSICAL
==================
VS: ___ 1519 Temp: 99.3 PO BP: 142/62 L Sitting HR: 69 RR:
20 O2 sat: 97% O2 delivery: RA
GENERAL: Alert and interactive. In no acute distress.
EYES: NCAT. Wearing sunglasses. Sclera anicteric and without
injection.
ENT: MMM. No cervical lymphadenopathy.
CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No
murmurs/rubs/gallops.
RESP: CTAB. No wheezes, rhonchi or rales. No increased work of
breathing.
ABDOMEN: Normal bowels sounds, non distended, non-tender to deep
palpation in all four quadrants. No organomegaly.
MSK: Lower extremities wrapped. No swelling noted above the
wraps
on upper calves.
SKIN: Warm and well perfused.
PSYCH: appropriate mood and affect
Pertinent Results:
INITIAL LABS
============
___ 12:30AM BLOOD WBC-7.0 RBC-2.46* Hgb-7.0* Hct-22.3*
MCV-91 MCH-28.5 MCHC-31.4* RDW-14.3 RDWSD-46.7* Plt ___
___ 12:30AM BLOOD Neuts-72.7* Lymphs-12.5* Monos-11.0
Eos-2.8 Baso-0.6 Im ___ AbsNeut-5.10 AbsLymp-0.88*
AbsMono-0.77 AbsEos-0.20 AbsBaso-0.04
___ 06:50AM BLOOD ___ PTT-27.3 ___
___ 12:30AM BLOOD Glucose-218* UreaN-102* Creat-7.3* Na-137
K-3.7 Cl-99 HCO3-24 AnGap-14
___ 12:30AM BLOOD Calcium-8.0* Phos-5.6* Mg-2.3
MICROBIOLOGY
============
None
IMAGING
=======
CXR (___):
Mild pulmonary vascular congestion without frank edema.
OTHER LABS
==============
___ 12:30AM BLOOD ___
___ 07:29AM BLOOD calTIBC-205* Ferritn-803* TRF-158*
DISCHARGE LABS
==============
___ 09:15AM BLOOD WBC-6.9 RBC-2.54* Hgb-7.2* Hct-22.7*
MCV-89 MCH-28.3 MCHC-31.7* RDW-13.9 RDWSD-45.6 Plt ___
___ 09:15AM BLOOD Glucose-124* UreaN-98* Creat-7.2* Na-142
K-3.7 Cl-100 HCO3-26 AnGap-16
___ 09:15AM BLOOD Calcium-7.8* Phos-5.5* Mg-2.2
Brief Hospital Course:
TRANSITIONAL ISSUES
===================
[ ] Discharge Hgb 7.2 - recheck stability at follow up
[ ] Discharge Cr 7.2 and BUN 98 (on HD)
[ ] Weight on discharge 79.4kg which is EDW
[ ] BP noted to be elevated during this hospitalization in
140s-160s; please recheck as outpatient and uptitrate
anti-hypertensives if necessary.
[ ] Patient determined to have elephantiasis nostra verrucose
secondary to chronic venous stasis. Evaluated by Dermatology who
recommended conservative management with excellent wound care
regimen with help of ___ consisting of the following:
- Leg elevation
- Apply vaseline, Xeroform, then wrap the legs in gauze, then
wrap with Ace bandage for compression
- Please ensure that patient has adequate perfusion to her
distal
extremities and toes with compression wrapping
- Change dressings daily
- Continue cleaning skin with gentle wound cleanser or burrow's
solution daily if oozing (acts as a drying agent)
Patient has dermatology follow-up.
[ ] Patient with discharge weight on 79.4kg. She is concerned
about losing too much weight as this weight is much lower than
her scale at home. Please continue to monitor weight.
[ ] Patient with significant anemia of chronic disease likely in
setting of CKD. She recently received IV iron and has been
continued on oral iron. ___ benefit from EPO.
[ ] Patient with severe peripheral neuropathy. Has podiatry
follow-up.
BRIEF HOSPITAL COURSE
=====================
Mrs. ___ is a ___ year old woman with chronic kidney disease
___ HTN/diabetes awaiting dialysis initiation and chronic venous
stasis who presented with worsening lower extremity swelling and
malodorous weeping determined to have chronic elephantiasis
nostra verrucose managed with IV diuresis and excellent wound
care. There was no sign of infection. There was no immediate
indication for HD during admission.
ACTIVE ISSUES
=============
# Elephantiasis nostra verrucosa
Mrs. ___ presented with ten days of foul-smelling and
weeping lower extremity wounds. She was evaluated by dermatology
and nephrology, who recommended conservative wound care
management consisting of leg elevation, daily application of
Vaseline then xeroform then wrap in gauze followed by ACE
bandage for compression. She was given intravenous diuretics
with clinical improvement and discharged with home ___ in place.
Weight on discharge 79.4kg. Will follow up with dermatology as
an outpatient.
CHRONIC ISSUES
==============
# CKD-Stage V
Patient at baseline Cr of 6.9-7.5 during admission. No
indication for more urgent initiation of HD at this point. She
was continued on her home medications and scheduled for
outpatient follow-up with nephrology for initiation of
intermittent hemodialysis through her maturing RUE fistula. She
has vein mapping scheduling in 1 month.
#Type II Diabetes
Complicated by diabetic retinopathy and nephropathy. She was
discharged on her home glycemic regimen.
#CODE: Full (presumed)
#CONTACT: ___ (mother) ___
>30 min spent on discharge planning including face to face time
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Brimonidine Tartrate 0.15% Ophth. 1 DROP BOTH EYES Q8H
2. CARVedilol 25 mg PO BID
3. dorzolamide-timolol 22.3-6.8 mg/mL right eye BID
4. amLODIPine 10 mg PO DAILY
5. Artificial Tears ___ DROP BOTH EYES Q6H:PRN dry eyes
6. Atorvastatin 40 mg PO QPM
7. Ferrous Sulfate 325 mg PO EVERY OTHER DAY
8. Torsemide 100 mg PO DAILY
9. Multivitamins 1 TAB PO DAILY
10. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Severe
11. sevelamer HYDROCHLORIDE 1600 mg oral TID W/MEALS
12. Glargine 10 Units Bedtime
Humalog 3 Units Breakfast
Humalog 3 Units Lunch
Humalog 3 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
13. Aspirin 81 mg PO DAILY
14. MetOLazone 5 mg PO 3X/WEEK (___)
15. Calcitriol 0.25 mcg PO 3X/WEEK (___)
16. Vitamin D 1000 UNIT PO DAILY
Discharge Medications:
1. Glargine 10 Units Bedtime
Humalog 3 Units Breakfast
Humalog 3 Units Lunch
Humalog 3 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
2. amLODIPine 10 mg PO DAILY
3. Artificial Tears ___ DROP BOTH EYES Q6H:PRN dry eyes
4. Aspirin 81 mg PO DAILY
5. Atorvastatin 40 mg PO QPM
6. Brimonidine Tartrate 0.15% Ophth. 1 DROP BOTH EYES Q8H
7. Calcitriol 0.25 mcg PO 3X/WEEK (___)
8. CARVedilol 25 mg PO BID
9. dorzolamide-timolol 22.3-6.8 mg/mL right eye BID
10. Ferrous Sulfate 325 mg PO EVERY OTHER DAY
11. MetOLazone 5 mg PO 3X/WEEK (___)
12. Multivitamins 1 TAB PO DAILY
13. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Severe
14. sevelamer HYDROCHLORIDE 1600 mg oral TID W/MEALS
15. Torsemide 100 mg PO DAILY
16. Vitamin D 1000 UNIT PO DAILY
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
PRIMARY DIAGNOSIS
======================
Elephantiasis nostra verrucose
Chronic Venous Stasis
SECONDARY DIAGNOSIS
======================
Chronic Kidney Disease
Diabetes
Chronic anemia, multifactorial
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory
Discharge Instructions:
Dear Ms. ___,
WHY WERE YOU ADMITTED TO THE HOSPITAL?
- Your leg wounds were leaking foul smelling fluid
WHAT WAS DONE WHILE YOU WERE IN THE HOSPITAL?
- You were seen by the Dermatology team who recommended specific
care for your wounds. There was no sign of infection
- You will go home with visiting nursing care for your wounds.
WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL?
- Please weigh yourself every morning when you wake up if
possible. If you weight increases by more than 3 pounds in one
day, then please call your doctor.
- You will have a visiting nurse come to your home to help with
dressing changes.
- Take all of your medications as prescribed (listed below)
- Follow up with your doctors as listed below
Please see below for more information on your hospitalization.
It was a pleasure taking part in your care here at ___. We
wish you all the best,
- Your ___ Care Team
Followup Instructions:
___
|
10816667-DS-25
| 10,816,667 | 24,128,174 |
DS
| 25 |
2149-04-20 00:00:00
|
2149-04-21 08:21:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Major Surgical or Invasive Procedure:
- ___: Tunneled HD line removal
- ___: Temporary HD line placement
- ___: Tunneled HD line placement
attach
Pertinent Results:
ADMISSION LABS:
___ 10:22AM BLOOD WBC-14.3* RBC-2.74* Hgb-7.8* Hct-25.8*
MCV-94 MCH-28.5 MCHC-30.2* RDW-15.9* RDWSD-54.2* Plt ___
___ 10:22AM BLOOD Neuts-90.5* Lymphs-1.5* Monos-3.8*
Eos-0.0* Baso-0.1 Im ___ AbsNeut-12.96* AbsLymp-0.21*
AbsMono-0.54 AbsEos-0.00* AbsBaso-0.02
___ 10:22AM BLOOD ___ PTT-25.7 ___
___ 10:22AM BLOOD Glucose-362* UreaN-67* Creat-5.5* Na-134*
K-4.5 Cl-97 HCO3-21* AnGap-16
___ 10:22AM BLOOD ALT-17 AST-22 AlkPhos-67 TotBili-0.6
___ 10:22AM BLOOD Albumin-2.7* Calcium-7.4* Phos-3.8 Mg-1.6
___ 10:22AM BLOOD Beta-OH-<0.2
___ 07:10AM BLOOD Free T4-1.3
___ 07:10AM BLOOD TSH-4.6*
DISCHARGE LABS:
___ 12:50 12.0* 2.80* 8.0* 26.2* 94 28.6 30.5*
15.4 51.8* 527*
___ 12:50 169*1 23* 3.1* 134* 4.1 92* 29 13
___ 12:50 8.5 2.4* 1.8
MICRO:
__________________________________________________________
___ 10:52 am BLOOD CULTURE Source: Line-dialysis.
Blood Culture, Routine (Pending): No growth to date.
__________________________________________________________
___ 9:57 am BLOOD CULTURE 2 OF 2.
Blood Culture, Routine (Pending): No growth to date.
__________________________________________________________
___ 7:06 am BLOOD CULTURE 1 OF 2.
Blood Culture, Routine (Pending): No growth to date.
__________________________________________________________
___ 10:00 am BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 6:02 am BLOOD CULTURE 1 OF 2.
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 10:15 am BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 7:21 am BLOOD CULTURE 1 OF 2.
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 11:34 pm BLOOD CULTURE Source: Venipuncture.
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 11:34 pm BLOOD CULTURE Source: Venipuncture.
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 10:03 am BLOOD CULTURE 2 OF 2.
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 6:42 am BLOOD CULTURE 1 OF 2.
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 9:22 am BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 7:20 am BLOOD CULTURE 1 OF 2.
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 7:30 am BLOOD CULTURE 2 OF 2.
**FINAL REPORT ___
Blood Culture, Routine (Final ___:
STAPH AUREUS COAG +.
Consultations with ID are recommended for all blood
cultures
positive for Staphylococcus aureus, yeast or other
fungi.
Susceptibility testing performed on culture # ___
___.
Aerobic Bottle Gram Stain (Final ___:
GRAM POSITIVE COCCI IN CLUSTERS.
Reported to and read back by ___, MD (___)
___ @ 9:02
AM.
__________________________________________________________
___ 7:05 am BLOOD CULTURE 1 OF 2.
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 7:01 am BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 8:46 am BLOOD CULTURE 2OF2.
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
__________________________________________________________
___ 7:15 am BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___:
STAPH AUREUS COAG +.
Consultations with ID are recommended for all blood
cultures
positive for Staphylococcus aureus, yeast or other
fungi.
FINAL SENSITIVITIES.
Staphylococcus species may develop resistance during
prolonged
therapy with quinolones. Therefore, isolates that are
initially
susceptible may become resistant within three to four
days after
initiation of therapy. Testing of repeat isolates may
be
warranted.
SENSITIVITIES: MIC expressed in
MCG/ML
_________________________________________________________
STAPH AUREUS COAG +
|
CLINDAMYCIN-----------<=0.25 S
ERYTHROMYCIN----------<=0.25 S
GENTAMICIN------------ <=0.5 S
LEVOFLOXACIN---------- 0.25 S
OXACILLIN------------- 0.5 S
TRIMETHOPRIM/SULFA---- <=0.5 S
Aerobic Bottle Gram Stain (Final ___:
Reported to and read back by ___ @ 0410 ON ___ -
___.
GRAM POSITIVE COCCI IN CLUSTERS.
___ 7:15 am BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___:
STAPH AUREUS COAG +.
Consultations with ID are recommended for all blood
cultures
positive for Staphylococcus aureus, yeast or other
fungi.
FINAL SENSITIVITIES.
Staphylococcus species may develop resistance during
prolonged
therapy with quinolones. Therefore, isolates that are
initially
susceptible may become resistant within three to four
days after
initiation of therapy. Testing of repeat isolates may
be
warranted.
SENSITIVITIES: MIC expressed in
MCG/ML
_________________________________________________________
STAPH AUREUS COAG +
|
CLINDAMYCIN-----------<=0.25 S
ERYTHROMYCIN----------<=0.25 S
GENTAMICIN------------ <=0.5 S
LEVOFLOXACIN---------- 0.25 S
OXACILLIN------------- 0.5 S
TRIMETHOPRIM/SULFA---- <=0.5 S
Aerobic Bottle Gram Stain (Final ___:
Reported to and read back by ___ @ 0410 ON ___ -
___.
GRAM POSITIVE COCCI IN CLUSTERS.
___ 5:30 pm BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___:
STAPH AUREUS COAG +.
Consultations with ID are recommended for all blood
cultures
positive for Staphylococcus aureus, yeast or other
fungi.
Susceptibility testing performed on culture # ___
(___).
Aerobic Bottle Gram Stain (Final ___:
GRAM POSITIVE COCCI IN CLUSTERS.
___ 9:28 am BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___:
STAPH AUREUS COAG +.
Consultations with ID are recommended for all blood
cultures
positive for Staphylococcus aureus, yeast or other
fungi.
FINAL SENSITIVITIES.
Staphylococcus species may develop resistance during
prolonged
therapy with quinolones. Therefore, isolates that are
initially
susceptible may become resistant within three to four
days after
initiation of therapy. Testing of repeat isolates may
be
warranted.
SENSITIVITIES: MIC expressed in
MCG/ML
_________________________________________________________
STAPH AUREUS COAG +
|
CLINDAMYCIN-----------<=0.25 S
ERYTHROMYCIN----------<=0.25 S
GENTAMICIN------------ <=0.5 S
LEVOFLOXACIN---------- 0.25 S
OXACILLIN------------- 0.5 S
TRIMETHOPRIM/SULFA---- <=0.5 S
Aerobic Bottle Gram Stain (Final ___:
GRAM POSITIVE COCCI IN CLUSTERS.
Reported to and read back by ___ @13:12
(___).
___ 7:08 am BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___:
STAPH AUREUS COAG +.
Consultations with ID are recommended for all blood
cultures
positive for Staphylococcus aureus, yeast or other
fungi.
Susceptibility testing performed on culture # ___
(___).
Aerobic Bottle Gram Stain (Final ___:
GRAM POSITIVE COCCI IN CLUSTERS.
___ 10:09 am BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___:
STAPH AUREUS COAG +.
Consultations with ID are recommended for all blood
cultures
positive for Staphylococcus aureus, yeast or other
fungi.
Susceptibility testing performed on culture # ___
___.
Aerobic Bottle Gram Stain (Final ___:
GRAM POSITIVE COCCI IN CLUSTERS.
___ 7:10 am BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___:
STAPH AUREUS COAG +.
Consultations with ID are recommended for all blood
cultures
positive for Staphylococcus aureus, yeast or other
fungi.
Susceptibility testing performed on culture # ___
___.
Aerobic Bottle Gram Stain (Final ___:
GRAM POSITIVE COCCI IN CLUSTERS.
___ 12:16 pm BLOOD CULTURE 2 OF 2.
**FINAL REPORT ___
Blood Culture, Routine (Final ___:
STAPH AUREUS COAG +.
Consultations with ID are recommended for all blood
cultures
positive for Staphylococcus aureus, yeast or other
fungi.
Susceptibility testing performed on culture # ___
___.
Anaerobic Bottle Gram Stain (Final ___:
GRAM POSITIVE COCCI IN CLUSTERS.
Aerobic Bottle Gram Stain (Final ___:
GRAM POSITIVE COCCI IN CLUSTERS.
___ 11:32 am BLOOD CULTURE 3 OF 3.
**FINAL REPORT ___
Blood Culture, Routine (Final ___:
STAPH AUREUS COAG +.
Consultations with ID are recommended for all blood
cultures
positive for Staphylococcus aureus, yeast or other
fungi.
Susceptibility testing performed on culture # ___
___.
Anaerobic Bottle Gram Stain (Final ___:
GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
Reported to and read back by ___ (___) AT
2224 ON
___.
Aerobic Bottle Gram Stain (Final ___:
GRAM POSITIVE COCCI IN CLUSTERS.
___ 10:22 am BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___:
STAPH AUREUS COAG +.
Consultations with ID are recommended for all blood
cultures
positive for Staphylococcus aureus, yeast or other
fungi.
FINAL SENSITIVITIES.
Staphylococcus species may develop resistance during
prolonged
therapy with quinolones. Therefore, isolates that are
initially
susceptible may become resistant within three to four
days after
initiation of therapy. Testing of repeat isolates may
be
warranted.
SENSITIVITIES: MIC expressed in
MCG/ML
_________________________________________________________
STAPH AUREUS COAG +
|
CLINDAMYCIN-----------<=0.25 S
ERYTHROMYCIN----------<=0.25 S
GENTAMICIN------------ <=0.5 S
LEVOFLOXACIN---------- 0.25 S
OXACILLIN------------- 0.5 S
TRIMETHOPRIM/SULFA---- <=0.5 S
Anaerobic Bottle Gram Stain (Final ___:
GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
Reported to and read back by ___ (___) AT
2125 ON
___.
Aerobic Bottle Gram Stain (Final ___:
GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
IMAGING:
TTE ___
IMPRESSION: Mildly dilated right ventricle with moderate to
severe tricuspid regurgitation and
moderate pulmonary hypertension. Ascites. Echocardiographic
evidence for diastolic dysfunction
with elevated PCWP. Very small pericardial effusion with
exaggerated respiratory variation in
tricuspid inflow velocities but no evidence of 2D evidence of
tamponade. No valvular vegetations
EMR 2853-P-IP-OP (O___) Name: ___ MRN: ___
Study Date: ___ 0:00:00 p. ___
seen. No 2D echocardiographic evidence for endocarditis. Normal
left ventricular systolic
function.
Compared with the prior TTE (images reviewed) of ___ ,
very small pericardial effusion is
seen, there is significantly more tricuspid regurgitation,
moderate pulmonary hypertension is present.
___ Imaging RENAL U.S.
1. No hydronephrosis bilaterally.
2. 2 mm nonobstructive stone in the lower pole the right kidney.
3. Small amount of layering debris is seen within the urinary
bladder.
___HEST W/O CONTRAST
1. Right lower lobe rounded consolidative opacity and additional
opacity in
the right middle lobe and left upper lobe, with surrounding
ground-glass
opacity, which are concerning for multifocal infection.
2. New prominent subcentimeter mediastinal lymph nodes, which
are most likely
reactive.
3. Partially distended urinary bladder with symmetric
circumferential
thickening, similar to prior. Findings may reflect cystitis in
the appropriate
clinical setting.
4. Diffuse anasarca.
5. Retroperitoneal and bilateral inguinal lymphadenopathy, which
is unchanged
compared to ___.
___BD & PELVIS W/O CON
1. Right lower lobe rounded consolidative opacity and additional
opacity in
the right middle lobe and left upper lobe, with surrounding
ground-glass
opacity, which are concerning for multifocal infection.
2. New prominent subcentimeter mediastinal lymph nodes, which
are most likely
reactive.
3. Partially distended urinary bladder with symmetric
circumferential
thickening, similar to prior. Findings may reflect cystitis in
the appropriate
clinical setting.
4. Diffuse anasarca.
5. Retroperitoneal and bilateral inguinal lymphadenopathy, which
is unchanged
compared to ___.
___ Cardiovascular Transesophageal Echo Final Report
No discrete vegetation or abscess seen. Mild-moderate mitral
regurgitation with
normal leaflet morphology. Moderate tricuspid regurgitation with
normal leaflet morphology.
Moderate pulmonary artery systolic hypertension. Very small
circumferential pericardial effusion.
___ Imaging US CHEST WALL SOFT TISS
1. No evidence of drainable fluid collection within left chest.
2. Interval decrease in size of a linear, hypoechoic tract
within the
subcutaneous tissues, likely sequela of prior tunneled
hemodialysis catheter
removal.
3. Partially occlusive thrombus within the left internal jugular
vein, better
assessed on the dedicated venous study.
___ Imaging BILAT UP EXT VEINS US
Partially occlusive thrombus within the left internal jugular
vein. No other
thrombus identified.
___ Imaging LIVER OR GALLBLADDER US
1. No evidence of hepatic lesions.
2. No intra or extrahepatic biliary dilatation.
Brief Hospital Course:
TRANSITIONAL ISSUES
===================
[ ] She will need ___ weeks of total antibiotic therapy for her
infection, Projected End Date: ___
[ ] please assess volume to see if torsemide dose is
appropriate- the dose was decreased after restarting HD because
of some lightheadedness after HD.
[ ] patient with tunneled line associated left internal jugular
clot, please continue to assess duration of ___,
___ likely be 3 months with end date ___
[ ] PLEASE OBTAIN WEEKLY CRP, CBC with differential, BUN, Cr and
fax to ATTN: ___ CLINIC - FAX: ___
[ ] consideration of CAD evaluation given troponin elevation
while inpatient
[ ] patient to lay down and rest post dialysis to ensure not
lightheaded
[ ] please adjust insulin as needed
[ ] recheck CBC within 1 week to ensure no leukocytosis and
monitor for infectious symptoms
[ ] please change tunneled line dressing daily
SUMMARY
=======
This is a ___ w/ history of DM2, ESRD, retinopathy, neuropathy,
HTN, HLD, chronic lymphedema and secondary elephantiasis, who
presented for fistulogram after being discharged 2 days prior
for a routine admission for HD initiation and was found to be
hypoxic and febrile to 103. The patient was subsequently found
to have MSSA bacteremia which was presumed to be from her
tunneled HD line. She underwent removal of her HD line on ___
with placement of temporary HD line on ___. Both a TTE and TEE
were w/out endocarditis, but with new TR and pHTN. Cultures
continued to be positive until ___ and she has continued to
have fevers. Given that the patient continued to have fevers in
spite of clearing her cultures, this raised concern for an
additional locus of infection. She underwent further work up
which was ultimately notable for a U/S of her left IJ showing a
partially occlusive thrombus for which she was started on
Heparin drip then apixaban.
ACUTE/ACTIVE HOSPITAL ISSUES
============================
# Tunneled HD Line Infection
# MSSA Bacteremia
# Fevers
The patient presented with fevers, malaise, purulent drainage
from her tunneled line. Her initial admission blood cultures
grew MSSA and she was started on Cefazolin (narrowed from
Cefazolin/Vancomycin which was started on admission). She
underwent removal of her tunneled HD line on ___ with
placement of temporary HD line on ___. Both a TTE and TEE were
without endocarditis, but did show new TR and pHTN. The patient
continued to grow positive blood cultures positive until ___
and she started to have fevers on ___ and ultimately
deveresced on ___. Given persistent fevers, her new temporary
HD line was pulled on ___. Given that the patient continued to
have fevers in spite of clearing her cultures, this raised
concern for an additional locus of infection. A U/S of her left
IJ showed a partially occlusive thrombus for which she was
started on Heparin gtt. Given lack of another new infectious
source, it was thought that her ongoing fevers were likely from
the clot. Ultimately the patient was discharged on apixaban
2.5mg PO BID after approval from her nephrologist. The patient
was discharged on Cefazolin with HD with likely 6 week course to
end ___.
#ESRD, CKD Stage V
Prior to discharge from her last hospitalization, the patient
had HD arranged for ___ at ___. Per
renal/transplant the patient's fistula may take up to 12 weeks
to mature. As above, the patient underwent removal of her
tunneled HD line on ___ and placement of temporary HD line on
___. She then underwent removal of her temporary HD line on
___ given persistent bacteremia and fevers. She had a line/HD
holiday until her cultures cleared and she was afebrile. She
ultimately had a left tunneled HD line placed on ___. She
was continued on Torsemide 80mg and Metolazone 5mg PO QD on non
HD days. She was continued on Sevelamer 1600 TID.
# Left IJ Thrombus
The patient was found to have a left IJ thrombus on ___ on U/S
of AV fistula graft. This was where her prior temporary HD
catheter had been. There was concern that this could be
contributing to her persistent fevers and thus she was treated
with IV heparin gtt while inpatient. Ultimately the patient was
discharged on apixaban 2.5mg PO BID for anticoagulation.
#Anemia
Aranesp was continued with HD while inpatient and she was
continued on ferrous sulfate QOD. She intermittently required
HgB transfusions while inpatient.
#Type II NSTEMI
The patient had an elevated troponin (higher than previous
baseline) on admission. She had no chest pain and no EKG
changes. Troponins since down trended. This was thought to be
most likely type 2 NSTEMI in setting of increased
demand/infection, with contribution from renal disease impairing
clearance. She was continued on ASA and Atorvastatin.
#Type II Diabetes
The patient's insulin regimen was changed during her last
admission, with improved control while in hospital but per
patient has still been running high at home. Her home lantus and
humalog doses were increased and she was continued on a sliding
scale insulin while inpatient.
################
>30 minutes spent on discharge planning and care coordination on
the day of discharge
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. amLODIPine 10 mg PO DAILY
2. Artificial Tears ___ DROP BOTH EYES Q6H:PRN dry eyes
3. Aspirin 81 mg PO DAILY
4. Atorvastatin 40 mg PO QPM
5. Brimonidine Tartrate 0.15% Ophth. 1 DROP BOTH EYES Q8H
6. Calcitriol 0.25 mcg PO 3X/WEEK (___)
7. CARVedilol 25 mg PO BID
8. dorzolamide-timolol 22.3-6.8 mg/mL right eye BID
9. Ferrous Sulfate 325 mg PO EVERY OTHER DAY
10. Multivitamins 1 TAB PO DAILY
11. sevelamer HYDROCHLORIDE 1600 mg oral TID W/MEALS
12. Vitamin D 1000 UNIT PO DAILY
13. Torsemide 100 mg PO DAILY
14. Glargine 12 Units Bedtime
Humalog 4 Units Breakfast
Humalog 4 Units Lunch
Humalog 6 Units Dinner
15. MetOLazone 5 mg PO DAILY
Discharge Medications:
1. Apixaban 2.5 mg PO BID
RX *apixaban [Eliquis] 2.5 mg 1 tablet(s) by mouth twice a day
Disp #*60 Tablet Refills:*0
2. CeFAZolin 3 g IV POST HD (SA)
3. CeFAZolin 2 g IV POST HD (___)
4. Glargine 18 Units Bedtime
Humalog 10 Units Breakfast
Humalog 10 Units Lunch
Humalog 10 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
5. Torsemide 80 mg PO DAILY
RX *torsemide 20 mg 4 tablet(s) by mouth once a day on
___ Disp #*120 Tablet Refills:*0
6. amLODIPine 10 mg PO DAILY
RX *amlodipine 10 mg 1 tablet(s) by mouth once a day Disp #*30
Tablet Refills:*0
7. Artificial Tears ___ DROP BOTH EYES Q6H:PRN dry eyes
8. Aspirin 81 mg PO DAILY
RX *aspirin 81 mg 1 tablet(s) by mouth once a day Disp #*30
Tablet Refills:*0
9. Atorvastatin 40 mg PO QPM
RX *atorvastatin 40 mg 1 tablet(s) by mouth daily at night Disp
#*30 Tablet Refills:*0
10. Brimonidine Tartrate 0.15% Ophth. 1 DROP BOTH EYES Q8H
11. Calcitriol 0.25 mcg PO 3X/WEEK (___)
RX *calcitriol 0.25 mcg 1 capsule(s) by mouth daily 3X/WEEK
(___) Disp #*30 Capsule Refills:*0
12. CARVedilol 25 mg PO BID
RX *carvedilol 25 mg 1 tablet(s) by mouth twice a day Disp #*60
Tablet Refills:*0
13. dorzolamide-timolol 22.3-6.8 mg/mL right eye BID
14. Ferrous Sulfate 325 mg PO EVERY OTHER DAY
RX *ferrous sulfate [Iron (ferrous sulfate)] 325 mg (65 mg iron)
1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0
15. MetOLazone 5 mg PO DAILY
RX *metolazone 5 mg 1 tablet(s) by mouth once a day on
___ Disp #*30 Tablet Refills:*0
16. Multivitamins 1 TAB PO DAILY
RX *multivitamin 1 capsule(s) by mouth once a day Disp #*30
Capsule Refills:*0
17. sevelamer HYDROCHLORIDE 1600 mg oral TID W/MEALS
RX *sevelamer HCl 800 mg 2 tablet(s) by mouth three times a day
with meals Disp #*90 Tablet Refills:*0
18. Vitamin D 1000 UNIT PO DAILY
RX *ergocalciferol (vitamin D2) 50 mcg (2,000 unit) 1 capsule(s)
by mouth once a day Disp #*30 Capsule Refills:*0
19.Outpatient Lab Work
___
PLEASE OBTAIN WEEKLY CRP, CBC with differential, BUN, Cr and fax
to ATTN: ___ CLINIC - FAX: ___
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
Primary Diagnosis:
MSSA Bacteremia
Catheter Associated Bloodstream Infection
Left Internal Jugular Vein Septic Thrombus
Secondary Diagnoses:
End Stage Renal Disease
Anemia
Pulmonary Hypertension
Type II NSTEMI
Elephantiasis nostra verrucose
Type II Diabetes
Hyperlipidemia
Hypertension
Glaucoma
Nutrition
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Ms. ___,
It was a pleasure caring for you at ___
___.
WHY WAS I IN THE HOSPITAL?
==========================
- You were admitted to the hospital because you were having
fevers and pus coming out of your dialysis line which was
concerning for an infection of your dialysis line.
WHAT HAPPENED TO ME IN THE HOSPITAL?
=======================================
- You were found to have bacteria in your blood
- You were given IV antibiotics to treat the infection in your
blood
- You were seen by the infectious disease doctors
- Your dialysis line was removed and you had a new one placed
once your cultures were negative. Unfortunately, your cultures
again became positive and this new line had to also be removed.
- You had an endoscopic ultrasound done of your heart to look
for a heart infection. This showed no heart infection.
- You had an ultrasound done of your neck to look for other
sources of bacteria that could lead to your blood cultures
continuing to be positive. This showed a blood clot that may
have been infected. You were started on a blood thinner for
this.
- You eventually had a new dialysis line placed and underwent
dialysis successfully
WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?
============================================
- Continue to take all your medicines and keep your
appointments.
- Please weigh yourself daily and contact your doctor if your
weight goes up or down by more than 3 lbs in a day or 5 pounds
in a week
We wish you the best!
Sincerely,
Your ___ Team
Followup Instructions:
___
|
10816916-DS-4
| 10,816,916 | 26,290,158 |
DS
| 4 |
2154-08-11 00:00:00
|
2154-08-12 19:22:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Erythromycin Base / Biaxin / Cipro / prednisone
Attending: ___.
Chief Complaint:
STEMI
Major Surgical or Invasive Procedure:
___ Cardiac Catheterization
Coronary angiography: right dominant
LMCA: No significant stenosis
LAD: No significant stenosis
LCX: No significant stenosis
RCA: Distal RCA obstruction s/p Two DES to Distal RCA lesions.
History of Present Illness:
___ with history of HLD who presented via EMS for inferior
STEMI, now s/p 2 DES to distal RCA.
Pt reports that she was in her USOH until this AM. She felt well
and helped her son with ___, which she tolerated without
any symptoms. Upon coming in the house she developed sudden
onset SOB. She describes severe air hunger without chest pain
and called her son who called ___. By the time EMS arrived she
has begun to feel substernal chest pain ___ without radiation
or associated nausea or diaphoresis. An EKG showed ST elevations
in II, III, AVF with reciprocal ST depressions in the precordial
leads. She was taken to ___ where CODE STEMI was activated.
She was loaded with ticagrelor and taken to cath lab where PCI
showed distal RCA occlusion which was stented with 2 DES. She
tolerated the procedure well. Post cath EKG showed resolution of
ST elevations with new Q wave in lead III, LAD and PRWP.
On arrival to the CCU, the patient is interactive, oriented and
comfortable.
Of note, patient reports increased stress associated with
tremors (no SOB or chest pain) in the setting of recently moving
homes.
REVIEW OF SYSTEMS:
(+) mild ___ edema with prolonged rest, stress
(-) exertional chest pain or dyspnea
Past Medical History:
- Chronic early repol in V1 (per patient history)
- HLD (intolerant of statins ___ myalgias)
- OA
- s/p appendectomy
- s/p Left knee replacement
Social History:
___
Family History:
No family history of early MI, cardiomyopathy, SCD
Father - ___ cancer
Sister - stomach cancer at ___
Sister - pancreatic cancer at ___
Sister - uterine cancer
Has been considered for familial cancer syndrome workup but
deferred given age.
Physical Exam:
ADMISSION PHYSICAL EXAM:
Gen: Pleasant, calm, NAD.
HEENT: No conjunctival pallor. No icterus. MMM. OP clear.
NECK: Supple, No LAD. JVP 1cm above clavicle at 30 degrees.
CV: RR, normal rhythm, normal S1,S2. No m/r/g
LUNGS: CTAB. No wheezes, rales, or rhonchi.
ABD: NABS. Soft, NT, ND. No HSM.
EXT: WWP, NO CCE. Full distal pulses bilaterally. No femoral
bruits. Right femoral artery sheath in place. Non tender. Trace
___ edema.
SKIN: No rashes/lesions, ecchymoses.
NEURO: A&Ox3. CN ___ grossly intact. Preserved sensation
throughout. ___ strength throughout. FNF normal.
DISCHARGE PHYSICAL EXAM:
Eyes: (Conjunctiva and lids: WNL) PERRL
Ears, Nose, Mouth and Throat: (Oral mucosa: WNL), (Teeth, gums
and palette: WNL)
Neurologic: Attentive, Follows simple commands, Responds to:
Unknown (i.e. not assessed), Movement: Not assessed, Tone: Not
assessed, Cranial Nerves: intact
Neck: (Right carotid artery: No bruit), (Left carotid artery: No
bruit), (Jugular veins: JVP, 1cm above clavicle at 30 deg)
Back / Musculoskeletal: (Chest wall structure: WNL)
Respiratory: (Effort: WNL), (Auscultation: WNL)
Cardiac: (Rhythm: Regular), (Palpation / PMI: WNL),
(Auscultation: S1: WNL, S2: WNL, S3: Absent, S4: Absent)
Abdominal / Gastrointestinal: (Bowel sounds: WNL)
Femoral Artery: (Right femoral artery: R femoral access sheath
in place without bleeding or hematoma)
Extremities / Musculoskeletal: (Muscle strength and tone: WNL),
(Dorsalis pedis artery: Right: 1+, Left: 1+), (Posterior tibial
artery: Right: 1+, Left: 1+), (Extremity details: trace)
Skin: ( WNL)
Pertinent Results:
CARDIAC ENZYMES:
___ 02:27PM BLOOD CK-MB-16* MB Indx-10.4* cTropnT-0.77*
___ 05:39PM BLOOD cTropnT-1.15*
___ 05:10AM BLOOD CK-MB-21* MB Indx-7.9* cTropnT-0.72*
___ 04:22PM BLOOD CK-MB-10 MB Indx-5.8 cTropnT-0.42*
ADMISSION LABS:
___ 11:00AM BLOOD WBC-6.7 RBC-4.33 Hgb-13.8 Hct-40.9 MCV-94
MCH-31.8 MCHC-33.7 RDW-14.0 Plt ___
___ 05:10AM BLOOD Neuts-62.8 ___ Monos-7.1 Eos-5.5*
Baso-0.6
___ 11:00AM BLOOD ___ PTT-25.4 ___
___ 02:27PM BLOOD Glucose-132* UreaN-17 Creat-0.6 Na-137
K-4.0 Cl-104 HCO3-22 AnGap-15
___ 02:27PM BLOOD Calcium-8.7 Phos-3.2 Mg-2.1
CARDIAC RISK STRATIFICATION:
___ 11:00AM BLOOD %HbA1c-6.0* eAG-126*
___ 02:27PM BLOOD Cholest-258* Triglyc-138 HDL-49
CHOL/HD-5.3 LDLcalc-181*
DISCHARGE LABS:
___ 07:50AM BLOOD WBC-5.1 RBC-4.15* Hgb-13.1 Hct-39.7
MCV-96 MCH-31.7 MCHC-33.1 RDW-13.8 Plt ___
___ 07:50AM BLOOD Glucose-146* UreaN-15 Creat-0.7 Na-141
K-4.0 Cl-103 HCO3-27 AnGap-15
___ 07:50AM BLOOD ALT-22 AST-35 LD(LDH)-250 AlkPhos-51
TotBili-1.6*
___ 07:50AM BLOOD Albumin-4.1 Calcium-9.6 Phos-3.5 Mg-2.2
STUDIES:
+ CXR: Heart size is normal. Ascending aortic dilatation is
suspected. Lungs are clear. There is no pleural effusion or
pneumothorax.
+ EKG:
___: NSR @ 78bpm. NA, NI. 4mm in STE in lead III > II.
With reciprocal ST depression in anterior leads.
___: NSR @ 100bpm. NA. LAD. Resolution of ST elevations.
PRWP
+ CARDIAC CATH:
Coronary angiography: right dominant
LMCA: No significant stenosis
LAD: No significant stenosis
LCX: No significant stenosis
RCA: Distal RCA obstruction s/p Two DES to Distal RCA lesions.
Brief Hospital Course:
___ with history of HLD who presented via EMS for inferior
STEMI, now s/p 2 DES to distal RCA.
# CORONARIES: RCA with 2 DES. No other vessels.
# PUMP:
# RHYTHM: NSR
#) STEMI: History of HLD. Developed sudden onset SOB and
substernal chest pain. EKG with 4mm STE in III>II. Concern that
some reciprocal changes may represent posterior infarct. Taken
immediately to cath lab with successful PCI of two DES to distal
RCA. On arrival to the CCU from cath lab the patient is without
SOB/chest pain and in comfortable. She was monitored for 24
hours following catheterization without an evidence of
hemodynamic instability or arrhythmic disturbances.
- aspirin 81 daily
- ticagrelor 180 BID
- metop 12.5 BID, with plan to uptitrate as needed.
- Will start atorvastatin 80mg daily.
- restart home valsartan 160mg as tolerated.
#) Dilated Ascending Aorta: Seen on CXR. No complaints of back
pain or any discomfort. Blood pressures concordant between arms.
TTE without evidence of aortic dilatation.
# CODE: DNR/DNI (confirmed)
# ICU consent: Done
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Valsartan 160 mg PO DAILY
2. Estrace (estradiol) 0.01 % (0.1 mg/gram) vaginal ___ and
___
3. Diclofenac Sodium ___ 75 mg PO BID
4. Atorvastatin 10 mg PO DAILY
5. Lorazepam 1.5 mg PO HS:PRN insomnia
6. NexIUM (esomeprazole magnesium) 20 mg oral qd
Discharge Disposition:
Home
Discharge Diagnosis:
___ elevation MI s/p two drug eluting stents to Right
Coronary Artery Disease
Hyperlipidemia
Hypertension
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear ___,
___ was a pleasure meeting ___ and taking care of ___ during your
hospital stay. ___ were admitted after having a heart attack. A
heart artery called the right coronary artery was found to be
blocked and two drug eluting stents were placed to open the
blockage. ___ have done well since the procedure and are ready
to go home. ___ are on two new medicines to help the stent stay
open and prevent another heart attack, Aspirin and Ticagrelor.
Do not stop taking these medicines or miss any doses unless Dr.
___ it is OK to do so.
___ will see Dr. ___ cardiologist in ___ in about a
month who will check another echocardiogram to see if the heart
has recovered. ___ will be able to go to cardiac rehab after
that appt.
Followup Instructions:
___
|
10816940-DS-18
| 10,816,940 | 27,690,963 |
DS
| 18 |
2124-09-17 00:00:00
|
2124-09-18 05:42:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
aspirin / NSAIDS (Non-Steroidal Anti-Inflammatory Drug) / NSAIDS
(Non-Steroidal Anti-Inflammatory Drug)
Attending: ___
Chief Complaint:
cough/dyspnea
Major Surgical or Invasive Procedure:
None
History of Present Illness:
Ms. ___ is an ___ year old female w/ h/o HTN, mild asthma,
glaucoma, arthritis, and early Alzheimer's who presents with
cough and dyspnea. She reports that her symptoms initially began
around ___ with sneezing and she then developed productive
coughing, chills, sore throat, and some body aches. She does
have some sick contacts in the family. Denies chest pain,
nausea, vomiting or diarrhea. General body aches, headache, +ST.
+sick contacts. She did get a flu shot. Denies h/o CHF.
In the ED initial vitals were: 99.0 54 183/60 24 98% RA. Labs
significant for Hct 33.8, eos 5.5, Cr 2 (baseline 1.8) with BUN
44. Trop was flat and lactate 0.6. A flu swab was obtained and
was negative. Blood cx were obtained. In the ED, ambulatory sats
were noted to be 88% but a CXR showed no acute cardiopulmonary
abnormality. She received ipratropium/albuterol nebs and gentle
IVF's. Given her ambulatory hypoxia, she was admitted for
further management. VS upon transfer: 99.3 105 140/72 25 98% RA.
On the floor, Ms. ___ had a very significant productive
cough, which is the most bothersome symptom for her. She also
mentioned that she frequently falls on her face and breaks her
glasses; she attributes this to "balance issues". She also
frequently finds streaks of blood in her stool and says this has
happened for "years". She reports having had 4 total
colonoscopies but does not remember when her last one was.
Past Medical History:
___ DISEASE (questionable, reportedly had a test
that was negative for the disease)
HYPERTENSION
ARTHRITIS
EARLY ALZHEIMER'S
GLAUCOMA
HYSTERECTOMY
HAND OPERATION
HIP REPLACEMENT
Social History:
___
Family History:
Patient unsure
Physical Exam:
PHYSICAL EXAM ON ADMISSION:
Vitals - 99.2 150/70 72 20 97 ra
GENERAL: NAD but coughing significantly. Appearing younger than
stated age.
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva,
MMM, NECK: nontender supple neck
CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs
LUNG: Reduced breath sounds with rales and rhonchi audible
without the stethoscope. Coughing frequently, sounds productive.
ABDOMEN: nondistended, +BS, nontender in all quadrants, no
rebound/guarding, no hepatosplenomegaly
EXTREMITIES: no cyanosis, clubbing or edema
NEURO: Conversing appropriately and able to give a history.
Moving all extremities well. Gait not assessed.
SKIN: warm and well perfused, no excoriations or lesions, no
rashes
PHYSICAL EXAM ON DISCHARGE:
Vitals: 98.4 (98.4) 139/70 (134-154/70-74) 70 (45-84) 20 96%
RA (96-100% RA)
General: alert, oriented, no acute distress
HEENT: Sclera anicteric, moist mucous membranes, oropharynx
clear
Lungs: mild scattered wheezing heard bilaterally
CV: RRR, normal s1/s2, no m/r/g
Abdomen: soft, nontender to palpation, bowel sounds +
Ext: Warm, well perfused, no edema in feet bilaterally
Neuro: grossly intact
Pertinent Results:
LABS ON ADMISSION:
==============
___ 02:45PM BLOOD WBC-4.6 RBC-3.83* Hgb-11.5* Hct-33.8*
MCV-88# MCH-30.0 MCHC-33.9 RDW-13.8 Plt ___
___ 02:45PM BLOOD Neuts-61.6 Lymphs-17.4* Monos-14.8*
Eos-5.5* Baso-0.7
___ 04:10PM BLOOD ___ PTT-29.5 ___
___ 02:45PM BLOOD Glucose-120* UreaN-44* Creat-2.0* Na-138
K-4.7 Cl-101 HCO3-25 AnGap-17
___ 06:15AM BLOOD ALT-13 AST-22 AlkPhos-45 TotBili-0.3
___ 02:45PM BLOOD proBNP-458
___ 02:45PM BLOOD cTropnT-<0.01
___ 06:15AM BLOOD Albumin-3.9 Calcium-8.8 Phos-3.1 Mg-2.0
___ 02:50PM BLOOD Lactate-0.6
LABS ON DISCHARGE:
==============
___ 07:04AM BLOOD WBC-6.1 RBC-3.35* Hgb-10.0* Hct-29.8*
MCV-89 MCH-29.8 MCHC-33.5 RDW-13.7 Plt ___
___ 07:04AM BLOOD Glucose-114* UreaN-43* Creat-2.0* Na-139
K-4.2 Cl-105 HCO3-24 AnGap-14
___ 07:04AM BLOOD Calcium-8.6 Phos-3.3 Mg-1.9
MICROBIOLOGY:
======================
___ Influenza A/B both negative by PCR
___ 2:45 pm BLOOD CULTURE
Blood Culture, Routine (Pending):
___ 11:45 pm Rapid Respiratory Viral Screen & Culture
Source: Nasopharyngeal swab.
Respiratory Viral Culture (Final ___:
TEST CANCELLED, PATIENT CREDITED.
Refer to respiratory viral antigen screen and respiratory
virus
identification test results for further information.
Respiratory Viral Antigen Screen (Final ___:
Positive for Respiratory viral antigens.
Specimen screened for: Adeno, Parainfluenza 1, 2, 3,
Influenza
A, B, and RSV by immunofluorescence.
Respiratory Virus Identification (Final ___:
POSITIVE FOR RESPIRATORY SYNCYTIAL VIRUS (RSV).
Viral antigen identified by immunofluorescence.
Reported to and read back by ___ ___
1120.
___ 6:15 am URINE OLD# ___.
URINE CULTURE (Preliminary):
ESCHERICHIA COLI. >100,000 ORGANISMS/ML..
PRESUMPTIVE IDENTIFICATION.
STUDIES:
===============
ECGStudy Date of ___ 5:20:56 ___
Sinus rhythm. Left axis deviation. Borderline left atrial
abnormality. Delayed R wave transition. Non-specific ST segment
flattening. Left ventricular hypertrophy. No previous tracing
available for comparison.
CHEST (PA & LAT)Study Date of ___ 3:50 ___
IMPRESSION:
No acute cardiopulmonary abnormality.
Brief Hospital Course:
___ w/ h/o HTN, mild asthma, glaucoma, arthritis, and early
Alzheimer's who presents with a 1-week history of cough,
dyspnea, chills, sneezing, nasal congestion, and sore throat.
Presented to ___ on ___, admitted for ambulatory sats of 88%.
CXR negative but RSV+ so presumed to have viral URI. Treated
with benzonatate, guaifenesin, cepachol lozenges for symptomatic
relief of cough. Given standing duonebs and then transitioned to
MDI w/ spacer. Respiratory status improved as a result and no
longer hypoxic on ambulation or rest. Also found to have dysuria
while in-house, urine cx preliminarily suggest E Coli;
prescribed 3d course of bactrim.
#Dyspnea/Dry cough: ___ RSV infection, which also likely caused
asthma exacerbation. Pt's other sx of chills, sneezing, nasal
congestion, and sore throat consistent with RSV. CXR
unremarkable and flu swab negative; low suspicion for bacterial
process. On repeat ambulatory sat, patient 91-94% on room air.
Given benzonatate, guaifenesin, cepachol lozenges for
symptomatic relief. Treated with combivent inhaler with spacer
to optimize asthma treatment.
# Dysuria: c/w patient's prior bouts of cystitis. UA revealed 13
WBCs and few bacteria. Urine cx appears to be growing E Coli.
Due to renal function, Bactrim SS BID x 3d. Urine cx to be
followed up at PCP ___.
# CKD: seen in ___ clinic at ___, no acute intervention
recommended. Baseline Cr 1.8, has ranged from 1.8-2.2 throughout
admission, varying with fluid status. Patient encouraged to
increase PO PO intake.
#Glaucoma: continued on brimonidine, dorzolamide/timolol, and
lumigan (took own meds).
#HTN: continued on aliskiren and amlodipine.
#Hx of Falls: patient reports not having fallen in over a year.
In the past, when she has fallen at home, there was no prodrome
and no LOC. No workup as per PCP. She lives alone and has no
services. Seen by ___ inpatient. Independent for ADLs and for
IADLs. Pt does participate in regular physical activity
including walking in the park across from her house. She drives
and has the Ride to get to appts. Performance Orientated
Mobility Assessment score of 23 is consistent with low risk for
falls; patient demonstrated ability to vary speed, step over and
around obstacles and complete higher level balance activities
without LOB. From ___ standpoint, patient was safe for home d/c.
Will followup with home ___.
#Hx of blood in stool: per patient, has occurred for years and
this is also noted in her ___ nephrology note from ___. On
___, colonoscopy showed diverticulosis and internal
hemorrhoids.
TRANSITIONAL ISSUES:
- F/u with PCP ___ 7 days
- Continue bactrim to complete 3day course (ending ___
- F/u urine cx sensitivities
- Combivent with spacer to relieve asthma exacerbation during
viral illness
- Will need f/u regarding asthma and titration of meds in future
- Followup with home ___
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Amlodipine 2.5 mg PO DAILY
2. Brimonidine Tartrate 0.15% Ophth. 1 DROP BOTH EYES BID
3. Lumigan (bimatoprost) 0.01 % ophthalmic daily
4. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID
5. Aliskiren 300 mg PO DAILY
Discharge Medications:
1. Amlodipine 2.5 mg PO DAILY
2. Lumigan (bimatoprost) 0.01 % ophthalmic daily
3. Brimonidine Tartrate 0.15% Ophth. 1 DROP BOTH EYES BID
4. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID
5. Aliskiren 300 mg PO DAILY
6. Sulfameth/Trimethoprim SS 1 TAB PO BID Duration: 3 Days
RX *sulfamethoxazole-trimethoprim 400 mg-80 mg 1 tablet(s) by
mouth twice daily Disp #*4 Tablet Refills:*0
7. Benzonatate 100 mg PO TID
RX *benzonatate 100 mg 1 capsule(s) by mouth three times daily
as needed Disp #*30 Capsule Refills:*0
8. Guaifenesin ___ mL PO Q6H:PRN cough
RX *guaifenesin 100 mg/5 mL 10 liquid(s) by mouth every 6 hours
as needed Disp #*473 Milliliter Milliliter Refills:*0
9. Cepastat (Phenol) Lozenge 1 LOZ PO Q2H:PRN sore throat
RX *phenol [Cepastat] 14.5 mg 1 lozenge every 2 hours as needed
Disp #*30 Lozenge Refills:*0
10. Ipratropium-Albuterol Inhalation Spray 1 INH IH Q6H:PRN
shortness of breath
RX *ipratropium-albuterol [Combivent Respimat] 20 mcg-100
mcg/actuation 1 puff inhalation every 6 hours as needed Disp #*1
Inhaler Refills:*0
Discharge Disposition:
Home
Discharge Diagnosis:
Primary:
- RESPIRATORY SYNCYTIAL VIRUS infection
- Asthma
- Urinary Tract Infection
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Ms. ___,
You were seen at ___ because of cough and shortness of breath.
Your chest x-ray was normal. You were found to have a viral
respiratory infection (RSV), which likely triggered your asthma.
You were treated with medications to relieve your cough, and
were given an inhaler with a spacer to help your asthma. At time
of discharge, your cough had improved and your blood oxygen
levels were normal.
Also, because you experienced some burning on urination, you
were treated with a 3-day course of antibiotics for a urinary
tract infection.
Please call your primary care doctor after discharge to schedule
an appointment to be seen within 7 days.
It wss our pleasure taking care of you. We wish you all the
best!
Sincerely,
Your ___ Team
Followup Instructions:
___
|
10816993-DS-5
| 10,816,993 | 23,142,822 |
DS
| 5 |
2158-01-18 00:00:00
|
2158-01-18 17:06:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
___ S/D
Attending: ___
___ Complaint:
Rash
Major Surgical or Invasive Procedure:
None
History of Present Illness:
Ms. ___ is a ___ ___ woman w/ PMH of
dermatomyositis, currently on MMF, hydroxychloroquine,
prednisone 15 mg daily who presented with worsening rash.
Patient reports that her rash began to worsen around a week or 2
ago. She noticed it on her thighs, upper arms, and around her
face -in particular, her cheeks and her eyelids. She notes that
these areas are new. The rash is very itchy, and at times
painful as well -it is severe enough that she has trouble
sleeping at night. She believes she may have had a fever the
night prior to presentation as well. She has not noted any
weakness. She has no trouble standing up from a seated position
or reaching over her head. She is able to confirm that she is
currently taking MMF twice a day, hydroxychloroquine once a day,
and prednisone 15 mg every day. She otherwise has no recent
changes to her medications.
On review of records, patient was last seen by rheumatology on
___. At this time, it was noted that she had proximal
muscle weakness, active rash, and an elevated CPK. They
discussed re-challenging with rituximab. However, it appears
that the patient did not receive this.
In the ED:
Initial vital signs were notable for: T 97.3, HR 80, BP 150/92,
RR 17, 100% RA
Exam notable for:
Blanching maculopapular rash over the cheeks, upper eyelids,
chest, knees. No intraoral involvement, involvement of the palms
or soles. ___ strength with bilateral upper and lower
extremities including the knee, hip, ankle, elbow.
Labs were notable for:
- CBC: WBC 4.1 (31%n, 47% l, 16%m), hgb 11.7, plt 220
- Lytes:
139 / 101 / 12 AGap=12
-------------- 91
5.5 \ 26 \ 0.5
- CRP 3.7
- CK: 1060-> 908
- lactate 0.9
Patient was given:
___ 14:30 PO/NG PredniSONE 30 mg
___ 15:27 IVF NS 1000 mL
Per ED, case was discussed with rheumatology attending, who
recommended the patient's prednisone be increased to 30 mg
daily.
Vitals on transfer: T 98.9, HR 70, BP 161/100, RR 16, 100% RA
Upon arrival to the floor, patient recounts history as above.
She describes an extremely itchy rash currently.
Past Medical History:
- dermatomyositis
- abdominal pain
- anemia
- back pain
- GERD
- headache
- hypertension
- migraines
- osteoarthritis
Social History:
___
Family History:
Sister with IBD and colon cancer (___)
Both parents died from MI- Mother (___)
Maternal aunt and sister - DM
Maternal cousin - ___ issues
Physical Exam:
ON ADMISSION:
VITALS: T 99.1, HR 84, BP 160/75, RR 18, 96% Ra
GENERAL: Alert and in no apparent distress, ambulating
independently in room
EYES: Anicteric, pupils equally round
ENT: Erythematous scaly rash on eyelids, cheeks. Oropharynx
without visible lesion, erythema or exudate
CV: Heart regular, no murmur, no S3, no S4. No JVD.
RESP: Lungs clear to auscultation with good air movement
bilaterally. Breathing is non-labored on room air.
GI: Abdomen soft, non-distended, non-tender to palpation. Bowel
sounds present. No HSM
GU: No suprapubic fullness or tenderness to palpation
MSK: Neck supple, moves all extremities, strength grossly full
and symmetric bilaterally in all limbs
SKIN: Facial rash as above. Several areas of erythematous,
blanching, maculopapular rash noted, including bilateral lateral
thighs, knees, elbows, upper arm, upper chest
NEURO: Alert, oriented, face symmetric, gaze conjugate with
EOMI, speech fluent. ___ strength in bilateral upper and lower
proximal and distal muscle groups. Steady gait.
PSYCH: pleasant, appropriate affect
====================================
VITALS: ___ 0828 Temp: 98.9 PO BP: 127/84 R Lying HR: 84
RR: 16 O2 sat: 99% O2 delivery: ra Dyspnea: 0 RASS: 0 Pain
Score: ___
GENERAL: Alert and in no apparent distress, appears comfortable,
conversant
EYES: Anicteric
ENT: Ears and nose without visible erythema, masses, or trauma.
Oropharynx without visible lesion, erythema or exudate. Moist
mucus membranes.
CV: RRR, no murmur, no S3, no S4. 2+ radial pulses bilaterally
RESP: Lungs clear to auscultation with good air movement
bilaterally. Breathing is non-labored on room air.
GI: Abdomen soft, non-distended, mildly tender in RLQ,
non-tender in epigastric region. Bowel sounds present.
GU: No suprapubic fullness or tenderness to palpation, no Foley
MSK: Moves all extremities, no joint tenderness of hands, knees
or ankles.
SKIN: Improved, mildly erythematous, maculopapular rash over
face including nasolabial folds. Resolved rash on neck and
anterior chest. Patch on right lateral thigh and patch on left
thigh improved, mildly erythematous. Scars on right thigh.
Slightly erythema over dorsum of both hands over MCP joints and
DIP joints, both knees and elbows. No rash of
axilla/abdomen/back.
NEURO: Alert, oriented x3, face symmetric, speech fluent, moves
all limbs
PSYCH: pleasant, appropriate affect
Pertinent Results:
LABS ON ADMISSION:
___ 12:53PM BLOOD WBC-4.1 RBC-4.30 Hgb-11.7 Hct-37.4 MCV-87
MCH-27.2 MCHC-31.3* RDW-14.6 RDWSD-46.2 Plt ___
___ 12:53PM BLOOD Neuts-31.6* ___ Monos-16.2*
Eos-4.4 Baso-0.5 Im ___ AbsNeut-1.29* AbsLymp-1.92
AbsMono-0.66 AbsEos-0.18 AbsBaso-0.02
___ 12:53PM BLOOD Glucose-91 UreaN-12 Creat-0.5 Na-139
K-5.5* Cl-101 HCO3-26 AnGap-12
___ 12:53PM BLOOD CK(CPK)-1060*
___ 08:40AM BLOOD ALT-40 AST-43* CK(CPK)-752* AlkPhos-52
TotBili-0.6
___ 08:40AM BLOOD Calcium-9.2 Phos-2.9 Mg-1.8
___ 12:53PM BLOOD CRP-3.7
___ 07:40AM BLOOD IgG-1153 IgA-239 IgM-61
___ 01:20PM BLOOD Lactate-0.9
___ 12:53PM URINE Color-Straw Appear-Hazy* Sp ___
___ 12:53PM URINE Blood-NEG Nitrite-NEG Protein-TR*
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.5 Leuks-TR*
___ 12:53PM URINE RBC-<1 WBC-2 Bacteri-NONE Yeast-NONE
Epi-21
___ 12:53PM URINE Mucous-RARE*
==========================================
LABS ON DISCHARGE:
___ 06:55AM BLOOD WBC-7.3 RBC-4.60 Hgb-12.7 Hct-39.9 MCV-87
MCH-27.6 MCHC-31.8* RDW-14.5 RDWSD-46.0 Plt ___
___ 07:20AM BLOOD Glucose-80 UreaN-21* Creat-0.5 Na-139
K-4.3 Cl-101 HCO3-22 AnGap-16
___ 07:20AM BLOOD ALT-60* AST-54* AlkPhos-47 TotBili-0.7
___ 06:55AM BLOOD CK(CPK)-376*
___ 07:40AM BLOOD IgG-1153 IgA-239 IgM-61
___ 01:20PM URINE Color-Yellow Appear-Clear Sp ___
___ 01:20PM URINE Blood-NEG Nitrite-NEG Protein-30*
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-TR*
___ 01:20PM URINE RBC-1 WBC-2 Bacteri-FEW* Yeast-NONE
Epi-<1
==========================================
MICROBIOLOGY:
Urine culture ___: MIXED BACTERIAL FLORA ( >= 3 COLONY
TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION.
Blood culture ___: No growth (final)
==========================================
IMAGING:
CHEST X-RAY ___:
No acute cardiopulmonary abnormality. Unchanged appearance of
the
cardiomediastinal silhouette.
Brief Hospital Course:
Ms. ___ is a ___ ___ woman with dermatomyositis
(on mycophenolate, hydroxychloroquine, prednisone 15 mg daily)
who presented with 1 week of worsening
rash, consistent with acute dermatomyositis flare.
ACUTE/ACTIVE PROBLEMS:
# Acute flare of dermatomyositis: She presented with worsening
rash in several areas, including her face, neck, chest, and
legs. She had no evidence of weakness on exam. CK was elevated
to 1060 on admission, but steadily decreased and was down to 376
prior to discharge. It was slightly decreased from ___ (was 1300). Her disease is refractory to mycophenolate,
hydroxychloroquine, and prednisone 15 mg daily. Prednisone was
increased from 15mg to 40mg daily. Rheumatology was consulted
and felt her disease is prednisone responsive, but this is not a
long term solution for controlling her disease. She requires
aggressive therapy, so she was started on Rituximab. She has
had prior adverse effects to methotrexate and has
contraindication to azathioprine. She got 1st dose of Rituximab
1g at week 0 (given on ___ and will need another dose at week
2. The major problem would be trying to get second dose, since
it is extremely expensive and rheum specialty pharmacy was
trying to find charitable donation to cover the cost. She was
continued on home hydroxychloroquine 200mg daily and
mycophenolate
1500mg BID. She was discharged on Prednisone 30mg daily. She
was started on prophylactic Bactrim SS daily for PCP prophylaxis
while high dose Prednisone and calcium/vitamin D to prevent
steroid-induced osteoporosis. Rheumatology will be scheduling
outpatient follow up with Dr. ___ for her ___ injection
of Rituximab.
# Dysphagia: She reported dysphagia with solids, which could be
related to her dermatomyositis. SLP recommended soft solids and
thin liquids, but no aspiration
was noted.
# Dyspnea on exertion: She specified dyspnea if she walks for
prolonged periods like 20 minutes or more, not with mild, brief
exertion. CXR ___ showed no abnormalities.
# Social situation
# Homelessness
# Lack of insurance: She was recently evicted from housing on
___. Her children are currently staying with family. ___ is
involved but she has a good relationship with them. She has a
probation officer. Social work was heavily involved. Financial
services saw her and working to enroll in ___
and hopefully should have insurance in two weeks.
# Nausea:
# Epigastric pain: Side effects of Rituximab include ___ with
nausea and her nausea began on ___, so this seemed most likely
to be a side effect. She had no vomiting. She was given 1L of
IV fluids and PRN Zofran and Maalox. Her epigastric pain and
nausea had resolved by the day of discharge.
# Bilateral hip pain: This "bone pain" was new as of ___, with
tenderness on exam without overlying skin changes, but may have
been a side effect of Rituximab (arthralgias can be side
effect). This pain resolved prior to discharge.
CHRONIC/STABLE PROBLEMS:
# Hypertension: She was normotensive and she was continued on
home diltiazem 180mg daily and lisinopril 20mg daily.
# GERD: She had some epigastric pain and tenderness, that seemed
worse after getting Rituximab and she was continued on
omeprazole. Her symptoms had improved prior to discharge.
# Constipation: She was treated with Senna, Colace, Miralax.
TRANSITION OF CARE ISSUES:
- I made her an appointment with Dr. ___ office at 10:30 AM on
___ for follow up (___). She may need to
reschedule this if she still doesn't have insurance then. She
wants to switch to a PCP here or ___, so may need to cancel
appointment, but on day of discharge, she told me she'd go to
her existing appointment.
- She is still waiting on getting Mass Health Limited. This is
going to impact her ability to get follow up with her PCP and
rheumatology, particularly for the Rituximab injection.
Check if applies: [ X ] Ms. ___ is clinically stable for
discharge today. The total time spent today on discharge
planning, counseling and coordination of care today was greater
than 30 minutes.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Diltiazem Extended-Release 180 mg PO DAILY
2. Hydroxychloroquine Sulfate 200 mg PO DAILY
3. Lisinopril 20 mg PO DAILY
4. mycophenolate mofetil 1500 mg oral BID
5. Omeprazole 20 mg PO DAILY
6. PredniSONE 15 mg PO DAILY
7. Triamcinolone Acetonide 0.025% Ointment 1 Appl TP DAILY
8. Calcium Carbonate 500 mg PO DAILY
9. Docusate Sodium 100 mg PO DAILY
Discharge Medications:
1. Polyethylene Glycol 17 g PO DAILY
2. Sarna Lotion 1 Appl TP QID:PRN itching
3. Senna 8.6 mg PO BID
4. Sulfameth/Trimethoprim SS 1 TAB PO DAILY
RX *sulfamethoxazole-trimethoprim 400 mg-80 mg 1 tablet(s) by
mouth Daily Disp #*30 Tablet Refills:*0
5. Vitamin D 1000 UNIT PO DAILY
6. PredniSONE 30 mg PO DAILY
RX *prednisone 10 mg 3 tablet(s) by mouth Daily Disp #*45 Tablet
Refills:*0
7. Calcium Carbonate 500 mg PO DAILY
8. Diltiazem Extended-Release 180 mg PO DAILY
RX *diltiazem HCl 180 mg 1 tablet(s) by mouth Daily Disp #*14
Tablet Refills:*0
9. Docusate Sodium 100 mg PO DAILY
10. Hydroxychloroquine Sulfate 200 mg PO DAILY
RX *hydroxychloroquine 200 mg 1 tablet(s) by mouth Daily Disp
#*14 Tablet Refills:*0
11. Lisinopril 20 mg PO DAILY
RX *lisinopril 20 mg 1 tablet(s) by mouth Daily Disp #*14 Tablet
Refills:*0
12. mycophenolate mofetil 1500 mg oral BID
RX *mycophenolate mofetil 500 mg 3 tablet(s) by mouth twice a
day Disp #*84 Tablet Refills:*0
13. Omeprazole 20 mg PO DAILY
RX *omeprazole 20 mg 1 capsule(s) by mouth Daily Disp #*14
Capsule Refills:*0
14. Triamcinolone Acetonide 0.025% Ointment 1 Appl TP DAILY
RX *triamcinolone acetonide 0.025 % Apply thin layer to affected
area Daily Refills:*0
Discharge Disposition:
Home
Discharge Diagnosis:
Dermatomyositis flare
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
You were hospitalized with a flare of dermatomyositis. Your
prednisone was increased to 30mg daily and you were continued on
your existing doses of mycophenolate and hydroxychloroquine.
You had your first infusion of Rituximab on ___. You
will need another infusion in 2 weeks. Rheumatology will
contact you regarding follow up.
You are being started on calcium and vitamin D supplementation
to help prevent steroid-induced osteoporosis. You are also
being started on an antibiotic called Bactrim to help prevent
rare causes of pneumonia that can occur if you're on high doses
of steroids (like the prednisone) for long periods of time.
It is extremely important to follow up with your primary care
doctor and rheumatologist in the next several weeks to make sure
that your dermatomyositis is controlled, because the potential
complications can be very severe. We understand that right now
you do not have insurance and it is difficult to pay for care,
but hopefully you will be set up with Mass Health soon. Our
social worker talked with you about shelters you can stay in.
Do not hesitate to contact your doctors' offices if you have
questions.
Followup Instructions:
___
|
10816993-DS-6
| 10,816,993 | 24,483,786 |
DS
| 6 |
2158-03-07 00:00:00
|
2158-03-19 18:40:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
___ S/D
Attending: ___.
Chief Complaint:
Hand pain
Major Surgical or Invasive Procedure:
EGD
History of Present Illness:
Ms. ___ is a ___ ___ speaking female with history of
dermatomyositis with recent admission for flare (on MMF, HCQ,
prednisone, and rituximab), who is presenting with finger pain.
Patient is interviewed with ___ phone interpreter. She
states that she first developed finger pain 3 days ago, and it
has become increasingly severe. It is located in the joints of
her right hand, especially the middle finger. She notes that she
is no longer able to make a fist. This has been associated with
new sores on her joints. She also notes that the rash on her
right thigh is worse, with a few openings that she has noticed.
No fevers. Facial rash has gotten better, and muscle aches have
also improved, though still some pain on right side.
Patient also reports that she has been feeling lightheaded, and
the morning of admission felt weak while in the shower and fell
back, hitting her head on the faucet. Continues to have
headache, which is now throughout her head. Dizziness has since
resolved.
She notes that insurance continues to be an issue, and that she
has run out of some of her medications. She notes that she still
does not have housing,
Per review of records, was admitted in ___ for flare of
her dermatomyositis. Her dose of steroids was increased at that
time, and she was given a dose of rituximab. They had planned to
give her a second dose as an outpatient, but have been unable to
get insurance authorization. Started tapering her steroids on
___ (reduced dose from 30mg at time of discharge to 15mg).
Past Medical History:
- dermatomyositis
- abdominal pain
- anemia
- back pain
- GERD
- headache
- hypertension
- migraines
- osteoarthritis
Social History:
___
Family History:
Sister with IBD and colon cancer (___)
Both parents died from MI- Mother (___)
Maternal aunt and sister - DM
Maternal cousin - ___ issues
Physical Exam:
ADMISSION EXAM
VITALS: T 98.7, HR 76, BP 130/81, RR 18, 99% RA
GENERAL: Alert and in no apparent distress
EYES: Anicteric, pupils equally round
ENT: Ears and nose without visible erythema, masses, or trauma.
Oropharynx without visible lesion, erythema or exudate
CV: Heart regular, no murmur, no S3, no S4. No JVD.
RESP: Lungs clear to auscultation with good air movement
bilaterally. Breathing is non-labored
GI: Abdomen soft, non-distended, non-tender to palpation. Bowel
sounds present. No HSM
GU: No suprapubic fullness or tenderness to palpation
MSK: Neck supple, moves all extremities, strength grossly full
and symmetric bilaterally in all limbs. L leg painful to
palpation
SKIN: Gottron's papules over finger joints, with ulceration over
R ___ finger MCP. Heliotrop rash. R upper leg with
hyperpigmented rash with three small, nondraining openings.
NEURO: Alert, oriented, face symmetric, gaze conjugate with
EOMI, speech fluent, moves all limbs, sensation to light touch
grossly intact throughout
PSYCH: pleasant, appropriate affect
Pertinent Results:
****************
ADMISSION LABS
****************
- CBC: WBC 5.5, hgb 11.7, plt 227
- Lytes:
142 / 107 / 9 AGap=15
------------- 120
4.3 \ 20 \ 0.5
- CK 324
- CRP 3.4
****************
DISCHARGE LABS
****************
___ 03:18PM BLOOD WBC-4.9 RBC-4.81 Hgb-13.0 Hct-41.6 MCV-87
MCH-27.0 MCHC-31.3* RDW-14.5 RDWSD-45.8 Plt ___
___ 03:18PM BLOOD Glucose-134* UreaN-15 Creat-0.7 Na-137
K-5.0 Cl-102 HCO3-23 AnGap-12
___ 03:18PM BLOOD Calcium-9.9 Phos-2.9 Mg-2.0
****************
IMAGING
****************
CT ADBEOMEN/PELVS W/ ___
1. No acute abdominopelvic process.
2. Sheet-like calcifications in the subcutaneous fat of the
flanks and gluteal regions are compatible with dermatomyositis,
progressed from ___.
Brief Hospital Course:
___ yo recently homeless F w/ dermatomyositis (on prednisone &
CellCept) who presented w/ right hand swelling and an ulcerative
lesion. Given prednisone burst and Remicade with dramatic
improvement in her symptoms.
She then developed epigastric abdominal pain and associated poor
PO; EGD showed gastritis, presumed to be steroid induced based
on timing of onset. The gastritis improved with several days of
acid suppression and supportive care.
#DERMATOMYOSITIS FLARE
The patient presented with acute onset of hand swelling and
ulceration, and ulceration over an old lesion on her thigh. This
was likely a flare of her known dermatomyositis. New lesions are
compatible with dermatomyositis as well. She was seen by
rheumatology and received a rituximab infusion with considerable
improvement in her hand pain and resolution of the ulcer. She
was continued on her home MMP and Plaquinel. Her home prednisone
was briefly increased too, but as below, she developed gastritis
and the dose was adjusted downward again. Continues TMP-SMX,
VitD/calcium, and PPI while on prednisone.
#GASTRITIS
Likely steroid-induced gastritis based on EGD findings abd
timing of onset after an increase in prednisone dose. CT
unremarkable for alternate cause of her pain. She was treated
with omeprazole 20 mg BID, ranitidine 150 mg daily, carafate,
and standing antiemetics. Symptoms improved with several days of
supportive care. She is discharged on a BID PPI for now.
#PLANTAR FASCITIS
Patient developed severe pain on of her plantar fascia. Exam c/w
plantar fasciitis. Checked with rheum to make sure this isn't an
obscure sign of her rheumatologic disease, but they confirmed
that it probably isn't). Unfortunately, cannot give NSAIDs with
her recovering gastritis. She was taught stretching exercises
(pulling the forefoot cephalad with the leg in extension using a
folded bedsheet). Giving a short course of PRN Ultram to help
with pain, as she will have to do significant ambulation in the
setting of homelessness.
#Homelessness
Discharged with instructions from social work about how to get
placement in a family shelter. Discharging physician gave her ___
personal gift of funds to hopefully support her in a transition
to stable housing.
***TRANSITIONAL ISSUES****
1) Ongoing adjustment of prednisone to balance disease control
with steroid side effects.
2) wean antacids, antiemetics, and analgesics as she continues
to spontaneously recover from her gastritis and her plantar
fasciitis.
3) Continue to assist her in transition to a stable housing
situation and offer ongoing support to this homeless mother of
three.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Diltiazem Extended-Release 180 mg PO DAILY
2. Docusate Sodium 100 mg PO DAILY
3. Hydroxychloroquine Sulfate 200 mg PO DAILY
4. Lisinopril 20 mg PO DAILY
5. mycophenolate mofetil 1500 mg oral BID
6. Omeprazole 20 mg PO DAILY
7. Sarna Lotion 1 Appl TP QID:PRN itching
8. Senna 8.6 mg PO BID
9. Polyethylene Glycol 17 g PO DAILY
10. Calcium Carbonate 500 mg PO DAILY
11. Triamcinolone Acetonide 0.025% Ointment 1 Appl TP DAILY
12. Vitamin D 1000 UNIT PO DAILY
13. Sulfameth/Trimethoprim SS 1 TAB PO DAILY
14. PredniSONE 15 mg PO DAILY
Discharge Medications:
1. Acetaminophen 1000 mg PO Q8H
RX *acetaminophen [Acetaminophen Extra Strength] 500 mg 2
tablet(s) by mouth three times a day Disp #*180 Tablet
Refills:*1
2. Ondansetron 8 mg PO TID
RX *ondansetron 8 mg 1 tablet(s) by mouth three times a day Disp
#*21 Tablet Refills:*0
3. Ranitidine 150 mg PO DAILY
RX *ranitidine HCl 150 mg 1 capsule(s) by mouth once a day Disp
#*7 Capsule Refills:*0
4. TraMADol 50 mg PO Q6H:PRN Foot pain
RX *tramadol 50 mg 1 tablet(s) by mouth every six (6) hours Disp
#*30 Tablet Refills:*0
5. Vitamin D 1000 UNIT PO DAILY
6. Omeprazole 20 mg PO BIDAC
RX *omeprazole 20 mg 1 capsule(s) by mouth BIDAC Disp #*60
Capsule Refills:*1
7. PredniSONE 20 mg PO DAILY
RX *prednisone 20 mg 1 tablet(s) by mouth once a day Disp #*30
Tablet Refills:*1
8. Calcium Carbonate 500 mg PO DAILY
RX *calcium carbonate 500 mg calcium (1,250 mg) 1 tablet(s) by
mouth once a day Disp #*30 Tablet Refills:*1
9. Diltiazem Extended-Release 180 mg PO DAILY
RX *diltiazem HCl 180 mg 1 capsule(s) by mouth once a day Disp
#*30 Capsule Refills:*1
10. Docusate Sodium 100 mg PO DAILY
RX *docusate sodium 100 mg 1 capsule(s) by mouth once a day Disp
#*30 Capsule Refills:*1
11. Hydroxychloroquine Sulfate 200 mg PO DAILY
RX *hydroxychloroquine 200 mg 1 tablet(s) by mouth once a day
Disp #*30 Tablet Refills:*1
12. Lisinopril 20 mg PO DAILY
RX *lisinopril 20 mg 1 tablet(s) by mouth once a day Disp #*30
Tablet Refills:*1
13. mycophenolate mofetil 1500 mg oral BID
RX *mycophenolate mofetil 500 mg 3 tablet(s) by mouth twice a
day Disp #*180 Tablet Refills:*1
14. Polyethylene Glycol 17 g PO DAILY
15. Sarna Lotion 1 Appl TP QID:PRN itching
RX *camphor-menthol [Sarna Anti-Itch] 0.5 %-0.5 % Apply to itchy
skin every six (6) hours Refills:*5
16. Senna 8.6 mg PO BID
RX *sennosides [senna] 8.6 mg 1 tablet(s) by mouth twice a day
Disp #*60 Tablet Refills:*1
17. Sulfameth/Trimethoprim SS 1 TAB PO DAILY
RX *sulfamethoxazole-trimethoprim 400 mg-80 mg 1 tab-cap by
mouth once a day Disp #*30 Tablet Refills:*1
18. Triamcinolone Acetonide 0.025% Ointment 1 Appl TP DAILY
RX *triamcinolone acetonide 0.025 % Apply to skin rash once a
day Refills:*1
19. Vitamin D 1000 UNIT PO DAILY
RX *ergocalciferol (vitamin D2) 2,000 unit 1 tablet(s) by mouth
once a day Disp #*30 Tablet Refills:*1
Discharge Disposition:
Home
Discharge Diagnosis:
Dermatomyositis with acute exacerbation
Gastritis
Plantar fasciitis
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
You were in the hospital for dermatomyositis. The disease flared
up and caused damage to your hands. You were treated with
prednisone and rituximab and got better.
Unfortunately you got gastritis. This was probably a side effect
of getting extra prednisone. We did an upper endoscopy, which
did not show anything else besides the gastritis. Please take
extra antacid and nausea medicine for a week while the gastritis
heals.
You also developed pain in your foot. This is probably plantar
fasciitis. Plantar fasciitis is a benign but annoying condition.
Stretch the foot out and walk around like normal. Take Tylenol
for the pain three times a day. Before walking a long way, take
tramadol (a stronger pain medicine).
For placement in a family shelter, please go to:
___ Office - ___
___ (south of ___)
___
___
**********
Traducción al español (por ___ médico)
Ud estubo ___ hospital por dermatomiositis. ___ se
inflamó y causó daños en las manos. Recibió tratamiento con
prednisona y rituximab y Ud mejoró.
Luego, tuvo inicio de gastritis. Este fue ___ un
efecto secundario de obtener prednisona extra. Hicimos una
endoscopia, que no mostró ___ más aparte ___. Por
favor, tome medicamentos antiácidos y para las náuseas ___
una semana ___.
Usted también desarrolló dolor ___ pie. Esto es ___
___ plantar (plantar fasciitis). ___ plantar es
una condición ___. Estira el pie y camina como
normal. Tome acetaminophen para el dolor tres veces al día.
Antes de caminar mucho, tome tramadol (un medicamento para el
dolor más ___.
También ___ recientemente. Para ___
colocación en un ___ para las familias:
___ Office - ___
___ ___ de ___)
___
___
Followup Instructions:
___
|
10817631-DS-10
| 10,817,631 | 25,587,982 |
DS
| 10 |
2152-09-29 00:00:00
|
2152-09-28 14:53:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
___
Attending: ___.
Chief Complaint:
Fever
Major Surgical or Invasive Procedure:
none
History of Present Illness:
Mr. ___ is a ___ man with history of CAD s/p
CABG, HTN, HLD, DMII, multiple myeloma s/p auto SCT currently on
pomalidomide/daratumumab presenting with weakness.
The patient has a history of multiple myeloma s/p auto SCT
(___). He was initially on Revlimid, then Ninlaro, and now
initiated ___ on pomalidomide/daratumumab/dexamethasone. The
patient and his wife report that he has progressively become
weaker over the past several months, but it has been worse in
the
past several weeks. He also notes that he has had drenching
sweats for over a year but this has also gotten worse recently.
He reports that his blood sugars have been labile since
initiating the dexamethasone, sometimes in the 300-400s, but
also
low in the ___.
About 3 weeks ago, the patient got up in the night to urinate
and
feel extremely weak. His wife found him lying on the floor in
the
bathroom. He was taken to BID-M on ___. There, he was found to
have febrile neutropenia and acute on chronic anemia. ID was
consulted and he underwent extensive infectious evaluation
including blood and urine cultures, sputum culture, Flu/RSV
swab;
Lyme, Anaplasma, Babesia, Erlichia negative; CT abdomen/pelvis;
TTE without vegetations. The patient was given
vancomycin/cefepime empirically for 10 days and defervesced. His
hospital course was complicated by an acute gout flare for which
he received prednisone and colchicine. He was discharged on ___.
The patient saw his oncologist Dr. ___ on ___. The plan at that
time was to hold Bactrim/acyclovir prophylaxis, hold aspirin
given worsened thrombocytopenia, resume atenolol, and to hold
pomalidomide. However, the patient took a dose on ___.
At home, he continued to feel extremely weak. He denies any
fevers at home, but noted ongoing drenching sweats. His wife
reports that she went to the supermarket and returned 45 minutes
later and found her husband on the floor. The patient reports
that he was sitting in a recliner and attempted several times to
stand but felt extremely weak and repeatedly fell back into the
recline. On his final attempt to stand he rocked forward and
fell
out of the chair. He denies any loss of consciousness. He denies
any antecedent symptoms such as chest pain, palpitations,
dizziness or lightheadedness. He felt too weak to prop himself
up, and when his wife returned she called EMS. He was taken to
___, where he was febrile to 100.5. He was give IV vancomycin,
IV cefepime, oral vancomycin for potential C. diff, and 1 unit
pRBCS. He was transferred to ___ for further care.
The patient additionally notes that he developed a dry cough
while at ___ but denies any shortness of breath. No abdominal
pain, nausea, vomiting. He had a few loose stools several days
prior to admission this has been ongoing related to
chemotherapy.
He has a rash on his forehead due to his use of ___ for his
actinic keratosis but no other rashes or lesions. No dysuria. No
known sick contacts.
In the ED, vitals: Tmax 102.7 80 122/66 16 98% RA
Exam notable for: CTAB no WRR, unlabored breathing
Labs notable for: WBC 5.5, Hb 7.9, plt 94, INR 1.6; trop
0.07->0.04, MB 3->2; UA with glucosuria
Imaging: CXR
Patient given: Magnesium 2 gm IV, insulin 6 units, Tylenol 1 gm,
erythromycin eye ointment
In our ED, he was noted to have left eye lid with scant purulent
appearing discharge. No pain or redness in the eye. Started on
erythromycin ointment for presumed bacterial conjunctivitis
On arrival to the floor, the patient reports that he feels
fatigued but otherwise has no complaints.
ROS: Pertinent positives and negatives as noted in the HPI. All
other systems were reviewed and are negative.
Past Medical History:
Hypertension
Dyslipidemia
Diabetes (type II with retinopathy)
BPH
Colon Polyps s/p polypectomy
Lung Nodule (right side- stable)
Basal cell CA
Diverticulosis
Multiple myeloma
Social History:
___
Family History:
Mother and father died of CAD in their ___
Physical Exam:
ADMISSION
VITALS: 99.7 125 / 80 67 18 94 RA
GENERAL: Alert and in no apparent distress
EYES: Anicteric, pupils equally round
ENT: Ears and nose without visible erythema, masses, or trauma.
Oropharynx without visible lesion, erythema or exudate
CV: Heart regular, no murmur
RESP: Lungs clear to auscultation with good air movement
bilaterally. Breathing is non-labored
GI: Abdomen soft, non-distended, non-tender to palpation. Bowel
sounds present.
GU: No suprapubic fullness or tenderness to palpation
MSK: Neck supple, moves all extremities, strength grossly full
and symmetric bilaterally in all limbs
SKIN: Rash on forehead
NEURO: Alert, oriented, face symmetric, gaze conjugate with
EOMI,
speech fluent, moves all limbs, sensation to light touch grossly
intact throughout
PSYCH: Very pleasant, appropriate affect
GENERAL: Alert and in no apparent distress
EYES: Anicteric sclera
ENT: Oropharynx without visible lesion, erythema or exudate.
CV: Heart regular, no murmur
RESP: Lungs clear to auscultation with good air movement
bilaterally. Breathing is non-labored.
GI: Abdomen is soft, non-distended, non-tender to palpation.
MSK: Neck supple, moves all extremities
SKIN: Crusted rash on face extending across midline
NEURO: Alert, oriented, speech fluent
PSYCH: Pleasant, appropriate affect
Pertinent Results:
ADMISSION
___ 11:30PM BLOOD WBC-5.5 RBC-2.86* Hgb-7.9* Hct-25.5*
MCV-89 MCH-27.6 MCHC-31.0* RDW-16.2* RDWSD-51.4* Plt Ct-94*
___ 11:30PM BLOOD Neuts-70.7 ___ Monos-7.7 Eos-0.2*
Baso-0.2 Im ___ AbsNeut-3.89 AbsLymp-1.08* AbsMono-0.42
AbsEos-0.01* AbsBaso-0.01
___ 11:30PM BLOOD ___ PTT-26.8 ___
___ 11:30PM BLOOD Glucose-182* UreaN-13 Creat-0.9 Na-136
K-4.3 Cl-102 HCO3-23 AnGap-11
___ 11:30PM BLOOD CK(CPK)-857*
___ 05:51AM BLOOD ALT-7 AST-19 LD(LDH)-96 CK(CPK)-109
AlkPhos-65 TotBili-0.9
___ 11:30PM BLOOD CK-MB-3 cTropnT-0.07*
___ 11:30PM BLOOD Calcium-9.6 Phos-3.5 Mg-1.2* Iron-40*
___ 08:48AM BLOOD PEP-PND FreeKap-134.6* FreeLam-1.3* Fr
K/L-103.5*
___ 11:30PM BLOOD calTIBC-120* Ferritn-1101* TRF-92*
___ 07:30AM BLOOD Cortsol-17.7
___ 11:30PM BLOOD TSH-3.4
___ 11:38PM BLOOD Glucose-178* Lactate-1.0
IMAGING
- CT Head (___): CT head that did not show acute hemorrhage,
mass, territorial infarct.
- CT chest (___)
1. Multiple lucent lesions scattered throughout the axial
skeleton are concerning for myelomatous involvement. Several of
the lesions including dominant lesions in the T6 and T7
vertebral
bodies, which were not FDG avid on the prior PET-CT appear
grossly unchanged. A probable lesion in the medial
aspect of the right clavicle, appears new from PET-CT ___ and is concerning for new or worsening myelomatous
involvement.
2. Small pulmonary nodules measure up to 2 mm, not definitely
seen on PET-CT ___, possibly due to poor resolution.
Recommend ___ month interval follow-up to assess for stability.
3. Assessment is moderately limited by respiratory motion, but
no
definite evidence of pneumonia or bronchitis.
- CT sinus (___)
1. There is moderate mucosal thickening of the bilateral ethmoid
air cells and left maxillary sinus with partial opacification of
the left maxillary sinus which may represent sinus disease in
the
appropriate clinical setting.
2. There is opacification of the left infundibulum.
3. Polypoid soft tissue in the left maxillary sinus may
represent
sinus polyposis.
4. The bilateral orbits are unremarkable.
___ 07:05AM BLOOD WBC-3.4* RBC-2.61* Hgb-7.3* Hct-23.2*
MCV-89 MCH-28.0 MCHC-31.5* RDW-15.4 RDWSD-49.4* Plt Ct-87*
___ 07:05AM BLOOD Glucose-93 UreaN-12 Creat-1.1 Na-136
K-3.4* Cl-100 HCO3-29 AnGap-7*
___ 07:05AM BLOOD Mg-1.4*
Brief Hospital Course:
Mr. ___ is a ___ man with history of CAD s/p CABG,
HTN, HLD, DMII, multiple myeloma s/p auto SCT currently on
pomalidomide/daratumumab presenting with weakness and fever.
#Fever
#Sinusitis
Patient recently was admitted to BID-M for neutropenic fever
with extensive evaluation without source identification. Patient
was treated with 10 day course of empiric vancomycin/cefepime.
He re-presented with recurrent fever. No clear localizing signs
or symptoms of infection other than cough and possible
conjunctivitis. CXR was without focal infiltrate. CT chest
showed no pneumonia. CT sinus showed possible sinusitis. Patient
did have loose stools prior to admission, but they were
self-limiting. Infectious disease and oncology were consulted to
help advise investigation and management. Patient was treated
with empiric broad spectrum antibiotics with IV vancomycin, IV
cefepime, and IV metronidazole, then transitioned to PO
levofloxacin and flagyl on ___ once it was determined that he
likely had viral URI +/- superimposed bacterial
conjunctivitis/sinusitis. He remained stable on this regimen and
was discharged on levofloxacin and metronidazole to complete a
14-day total course on ___.
# Acute metabolic encephalopathy
Delirium, febrile effects related to immunotherapy versus
infection. Infectious workup and management as above. His
encephalopathy resolved with the aforementioned treatment.
# Multiple myeloma
# Anemia/thrombocytopenia: Currently receiving treatment with
daratumumab/pomalidomide. Intention had been to hold
pomalidomide, but patient took 2 doses since recent discharge.
Held daratumumab/pomalidomide but per Atrius onc. He will see
his oncologist Dr. ___ on ___ to discuss resuming therapy.
He received 1 U pRBC for symptomatic anemia and Hgb <7.
# CAD s/p CABG
# Demand ischemia: Patient with mild troponin elevation on
admission, likely represents mild demand in setting of acute
illness. Patient is asymptomatic and EKG was without acute
ischemic changes. His home cardiac medications were resumed.
# DMII: Labile blood sugars in setting of recent dexamethasone
use. His home medications were resumed
# Weakness
# Fall
Patient with global weakness in setting of febrile illness,
labile blood sugars, and multiple myeloma on new immunotherapy
regimen. ___ worked with the patient, and his mobility progressed
to where they felt he would be safe to return home with home ___.
# Conjunctivitis (viral versus bacterial): Patient had scant
purulent discharge in left eye in ED and started on
erythromycin. He completed 7 days of erythromycin ointment.
# Gout: No evidence of acute flare.
Mr. ___ was seen and examined on the day of discharge and is
clinically stable for discharge today. The total time spent
today on discharge planning, counseling and coordination of care
was greater than 30 minutes.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Colchicine 0.6 mg PO DAILY
2. Nateglinide 120 mg PO TIDAC
3. pomalidomide 2 mg oral DAILY
4. Dexamethasone 20 mg PO 1X/WEEK (___)
5. fluorouracil 5 % topical DAILY
6. Omeprazole 20 mg PO DAILY
7. colestipol 5 gram oral DAILY
8. Cyanocobalamin 1000 mcg PO DAILY
9. MetFORMIN XR (Glucophage XR) 1000 mg PO BID
10. Glargine 22 Units Bedtime
11. FoLIC Acid 1 mg PO DAILY
12. magnesium chloride 64 mg oral BID
13. Lisinopril 10 mg PO DAILY
14. Atenolol 25 mg PO DAILY
15. Atorvastatin 20 mg PO QPM
16. Aspirin 81 mg PO DAILY
17. Fish Oil (Omega 3) 1000 mg PO DAILY
18. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN Chest pain
Discharge Medications:
1. Benzonatate 200 mg PO TID Cough
RX *benzonatate 100 mg 1 capsule(s) by mouth three times a day
Disp #*30 Capsule Refills:*1
2. GuaiFENesin ER 1200 mg PO Q12H
RX *guaifenesin [Mucus-ER MAX] 1,200 mg 1 tablet(s) by mouth
twice a day Disp #*28 Tablet Refills:*1
3. LevoFLOXacin 750 mg PO DAILY
RX *levofloxacin 750 mg 1 tablet(s) by mouth once a day Disp #*8
Tablet Refills:*0
4. MetroNIDAZOLE 500 mg PO/NG Q8H
RX *metronidazole 500 mg 1 tablet(s) by mouth every eight (8)
hours Disp #*24 Tablet Refills:*0
5. Multivitamins W/minerals 1 TAB PO DAILY
RX *multivitamin,tx-minerals 1 tablet(s) by mouth once a day
Disp #*90 Tablet Refills:*3
6. Aspirin 81 mg PO DAILY
7. Atenolol 25 mg PO DAILY
8. Atorvastatin 20 mg PO QPM
9. colestipol 5 gram oral DAILY
10. Cyanocobalamin 1000 mcg PO DAILY
11. Dexamethasone 20 mg PO 1X/WEEK (___)
12. Fish Oil (Omega 3) 1000 mg PO DAILY
13. FoLIC Acid 1 mg PO DAILY
14. Glargine 22 Units Bedtime
15. Lisinopril 10 mg PO DAILY
16. magnesium chloride 64 mg oral BID
17. MetFORMIN XR (Glucophage XR) 1000 mg PO BID
18. Nateglinide 120 mg PO TIDAC
19. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN Chest pain
20. Omeprazole 20 mg PO DAILY
21. HELD- fluorouracil 5 % topical DAILY This medication was
held. Do not restart fluorouracil until your oncologist tells
you to
22. HELD- pomalidomide 2 mg oral DAILY This medication was
held. Do not restart pomalidomide until your oncologist tells
you to
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
Febrile illness
Acute metabolic encephalopathy
Multiple myeloma
Anemia and thrombocytopenia
CAD s/p CABG
Demand ischemia
Diabetes mellitus
Weakness
Fall
Conjunctivitis
Essential hypertension
Hyperlipidemia
Gout
Actinic keratosis:
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Mr. ___,
You were admitted to ___ with an infection. We treated you for
a respiratory infection, and your symptoms improved. We would
like you to complete a 14-day course of antibiotics to help
clear this up. Your oncologist would like to see you in clinic
on ___.
Followup Instructions:
___
|
10817631-DS-11
| 10,817,631 | 23,330,902 |
DS
| 11 |
2152-10-15 00:00:00
|
2152-10-15 14:57:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
___
Attending: ___.
Chief Complaint:
HYPERCALCEMIA ___ MULTIPLE MYELOMA PROGRESSION
Major Surgical or Invasive Procedure:
None
History of Present Illness:
Mr. ___ is a ___ year old man with relapsed multiple myeloma
with multiple recent admissions for fevers, cough, and weakness
who is admitted from the ED with persistent weakness and falls.
Recently admitted ___ to ___ on HMED with weakness and
neutropenic fever. He was treated with Vancomycin, cefepime, and
metronidazole before transitioning to po levofloxacin and flagyl
with planned completion on ___. No source definitively
identified but thought viral URI +/- superimposed bacterial
conjunctivitis/sinusitis. Course otherwise notable for
encephalopathy and weakness. His daratumumab / pomalidomide /
dexamethasone were held. He had a similar hospitalization at
___ from ___ to ___. He apparently was considering SNF
placement, but reportedly could not be discharged to SNF due to
chemotherapy.
Since discharge home he has remained extremely weak, with severe
difficult ambulating around his home. He has had two additional
falls over the weekend, last yesterday. Also notes frequent
night
sweats with a FSBG of 44 this am. He otherwise denies headaches.
No known fevers and his cough has resolved. No visual changes.
No
dysphagia or odynophagia. No CP, SOB or cough. He had a day of
nausea with emesis x2 last week but none since. Appetite is very
poor but is tolerating po. No abdominal pain. He notes frequent
urination but no dysuria. He had four episodes of diarrhea
yesterday. Because of severe weakness and inability to get out
of
his chair this morning, he presented to ___.
Past Medical History:
Hypertension
Dyslipidemia
Diabetes (type II with retinopathy)
BPH
Colon Polyps s/p polypectomy
Lung Nodule (right side- stable)
Basal cell CA
Diverticulosis
Multiple myeloma
Social History:
___
Family History:
Mother and father died of CAD in their ___
Physical Exam:
ADMISSION PHYSICAL EXAM:
VS: T 98.0 HR 67 BP 122/58 RR 18 SAT 96% O2 on RA
GENERAL: Pleasant chronically ill appearing man sitting up in
bed
in no distress
EYES: Anicteric sclerea, PERLL, EOMI;
ENT: Dry MM. Oropharynx clear without lesion, JVD not elevated
CARDIOVASCULAR: Regular rate and rhythm, no murmurs, rubs, or
gallops
RESPIRATORY: Appears in no respiratory distress, clear to
auscultation bilaterally, no crackles, wheezes, or rhonchi
GASTROINTESTINAL: Normal bowel sounds; nondistended; soft,
nontender without rebound or guarding; no hepatomegaly, no
splenomegaly
MUSKULOSKELATAL: Warm, well perfused extremities without lower
extremity edema; Decreased bulk
NEURO: Alert, oriented, CN III-XII intact, motor and sensory
function grossly intact, FTN intact
SKIN: Excoriation/scabs over forehead and nose
LYMPHATIC: No cervical, supraclavicular, submandibular
lymphadenopathy. No significant ecchymoses
DISCHARGE PHYSICAL EXAM:
VS: T 98.8 BP 138/54 HR 74 R 18 O2Sat 99 RA
GENERAL: Pleasant chronically ill appearing man sitting up in
bed
in no distress, alert, oriented to self, place, and situation.
EYES: Anicteric sclerea, PERLL, EOMI;
ENT: Dry MM. Oropharynx clear without lesion, JVD not elevated
CARDIOVASCULAR: Regular rate and rhythm, no murmurs, rubs, or
gallops
RESPIRATORY: Appears in no respiratory distress, clear to
auscultation bilaterally, no crackles, wheezes, or rhonchi
GASTROINTESTINAL: Normal bowel sounds; nondistended; soft,
nontender without rebound or guarding; no hepatomegaly, no
splenomegaly
MUSKULOSKELATAL: Warm, well perfused extremities without lower
extremity edema; Decreased bulk
NEURO: Alert, oriented to self, place, situation, time
SKIN: Skin type II. Scattered scaly, erythematous plaque with
hemorrhagic crust on forehead, well healing.
ACCESS: PIV
Pertinent Results:
ADMISSION LABS:
___ 06:51PM CALCIUM-13.7* PHOSPHATE-3.5 MAGNESIUM-0.9*
___ 06:51PM WBC-4.7 RBC-2.84* HGB-8.1* HCT-26.0* MCV-92
MCH-28.5 MCHC-31.2* RDW-15.8* RDWSD-50.5*
___ 06:51PM GLUCOSE-58* UREA N-12 CREAT-1.0 SODIUM-136
POTASSIUM-4.0 CHLORIDE-102 TOTAL CO2-28 ANION GAP-6*
___ 06:30AM BLOOD FreeKap-269.3* FreeLam-1.1* Fr K/L-244.8*
b2micro-17.3*
___ 12:40PM BLOOD PEP-ABNORMAL B IgG-4791* IgA-11* IgM-<5*
___ 12:40PM BLOOD TotProt-10.3* Calcium-12.7* Phos-3.6
Mg-2.0
DISCHARGE LABS:
___ 06:20AM BLOOD WBC-5.9 RBC-2.67* Hgb-7.8* Hct-24.3*
MCV-91 MCH-29.2 MCHC-32.1 RDW-17.0* RDWSD-53.7* Plt ___
___ 06:20AM BLOOD Glucose-88 UreaN-10 Creat-0.9 Na-137
K-3.9 Cl-102 HCO3-24 AnGap-11
___ 06:20AM BLOOD Calcium-8.8 Phos-4.8* Mg-1.5*
PERTINENT IMAGING:
MRI HEAD W/ W/O CONTRAST ___
1. No acute infarcts, mass effect or hydrocephalus.
2. No enhancing brain lesions or leptomeningeal enhancement.
3. Marrow signal abnormalities at the clivus and upper cervical
spine is a
nonspecific finding and could indicate marrow infiltrative
process from
myeloma or marrow hyperplasia.
Brief Hospital Course:
Mr. ___ is a ___ year old man with relapsed multiple myeloma
with multiple recent admissions for fevers, cough, and weakness
who was admitted with persistent weakness and falls in the
setting of profound hypercalcemia, hypomagnesemia, and AMS. His
calcium normalized after dexamethasone and pamidronate, and his
mental status also improved over the course of the
hospitalization.
TRANSITIONAL ISSUES:
[] Follow up with Dr. ___ on ___ for further treatment of
multiple myeloma
[] Check Calcium, Blood Glucose, Magnesium on ___
[] Check Hgb on ___, transfuse for hgb<7 (required 1u prbcs
on ___
[] Follow up on blood sugars; discharged on glargine 10u at
bedtime (home dose was 22u, dose reduced to low morning blood
glucose close to discharge); discharged on home metformin; home
nateglinide held on discharge, can be restarted by outpatient
provider
[] Follow up about re-starting atenolol (held in the setting of
low heart rates and low pressures)
[] Started on acyclovir ppx
# HYPERCALCEMIA OF MALIGNANCY:
# HYPOMAGNESEMIA:
# ENCEPHALOPATHY
Patient had hypercalcemia in setting of relapsed multiple
myeloma. His corrected calcium on admission was 15.1. He was
given Pamidronate 90mg IV as well as dexamethasone 40mg for four
days. On discharge, it was 10.2 when corrected for albumin. His
mental status on admission was altered as he made several
comments not consistent with his environment. His mental status
improved with correction of calcium. A complete work up
including, TSH, RPR, B12, and MRI was done with consultation of
neurology and everything was within in normal limits. On
discharge, mental status was clear.
# HYPOGLYCEMIA ___ STEROID TAPER
# DMII
Patient initially had symptomatic hypoglycemia, then was
hyperglycemic in the setting of dexamethasone. With insulin
titration, had some low blood sugars. On discharge his insulin
regimen is 10 units of lantus at night (takes 22 units of lantus
at home prior to admission). His fasting BG on the morning of
discharge was 88. Metformin held during hospitalization, will be
continued on discharge. Nateglinide 120 mg PO TIDAC held during
hospitalization and on discharge, can be started by PCP.
# HEMATURIA
Patient complained of blood in urine with no other urinary
symptoms. He had no discoloration of urine, but on exam he had
gross blood at the end of the meatus. He has not been
catheterized this hospitalization. A UA showed moderate blood in
urine with glucose ~300. On the following day his symptoms
resolved.
# BRADYCARDIA
During his 4 day steroid regimen, his HR dropped to 30's and
40's. Upon completion of steroid course, his HR resumed to the
the ___. The etiology of this was most likely ___ atenolol
and recent dexamethasone course. His home atenolol was held on
discharge and can be restarted in outpatient setting.
# MULTIPLE MYELOMA
He is s/p Auto-SCT (___) with newly relapsed disease and now
s/p cycle 1 of Dex/Pomalidomide/Daratumumab. He received
dexamethasone 40mg for 4 days in the hospital. Plan, per Dr.
___, is to resume Dex/Pomalidomide/Daratumumab as outpatient
with Dr. ___ ___.
CHRONIC ISSUES:
# CAD sp CABG
# S/p CEA
# HLD
# HTN
His home ASA 162mg daily, home lisinopril, and home atorvastatin
were continued in the hospital.
# Skin cancer
He had been using topical ___ x3 weeks and was on a break when
he was admitted. We monitored his skin and he had no concerning
lesions. Can be followed up in outpatient setting.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 162 mg PO DAILY
2. Atorvastatin 20 mg PO QPM
3. Cyanocobalamin 1000 mcg PO DAILY
4. FoLIC Acid 1 mg PO DAILY
5. Omeprazole 20 mg PO DAILY
6. Benzonatate 200 mg PO TID:PRN Cough
7. Fish Oil (Omega 3) 1000 mg PO DAILY
8. Multivitamins W/minerals 1 TAB PO DAILY
9. MetFORMIN XR (Glucophage XR) 1000 mg PO BID
10. LevoFLOXacin 750 mg PO DAILY
11. MetroNIDAZOLE 500 mg PO/NG Q8H
12. Atenolol 12.5 mg PO DAILY
13. colestipol 5 gram oral DAILY
14. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN Chest pain
15. magnesium chloride 64 mg oral BID
16. Nateglinide 120 mg PO TIDAC
17. Lisinopril 10 mg PO DAILY
18. fluorouracil 5 % topical DAILY
19. Glargine 22 Units Bedtime
20. Acetaminophen 650 mg PO Q12H:PRN Pain - Mild/Fever
Discharge Medications:
1. Acyclovir 400 mg PO Q12H
RX *acyclovir 400 mg 1 capsule(s) by mouth twice a day Disp #*60
Tablet Refills:*0
2. Glargine 10 Units Bedtime
3. Acetaminophen 650 mg PO Q12H:PRN Pain - Mild/Fever
4. Aspirin 162 mg PO DAILY
5. Atorvastatin 20 mg PO QPM
6. Benzonatate 200 mg PO TID:PRN Cough
7. colestipol 5 gram oral DAILY
8. Cyanocobalamin 1000 mcg PO DAILY
9. Fish Oil (Omega 3) 1000 mg PO DAILY
10. FoLIC Acid 1 mg PO DAILY
11. Lisinopril 10 mg PO DAILY
12. magnesium chloride 64 mg oral BID
13. MetFORMIN XR (Glucophage XR) 1000 mg PO BID
Do Not Crush
14. Multivitamins W/minerals 1 TAB PO DAILY
15. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN Chest pain
16. Omeprazole 20 mg PO DAILY
17. HELD- Atenolol 12.5 mg PO DAILY This medication was held.
Do not restart Atenolol until you see your pcp
18. HELD- Nateglinide 120 mg PO TIDAC This medication was held.
Do not restart Nateglinide until you see your primary care
doctor.
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
HYPERCALCEMIA ___ MULTIPLE MYELOMA PROGRESSION
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
It was a pleasure caring for you at ___ ___
___.
WHY WAS I IN THE HOSPITAL?
- You were admitted for high calcium levels and confusion.
WHAT HAPPENED TO ME IN THE HOSPITAL?
- You were given a medication and some fluids to decrease your
calcium.
- You had some low blood sugars after we took you off the
steroid and we titrated your medications to fix your sugars
WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?
- Continue to take all your medicines and keep your
appointments.
We wish you the best!
Sincerely,
Your ___ Team
Followup Instructions:
___
|
10818031-DS-20
| 10,818,031 | 29,324,388 |
DS
| 20 |
2189-07-25 00:00:00
|
2189-07-25 17:15:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: SURGERY
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Abdominal pain
Major Surgical or Invasive Procedure:
___: ___
History of Present Illness:
___ with 2 weeks of lower pelvic pain/pressure. Seen by her
Ob-Gyn with pelvic U/S showing "cysts." Patient's symptoms
became
worse over the past ___ days with increasing focal LLQ
tenderness, - flatus/BM, fevers/chills, poor appetite and
increasing abd distention. Seen at OSH (___) and CT A/P
obtainined which was "normal" per patient. Seen by her Ob-Gyn
again recently with labs showing leukocytosis and CT scan
performed showing LBO with sigmoid volvulus.
Past Medical History:
PMhx: Omphalocele, SBO
PShx: Omphalocele reduction, CCY, C-section X 2
Social History:
___
Family History:
No GI malignancy/IBD
Physical Exam:
On admission:
PE: 101.6 112 119/72 18 99%
A+OX3
RRR
CTAB
Distended, focal peritonitis on LLQ with guarding
rectal exam WNL, guiac negative, no masses felt
no c/c/e
On discharge:
___
Gen: awake, alert, NAD
HEENT: MMM
CV: RRR
Pulm: Nonlabored breathing
Abd: soft, appropriately tender, nondistended. ostomy pink,
+gas / stool. incision opened at middle aspect with
serosanguinous drainage, no erythema/induration.
Ext: no ___
Pertinent Results:
___ 05:00AM BLOOD WBC-15.6* RBC-2.76* Hgb-8.9* Hct-27.2*
MCV-99* MCH-32.3* MCHC-32.8 RDW-13.7 Plt ___
___ 04:00AM BLOOD WBC-16.0* RBC-2.84* Hgb-9.2* Hct-28.3*
MCV-100* MCH-32.3* MCHC-32.4 RDW-13.8 Plt ___
___ 04:55AM BLOOD WBC-14.5* RBC-2.92* Hgb-9.1* Hct-29.5*
MCV-101* MCH-31.1 MCHC-30.7* RDW-13.9 Plt ___
___ 05:35AM BLOOD WBC-14.2* RBC-2.96* Hgb-9.7* Hct-29.9*
MCV-101* MCH-32.6* MCHC-32.3 RDW-13.4 Plt ___
___ 05:25AM BLOOD WBC-15.4* RBC-3.22* Hgb-10.4* Hct-31.9*
MCV-99* MCH-32.2* MCHC-32.4 RDW-13.3 Plt ___
___ 08:02AM BLOOD WBC-16.4* RBC-3.51* Hgb-11.6* Hct-35.1*
MCV-100* MCH-33.0* MCHC-33.0 RDW-13.2 Plt ___
___ 01:21AM BLOOD WBC-16.8* RBC-3.71* Hgb-11.9* Hct-36.6
MCV-99* MCH-32.0 MCHC-32.5 RDW-13.0 Plt ___
___ 06:15PM BLOOD WBC-16.5* RBC-3.74* Hgb-12.1 Hct-36.9
MCV-99* MCH-32.3* MCHC-32.7 RDW-13.0 Plt ___
___ 05:00AM BLOOD Plt ___
___ 04:00AM BLOOD Plt ___
___ 04:55AM BLOOD Plt ___
___ 04:00AM BLOOD Glucose-85 UreaN-9 Creat-1.2* Na-140
K-4.0 Cl-105 HCO3-29 AnGap-10
___ 04:55AM BLOOD Glucose-128* UreaN-9 Creat-1.3* Na-138
K-3.5 Cl-102 HCO3-27 AnGap-13
___ 05:35AM BLOOD Glucose-115* UreaN-11 Creat-1.4* Na-134
K-3.4 Cl-99 HCO3-27 AnGap-11
CT A/P: LBO ___/ sigmoid volvulus with ascites
___ 04:00AM BLOOD Calcium-7.9* Phos-3.5 Mg-1.7
___ 04:55AM BLOOD Calcium-7.9* Phos-3.1 Mg-1.9
___ 06:26PM BLOOD Lactate-0.9
Brief Hospital Course:
he patient was admitted to the Acute Care Surgical Service on
___ for a sigmoid volvulus and went to the OR for a
___ procedure. The procedure went well without
complication (reader referred to the Operative Note for
details). Of note, there was purulent fluid in the abdomen for
which cultures were sent and the patient was placed on
antibiotics (see below). After a brief, uneventful stay in the
PACU, the patient arrived on the floor in good condition.
Neuro: The patient received a dilaudid PCA with good effect and
adequate pain control. When tolerating oral intake, the patient
was transitioned to oral pain medications.
CV: The patient remained stable from a cardiovascular
standpoint; vital signs were routinely monitored.
Pulmonary: The patient remained stable from a pulmonary
standpoint; vital signs were routinely monitored. Good pulmonary
toilet, early ambulation and incentive spirometry were
encouraged throughout hospitalization.
GI/GU/FEN: Post-operatively, the patient was made NPO with IV
fluids. Diet was advanced when appropriate, which was well
tolerated. Patient's intake and output were closely monitored,
and IV fluid was adjusted when necessary. Electrolytes were
routinely followed, and repleted when necessary. The patient
received ostomy teaching and the ostomy was pink at the time of
discharge.
ID: The patient had purulent fluid noted at the time of the
operation and a perforation was suspected. She was placed on
broad spectrum antibiotics post-operatively and when tolerating
a PO diet was switched to augmentin for a total of one week
course. On POD5, she noted increasing drainage from her wound,
and there was mild associated erythema. Two staples were
removed and purulent fluid was expressed and cultures were sent.
The wound is being packed wet to dry. She was discharged on a
one week total course of augmentin.
Hematology: The patient's complete blood count was examined
routinely; no transfusions were required.
Prophylaxis: The patient received subcutaneous heparin and
venodyne boots were used during this stay; was encouraged to get
up and ambulate as early as possible.
At the time of discharge, the patient was doing well, afebrile
with stable vital signs. The patient was tolerating a regular
diet, ambulating, voiding without assistance, and pain was well
controlled. The patient received discharge teaching and
follow-up instructions with understanding verbalized and
agreement with the discharge plan. She will follow up with the
___ clinic in two weeks.
Discharge Medications:
1. Amoxicillin-Clavulanic Acid ___ mg PO Q12H
RX *amoxicillin-pot clavulanate 875 mg-125 mg 1 tablet(s) by
mouth twice daily Disp #*4 Tablet Refills:*0
2. Acetaminophen 1000 mg PO Q6H:PRN pain
3. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN pain
RX *oxycodone 5 mg ___ tablet(s) by mouth every four hours for
pain Disp #*40 Tablet Refills:*0
4. Docusate Sodium 100 mg PO BID
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice daily
Disp #*60 Capsule Refills:*0
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
large bowel onstruction ___ sigmoid voluvlus s/p ex-lap sigmoid
colectomy and ___
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Please call your doctor or nurse practitioner or return to the
Emergency Department for any of the following:
*You experience new chest pain, pressure, squeezing or
tightness.
*New or worsening cough, shortness of breath, or wheeze.
*If you are vomiting and cannot keep down fluids or your
medications.
*You are getting dehydrated due to continued vomiting, diarrhea,
or other reasons. Signs of dehydration include dry mouth, rapid
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a
bowel movement.
*You experience burning when you urinate, have blood in your
urine, or experience a discharge.
*Your pain in not improving within ___ hours or is not gone
within 24 hours. Call or return immediately if your pain is
getting worse or changes location or moving to your chest or
back.
*You have shaking chills, or fever greater than 101.5 degrees
Fahrenheit or 38 degrees Celsius.
*Any change in your symptoms, or any new symptoms that concern
you.
Please resume all regular home medications, unless specifically
advised not to take a particular medication. Also, please take
any new medications as prescribed.
Please get plenty of rest, continue to ambulate several times
per day, and drink adequate amounts of fluids. Avoid lifting
weights greater than ___ lbs until you follow-up with your
surgeon.
Avoid driving or operating heavy machinery while taking pain
medications.
Incision Care:
*Please call your doctor or nurse practitioner if you have
increased pain, swelling, redness, or drainage from the incision
site.
*Avoid swimming and baths until your follow-up appointment.
*You may shower, and wash surgical incisions with a mild soap
and warm water. Gently pat the area dry.
*If you have staples, they will be removed at your follow-up
appointment.
*If you have steri-strips, they will fall off on their own.
Please remove any remaining strips ___ days after surgery.
Monitoring Ostomy output/ Prevention of Dehydration:
*Keep well hydrated.
*Replace fluid loss from ostomy daily.
*Avoid only drinking plain water. Include Gatorade and/or other
vitamin drinks to replace fluid.
*Try to maintain ostomy output between 1000mL to 1500mL per day.
*If Ostomy output >1 liter, take 4mg of Imodium, repeat 2mg with
each episode of loose stool. Do not exceed 16mg/24 hours.
Please follow up with ACS and your primary care within two
weeks as scheduled for you. See below.
Followup Instructions:
___
|
10818910-DS-25
| 10,818,910 | 28,136,223 |
DS
| 25 |
2146-06-06 00:00:00
|
2146-06-06 17:46:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
nausea, vomiting, increased ostomy output
Major Surgical or Invasive Procedure:
None.
History of Present Illness:
___ hx Crohn's s/p colectomy with ostomy, hysterectomy,
oophorectomy. She presents as transfer from ___
with acute onset of nausea, vomiting, abdominal pain, and
increased ostomy output.
She was in her USOH until ___, when she developed worsening
abdominal discomfort just beneath the umbilicus and in the RLQ.
The pain worsened, but she was able to eat dinner as normal. She
went to sleep, but was awakened from sleep with severe abdominal
pain, nausea, and vomiting. She had been warned by her surgeon
that she would likely develop a small bowel obstruction one day
(she is an ___ - cardiac/neuro). Would have come to ___, but
couldn't drive herself. EMS took her to ___. She
was given morphine/zophran, IVF which improved her symptoms.
Subsequently KUB was performed which showed no perforation. She
was offered transfer to ___ for evaluation because her
surgical care is here, which she accepted.
In the ED, initial VS 97.0 78 105/69 19 99% RA
- Patient reported her pain, nausea and vomiting had resolved in
the ED; she also noted ostomy output was decreased.
- Exam notable for soft, nondistended abd, diffuse ttp most
significant in the bilateral lower quadrants.
- Labs notable for normal CBC, normal chemistry, normal LFTs,
CRP 1.0.
- ECG showed NSR with one PAC.
- CTAP was concerning for early or partial SBO (full report
below).
- Surgery and GI were consulted; admission to Medicine was
recommended for serial abdominal exams.
On arrival to the floor, she endorses the above. Denies chest
pain, dizziness, shortness of breath or numbness/tingling. No
fever or chills. Patient denies recent travel, no sick contacts
and no foreign food ingestions.
Of note, patient states she has hx of Crohn's. Initially dx'ed
with UC. However, has had oral ulcers and lesions throughout the
GI tract. However, bx has never been definitively positive for
Crohn's. However, GI has treated her as crohn's. She has hx of
colectomy. Reason for this is an episode of toxic megacolon. She
states that she was in hospital for Crohn's flare when she
developed "massive hemorrhage from below," passed out, woke with
colectomy.
==================
Review of Systems:
(+) per HPI
(-) fever, chills, night sweats, headache, vision changes,
rhinorrhea, congestion, sore throat, cough, shortness of breath,
chest pain, abdominal pain, nausea, vomiting, diarrhea,
constipation, BRBPR, melena, hematochezia, dysuria, hematuria.
Past Medical History:
Past Medical History:
- indeterminate colitis (Crohn's vs UC)
- hx of DVT
- GERD
- lupus anticoagulant antibody
- back pain
- ___ asthma
- gestational diabetes.
Past Surgical History:
- colectomy and ileostomy
- hysterectomy
- L oophorectomy for symptomatic ovarian cyst
- R oophorectomy for symptomatic ovarian cyst
- multiple exploratory laparotomies with LOA
Social History:
___
Family History:
adopted, unknown
Physical Exam:
ADMISSION PHYSICAL EXAM:
========================
Vitals: 97.9 PO 96 / 56 71 16 99 RA
Genl: tired but nontoxic, NAD
HEENT: PERRL, no icterus, MMM
Cor: RRR NMRG
Pulm: CTAB
Abd: soft, nondistended. midline incisions, healed. ostomy with
bag in place containing flatus and watery output. minimal ttp
greatest just below umbilicus and RLQ.
Neuro: AOX3
MSK: extr wwp without edema
DISCHARGE PHYSICAL EXAM:
========================
Vitals: Tc 98.1 Tm 98.8 BP 109/52 (___) HR ___ RR
18 O2sat 100% RA , 24 hr I/O: 1655/115 (ostomy 115 cc) 8 hr
I/O: ___
General: tired, NAD, resting comfortably in bed
HEENT: PERRL, no icterus, MMM
Cor: RRR No M/R/G
Pulm: Nonlabored breathing. CTAB
Abd: soft, nondistended. midline incisions, healed. Ostomy with
bag in place containing flatus and ___ output. No
longer ttp in lower abdomen. No rebound or guarding.
Neuro: A&OX3
EXTREMITIES: wwp without edema, clubbing, or cyanosis
Pertinent Results:
ADMISSION LABS:
========================
___ 07:00AM URINE ___
___ 07:00AM URINE ___
___ 07:00AM URINE ___
___ 07:00AM URINE GR ___
___ 07:00AM URINE ___ SP ___
___ 07:00AM URINE ___
___
___
___ 07:00AM URINE ___
___
___ 07:00AM URINE ___
___ 05:15AM ___ UREA ___
___ TOTAL ___ ANION ___
___ 05:15AM ___ this
___ 05:15AM ALT(SGPT)-11 AST(SGOT)-22 ALK ___ TOT
___
___ 05:15AM ___
___ 05:15AM ___
___ 05:15AM ___
___ 05:15AM ___
___
___ 05:15AM ___
___ IM ___
___
___ 05:15AM PLT ___
MICROBIOLOGY:
========================
STOOL CONSISTENCY: WATERY Source: Stool. ___ 11:12
am)
MICROSPORIDIA STAIN (Final ___: NO MICROSPORIDIUM
SEEN.
CYCLOSPORA STAIN (Final ___: NO CYCLOSPORA SEEN.
C. difficile DNA amplification assay (Final ___:
Negative for toxigenic C. difficile by the Illumigene DNA
amplification assay. (Reference ___.
FECAL CULTURE (Final ___: NO SALMONELLA OR SHIGELLA
FOUND.
CAMPYLOBACTER CULTURE (Final ___: NO CAMPYLOBACTER
FOUND.
OVA + PARASITES (Final ___: NO OVA AND PARASITES
SEEN.
FECAL CULTURE - R/O VIBRIO (Final ___: NO VIBRIO
FOUND.
FECAL CULTURE - R/O YERSINIA (Final ___: NO YERSINIA
FOUND.
FECAL CULTURE - R/O E.COLI 0157:H7 (Final ___: NO
E.COLI 0157:H7 FOUND.
Cryptosporidium/Giardia (DFA) (Final ___: NO
CRYPTOSPORIDIUM OR GIARDIA SEEN.
IMAGING:
========================
CT ABD & PELVIS w/contrast (___):
IMPRESSION:
1. Status post total colectomy and right lower quadrant
ileostomy with prominent ___ small bowel loops within
the pelvis and a gradual transition to collapsed loops in the
right lower quadrant, findings concerning for an early or
partial small bowel obstruction. No discrete transition point.
2. Normal small bowel wall thickness and enhancement.
3. Small amount of nonhemorrhagic free fluid within the pelvis.
KUB (supine and erect) (___):
FINDINGS:
Multiple surgical clips are again demonstrated throughout the
abdomen, better visualized on the CT examination from ___. A normal bowel gas pattern is demonstrated. There is no
free air. The lung bases are clear.
IMPRESSION:
Normal bowel gas pattern. No radiographic evidence of bowel
obstruction or ileus.
KUB (supine and erect) (___):
FINDINGS:
There is a paucity of bowel gas throughout the abdomen. There
are no abnormally dilated ___ loops of small and large
bowel. A right lower quadrant ostomy is noted.
There is no free intraperitoneal air. Osseous structures are
unremarkable. Multiple semi circular surgical clips are seen
over the abdomen.
IMPRESSION:
Examination is limited by paucity of bowel gas. No ___
loops of dilated small or large bowel to indicate bowel
obstruction.
PERTINENT & DISCHARGE LABS:
==========================
___ 06:31AM BLOOD ___
___ Plt ___
___ 10:15PM BLOOD ___
___ Plt ___
___ 05:41AM BLOOD ___
___ Plt ___
___ 07:45AM BLOOD ___
___ Plt ___
___ 07:20AM BLOOD ___
___ Plt ___
___ 06:33AM BLOOD ___
___ Plt ___
___ 07:35AM BLOOD ___
___ Plt ___
___ 07:45AM BLOOD ___
___
___
___ 07:20AM BLOOD ___
___ Im ___
___
___ 06:33AM BLOOD ___
___
___
___ 07:35AM BLOOD ___
___ Im ___
___
___ 06:31AM BLOOD Plt ___
___ 10:15PM BLOOD Plt ___
___ 05:41AM BLOOD Plt ___
___ 07:45AM BLOOD Plt ___
___ 07:20AM BLOOD Plt ___
___ 06:33AM BLOOD Plt ___
___ 07:35AM BLOOD Plt ___
___ 06:31AM BLOOD ___
___
___ 05:41AM BLOOD ___
___
___ 07:45AM BLOOD ___
___
___ 07:20AM BLOOD ___
___
___ 06:33AM BLOOD ___
___
___ 07:35AM BLOOD ___
___
___ 06:31AM BLOOD ___
___ 05:41AM BLOOD ___
___ 07:45AM BLOOD ___
___ 07:20AM BLOOD ___
___ 06:33AM BLOOD ___
___ 07:35AM BLOOD ___
Brief Hospital Course:
Ms. ___ is a ___ female with ___ hx Crohn's s/p
colectomy with ostomy, hysterectomy, oophorectomy. She presented
as transfer from ___ with acute onset of
nausea, vomiting, lower abdominal pain, and increased ostomy
output.
#Partial Small Bowel Obstruction: On admission, the patient was
nauseous and had pain and tenderness in her LLQ>RLQ. Her labs
were notable for a CBC wnl, chem10 wnl, lipase wnl, LFTs wnl,
bland UA. CRP 1.0. She had a CT abdomen/pelvis which revealed a
prominent ___ small bowel loops within the pelvis and a
gradual transition to collapsed loops in the right lower
quadrant, which was c/f an early or partial small bowel
obstruction. Pt's SBO was likely related to intraabdominal
adhesions from her many prior abdominal surgeries, although a
contribution from gastroenteritis was considered given that
patient had increased, watery ostomy output. Patient was
initially made NPO for bowel rest and started on IVF. Her nausea
was controlled with IV ondansetron. Her nausea progressively
improved, and her abdominal pain and tenderness resolved. Her
diet was progressively advanced to clear sips, and ultimately to
a full, regular diet including her PO medications, at which
point mIVF were discontinued. Patient was tolerating regular,
full diet on discharge. Of note, patient had several infectious
studies as part of a workup for gastroenteritis, which were all
negative, including C diff, Salmonella, Shigella, Campylobacter,
Yersinia, E. coli: 0157:H7, Cryptosporidium, Giardia,
Cyclospora, and microsporidium, O&P. Guaiac neg x1 on ___.
#Leukopenia: Patient became leukopenic during admission w/WBC
2.8 on ___ from 6.1 on ___. She remained leukopenic throughout
the remainder of her hospitalization with WBC 2.7 at time of
discharge on ___. We initially considered that this was
dilutional b/c of mild decrease in all counts at first, however,
draws from the ___ line consistently demonstrated
leukopenia, while other counts have normalized. Considered that
leukopenia was ___ to infection, although it has been persistent
regardless of pt's improvement in clinical status, and negative
infectious ___. Also considered that it might be related to
her home ___, which was held iso leukopenia. Have
sent labs for thiopurine metabolites to assess for this
possibility.
#Crohn's disease: Patient's ___ was held in the
setting of leukopenia as above. Labs for thiopurine metabolites
are pending at the time of discharge. Initially received IV
ondansetron for nausea as above, which was changed to home PO
ondansetron as patient's nausea improved and she tolerated PO
intake.
___ asthma: Patient did not have any symptoms
during hospitalization. Was continued on home albuterol inhaler.
#Hx of PVCs: Pt's home atenolol was held while NPO and restarted
prior to discharge.
#GERD: Held patient's home omeprazole while NPO, but restarted
once tolerating PO.
#Estrogen supplementation: Held estradiol 1mg daily while NPO,
was restarted once tolerating full diet for discharge.
TRANSITIONAL ISSUES:
====================
- Patient was persistently leukopenic, WBC ___ range, during
admission. ___ was held and labs for thiopurine
metabolites are pending. Please check CBC at PCP ___ to
evaluate restarting ___.
- Code status: full
- HCP: ___, Husband ___
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol Inhaler ___ PUFF IH Q4H:PRN dyspnea
2. Atenolol 12.5 mg PO BID
3. Estradiol 1 mg PO DAILY
4. Mercaptopurine 25 mg PO BID
5. Ondansetron 4 mg PO Q6H:PRN nausea
6. Pantoprazole 20 mg PO Q12H
Discharge Medications:
1. Albuterol Inhaler ___ PUFF IH Q4H:PRN dyspnea
2. Estradiol 1 mg PO DAILY
3. Ondansetron 4 mg PO Q6H:PRN nausea
4. Pantoprazole 20 mg PO Q12H
Discharge Disposition:
Home
Discharge Diagnosis:
PRIMARY DIAGNOSES:
=================
Partial Small Bowel Obstruction
Leukopenia
SECONDARY DIAGNOSES:
=================
Crohn's disease
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Ms. ___,
You were admitted with nausea, vomiting, lower abdominal pain,
and increased ostomy output. You had CT imaging of your abdomen
which were concerning for partial small bowel obstruction. Your
small bowel obstruction is likely related to scarring from your
previous abdominal surgeries. We also considered that you may
have had a gastroenteritis that may have contributed, although
all of your infectious studies were negative. We treated you
with "bowel rest" meaning that we waited for your symptoms to
improve before having you eat, and in the interim, we gave you
IV fluids. Over the course of a few days, your nausea improved,
and you were gradually progressed from a liquid to a full,
regular diet. Of note, your WBC was persistently low during your
hospitalization, and because of this, we had to stop your
___ as this can be associated with a low WBC count.
Please make sure that you talk to your gastroenterologist before
starting to take ___.
We have made the following appointments for you:
# Appointment at your PCP's office with Dr. ___ on
___ at 11:00 AM at ___ floor,
___
# Gastroenterology will call you to schedule an appointment. If
you have not heard from them within 2 business days following
discharge, please call their office at ___.
It was a pleasure taking care of you!
We wish you all the best!
Your team at ___
Followup Instructions:
___
|
10819462-DS-7
| 10,819,462 | 25,434,274 |
DS
| 7 |
2181-09-15 00:00:00
|
2181-09-15 16:20:00
|
Name: ___. Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Back pain
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ with history of HTN, chronic renal insufficiency, asthma,
OSA, and GERD, who presented to ED with worsening low back pain.
Patient was in usual state of health until about 5 days ago,
when he reports he woke up with left-sided lower back pain. He
initially reports just discomfort, but over the next day the
pain progressed to a sharp, stabbing pain unlike any pain he has
had before. The pain is mainly in the left sacral area, but
does not radiate down into the leg left. He denies any
preceding injury or trauma. He also denies any fevers, chills,
lower extremity weakness/numbness/tingling, urinary retention or
bowel dysfunction. Does report two month history of slight
urine leaking when he goes to the bathroom. He has no known
history of malignancy and denies any history of IVDU. States he
recently had his prostate checked by his PCP and was told
everything was normal. States he was initially able to work,
but over the past few days has progressive difficulty ambulating
due to pain. The pain is not constant, and will improve when he
is still for a period of time, but is exacerbated when he first
gets up and when he walks around.
Saw his PCP two days ago, and was prescribed naproxen and
cyclobenzaprine. States he took naproxen but without relief of
pain, and therefore presented to ED for evaluation yesterday.
In the ED, initial vitals were 98.6 61 124/84 14 98% RA. On
exam, he had no TTP along the midline of the back or in the left
paraspinal area. Did have pain with left leg raise, with pain
most prominent in the sacral area. No labs done. He had x-rays
of the lumbo-sacral spine, hip, and pelvis which were negative
for fracture. Pain initially treated with toradol and diazepam.
He subsequently received oxycodone-acetaminophen and IV
hydromorphone. Plan was to trial him on oral pain medication
this morning, but patient was having difficulty walking due to
pain that was not adequately controlled on oral medication.
Therefore, he is being admitted for pain control and possible
further work-up. Vitals prior to transfer 97.6 63 126/84 18 96%
RA.
On arrival to the floor, patient states he is comfortable, with
no significant back pain while at rest.
Review of sytems:
(+) Per HPI.
(-) Denies fever, chills, night sweats, recent weight loss or
gain. Denies headache, sinus tenderness, rhinorrhea or
congestion. Denies cough, shortness of breath. Denies chest
pain, tightness, or palpitations. Denies nausea, vomiting,
diarrhea, constipation or abdominal pain. No recent change in
bowel habits. No dysuria. No arthralgias or myalgias other than
back pain as above.
Past Medical History:
Hypertension
Obesity
OSA (unable to tolerate CPAP)
Asthma
GERD
Chronic renal insufficiency (Cr 1.4-1.6 in ___ system)
Arthritis
Club feet
Prior foot and knee surgeries
Social History:
___
Family History:
CAD in uncle, grandfather. Mother had lung cancer. Father had
leukemia.
Physical Exam:
ADMISSION EXAM:
VS: 97.9 140/92 66 22 99% RA, weight 149.7 kg
GENERAL: obese but otherwise well appearing male, resting in
bed, NAD
HEENT: PERRL, EOMI, sclera anicteric, MMM, OP clear
NECK: supple, no cervical LAD, unable to assess JVP due to body
habitus
CARDIAC: RRR, no r/m/g
LUNGS: CTAB, no wheezing/rales/rhonchi
ABDOMEN: obese, soft, NT, ND, no organomegaly, no
guarding/rebound, normoactive bowel sounds
EXTREMITIES: warm, well-perfused, 2+ pulses, no edema
NEURO: CN II-XII grossly intact, strength ___ throughout,
sensation grossly intact to light touch, Patellar reflexes 2+
and symmetric bilaterally, Achilles reflexes diminished but
symmetric bilaterally, down-going toes, back pain in left sacral
area upon lifting left leg to 40 degrees but no pain with
lifting right leg, (normal rectal tone per attending Dr. ___
___
BACK: no mid-line tenderness to palpation, no TTP along
paraspinal muscles in lumbar area
SKIN: no rashes or jaundice, back slightly diaphoretic
PSYCH: calm, appropriate affect
DISCHARGE EXAM:
VS: 97.9 113/78 74 20 100% RA
GENERAL: obese but otherwise well appearing male, resting in
bed, NAD
HEENT: sclera anicteric, MMM, OP clear
NECK: supple, unable to assess JVP due to body habitus
CARDIAC: RRR, no r/m/g
LUNGS: CTAB, no wheezing/rales/rhonchi
ABDOMEN: soft, NT, ND, no guarding/rebound, normoactive bowel
sounds
EXTREMITIES: warm, well-perfused, 2+ pulses, no edema
BACK: no midline tenderness to palpation, straight leg raise on
left elicited back pain at about 40 degrees
NEURO: strength ___ lower ext, sensation grossly intact to light
touch low extremities, Patellar reflexes 2+ and symmetric
bilaterally, down-going toes
Pertinent Results:
ADMISSION LABS:
___ 03:25PM BLOOD WBC-6.7 RBC-5.28 Hgb-16.4 Hct-49.0 MCV-93
MCH-31.1 MCHC-33.5 RDW-14.2 Plt ___
___ 03:25PM BLOOD Neuts-67.8 ___ Monos-6.7 Eos-4.0
Baso-0.9
___ 03:25PM BLOOD ___ PTT-35.0 ___
___ 03:25PM BLOOD Glucose-90 UreaN-18 Creat-1.5* Na-139
K-4.3 Cl-99 HCO3-30 AnGap-14
___ 03:25PM BLOOD Calcium-9.4 Phos-4.0 Mg-2.0
DISCHARGE LABS:
___ 07:30AM BLOOD Glucose-79 UreaN-18 Creat-1.3* Na-134
K-4.1 Cl-97 HC___ AnGap-12
IMAGING:
L-spine x-ray ___: There is minimal leftward convex
curvature, but no spondylolisthesis. The vertebral body heights
and interspaces appear preserved with minimal anterior
osteophyte formation among levels. There is no evidence for
fracture, dislocation or bone destruction. IMPRESSION: Very mild
degenerative changes.
Hip/Pelvic x-ray ___: There is no evidence for fracture,
dislocation or bone destruction. The hip joint spaces are
preserved. The mineralization appears within normal limits.
Bilaterally, there is a convex contour to the femoral head-neck
junction with an appearance that may reflect a pre-disposition
to femoroacetabular impingement in the appropriate clinical
setting, but correlation with physical findings and time course
of symptoms is suggested. IMPRESSION: No evidence of fracture.
Findings which may relate to a pre-disposition to
femoroacetabular impingement, for which correlation with
clinical presentation and findings is recommended. MR
arthrography may be helpful to assess further if clinically
indicated.
MRI L-spine ___: From T11-12 to L3-4, mild degenerative disc
disease and minimal bulging seen. At L4-5, disc bulging and a
left-sided disc herniation extends inferiorly to the left
lateral recess of L5 and could result in irritation of left L5
nerve root. At L5-S1 level, mild degenerative disc disease seen.
The distal spinal cord and paraspinal soft tissues are
unremarkable. IMPRESSION: Left-sided disc herniation at L4-5
level extending inferiorly ___ could result in irritation of
left L5 nerve root. Mild degenerative changes at other levels.
Brief Hospital Course:
___ with history of HTN, chronic renal insufficiency, asthma,
OSA, and GERD, who presented with worsening back pain. Was
neurologically intact but found to have a left-sided disc
herniation at L4-5 level, likely causing an L5 radiculopathy.
ACTIVE ISSUES:
# Lumbar radiculopathy: Patient presented with 5 day history of
worsening back pain, without clear antecedent trauma. He had no
red flag symptoms and was neurologically intact. Due to the
severity of his pain and difficulty ambulating due to pain, he
was admitted for pain control and ___ evaluation. X-rays of the
L-spine, hip, and pelvis were negative for fracture. MRI of
L-spine showed left-sided disc herniation at L4-5 level
extending inferiorly, possibly causing irritation of the left L5
nerve root. Was felt that lumbar radiculopathy was most likely
etiology of his pain. While x-rays showed pre-disposition to
femoroacetabular impingement, location of current pain not c/w
this diagnosis. His pain was reasonably controlled with
standing acetaminophen and tramadol. Was initially on IV
hydromorphone, and transitioned to oxycodone 10 mg PO Q4H prn
pain prior to discharge. Was evaluated by ___, and will continue
outpatient ___ on discharge. Will follow-up with PCP and pain
clinic, and if pain not improving with conservative therapy may
benefit from referral to Ortho-Spine.
# Hypertension: BP intermittently elevated during the
hospitalization, in setting of acute pain. Continued home
moexipril-hydrochlorothiazide. If BP remains elevated once
acute pain resolves, may need uptitration of home
antihypertensive regimen.
CHRONIC ISSUES:
# CKD Stage 3: Last Cr in our system was 1.4-1.6. Per notes,
attributed to adverse effect of antibiotic therapy after patient
treated for empyema in ___. Cr was stable this admission,
ranging 1.3-1.5. Avoided NSAIDs.
# Asthma/Seasonal allergies: Stable. Continued home Advair,
albuterol inhaler as needed. Continued fluticasone nasal spray,
fexofenadine as needed.
# GERD: Stable. Continued home omeprazole.
TRANSITIONAL ISSUES:
#If pain does not continue to improve with conservative
management, would refer patient to Ortho-Spine.
#Hip x-rays show pre-disposition to femoroacetabular
impingement. If patient develops hip pain in future would
consider this diagnosis and refer to Ortho.
#BP intermittently elevated in hospital. If BP control does not
improve with improved pain control, may need uptitration of
antihypertensives.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID
2. Astepro *NF* (azelastine) 0.15 % (205.5 mcg) NU BID
3. Fexofenadine 60 mg PO DAILY:PRN allergy symptoms
4. Fluticasone Propionate NASAL 2 SPRY NU DAILY
5. Aspirin 81 mg PO DAILY
6. Moexipril 15 mg PO DAILY
7. Hydrochlorothiazide 25 mg PO DAILY
8. Omeprazole 20 mg PO DAILY
9. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB/wheezing
10. Naproxen Dose is Unknown PO Frequency is Unknown
11. Cyclobenzaprine Dose is Unknown PO Frequency is Unknown
Discharge Medications:
1. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB/wheezing
2. Aspirin 81 mg PO DAILY
3. Fexofenadine 60 mg PO DAILY:PRN allergy symptoms
4. Fluticasone Propionate NASAL 2 SPRY NU DAILY
5. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID
6. Hydrochlorothiazide 25 mg PO DAILY
7. Moexipril 15 mg PO DAILY
8. Omeprazole 20 mg PO DAILY
9. Acetaminophen 1000 mg PO TID
RX *acetaminophen 500 mg 2 tablet(s) by mouth three times a day
Disp #*180 Tablet Refills:*0
10. Docusate Sodium 100 mg PO BID
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day
Disp #*60 Capsule Refills:*0
11. Senna 1 TAB PO BID:PRN constipation
RX *sennosides [senna] 8.6 mg 1 cap by mouth twice a day Disp
#*60 Capsule Refills:*0
12. TraMADOL (Ultram) 50 mg PO QID
RX *tramadol 50 mg 1 tablet(s) by mouth every six (6) hours Disp
#*90 Tablet Refills:*0
13. Astepro *NF* (azelastine) 0.15 % (205.5 mcg) NU BID
14. OxycoDONE (Immediate Release) 10 mg PO Q4H:PRN pain
RX *oxycodone 10 mg 1 tablet(s) by mouth every four (4) hours
Disp #*30 Tablet Refills:*0
15. Outpatient Physical Therapy
Left sided L5 radiculopathy
ICD-9: 722.10 (Displacement of lumbar intervertebral disc
without myelopathy)
Evaluation and Treatment
Discharge Disposition:
Home
Discharge Diagnosis:
Primary: lumbar radiculopathy, herniated disc
Secondary: hypertension, chronic kidney disease
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid
(crutches).
Discharge Instructions:
Mr. ___,
It was a pleasure taking part in your care during your admission
to ___. You were admitted to
the hospital with severe pain in the lower left side of your
back. An MRI showed that you have a herniated disc, which is
likely irritating the L5 nerve root and causing your back pain.
This type of pain is called a lumbar radiculopathy. We gave you
pain medication, had you work with physical therapy, and your
pain improved. You are now stable for discharge home, but you
will need to continue working with physical therapy as an
outpatient.
You may continue to take acetaminophen, tramadol, and oxycodone
as needed for your pain. These medications can cause
constipation, so it is important you drink plenty of fluids and
eat a high fiber diet. You can also take an over-the-counter
stool softener, such as docusate sodium, to help prevent
constipation, as well as a medication called senna.
You should follow-up with your primary care doctor, and we have
also set you up to see a pain specialist. Please discuss with
your primary care doctor about whether you should see an
Orthopedic specialist if your back pain does not continue to
improve.
Followup Instructions:
___
|
10819468-DS-10
| 10,819,468 | 28,511,056 |
DS
| 10 |
2170-04-12 00:00:00
|
2170-04-13 18:28:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: SURGERY
Allergies:
Lactulose
Attending: ___.
Chief Complaint:
Umbilical hernia
Major Surgical or Invasive Procedure:
umbilical hernia repair with mesh ___
History of Present Illness:
___ ETOH Cirrhosis (Child A) c/b esophageal varicies,
splenomegaly, and HRS gets HD via RUE AVF MWF. Patient has h/o
umbilical hernia in the past, and over several years, this
hernia
has been getting larger. Currently the hernia interferes with
his
ADLs. Patient notes that he has difficulty ambulating and
sitting
down due to the size of the hernia. Additionally, he states that
he is more constipated. No f/c, tolerating regular diet and
passing flatus still. Last C-scope in ___ with small
diverticula seen. Patient on prior imaging has trace ascites and
has never required a paracentesis before.
Patient recently lost PCP care and was seen by his hepatologist
who instructed him to come into the ED for further evaluation of
this hernia.
Past Medical History:
1. Multiple admissions to ___ for upper and lower GI
bleeds.
--___: transfused 9U PRBC, 8U FFP and 10U plts. No
noted varices on EGD ___. Thought to be secondary to erosive
esophagitis.
--___: OSH transfused 14U PRBC, 1U FFP and 2Uplts.
Gastropathy noted on EGD at ___.
2. EtOH cirrhosis: acute EtOH hepatitis in ___ (was not
started on corticosteroids due to GI bleed, UTI and ___ was
started on pentoxyphyline to prevent HRS with a planned 4 week
course from ___ (last day ___ negative hepatitis A, B
and C serologies. Complicated by GI bleeds as above in the past
(but no varices), and possible history of HRS.
3. CKD: Cr baseline around 3.0. Was HD-dependent via RUE fistula
until ___. Diagnosis was multifactorial from ATN +/-
NSAIDs +/- HRS. He resumed HD (MWF) in ___ after recurrent
HRS/ATN.
4. MRSA bacteremia ___ treated with vancomycin
5. EtOH abuse with h/o seizures in the setting of heavy alcohol
consumption
6. Gastroesophageal Reflux Disease
7. MVA ___: Right femur fracture with ___ placement, pelvic
fracture
8. Asthma
Social History:
___
Family History:
Mother - ___ ___ alcoholic liver disease
Father - ___ ___ colon cancer, diagnosed in his ___. No
other family history of colon cancer.
Physical Exam:
98.6 88 107/47 18 100% ra
NAD, A+OX3
No jaundice
RRR
CTAB
RUE - aneurysmal AVF + thrill
Soft, large multilobulated umbilical hernia, able to be reduced
very slowly at bedside however recurs again, no
cellulitis/induration to suggest strangulation. No evidence of
ascites on examination
mild edema b/l
Labs:
CBC: 6.6/17.3/197, repeat Hct 17
Chem: ___
Coag: ___
lactate: 1.3
___
Pertinent Results:
___ 10:45AM BLOOD WBC-6.6 RBC-1.85*# Hgb-5.7*# Hct-17.3*#
MCV-93 MCH-30.7 MCHC-32.9 RDW-21.2* Plt ___
___ 06:50AM BLOOD WBC-7.8 RBC-2.86* Hgb-9.0* Hct-26.2*
MCV-92 MCH-31.4 MCHC-34.3 RDW-18.6* Plt ___
___ 06:50AM BLOOD Plt ___
___ 06:40AM BLOOD ___ PTT-35.4 ___
___ 06:50AM BLOOD Glucose-93 UreaN-29* Creat-4.2* Na-130*
K-3.9 Cl-95* HCO3-23 AnGap-16
___ 07:15AM BLOOD ALT-11 AST-23 AlkPhos-138* TotBili-1.4
___ 06:50AM BLOOD Albumin-2.8* Calcium-8.6 Phos-2.8 Mg-1.6
___ 06:45AM BLOOD calTIBC-170* Ferritn-1038* TRF-131*
___ 6:00 pm SPUTUM Source: Expectorated.
**FINAL REPORT ___
GRAM STAIN (Final ___:
___ PMNs and >10 epithelial cells/100X field.
Gram stain indicates extensive contamination with upper
respiratory
secretions. Bacterial culture results are invalid.
PLEASE SUBMIT ANOTHER SPECIMEN.
RESPIRATORY CULTURE (Final ___:
TEST CANCELLED, PATIENT CREDITED.
Brief Hospital Course:
___ y.o. male with ETOH Cirrhosis (Child A) and HRS admitted to
Dr. ___ service with reducible umbilical hernia. No
evidence of strangulation. Hct was low and repeat was 17. 2
units of PRBC were transfused. Hct increased to 26.
Hepatology was consulted and on ___, they performed an EGD
noting severe esophagitis with ulcerations, moderate erosive
antral gastritis and duodenitis suggestive of chemical
gastritis, NSAIDs induced. Misoprostol, Carafate and bid
omeprazole was started per hepatology recommendations. HCT
remained stable. H. pylori was negative. He was instructed on
multiple occasions to not take NSAIDS (takes after HD for
headache/malaise). Instructed to take tylenol (no more than
2grams per day).
0n ___ he was dialyzed then went to the OR for umbilical hernia
repair with mesh. Surgeon was Dr. ___. Please refer to
operative notes for details. A CXR was done the next day on ___
for fever. A right, partially, loculated pleural effusion and
bibasilar atelectasis was noted. The right mid and lower lobes
were concerning for infiltrate. Blood cultures were sent and
then he was started on Levaquin. Blood cultures were pending. UA
and urine culture were negative. Repeat CXR was unchanged on
___.
Diet was advanced and tolerated. IV omeprazole was switched to
oral. He was passing flatus and had a BM. Incision was intact
without redness or drainage. An abdominal binder was placed on
him. He was ambulating independently and felt well enough to go
home on ___ after his dialysis session. Follow up appointment
with Dr. ___ was set for ___. Visiting nurse services were
arranged to follow him at home.
He will f/u with Dr. ___ in ___ and at that time plans for
f/u EGD will be determined.
Medications on Admission:
Lasix 80", Metoprolol ER 25", Midodrine 5 on HD days, Nadolol
20', omeprazole 40', nephrocaps 1', rifaximin 550" (on hold),
Tums, sodium bicarb 650", thiamine 100'
All: NKDA
Discharge Medications:
1. Acetaminophen 325-650 mg PO Q6H:PRN pain / fever
do not take more than 3000mg per day
2. Benzonatate 100 mg PO QID:PRN cough
RX *benzonatate 100 mg 1 capsule(s) by mouth every six (6) hours
Disp #*56 Capsule Refills:*0
3. Calcium Carbonate 500 mg PO BID
Tums
4. Docusate Sodium 100 mg PO BID
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day
Disp #*60 Capsule Refills:*1
5. Furosemide 80 mg PO BID
6. Midodrine 5 mg PO QMOWEFR
7. Misoprostol 200 mcg PO QIDPCHS
RX *misoprostol 200 mcg 1 tablet(s) by mouth four times a day
Disp #*28 Tablet Refills:*0
8. Nadolol 20 mg PO DAILY
9. Nephrocaps 1 CAP PO DAILY
10. Omeprazole 40 mg PO BID
increased dose for gastritis finding
RX *omeprazole 40 mg 1 capsule,delayed ___ by
mouth twice a day Disp #*60 Capsule Refills:*2
11. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN pain
RX *oxycodone 5 mg 1 tablet(s) by mouth every six (6) hours Disp
#*40 Tablet Refills:*0
12. Sucralfate 1 gm PO QID
RX *sucralfate 1 gram/10 mL 10 ml Suspension(s) by mouth four
times a day Disp #*300 Milliliter Refills:*0
13. Levofloxacin 250 mg PO DAILY pneumonia
on dialysis days, take after dialysis
RX *levofloxacin 250 mg 1 tablet(s) by mouth once a day Disp #*6
Tablet Refills:*0
14. Thiamine 100 mg PO DAILY
15. Albuterol Inhaler ___ PUFF IH Q4H:PRN shortness of
breath/wheeze
RX *albuterol ___ puffs inh every four (4) hours Disp #*1
Inhaler Refills:*0
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
ESRD
Umbilical hernia
Pneumonia
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Please call Dr. ___ office office ___ if you
have any of the following: temperature of 101 or greater,chills,
nausea, vomiting, increased pain, abdominal bloating, incision
redness/bleeding/drainage, constipation or diarrhea
-no heavy lifting/straining (do not lift anything heavier than
10 pounds)
DO NOT TAKE ANY MOTRIN/ADVIL/IBUPROFEN/ALEVE OR NSAIDS
(non-steroidal anti-infammatory medication)
You may take tylenol for headache or malaise after dialysis, but
no more than 2000mg per day.
-you may shower, but no tub baths or swimming
-do not apply powder/lotion or ointment to incision
-no driving while taking pain medication
-continue your usual hemodialysis schedule
Followup Instructions:
___
|
10819468-DS-11
| 10,819,468 | 27,637,934 |
DS
| 11 |
2170-05-05 00:00:00
|
2170-05-05 17:48:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Lactulose
Attending: ___.
Chief Complaint:
nausea, vomiting, weakness
Major Surgical or Invasive Procedure:
none
History of Present Illness:
___ with PMH ETOH Cirrhosis (Child A) c/b esophageal varicies,
splenomegaly, and HRS (HD via RUE AVF MWF) with recent admission
for anemia and umbilical hernia repair with mesh ___, course
complicated by PNA. He is now presenting with nausea, vomiting
and weakness.
Since discharge, from ___ on ___, he has attended one HD session
on ___. Subsequently he had "black diarrhea" and felt weak for
a few days and did not return for dialysis. His diarrhea
resolved within 3 days and turned brown in color. Also, one week
ago, he started having nausea, non-bloody vomiting (last emesis
___ and poor po intake. He also had increased itchiness and
swelling of lower extremities, right more than left, that is
worse than his baseline. During that time he did not have
abdominal pain, fever/chills, chest pain or SOB. Still producing
good amounts of yellow urine. He did miss his appointment for
suture removal from umbilical hernia repair. He was prompted to
come to ED by HD unitl as he missed multiple HD sessions.
He also resumed drinking vodka ___, last drink was 15 hours
ago. He was previously sober since ___, but was tempted to
drink because he was home alone. Of note, he has had prior
alcohol withdrawal seizures.
On arrival to ED his vitals were 98.1 135/59 114 20 98%RA. ___
dopplers were negative for DVT. He received Diazepam 5mg po x1.
Initial labs notable for WBC 3.1, HCT 25, PLT 43, Na 125, Cr
3.2. Urinalysis with moderate blood, bacteria, 2wbc, no
nitrities or leuk est. He was evaluated by nephrology prior to
admission.
On the floor, he denies complaints. Initial vitals are 97.9
146/64 107 20 95RA.
Review of Systems:
(+) as per HPI
(-) fever, chills, night sweats, headache, vision changes,
rhinorrhea, congestion, sore throat, cough, shortness of breath,
chest pain, abdominal pain,constipation, BRBPR, hematochezia,
dysuria, hematuria.
Past Medical History:
ETOH Cirrhosis (Child A)
HRS (baseline Cr 3.0) requiring HD MWF Started HD in ___ and
then on and off dialysis, had been off dialysis from ___ and
then
restarted treatment in ___
Erosive esophagitis
portal gastropathy
barretts
ETOH abuse (not on txp list)
MRSA bacteremia ___ treated with vancomycin
seizures ___ ETOH abuse
asthma
umbilical hernia - mesh repair ___
MVA ___: pelvix fx and Right femur fracture with ___
placement
Social History:
___
Family History:
Mother - ___ ___ alcoholic liver disease
Father - ___ ___ colon cancer, diagnosed in his ___. No
other family history of colon cancer.
Physical Exam:
Admission Physical Exam:
Vitals- 97.9 146/64 107 20 95RA.
General: Alert, oriented, no acute distress, sitting up in bed
HEENT: mild scleral icterus, dry oral mucosa.
Neck: supple, JVP not elevated
CV: Sinus tachycardia, no m/r/g.
Lungs: Decreased aeration at right base. Dullness to percussion
___ way up right lung field. Left side with good aeration. No
crackles or wheezesl.
Abdomen: Vertical incision site with sutures in place, no
discharge or erythema. Abd is soft, NT/ND, +BS. Hepatomegaly
3-4cm below costal margin. + splenomegaly. No ascites. No
guarding or rebound.
Ext: warm, 1+ edema on right to mid shin, trace on left lower
ext, skin erythematous with chronic skin changes. No asterixis
Access: RightUE fistula with palpable thrill, and bruit
Discharge Physical Exam:
Vitals- TM 99.9 104-127/55-63 ___ 18 99RA
80.7KG
i/o: nr
General: Alert, oriented, no acute distress
HEENT: mild scleral icterus, dry oral mucosa.
Neck: supple, JVP not elevated
CV: RRR, no m/r/g.
Lungs: Decreased aeration at right base. Dullness to percussion
___ way up right lung field. Left side with good aeration. No
crackles or wheezesl.
Abdomen: Vertical incision sutures removed, no discharge or
erythema. Abd is soft, NT/ND, +BS. Hepatomegaly 3-4cm below
costal margin. + splenomegaly. No ascites. No guarding or
rebound.
Ext: warm, 1+ edema on right to mid shin, trace on left lower
ext, skin erythematous with chronic skin changes. No asterixis
Access: RightUE fistula with palpable thrill, and bruit
Pertinent Results:
ADMISSION LABS:
___ 09:10AM BLOOD WBC-4.0 RBC-3.08* Hgb-9.6* Hct-26.6*
MCV-87 MCH-31.1 MCHC-36.0* RDW-15.9* Plt Ct-UNABLE TO
___ 09:10AM BLOOD Neuts-74.5* Lymphs-13.8* Monos-8.9
Eos-2.5 Baso-0.2
___ 09:10AM BLOOD Glucose-108* UreaN-62* Creat-3.2* Na-125*
K-3.4 Cl-83* HCO3-26 AnGap-19
___ 09:10AM BLOOD ALT-24 AST-73* LD(LDH)-489* AlkPhos-253*
TotBili-2.0* DirBili-0.9* IndBili-1.1
___ 09:10AM BLOOD Albumin-3.8
DISCHARGE LABS:
___ 08:29AM BLOOD WBC-3.9* RBC-2.77* Hgb-8.5* Hct-25.3*
MCV-91 MCH-30.7 MCHC-33.7 RDW-16.3* Plt Ct-60*
___ 07:20AM BLOOD ___ PTT-34.1 ___
___ 08:29AM BLOOD Glucose-97 UreaN-65* Creat-3.7* Na-136
K-3.2* Cl-98 HCO3-26 AnGap-15
___ 08:29AM BLOOD Albumin-3.2* Calcium-8.5 Phos-1.3* Mg-1.7
URINE
___ 11:41AM URINE Color-Yellow Appear-Clear Sp ___
___ 11:41AM URINE Blood-MOD Nitrite-NEG Protein-TR
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG
___ 11:41AM URINE RBC-16* WBC-2 Bacteri-FEW Yeast-NONE
Epi-0 TransE-<1
___ 08:49PM URINE pH-7 Hours-24 Volume-800 UreaN-343
Creat-74
___ 03:33PM URINE Hours-RANDOM UreaN-352 Creat-86 Na-19
K-14 Cl-LESS THAN
___ 03:33PM URINE Osmolal-229
___ 08:49PM URINE 24Creat-592
___ URINE CULTURE (Final ___: NO GROWTH.
===============================================
IMAGING:
___ ___: The right common femoral, superficial femoral,
popliteal, peroneal, and posterior tibial veins all demonstrate
normal compressibility, flow and augmentation were appropriate.
There is normal phasicity in bilateral common femoral veins.
A 4.0 x 1.6 x 1.0 cm ___ cyst is noted in the right
popliteal fossa. Soft tissue edema is seen in the subcutaneous
tissues.
1) No evidence of deep venous thrombosis in the right lower
extremity.
2) ___ cyst.
3) Soft tissue edema.
CXR: ___: Stable large right pleural effusion with associated
atelectasis of the right lower lobe; please note, infection in
this area cannot be entirely excluded.
EKG: Sinus tachycardia with RBBB.
Brief Hospital Course:
___ with PMH ETOH Cirrhosis (Child A) c/b esophageal varicies,
splenomegaly, and HRS (HD via RUE AVF MWF) with recent admission
for umbilical hernia repair with mesh ___, course
complicated by PNA, now representing with n/v and weakness in
setting of being off HD x 2.5 weeks.
# Nausea/Vomiting: Although he presented for nausea/vomiting, no
episodes during this admission. Most likely his nausea/vomiting
was caused by his alcohol consumption just prior to admission.
No evidence of infection (specifically no SBP or UTI), GI bleed,
uremia or hepatic encephalopathy.
# Hyponatremia: He presented with Na to 125 without evidence of
mental status changes. This improved with fluid restriction.
Etiology ___ poor po intake, vomiting and chronic renal/liver
disease.
# ESRD/HD: He is known CKD stage 5 who has been off-and-on
dialysis since ___. Last HD session was ___ and his BUN/Cr was
remarkably stable at his baseline. Still producing good urine.
Also no asterixis, fluid overload, or mental status changes
consistent with uremia. 24 urine collection obtained, which
showed creatinine clearance of 11. He was restarted on dialysis
___ and will resume home dialysis schedule of MWF.
#Alcoholism: He has a history of alcohol abuse with prior
alcohol withdrawal related seizures. Was previously sober for 3
months, however resumed drinking prior to this admission. He
was kept on CIWA, but did not actively withdraw. He was
continued on thiamine.
CHRONIC ISSUES:
# H/o Eophageal Varices/Gastritis: stable, he continued home
meds (omeprazole, sucralfate/misoprostol).
# Alcoholic Cirrhosis : Child A. There was no indication for
SBP prophylaxis during this admission. Small ascites present.
He was kept on nadalol and started on spironolactone.
# Thrombocytopenia: stable at baseline ___ splenomegaly and
liver disease. Given PLT <50, he was not anticoagulated with
heparin. PLT to 43, within previous baseline.
# Anemia: stable, secondary to ESRD.
TRANSITIONAL ISSUES:
-full code
-Liver follow-up in 1 month with next EGD in 2 months.
-Current alcohol use precludes liver transplant.
-f/u with outpt Nephrologist, continue outpt HD
-re-check his plt # to assess for stability or improvement in
his thrombocytopenia
-consider repeat CXR to re-evaluate the right sided pleural
effusion and atelectasis seen on PCXR on ___
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 325-650 mg PO Q6H:PRN pain / fever
do not take more than 3000mg per day
2. Benzonatate 100 mg PO QID:PRN cough
3. Calcium Carbonate 500 mg PO BID
Tums
4. Docusate Sodium 100 mg PO BID
5. Furosemide 80 mg PO BID
6. Midodrine 5 mg PO QMOWEFR
7. Misoprostol 200 mcg PO QIDPCHS
8. Nadolol 20 mg PO DAILY
9. Nephrocaps 1 CAP PO DAILY
10. Omeprazole 40 mg PO BID
increased dose for gastritis finding
11. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN pain
12. Sucralfate 1 gm PO QID
13. Levofloxacin 250 mg PO DAILY pneumonia
on dialysis days, take after dialysis
14. Thiamine 100 mg PO DAILY
15. Albuterol Inhaler ___ PUFF IH Q4H:PRN shortness of
breath/wheeze
Discharge Medications:
1. Acetaminophen 325-650 mg PO Q6H:PRN pain / fever
2. Albuterol Inhaler ___ PUFF IH Q4H:PRN shortness of
breath/wheeze
3. Benzonatate 100 mg PO QID:PRN cough
4. Furosemide 80 mg PO BID
5. Misoprostol 200 mcg PO QIDPCHS
6. Nadolol 20 mg PO DAILY
7. Nephrocaps 1 CAP PO DAILY
8. Omeprazole 40 mg PO BID
9. Sucralfate 1 gm PO QID
10. Thiamine 100 mg PO DAILY
11. Calcium Carbonate 500 mg PO BID
12. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN pain
13. Midodrine 5 mg PO QMOWEFR
used as needed for hypotension at dialysis
14. Spironolactone 25 mg PO DAILY
RX *spironolactone 25 mg 1 tablet(s) by mouth daily Disp #*30
Tablet Refills:*3
Discharge Disposition:
Home
Discharge Diagnosis:
End stage renal disease
Hepatorenal syndrome
Alcohol Withdrawal
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you while you were admitted to
___. You were admitted because of nausea, vomiting and
weakness. You had numerous blood tests which showed that your
body still requires hemodialysis for proper functioning. You
were restarted on hemodialysis with the plan to continue on an
outpatient basis. Your next session will be ___ at
your regular dialysis unit.
You were also monitored closely to prevent severe alcohol
withdrawal. You did not show signs of this.
Followup Instructions:
___
|
10819799-DS-27
| 10,819,799 | 25,829,369 |
DS
| 27 |
2150-06-24 00:00:00
|
2150-06-24 20:31:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Aspirin / Keflex / Neurontin
Attending: ___.
Chief Complaint:
confusion
Major Surgical or Invasive Procedure:
Foley catheter insertion and removal
History of Present Illness:
___ yo M with DM2, h/o CVA, HTN, presenting with altered mental
status since yesterday evening.
.
Per ___, patient was found on the floor around 9 p.m.
yesterday, confused, agitated, unable to stand. He had last been
seen 15 minutes, at which time he was calm, confused. At
baseline, he is oriented to self and place and intermittently to
time. He has a history of chronic leg pain. Per family, patient
is oriented to place at baseline, knows family, who president
is, not always oriented to date.
.
In the ED, initial vital signs were T 98.4, HR 96, BP 125/65, RR
18, Sat 97%/RA. Per ED report, EKG showed SR 89,Q waves in inf
leads c/w prior, no acute ST changes. CT head was limited by
motion artifact but showed no obvious bleed. The patient was
given no medications.
.
On the medical floor, the patient was confused and did not
respond appropriately to questions.
.
REVIEW OF SYSTEMS: unable to obtain secondary to altered mental
status
Past Medical History:
# DM2 on insulin
# CVA in early ___ with residual speech hesitancy, mild L
weakness
# HTN
# Chronic venous insufficiency
# discogenic LBP s/p distant spinal surgery x 2
# obesity
# h/o EtOH abuse
# Dyslipidemia
# left toe ulcer s/p Percutaneous angioplasty of left popliteal
artery, tibial-peroneal trunk, and anterior tibital artery.
Social History:
___
Family History:
DM in twin brother.
Physical Exam:
Vital signs: T 97.8, HR 85, BP 160/85, RR 18, O2 Sat 95%/RA
Gen: Confused. Oriented only to self. Agitated.
HEENT: NC/AT. Anicteric sclerae. Moist mucous membranes. OP
clear.
Neck: Supple.
Resp: Normal respiratory effort. CTAB.
CV: RRR. Normal s1 and s2. No M/G/R.
Abd: +BS. Soft. NT/ND. No rebound or guarding.
Ext: Warm and well-perfused. Radial and DP pulses 2+
bilaterally. Markedly tender to palpation of left tibia.
Neuro: Exam limited by mental status. Oriented only to self.
PERRL. EOMI. Face symmetric. Palate elevates symmetrically.
Tongue protrudes in midline. Strength assessment limited by
patient cooperation, but no asymetry noted.
.
Discharge exam:
Vital signs: T 97.8 BP 148/70 HR 64 RR 20 Sat 98%/RA
Gen: NAD
Neck: Supple.
Resp: Normal respiratory effort. CTAB.
CV: RRR. Normal s1 and s2. No M/G/R.
Abd: +BS. Soft. NT/ND. No rebound or guarding.
Ext: Warm and well-perfused. No edema.
Alert. Oriented to self, ___, family. Pupils
equal. Right pupil round and reactive. Left pupil slightly
irregular and reactive. EOMI. Facial movement normal. Tongue
protrudes in midline. Strength ___ throughout bilateral upper
extremities and RLE. In LLE, strength at ___ for hip flexion,
and ___ for plantarflexion and dorsiflexion, with movement
limited by weakness and pain (chronic).
Pertinent Results:
Admission labs:
___ 09:30AM BLOOD WBC-10.9 RBC-4.54* Hgb-12.4* Hct-39.3*
MCV-87 MCH-27.2 MCHC-31.4 RDW-15.0 Plt ___
___ 09:30AM BLOOD ___ PTT-32.0 ___
___ 09:30AM BLOOD Glucose-172* UreaN-31* Creat-1.3* Na-138
K-4.9 Cl-100 HCO3-27 AnGap-16
___ 09:30AM BLOOD ALT-13 AST-18 CK(CPK)-153 AlkPhos-72
TotBili-0.3
___ 11:23PM BLOOD Calcium-8.7 Phos-3.6 Mg-2.5
.
Urinalysis:
___ 11:30AM URINE Color-Yellow Appear-Clear Sp ___
___ 11:30AM URINE Blood-NEG Nitrite-NEG Protein-TR
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG
___ 11:30AM URINE RBC-<1 WBC-1 Bacteri-FEW Yeast-NONE
Epi-<1
___ 11:30AM URINE CastHy-7*
.
Micro:
URINE CULTURE ___: NO GROWTH.
Blood culture ___: pending
.
Reports:
.
EKG ___: Sinus rhythm. There are non-diagnostic Q waves in
the inferior leads. Compared to the previous tracing of ___
there is no significant change.
.
CT head w/o contrast ___: Severely limited exam due to
motion. Within that limitation, there are no large areas of
acute hemorrhage or definite area of acute infarction. The area
of prior infarction in the left occipital lobe has not
significantly changed. Area of prior infarction in the left
inferior temporal lobe is not well seen. No obvious fractures
identified.
.
CXR PA and lateral ___: Low lung volumes. Mildly prominent
pulmonary vascular engorgement, no signs of overt pulmonary
edema. No focal opacities concerning for pneumonia.
.
Pelvis/hip x-rays ___: No fracture. Severe osteoarthritis,
right hip.
.
Left knee/tibia/fibula ___: No acute fracture identified,
although images of the knee are suboptimal. No knee effusion.
Extensive vascular calcifications are noteworthy. Equivocal old
avulsion fracture involving the medial malleolus and probable
incidental plantar and posterior calcaneal spurs. Ankle mortise
congruent with talus.
IMPRESSION: No acute fracture.
Brief Hospital Course:
___ yo M with h/o CVA, DM2, HTN, presenting with altered mental
status.
# Delirium: The patient presented with confusion and agitation,
along with a fall. CT head was limited by motion artifact but
did not show a large bleed. No infectious cause of the patient's
delirium was identified. However, the patient was found to be in
urinary retention, relieved with a Foley catheter. It was noted
that the patient's medication list included Percocet, tramadol,
and trazodone, and these were held. The patient's mental status
improved to his prior baseline. He has chronic moderate left
lower extremity weakness, but there were no new neurologic
deficits.
# s/p Fall: The patient sustained an unwitnessed fall at
___. CT head was severely limited due to motion but
did not show any acute abnormalities. Imaging of the bilateral
hips and left tibia/fibia were negative for fracture. MI was
ruled out with serial cardiac enzymes.
# Urinary retention: The patient was found to be retaining
urine, with 600 cc of urine in his bladder. A Foley catheter was
placed. Terazosin was changed to tamsulosin, and finasteride was
started. The Foley was removed on ___. The patient was able to
void, and post-void residual was 0 just prior to discharge.
# Gross hematuria: On ___, the patient was noted to have some
bleeding around his Foley catheter, as well as some blood in the
urine. This was presumed to be related to pulling at the
catheter, although no pulling was directed observed. The
patient's urine went from red to pink, and the catheter was
removed. The hematuria had completely resolved prior to
discharge.
# Acute kidney injury: The patient presented with creatinine
1.3. This was felt to be of pre-renal etiology. Diuretics and
lisinopril were intially held. As the patient's creatinine
improved, lisinopril was restarted. With this treatment, the
patient's creatinine improved to 1.0. Lasix can be restarted at
reduced dose (20 mg daily) after discharge. The patient's volume
status should be monitored closely to avoid dehydration or fluid
overload.
# DM2: The patient was not eating well on arrival, so his home
insulin regimen was stopped, and he was placed on an insulin
sliding scale. He had blood sugars in the low 200s on this
regimen, so NPH was added. He was discharged on NPH 10 units QAM
and 5 units QPM. His insulin can titrated as needed at the
___.
# HTN: The patient was felt to be volume-depleted on admission,
so lisinopril, furosemide, and atenolol were held. The patient
was treated with IV fluids, with normalization of his volume
status. Atenolol and lisinopril were restarted. Furosemide was
held. Lasix can be restarted at reduced dose (20 mg daily) after
discharge. The patient's volume status should be monitored
closely to avoid dehydration or fluid overload.
# h/o stroke: Plavix was initially held, but was subsequently
restarted. There was no evidence of a new stroke, as the
patient's mental status and neurologic exam returned to its
previous baseline.
# Chronic lower extremity pain: Percocet and tramadol were held
in the setting of altered mental status, and the patient was
started on standing Tylenol ___ mg TID.
# Pressure ulcer: The patient was noted to have a stage 2
decubitus pressure ulcer. A Mepilex dressing was placed. He will
need frequent repositioning.
# Communication: Healthcare proxy is daughter ___
___
# Code status: FULL CODE, per healthcare proxy
___ on ___:
calcium 500 mg with D 1 tablet by mouth daily
atenolol 25 mg daily
furosemide 40 mg daily
lisinopril 15 mg daily
Plavix 75 mg daily
sertraline 75 mg daily
simvastatin 40 mg daily
docusate 100 mg BID
tramadol 50 mg TID PRN
terazosin 2 mg QHS
acetaminophen 650 mg TID PRN
bisacodyl 10 mg PR PRN
Compro 25 mg suppository PRN
fleet enema PRN
milk of magnesia 30 mL PRN constipation
Percocet ___ Q8H PRN pain
senna 8.6 mg BID PRN constipation
trazodone 25 mg PRN agitation
Novolin 70-30 40 units QAM and 20 units QPM
Novolog sliding scale
Discharge Medications:
1. Calcium 500 + D 500 mg(1,250mg) -400 unit Tablet Sig: One (1)
Tablet PO once a day.
2. atenolol 25 mg Tablet Sig: One (1) Tablet PO once a day.
3. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
4. sertraline 25 mg Tablet Sig: Three (3) Tablet PO DAILY
(Daily).
5. simvastatin 40 mg Tablet Sig: One (1) Tablet PO once a day.
6. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2
times a day).
7. tamsulosin 0.4 mg Capsule, Ext Release 24 hr Sig: One (1)
Capsule, Ext Release 24 hr PO HS (at bedtime).
8. bisacodyl 10 mg Suppository Sig: One (1) suppository Rectal
once a day as needed for constipation.
9. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a
day) as needed for constipation.
10. lisinopril 5 mg Tablet Sig: Three (3) Tablet PO DAILY
(Daily).
11. furosemide 20 mg Tablet Sig: One (1) Tablet PO once a day.
12. finasteride 5 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
13. NPH insulin human recomb 100 unit/mL Suspension Sig: as
directed Subcutaneous twice a day: Give 10 units in the morning
and 5 units before dinner.
14. Novolog 100 unit/mL Solution Sig: as directed Subcutaneous
as directed: Please use attached sliding scale.
15. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO TID (3
times a day).
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
Primary:
delirium
urinary retention
gross hematuria
.
Secondary:
diabetes mellitus
Discharge Condition:
Mental Status: Confused - always.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or
wheelchair.
Discharge Instructions:
You came to the hospital with confusion. There was no evidence
of infection. You were found to be retaining urine, and a Foley
catheter was placed. You were started on medications called
tamsulosin and finasteride for urinary retention. We were able
to remove the Foley catheter, and you were able to urinate
without difficulty.
.
You were thought to be a little dehydrated, so you were given IV
fluids and furosemide (diuretic) was held. It will be restarted
at a lower dose at the ___.
.
You had some blood in your urine, which was thought to be
related to the Foley catheter. The catheter was removed, and the
blood in your urine resolved.
.
There are some changes to your medications:
START finasteride for urinary symptoms.
START tamsulosin for urinary symptoms.
DECREASE furosemide to 20 mg daily.
STOP terazosin
STOP Percocet
STOP tramadol
STOP trazodone
STOP Novolin 70/30 and START NPH (not 70/30) 10 units in the
morning and 5 units before dinner.
USE attached Novolog insulin sliding scale.
Followup Instructions:
___
|
10819799-DS-28
| 10,819,799 | 23,262,517 |
DS
| 28 |
2150-07-12 00:00:00
|
2150-07-12 16:47:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Aspirin / Keflex / Neurontin
Attending: ___.
Chief Complaint:
Confusion, agitation
Major Surgical or Invasive Procedure:
None
History of Present Illness:
Mr. ___ is a ___ with a history of hypertension, type II
diabetes, dyslipidemia, CVA in ___ with residual speech
hesitancy and mild left-sided weakness, and baseline dementia
(per records, oriented to person and place, often not oriented
to date/time) who presents from ___ where he is a long
term care resident with increased confusion. His only active
complaint is painful legs. Of note, patient was recently
admitted from ___ for confusion and similar symptoms and
was found to be retaining urine and had a UTI.
In the ED, initial vs were: T 98.2, HR 79, BP 170/66, RR 14, O2
sat 94% RA. Labs were notable for WBC of 11.4 (79% PMNs, no
bands), Hct 34.6 (baseline mid-30s), creatinine 1.1 (baseline),
lactate 2.3, and U/A with > 182 WBCs, ___, -nitrates. Legs were
noted to be swollen (R > L) and tender to palpation (spontaneous
void of 400 cc foul-smelling urine). Imaging was notable for
head CT with no evidence of acute intracranial process
(preliminary read), clear CXR (preliminary read), and bilateral
lower extremity ultrasound negative for DVT (preliminary read).
Patient was given 1g IV meropenem for UTI given his
cephalosporin allergy to Keflex and history of UTI with Proteus
resistant to cipro and Bactrim. Also received acetaminophen for
pain. He became agitated in the ED prior to transfer and was
given olanzapine 5 mg IM and droperidol 5 mg iv. Vitals on
transfer were T 99.2, HR 64, BP 159/60, RR 18, O2 sat 98% on RA.
On the floor, he was somnolent and would open eyes briefly but
not answering questions.
Past Medical History:
- Type II diabetes mellitus on insulin
- CVA in early ___ with residual speech hesitancy, mild L
weakness
- Hypertension
- Chronic venous insufficiency
- Discogenic LBP s/p distant spinal surgery x 2
- Obesity
- History of alcohol abuse
- Dyslipidemia
- Left toe ulcer s/p Percutaneous angioplasty of left popliteal
artery, tibial-peroneal trunk, and anterior tibital artery
Social History:
___
Family History:
Per records, has a twin brother also with diabetes.
Physical Exam:
Admission Physical Exam:
Vitals: T: 98.3 BP:111/48 P: 74 R: 20 O2: 93% on RA
General: somnolent, no acute distress
HEENT: Sclera anicteric, MMM, oropharynx clear
Neck: supple, JVP not elevated, no LAD
Lungs: Clear to auscultation bilaterally, no wheezes, rales,
ronchi
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,
gallops
Abdomen: soft, non-tender, non-distended, bowel sounds present,
no rebound tenderness or guarding, no organomegaly
Ext: chronic venous stasis changes
Neuro: patient somnolent and would open eyes briefly to sternal
rub, Pupils equal, round and reactive to light. EOMI. No obvious
facial movement normal.
Discharge PE:
Vitals: Tm: 98.8 Tc: 97.5 P: 75 (68-92) BP: 148/57
(108-142/50-70) RR: 18 SpO2: 95% RA
General: alert, oriented to person, place ("hospital"), date and
month but not year
HEENT: MMM
Neck: supple, JVP not elevated, no LAD
Lungs: Clear to auscultation bilaterally, + wheezes at R lung
base
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,
gallops
Abdomen: obese, soft, non-tender, non-distended, bowel sounds
present, no rebound tenderness or guarding, no organomegaly
Ext: 1+ pitting edema to knees, blue-brown discoloration of BLEs
c/w chronic venous stasis changes
Neuro: speech hesistancy, PERRL, pain to light touch over BLEs
Pertinent Results:
Hematology:
___ 06:35AM BLOOD WBC-7.2 RBC-4.18* Hgb-11.3* Hct-37.1*
MCV-89 MCH-27.0 MCHC-30.4* RDW-15.1 Plt ___
___ 06:55AM BLOOD WBC-13.5* RBC-3.98* Hgb-10.7* Hct-34.5*
MCV-87 MCH-27.0 MCHC-31.1 RDW-15.0 Plt ___
___ 10:10AM BLOOD WBC-11.4* RBC-4.08* Hgb-11.5* Hct-34.6*
MCV-85 MCH-28.1 MCHC-33.1 RDW-14.7 Plt ___
Chemistries:
___ 10:10AM BLOOD Neuts-71.9* ___ Monos-3.8 Eos-3.1
Baso-0.7
___ 06:35AM BLOOD Glucose-179* UreaN-25* Creat-1.0 Na-141
K-4.4 Cl-106 HCO3-28 AnGap-11
___ 06:55AM BLOOD Glucose-198* UreaN-29* Creat-1.0 Na-138
K-4.7 Cl-107 HCO3-26 AnGap-10
___ 10:10AM BLOOD Glucose-176* UreaN-31* Creat-1.1 Na-138
K-5.0 Cl-101 HCO3-26 AnGap-16
Other:
- Blood culture ___: Pending
- Urine culture ___: (prelim) GNRs >100,000
Imaging:
CXR ___:
FINDINGS: The lungs are low in volumes, giving appearance of
vascular
crowding. No focal consolidation is seen with mild retrocardiac
atelectasis.
There is no pneumothorax. No pleural effusion is identified. The
heart is
top normal in size.
IMPRESSION: Low lung volumes without evidence of acute process.
Vascular ___ venous studies ___:
IMPRESSION: No DVT with non-visualization of the right calf
veins.
CT Head ___:
IMPRESSION: There is no evidence of hemorrhage, edema, mass,
mass effect, or infarction. Severe periventricular white matter
changes suggest chronic small vessel ischemic disease. The white
matter changes are more extensive in the tracts of the left
brain, causing ex vacuo dilatation of the left lateral
ventricle. Otherwise, there is preservation of gray-white matter
differentiation. The basal cisterns appear patent. Prominent
sulci and ventricles are consistent with age-related atrophy.
There is no evidence of fractures. The paranasal sinuses,
mastoid air cells and middle ear cavities are clear.
Atherosclerotic vascular calcifications are more prominent in
the vertebral arteries and carotid siphons.
IMPRESSION: No evidence of acute intracranial process.
Brief Hospital Course:
Patient is a ___ y/o M with PMH of hypertension, type II
diabetes, dyslipidemia, CVA in ___ with residual speech
hesitancy and mild left-sided weakness, and baseline dementia
who initially presented from ___ with
confusion/agitation and was found to have a UTI, now with
improved orientation and alertness.
#Confusion/ agitation: Was likely toxic-metabolic encephalopathy
in the setting of his UTI. His somnolence on arrival to the
floor was likely related to receiving droperidol and olanzapine
in the ED. Upon discharge, he was alert, oriented x3. His
tramadol, amitripyline and sertraline were initially held but
restarted when his confusion improved. His trazadone was held.
His UTI was treated as below.
#UTI: UA consistent UTI. WBC increased to 13 and improved to 7.2
upon discharge. His dysuria improved with treatment. He was
initially treated with meropenem as he has cephalosporin allergy
(unknown effect) and hx of proteus UTI resistant to
bactrim/cipro. However, he has received augmentin in the past
and prior proteus senstive to ampicillin. He was transitioned to
amoxicillin-clavulonic acid upon discharge for 5 more days for a
total 7 day course for complicated UTI.
# DM2: relatively at goal. Continued home insulin regimen and
diabetic diet.
# HTN: well controlled. He was restarted on home lasix,
atenolol, lisinopril.
# h/o stroke: baseline speech hesistancy. He was continued on
his home plavix.
# Chronic lower extremity pain: complains of chronic pain. No
DVT on US. He was continued on his home tramadol and tylenol ___
mg TID.
#CODE: Full (confirmed with HCP, daughter ___
___ on Admission:
Preadmission medications listed are correct and complete.
Information was obtained from ___ records.
1. Furosemide 20 mg PO DAILY
2. Finasteride 5 mg PO DAILY
3. Acetaminophen 650 mg PO TID
4. NPH 10 Units Breakfast
NPH 5 Units Dinner
Insulin SC Sliding Scale using Novolog Insulin
5. TraMADOL (Ultram) 50 mg PO TID
6. Amitriptyline 25 mg PO HS
7. traZODONE 12.5 mg PO BID:PRN agitation
8. Calcium Carbonate 500 mg PO DAILY
9. Clopidogrel 75 mg PO DAILY
10. Sertraline 75 mg PO DAILY
11. Simvastatin 40 mg PO DAILY
12. Docusate Sodium 100 mg PO BID
13. Tamsulosin 0.4 mg PO HS
14. Senna 1 TAB PO BID:PRN constipation
15. Lisinopril 15 mg PO DAILY
16. Milk of Magnesia 30 mL PO DAILY:PRN constipation
17. Bisacodyl ___AILY:PRN constipation
18. Fleet Enema ___AILY:PRN constipation
19. Atenolol 25 mg PO DAILY
Hold for SBP<100, HR< 60
Discharge Medications:
1. Acetaminophen 650 mg PO TID
2. Bisacodyl ___AILY:PRN constipation
3. Atenolol 25 mg PO DAILY
Hold for SBP<100, HR< 60
4. Calcium Carbonate 500 mg PO DAILY
5. Clopidogrel 75 mg PO DAILY
6. Docusate Sodium 100 mg PO BID
7. Finasteride 5 mg PO DAILY
8. Furosemide 20 mg PO DAILY
9. NPH 10 Units Breakfast
NPH 5 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
10. Lisinopril 15 mg PO DAILY
11. Senna 1 TAB PO BID:PRN constipation
12. Simvastatin 40 mg PO DAILY
13. Tamsulosin 0.4 mg PO HS
14. TraMADOL (Ultram) 50 mg PO TID
15. Dextrose 50% 12.5 gm IV PRN hypoglycemia protocol
16. Glucagon 1 mg IM Q15MIN:PRN hypoglycemia protocol
17. Amoxicillin-Clavulanic Acid ___ mg PO Q12H Duration: 5 Days
For 5 more days, last day ___
18. Amitriptyline 25 mg PO HS
19. Fleet Enema ___AILY:PRN constipation
20. Milk of Magnesia 30 mL PO DAILY:PRN constipation
21. Sertraline 75 mg PO DAILY
22. traZODONE 12.5 mg PO BID:PRN agitation
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
Primary diagnosis: UTI
Associated diagnoses: delirium ___ toxic-metabolic
encephalopathy in the setting of UTI
Secondary diagnoses: Diabetes type 2, HTN, s/p CVA, dementia,
chronic venous stasis
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
You were admitted to the hospital because of confusion that was
noted at ___. You were found to have a urinary tract
infection. Your infection was treated with intravenous
antibiotics. Your signs of infection have now improved and your
mental status is improved to baseline. After discharge from the
hospital you will take oral antibiotics.
Followup Instructions:
___
|
10819799-DS-31
| 10,819,799 | 27,969,861 |
DS
| 31 |
2150-10-01 00:00:00
|
2150-10-04 19:56:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Aspirin / Keflex / Neurontin
Attending: ___.
Chief Complaint:
vomiting
Major Surgical or Invasive Procedure:
___ guided percutaneous cholecystostomy tube exchange ___.
History of Present Illness:
___ h/o dementia, chronic cholecystitis s/p perc chole tube with
plan for elective lap chole p/w vomiting. Pt is a poor historian
and has trouble remembering why he came to the hospital. When
asked if it was due to nausea and vomiting pt said yes. Pt said
vomit was yellowish, which was confirmed by nursing home note.
Nausea began last night. Per ___ home facility, patient was
eating breakfast this morning, then vomited his undigested food
and pills. He then vomited again before and During lunch.
refused clear liquids after lunch. His vomit was described as
yellow, then clear. No blood. Pt denies fevers, chills, cp, sob,
diarrhea, changes to urinary habits. At home, 8am vitals:
123/59, 82, 97.3, 18, 96% RA. At 10am: 182/65, 77, 97.1, 92% RA.
.
In the ED, VS 96.8 78 148/58 18 97%. On exam, alert + oriented
to place and person, not time, Cardiac-rrr, Lungs-ctab,
Abdomen-soft nt nd, perc chole tube well healed without
erythema/exudate and draining bile well. Labs significant for
CHEM-7 and CBC unchanged from prior. LFTs and lipase, u/a --> no
uti, cxr --> lungs clear, surgery c/s --> ruq u/s to ensure tube
is draining, ruq u/s --> unable to visualize tube, per surg,
tube study in am to confirm chole tube is in place.
.
On arrival to the floor, VS 97.3, 163/66, 79, 18, 97% RA. Pt
denies nausea or abd pain and has no c/o.
Past Medical History:
- Type II diabetes mellitus on insulin
- CVA in early ___ with residual speech hesitancy, mild L
weakness
- Hypertension
- Chronic venous insufficiency
- Discogenic LBP s/p distant spinal surgery x 2
- Obesity
- History of alcohol abuse
- Dyslipidemia
- Left toe ulcer s/p Percutaneous angioplasty of left popliteal
artery, tibial-peroneal trunk, and anterior tibital artery
Social History:
___
Family History:
Per records, has a twin brother also with diabetes.
Physical Exam:
ADMIT:
VITALS: 97.3 163/66 79 18 97% RA
GENERAL: elderly male, NAD
HEENT: PERRL, EOMI
LUNGS: CTAB
HEART: RRR, normal S1 S2, no MRG
ABDOMEN: Soft, TTP over drain site. mild erythema around drain
but no pus or weeping. abd discomfort with palpation diffusely.
neg murphys sign, NABS. chole drain tubing cracked and leaking
bile
EXTREMITIES: No c/c/e. healed abrasian over right foot dorsum
with steri-strips intact. chronic venous stasis changes in ___
skin with hyperpigmentation and superficial ulceration over
right shin. ___ TTP.
NEUROLOGIC: A+OX3
D/C:
Vitals: Tm 98.4, Tc 98.0, P 68 (61-80), BP 132/50
(132-150/50-70), RR 18, 96%RA
GENERAL: Alert, interactive, well-appearing Caucasian gentleman
in NAD
HEENT: PERRLA, sclerae anicteric, OP clear
HEART: RRR, nl S1-S2, no MRG
LUNGS: Crackles at both bases bilaterally.
ABDOMEN: NABS, soft/NT/ND, no masses or HSM. Perc chole tube
site is mildly erythematous without warmth or tenderness to
palpation. Tube is leaking bile externally.
EXTREMITIES: WWP, chronic venous stasis changes present.
Dressing on dorsum of R foot is clean/dry/intact. Has
steristripped wound on dorsum of R foot that is healing well.
Tender to palpation.
NEURO: awake, A&Ox2 (not oriented to time), CNs II-XII grossly
intact
Pertinent Results:
___ 05:35PM PLT COUNT-224
___ 05:35PM NEUTS-73.5* ___ MONOS-3.7 EOS-2.7
BASOS-0.5
___ 05:35PM ALBUMIN-3.9
___ 05:35PM ALBUMIN-3.9
___ 05:35PM ALT(SGPT)-25 AST(SGOT)-18 ALK PHOS-119 TOT
BILI-0.2
___ 05:35PM estGFR-Using this
___ 05:35PM GLUCOSE-156* UREA N-34* CREAT-1.3* SODIUM-139
POTASSIUM-5.3* CHLORIDE-104 TOTAL CO2-22 ANION GAP-18
___ 05:44PM LACTATE-1.3
___ 06:35PM URINE MUCOUS-RARE
___ 06:35PM URINE HYALINE-8*
___ 06:35PM URINE RBC-3* WBC-31* BACTERIA-NONE YEAST-NONE
EPI-6
___ 06:35PM URINE BLOOD-TR NITRITE-NEG PROTEIN-TR
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0
LEUK-MOD
___ 06:35PM URINE COLOR-Yellow APPEAR-Hazy SP ___
Time Taken Not Noted Log-In Date/Time: ___ 10:48 pm
URINE
**FINAL REPORT ___
URINE CULTURE (Final ___:
YEAST. 10,000-100,000 ORGANISMS/ML..
Blood Culture, Routine (Final ___:
STAPHYLOCOCCUS, COAGULASE NEGATIVE.
Isolated from only one set in the previous five days.
SENSITIVITIES PERFORMED ON REQUEST..
OF TWO COLONIAL MORPHOLOGIES.
Anaerobic Bottle Gram Stain (Final ___:
Reported to and read back by ___. ___ @ 2245,
___.
GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
Aerobic Bottle Gram Stain (Final ___:
GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
___ 5:30 pm BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___: NO GROWTH.
Brief Hospital Course:
___ h/o dementia, chronic cholecystitis s/p percutaneous
cholecystostomy tube with plan for elective lap cholecystectomy
presents with vomiting.
ACTIVE ISSUES:
# Broken cholecystostomy tube: Interventional radiology replaced
his tube on ___, and surgery will see his as outpatient for
elective cholecystectomy. He had no abdominal pain, fevers, or
leukocytosis during admission and vital signs were stable.
# STAPHYLOCOCCUS, COAGULASE NEGATIVE cultured from blood: The
patient was on vancomycin briefly and then antibiotics were
discontinued once coag neg staph grew suggestive of contaminant.
He remained hemodynamically stable with no leukocytosis on
discharge.
INACTIVE ISSUES:
# Type II diabetes: The patient was continued home insulin
regimen
# History of CVA: The patient was continued on Plavix.
# Hypertension: The patient was continued on his home
medications.
# Low back pain: The patient was continued on tramadol and
amitriptyline.
# Dementia: The patient was continued on trazodone as needed for
agitation as well as sertraline.
# BPH: continued Finasteride and tamsulosin.
TRANSITIONAL ISSUES:
- Will need general surgery follow-up for percutaneous
cholecystostomy tube
- Urine culture showed 10,000-100,000 colonies of yeast, patient
was asymptomatic
Medications on Admission:
Preadmission medications listed are correct and complete.
Information was obtained from Family/Caregiver.
1. magnesium carbonate *NF* 400 mg Miscellaneous BID
2. Docusate Sodium 100 mg PO BID
3. Senna 1 TAB PO HS
4. Simvastatin 40 mg PO HS
5. Clopidogrel 75 mg PO DAILY
6. TraMADOL (Ultram) 50 mg PO TID
7. traZODONE 25 mg PO TID:PRN agitation
8. NPH 10 Units Breakfast
NPH 5 Units Bedtime
9. Finasteride 5 mg PO DAILY
10. Lisinopril 15 mg PO DAILY
11. Furosemide 20 mg PO DAILY
12. Amitriptyline 25 mg PO HS
13. Sertraline 75 mg PO DAILY
14. Bisacodyl 10 mg PR HS:PRN constipation
15. Calcium Carbonate 500 mg PO DAILY
16. Metoprolol Succinate XL 25 mg PO DAILY
17. Acetaminophen 650 mg PO TID:PRN pain
18. Tamsulosin 0.4 mg PO HS
Discharge Medications:
1. Acetaminophen 650 mg PO TID:PRN pain
2. Amitriptyline 25 mg PO HS
3. Bisacodyl 10 mg PR HS:PRN constipation
4. Clopidogrel 75 mg PO DAILY
5. Calcium Carbonate 500 mg PO DAILY
6. Docusate Sodium 100 mg PO BID
7. Finasteride 5 mg PO DAILY
8. Furosemide 20 mg PO DAILY
9. NPH 10 Units Breakfast
NPH 5 Units Bedtime
10. Lisinopril 15 mg PO DAILY
11. Metoprolol Succinate XL 25 mg PO DAILY
12. Senna 1 TAB PO HS
13. Sertraline 75 mg PO DAILY
14. Simvastatin 40 mg PO HS
15. Tamsulosin 0.4 mg PO HS
16. TraMADOL (Ultram) 50 mg PO TID:PRN pain
hold for sedation or RR<10
17. traZODONE 25 mg PO TID:PRN agitation
18. magnesium carbonate *NF* 400 mg Miscellaneous BID
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
cholecystitis
Type II diabetes mellitus
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you during your hospitalization
at ___. You were admitted because of nausea and vomiting. Your
biliary drain was replaced because it was broken and leaking.
You improved over the course of the hospitalization and were
discharged back to ___. Please follow up with your
primary care doctor within the next week.
Followup Instructions:
___
|
10819799-DS-33
| 10,819,799 | 29,187,647 |
DS
| 33 |
2151-01-13 00:00:00
|
2151-01-14 20:52:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Aspirin / Keflex / Neurontin
Attending: ___.
Chief Complaint:
Altered Mental Status
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ hx of dementia, A&Ox1 at baseline, recent laparoscopic
cholecystectomy for chronic cholecystitis presenting with change
in mental status. Patient was transferred from ___ ___
___ where he lives. At 8am staff noticed that he wasn't
talking, wouldn't eat. He is also twitching all limbs
intermittently. Touching his lowers legs which are normally
exquisitely tender does not elicit any pain today. Patient had
normal vitals and a FSBS of 158. He was transferred here for
further evaluation.
The patient was recently discharged on ___ s/p cholecystectomy
for chronic cholecystitis. He aslo had percutaneous
cholecystostomy tube placement (___) and acute cholecystitis
following replacement of tube (___). The previous hospital
course was complicated by ileus and atrial fibrillation. He
spontaneously converted to NSR, the patient was discharged with
warfarin for one month and lopressor for rate control with
cardiology follow up. At the time of discharge, the patient had
erythema around his umbilicus. The incision was opened and some
purulent drainage was seen. The wound was packed with wet to dry
packing and the patient will continue on PO Bactrim for a total
course of 7 days.
In the ED, initial vital signs were T98.1 P77 BP118/47 RR26
97%/RA. A+Ox1. Labs reveal Na of 127, K of 5.7, Cr 1.6 from
baseline 0.6. Patient was given kayexalate 60 grams x 1. CXR
with no acute cardiopulmonary processes (final read pending).
On the floor, T 98.3, 118/54, 81, 22, 98% RA. Patient has no
complaints. On ROS he denies, CP, dysuria, dyspnea,
constipation, diarrhea, N/V/D, fever, sweats, chills, headache,
pain.
Past Medical History:
- Type II diabetes mellitus on insulin
- CVA in early ___ with residual speech hesitancy, mild L
weakness
- Hypertension
- Chronic venous insufficiency
- Discogenic LBP s/p distant spinal surgery x 2
- Obesity
- History of alcohol abuse
- Dyslipidemia
- Left toe ulcer s/p Percutaneous angioplasty of left popliteal
artery, tibial-peroneal trunk, and anterior tibital artery
Social History:
___
Family History:
Per records, has a twin brother also with diabetes.
Physical Exam:
ADMISSION PHYSICAL EXAM
Vitals- T 98.3, 118/54, 81, 22, 98% RA
General- Alert, oriented only to person, no place, year, month,
no acute distress
HEENT- Sclera anicteric, MMM, oropharynx clear
Neck- supple, JVP not elevated, no LAD
Lungs- Clear to auscultation bilaterally, no wheezes, rales,
ronchi
CV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,
gallops
Abdomen- soft, non-tender, non-distended, bowel sounds present,
no rebound tenderness or guarding, no organomegaly, 2 cm
surgical wound that is open and mildly erythematous, two 1 cm
surgical scars in RUQ that are clean and healing well
GU- no foley
Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
Neuro- CNs2-12 intact, motor function grossly normal, episode of
non-responsiveness during exam with twitching
Discharge
O:
VS 98.2 98 127-162/40-64 ___ 18 98%RA
General: Sleeping in NAD.
Neuro: A&O x2 to self and place.
Neck: No JVD at 45 degrees and flat. No lymphadenopathy
Cardiovascular: RRR. Normal S1 and S2. No m/g/r.
Respiratory: CTAB with no wheezes, crackles, or rhonchi.
Abdomen: Soft, NTND, no signs of infection of open incision.
Extremities: Bilateral venous stasis. Warm with distal pulses.
Pertinent Results:
ADMISSION LABS
___ 12:00PM BLOOD WBC-12.7* RBC-3.76* Hgb-10.0* Hct-31.7*
MCV-84 MCH-26.6* MCHC-31.5 RDW-14.0 Plt ___
___ 12:00PM BLOOD Neuts-64.4 ___ Monos-4.5 Eos-2.9
Baso-0.6
___ 12:00PM BLOOD ___ PTT-33.6 ___
___ 12:00PM BLOOD Glucose-145* UreaN-24* Creat-1.6* Na-129*
K-5.7* Cl-94* HCO3-28 AnGap-13
___ 12:00PM BLOOD ALT-23 AST-26 AlkPhos-101 TotBili-0.2
___ 12:00PM BLOOD Albumin-3.3*
___ 12:18PM BLOOD Lactate-1.1 K-5.6*
Micro:
___ 12:00 pm BLOOD CULTURE 2 OF 2.
Blood Culture, Routine (Pending):
___ 2:47 pm URINE
**FINAL REPORT ___
URINE CULTURE (Final ___: NO GROWTH.
___ 1:34 pm STOOL CONSISTENCY: NOT APPLICABLE
Source: Stool.
**FINAL REPORT ___
C. difficile DNA amplification assay (Final ___:
Negative for toxigenic C. difficile by the Illumigene DNA
amplification assay.
(Reference Range-Negative).
Discharge:
___ 09:25AM BLOOD WBC-8.0 RBC-3.74* Hgb-10.0* Hct-31.6*
MCV-85 MCH-26.6* MCHC-31.5 RDW-13.9 Plt ___
___ 09:25AM BLOOD Glucose-187* UreaN-17 Creat-1.2 Na-133
K-4.3 Cl-98 HCO3-26 AnGap-13
___ 09:25AM BLOOD Calcium-8.3* Phos-3.4# Mg-2.4
___ Cardiovascular ECG
Sinus rhythm. Non-specific anterolateral ST-T wave
abnormalities. Compared to the previous tracing of ___ no
diagnostic interval change.
___ Radiology CHEST (PORTABLE AP)
IMPRESSION: Haziness at right costophrenic angle, cannot
exclude small
pleural effusion. Otherwise, no focal consolidation.
___ Radiology CHEST (PA & LAT
FINDINGS: As compared to the previous radiograph, there is no
relevant
change. Low lung volumes. No acute changes. Borderline size
of the cardiac silhouette. Borderline diameter of the vascular
hilar structures. Known areas of hypoventilation at both lung
bases. No larger pleural effusions.
The study and the report were reviewed by the staff radiologist.
___ Neurophysiology EEG
IMPRESSION: Abnormal EEG due to the slow disorganized
background. This
indicates a widespread encephalopathy. Medications, metabolic
disturbances,
and infection are among the common causes. There were no areas
of prominent
focal slowing, and there were no epileptiform features
Brief Hospital Course:
This is a ___ yo M with history of dementia (A&O x 1 to self
baseline), DM2, and status post laparoscopy cholecystectomy on
___ who was transferred from his nursing home with an acute
confusional state and limb shaking movements.
# AMS: Patient presenting with acute change in mental status-
difficulty swallowing pills, twitching legs, and lack of normal
leg pain. Differential diagnosis included infection, stroke,
electrolyte abnormality, hypoglycemia. Labs were notable for
elevated WBC of 12.7, sodium of 129, Cr of 1.6, potassium 5.7.
Infectious work up was negative- normal UA, no acute processes
on CXR and white blood cell count decreased to 9 without
intervention. Patient also finished 7 day course of
ciprofloxacin for surgical incision. Hyponatremia was mild at
129 and unlikely to cause altered mental status, this improved
with IVF. On exam, the patient was noted to have one episode of
twitching with decreased level of responsiveness concerning for
seizure. He did not have any focal abnormalities, making stroke
very unlikely. An EEG was performed to look for seizure,
however there was no evidence of seizure. The patient was
treated with IVF for dehydration evident on exam and lab
abnormalities. His sodium improved to 133, Cr 1.2 (baseline) and
K 4.3 with IVF suggesting dehydration, likely secondary to
furosemide and decreased PO fluids. The patient is now better
than his baseline, and is oriented to self and place (BID
hospital).
# Acute renal failure - Patient presenting with acute renal
failure with Cr of 1.6 up from baseline of ___. After 2L IVF,
the Cr improved to 1.2. Etiology most likely prerenal.
BUN/Cr=15, FEUrea 43%. Urine electrolytes difficult to interpret
in setting of furosemide, however given complete clinical
picture appears to be pre-renal. Patient had a foley for
decreased urine output and bladder scan showing >440 cc. Foley
drained 600 cc, making post renal unlikey. Patient was able to
pass voiding trial. Furosemide discontinued and lisinopril held
while in ___. His furosemide was for venous stasis, and he was
therefore prescribed graduated compression stockings in lieu of
furosemide.
# Hyponatremia: Patient presented with hyponatremia of 129 that
is down from recent value of 136. He appeared to be hypovolemic
on exam aside from lower extremity edema secondary to chronic
venous stasis, most likely caused by decreased effective
circulating volume secondary to furosemide. This improved to
133 with with IVF hydration consistent with hypovolemic
hyponatremia. ECHO in ___ (LVEF>50%).
# Hyperkalemia: 5.7 on admission without any EKG changes. Most
likely caused by ___ and ___. Resolved after IV fluid
challenge.
# Diarrhea: New onset of watery diarrhea (> 4 BM) after
admission in the setting of finishing bactrim for wound
infection two days prior, concerning for C difficile colities.
C. difficile testing was negative. Patient has baseline fecal
incontinence.
# Leukocytosis: Patient presented with mild leukocytosis of 12.7
down from 13.3 on recent discharge. He finished a course of
ciprofloxacin on the day prior to admission for a surgical wound
infection. Surgery evaluated and felt his wound looked
improved. There was no other evidence of infection; normal chest
x-ray, clean UA. Blood cultures pending on discharge.
Leukocytosis resolved, may have been hemoconcentration.
# Anemia: Patient with anemia that is new but stable, s/p
surgery. No evidence of acute bleeding. ___ be followed up by
primary care physician.
# Afib: Patient developed atrial fibrillation in ___ period
of last admission. He spontaneously converted to NSR prior to
planned cardioversion. He was discharged on coumadin with
cardiology follow up. CHADS2 score of 5 and subtherapeutic INR
of 1.7 with past history of prior stroke. Patient was in normal
sinus rhythm on presenation. He was monitored on telemetry and
stayed in sinus rhythm. He was bridged with IV heparin weight
based until INR therapeutic. He received 3.5mg of warfarin
daily here. Metoprolol 50 mg BID was continued. Previous echo
in ___ EF>50% no significant valvular disease
Transitional Issues:
- discontinued furosemide
- recommend elevation and compression stockings for venous
stasis
- blood cultures pending
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Furosemide 40 mg PO DAILY
2. NPH 10 Units Breakfast
NPH 5 Units Bedtime
3. Clopidogrel 75 mg PO DAILY
4. Lisinopril 15 mg PO DAILY
5. Simvastatin 40 mg PO QHS
6. TraMADOL (Ultram) 50 mg PO TID:PRN pain
hold for sedation, RR<10
7. Acetaminophen 650 mg PO TID:PRN pain
8. Metoprolol Tartrate 50 mg PO BID
9. Warfarin Dose is Unknown PO DAILY16
10. Finasteride 5 mg PO DAILY
11. Senna 1 TAB PO HS
12. Sertraline 75 mg PO DAILY
13. Amitriptyline 25 mg PO HS
14. Calcium Carbonate 500 mg PO DAILY
15. Docusate Sodium 100 mg PO BID
16. magnesium carbonate *NF* 400 mg Miscellaneous BID
17. Tamsulosin 0.4 mg PO HS
18. Bisacodyl 10 mg PR HS:PRN constipation
Discharge Medications:
1. Acetaminophen 650 mg PO TID:PRN pain
2. Amitriptyline 25 mg PO HS
3. Calcium Carbonate 500 mg PO DAILY
4. Clopidogrel 75 mg PO DAILY
5. Docusate Sodium 100 mg PO BID
6. Finasteride 5 mg PO DAILY
7. NPH 10 Units Breakfast
NPH 5 Units Bedtime
8. Metoprolol Tartrate 50 mg PO BID
9. Senna 1 TAB PO HS
10. Sertraline 75 mg PO DAILY
11. Simvastatin 40 mg PO QHS
12. Tamsulosin 0.4 mg PO HS
13. TraMADOL (Ultram) 50 mg PO TID:PRN pain
hold for sedation, RR<10
14. Warfarin 3.5 mg PO DAILY16
15. Bisacodyl 10 mg PR HS:PRN constipation
16. magnesium carbonate *NF* 400 mg Miscellaneous BID
17. Lisinopril 15 mg PO DAILY
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
Primary: Dehydration, Acute renal failure, Hyponatremia,
Confusion
Secondary: Dementia, Atrial Fibrillation
Discharge Condition:
Mental Status: Confused - always.
Level of Consciousness: Lethargic but arousable.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Mental Status: Confused - always.
Level of Consciousness: Lethargic but arousable.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Mr. ___,
It was a pleasure taking care of you during your
hospitalization. You were admitted to ___ with confusion and
a high white count. There was no signs of infection and your
white count decreased. You also had electrolyt abnormalities
(low sodium and high potassium). We gave you intravenous fluids
and stopped your Lasix and this resolved. We think that you were
dehydrated.
Medications:
Please stop taking furosemide Lasix)
Followup Instructions:
___
|
10819799-DS-36
| 10,819,799 | 20,385,993 |
DS
| 36 |
2153-04-04 00:00:00
|
2153-04-04 18:01:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Aspirin / Keflex / Neurontin
Attending: ___.
Chief Complaint:
Hypotension
Major Surgical or Invasive Procedure:
None
History of Present Illness:
Mr. ___ is an ___ with past medical history of CVA ___
with residual speech hesitancy, Type 2 DM, PVD and recent
admission for AMS believed to be secondary to medications who
presented from ___ with altered mental status,
fevers, and new hypoxia to SaO2 85% on room air. Per nursing at
___, the patient was found to be agitated and
confused. That evening, he became febrile to ___ in the setting
of continued agitation, confusion, and muscle twitching. In
addition, he does not have a history of aspiration or nursing
concern for aspiration. The morning of admission, in addition to
the above symptoms he developed hypoxia to 85% and was placed on
2L. At that point, he was transferred to ___ for further care.
In the ED, initial vitals were 102.4 93 90/46 97% 6L. Exam was
notable for pt being non-verbal but following commands,
diaphoretic, coarse breath sounds. Labs notable for negative
influenza A/B PCR, WBC 18.0 with 83.6% PMNs, H/H 11.4/34.3, plts
159, Na 136, K 5.3, HCO3 25, BUN 56, Cr 2.0 from baseline 0.6,
LFTs WNL, lactate 1.7, INR 4.0, UA with 1 WBC and negative ___
and nitrites. Blood cx x 2 and urine cx sent. Pt received 3L NS,
Levofloxacin 500mg IV x 1, Ceftriaxone 1g IV x 1, Azithromycin
500mg IV x 1, Vancomycin 1g IV x 1, Tylenol ___ PR x 1.
In the ED, pt was hypotensive to SBP 70's to 80's, with low
reading of 72/50. A right IJ CVL was placed, and pt was started
on levophed with improvement in BP to 100-150/50-70.
Past Medical History:
- Type II diabetes mellitus on insulin
- CVA in early ___ with residual speech hesitancy, mild L
weakness
- Hypertension
- Chronic venous insufficiency
- Discogenic LBP s/p distant spinal surgery x 2
- Obesity
- History of alcohol abuse
- Dyslipidemia
- Left toe ulcer s/p Percutaneous angioplasty of left popliteal
artery, tibial-peroneal trunk, and anterior tibital artery
Social History:
___
Family History:
Per records, has a twin brother also with diabetes.
Physical Exam:
ADMISSION:
Vitals- 98.4 88 155/55 (on levophed 0.03) 19 94% on 4L NC
GENERAL: Somnolent, oriented x 2, no acute distress
HEENT: Sclera anicteric, MMM
NECK: supple, RIJ CVL
LUNGS: crackles at the bases bilaterally, no rhonchi
CV: Distant sounds, regular rate and rhythm, normal S1 S2, no
murmurs, rubs, gallops
ABD: soft, non-tender, non-distended, bowel sounds present, no
rebound tenderness or guarding, no organomegaly, ostomy with
light brown stool in RLQ
EXT: Warm, well perfused, no clubbing, cyanosis or edema
SKIN: No evidence of open wounds or cellulitis
NEURO: Moves all 4 extremities
DISCHARGE:
VS: 98.2 148/61 82 18 99RA
GENERAL: Awake and interactive, upright in bed
HEENT: MMM, sclera anicteric
NECK: Supple
PULM: Distant crackles at the bases bilaterally, though overall
relatively clear
CV: Irregular, (+)S1/S2 no m/r/g
ABD: Soft, non-tender, non-distended, bowel sounds present, RLQ
ostomy with stool output
EXTREM: Warm, well perfused, no clubbing, cyanosis or edema
SKIN: No evidence of open wounds or cellulitis
NEURO: Moves all 4 extremities, expressive aphasia
Pertinent Results:
ADMISSION:
___ 04:40AM BLOOD WBC-18.0*# RBC-4.15* Hgb-11.4* Hct-34.3*
MCV-83 MCH-27.5 MCHC-33.2 RDW-15.6* Plt ___
___ 04:40AM BLOOD Neuts-83.6* Lymphs-12.6* Monos-3.3
Eos-0.3 Baso-0.2
___ 04:40AM BLOOD ___ PTT-42.7* ___
___ 04:40AM BLOOD Glucose-262* UreaN-56* Creat-2.0* Na-136
K-5.3* Cl-101 HCO3-25 AnGap-15
___ 04:40AM BLOOD ALT-22 AST-18 AlkPhos-85 TotBili-0.3
___ 04:40AM BLOOD Albumin-3.5 Calcium-8.6 Phos-3.6 Mg-2.1
DISCHARGE:
___ 05:57AM BLOOD WBC-10.8 RBC-3.88* Hgb-10.5* Hct-31.7*
MCV-82 MCH-27.2 MCHC-33.2 RDW-15.3 Plt ___
___ 05:57AM BLOOD Glucose-136* UreaN-19 Creat-0.8 Na-134
K-4.1 Cl-99 HCO3-23 AnGap-16
___ 05:57AM BLOOD ___ PTT-47.0* ___
___ 05:57AM BLOOD Calcium-8.1* Phos-2.0* Mg-1.7
IMAGING:
___ CXR
Low lung volumes, with bibasilar atelectasis, greater on the
right, however, left basilar pneumonia cannot be excluded.
Stable cardiomegaly.
___ CT Head
1. No acute intracranial hemorrhage.
2. Multifocal encephalomalacia in left cerebral hemisphere and
right pons consistent with prior infarct.
3. Mucosal thickening of left maxillary and anterior ethmoidal
air cells.
Brief Hospital Course:
Mr. ___ is an ___ with history of history of stroke (___)
with residual speech deficits, dementia, diabetes mellitus, and
atrial fibrillation who presented with altered mental status and
hypoxia, found to have sepsis likely secondary to pneumonia.
ACUTE ISSUES
#Septic shock, pneumonia
Presenting from ___ with hypoxemia and altered mental
status, found to have possible pneumonia on CXR with
leukocytosis. He was hypotensive in the ED requiring pressors
and several IV fluid boluses. His blood pressure quickly
stabilized overnight. His antibiotic regimen was narrowed during
his MICU stay, initially vancomycin, cefepime, and azithromycin,
and later to azithromycin and cefpodoxime for seven day total
antibiotic course.
#Altered mental status/Encephalopathy
Thought to be most likely secondary to the patient's infection
with possible contribution of his many medications which are
known to cause altered mental status in the elderly. His
gabapentin was downtitrated and recommendations were made to be
judicious about the use of some of his medications which can
cause mental status changes.
#Acute kidney injury
Patient found to have creatinine of 2.2 on admission from
baseline of 0.6. Patient received significant rehydration with
improvement of his creatinine to near baseline. Creatinine on
discharge 0.8.
#Atrial fibrillation complicated by supratherapeutic INR
Patient with history of AF and elevated CHADS2 score 5. On
warfarin for anticoagulation and metoprolol for rate control.
Presenting with INR of 4.0, which remained elevated during his
hospitalization. The patient's warfarin was held and his INR was
trended. INR remains elevated on discharge without signs of
bleeding.
#Diabetes mellitus
He was continued on his home insulin regimen.
#CHF
He was continued on his home metoprolol and lisinopril.
#Hypertension
He was continued on his home metoprolol and lisinopril. HCTZ was
held at time of discharge for planned restart at ___.
#History of CVA
He was continued on his home clopidogrel.
#CAD/Hyperlipidemia
He was continued on his home simvastatin.
#Chronic back
Patient with history of back pain s/p spinal surgery. His pain
regimen has been downtitrated recently given presentation of
altered mental status before.
His home tramadol and gabapentin was held during his
hospitalization and restarted upon discharge.
#BPH
He was continued on his home finasteride.
#Depression and dementia
He was continued on his home sertraline and desipramine. His
home trazodone was restarted upon discharge.
TRANSITIONAL ISSUES
-Please trend INR and restart warfarin at home doses once INR
<3. Warfarin dosing may require adjustment given concurrent use
of antibiotics.
-Consider downtitrating many of the patient's sedating
medications to prevent altered mental status.
-Patient was largely restarted on his home antihypertensive
regimen, though HCTZ was still held at discharge. This can be
restarted at ___ once his blood pressures have
stabilized.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO Q6H:PRN pain
2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of
breath
3. Bisacodyl ___AILY:PRN constipation
4. Clopidogrel 75 mg PO DAILY
5. Desipramine 50 mg PO QHS
6. Docusate Sodium 100 mg PO BID
7. Finasteride 5 mg PO DAILY
8. Hydrochlorothiazide 25 mg PO DAILY
9. Lisinopril 60 mg PO DAILY
10. Metoprolol Tartrate 50 mg PO DAILY
11. Milk of Magnesia 30 mL PO DAILY:PRN constipation
12. Prochlorperazine 25 mg PR Q12H:PRN nausea
13. Senna 8.6 mg PO DAILY:PRN constipation
14. Sertraline 150 mg PO DAILY
15. TraZODone 25 mg PO HS:PRN if first, smaller dose, does not
work
16. TraZODone 12.5 mg PO HS:PRN sleep
17. TraMADOL (Ultram) 25 mg PO Q8H:PRN pain
18. Simvastatin 20 mg PO DAILY
19. Warfarin 6 mg PO DAILY16
20. Amlodipine 10 mg PO DAILY
21. Gabapentin 400 mg PO BID
22. Desipramine 25 mg PO QAM
23. 70/30 10 Units Breakfast
70/30 5 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
Discharge Medications:
1. Acetaminophen 650 mg PO Q6H:PRN pain
2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of
breath
3. Amlodipine 10 mg PO DAILY
4. Bisacodyl ___AILY:PRN constipation
5. Clopidogrel 75 mg PO DAILY
6. Desipramine 50 mg PO QHS
7. Docusate Sodium 100 mg PO BID
8. Finasteride 5 mg PO DAILY
9. Gabapentin 200 mg PO BID
10. 70/30 10 Units Breakfast
70/30 5 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
11. Lisinopril 60 mg PO DAILY
12. Metoprolol Tartrate 50 mg PO DAILY
13. Milk of Magnesia 30 mL PO DAILY:PRN constipation
14. Senna 8.6 mg PO DAILY:PRN constipation
15. Sertraline 150 mg PO DAILY
16. Simvastatin 20 mg PO DAILY
17. Azithromycin 250 mg PO Q24H
Please continue through ___ for total of seven days of
antibiotics.
18. Cefpodoxime Proxetil 400 mg PO Q12H
Please continue through ___ for total of seven days of
antibiotics.
19. Desipramine 25 mg PO QAM
20. Warfarin 6 mg PO DAILY16
21. Hydrochlorothiazide 25 mg PO DAILY
22. Prochlorperazine 25 mg PR Q12H:PRN nausea
23. TraMADOL (Ultram) 25 mg PO Q8H:PRN pain
24. TraZODone 25 mg PO HS:PRN if first, smaller dose, does not
work
25. TraZODone 12.5 mg PO HS:PRN sleep
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
Pneumonia
Severe sepsis
Atrial fibrillation, supratherapeutic INR
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Mr. ___,
You were admitted from ___ with low oxygen levels and
confusion. You were found to have a pneumonia causing a low
blood pressure. You were cared for in the ICU initially, but
became well enough to go to the medical floor. Please continue
taking antibiotics as directed.
You warfarin levels (INR) were found to be very high during your
admission, possible because of your illness. Please monitor your
INR blood test and restart the warfarin as directed.
Followup Instructions:
___
|
10819930-DS-11
| 10,819,930 | 26,920,336 |
DS
| 11 |
2120-01-14 00:00:00
|
2120-01-15 17:21:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Imitrex / Nexium
Attending: ___.
Chief Complaint:
RUQ Pain
Major Surgical or Invasive Procedure:
None
History of Present Illness:
Ms. ___ is a ___ with hx of chronic abdominal pain,
migraines, and relapsing/remitting MS who presents with acute on
chronic RUQ
abdominal pain concerning for symptomatic cholelithiasis.
.
Pt has had chronic abdominal pain for past several months and
has been worked up extensively by gastroenterology. She has been
ruled out for celiac disease and had a recent EGD showing
gastritis, though biopsies were all normal and negative for
HPylori. Pt was started on a PPI but discontinued it when the
medication was making her nauseous - also on dicyclamine per GI.
Pt had a recent CCK HIDA scan which was normal as well as a
normal abd CT.
.
She has been without pain recently until 2 days ago
(___ morning), when she again developed RUQ crampy,
sharp pain, similar to prior episodes. It started in the morning
and resolved somewhat allowing her to attempt to eat THaksgiving
dinner (which consisted of a fair amount of cheese). She states
that while prior episodes resolved after a few hours, this one
has not. After dinner, however, she developed pain ___
later and then she began to vomit 90-120min later and has not
been able to keep down food since. She tried a couple other
times and had the same experience with worsening pain followed
by vomiting. Pain is always in the epigastrium/RUQ and is
similar in location to prior episodes. She has mild
constipation, but denies diarrhea, fevers, chills, melana,
hematochezia, rash, cough, sick contacts. Additionally, she did
note that her urine seemed a bit dark yesterday.
.
In the ED, initial VS:98.8 63 149/92 16 100%. LFTs and Lipase
normal. RUQ U/S showed stones in gallbladder and possible stone
in cystic duct. ACS was consulte regarding symptomatic
cholelithiasis but said would like input from GI for other
reasons for pain before commiting to surgery and requested
admission to medicine for a GI consult. Pt was given zofran 4mg
iv at 0130 and dilaudid 1mg iv at 0130. pt given another
dilaudid 1mg iv at 0520 Temp - 98.2 oral, HR - 59, BP - 102/67,
RR - 16, O2 Sat - 100% room air
Past Medical History:
Multiple Sclerosis (Dx ___ L
numbness most normal presentation)
Migraines
Anxiety/Panic attacks
Chronic Abd Pain (since beginning ___
Lactose Intolerance
Social History:
___
Family History:
Mother with ovarian cyst and ?breast CA and s/p CCY and
fibromyalgia
Uncle with Type ___ DM
Physical Exam:
ADMISSION PHYSICAL EXAM:
VS - Temp 96.9F, BP 104/64, HR 64, R 16, O2-sat 100% RA
GENERAL - obese, well-appearing in NAD, slightly uncomfortable
HEENT - PERRLA, EOMI, sclerae anicteric, MMM, OP clear
NECK - supple, no cervical LAD
LUNGS - CTA bilat ant, no r/rh/wh, good air movement, resp
unlabored
HEART - PMI non-displaced, RRR, no MRG, nl S1-S2
ABDOMEN - NABS, soft/TTP in RUQ, slightly worse with
inspiration, no masses or HSM, no rebound/guarding
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs)
SKIN - no rashes or lesions
NEURO - awake, A&Ox3, CNs ___ grossly intact, muscle strength
___ throughout, sensation grossly intact throughout
DISCHARGE PHYSICAL EXAM:
VS: 98.9 98.2 118/76 72 14 100%RA
GEN: obese, NAD, laying in bed comfortable
HEENT - PERRLA, EOMI, sclerae anicteric, MMM, OP clear
NECK - supple, no cervical LAD
LUNGS - CTA bilat ant, no r/rh/wh, good air movement, resp
unlabored
HEART - RRR, no MRG, nl S1-S2
ABDOMEN - NABS, soft/mildly TTP in RUQ, slightly worse with deep
inspiration, no masses or HSM, no rebound/guarding. Exam
unchanged from prior.
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs)
SKIN - no rashes or lesions
NEURO - awake, A&Ox3
Pertinent Results:
ADMISSION LABS:
___ 01:10AM BLOOD WBC-6.7 RBC-4.10* Hgb-13.2 Hct-38.5
MCV-94 MCH-32.1* MCHC-34.2 RDW-12.4 Plt ___
___ 01:10AM BLOOD Neuts-73.5* ___ Monos-4.0 Eos-1.9
Baso-0.2
___ 05:10AM BLOOD ESR-10
___ 01:10AM BLOOD Glucose-116* UreaN-8 Creat-0.6 Na-138
K-4.1 Cl-105 HCO3-22 AnGap-15
___ 01:10AM BLOOD ALT-15 AST-24 LD(LDH)-184 AlkPhos-63
TotBili-0.2
___ 01:10AM BLOOD Calcium-9.2 Phos-4.0 Mg-2.0
___ 01:10AM BLOOD CRP-1.7 CA125-16
___ 01:53AM BLOOD Lactate-2.4*
DISCHARGE LABS:
___ 07:50AM BLOOD WBC-4.0 RBC-3.91* Hgb-13.1 Hct-36.6
MCV-94 MCH-33.5* MCHC-35.8* RDW-12.3 Plt ___
___ 07:50AM BLOOD Glucose-119* UreaN-7 Creat-0.7 Na-138
K-3.7 Cl-103 HCO3-25 AnGap-14
RADIOLOGY:
HIDA Scan - IMPRESSION: Normal hepatobiliary study.
LIVER OR GALLBLADDER US (SINGLE ORGAN) Study Date of ___
1:16 AM
FINDINGS: The liver appears normal in echotexture with no focal
liver lesions identified. The gallbladder demonstrates
gallstones, but there is no evidence of gallbladder wall
thickening or surrounding pericholecystic fluid. No sonographic
___ sign was elicited. Overall, findings suggest
cholelithiasis without any specific signs for cholecystitis. The
common bile duct measures 0.3 cm and is within normal limits.
The main portal vein is patent. There is no free fluid. There
appears to be a small stone within the cystic duct.
IMPRESSION:
1. Cholelithiasis without specific signs for cholecystitis.
2. Stone noted within the cystic duct.
Brief Hospital Course:
Ms. ___ is a ___ yo F w chronic intermittent right upper
quadrant abdominal pain most clinically consistent w symptomatic
cholelithiasis.
.
#Right Upper Quadrant Pain- The current presentation is most
clinically consistent with symptomatic cholethiasis. A right
upper quadrant ultrasound confirmed the presence of stones in
the gallbladder (the largest measuring 1.2cm) including a stone
in the cystic duct but showed no evidence of acute
cholecystitis. General Surgery evaluated the patient a felt that
considering her ultrasound did not show acute cholecystitis that
a cholecystectomy did not have to be emergently performed. GI
was also consulted and recommended that a HIDA scan be ordered.
They also felt her symptoms could be due to irritable bowel
syndrome and recommended that we continue her on Dicyclomine
10mg three times per day. They recommended that further workup
occur as an out patient. Her pain was controlled with
Acetaminophen, Toradol and Tramadol. Her diet was slowly
advanced from NPO to full liquids as tolerated. HIDA scan was
performed and was unremarkable. The patient was discharged on
___ with plans to f/u with her GI physician ___ and
with surgery for possible elective CCY.
#Migraines- The patient has a known history of migraines in the
past. We continued Amitriptyline 25 mg prn to be used for
headaches while she was in the hosptial.
#Transitional-
1) Need for outpatient cholecystectomy to be addressed with
surgery
Medications on Admission:
AMITRIPTYLINE - 25 mg daily as needed for migraine/MS ___
DICYCLOMINE - 10 mg three times a day
RANITIDINE HCL - 150 mg BID
Discharge Medications:
1. dicyclomine 10 mg Capsule Sig: One (1) Capsule PO TID (3
times a day).
2. amitriptyline 50 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily)
as needed for headache.
3. ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO BID (2
times a day).
4. prochlorperazine maleate 5 mg Tablet Sig: One (1) Tablet PO
three times a day as needed for nausea for 4 days: Please do not
drive a car or operate heavy machinery until you know how
compazine affects you.
Disp:*12 Tablet(s)* Refills:*0*
5. tramadol 50 mg Tablet Sig: One (1) Tablet PO at bedtime as
needed for pain for 3 days: Please do not drive a car or operate
heavy machinery if taking tramadol.
Disp:*3 Tablet(s)* Refills:*0*
6. Tylenol ___ mg Tablet Sig: ___ Tablets PO three times a day
for 3 days.
Disp:*18 Tablet(s)* Refills:*0*
Discharge Disposition:
Home
Discharge Diagnosis:
Primary Diagnosis:
1. Abdominal pain
Secondary Diagnosis:
2. Migraines
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Ms. ___,
It was a pleasure taking care of you at ___
___. You were admitted to the hosptial with abdominal
pain. An ultrasound of your abdomen showed that there a stones
in your gallbladder but none that were causing a blockage and
inflammation that could explain your abdominal pain. You had a
HIDA scan of your gallbladder performed which was normal. We
recommend you keep your appointment with Dr. ___ on ___
for further work up of this problem.
Note the following changes to your home medication regimen:
1) Please START Tramadol 50mg at night as needed for pain until
you follow-up with your Gastroenterologist on ___.
2) Please START Compazine 5mg 3 times daily as needed for nausea
until you follow-up with your Gastroenterologist on ___.
3) Please START Acetaminophen (tylenol) every 8 hours as long as
pain persists.
See below for instructions regarding follow-up care:
Followup Instructions:
___
|
10819935-DS-4
| 10,819,935 | 25,355,672 |
DS
| 4 |
2183-06-07 00:00:00
|
2183-06-07 21:31:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Motrin / Penicillins / Tylenol
Attending: ___.
Chief Complaint:
Altered Mental Status
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ hx of bipolar, IVDU many years ago on suboxone presents
after being found unresponsive tonight by his sister. He has had
3 days of N/V and took a dose of his trazadone tonight because
he wanted to sleep. He was then found unresponsive by sister.
Last seen well at 1330 ___. Family reported to EMS patient
has been drinking large quantities of soda with little water
past few days. Per EMS, pupils dilated and alert to name only.
En route to ED, however, pinpoint pupils. Was given narcan
without change. Meds in patient's room included trazodone,
alprazolam, codeine, abilify, omeprazole.
At ___ his initial BP 90/s HR 116. He was altered
and slurring his speech. He was found to have BUN/Cr of 95/6.4,
Na of 116, Lactate 5.8 and lipase 414. AST 80, ALT 106, TBili
2.8, Dbili 1.16 He was given 2L NS bolus over 30 min at 2300,
and 1L NS bolus at ~0030, as well as 40mEq PO K zofran. He was
transferred here because there were no ICU beds at ___.
In the ED, initial vs were: 98.4 98 122/75 20 94% RA. He was
initially asymptomatic. He denied taking any other substances
and denied SI or intentional overdose. He had no complaints and
denied nausea, fever, pains. He appeared dehydrated but
otherwise had an unremarkable exam including a benign abdomen.
He received maintenance NS. Na 125 up from 116 at OSH. While in
the ED he became altered, pulling at lines and foley and not
answering questions or following commands. He was given 2mg
Ativan and 5mg Haldol and placed in mechanical restraints. Head
CT w/out did not show any acute findings including cerebral
edema. He was given zofran for nausea, and started on empiric
cipro/flagyl for concern of abdominal process. RUQ u/s was
obtained with no acute findings.
On the floor, patient is somnolent. He is unable to correctly
answer most questions and falls asleep during questioning and
exam. He briefly became hypoxic to ___ requiring addition of low
flow nasal canula.
Past Medical History:
Polysubstance abuse (clonazepam, oxycodone, IVDU)
Bipolar Disorder
Past psych admissions
PTSD
ADHD
GERD
Chronic back pain
Knee surgery
Left shoulder surgery
Sleep terrors
Social History:
___
Family History:
NC
Physical Exam:
ADMISSION PHYSICAL EXAM:
Vitals: 98.5 p78 105/43 R13 96% on RA then to 80%s. Improved to
97% on 4L NC
General: Disheveled male, NAD, very somnolent
HEENT: Pupils reactive, equal 3->2mm bilaterally, tongue
protrudes midline, atraumatic
Neck: No LAD, supple and freely mobile
Lungs: Bilateral air entry
CV: S1, S2 regular. Pulses 2+ throughout
Abdomen: Soft, nontender throughout to deep palpation.
Nonperitoneal.
GU: foley
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema. Recent lab draw needle sites but no obvious track marks
Neuro: A+Ox2 (knows name, location - "hospital," not month or
year)
Skin: erythematous rash over face and neck.
DISCHARGE PHYSICAL EXAM:
VS: 98.2, 105/65, 70, 20, 98% RA
General- Alert, oriented, no acute distress
HEENT- Sclera anicteric, MMM, oropharynx clear
Neck- supple, JVP not elevated, no LAD
Lungs- CTAB no wheezes, rales, rhonchi
CV- RRR, Nl S1, S2, No MRG
Abdomen- soft, NT/ND bowel sounds present, no rebound tenderness
or guarding, no organomegaly
GU- no foley
Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
Neuro- CNs2-12 intact, motor function grossly normal, normal
finger-to-nose test, no asterixis
Pertinent Results:
LABS:
On Admission:
___ 03:03PM BLOOD Glucose-112* UreaN-86* Creat-5.7* Na-125*
K-5.3* Cl-74* HCO3-30 AnGap-26*
___ 02:50AM BLOOD WBC-12.3* RBC-4.51* Hgb-13.7* Hct-39.0*
MCV-86 MCH-30.3 MCHC-35.1* RDW-11.8 Plt ___
___ 02:50AM BLOOD Neuts-81.6* Lymphs-9.4* Monos-8.5 Eos-0.2
Baso-0.3
___ 02:50AM BLOOD ___ PTT-28.9 ___
___ 02:50AM BLOOD Glucose-101* UreaN-80* Creat-5.7* Na-125*
K-3.2* Cl-72* HCO3-36* AnGap-20
___ 02:50AM BLOOD ALT-80* AST-73* AlkPhos-55 TotBili-2.1*
___ 02:50AM BLOOD Lipase-104*
___ 09:39AM BLOOD Calcium-7.6* Phos-6.8* Mg-2.1
___ 06:14AM BLOOD Osmolal-289
___ 03:04AM BLOOD Lactate-2.3*
On discharge:
___ 06:33AM BLOOD Glucose-97 UreaN-74* Creat-3.5* Na-135
K-4.4 Cl-94* HCO3-33* AnGap-12
___ 06:33AM BLOOD Calcium-9.0 Phos-3.0 Mg-2.0
Misc:
___ 12:35PM BLOOD Glucose-118* UreaN-86* Creat-4.6* Na-125*
K-3.1* Cl-82* HCO3-33* AnGap-13
___ 03:14AM BLOOD ALT-73* AST-48* LD(LDH)-196 AlkPhos-54
TotBili-0.7
___ 06:14AM BLOOD Lipase-93*
___ 10:44PM BLOOD Lactate-1.0
___ 06:40AM BLOOD WBC-9.5 RBC-4.50* Hgb-13.5* Hct-39.9*
MCV-89 MCH-30.1 MCHC-33.9 RDW-11.8 Plt ___
MICROBIOLOGY:
___ URINE CULTURE (Final ___: <10,000 organisms/ml.
___ Blood cx pending x2
IMAGING:
___ CT head w/out:
No acute intracranial process. No evidence of cerebral edema.
___ RUQ u/s:
no acute abnormalities
___ Renal US:
No hydronephrosis. Slightly increased echogenicity of the renal
parenchyma
suggesting medical renal disease. Normal renal vasculature.
Brief Hospital Course:
___ with history of Bipolar disorder, polysubstance abuse, PTSD
who presented with altered mental status in setting of recent GI
illness, hyponatremia, renal failure and psychoactive medication
use.
ACTIVE ISSUES BY PROBLEM:
# Toxic-metabolic Encephalopathy: Likely secondary to
symptomatic hyponatremia and renal failure in addition to
medication effects. CT head was negative with no focal
neurological findings. Urine tox screen only positive for
benzos, which he is prescribed. With gradual normalization of
his electrolytes, his mental status improved back to baseline.
# Hyponatremia: Likely hypovolemic with solute losses from
vomiting with GI illness combined with large volumes of intake
with low solute. His sodium levels corrected on their won with
resumption of normal diet and fluid intake. Na on discharge was
135. He should have his electrolytes rechecked at his follow up
PCP ___
# Acute kidney injury: Nephrology consulted who believed that
his original kidney injury was from severe dehydration in the
setting of acute nause/vomiting and that he also likely
developed from ATN. They expected his renal function to likely
make a full recovery. He was allowed a regular diet without
fluid restriction for management and his creatinine trended down
to 3.4 on discharge. His Cr should be rechecked at his next PCP
appointment and if Cr has not returned to normal, can consider
referral to nephrology.
TRANSITIONS OF CARE:
- Hyponatremia: should have Na checked at follow up visit to PCP
to ensure it has remained normal after discharge
- Renal failure: Cr decreased from 6.4->3.4 on discharge and is
expected to keep falling. Should have repeat Cr rechecked at
visit with PCP. If renal function does not fully recover, can
consider referral to nephrology.
- No medication changes were made except holding his terbinafine
given his decreased renal function
- FULL CODE this admission
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires
futher investigation.
1. QUEtiapine extended-release 300 mg PO QHS
2. TraZODone 400 mg PO HS
3. Aripiprazole 50 mg PO HS
4. ALPRAZolam 1 mg PO TID
5. CloniDINE Dose is Unknown PO Frequency is Unknown
6. Buprenorphine-Naloxone (2mg-0.5mg) Dose is Unknown SL
Frequency is Unknown
Discharge Medications:
1. ALPRAZolam 1 mg PO BID
2. Amphetamine Salt Combo (dextroamphetamine-amphetamine) 5 mg
oral daily
3. Aripiprazole 20 mg PO HS
4. Buprenorphine-Naloxone (8mg-2mg) 3 TAB SL DAILY
5. CloniDINE 0.2 mg PO TID
6. TraZODone 300 mg PO HS
Discharge Disposition:
Home
Discharge Diagnosis:
Primary diagnoses:
Hyponatremia
Acute kidney injury
Acute encephalopathy
Secondary diagnoses:
Attention deficit disorder
Anxiety
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr ___,
It was a pleasure taking care of you at ___!
You were admitted to the hospital with severe confusion, low
sodium and kidney failure. We believe that the stomach bug you
had caused you to throw up too much sodium and get dehydrated,
then affecting your kidneys. You sodium is now back to normal
and your kidneys are continuing to improve. We expect you to
make a full recovery.
Once you go home, continue to eat plenty of food and drink when
you are thirsty, avoiding just plain water if able. Do not take
anymore drugs other than those you are prescribed!
Followup Instructions:
___
|
10819935-DS-6
| 10,819,935 | 24,995,393 |
DS
| 6 |
2184-05-09 00:00:00
|
2184-05-09 20:56:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Motrin / Penicillins / Tylenol
Attending: ___.
Chief Complaint:
Altered Mental Status
Major Surgical or Invasive Procedure:
Endotracheal Intubation
History of Present Illness:
___ with PMH of Anxiety, substance abuse, bipolar disorder,
polysubstance abuse and IVDU presented to ___ with altered
mental status. Per report, the pt had not been feeling well over
the past three days, becoming increasingly agitated. His mother
came home over the past couple of days noting noting items
around the house in disarray, although her son did not recall
making such changes. Per a friend's report, he has been
injecting suboxone daily. On presentation at the OSH, he was
agitated and combative. On exam, he was diaphoretic, tachycardic
to 140s, normotensive, febrile to 104.5. There was no report of
clonus or rigidity. Labs were significant for a WBC 19 (88
PMNs), Na 125, K 2.8, Cl 74, HCO3 36, AST 316, TB 1.2, DB 0.36,
CK > 20k, lactate of 3.3, UA with large blood. Trops were 0.116.
Salicylates and tylenol level was negative. Non-contrast head CT
was negative. He had a tonic-clonic seizure, was given 6mg
ativan for seizure and concern for serotonin syndrome, and was
intubated for airway protection. He was not actively cooled, but
was given PR tylenol. He was also given 1 dose of vanc/CTX, and
1200cc fluid bolus. He was then transferred to ___.
In the ___, initial vitals: 100.0 (Tmax 100.8) 117 131/76 23 99%
and intubation. On exam, he was flushed and diaphoretic, pupils
were 1mm and reactive, no hyperreflexia, no clonus, no rigidity.
His labs were notable for WBC 18.1, INR 1.3, Na 130, K 2.6, Cl
82, HCO3 34, Cr 1.5, Mg 2.7, Phos 4.6, ALT 79, AST 697, LDH
1089, CK ___, lactate 1.8, trop 0.03. UA positive for blood.
Serum tox was positive for acetaminophen level of 6 and for
BZDs. Initial ABG showed pH 7.52, pCO2 44. CSF was sampled to
rule out meningitis: 1 WBC, 1 RBC, Protein 17, Glucose 93. CXR
showed opacities in the right middle lobe. EKG showed normal
QRS and QTc. He was given 2L LR and K was repleted. He was
admitted to the MICU for further monitoring.
On arrival to the MICU, the patient is intubated and sedated. He
is hemodynamically stable. IVF initiated.
Past Medical History:
Polysubstance abuse (clonazepam, oxycodone, IVDU)
Bipolar Disorder
Past psych admissions
PTSD
ADHD
GERD
Chronic back pain
Knee surgery
Left shoulder surgery
Sleep terrors
Social History:
___
Family History:
family history remarkable for ulcer disease in mother, s/p
gastrectomy
Physical Exam:
Admission Exam:
Vitals- T:99.9 (rectal), BP: 123/78, P: 100, O2: 100% on CMV
FiO2 50%, 450 Vt, RR 16, PEEP 5.
GENERAL: Intubated, sedated, no acute distress
HEENT: Sclera anicteric, dry MM, oropharynx clear
NECK: supple, JVP not elevated, no LAD
LUNGS: Clear to auscultation bilaterally, no wheezes, rales,
rhonchi
CV: Tachycardic, regular rate and rhythm, normal S1 S2, no
murmurs, rubs, gallops
ABD: soft, non-tender, non-distended, hypoactive bowel sounds
present, no rebound tenderness or guarding, no organomegaly
EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
SKIN: Multiple track marks in the bilateral antecubital fossa,
red/warm/dry skin. Erythematous rash all over, flushed. Areas of
induration in left antecubital region and right anterior shin.
Neuro: Cranial nerve reflexes intact (pupils 2mm and sluggish,
corneals intact).
Discharge Exam:
Vitals- 98.2 127/79 90 18 95%RA
GENERAL: Middle aged male, NAD, lying in bed
HEENT: Sclera anicteric, dry MM, oropharynx clear
NECK: supple, JVP not elevated, no LAD
LUNGS: lungs CTAB
CV:regular rate and rhythm, normal S1 S2, no murmurs, rubs,
gallops
ABD: soft, non-tender, non-distended, hypoactive bowel sounds
present, no rebound tenderness or guarding
EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
SKIN: Multiple track marks in the right antecubital fossa,
red/warm/dry skin.
Neuro: Hearing decreased in left ear, CN ___ otherwise intact,
AO x3
Pertinent Results:
___ 02:48AM TYPE-ART RATES-20/ TIDAL VOL-500 PEEP-5
O2-100 PO2-203* PCO2-44 PH-7.52* TOTAL CO2-37* BASE XS-12
AADO2-460 REQ O2-79 -ASSIST/CON INTUBATED-INTUBATED
___ 02:55AM PLT SMR-NORMAL PLT COUNT-310
___ 02:55AM ___ PTT-32.8 ___
___ 02:55AM HYPOCHROM-NORMAL ANISOCYT-NORMAL
POIKILOCY-NORMAL MACROCYT-NORMAL MICROCYT-NORMAL
POLYCHROM-NORMAL
___ 02:55AM NEUTS-89.8* LYMPHS-6.0* MONOS-2.9 EOS-1.1
BASOS-0.1
___ 02:55AM WBC-18.1* RBC-5.12 HGB-15.7 HCT-42.6 MCV-83
MCH-30.6 MCHC-36.8* RDW-12.7
___ 02:55AM ASA-NEG ETHANOL-NEG ACETMNPHN-6* bnzodzpn-POS
barbitrt-NEG tricyclic-NEG
___ 02:55AM TSH-0.37
___ 02:55AM TRIGLYCER-135
___ 02:55AM ALBUMIN-4.0 CALCIUM-8.7 PHOSPHATE-4.6*
MAGNESIUM-2.7*
___ 02:55AM cTropnT-0.03*
___ 02:55AM LIPASE-22
___ 02:55AM ALT(SGPT)-79* AST(SGOT)-697* LD(LDH)-1809*
___ ALK PHOS-68 TOT BILI-0.8
___ 02:55AM GLUCOSE-121* UREA N-19 CREAT-1.5* SODIUM-130*
POTASSIUM-2.6* CHLORIDE-82* TOTAL CO2-34* ANION GAP-17
___ 03:09AM LACTATE-1.8
___ 03:09AM COMMENTS-GREEN TOP
___ 03:30AM URINE RBC-2 WBC-7* BACTERIA-FEW YEAST-NONE
EPI-0
___ 03:30AM URINE BLOOD-LG NITRITE-NEG PROTEIN-100
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0
LEUK-NEG
___ 03:30AM URINE COLOR-Red APPEAR-Hazy SP ___
___ 03:30AM CEREBROSPINAL FLUID (CSF) WBC-1 RBC-1* POLYS-6
___ MACROPHAG-2
___ 03:30AM URINE bnzodzpn-POS barbitrt-NEG opiates-NEG
cocaine-NEG amphetmn-NEG mthdone-NEG
___ 03:30AM URINE HOURS-RANDOM
___ 03:30AM CEREBROSPINAL FLUID (CSF) PROTEIN-17
GLUCOSE-93
___ 07:08AM PLT COUNT-245
___ 07:08AM WBC-15.9* RBC-4.48* HGB-13.7* HCT-37.7*
MCV-84 MCH-30.6 MCHC-36.4* RDW-12.8
___ 07:08AM CALCIUM-7.8* PHOSPHATE-3.1 MAGNESIUM-2.4
___ 07:08AM ALT(SGPT)-98* AST(SGOT)-746* ___
___ ALK PHOS-60 TOT BILI-1.0
___ 07:08AM GLUCOSE-126* UREA N-20 CREAT-1.7* SODIUM-135
POTASSIUM-2.5* CHLORIDE-93* TOTAL CO2-32 ANION GAP-13
___ 10:47AM freeCa-1.03*
___ 10:47AM LACTATE-1.2
___ 10:47AM TYPE-ART TEMP-37.8 ___ TIDAL VOL-480
PEEP-5 O2-50 PO2-90 PCO2-49* PH-7.45 TOTAL CO2-35* BASE XS-8
-ASSIST/CON INTUBATED-INTUBATED
___ 12:37PM OTHER BODY FLUID FluAPCR-NEGATIVE
FluBPCR-NEGATIVE
___ 03:23PM ___ PTT-37.6* ___
___ 03:23PM CALCIUM-7.7* PHOSPHATE-2.5* MAGNESIUM-2.3
___ 03:23PM ALT(SGPT)-101* AST(SGOT)-792* LD(___)-1898*
ALK PHOS-55
___ 03:23PM GLUCOSE-101* UREA N-22* CREAT-1.9* SODIUM-137
POTASSIUM-3.4 CHLORIDE-101 TOTAL CO2-26 ANION GAP-13
___ 05:34PM LACTATE-1.0
___ 05:34PM TYPE-ART PO2-124* PCO2-42 PH-7.43 TOTAL
CO2-29 BASE XS-3
___ 05:34PM LACTATE-1.0
RUQ US
1. Redemonstration of 2 hepatic hemangiomas, unchanged.
2. Small bilateral pleural effusions.
ECHO: Normal regional and global biventricular systolic
function. Normal diastolic function. No pathologic valvular
abnormalities.
CXR: Residual mild pulmonary vascular congestion/interstitial
edema, improved from ___. Trace right pleural
effusion.
Discharge Labs:
___ 05:35AM BLOOD WBC-11.1* RBC-3.72* Hgb-10.9* Hct-32.3*
MCV-87 MCH-29.2 MCHC-33.6 RDW-12.9 Plt ___
___ 05:35AM BLOOD Glucose-101* UreaN-22* Creat-2.0* Na-140
K-4.0 Cl-99 HCO3-34* AnGap-11
___ 05:35AM BLOOD ALT-137* AST-133*
___ 05:48AM BLOOD Calcium-8.1* Phos-2.4* Mg-1.8 Iron-22*
___ 05:48AM BLOOD calTIBC-135* Ferritn-418* TRF-104*
___ 03:32AM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE
HBcAb-NEGATIVE HAV Ab-NEGATIVE IgM HAV-NEGATIVE
___ 04:04AM BLOOD HIV Ab-NEGATIVE
___ 03:32AM BLOOD HCV Ab-NEGATIVE
Brief Hospital Course:
___ yo M with history of polysubstance abuse, IVDU, anxiety,
depression, presents after acute agitation and seizure thought
to be due to a sympathomimetic overdose and is now s/p
intubation/extubation with ___ and rhabdomyolysis.
# Acute encephalopathy: Presenting with agitation at ___
(reports of needing to be restrained by 5 security guards), Pt
had evidence of sympathetic overdrive with fever, tachycardia,
diaphoresis, and agitation, hypoactive bowel sounds. Toxicology
was consulted. Patient has reportedly made dimethyltryptamine,
which is a psychedelic medication that contains serotonin and
melatonin analogs. Clembuterol was also a consideration given
the patients hypokalemia and tachycardia, but less likely given
there is no hypocalcemia or hyperglycemia. The patient also
takes alprazolam at baseline and could have been experiencing
BZD withdrawal. Seratonin syndrome was also on the differential
given the use of multiple serotonergic medications including
trazadone. Tylenol levels were negative. He was treated
supportively with benzodiazepines and IVF while in the ICU. He
self extubated and was transferred to the floor where he was
restarted on his home alprazolam. He did not experience any more
agitation after floor transfer. He has had 2 similar
presentations in the past where drug use has been suspected but
he has firmly denied any drug use before his current
presentation.
# Seizures: Pt had generalized tonic-clonic seizure at OSH. It
was most likely provoked ___ high fever and severe electrolyte
abnormalities (hyponatremia). The pt has no clinical evidence of
ongoing seizures. CT head negative at OSH. EEG here did not
demonstrate any seizures or seizure focus. He was maintained on
ativan per CIWA protocol and as substitution for his xanax. He
did not have any recurrence of seizures.
# Rhabdomyolysis: CK elevated at OSH and rising on presentation
to ___. Possible etiologies include fever, NMS, prolonged time
of immobility, and seizure. He was treated aggressively with
fluid resuscitation until CK trended to less than 5K. He
required multiple doses of IV lasix to help with diuresis due to
pulmonary edema.
# ___: Baseline of 1.0 and presented with Cr of 1.5 which
trended up to 2.8. This was thought to be due to ATN and
rhabdomyolysis. His Cr trended down with fluid resuscitation and
it was 2.0 on discharge.
#H/o drug use: Patient firmly denies any recent drug use, but
presentation was concerning for possible overdose of a
sympathomimetic (amphetamine, bath salt, etc.). SW saw the
patient and offered resources, but patient was not interested in
a halfway house or rehab center.
#Anemia: normocytic, downtrending Hct since arrival. Retic count
was low and ferritin high, so thought to be due to anemia of
inflammation. Should be followed as outpatient.
#Anxiety/Depression: Continue home Xanax, Abilify, Clonidine;
Did not continue Trazadone, as this medication was also
implicated in patient's last similar presentation in ___.
Unsure at this point if it was causative, but due to multiple
seratonin modulating drugs, recommended that the patient stop
taking trazadone.
#Superficial thrombophlebitis:Clot was seen in the cephalic vein
of the RUE on US. Patient initially started on heparin and
warfarin in the ICU but this was stopped on the floor as the
patient was asymptomatic.
Transitional Issues:
-Patient firmly denies drug use in the days preceding this
admission, as well as the previous admissions for similar
presentations. There is no clear evidence to confirm the
presence or absence of drug use (sympathomimetics, bath salts)
during these admissions.
-Cr 2.0 on discharge and should be checked on ___ for resolution
of the ___
-Patient endorsed SI ("I wish I had never woken up"). He has no
intent to harm himself, no plan, and no firearm. Please monitor
for depression and continued SI.
-Trazadone discontinued on this admission in case these repeated
cases of agitation and sympathetic stimulation were due to
seratonin syndrome.
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. ALPRAZolam 1 mg PO QID:PRN anxiety
2. ARIPiprazole 20 mg PO DAILY
3. Buprenorphine-Naloxone (8mg-2mg) 3 TAB SL DAILY
4. CloniDINE 0.2 mg PO TID
5. TraZODone 300 mg PO QHS:PRN insomnia
6. Adderall (dextroamphetamine-amphetamine) 30 mg oral TID
7. Prazosin 2 mg PO QHS
Discharge Medications:
1. ALPRAZolam 1 mg PO QID:PRN anxiety
RX *alprazolam 1 mg 1 tablet(s) by mouth four times daily Disp
#*4 Tablet Refills:*0
2. ARIPiprazole 20 mg PO DAILY
3. Buprenorphine-Naloxone (8mg-2mg) 1 TAB SL DAILY
4. CloniDINE 0.2 mg PO TID
5. Prazosin 2 mg PO QHS
Discharge Disposition:
Home
Discharge Diagnosis:
Primary:
Acute encephalopathy
Respiratory Failure
Rhabdomyolysis
Acute Kidney Injury
Pulmonary Edema
Secondary:
Anxiety
Depression
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
You were admitted to the hospital because you were confused and
agitated. You needed to be put on the breathing machine because
you had a seizure. You also developed some muscle breakdown and
injured your kidneys. At this time we do not know what caused
this series of events, but we think it is possible you may have
taken some type of drug. We understand that you deny any drug
use, but if you are consuming or injecting any type of drug, we
want you to understand that you could seriously damage your
health, which would include kidney failure and even death.
Please follow up with your other providers for continued
management of your other health issues.
Sincerely,
Your ___ Team
Followup Instructions:
___
|
10819991-DS-16
| 10,819,991 | 27,823,541 |
DS
| 16 |
2114-11-05 00:00:00
|
2114-11-05 16:14:00
|
Name: ___ Unit ___: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: NEUROLOGY
Allergies:
___ Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Increasing event frequency ? seizures
Major Surgical or Invasive Procedure:
None
History of Present Illness:
HPC:
___ with a PMH of a significant head injury with loss of
consciousness < age ___, a febrile seizure age ___ and
functional dysphagia on swallow assessment in ___ presents
from neurology clinic after escalating episodes of possible
seizures and had further episodes today including in the ___.
The patient has had escalating events over the past 3 weeks. He
was in his usual state of health until ___ after a night
of
drinking and having fun he woke up feeling hungover and "out of
it" and noted problems with his memory and developed a headache
and took ibuprofen for this. Then on ___ he had a
prolonged
episode when he was unable to speak at all save making some
sounds. He was able to understand and follow commands. He was
transported to ___ and en route he had an episode
in
the back of the car when he was unaware and became stiff, eyes
rolled back and head and all 4 limbs were shaking which lasted
for a few minutes and afterwards felt tired but was not confused
or disoriented. He still was unable to speak after this episode.
He has ___ tongue biting or incontinence which has been
consistent
throughout all his episodes. His mutism lasted for perhaps ___
hours and resolved. He had workup for a stroke with a CT head
which was normal and HIV and syphilis were both negative and
normal prolactin. He was discharged on Keppra 500mg bid the
following day. On ___ he had tremors of all 4 limbs on and
off and was aware with these and again presented to ___ and this was felt due to anxiety and was prescribed
rectal diazepam with a plan for an outpatient EEG and MRI. On
___ he had shaking intermittently with a feeling of
tightness in his neck and went back to the ___ and at
that
point they attempted an MRI but he had an episode in the scanner
with partial awareness and shaking of all 4 limbs for roughly 1
minute was given benzos and the scan was aborted. He felt back
to
his normal after 2 minutes with ___ clear post-ictal period.
Again
___ tongue-biting or incontinence. He then had an o/p EEG on
___ when he captured an episode during photic stimulation
and the report was normal. He also had an MRI head which we do
not have the images or the report for which apparently per the
patient showed "post seizure changes". He saw his PCP ___
___
and was referred to neurology. He was seen by a neurologist Dr
___ who felt he may have had 1 epileptic and other
non-epileptic events and Keppra was increased to 1500mg bid and
clonazepam added. He then had a period without any events but
continued tremors until he had a further episode on ___
when his room-mate heard noises from his room and per
documentation "saw him thrashing around in the bed" shaking all
4
limbs and lips turned blue/white per his room-mate who gave him
rectal diazepam. 911 was called and he again presented to
___. He had labs taken including CMP which were normal and
was discharged. On ___ out of fear of him having another
seizure, he self-increased his clonazepam to 2mg bid and had
tremors and shakes but ___ events. By ___ he had run out of
clonazepam. He then saw his PCP ___ ___ and plans were then to
have an ambulatory EEG on ___. Since then, he had 2
episodes yesterday with him shaking uncontrollably at roughly
7pm
and was unresponsive but trying to talk but his teeth were
clenched making a vibrating sound. This lasted 3.5 minutes again
with a very short period before he was back to his normal self.
He then had a syncopal episode that evening after micturating
and
fell and hit the bathroom scale.. He had a further episode this
morning at 06:30 which was preceded by a tingling feeling all
over which was present with some of his other episodes and again
lasted for ___ minutes with 2 minutes until he was back to
normal. He had a further event en route to his neurology
appointment with ___ ___ after he wanted to transfer his
care to our system. She found him encephalopathic and sent him
to
___ ___ for admission. Here, he had a further episode in the ___
with possibly a slight preceding tingling and then becoming
stiff
and high frequency shaking of all 4 limbs but only lasted ___
with ___ significant post-ictal period.
He currently "feels like shit" and notes a persistent left
temporal throbbing headache without nausea or vomiting but
present photo/phonophobia. He feels the Keppra makes him feel
"out of it". His partner also states that he has had some
episodes of staring when he would be walking and then stare
straight ahead and be unresponsive and this would last for a few
minutes. He has also been doing psychotherapy.
He had hypoglycaemia in the ___ with an initial ___ ___ and then
dropped to ___ had an amp of D50 and then dropped to 54 and had
another amp. He still has a left temporal headache.
He notes that he has been very stressed since he started a new
job as a ___ for a small ___
in ___ which is very deadline driven ad has 4 bosses who are
very exacting. Since the start of his symptoms he has been doing
work at home but actually had a seizure during a client call.
He feels his mood is not depressed but is low. He feels his
memory has been impaired since starting Keppra. He vomited on
the
first day back at work possibly due to anxiety but not since. He
has been finding it hard to get to sleep and has slept
restlessly
since his last event overnight and is scared to fall asleep. He
also notes bilateral tinnitus 2 days ago which has settled. He
has chronic manageable dysphagia. He endorses occasional chest
pain and diarrhoea.
On neuro ROS, the pt denies loss of vision, blurred vision,
diplopia, dysarthria, dysphagia, lightheadedness, vertigo, or
hearing difficulty. Denies difficulties producing or
comprehending speech. Denies focal weakness, numbness,
parasthesiae. ___ bowel or bladder incontinence or retention.
On general review of systems, the pt denies recent fever or
chills. ___ night sweats or recent weight loss or gain. Denies
cough, shortness of breath. Denies palpitations. Denies
nausea,
vomiting, constipation or abdominal pain. ___ recent change in
bowel or bladder habits. ___ dysuria. Denies arthralgias or
myalgias. Denies rash.
Past Medical History:
PMH:
- Functional dysphagia felt on swallow assessment ___ to
be
a learned behaviour
- Chronic headaches worse with increased setress now ___ days
per
week
- Febrile seizure age ___ none since
- Head injury age ___ falling off a ___ with LOC age
<___
- Chronic right hearing loss
- ___ h/o meningitis or encephalitis
Social History:
___
Family History:
Family Hx:
Mother - T2DM
Maternal great great uncle had seizures and died from this
An aunt had a stroke in old age
Father - Does not know
Sibs - many adn all are well
Children - none
There is ___ history of developmental disability, learning
disorders, migraine headaches, strokes less than 50,
neuromuscular disorders, dementia or movement disorders.
Physical Exam:
Physical Exam on admission:
Vitals: T:97.6 P:73 R:16 BP:116/63 SaO2:99% RA
General: Awake, cooperative, appears anxious and tremulous.
HEENT: NC/AT, ___ scleral icterus noted, MMM, ___ lesions noted in
oropharynx. ___ evidence of tongue bites.
Neck: Supple, ___ carotid bruits appreciated. ___ nuchal rigidity.
Full range of motion.
Pulmonary: Lungs CTA bilaterally without R/R/W
Cardiac: RRR, nl. S1S2, ___ M/R/G noted
Abdomen: soft, slight suprapubic tenderness, ND, normoactive
bowel sounds, ___ masses or organomegaly noted.
Extremities: ___ C/C/E bilaterally, 2+ radial, DP pulses
bilaterally. Calves SNT bilaterally.
Skin: ___ rashes or lesions noted ave old tattoos.
Neurological examination:
- Mental Status:
ORIENTATION - Alert, oriented x 4
The pt. had good knowledge of current events.
SPEECH
Able to relate history without difficulty.
Language is fluent with intact repetition and comprehension.
Normal prosody. There were ___ paraphasic errors.
Speech was not dysarthric.
NAMING Pt. was able to name both high and low frequency objects.
READING - Able to read without difficulty
ATTENTION - Attentive, able to name ___ backward without
difficulty.
REGISTRATION and RECALL
Pt. was able to register 3 objects and recall ___ at 5 minutes.
COMPREHENSION
Able to follow both midline and appendicular commands
There was ___ evidence of apraxia or neglect but had soe initial
confusion regarding sides but was normal.
- Cranial Nerves:
I: Olfaction not tested.
II: PERRL 6.5 to 4mm and brisk. VFF to confrontation.
Funduscopic
exam reveals ___ papilledema, exudates, or hemorrhages.
III, IV, VI: EOMI with bilateral endgaze nystagmus. Normal
pursuits and saccades.
V: Facial sensation intact to light touch. Good power in muscles
of mastication.
VII: ___ facial weakness, facial musculature symmetric although
he
speaks out of the left side of his mouth more and states this is
chronic with a logstanding "twisted lip".
VIII: Hearing intact to finger-rub on left and absent
chronically
on the right.
IX, X: Palate elevates symmetrically.
XI: ___ strength in trapezii and SCM bilaterally.
XII: Tongue protrudes in midline with normal velocity movements.
- Motor: Normal bulk, tone throughout. ___ pronator drift
bilaterally.
Bilateral postural tremor noted. ___ asterixis noted.
SAb SAdd ElF ElE WrE FFl FE IO HipF HipE KnF KnE AnkD ___
L 5 5 ___ ___ 5 ___ ___
R 5 5 ___ ___ 5 ___ ___
- Sensory: ___ deficits to light touch, pinprick, cold sensation,
vibratory sense, proprioception throughout in UE and ___ save
decreasd sensation to temperature and pinptick in the left
lateral calf and decreased vibration in the left great toe . ___
extinction to DSS.
- DTRs:
BJ SJ TJ KJ AJ
L ___ 2 1
R ___ 2 1
There was ___ evidence of clonus.
___ negative.
Plantar response was flexor bilaterally.
- CoordinationSlight bilateral action tremor, normal finger
tapping. ___ dysdiadochokinesia noted. ___ dysmetria on FNF or HKS
bilaterally.
- Gait:
Gait was stable on standing and Romberg testing without sway but
very unstable when walking.
EXAM ON DISCHARGE:
T 98.7 BP 107/65 (lying) -> 114/62 (standing) HR 52 (lying) ->
92 (standing) RR 18 O2sat 100%
Gen: NAD, comfortable
Resp: nonlabored
MS: alert, oriented, conversing appropriately
Pertinent Results:
Laboratory Data:
Bloods:
139 99 12 72 AGap=16
------------<
4.2 28 1.0
Ca: 9.2 Mg: 2.1 P: 4.0
ALT: 23 AP: 60 Tbili: 0.5 Alb: 4.6
AST: 38 LDH: Dbili: TProt:
___: Lip:
Comments: ALT: Hemolysis Falsely Elevates Alt
AST: Hemolysis Falsely Elevates Ast.
Serum ASA, EtOH, Acetmnphn, Benzo, Barb, Tricyc Negative
98
7.6 14.1 203
40.8
N:52.2 L:41.6 M:4.2 E:1.0 Bas:0.9
Urine:
UA negative
Urine Benzos, Barbs, Opiates, Cocaine, Amphet, Mthdne Negative
Benzodiazepine
EKG ___
Sinus bradycardia. A-V conduction delay. Voltage may be
appropriate for age.
___ previous tracing available for comparison.
TRACING #1
Read by: ___
___ Axes
Rate PR QRS QT/QTc P QRS T
52 226 92 436/422 44 70 21
CXR ___
FINDINGS: The lungs are clear. There is ___ pleural effusion,
pneumothorax or
focal airspace consolidation. The cardiac and mediastinal
contours are
normal. The hilar structures are unremarkable.
IMPRESSION: Normal chest radiograph.
CT Head ___
FINDINGS: There is ___ evidence of hemorrhage, edema, mass, mass
effect, or
large vascular territory infarction. The ventricles and sulci
are normal in
size and configuration. The basal cisterns are patent. There
is preservation
of gray-white matter differentiation. ___ fracture is
identified. The
visualized paranasal sinuses and mastoid air cells are clear.
Cerumen is
incidentally noted in the bilateral middle ear canals. The soft
tissues are
unremarkable.
IMPRESSION: ___ acute intracranial abnormality.
TTE ___
Echocardiographic Measurements
Results Measurements Normal Range
Left Atrium - Long Axis Dimension: 3.3 cm <= 4.0 cm
Left Atrium - Four Chamber Length: *5.5 cm <= 5.2 cm
Left Atrium - Peak Pulm Vein S: 0.5 m/s
Left Atrium - Peak Pulm Vein D: 0.5 m/s
Left Atrium - Peak Pulm Vein A: *0.4 m/s < 0.4 m/s
Right Atrium - Four Chamber Length: 4.8 cm <= 5.0 cm
Left Ventricle - Septal Wall Thickness: 0.9 cm 0.6 - 1.1 cm
Left Ventricle - Inferolateral Thickness: 0.9 cm 0.6 - 1.1 cm
Left Ventricle - Diastolic Dimension: 4.5 cm <= 5.6 cm
Left Ventricle - Systolic Dimension: 2.4 cm
Left Ventricle - Fractional Shortening: 0.47 >= 0.29
Left Ventricle - Ejection Fraction: 60% to 65% >= 55%
Left Ventricle - Lateral Peak E': 0.16 m/s > 0.08 m/s
Left Ventricle - Septal Peak E': 0.10 m/s > 0.08 m/s
Left Ventricle - Ratio E/E': 8 < 15
Aorta - Sinus Level: 3.3 cm <= 3.6 cm
Aorta - Ascending: 2.8 cm <= 3.4 cm
Aorta - Arch: 2.3 cm <= 3.0 cm
Aortic Valve - Peak Velocity: 1.3 m/sec <= 2.0 m/sec
Mitral Valve - E Wave: 1.0 m/sec
Mitral Valve - A Wave: 0.6 m/sec
Mitral Valve - E/A ratio: 1.67
TR Gradient (+ RA = PASP): 15 mm Hg <= 25 mm Hg
Findings
LEFT ATRIUM: Elongated LA.
RIGHT ATRIUM/INTERATRIAL SEPTUM: Normal RA size. ___ ASD by 2D or
color Doppler. Normal IVC diameter (<=2.1cm) with >50% decrease
with sniff (estimated RA pressure ___ mmHg).
LEFT VENTRICLE: Normal LV wall thickness, cavity size and
regional/global systolic function (LVEF >55%). TDI E/e' < 8,
suggesting normal PCWP (<12mmHg). ___ resting or Valsalva
inducible LVOT gradient.
RIGHT VENTRICLE: Normal RV chamber size and free wall motion.
AORTA: Normal diameter of aorta at the sinus, ascending and arch
levels. ___ 2D or Doppler evidence of distal arch coarctation.
AORTIC VALVE: Mildly thickened aortic valve leaflets (3). ___ AS.
___ AR.
MITRAL VALVE: Normal mitral valve leaflets with trivial MR. ___
MVP.
TRICUSPID VALVE: Normal tricuspid valve leaflets with trivial
TR. Normal PA systolic pressure.
PULMONIC VALVE/PULMONARY ARTERY: Normal pulmonic valve leaflet.
___ PS. Physiologic PR.
PERICARDIUM: ___ pericardial effusion.
Conclusions
The left atrium is elongated. ___ atrial septal defect is seen by
2D or color Doppler. The estimated right atrial pressure is ___
mmHg. Left ventricular wall thickness, cavity size and
regional/global systolic function are normal (LVEF >55%). Tissue
Doppler imaging suggests a normal left ventricular filling
pressure (PCWP<12mmHg). There is ___ left ventricular outflow
obstruction at rest or with Valsalva. Right ventricular chamber
size and free wall motion are normal. The diameters of aorta at
the sinus, ascending and arch levels are normal. The aortic
valve leaflets (3) are mildly thickened. There is ___ aortic
valve stenosis. ___ aortic regurgitation is seen. The mitral
valve appears structurally normal with trivial mitral
regurgitation. There is ___ mitral valve prolapse. The estimated
pulmonary artery systolic pressure is normal. There is ___
pericardial effusion.
IMPRESSION: Normal biventricular size and function. ___
clinically significant valvular disease is seen. ___ prior exams
for comparison.
Brief Hospital Course:
ASSESSMENT:
___ with a PMH of a significant head injury with loss of
consciousness < age ___, a febrile seizure age ___ and
functional dysphagia on swallow assessment in ___, who
presented
from neurology clinic after several non-stereotyped episodes of
possible seizures, with escalating frequency despite increasing
doses of AEDs.
The patient has had multiple episodes with varying semiologies
including staring, convulsion-like and a prolonged episode of
mutism
with varying degrees of awareness and ___ clear post-ictal
period.
He has also had significant escalation of symptoms despite a
significant dose of anti-convulsant. He has ___ clear post-ictal
period and given significant anxiety, previous functional
symptoms and significant stress at least some of these events
may well be non-epileptic in nature. He was admitted to the
epilepsy service for EEG LTM and medication adjustment.
On examination, orthostatic hypotension was documented on a
couple of occasions. On neuro exam, pt had a slight bilateral
postural tremor and
mental status was normal apart from significant anxiety. CN
examination revealed bilateral endgaze nystagmus and chronic
right decreased hearing and he speaks out of the left side of
his mouth more although face on examination is symmetric and
states this is chronic with a longstanding "twisted lip". Gait
was
stable on standing and Romberg testing without sway but very
unstable when walking.
Several of pt's episodes of unresponsiveness and body stiffening
were observed by MDs and captured on video EEG. There was ___ EEG
change with any of those movements, also ___ significant changes
on telemetry except for occasional mild sinus tachycardia.
Interictal EEG was also completely benign without epileptiform
discharges. When interviewed after one of those events, pt
admitted to dissociative features, i.e., being "sort of
conscious" during the event but "in a far away place"; he knew
who had been in the room and what they had said to him.
Therefore, a diagnosis of psychogenic nonepileptic seizures is
most appropriate for these events. Levetiracetam was weaned off
during this admission, and at this point, we do not see any
indication for antiepileptics. Pt was counseled extensively
about physical manifestations of stress, and the need to get
help to reduce his stress level, e.g., through therapy or
relaxation techniques. He seemed receptive to this message. He
also met extensively with social work. The diagnosis of PNES was
communicated to pt's neurologist, Dr. ___ she ___ have
close follow-up with him. Pt also indicated that he will make an
appointment with his therapist to discuss.
Unrelated to the above episodes of unresponsiveness, pt had a
couple of witnessed syncopal events, and had orthostatism
documented on a couple of occasions. He had a benign cardiac
exem and telemetry. EKG only showed mildly bradycardic sinus
arrhythmia with borderline ___ AV block and early
repolarization changes, within normal limits for a young
athlete. TTE was benign. Pt was evaluated by cardiology, who
concurred that a diagnosis of vasovagal syncope is most
appropriate. After discussion with his PCP ___ was
provided with support stockings and a trial of midodrine 5 mg
BID. Pt will f/u with Dr. ___ week.
Pt was evaluated by ___, and was deemed safe for discharge home,
with a planned home safety evaluation. He was given education
about syncope precautions.
Pt expressed the desire to stop his other medications
(clonazepam and citalopram) as he didn't think they were
helping, so these were held during the admission.
Medications on Admission:
Medications:
Keppra 1500mg bid
Clonaxepa,m 0.5mg bid
Citaloram 20mg HS
Diazepam PR PRN
Discharge Medications:
1. Midodrine 5 mg PO BID
RX *midodrine 5 mg 1 tablet(s) by mouth twice daily Disp #*60
Tablet Refills:*0
2. Outpatient Physical Therapy
Discharge Disposition:
Home With Service
Facility:
___
___ Diagnosis:
1: Vaso-vagal syncope
2: Stress reaction/ non-epileptic events.
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
You were admitted to the hospital for characterization of
episodes of sudden unresponsiveness and shaking. We discovered
that your events are of two different types: on the one hand,
you have fainting spells that are caused by an overactive
autonomic nervous system; this is a common problem that many
young people have; on the other hand, you have episodes of
unresponsiveness that are stress reactions. Some other terms
that people use for these events are PNES (psychogenic
non-epileptic seizures) or pseudoseizures. Fortunately, your
events do not have any brain wave changes on the EEG, and thus
they are not epileptic seizures. You do not need to take a
seizure medication.
We discussed your two problems with your PCP, ___, and
with your neurologist, Dr. ___. Dr. ___
trying a medication called midodrine to keep your blood pressure
up in order to keep him from fainting. You should try to avoid
situations that can provoke fainting, such as prolonged standing
or running in the heat, hot showers, and dehydration. She would
like you to call her office to schedule a follow up next week.
Dr. ___ also like you to call her office to schedule
follow up next week.
Please also call ___ to schedule an appointment with
Mrs. ___, your therapist. We recommend that you work with her
on relaxation techniques and lifestyle changes that can diminish
your stress level.
Your only new medication is midodrine. We stopped the
levetiracetam (Keppra) seizure medication because we do not
think you need it. At your request, we also stopped the
citalopram (Celexa) and clonazepam (Klonopin).
It was a pleasure taking care of you in the hospital.
Followup Instructions:
___
|
10820044-DS-7
| 10,820,044 | 25,001,669 |
DS
| 7 |
2171-08-22 00:00:00
|
2171-08-22 15:43:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Shortness of breath
Major Surgical or Invasive Procedure:
PCI with 1 DES placed to RCA (___)
History of Present Illness:
Mrs. ___ is a ___ year-old
woman with a history of hypertension, hyperlipidemia, current
smoker, and atrial fibrillation (on apixaban) who presented to
the ED with acute onset shortness of breath.
She says that at about 3 am she had sudden onset shortness on
breath upon waking and presented to ___ for evaluation.
She was also complaining of some vague symptoms, feeling
somewhat
strange but is unable to specify specific symptoms.
Patient reports that she exercises 2x week, usually on the bike,
and has not experienced recent chest pain or abnormal shortness
of breath while exercising. She has noticed over the last two
weeks that her heart rates on the bike will get up to the 170s
whereas prior to that her max rate would be ___.
She notably denied any new palpitations, lightheadedness, chest
discomfort, orthopnea, peripheral edema, or PND. She has a
chronic cough but no fever or chills (although notes she did
have
a temperature to 100.3 at ___. She reports that she had PFTs
several years ago and was not diagnosed with COPD. Her chronic
cough is productive of sputum at baseline but there has been no
increased sputum or change in color. No recent immobilization,
surgeries, travel, or unilateral leg swelling. About 1 month ago
she did have some intermittent palpitations that lasted about 1
minute and improved with diltiazem and metoprolol. She has been
on metoprolol for several years and the diltiazem was added
about
one month ago.
At ___ her CXR demonstrated atypical right sided vascular
congestion with an elevated troponin of 0.13. She was also noted
to be in atrial fibrillation with a new left bundle branch
block.
She got aspirin, Lasix 20 IV, started on heparin drip.
Past Medical History:
- Atrial fibrillation
- Hypertension
- Hyperlipidemia
- Peripheral Vascular disease
- Tobacco use disorder
- Anxiety
- R colectomy due to cecal volvulus
- R nephrectomy due to malignancy
- Partial hip replacement
- Chronic low back pain
Social History:
___
Family History:
Positive family history for CAD; her mother had
CAD, but died in her ___. No history of DM. Brother has AF.
Physical Exam:
ADMISSION EXAM:
VS: ___ 1711 Temp: 98.2 PO BP: 140/79 HR: 122 RR: 20 O2
sat: 96% O2 delivery: ra Dyspnea: 3 RASS: 0 Pain Score: ___
GENERAL: No acute distress, sitting up in bed
HEENT: Sclera anicteric. PERRL. EOMI. Conjunctiva were pink. No
pallor or cyanosis of the oral mucosa. No xanthelasma.
NECK: Supple. No JVD.
CARDIAC: Tachycardic. Irregular. No murmurs, rubs, or gallops.
no thrills or lifts.
LUNGS: No chest wall deformities or tenderness. Mildly
increased
work of breathing. Bibasilar crackles. No wheezes.
ABDOMEN: Soft, non-tender, non-distended. No hepatomegaly. No
splenomegaly. Vertical incision scar in the mid abdomen.
EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or
peripheral edema.
SKIN: No significant skin lesions or rashes.
PULSES: Peripheral pulses not palpable.
DISCHARGE EXAM:
Temp: 97.7 (Tm 98.8), BP: 115/70 (90-148/60-81), HR: 71
(58-107),
RR: 16 (___), O2 sat: 96% (82-100), O2 delivery: RA
HEENT: JVP not elevated
Lungs: Normal work of breathing. Decreased breath sounds at
bases
b/l. No wheezing, rales or ronchi
CV: Tachycardia, irregular, no m/r/g
Abdomen: Soft, ND. Non-tender to palpation throughout
Ext: Trace pitting edema bilaterally. DP pulses 2+ and equal b/l
Pertinent Results:
ADMISSION LABS:
___ 07:58AM BLOOD WBC-15.0* RBC-3.98 Hgb-12.9 Hct-39.1
MCV-98 MCH-32.4* MCHC-33.0 RDW-13.3 RDWSD-48.1* Plt ___
___ 07:50AM BLOOD ___ PTT-143.5* ___
___ 07:58AM BLOOD Glucose-144* UreaN-15 Creat-1.1 Na-145
K-4.8 Cl-102 HCO3-22 AnGap-21*
___ 05:45AM BLOOD ALT-18 AST-37 AlkPhos-90 TotBili-1.0
___ 07:58AM BLOOD cTropnT-0.16* proBNP-6871*
___ 05:45AM BLOOD Calcium-10.0 Phos-2.9 Mg-2.1
DISCHARGE LABS:
___ 08:45AM BLOOD WBC-9.4 RBC-4.12 Hgb-13.4 Hct-41.7
MCV-101* MCH-32.5* MCHC-32.1 RDW-13.3 RDWSD-49.6* Plt ___
___ 08:45AM BLOOD ___
___ 08:45AM BLOOD Glucose-96 UreaN-20 Creat-0.9 Na-142
K-5.1 Cl-107 HCO3-18* AnGap-17
___ 08:45AM BLOOD Phos-3.4 Mg-2.0
STUDIES:
___ EKG: NSR, normal intervals, no ischemic ST changes
changes or TWIs
___ EKG: Afib with new LBBB, negative Sgarbossa
Nuclear Stress Test ___:
FINDINGS: Left ventricular cavity size is normal, with an
end-diastolic volume of 82 mL. Rest and stress perfusion images
reveal a moderate, partially reversible inferolateral defect.
Gated images reveal global hypokinesis. The calculated left
ventricular ejection fraction is 48%.
IMPRESSION: 1. Moderate, partially reversible inferolateral
defect. 2. Low ejection fraction calculated at 48% and global
hypokinesis.
TTE ___:
EF 54%. IMPRESSION: Suboptimal image quality.Normal left
ventricular cavity size with mild regional
systolic dysfunction most consistent with single vessel coronary
artery disease (PDA distribution). Mild pulmonary artery
systolic hypertension. Mild mitral regurgitation.
Coronary Angiogram ___:
The coronary circulation is right dominant. Heavily calcified
vessels.
LM: The Left Main, arising from the left cusp, is a large
caliber vessel and is normal. This vessel bifurcates into the
Left Anterior Descending and Left Circumflex systems.
LAD: The Left Anterior Descending artery, which arises from the
LM, is a large caliber vessel. There is a 30% stenosis in the
proximal and mid segments. The ___ Diagonal, arising from the
proximal segment, is a small caliber vessel. The Septal
Perforator, arising from the proximal segment, is a small
caliber vessel. The ___ Diagonal, arising from the mid segment,
is a medium caliber vessel. There is a 50% stenosis in
the proximal segment.
Cx: The Circumflex artery, which arises from the LM, is a large
caliber vessel. There is a 60% eccentric and stenosis in the
ostium and proximal segment. The Obtuse Marginal, arising from
the proximal segment, is a medium caliber vessel. The Inferior
lateral of the OM, arising from the proximal segment, is a
medium caliber vessel.
RCA: The Right Coronary Artery, arising from the right cusp, is
a large caliber vessel. There is a 50% stenosis in the proximal
segment. There is a 90% stenosis in the distal segment extneding
into the
posterolateral segment. The Acute Marginal, arising from the
proximal segment, is a small caliber vessel. The Right Posterior
Descending Artery, arising from the distal segment, is a medium
caliber vessel.
There is a 70% stenosis in the proximal segment. The Right
Posterolateral segment, arising from the distal segment, is a
medium caliber vessel. There is a 90% stenosis in the ostium.
The Inferior lateral of the RV, arising from the mid segment, is
a medium caliber vessel.
Brief Hospital Course:
Mrs. ___ is a ___ year old woman with a history of atrial
fibrillation (previously on apixaban) who presented to the ED
with acute onset shortness of breath presenting with an NSTEMI,
HFpEF exacerbation and Afib with RVR. Found to have new
basal-inferior hypokinesis on echo, and reversible inferolateral
defect on
stress test. She had PCI with DES to distal RCA.
TRANSITIONAL ISSUES:
[] This patient is being discharged on dual antiplatelet therapy
AND anticoagulation (for atrial fibrillation). Please monitor
for bleeding.
[] Please discontinue aspirin in one month (___)
[] Pt had stent placed and MUST CONTINE PLAVIX. DO NOT
DISCONTINUE THIS MEDICATION WITHOUT TALKING TO A CARDIOLOGIST.
[] This pt would benefit from ___ if blood pressures can
tolerate.
[] Pt presented in acute heart failure, please continue to
monitor volume status.
[] Pt will need repeat TTE in ___ months to evaluate EF.
[] PLEASE ENCOURAGE SMOKING CESSATION
[] DISCHARGE WEIGHT 59.8 kg(131.83 lb)
[] DISCHARGE CREATININE 0.9
ACUTE ISSUES:
#NSTEMI
On presentation, patient reported acute shortness of breath with
no chest pain. Troponin peaked at 0.16 and EKG showed new LBBB
block. She had an echocardiogram which showed new basal-inferior
hypokinesis and EF 54%. Pharmacologic nuclear stress test showed
a reversible inferolateral defect. PCI (___) was performed and
showed two vessel disease (LCx and RCA) with a drug eluting
stent placed to distal RCA. She is now on triple therapy with
ASA, clopidogrel and rivaroxaban (for atrial fibrillation). ASA
can be discontinued in 1 month. Please continue clopidogrel for
___ year.
#Afib with RVR
Patient initially presented with Afib and rates as high as
150bpm. She did not experience palpitations or chest pain but
felt "off". She converted to normal sinus rhythm on metoprolol
and diltiazem. Sotalol was started once she was in sinus rhythm,
but then discontinued due to prolonged Qtc >500ms. We continued
metoprolol and diltiazem for rate control and felt that she does
not require antiarrhythmic control for now since the Afib with
RVR was likely due to a new ischemic event as above. She
remained in sinus rhythm on those two rate control agents and
anticoagulation was changed from apixiban to rivaroxaban 20mg
for anticoagulation due to stent placement.
#HFpEF with newly reduced EF
Patient initially presented with volume overload and was
diuresed with IV Lasix 20mg. Echo in ___ was notable for
preserved EF and echo on this admission showed newly reduced to
EF ___ in the setting of new ischemic event as above. She
required minimal diuresis and dry weight at discharge was 59.8
kg (131.83 lb) with Cr of 0.9. She did not require oral
maintenance diuresis while inpatient.
CHRONIC ISSUES:
#Smoking Cessation
Continued nicotine patch daily
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. LORazepam 0.5 mg PO BID:PRN anxiety
2. TraMADol 50-100 mg PO Q4H:PRN Pain - Moderate
3. Gabapentin 400 mg PO TID
4. Apixaban 5 mg PO BID
5. Metoprolol Tartrate 50 mg PO BID
6. magnesium hydroxide 200 mg oral DAILY
7. Simvastatin 20 mg PO QPM
8. Diltiazem Extended-Release 240 mg PO DAILY
9. minoxidil 5 % topical BID
10. Aspirin 81 mg PO DAILY
11. FoLIC Acid 0.4 mg PO DAILY
12. Vitamin D 4000 UNIT PO DAILY
13. Timolol Maleate 0.5% 1 DROP BOTH EYES BID
14. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS
Discharge Medications:
1. Atorvastatin 80 mg PO QPM
RX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30
Tablet Refills:*0
2. Clopidogrel 75 mg PO DAILY
DO NOT STOP TAKING THIS MEDICATION.
RX *clopidogrel 75 mg 1 tablet(s) by mouth daily Disp #*30
Tablet Refills:*3
3. Metoprolol Succinate XL 100 mg PO DAILY
RX *metoprolol succinate 100 mg 1 tablet(s) by mouth daily Disp
#*30 Tablet Refills:*0
4. Nicotine Patch 21 mg/day TD DAILY
RX *nicotine 21 mg/24 hour apply one patch daily Disp #*28 Each
Refills:*0
5. Rivaroxaban 20 mg PO DINNER
RX *rivaroxaban [___] 20 mg 1 tablet(s) by mouth daily Disp
#*30 Tablet Refills:*0
6. Aspirin 81 mg PO DAILY
7. Diltiazem Extended-Release 240 mg PO DAILY
8. FoLIC Acid 0.4 mg PO DAILY
9. Gabapentin 400 mg PO TID
10. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS
11. LORazepam 0.5 mg PO BID:PRN anxiety
12. magnesium hydroxide 200 mg oral DAILY
13. minoxidil 5 % topical BID
14. Timolol Maleate 0.5% 1 DROP BOTH EYES BID
15. TraMADol 50-100 mg PO Q4H:PRN Pain - Moderate
16. Vitamin D 4000 UNIT PO DAILY
17.Outpatient Physical Therapy
cardiac rehab
410.71
18.Outpatient Physical Therapy
cardiac rehab
410.71
Discharge Disposition:
Home
Discharge Diagnosis:
Primary diagnosis:
NSTEMI
Secondary diagnosis:
Atrial Ribrillation with RVR
Acute Diastolic Heart Failure
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear ___,
___ was a pleasure taking care of you at the ___
___!
- You were admitted to the hospital because you had shortness of
breath.
- You were found to have had a heart attack. Your heart arteries
were examined (cardiac catheterization) which showed a blockage
of one of the arteries. This was opened by placing a tube called
a stent in the artery.
- You were given medications to prevent future blockages.
WHAT SHOULD YOU DO WHEN YOU GO HOME?
- It is very important to take your aspirin and clopidogrel
(also known as Plavix) every day.
- These two medications keep the stents in the vessels of the
heart open and help reduce your risk of having a future heart
attack.
- If you stop these medications or miss ___ dose, you risk causing
a blood clot forming in your heart stents and having another
heart attack
- You were also on a blood thinner called Apixaban to help
prevent a stroke, due to atrial fibrillation. We changed this
blood thinner to one called Rivaroxaban (Xarelto) because this
is more suitable in patients who have had a stent.
Thank you for allowing us to be involved in your care, we wish
you all the best!
Your ___ Healthcare Team
Followup Instructions:
___
|
10820114-DS-13
| 10,820,114 | 24,563,575 |
DS
| 13 |
2197-09-08 00:00:00
|
2197-09-10 09:51:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Sulfa (Sulfonamide Antibiotics) / Lisinopril
Attending: ___
Chief Complaint:
fever
Major Surgical or Invasive Procedure:
Fluoro-guided lumbar puncture
History of Present Illness:
Pt with Stage IV Follicular Lymphoma and prostate CA treated
with one cycle of Bendamustine and Rituxan (R on ___ who
presents to the ER with fever to 103 and rigors.
The patient reports having a cough after his first dose of
Bendamustine on ___ which was productive of white sputum. CXR
___ was negative for acute process, and his cough has resolved
without any therapy. The patient was supposed to have his
second cycle of chemotherapy on ___ (by his report), but was
dehydrated; he was given IVF in clinic as well as Ceftriaxone 1g
IV for presumed UTI. He also received his first dose of
Rituxan. He was discharged on Cipro 500mg PO BID for 14 days;
UA since that time shows no evidence of infection. The patient
is not the best historian, but reports feeling "just awful" for
the past few days. He denies any dysuria, diarrhea, pain,
cough, sick contacts, or focal symptoms concerning for a focus
of infection. He does not have a port. His temperature on the
evening of ___ was elevated and the next day reached a max of
103.4. He states that he has neck and head soreness that
accompanied his cough but this has since subsided.
.
Vitals in the ER: 99.8 106 131/61 16 95% RA
Pt received Cefepime 2g IV, Tylenol ___ PO, and 2L IVF.
.
REVIEW OF SYSTEMS:
(+) Per HPI; constipation
(-) Denies recent weight loss or gain. Denies headache,
rhinorrhea or congestion. Denies cough, shortness of breath, or
wheezing. Denies chest pain, chest pressure, or weakness. Denies
nausea, vomiting, diarrhea, abdominal pain. Denies dysuria,
arthralgias or myalgias. Denies rashes or skin changes. All
other ROS negative
.
Past Medical History:
ONCOLOGIC HISTORY
Mr. ___ is a ___
gentleman with a history of newly diagnosed follicular lymphoma
with bulky lymphadenopathy, both above and below the diaphragm.
Did have a PET scan on ___, which revealed extensive
disease with bulky lymphadenopathy above and below the diaphragm
as well as some splenomegaly and osseous involvement. Also,
upon
initial presentation, he did have a question of some muscle
wasting, fatigue and sweat. His oncologist then had decided to
monitor him
off treatment with plan for repeat PET scan in approximately a
month from his prior one. However, the patient called two weeks
ago to report new/worsening pain in left shoulder, chest and
axilla region. They repeated a CT scan of his torso, which
revealed some further progression of his disease and also the
patient reported feeling somewhat more fatigued with some
worsening night sweats as well as some ongoing poor appetite and
it was decided that they would initiate treatment. He did have
a
bone marrow biopsy as part of staging of his disease, which
revealed extensive involvement of his lymphoma.
- ___ C1 D1 Bendamustine
- Rituxan ___
Past Medical History:
1. Gout.
2. Hypertension.
3. Obstructive sleep apnea.
4. Hx. Supraventricular tachycardia.
5. Prostate cancer.
6. CKD
7. Diastolic Dysfunction
Past Surgical History:
1. Procedure on his right elbow.
2. Procedure on his left knee.
Social History:
___
Family History:
His older brother had ___ lymphoma and
his younger brother had colon cancer.
Physical Exam:
Vitals: T98.2 bp 132/70 HR 81 RR 18 SaO2 96 RA
GEN: NAD, awake, alert
HEENT: supple neck, dry mucous membranes, no oropharyngeal
lesions; eyes have puffy appearance which is chronic, heridetary
PULM: normal effort, CTAB
CV: RRR, no r/m/g/heaves
ABD: soft, NT, ND, bowel sounds present
EXT: normal perfusion
SKIN: warm, dry
NEURO: AOx3, no focal sensory or motor deficits
PSYCH: flat affect, cooperative
Vital signs stable, afebrile
Pertinent Results:
ADMIT LABS:
--------------------
___ 09:30PM LACTATE-1.0
___ 09:26PM GLUCOSE-122* UREA N-14 CREAT-1.4* SODIUM-134
POTASSIUM-4.0 CHLORIDE-100 TOTAL CO2-24 ANION GAP-14
___ 09:26PM WBC-5.1 RBC-3.85* HGB-11.0* HCT-33.4* MCV-87
MCH-28.5 MCHC-32.9 RDW-14.6
___ 09:26PM NEUTS-65 BANDS-2 ___ MONOS-7 EOS-2
BASOS-0 ATYPS-3* METAS-1* MYELOS-0
___ 09:26PM HYPOCHROM-NORMAL ANISOCYT-NORMAL
POIKILOCY-NORMAL MACROCYT-NORMAL MICROCYT-NORMAL
POLYCHROM-NORMAL
___ 09:26PM PLT SMR-LOW PLT COUNT-81*
___ 09:26PM ___ PTT-29.5 ___
___ 09:10PM URINE COLOR-Yellow APPEAR-Clear SP ___
___ 09:10PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-30
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5
LEUK-NEG
___ 09:10PM URINE RBC-5* WBC-1 BACTERIA-NONE YEAST-NONE
EPI-0
___ 09:10PM URINE HYALINE-28*
___ 09:10PM URINE MUCOUS-MANY
.
DISCHARGE LABS:
------------------
___ 10:15AM BLOOD WBC-2.1* RBC-2.78* Hgb-7.7* Hct-24.4*
MCV-88 MCH-27.8 MCHC-31.7 RDW-14.7 Plt ___
___ 10:15AM BLOOD Neuts-66.4 ___ Monos-8.7 Eos-1.9
Baso-0.1
___ 10:15AM BLOOD Plt ___
___ 10:15AM BLOOD ___ PTT-33.2 ___
___ 10:15AM BLOOD Glucose-162* UreaN-11 Creat-1.1 Na-137
K-3.9 Cl-105 HCO3-25 AnGap-11
___ 10:15AM BLOOD ALT-50* AST-25 LD(LDH)-119 AlkPhos-85
TotBili-0.4
___ 10:15AM BLOOD Albumin-3.0* Calcium-8.6 Phos-2.6* Mg-2.0
.
MICRO:
___ B D Glucan NEGATIVE
___ Galactomannan NEGATIVE
___ and ___ Adenovirus PCR NEGATIVE
___ Mycoplasma pneumo IgG POSITIVE, IgM NEGATIVE
___ EBV NEGATIVE
CSF:
___
CMV, EBV, HSV negative
___ 11:00AM CEREBROSPINAL FLUID (CSF) WBC-9 RBC-4400*
Polys-36 ___ Monos-15 Eos-1
___ 11:00AM CEREBROSPINAL FLUID (CSF) WBC-4 RBC-5725*
Polys-44 ___ Monos-15 Eos-1
___ 11:00AM CEREBROSPINAL FLUID (CSF) TotProt-56*
Glucose-70
.
IMAGING:
CXR - no acute intrathoracic process
.
___ CT CHEST:
IMPRESSION:
1. No obvious evidence of active infectious or inflammatory
process in the neck or chest. No evidence of pneumonia.
2. Significant decrease in size of bilateral axillary lymph
nodes which no longer meet CT size criteria for pathological
enlargement. Interval increase in the degree of minimal fat
stranding surrounding lymph nodes likely represents
post-treatment change.
3. A single focus of minimally enlarged lymph nodes in the IIb
cervical
station on the right with minimal fat stranding, also likely
represents
post-treatment change given the morphologic similarity to the
changes in the axillary lymph nodes.
.
___. No obvious evidence of active infectious or inflammatory
process in the neck or chest. No evidence of pneumonia.
2. Significant decrease in size of bilateral axillary lymph
nodes which no longer meet CT size criteria for pathological
enlargement. Interval increase in the degree of minimal fat
stranding surrounding lymph nodes likely represents
post-treatment change.
3. A single focus of minimally enlarged lymph nodes in the IIb
cervical
station on the right with minimal fat stranding, also likely
represents
post-treatment change given the morphologic similarity to the
changes in the axillary lymph nodes.
.
___ CHEST
IMPRESSION: Small bilateral pleural effusions with bibasilar
consolidations concerning for pulmonary edema or pneumonia.
.
___ ___
No evidence of deep vein thrombosis in the right lower
extremity.
___
CT ABD PELVIS
1. No acute intra-abdominal pathology identified.
2. Interval development of new small bilateral pleural
effusions with
associated subsegmental atelectasis. For further details of the
chest, please refer to dedicated report of CT chest done same
day.
3. Slight interval improvement in retroperitoneal, periportal
and inguinal lymphadenopathy.
4. Other chronic findings such as mild splenomegaly as above.
.
___ CT CHEST
IMPRESSION:
1. Small bilateral pleural effusions and residual dependent
pulmonary edema, new since ___.
2. No evidence of intrathoracic infection.
3. No central adenopathy. Left axillary adenopathy improved
since ___.
4. Probable anemia.
.
___ CT HEAD
1. No evidence of acute intracranial abnormalities.
2. Moderate diffuse ventricular enlargement, out of proportion
of sulcal
enlargement. This could reflect cerebral atrophy with central
predominance. Alternatively, this could reflect communicating
hydrocephalus. If subependymal lymphomatous involvement or
other intracranial lymphomatous involvement is highly suspected,
then further evaluation would be best performed by MRI. MRI
would also be more sensitive for intracranial infection.
3. 6 x 4 mm sclerotic lesion in the outer table of the left
parietal bone at the vertex most likely represents an osteoma.
Given the history of lymphoma, follow-up could be obtained to
assess stability.
.
___ CT SINUS
1. A single right middle ethmoid air cell contains mild
aerosolized
secretions, which is in the absence of associated fluid is a
nonspecific
finding with regard to the possibility of acute sinusitis. No
fluid in the
paranasal sinuses to clearly suggest acute sinusitis.
2. Mild mucosal thickening in the paranasal sinuses indicates
mild chronic
inflammation.
.
___ MR HEAD
No evidence of mass, mass effect or abnormally enhancing
lesions.
.
Brief Hospital Course:
___ with PMH HTN, h/o SVT, stage IV follicular lymphoma and
prostate CA presents wtih fevers to 102 for 2 days and neck pain
with cough.
.
#Fever and rigors - Pt presented with fevers to 102-103, and
with headache, neck pain, drenching nightsweats and poor PO
intake. Extensive infectious work-up was undertaken for
bacterial, viral, and fungal causes without any positive tests.
Headache/neck pain was not thought to be meningitis, as pt was
tender on lateral posterior neck and tender on scalp in
occipital area, without any visual disturbances. Pt was
empirically treated with vanc/unasyn, evetually on
vanc/zosyn/levofloxacin/tamiflu. Pt underwent extensive imaging
including CT head, neck, chest, abd, pelvis which were only
notable for ventriculomegaly in head. Subsequent MRI was
negative for acute hydrocephalus or other evidenec of acute
disease. As culture data returned, vanc/zosyn/tamiflu were
stopped. Pt underwent LP, for ? lymphoma in brain without any
abnormalities concerning for infection or lymphoma. Pt seemed to
defervesce spontaneously. At discharge, it is thought that pt
likely had a viral infection, which caused his illness.
.
In the setting of getting IVF for fevers and poor PO intake, pt
developed some pulm edema requiring O2, but was given 40iv lasix
with complete resolution of O2 requirement.
.
# Pancytopenia: Pt's pancytopenia is attributed to his acute
viral illness. Outpatient team may recheck CBC and consider BM
biopsy is this does not resolve within ___ weeks of discharge.
.
#Stage IV Follicular Lymphoma s/p ___ C1 D1 Bendamustine
and Rituxan ___. Pt did not receive any chemotherapy while
hospitalized.
.
#Prostate CA - ___ 6, no active treatment at this time. Pt
was continued on flomax.
.
#CKD III with mild Cr elevation (Cr 1.2 -> 1.4): Losartan was
stopped on admission due to worsening Cr and was not resumed as
pt's SBPs were in 100-120s and metoprolol was increased for SVT.
.
#Hx of SVT - Pt had episode of SVT in 130-150s which terminated
spontaneously. Pt only minimally symptomatic and HD stable.
Metoprolol was incrased from 25mg po xl to 75 po xl.
.
TRANSITION ISSUES:
# The following medications were stopped, please consider
whether they need to be restarted: losartan stopped bc SBPs in
100-120s and metoprolol dose was increased for SVT, ASA stopped
for thrombocytopenia.
# Metoprolol was increased rfom 25xl to 75xl for SVT
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Ondansetron 8 mg PO Q8H:PRN nausea
2. Losartan Potassium 50 mg PO DAILY
3. Allopurinol ___ mg PO DAILY
4. Metoprolol Succinate XL 25 mg PO HS
5. Multivitamins 1 TAB PO DAILY
6. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain
7. sildenafil *NF* 100 mg Oral daily PRN sex
8. Aspirin 81 mg PO DAILY
9. Tamsulosin 0.8 mg PO HS
10. albuterol sulfate *NF* 90 mcg/actuation Inhalation q4 PRN
dyspnea
11. Vitamin D 1000 UNIT PO DAILY
12. Ciprofloxacin HCl 500 mg PO Q12H
starting ___ for 14 days
Discharge Medications:
1. Allopurinol ___ mg PO DAILY
2. Multivitamins 1 TAB PO DAILY
3. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain
RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours
Disp #*10 Tablet Refills:*0
4. Tamsulosin 0.8 mg PO HS
5. Vitamin D 1000 UNIT PO DAILY
6. albuterol sulfate *NF* 90 mcg/actuation Inhalation q4 PRN
dyspnea
7. Ondansetron 8 mg PO Q8H:PRN nausea
8. Metoprolol Succinate XL 75 mg PO DAILY
RX *metoprolol succinate 25 mg 3 tablet extended release 24
hr(s) by mouth daily Disp #*90 Tablet Refills:*0
9. Sildenafil *NF* 100 mg ORAL DAILY PRN sex
___. Levofloxacin 750 mg PO DAILY
please stop taking this medication after ___
RX *levofloxacin 750 mg 1 tablet(s) by mouth daily Disp #*3
Tablet Refills:*0
Discharge Disposition:
Home
Discharge Diagnosis:
Fever of unknown origin
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
You were admitted to the hospital for high fevers, headaches,
neck pain, and overall because you were feeling unwell. We
initially placed you on several antibiotics and tested your
blood for several infections. None of these tests showed the
specific infection you may have. We also took several CT scans
of your head, neck, chest, and abdomen, none of which showed
anything concerning for infection. Because of an abnormality on
your CT head, we also got an MRI of your head and performed a
lumbar puncture, which were all reassuring. We think you had a
viral illness, from which your body is slowly recovering.
Followup Instructions:
___
|
10820114-DS-16
| 10,820,114 | 26,397,856 |
DS
| 16 |
2199-11-06 00:00:00
|
2199-11-08 11:14:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Sulfa (Sulfonamide Antibiotics) / Lisinopril
Attending: ___.
Chief Complaint:
Fever, Inability to urinate
Major Surgical or Invasive Procedure:
None
History of Present Illness:
In brief, Mr. ___ is a ___ y/o M with PMHx of NHL in
remission, 3+3 ___ Prostate cancer under surveillance by
Urology, penile implant (___), SVT and dCHF who presented to
___ ED with urinary retention and fevers to ___ F since ___.
No prior history of AUR or nephrolithiasis, one prior UTI and
episode of prostatitis. Foley placed with minimal return. CT
Abd/Pelvis reveals 2 mm non-obstructing stone in Rt kidney
without hydronephrosis and no other intra-abdominal or
intra-pelvic process. U/A revealed pyuria, Urine culture reveals
GNR, patient started on empiric Abx with IV Ceftriaxone.
Past Medical History:
Past Medical History:
1. Gout.
2. Hypertension.
3. Obstructive sleep apnea.
4. Hx. Supraventricular tachycardia.
5. Prostate cancer.
6. CKD
7. Diastolic Dysfunction
Past Surgical History:
1. Procedure on his right elbow.
2. Procedure on his left knee.
Social History:
___
Family History:
His older brother had ___ lymphoma and
his younger brother had colon cancer.
Physical Exam:
ADMISSION PHYSICAL EXAM:
VS - 98.7 138/64 69 12 97%RA
General: well appearing male in NAD, laying comfortably in bed
HEENT: NC/AT, PERRL, EOMI, anicteric sclera, MOM, oropharynx
without edema, erythema, exudate
Neck: supple, no JVD, no bruits
CV: Regular rate, nl S1 S2, no M/R/G
Lungs: CTAB, no W/R/R
Abdomen: Soft, tenderness to deep palpation in the suprapubic
region, no other tenderness, no rebound, no masses, no HSM,
normal BS
GU: no CVA tenderness, foley in place, mild irritation of penile
tip at foley insertion, FC draining turbid yellow urine
Ext: warm, well perfused, 2+ peripheral pulses, no edema
Neuro: A&Ox4, SILT bilaterally ___, no gross motor deficits
Skin: no rashes / lesions
DISCHARGE PHYSICAL EXAM:
VS - 98.7 130/66 72 20 99%RA
General: well appearing male in NAD, laying in bed
HEENT: PERRL, EOMI, anicteric sclera, MOM, oropharynx without
edema, erythema, exudate
Neck: supple, no JVD
CV: Regular rate, nl S1 S2, no M/R/G
Lungs: CTAB, no W/R/R
Abdomen: Soft, tenderness to deep palpation in the suprapubic
region, no other tenderness, no rebound, normal BS
GU: no discharge or irritation of penis, Clear yellow urine in
urinal at bedside
Ext: warm, well perfused, 2+ peripheral pulses, no edema
Neuro: alert and oriented, no gross deficits
Pertinent Results:
ADMISSION STUDIES
LABS
___ 07:00PM BLOOD WBC-9.3# RBC-3.89* Hgb-11.3* Hct-36.6*
MCV-94# MCH-29.0 MCHC-30.9* RDW-14.6 RDWSD-50.4* Plt Ct-83*
___ 07:00PM BLOOD Neuts-75.1* Lymphs-7.0* Monos-16.8*
Eos-0.6* Baso-0.2 Im ___ AbsNeut-6.99* AbsLymp-0.65*
AbsMono-1.57* AbsEos-0.06 AbsBaso-0.02
___ 07:00PM BLOOD Glucose-97 UreaN-10 Creat-1.3* Na-135
K-5.0 Cl-100 HCO3-23 AnGap-17
___ 07:00PM BLOOD PSA-107.3*
___ 10:36PM BLOOD Lactate-1.4
___ 08:20AM URINE Color-Yellow Appear-Hazy Sp ___
___ 08:20AM URINE Blood-SM Nitrite-NEG Protein-100
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-LG
___ 08:20AM URINE RBC-10* WBC->182* Bacteri-FEW Yeast-NONE
Epi-1
___ 08:20AM URINE CastHy-3*
___ 08:20AM URINE WBC Clm-FEW Mucous-RARE
IMAGING
___ CT ABD AND PELVIS W/O CONTRAST
IMPRESSION: 2 mm non-obstructing right renal calculus. No
hydronephrosis.
DISCHARGE STUDIES
LABS
___ 06:35AM BLOOD WBC-5.1 RBC-3.85* Hgb-11.0* Hct-34.9*
MCV-91 MCH-28.6 MCHC-31.5* RDW-14.2 RDWSD-46.5* Plt ___
___ 06:35AM BLOOD Glucose-106* UreaN-11 Creat-1.2 Na-138
K-3.7 Cl-104 HCO3-26 AnGap-12
MICRO
___ 9:15 pm BLOOD CULTURE x 2; pending at discharge
___ 8:20 am URINE CULTURE (Final ___:
ESCHERICHIA COLI. 10,000-100,000 ORGANISMS/ML..
SENSITIVITIES: MIC expressed in
MCG/ML
_________________________________________________________
ESCHERICHIA COLI
|
AMPICILLIN------------ =>32 R
AMPICILLIN/SULBACTAM-- 16 I
CEFAZOLIN------------- <=4 S
CEFEPIME-------------- <=1 S
CEFTAZIDIME----------- <=1 S
CEFTRIAXONE----------- <=1 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------ <=1 S
MEROPENEM-------------<=0.25 S
NITROFURANTOIN-------- 32 S
PIPERACILLIN/TAZO----- <=4 S
TOBRAMYCIN------------ <=1 S
TRIMETHOPRIM/SULFA---- <=1 S
Brief Hospital Course:
___ y/o M with PMHx of NHL in remission, 3+3 ___ Prostate
cancer under surveillance by Urology, penile implant (___),
SVT and ___ who presented on ___ with urinary retention and
fevers to ___ F since ___, likely secondary to complicated UTI.
ACTIVE ISSUES
# UTI, complicated. Urine Cx positive for E Coli, Imaging
reveals non-obstructing renal calculus without hydonephrosis.
Urology intially advised broad spectrum antibiotic coverage of
pseudomonas and enterococcus. Started on IV Ceftriaxone pending
urine culture results, which revealed pan sensitive E. Coli.
Transitioned to PO Cipro for a 10 day course of treatment.
# Urinary Obstruction w/ mild ___. Unclear etiology but improved
with foley placement. CT abdomen unimpressive for other clear
etiology. Has known prostate cancer being monitored. Patient
voided successfully after foley was removed. Continued home
flomax. Follow up with Dr ___ in ___ weeks to discuss
further BPH management.
CHRONIC ISSUES
# Hypertension. Controlled with home meds.
# H/O SVT. Controlled on home metoprolol.
# Gout. No evidence of exacerbation, controlled on home
allopurinol.
TRANSITIONAL ISSUES
- Patient will take Ciprofloxacin 500 mg BID from ___ for
complicated UTI
- Patient should follow up with Dr ___ on ___
___ at 8:30 AM) to discuss further BPH management (eg.
TURP)
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY
2. Tamsulosin 0.4 mg PO QHS
3. Gabapentin 300 mg PO TID
4. Metoprolol Succinate XL 75 mg PO DAILY
5. Albuterol Inhaler 2 PUFF IH Q4H:PRN Wheezing, SOB
Discharge Medications:
1. Albuterol Inhaler 2 PUFF IH Q4H:PRN Wheezing, SOB
2. Aspirin 81 mg PO DAILY
3. Gabapentin 300 mg PO TID
4. Metoprolol Succinate XL 75 mg PO DAILY
5. Tamsulosin 0.4 mg PO QHS
6. Ciprofloxacin HCl 500 mg PO Q12H
RX *ciprofloxacin HCl [Cipro] 500 mg 1 tablet(s) by mouth twice
a day Disp #*20 Tablet Refills:*0
Discharge Disposition:
Home
Discharge Diagnosis:
Primary:
- E. coli UTI with sepsis
- Dehydration
Secondary:
- Follicular lymphoma s/p 6 cycles of R-bendamustine
- Prostate cancer
- Gout
- Hypertension
- S/P 2-piece penile prosthesis ___
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
You were admitted to the hospital because you had a fever and
some urinary retention. You were found to have a urinary tract
infection which likely caused these symptoms. You were treated
with intravenous antibiotics and then transitioned to oral
antibiotics which you should continue for 10 more days.
Please follow up with your primary care physician and urologist
at the appointments scheduled for you (see below).
It was a pleasure meeting and taking care of you while you were
in the hospital.
-Your ___ Team
Followup Instructions:
___
|
10820164-DS-15
| 10,820,164 | 22,927,079 |
DS
| 15 |
2152-12-06 00:00:00
|
2152-12-07 18:53:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Fever and diarrhea
Major Surgical or Invasive Procedure:
ERCP (___): Biliary stent removal
History of Present Illness:
___ yo M with PMH of HCV with cirrhosis and HCC s/p liver
transplant ___ currently with fibrosing cholestatic HCV on
Sofosbuvir and focal aneurysmal dilation of hepatic artery per
___ liver biopsy who p/w fever, abdominal pain, and diarrhea.
Has a blood transfusion ___ for anemia attributed to
ribavirin therapy. He subsequently developed diarrhea at home
which he had throughout ths weekend. Denies melena and
hematochezia. Associated with generalized abdominal pain worst
in RLQ and fevers/chills to 103. Patient denies N/V, CP, and
SOB. He has not made any recent changes to his diet, traveled,
or been around anyone with a GI illness. Patient has no history
of CMV infection.
In the ED initial vitals were 102.2, 117, 148/93, 16, 100% RA.
Initial labs remarkable for Cr of 2, AP of 143, H/H of 8.2/25.2,
and Plt of 99. Lactate was 2.3. CXR was unremarkable. Patient
was given Tylenol for fever and started on empiric antibiotics
with ciprofloxacin and Flagyl per hepatology fellow. HCV and CMV
sent. On the floor initial vital signs were 97.2, 88, 115/62,
20, 98% RA. Patient reports mild chills and lower abdominal pain
but he is otherwise without symptoms at this time.
Past Medical History:
- Chronic HCV with HCC s/p transplant in ___
- Fibrosing cholestatic HCV
- Grade I esophageal varices per ___ EGD
- Hypertension
- Chronic kidney disease, stage III with baseline Cr ___
- GERD
- Schatzki's ring
- Hiatal hernia
- Gastritis and duodenitis
- Osteoporosis
Social History:
___
Family History:
Lung cancer in mother.
Physical Exam:
ADMISSION EXAM
VS: 97.2, 88, 115/62, 20, 98% RA
General: ___ male, AAOx3, NAD
HEENT: Sclera anicteric, PERRLA, EOMI, MMM, oropharynx clear
Neck: Supple, JVP not elevated, no LAD
CV: RRR, nl S1/S2, no MRG
Lungs: CTAB, no wheezes/rales/rhonchi
Abdomen: Soft, RLQ tenderness, ___, no
rebound/guarding, mild splenomegaly, RUQ scar
GU: Deferred
Ext: Warm, ___, no cyanosis/clubbing/edema
Neuro: CN ___ grossly intact
Skin: No concerning lesions
DISCHARGE EXAM
VS: 98.1, 64, 126/80, 18, 100% RA
General: ___ male, AAOx3, NAD
HEENT: Sclera anicteric, PERRLA, EOMI, MMM, oropharynx clear
Neck: Supple, JVP not elevated, no LAD
CV: RRR, nl S1/S2, no MRG
Lungs: CTAB, no wheezes/rales/rhonchi
Abdomen: Soft, mild RUQ tenderness, no rebound/guarding, RUQ
scar
Ext: Warm, ___, no cyanosis/clubbing/edema
Neuro: CN ___ grossly intact
Pertinent Results:
ADMISSION LABS
___ 10:27AM BLOOD ___
___ Plt ___
___ 10:27AM BLOOD ___
___
___ 10:27AM BLOOD ___ ___
___ 10:27AM BLOOD ___
___
___ 10:27AM BLOOD ___
___ 10:27AM BLOOD ___
___ 06:10AM BLOOD ___
___ 10:33AM BLOOD ___
___ 02:16PM URINE ___ Sp ___
___ 02:16PM URINE ___
___
___ 02:16PM URINE ___
DISCHARGE LABS
___ 05:57AM BLOOD ___
___ Plt ___
___ 05:57AM BLOOD ___
___
___ 05:57AM BLOOD ___ ___
___ 05:57AM BLOOD ___
___
___ 05:57AM BLOOD ___
___ 05:57AM BLOOD ___
___ 05:57AM BLOOD ___
MICROBIOLOGY
All other blood, urine, stool cultures NEGATIVE or PENDING on
discharge
Blood Culture, Routine (___):
PSEUDOMONAS AERUGINOSA. FINAL SENSITIVITIES.
SENSITIVITIES: MIC expressed in MCG/ML
___________________________________________________
PSEUDOMONAS AERUGINOSA
|
CEFEPIME-------------- 2 S
CEFTAZIDIME----------- 4 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------ <=1 S
MEROPENEM-------------<=0.25 S
PIPERACILLIN/TAZO----- 8 S
TOBRAMYCIN------------ <=1 S
CMV viral load (___): CMV DNA detected, less than 137 IU/mL.
HCV viral load (___): ___ NOT DETECTED.
IMAGING
RUQ US (___): 1. Status post liver transplant with no
concerning liver lesions. Right lobe hemangioma is again noted.
2. Patent hepatic vasculature. It is worth noting that the
previously visualized focal aneurysm up to 7 mm on CT torso from
___ at the anastomosis of the hepatic arteries and is
not visualized on today's study due to overlying bowel gas.
Further evaluation of this region may be with a dedicated CT
scan with contrast.
CXR (___): Unremarkable chest radiographic examination.
ENDOSCOPY
ERCP (___): The previously placed plastic biliary stent was
seen in the right upper quadrant on the scout film. Erythema,
congestion and granularity in the first and second parts of the
duodenum compatible with duodenitis. Previous plastic biliary
stent in the major papilla. This was removed successfully using
a snare. Cholangiogram was not performed during this procedure.
Brief Hospital Course:
___ yo M with PMH of HCV with cirrhosis and ___ s/p liver
transplant ___ currently with fibrosing cholestatic HCV on
Sofosbuvir and focal aneurysmal dilation of hepatic artery per
___ liver biopsy who p/w fever, abdominal pain, and diarrhea.
ACTIVE ISSUES
# Fever and diarrhea: Symptoms began after a blood transfusion.
Presentation was somewhat concerning for CMV colitis. CMV viral
load revealed detectable virus but not enough to be quantified,
arguing against CMV colitis. C. diff colitis considered but C.
diff toxin assay was negative. Patient was started on vancomycin
and ciprofloxacin on admission. Flagyl was added given concern
for diverticulitis. Blood cultures grew ___
Pseudomonas for which vancomycin was discontinued and
ciprofloxacin and Flagyl were continued. Treatment resulted in
significant improvement in his symptoms. ID was consulted and
they recommended a 14 day course of antibiotics. Patient has a
PICC placed for outpatient IV antibiotic therapy. He
subsequently underwent ERCP for removal of a previously placed
biliary stent given that it is a nidus for infection. The
procedure was successful and was remarkable only for mild
duodenitis. Patient was discharged on a 14 day course of
ciprofloxacin IV and Flagyl PO.
# ___ on CKD: Stage III with baseline Cr ___. Cr was
slightly elevated at 2.0 on admission. Likely ___ in the
setting of volume depletion due to the diarrhea for which
patient was treated with gentle IV fluids. Cr returned to
baseline the next day confirming suspicion for ___.
Home Epoeitin and vitamin D were continued in hospital.
CHRONIC ISSUES
# Cirrhosis: Due to chronic HCV infection. Complicated by ___.
Patient underwent liver transplant in ___ but has since
developed fibrosing cholestatic disease. Being managed with
___ and sofosbuvir (study drug) and tacrolimus and MMF for
immunosuppression. Childs class A. MELD is ___. Patient was
continued on home sofosbuvir and ribavirin was added per the
study protocol. Tacrolimus was continued. Home interferon and
MMF were held due to sepsis in the setting of immunosuppression.
Prophylactic Bactrim was continued. Patient was discharged on
his ___ regimen with the exception of interferon which
patient will discuss restarting on ___ with Dr. ___
week.
# Anemia: Baseline anemia due to chronic disease and ribavirin.
The patient received 2 units pRBCs on ___ and bumped
appropriately. Hct remained stable subsequently.
# Esophageal varices: Grade I per ___ EGD. Not on nadolol.
# Hypertension: Stable. Continued metoprolol.
TRANSITIONAL ISSUES
- Discharged on 14 day course of ciprofloxacin IV and Flagyl PO
- ___ held on discharge
- If recurrent diarrhea should undergo colonoscopy to check for
CMV ulcers per ID
- Monitor CBC while on ribavirin given risk for worsening anemia
- ___ with PCP scheduled
- ___ with Liver Clinic scheduled
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Metoprolol Tartrate 50 mg PO BID
2. Mycophenolate Mofetil 500 mg PO BID
3. Ondansetron 4 mg PO Q6H:PRN nausea/vomiting
4. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN pain
5. Peginterferon ___ 135 mcg SC 1X/WEEK (WE)
6. Bactrim ___ mg oral DAILY
7. Tacrolimus 2 mg PO Q12H
8. Epoetin Alfa 60,000 units SC 1X/WEEK (___)
9. Vitamin D 1000 UNIT PO DAILY
Discharge Medications:
1. Epoetin Alfa 60,000 units SC 1X/WEEK (___)
2. Metoprolol Tartrate 50 mg PO BID
3. Ondansetron 4 mg PO Q6H:PRN nausea/vomiting
4. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN pain
RX *oxycodone 5 mg 1 tablet(s) by mouth every six (6) hours Disp
#*20 Tablet Refills:*0
5. Tacrolimus 2 mg PO Q12H
6. Vitamin D 1000 UNIT PO DAILY
7. Sofosbuvir Study Med 400 Mg ORALLY ONCE A DAY Duration: 24
Weeks
8. Bactrim ___ mg oral DAILY
9. Mycophenolate Mofetil 500 mg PO BID
10. Ciprofloxacin 400 mg IV Q12H
RX *ciprofloxacin in D5W 400 mg/200 mL 400 mg IV every twelve
(12) hours Disp #*16 Vial Refills:*0
11. Ribavirin 200 mg PO DAILY
RX *ribavirin 200 mg 1 tablet(s) by mouth DAILY Disp #*30
Capsule Refills:*0
12. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H
RX *metronidazole 500 mg 1 tablet(s) by mouth every eight (8)
hours Disp #*24 Tablet Refills:*0
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
Infectious enterocolitis
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you while you were a patient at
___. You came to us with fevers
and diarrhea. Blood cultures revealed that this was likely due
to an infection in your blood. We treated you with antibiotics
which resulted in significant improvement in your symptoms. You
will be discharged with several more days of IV and oral
antibiotics. We continued you on all pf your liver medications
with the exception of interferon which you should NOT take until
following up in with Dr. ___ on ___. While
you were here we also removed your biliary stent. The procedure
went well without complications.
Please be sure to take all of your medications as listed below.
Please keep all of your ___ appointments.
Followup Instructions:
___
|
10820804-DS-7
| 10,820,804 | 25,118,663 |
DS
| 7 |
2138-08-13 00:00:00
|
2138-08-13 18:38:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
Keflex / cephalexin / clindamycin / sulfamethoxazole / ibuprofen
Attending: ___
Chief Complaint:
Right neck/shoulder pain
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ male with cardiac history notable for CABG (LIMA to
LAD, SVG to OMI, SVG, to L-PDA), multiple stents, CHB s/p
pacemaker implantation, paroxysmal AF (s/p MAZE, not on
anti-coagulation), ESRD (HD ___, DM2, and HTN presented for
severe right sided neck pain c/b episode of his typical angina
symptoms while in the ED.
Patient initially here for right neck pain for the last 3 days
after sleeping on a pillow uncomfortably. Prescribed
cyclobenozprine by his PCP but this did not help. Pain radiates
up right shoulder to right-posterior neck. No headache or
dizziness.
While walking to his bed in the ED, he developed sudden onset of
left-sided chest pain that is sharp and worse with breathing.
Patient put on oxygen and felt better. Pain similar to prior
presentation w/ MI.
Past Medical History:
- Multi-vessel CAD
- s/p 3v-CABG (LIMA-LAD, SVG-OM, SVG-LPDA) in ___ + MAIZE
procedure
- DES to RCA ___ DEX x 2 to LAD and LCx (___)
- PAF initially on warfarin but stopped after MAZE in ___
- Hypertension
- Diabetes mellitus, type 2
- Diabetic nephropathy
- ESRD, on HD ___) since ___
- Obesity
- Former smoker, quit ___ ago.
- Asthma, on prn inhalers
- Partial thyroidectomy in ___
- Depression ___
- R toe amputation due to frostbite
Social History:
___
Family History:
Mother: HTN, DM, CAD
No FH of early MI, arrhythmia, cardiomyopathies, sudden cardiac
death.
Physical Exam:
ADMISSION PHYSICAL EXAM:
Vitals: 98.3 78 145/68 18 100 RA
GEN: AAOx3. Uncomfortable but in no distress. Appears stated
age.
NEURO: CNIII-XII intact. Full strength upper and lower
extremities. Gait stable. No sensory deficits. Speech normal.
HEENT: Flexion and extension of head normal, rotation limited by
severe pain. No obvious deformity. Tender to palpation over
right
trapezius.
CARD: ___ systolic murmur most prominent over right sternal
border. Regular rate, rhythm.
PULM: Distant breath sounds but otherwise clear to auscultation.
ABD: Soft, non-tender, non-distended.
DISCHARGE PHYSICAL EXAM:
Vitals: 98.4 64 (64-78) 129/67 (129-169/58-68) 16 97% RA
GEN: AAOx3. Comfortable in NAD. Appears stated age.
HEENT: neck ROM improved today. + Spurling test. No obvious
deformity. less TTP on right trapezius.
CARD: ___ systolic murmur most prominent over right sternal
border, radiating to carotids. Regular rate, rhythm.
PULM: Distant breath sounds but otherwise clear to auscultation.
ABD: Soft, non-tender, non-distended.
Pertinent Results:
PERTINENT STUDIES:
CXR (___):
Lungs are hyperinflated, but clear. Heart size top-normal. No
pulmonary
edema or pleural effusion. Previous vascular congestion has
resolved.
Transvenous right atrial right ventricular pacer leads in
standard placements.
CXR (___):
Bibasilar opacities may represent atelectasis, however,
superimposed pneumonia
cannot be excluded in the appropriate clinical setting.
C-SPINE X-RAY NON-TRAUMA (___)
Degenerative changes. Straightening of the normal cervical
lordosis.
Patient's head is tilted toward the right.
SHOULDER X-RAY NON-TRAUMA (___)
1. No fracture or dislocation.
2. Findings suggest rotator cuff calcific tendinitis.
3. Mild acromioclavicular degenerative change.
ADMISSION LABS:
___ 03:00AM BLOOD WBC-12.7* RBC-3.70* Hgb-11.0* Hct-34.7*
MCV-94 MCH-29.7 MCHC-31.7* RDW-13.6 RDWSD-47.1* Plt ___
___ 03:00AM BLOOD Neuts-65.2 ___ Monos-9.3 Eos-2.8
Baso-0.2 Im ___ AbsNeut-8.29*# AbsLymp-2.81 AbsMono-1.18*
AbsEos-0.36 AbsBaso-0.02
___ 03:00AM BLOOD Plt ___
___ 10:10AM BLOOD ___
___ 03:00AM BLOOD Glucose-294* UreaN-66* Creat-6.5*# Na-138
K-6.0* Cl-95* HCO3-21* AnGap-22*
___ 03:00AM BLOOD cTropnT-0.04*
___ 10:10AM BLOOD Calcium-9.8 Phos-6.7* Mg-2.1
___ 06:17AM BLOOD K-5.7*
___ 03:12AM URINE Color-Straw Appear-Clear Sp ___
___ 03:12AM URINE Blood-TR* Nitrite-NEG Protein-100*
Glucose-300* Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.5 Leuks-NEG
___ 03:12AM URINE RBC-2 WBC-4 Bacteri-FEW* Yeast-NONE Epi-0
PERTINENT LABS:
___ 06:05AM BLOOD WBC-9.4 RBC-3.44* Hgb-10.4* Hct-32.7*
MCV-95 MCH-30.2 MCHC-31.8* RDW-13.7 RDWSD-47.1* Plt ___
___ 06:05AM BLOOD Glucose-92 UreaN-40* Creat-5.1*# Na-141
K-4.6 Cl-95* HCO3-31 AnGap-15
___ 03:00AM BLOOD cTropnT-0.04*
___ 10:10AM BLOOD CK-MB-4 cTropnT-0.08*
___ 06:20PM BLOOD CK-MB-4 cTropnT-0.14*
___ 06:05AM BLOOD CK-MB-3 cTropnT-0.16*
___ 10:10AM BLOOD CK-MB-3 cTropnT-0.14*
DISCHARGE LABS:
___ 06:05AM BLOOD WBC-9.4 RBC-3.44* Hgb-10.4* Hct-32.7*
MCV-95 MCH-30.2 MCHC-31.8* RDW-13.7 RDWSD-47.1* Plt ___
___ 06:05AM BLOOD Plt ___
___ 06:05AM BLOOD Glucose-92 UreaN-40* Creat-5.1*# Na-141
K-4.6 Cl-95* HCO3-31 AnGap-15
___ 10:10AM BLOOD CK-MB-3 cTropnT-0.14*
___ 06:05AM BLOOD Calcium-9.9 Phos-6.2* Mg-2.0
MICRO:
___ CULTURE-FINALEMERGENCY WARD
Brief Hospital Course:
___ male with significant cardiac history notable for
CABG (LIMA to LAD, SVG to OMI, SVG, to L-PDA), multiple stents,
CHB s/p
PPM (___), paroxysmal AF (s/p MAZE ___, not on
anti-coagulation), ESRD (HD ___, IDDM2, HTN presented for
worsening right shoulder/neck pain and admitted for episode of
stable angina that occurred while in ED.
# Neck Pain: He presented initially for severe neck pain,
unresponsive to outpatient trial of cyclobenzaprine. Pain
improved with lidocaine patch and acetaminophen. Spurling sign
positive. C-spine x-ray demonstrated degenerative changes. No
other evidence of emergent cause for his symptoms. Improved
overnight and felt more comfortable the following day. Advised
to treat with Tylenol at home until further PCP follow up.
# Demand ischemia: Patient did not initially have chest pain
upon arrival to ED. Experienced one episode of his baseline
stable angina while ambulating in ED. Subsequent EKG showed
evidence of ST elevation in aVR, however diffuse ST depressions
in precordial leads were suggestive of global demand ischemia
rather than acute infarction. His troponins were initially
rising and peaked at 0.14 (likely related to ESRD than true
ischemic episode). CKMB was stable throughout at 4. Completely
asymptomatic throughout admission. Carvedilol, atorvastatin,
ASA, Plavix, and Imdur were continued.
# ESRD: Hemodialyzed ___ (-2800 cc). Continued regular
home medications.
# Leukocytosis: Borderline elevated WBC on admission which
returned to baseline. Attributed to demarginalization in the
setting of pain response.
CHRONIC ISSUES:
#Anemia: Remained stable.
#Type 2 IDDM: Continued insulin sliding scale.
#HTN: Continued home amlodipine. Mildly elevated BPs in
130s-140s so increased carvedilol to 12.5 mg BID.
#Asthma: continued home albuterol nebs and fluticasone
#GERD: continued home pantoprazole.
TRANSITIONAL ISSUES
======================
[] Consider titrating BP medications given systolic pressure
140s throughout admission.
[] Consider d/c Plavix as he is >30 months since PCI (___)
and risk of bleeding given ESRD.
[] Will need follow up regarding ongoing MSK neck/shoulder pain
#CODE: full (confirmed)
#CONTACT: HCP: ___ (son) ___
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Glargine 40 Units Lunch
Glargine 40 Units Bedtime
Insulin SC Sliding Scale using Novolog Insulin
2. Pantoprazole 40 mg PO Q24H
3. Renagel 2400 mg oral TID W/MEALS
4. Isosorbide Mononitrate (Extended Release) 90 mg PO DAILY
5. Furosemide 80 mg PO DIALYSIS-OFF DAYS
6. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing
7. Fluticasone Propionate 110mcg 2 PUFF IH BID
8. Carvedilol 6.25 mg PO BID
9. amLODIPine 5 mg PO BID
10. Nitroglycerin Patch 0.2 mg/hr TD Q24H
11. Clopidogrel 75 mg PO DAILY
12. coenzyme Q10 100 mg oral DAILY
13. Aspirin 81 mg PO DAILY
14. Atorvastatin 20 mg PO QPM
15. Nephrocaps 1 CAP PO DAILY
Discharge Medications:
1. Acetaminophen 500 mg PO Q4H
2. Carvedilol 12.5 mg PO BID
RX *carvedilol 12.5 mg 1 tablet(s) by mouth twice daily Disp
#*60 Tablet Refills:*0
3. Glargine 40 Units Lunch
Glargine 40 Units Bedtime
Insulin SC Sliding Scale using Novolog Insulin
4. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing
5. amLODIPine 5 mg PO BID
6. Aspirin 81 mg PO DAILY
7. Atorvastatin 20 mg PO QPM
8. Clopidogrel 75 mg PO DAILY
9. coenzyme Q10 100 mg oral DAILY
10. Fluticasone Propionate 110mcg 2 PUFF IH BID
11. Furosemide 80 mg PO DIALYSIS-OFF DAYS
12. Isosorbide Mononitrate (Extended Release) 90 mg PO DAILY
13. Nephrocaps 1 CAP PO DAILY
14. Nitroglycerin Patch 0.2 mg/hr TD Q24H
15. Pantoprazole 40 mg PO Q24H
16. Renagel 2400 mg oral TID W/MEALS
Discharge Disposition:
Home
Discharge Diagnosis:
Primary Diagnosis:
------------------
Stable Angina
Musculoskeletal neck/shoulder pain
Degenerative changes of cervical spine
Secondary Diagnoses:
--------------------
- Hypertension
- Diabetes mellitus, type 2
- Diabetic neuropathy
- End Stage Renal Disease
- Obesity
- Asthma
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you.
Why were you in the hospital?
- You had right-sided neck and shoulder pain.
- 1 episode of chest pain in the ER.
What was done for you in the hospital?
- We checked lab tests that did not show any injury to your
heart.
- We took x-rays of your neck and shoulder.
- You were given medications to help manage your neck pain.
- You received your scheduled hemodialysis.
WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL?
- Take all of your medications as prescribed (listed below).
- Follow up with your doctors as listed below.
- Seek medical attention if you have new or concerning symptoms
or you develop chest pain, swelling in your legs, abdominal
distention, or shortness of breath at night.
It was a pleasure participating in your care. We wish you the
best!
- Your ___ Care Team
Followup Instructions:
___
|
10821855-DS-17
| 10,821,855 | 24,041,295 |
DS
| 17 |
2185-07-02 00:00:00
|
2185-07-03 14:09:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
Penicillins
Attending: ___.
Chief Complaint:
UTI, abdominal pain
Major Surgical or Invasive Procedure:
None
History of Present Illness:
Ms. ___ is a ___ year old woman with a history of two
intracerebral aneurysms s/p clipping ___, HTN, IDDM, stage IV
sacral decub who was advised to present to the ED due to
abnormal labs.
Approximately 5 days ago her ___ was taking her vitals and noted
her temperature to be "very low." She was told it was as low as
___. She then presented to ___ for further
evaluation. At the time she endorsed abdominal pain, nausea, and
flank pain. She was discharged on PO Cipro for UTI. She received
a call yesterday which said "please return to the hospital asap
as you have an infection that necessitates IV antibiotics." She
was unaware of further details. Records from ___ reveal
+E.coli UTI by culture with sensitivity to Zosyn, imipenem,
meropenem, and cefepime only. Positive blood cultures noted at
___ "several days later". She presented to ___ ED rather
than returning to ___.
In the ED, initial vitals were: Pain 10 T 98.4 HR 70 BP 129/65
RR 18 96% RA
Exam was notable for an obese woman lying in bed. Sacral
decubitus site clean and dry without erythema. Lungs clear.
Abdomen soft and tender.
Labs notable for WBC 9.4 Hgb 11.3 Hct 34.6 Plt 257. Chemistry
notable for glucose 221 and otherwise WNL. Lactate 1.5.
UA with large leuk, neg nitrite, many bacteria.
She received: diazepam 5 mg x2 PO, Cefepime 2g IVx1, Percocet PO
x1 for shoulder pain sustained on ambulance ride
She is admitted for further management of UTI/Pyelo.
Vitals on transfer: Pain 10 T 98.6 HR 74 BP 144/61 RR 18 97% RA
On the floor, she appears comfortable.
Review of systems is notable for a several week history of
abdominal pain and nausea. She feels that her abdomen has
significantly increased in size during this time. She also
endorses brown vaginal discharge, prominent at night. She
endorses constipation, denies diarrhea. She denies chest pain,
dyspnea, headache, arthralgias, myalgias.
Past Medical History:
paraplegia s/p MVA - ___
syringomyelia
DMII
CVA
Brain aneurysm
neuropathy
hypothyroidism
HTN
HLD
Depression
Urgency incontinence
GERD
HCV
Ischial Decubitus ulcer
Social History:
___
Family History:
Mother: ___, DM, Stroke
Father: ___, DM, CAD
Physical Exam:
ADMISSION PHYSICAL EXAM:
Vital Signs: 99.0 152/50 72 18 98% RA
General: Alert, oriented, no acute distress
HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL,
neck supple, JVP not elevated, no LAD. Seborrheic dermatitis of
the face
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,
gallops
Lungs: Clear to auscultation bilaterally, no wheezes, rales,
rhonchi
Abdomen: Soft, diffusely tender throughout, most notably in the
RUQ
GU: Chronic indwelling foley draining clear urine. + paraspinal
muscle tenderness though no overt flank pain
Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
Neuro: Alert and oriented x3, paraplegic
DISCHARGE PHYSICAL EXAM:
VS: 98.9/98.6 116-125/49-53 ___ 18 96% RA
General: Alert, comfortable appearing, NAD
HEENT: sclera anicteric, conjunctivae noninjected, erythematous
macular rash with some scale in patches on her face
CV: Heart sounds distant. Regular rate and rhythm, normal S1 +
S2, no murmurs, rubs, gallops
Lungs: Poor effort but otherwise clear to auscultation
bilaterally Abdomen: soft, nondistended, mild ttp in lower
quadrants bilaterally, no rebound, guarding, or rigidity
GU: Chronic indwelling foley draining clear urine.
Ext: Warm, well perfused
Neuro: Alert and interactive, paraplegic
Pertinent Results:
ADMISSION LABS:
___ 05:50PM BLOOD WBC-9.4 RBC-3.98 Hgb-11.3 Hct-34.5 MCV-87
MCH-28.4 MCHC-32.8 RDW-14.6 RDWSD-46.1 Plt ___
___ 05:50PM BLOOD Neuts-63.5 ___ Monos-6.8 Eos-2.5
Baso-0.2 Im ___ AbsNeut-5.93 AbsLymp-2.49 AbsMono-0.64
AbsEos-0.23 AbsBaso-0.02
___ 05:50PM BLOOD Neuts-63.5 ___ Monos-6.8 Eos-2.5
Baso-0.2 Im ___ AbsNeut-5.93 AbsLymp-2.49 AbsMono-0.64
AbsEos-0.23 AbsBaso-0.02
___ 05:50PM BLOOD Glucose-221* UreaN-9 Creat-0.6 Na-139
K-3.8 Cl-101 HCO3-26 AnGap-16
___ 05:03AM BLOOD Calcium-8.9 Phos-3.7 Mg-2.0
___ 05:03AM BLOOD ALT-17 AST-14 AlkPhos-111* TotBili-0.3
___ 05:25PM URINE Color-Yellow Appear-Hazy Sp ___
___ 05:25PM URINE Blood-TR Nitrite-NEG Protein-30
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-8* pH-6.5 Leuks-LG
___ 05:25PM URINE RBC-2 WBC-22* Bacteri-MANY Yeast-NONE
Epi-2 TransE-<1
PERTINENT LABS:
___ 05:03AM BLOOD %HbA1c-8.4* eAG-194*
___ 09:32PM URINE Color-Straw Appear-Clear Sp ___
___ 09:32PM URINE Blood-NEG Nitrite-NEG Protein-NEG
Glucose-1000 Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG
DISCHARGE LABS:
___ 07:04AM BLOOD WBC-7.1 RBC-3.88* Hgb-11.2 Hct-34.7
MCV-89 MCH-28.9 MCHC-32.3 RDW-14.5 RDWSD-46.7* Plt ___
___ 07:04AM BLOOD Glucose-314* UreaN-17 Creat-0.6 Na-135
K-4.2 Cl-96 HCO3-26 AnGap-17
___ 07:04AM BLOOD Calcium-9.0 Phos-4.3 Mg-1.8
___ 07:04AM BLOOD ALT-17 AST-13 AlkPhos-102 TotBili-0.2
MICROBIOLOGY:
___ 5:50 pm BLOOD CULTURE
**FINAL REPORT ___
Blood Culture, Routine (Final ___:
STAPHYLOCOCCUS, COAGULASE NEGATIVE.
Isolated from only one set in the previous five days.
SENSITIVITIES PERFORMED ON REQUEST..
CORYNEBACTERIUM SPECIES (DIPHTHEROIDS).
Isolated from only one set in the previous five days.
Reported to and read back by ___ AT 10:05 ON
___.
Anaerobic Bottle Gram Stain (Final ___:
Reported to and read back by ___. ___ @ 6PM ON
___.
GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
Aerobic Bottle Gram Stain (Final ___:
GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
**FINAL REPORT ___
URINE CULTURE (Final ___: NO GROWTH.
IMAGING:
___ RUQ US:
Echogenic liver consistent with steatosis. Other forms of liver
disease
including steatohepatitis, hepatic fibrosis, or cirrhosis cannot
be excluded on the basis of this examination.
___ Transvaginal pelvic US:
Very limited exam. Thickened, mildly heterogeneous endometrium
(11 mm) for
which further evaluation is recommended with endometrial biopsy
for tissue
sampling.
Brief Hospital Course:
___ is a ___ with a history of paraplegia
secondary to a MVA, IDDM, intracerebral aneurysms s/p clipping,
stage IV sacral decubitous ulcer, chronic indwelling Foley with
recurrent UTIs and a history of cleared HCV infection (s/p IFN
and ribavirin) who presented with migratory abdominal pain,
post-menopausal vaginal bleeding, and MDR UTI.
Investigations/interventions:
# Urinary tract infection: Presented with hypothermia and
rigors. Cultures at ___ grew MDR E. coli (sensitive
to cefepime, Zosyn, ertapenem, and amikacin). She was
transferred to ___ where ID was consulted. She completed a 7
day course of cefepime. If she has further UTIs, consider
restarting suppressive fosfomycin
# Abdominal pain: Patient presented with acute on chronic
abdominal pain and report of alternating constipation and
diarrhea. Pain improved with laxatives but did not completely
resolve, IBS suspected.
# possible cirrhosis: Pt with history of HepC cleared s/p prior
treatment. During this admission the workup of abdominal pain
included RUQ U/S which showed a coarsed nodular liver. Her LFTs
were normal. A HCV viral load was ordered at was pending at time
of discharge. An appointment with hepatology was scheduled on
discharge.
# Post-menopausal vaginal bleeding: She reported 3 months of
vaginal bleeding. A transvaginal US found endometrial thickening
(11 mm). She was set up with a gynecology appointment at
discharge for follow up for endometrial biopsy.
# Insulin dependent diabetes mellitus: Despite her Hgb A1c 8.4,
she endorsed poorly controlled blood sugars with highs in the
300-400s and frequent hypoglycemic events as well at home. She
took irregular and inconsistent amounts of humulin throughout
the day. During this admission, BGs were very difficult to
control ___ diabetes service was consulted. She declined
followup with ___ stating that she preferred a more local
endocrinology provider. She would ideally be scheduled with a
local provider at her followup visit.
Transitional issues:
- Patient was discharged on lantus 36 units in the morning and
40 units at night with Humalog 25 units with meals plus Humalog
sliding scale. She was advised to have endocrinology followup
- Patient was treated with a 7 day course of cefepime for MDR
UTI
- If patient continues to have UTIs, ID recommended re-starting
suppressive therapy with fosfomycin and considering GU imaging
- Patient with 3 months vaginal bleeding and endometrial
thickening on US; she is schedule for gyn follow up
- Patient found to have steatosis/possible fibrosis on RUQ US
and was scheduled for hepatology follow up; an HCV VL was
pending on discharge
- CODE: full
- CONTACT: ___ (roommate, HCP): ___
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Gabapentin 1200 mg PO QHS
2. Levothyroxine Sodium 75 mcg PO DAILY
3. Lisinopril 5 mg PO DAILY
4. Omeprazole 20 mg PO BID
5. Pravastatin 80 mg PO QPM
6. Humalog 75 Units Breakfast
Humalog 75 Units Lunch
Humalog 75 Units Dinner
7. Methadone 10 mg PO DAILY
8. Diazepam ___ mg PO TID
9. Gabapentin 1200 mg PO QAM
10. Gabapentin 900 mg PO QPM
11. FLUoxetine 20 mg PO DAILY
12. Docusate Sodium 100 mg PO BID
13. OxyCODONE--Acetaminophen (5mg-325mg) ___ TAB PO Q4-6H:PRN
pain
Discharge Medications:
1. Diazepam ___ mg PO TID
2. Docusate Sodium 100 mg PO BID
3. Gabapentin 1200 mg PO QHS
4. Levothyroxine Sodium 75 mcg PO DAILY
5. Lisinopril 5 mg PO DAILY
6. Omeprazole 20 mg PO BID
7. OxyCODONE--Acetaminophen (5mg-325mg) ___ TAB PO Q4-6H:PRN
pain
8. Pravastatin 80 mg PO QPM
9. FLUoxetine 20 mg PO DAILY
10. Gabapentin 1200 mg PO QAM
11. Gabapentin 900 mg PO QPM
12. Methadone 10 mg PO DAILY
13. Glargine 36 Units Breakfast
Glargine 40 Units Bedtime
Humalog 25 Units Breakfast
Humalog 25 Units Lunch
Humalog 25 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
RX *insulin glargine [Lantus] 100 unit/mL AS DIR 36 Units before
BKFT; 40 Units before BED; Disp #*4 Vial Refills:*0
RX *insulin lispro [Humalog] 100 unit/mL AS DIR Up to 20 Units
QID per sliding scale 25 Units before LNCH; Units QID per
sliding scale 25 Units before DINR; Disp #*4 Vial Refills:*0
RX *insulin syringe-needle U-100 [BD Insulin Syringe ___
29 gauge x ___ use to administer insulin as directed Disp #*100
Syringe Refills:*1
14. Ketoconazole 2% 1 Appl TP BID:PRN rash
RX *ketoconazole 2 % apply to rash on face twice daily
Refills:*0
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
Primary diagnoses:
Urinary tract infection
Abdominal pain
Endometrial thickening
Post-menopausal vaginal bleeding
Secondary diagnoses:
IDDM
hypertension
paraplegia
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or
wheelchair.
Discharge Instructions:
Dear Ms. ___,
You were hospitalized at ___
because you had a urinary tract infection requiring treatment
with antibiotics through an IV.
You also had abdominal pain and had an ultrasound of your liver
which showed fat deposition and possibly some fibrosis
(scarring). This was likely unrelated to your abdominal pain but
you should follow up with a liver doctor because of this
finding. An appointment is listed below. Your abdominal pain
improved with treatment of your constipation.
You also had been having vaginal bleeding. An ultrasound showed
thickening of the lining of your uterus (this lining is called
the endometrium). You should follow up with gynecology for an
endometrial biopsy. An appointment is listed below.
Lastly, your insulin medications have been changed. You should
follow up with the diabetes doctors as below.
It was a pleasure participating in your care. We wish you all
the best in the future.
Sincerely,
Your ___ team
Followup Instructions:
___
|
10821892-DS-19
| 10,821,892 | 20,918,371 |
DS
| 19 |
2185-03-25 00:00:00
|
2185-03-30 14:49:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: OBSTETRICS/GYNECOLOGY
Allergies:
epinephrine / Augmentin
Attending: ___.
Chief Complaint:
Fevers and lower abdominal pain
Major Surgical or Invasive Procedure:
Ultrasound-guided drainage of abscesses
History of Present Illness:
___ G1P1 with h/o bilateral TOAs in ___ s/p ___ guided
drainage and course of abx who presents to ED with lower abd
pain and fever to 102. States recovered well from TOAs in ___
and the day before admission started to have lower abdominal
pain, constant, ___. Had nausea and vomiting. Did not have
vaginal discharge, changes in bowel/bladder habits, or dysuria.
Re: course in ___, was admitted to GYN for PID/bilateral
TOAs. Initially started on gent/clinda. Underwent bilateral ___
guided drainage. ID was consulted who changed abx to zosyn then
unasyn. Discharged home with course of augmentin, but stopped
course early ___ hives. During this course, was ? bowel etiology
s/p CT scan and ACS consult to thought etiology more likely
gynecologic.
The preliminary read on the ___ pelvic ultrasound was:
Complex bilateral adnexal collections with tubular appearance
and internal echoes suggestive of pyosalpinges are new compared
to the prior study of ___.
Past Medical History:
POB/GYNH:
- ___ s/p LTCS.
- Denies hx of STIs, abnormal Pap tests.
- LMP approx 2 weeks ago.
- Sexually active with husband only.
- Endorses dypareunia since c-section ___ years ago.
- Also reports recent yeast infections after intercourse.
PMH:
- Ventricular bigeminy
PSURGH: LTCS
All: latex -> rash, epinephrine -> palpitations
Social History:
___
Family History:
Denies hx of breast, ovary, uterine, colon cancers.
Physical Exam:
Afebrile.
General: appears well, not diaphoretic as on admission
CV: RRR
Resp: bibasilar crackles c/w atelectasis
Abd: soft, non-tender, non-distended. minimal tenderness to
palpation.
Ext: no edema
Skin: no rashes
Pertinent Results:
___ 07:35AM BLOOD WBC-10.2 RBC-4.08* Hgb-12.7# Hct-39.4
MCV-97 MCH-31.0 MCHC-32.2 RDW-13.3 Plt ___
___ 07:30AM BLOOD WBC-7.7 RBC-3.28* Hgb-10.1* Hct-32.6*
MCV-100* MCH-30.8 MCHC-31.0 RDW-13.5 Plt ___
___ 08:10AM BLOOD WBC-12.1* RBC-3.32* Hgb-10.1* Hct-32.5*
MCV-98 MCH-30.6 MCHC-31.2 RDW-13.6 Plt ___
___ 04:45AM BLOOD WBC-14.7* RBC-3.63* Hgb-11.3* Hct-35.1*
MCV-97 MCH-31.1 MCHC-32.2 RDW-13.2 Plt ___
___ 07:15AM BLOOD WBC-15.7* RBC-3.91* Hgb-12.1 Hct-37.6
MCV-96 MCH-30.9 MCHC-32.1 RDW-13.5 Plt ___
___ 09:50PM BLOOD WBC-13.1*# RBC-4.18* Hgb-13.1 Hct-40.4
MCV-97 MCH-31.4 MCHC-32.5 RDW-13.4 Plt ___
___ 07:35AM BLOOD Neuts-75.9* Lymphs-17.3* Monos-6.0
Eos-0.4 Baso-0.3
___ 07:30AM BLOOD Neuts-68.8 ___ Monos-8.7 Eos-0.9
Baso-0.4
___ 08:10AM BLOOD Neuts-85.9* Lymphs-9.0* Monos-4.0 Eos-1.0
Baso-0.1
___ 04:45AM BLOOD Neuts-90.3* Lymphs-6.4* Monos-2.2 Eos-1.0
Baso-0.1
___ 07:15AM BLOOD Neuts-89.6* Lymphs-6.8* Monos-2.9 Eos-0.6
Baso-0.1
___ 09:50PM BLOOD Neuts-88* Bands-2 Lymphs-5* Monos-5 Eos-0
Baso-0 ___ Myelos-0
___ 09:50PM BLOOD Hypochr-NORMAL Anisocy-NORMAL
Poiklo-NORMAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL
___ 07:35AM BLOOD Plt ___
___ 07:35AM BLOOD ___ PTT-34.1 ___
___ 07:30AM BLOOD Plt ___
___ 08:10AM BLOOD Plt ___
___ 08:10AM BLOOD ___ PTT-33.9 ___
___ 04:45AM BLOOD Plt ___
___ 04:45AM BLOOD ___ PTT-34.6 ___
___ 07:15AM BLOOD Plt ___
___ 07:15AM BLOOD ___ PTT-34.2 ___
___ 09:50PM BLOOD Plt Smr-NORMAL Plt ___
___ 07:35AM BLOOD ___
___ 08:10AM BLOOD ___
___ 04:45AM BLOOD ___
___ 07:15AM BLOOD ___
___ 07:35AM BLOOD ESR-88*
___ 04:45AM BLOOD Glucose-95 UreaN-10 Creat-0.7 Na-135
K-3.3 Cl-106 HCO3-20* AnGap-12
___ 09:50PM BLOOD Glucose-92 UreaN-11 Creat-0.7 Na-138
K-3.4 Cl-103 HCO3-21* AnGap-17
___ 07:35AM BLOOD Calcium-8.7 Phos-3.4# Mg-1.8
___ 04:45AM BLOOD Calcium-8.5 Phos-1.7*# Mg-1.7
___ 10:40PM URINE Color-Yellow Appear-Clear Sp ___
___ 10:40PM URINE Blood-NEG Nitrite-NEG Protein-30
Glucose-NEG Ketone-40 Bilirub-NEG Urobiln-NEG pH-7.5 Leuks-SM
___ 10:40PM URINE RBC-<1 WBC-18* Bacteri-FEW Yeast-NONE
Epi-6
Brief Hospital Course:
On ___, Ms. ___ was admitted to the gynecology service
for treatment of suspected bilateral tuboovarian abscesses. She
was febrile the day of admission to 103.0. She was empirically
started on unasyn and doxycycline, which was then changed to
ceftriaxone and flagyl based on culture results from her prior
tuboovarian abscesses. Chlamydia and gonorrhea testing performed
on admission were negative.
A pelvic ultrasound done the day of admission showed bilateral
pyelosalpinges. By pelvic ultrasound, there was not sufficient
fluid to aspirate, so a CT was performed on hospital day two to
better evaluate fluid collections and the presence of pelvic
abscesses. The CT revealed bilateral pyosalpinges and 7 cm
pelvic abscess.
She underwent an ultrasound-guided aspiration of 110ccs from the
abscess and placement of a drain on hospital day two, which
drained 40cc. The gram stain of the fluid from her abscess
showed gram negative rods, but bacteria did not grow for
sensitivities. Blood cultures taken during the admission were
also negative.
On hospital day three the drain fell out, and a follow up
ultrasound showed insufficient fluid for aspiration. On hospital
day three she had a repeat pelvic ultrasound showing fluid
collection and 65cc was aspirated. She had an isolated fever to
101.3, but had shown significant clinical improvement.
Her last fever was 101.1 on hospital day four (___). She was
transitioned to a PO regimen of metronidazole and levofloxacin.
She continued to remain afebrile on hospital day five. Although
the plan was to monitor her vitals and symptoms for a 48-hour
time period, the patient chose to leave against medical advice
on hospital day 5.
During her hospitalization she was also noted to have a
prolonged INR of 2.0 on hospital day one, which was thought to
be due to the imflammatory reaction caused by her pelvic
infection. She was given vitamin K and monitored closely for
bleeding. Her follow up INRs were 1.2-1.4's.
Medications on Admission:
- Clotrimazole-betamethasone 1 %-0.05 % topical cream. Apply to
rash once daily x one week.
Discharge Medications:
1. Levofloxacin 500 mg PO Q24H
RX *levofloxacin 500 mg 1 tablet(s) by mouth daily Disp #*14
Tablet Refills:*0
2. MetRONIDAZOLE (FLagyl) 500 mg PO TID
RX *metronidazole 500 mg 1 tablet(s) by mouth three times a day
Disp #*42 Tablet Refills:*0
Discharge Disposition:
Home
Discharge Diagnosis:
tubo-ovarian abscess
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Ms. ___,
You were admitted to the gynecology service for bilateral
tuboovarian abscesses. You were treated with antibiotics. You
have recovered well and the team believes you are ready to be
discharged home. Please call Dr. ___ office with any
questions or concerns at ___. Please follow the
instructions below.
You should continue to take oral antibiotics - levofloxacin once
daily and metronidazole three times daily up until surgery date,
will discuss if needed post-op.
General instructions:
* Take your medications as prescribed.
* Do not drive while taking narcotics.
* Take a stool softener such as colace while taking narcotics to
prevent constipation.
* Do not combine narcotic and sedative medications or alcohol.
* Do not take more than 4000mg acetaminophen (APAP) in 24 hrs.
* No strenuous activity until your post-op appointment.
Call your doctor for:
* fever > 100.4
* severe abdominal pain
* difficulty urinating
* vaginal bleeding requiring >1 pad/hr
* abnormal vaginal discharge
* nausea/vomiting where you are unable to keep down fluids/food
or your medication
To reach medical records to get the records from this
hospitalization sent to your doctor at home, call ___.
Followup Instructions:
___
|
10821939-DS-21
| 10,821,939 | 25,285,253 |
DS
| 21 |
2147-11-02 00:00:00
|
2147-11-02 16:33:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Major Surgical or Invasive Procedure:
None
attach
Pertinent Results:
ADMISSION LABS
==============
___ 12:21PM BLOOD WBC-9.5 RBC-4.70 Hgb-16.0 Hct-46.8
MCV-100* MCH-34.0* MCHC-34.2 RDW-12.5 RDWSD-46.3 Plt ___
___ 12:21PM BLOOD Neuts-84.0* Lymphs-5.8* Monos-7.7 Eos-1.6
Baso-0.4 Im ___ AbsNeut-7.98* AbsLymp-0.55* AbsMono-0.73
AbsEos-0.15 AbsBaso-0.04
___ 12:21PM BLOOD ___ PTT-26.7 ___
___ 12:21PM BLOOD Glucose-100 UreaN-106* Creat-1.9* Na-131*
K-5.8* Cl-88* HCO3-25 AnGap-18
___ 12:21PM BLOOD Albumin-4.0 Calcium-10.1 Phos-5.3* Mg-2.4
___ 12:21PM BLOOD ALT-16 AST-22 AlkPhos-113 TotBili-0.8
___ 12:21PM BLOOD Lipase-44
___ 12:21PM BLOOD proBNP-4881*
___ 12:21PM BLOOD cTropnT-0.04*
___ 07:17PM BLOOD CK-MB-3 cTropnT-0.02*
PERTINENT STUDIES
=================
___ CT Torso
1. Status post left pneumonectomy, esophagectomy, and gastric
pull-through.
2. Emphysema and evidence of chronic small airway disease in the
right lung.
3. No evidence of recurrent malignancy in the chest.
4. No acute process or evidence malignancy in the abdomen or
pelvis.
5. Cholelithiasis.
6. Heavy colonic stool burden.
DISCHARGE LABS
===============
___ 07:20AM BLOOD WBC-7.2 RBC-3.62* Hgb-12.5* Hct-37.2*
MCV-103* MCH-34.5* MCHC-33.6 RDW-13.1 RDWSD-49.8* Plt ___
___ 07:20AM BLOOD Glucose-94 UreaN-45* Creat-1.1 Na-141
K-5.8* Cl-102 HCO3-27 AnGap-12
___ 07:20AM BLOOD Calcium-9.2 Phos-2.4* Mg-2.2
Brief Hospital Course:
=====================
TRANSITIONAL ISSUES
=====================
[] Adjust diuretic as needed given poor PO intake. Home diuretic
changed to PRN dosing only if patient has weight gain given
presentation with profound intravascular volume depletion.
[] Consider interventions to increase appetite. Patient reports
"acid taste" that makes eating unpleasant, but on PPI
[] Consider uptitrating lisinopril as tolerated. Lisinopril held
on admission iso ___ and symptomatic hypotension, restarted at
much lower dose of 5 mg
[] Repeat CBC and chemistry panel in 1 week, particularly Cr
given ___ on presentation
[] Ensure that patient is up-to-date with all preventative
vaccinations and screenings
[] Review if constipation still present and address accordingly
Discharge wt: 105 lb
Discharge Cr: 1.1
=====================
ASSESSMENT AND PLAN:
=====================
Mr. ___ is an ___ year-old man with a history of HTN, HLD,
HFrEF (EF 30%, severe 4+ MR, 4+ TR), prior stomach and
esophageal adenocarcinoma s/p resection and chemoradiation ___
years ago now in remission, pulmonary HTN, prior L pneumonectomy
for childhood bronchiectasis, hypothyroidism, and atrial
fibrillation, who presents with weakness, profound weight loss,
hypotension, and ___, likely ___ poor PO intake and
intravascular volume depletion.
He received 2L IVF in the ED w/ symptomatic improvement of
weakness and dizziness. His torsemide was held iso likely
intravascular volume depletion. He was then encouraged to
increase PO intake without repeat episodes of weakness or
dizziness. His lisinopril was held and then restarted at a low
dose in the setting of symptomatic hypotension. At discharge,
his BPs were stable and Cr had normalized.
CORONARIES: No significant CAD.
PUMP: EF 34%, 4+ MR, 4+ TR
RHYTHM: atrial fibrillation
===============
ACTIVE ISSUES:
===============
# Dehydration, malnutrition
# ___
The patient presents with subacute to chronic weight loss in the
setting of poor PO intake, which ultimately led to his current
presentation. +orthostatics VS ___, likely intravascular volume
depletion given poor PO intake and patient symptomatically
improving after 2L of IV fluids in the ED. No evidence of
recurrence of malignancy on EGD from ___, however this is
something to consider given his profound weight loss, decreased
PO intake, continued reflux sx through lansoprazole, difficulty
w/ TEE, and esophageal cancer hx x2. Possibly some component
from
GERD given acid reflux sensation. The patient does not appear
volume overloaded, thus making cardiorenal syndrome or a heart
failure exacerbation less likely. We consulted nutrition and
adjusted his diet accordingly. Notably, then recommended tube
feeds if within goals of care of the patient, which we did not
pursue. Her underwent CT torso to evaluate for esophageal
abnormalities given his hx of gastric/esophageal cancer with
recent weight loss and poor PO intake, which was not concerning
for any abnormality. We held home torsemide, initially held
lisinopril iso ___ and symptomatic hypotension, and restarted
lisinopril at low dose prior to discharge.
# HFrEF (last EF 34%):
The patient has HFrEF that appears stable at this time. There is
no clinical evidence of volume overload and BNP is lower than
prior heart failure exacerbation. We held his home diuretic
while giving IVF for intravascular volume depletion and
restarted him on his home dose but PRN given his poor PO intake.
We encouraged PO intake to replete his volume status. Lisinopril
was initially held iso ___ and symptomatic hypotension, and
later restarted lisinopril at low dose prior to discharge for
afterload reduction. Metop was reduced as lisinopril was
uptitrated to keep him hemodynamically stable. We continued home
ASA and statin for primary prevention. He was euvolemic at
discharge.
# Elevated troponin, resolved
Likely type II NSTEMI in the setting of dehydration and poor PO
intake. No evidence of coronary disease on recent cardiac cath
make type I NSTEMI unlikely. Trop downtrended after peak at
0.04.
================
CHRONIC ISSUES:
================
# Atrial fibrillation
Home metop reduced as lisinopril restarted per above. We did not
start anti-coagulation per family and patient discussion with
outpatient cardiologist
# Hypothyroidism
Continued home levothyroxine
# COPD
Continued home inhalers
# GERD
Continued home lansoprazole
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY
2. Cyanocobalamin 1000 mcg PO DAILY
3. Lansoprazole Oral Disintegrating Tab 30 mg PO BID
4. Levothyroxine Sodium 112 mcg PO DAILY
5. Metoprolol Succinate XL 50 mg PO DAILY
6. Simvastatin 5 mg PO QPM
7. Ipratropium Bromide MDI 2 PUFF IH TID
8. Torsemide 20 mg PO DAILY
9. Lisinopril 40 mg PO DAILY
10. Albuterol Inhaler 1 PUFF IH Q6H:PRN wheezing
Discharge Medications:
1. Multivitamins W/minerals 1 TAB PO DAILY
2. Lisinopril 5 mg PO DAILY
RX *lisinopril 5 mg 1 tablet(s) by mouth once a day Disp #*30
Tablet Refills:*0
3. Metoprolol Succinate XL 25 mg PO DAILY
RX *metoprolol succinate 25 mg 1 tablet(s) by mouth once a day
Disp #*30 Tablet Refills:*0
4. Torsemide 20 mg PO DAILY:PRN weight gain more than 3 pounds
RX *torsemide 20 mg 1 tablet(s) by mouth once a day Disp #*30
Tablet Refills:*0
5. Albuterol Inhaler 1 PUFF IH Q6H:PRN wheezing
6. Aspirin 81 mg PO DAILY
7. Cyanocobalamin 1000 mcg PO DAILY
8. Ipratropium Bromide MDI 2 PUFF IH TID
9. Lansoprazole Oral Disintegrating Tab 30 mg PO BID
10. Levothyroxine Sodium 112 mcg PO DAILY
11. Simvastatin 5 mg PO QPM
Discharge Disposition:
Home
Discharge Diagnosis:
PRIMARY DIAGNOSIS
==================
___
SECONDARY DIAGNOSIS
====================
HFrEF
Atrial fibrillation
Hypothyroidism
COPD
GERD
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you at ___
___.
WHY WAS I ADMITTED TO THE HOSPITAL?
==========================================
- You came to the hospital because you were feeling weak. You
were admitted to the hospital because you had kidney injury,
probably from not eating and drinking enough.
WHAT HAPPENED WHILE I WAS IN THE HOSPITAL?
===============================================
- You received a lot of intravenous (IV) fluid because you were
dehydrated. You felt a lot better after you were rehydrated.
- We adjusted your medicines to hopefully prevent you from
getting dehydrated again. Most importantly, you should take your
water pill (torsemide) only when your weight goes up
- A CT scan was done but did not show any abnormal findings in
you chest or abdomen
WHAT SHOULD I DO WHEN I GO HOME?
====================================
- Your discharge weight: 105 pounds. Weigh yourself when you get
home from the hospital without clothes. This will be your
baseline weight.
- If your weight is more than 3 pounds above your baseline (105
lbs) in the morning when you weigh yourself, take 20 mg of your
torsemide. You should continue to check your weight every
morning and take torsemide again if your weight is still more
than 3 pounds above 105 lbs.
- You should continue to take your medications as prescribed.
- If you are experiencing new or concerning chest pain that is
coming and going you should call the heartline at ___.
If you are experiencing persistent chest pain that isn't getting
better with rest or nitroglycerin you should call ___.
- You should also call the heartline if you develop swelling in
your legs, abdominal distention, or shortness of breath at
night.
- You should attend the appointments listed below.
- Weigh yourself every morning, call your doctor if your weight
goes up more than 5 lbs.
- Take over-the-counter Senna and Miralax to prevent
constipation and call your PCP if you are having trouble with
bowel movements.
We wish you the best!
Your ___ Care Team
Followup Instructions:
___
|
10821939-DS-22
| 10,821,939 | 21,608,018 |
DS
| 22 |
2147-12-16 00:00:00
|
2147-12-16 20:06:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Major Surgical or Invasive Procedure:
None
attach
Pertinent Results:
ADMISSION LABS
===============
___ 02:35PM BLOOD WBC-6.8 RBC-4.61 Hgb-15.8 Hct-47.8
MCV-104* MCH-34.3* MCHC-33.1 RDW-15.1 RDWSD-58.6* Plt ___
___ 02:35PM BLOOD Neuts-84.0* Lymphs-6.4* Monos-8.6
Eos-0.1* Baso-0.3 Im ___ AbsNeut-5.73 AbsLymp-0.44*
AbsMono-0.59 AbsEos-0.01* AbsBaso-0.02
___ 02:35PM BLOOD Glucose-99 UreaN-46* Creat-1.5* Na-127*
K-6.6* Cl-87* HCO3-22 AnGap-18
___ 12:37AM BLOOD ___ pO2-53* pCO2-59* pH-7.27*
calTCO2-28 Base XS-0 Comment-GREEN TOP
___ 04:05PM BLOOD K-5.6*
INTERIM LABS
============
___ 09:40PM BLOOD ___
___ 07:28AM BLOOD ___ Folate-18
___ 07:28AM BLOOD Osmolal-281
___ 03:50PM BLOOD CRP-10.8*
___ 07:40AM BLOOD ___ pO2-34* pCO2-58* pH-7.33*
calTCO2-32* Base XS-2 Comment-GREEN TOP
___ 06:24AM BLOOD ___ pO2-29* pCO2-56* pH-7.37
calTCO2-34* Base XS-3 Comment-GREEN TOP
DISCHARGE LABS
===============
___ 07:40AM BLOOD WBC-5.3 RBC-3.65* Hgb-12.4* Hct-38.1*
MCV-104* MCH-34.0* MCHC-32.5 RDW-14.8 RDWSD-57.1* Plt ___
___ 07:40AM BLOOD ___ PTT-28.9 ___
___ 07:40AM BLOOD Glucose-84 UreaN-37* Creat-1.1 Na-134*
K-4.1 Cl-90* HCO3-30 AnGap-14
___ 07:40AM BLOOD ALT-41* AST-49* AlkPhos-120 TotBili-0.7
___ 07:40AM BLOOD Calcium-8.7 Phos-3.0 Mg-1.9
REPORTS
=========
___
IMPRESSION:
Increased opacity at the right lung base appears new from prior
study dated ___, suspicious for aspiration/pneumonia in the
appropriate
clinical setting.
___
IMPRESSION: Moderate global biventricular systolic dysfunction.
At least moderate to severe
mitral and tricuspid regurgitation. Moderate to severe pulmonary
hypertension.
Brief Hospital Course:
ASSESSMENT AND PLAN:
====================
Mr. ___ is an ___ year old male with HFrEF (EF 30%),
severe MR and TR, pulmonary HTN, atrial fibrillation not on AC,
HTN, HLD, a history of stomach and esophageal adenocarcinoma
status post resection and chemoradiation in remission ___
years), and remote L pneumonectomy for bronchiectasis in
childhood; he presented from home to the ED for dyspnea,
fatigue, and poor PO intake. He was found to have a right
basilar pneumonia, was well as acute kidney injury and signs of
fluid overload. His weight on admission was 115 pounds on
admission; this is increased from his last recorded weight of
105 pounds on ___. His pneumonia was treated with IV
antibiotics for 5 days. He underwent several days of IV
diuresis, as well as 1.5L-2L oral fluid restriction, with
significant improvement in clinical status.
TRANSITIONAL ISSUES
====================
[] His lisinopril was held prior to admission for ___. This was
restarted at discharge at 2.5mg daily, to help prevent cardiac
remodeling in Heart Failure.
[] This patient is not on spironolactone, which has been shown
to have a mortality benefit for symptomatic heart failure. His
PCP or cardiologist should consider whether this might be a
useful medication for him.
[] He was discharged on 20mg of Torsemide daily. He has
instructions to weigh himself daily, and to contact his PCP
cardiologist if his weight fluctuates by more than 3 pounds from
his ideal weight.
[] His discharge weight was 107 pounds. He will weigh himself
daily in the morning. If his weight reaches over 110 pounds (an
increase of 3 pounds) or drops to under 104 pounds (a decrease
of 3 pounds), he should call his doctor to make adjustments to
his diuretics.
[] He should continue to discuss the possibility of
venous-access valve replacement with his cardiologist.
[] His PCP should see him within 4 days to assess the following:
-BUN/CR (last 37/1.1)
-Na (last 134)
-K+ (last 4.1)
-weight (last 107.8 pounds).
[] His B12 level was very high in-hospital. For this reason, his
B12 supplementation was stopped. His PCP should consider whether
to restart this supplement.
[] He should take stool softeners for constipation at home as
needed.
# CODE STATUS: FULL CODE (confirmed)
# CONTACT: Name of health care proxy: ___
Relationship: wife
Phone number: ___
Cell phone: ___
ACUTE ISSUES:
=============
# Heart Failure with Reduced EF
Last EF: 34%. Severe mitral and tricuspid regurgitation. His MR
and TR have been severe and progressive, and he is undergoing
outpatient workup with Dr. ___ transcatheter
mitral valve replacement. He presented with an elevated BNP,
hyponatremia, and 10 pound weight gain since last admission,
indicative of likey fluid overload. Per patient report, he was
noting taking his diuretics at all, and was drinking fluids
aggressively, as he was told to avoid dehydration. He was
treated in-hospital with IV lasix and a fluid restriction of 1.5
to 2L daily. With this regimen, he was able to diurese close to
1L of additional fluid per day. Upon discharge, he will continue
on daily diuresis of PO Torsemide 20mg daily, and will continue
on a fluid restriction of 2L. He has strict instructions to call
his PCP/Cardiologist if his weight fluctuates by more than 3
pounds (up or down) from his discharge weight of 107 lbs, in
order to make adjustments to his diuretic regimen.
#Community acquired pneumonia
#?Aspiration pneumonia
Presented with dyspnea x5 days, likely secondary to both
worsening heart failure and R lung opacity noted on chest Xray.
There is some concern for aspiration given location and his
esophageal resection. Bedswide speech and swallow without any
concerns. He was treated with a 5 day course of
ceftriaxone/azithromycin for presumed aspiration pneumonia.
#Atrial Fibrillation
Not on anticoagulation. His metoprolol was initially held, and
he developed tachycardia to the 130's. His metoprolol was
restarted with good effect.
# Combined Respiratory and metabolic acidosis
Patient presented with a venous pH of 7.27, pCO2 59, bicarb 22
and lactate 3.1. His acidosis was likely secondary to his acute
kidney injury, lactic acidosis, incomplete respiratory
compensation due to underlying lung disease and pneumonectomy.
His acid-base status improved with diuresis.
# ___
Patient presented with a creatinine of 1.5, from baseline 0.9.
Given his volume status, the etiology is likely cardiorenal. His
creatinine improved with diuresis, back to baseline. Discharge
BUN/CR: 37/1.1.
# Hyponatremia
Patient presented with hyponatremia to 126, likely hypoosmotic,
hypervolemic hyponatremia due to CHF. It improved daily with
diuresis, although there is likely a chronic component.
Discharge sodium: 134.
# Hyperkalemia
-Initially with serum K 6.6, however whole blood K 5.6 on
recheck. No peaked T-waves on ECG. Likely elevated in the
setting of ___, responsive to IV diuresis. Spironolactone was
held (although it is noted that he has not been taking this
since last hospitalization. Discharge K: 4.1
CHRONIC/RESOLVED ISSUES:
======================
# Hypothyroidism
- continued home Levothyroxine Sodium ___ M-F and 224 ___ and
___
# COPD
- continued home inhalers
# GERD
- continued home lansoprazole
# Moderate pulmonary artery hypertension on TTE ___
# Restrictive lung disease
Followed by Dr. ___ seen ___. Restrictive lung
disease secondary to past pneumonectomy with fairly well
compensated obstructive airway disease and likely intermittent
aspiration. Last PFTs with FEV1 and vital capacity 0.99 and 1.52
(37 and 41% predicted respectively). FEV1 to vital capacity
ratio is 65% (91% predicted). He was continued on home albuterol
2 puffs TID and Atrovent 2 puffs TID
.
.
.
Time in care: >30 minutes in discharge-related activities on the
day of discharge.
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires
further investigation.
1. Aspirin 81 mg PO DAILY
2. Cyanocobalamin 1000 mcg PO DAILY
3. Levothyroxine Sodium 112 mcg PO DAILY
4. Simvastatin 5 mg PO QPM
5. Albuterol Inhaler 1 PUFF IH Q6H:PRN wheezing
6. Metoprolol Succinate XL 25 mg PO DAILY
7. Ipratropium Bromide MDI 2 PUFF IH TID
8. Torsemide 20 mg PO DAILY:PRN weight gain more than 3 pounds
9. Multivitamins W/minerals 1 TAB PO DAILY
10. Lansoprazole Oral Disintegrating Tab 30 mg PO DAILY
11. Levothyroxine Sodium 112 mcg PO 2X/WEEK (___)
Discharge Medications:
1. Lisinopril 2.5 mg PO DAILY
RX *lisinopril 2.5 mg 1 tablet(s) by mouth once a day Disp #*30
Tablet Refills:*0
2. Zinc Sulfate 220 mg PO DAILY Duration: 14 Days
RX *zinc sulfate 220 mg (50 mg zinc) 1 capsule(s) by mouth once
a day Disp #*14 Capsule Refills:*0
3. Torsemide 20 mg PO DAILY
RX *torsemide 20 mg 1 tablet(s) by mouth once a day Disp #*30
Tablet Refills:*0
4. Albuterol Inhaler 1 PUFF IH Q6H:PRN wheezing
5. Aspirin 81 mg PO DAILY
6. Ipratropium Bromide MDI 2 PUFF IH TID
7. Lansoprazole Oral Disintegrating Tab 30 mg PO DAILY
8. Levothyroxine Sodium 112 mcg PO DAILY
9. Levothyroxine Sodium 112 mcg PO 2X/WEEK (___)
10. Metoprolol Succinate XL 25 mg PO DAILY
11. Multivitamins W/minerals 1 TAB PO DAILY
12. Simvastatin 5 mg PO QPM
13. HELD- Cyanocobalamin 1000 mcg PO DAILY This medication was
held. Do not restart Cyanocobalamin until you see your PCP
___:
Home With Service
Facility:
___
Discharge Diagnosis:
FINAL DIAGNOSIS
=================
Heart Failure with Reduced Ejection Fraction
Acute Kidney Injury
Pneumonia
SECONDARY DIAGNOSES
====================
Mitral Regurgitation
Tricuspid Regurgitation
Esophageal Resection
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
It was a privilege caring for you at ___.
WHY WAS I IN THE HOSPITAL?
- You came to the hospital because you were having shortness of
breath, fatigue, and decreased appetite. You were diagnosed with
a pneumonia, and volume overload.
WHAT HAPPENED TO ME IN THE HOSPITAL?
- Your pneumonia was treated with antibiotics through an IV.
- Your weight was up significantly from your last
hospitalization. For this reason, you were started on
medications to remove excess fluid from your body.
- With the medications, your weight decreased, and your overall
status improved.
- You were feeling better, and you were ready to leave the
hospital.
WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?
- Weigh yourself as soon as you get home from the hospital, and
record this weight. This is your goal weight, as you are feeling
good at this weight.
-Continue to weigh yourself each day, before you eat and before
you take your medications.
-If your weight increases by more than 3 pounds from your goal
weight at any point, you may need to increase your diuretic dose
because you are holding on to too much water. You should call
your cardiologist if this happens.
-If your weight decreased by more than 3 pounds from your goal
weight at any time, and you are feeling dizzy, weak, or
lightheaded, you may need to decrease your diuretic dose because
you are losing too much water. You should call your cardiologist
if this happens.
-Please drink only when you are thirsty, and do not force
yourself to drink. You should drink about 2L of fluid each day.
-You should take stool softeners at home so that you have a
bowel movement every few days.
We wish you the best!
Sincerely,
Your ___ Team
Followup Instructions:
___
|
10821939-DS-23
| 10,821,939 | 21,615,317 |
DS
| 23 |
2148-01-07 00:00:00
|
2148-01-08 10:42:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___
Major Surgical or Invasive Procedure:
none
attach
Pertinent Results:
ADMISSION LABS
==============
___ 05:35PM BLOOD WBC-5.3 RBC-4.32* Hgb-14.8 Hct-46.3
MCV-107* MCH-34.3* MCHC-32.0 RDW-15.6* RDWSD-62.2* Plt ___
___ 05:40AM BLOOD WBC-4.5 RBC-4.18* Hgb-14.2 Hct-44.9
MCV-107* MCH-34.0* MCHC-31.6* RDW-15.7* RDWSD-61.7* Plt ___
___ 05:35PM BLOOD Plt ___
___ 05:40AM BLOOD ___ PTT-31.2 ___
___ 05:40AM BLOOD Plt ___
___ 06:45AM BLOOD ___ PTT-28.6 ___
___ 05:35PM BLOOD Glucose-99 UreaN-32* Creat-1.4* Na-144
K-4.7 Cl-99 HCO3-30 AnGap-15
___ 05:40AM BLOOD Glucose-98 UreaN-36* Creat-1.3* Na-144
K-4.4 Cl-98 HCO3-33* AnGap-13
___ 04:55PM BLOOD Glucose-140* UreaN-39* Creat-1.3* Na-144
K-3.9 Cl-97 HCO3-32 AnGap-15
___ 06:45AM BLOOD Glucose-125* UreaN-41* Creat-1.4* Na-145
K-5.2 Cl-100 HCO3-31 AnGap-14
___ 05:35PM BLOOD cTropnT-0.04*
___ 05:35PM BLOOD ___
___ 05:40AM BLOOD Calcium-9.8 Phos-4.9* Mg-2.1 Iron-86
___ 04:55PM BLOOD Calcium-9.2 Phos-4.3 Mg-2.1
___ 06:45AM BLOOD Calcium-9.7 Phos-4.4 Mg-2.2
INTERVAL LABS
================
___ 06:45AM BLOOD WBC-5.7 RBC-3.84* Hgb-13.0* Hct-41.2
MCV-107* MCH-33.9* MCHC-31.6* RDW-15.9* RDWSD-62.6* Plt ___
___ 06:45AM BLOOD ___ PTT-28.6 ___
___ 05:40PM BLOOD Glucose-95 UreaN-37* Creat-1.3* Na-143
K-4.8 Cl-99 HCO3-36* AnGap-8*
___ 12:45PM BLOOD Glucose-130* UreaN-53* Creat-2.6* Na-143
K-5.5* Cl-99 HCO3-31 AnGap-13
___ 07:29PM BLOOD Glucose-99 UreaN-56* Creat-2.3* Na-145
K-4.9 Cl-99 HCO3-31 AnGap-15
___ 06:40AM BLOOD Glucose-108* UreaN-58* Creat-2.3* Na-144
K-5.4 Cl-98 HCO3-29 AnGap-17
___ 12:45PM BLOOD Calcium-9.1 Phos-6.5* Mg-2.3
___ 07:29PM BLOOD Calcium-10.1 Phos-5.6* Mg-2.4
___ 06:40AM BLOOD Calcium-9.8 Phos-5.6* Mg-2.3
DISCHARGE LABS
==============
___ 06:40AM BLOOD WBC-7.5 RBC-3.42* Hgb-11.9* Hct-37.6*
MCV-110* MCH-34.8* MCHC-31.6* RDW-16.4* RDWSD-65.6* Plt ___
___ 07:06AM BLOOD ___ PTT-27.2 ___
___ 06:26AM BLOOD Glucose-100 UreaN-60* Creat-2.2* Na-146
K-4.9 Cl-102 HCO3-27 AnGap-17
IMAGING
=======
___ CXR
IMPRESSION:
Status post left pneumonectomy an esophagectomy with gastric
pull-through,
with similar postoperative appearance.
Slight blunting of the right costophrenic angle is similar to
possibly
slightly improved. No definite new focal consolidation.
___ CXR
IMPRESSION:
1. Status post left pneumonectomy and esophagectomy with gastric
pull-through,
with similar postoperative appearance.
2. Unchanged opacity at the right lung base, most consistent
with atelectasis
or aspiration/pneumonia in the appropriate clinical setting.
Otherwise, there
is no evidence of new focal consolidation within the right
hemithorax.
Brief Hospital Course:
Mr. ___ is an ___ y/o M w/ PMH of HFrEF (EF 30%), severe
MR and TR, pulmonary HTN, atrial fibrillation not on AC, HTN,
HLD, h/o stomach and esophageal adenocarcinoma s/p resection and
chemoradiation in remission ___ years), and remote L
pneumonectomy for bronchiectasis in childhood who presented
___ with intermittent dyspnea, weight loss and ___, improving
with diuresis but then diuresis was held iso relative
hypotension and developed ATN ___ poor PO intake because of
dietary restrictions for aspiration risk. ___ was initially
recommended to have a feeding tube however patient had declined.
___ was discharged on ___ with TMVR eval outpatient on ___,
and discharged on diet recommendation of pureed/nectar
pre-thickened liquids in the time being until ___ is evaluated by
speech and swallow as an outpatient. ___ was also noted to have a
superficial thrombophlebitis in the right arm which is treated
with heat packs and was newly started on apixaban this admission
for Afib stroke prophylaxis.
TRANSITIONAL ISSUES
===================
[ ] Lisinopril 2.5mg was held secondary to ___, and home
diuretics were also stopped due to relative hypotension / ___.
[ ] Patient to complete swallowing evaluation including VEES in
the Speech and Swallow Department as an outpatient. The
inpatient ___ team has arranged this appointment and the
patient has the information to call to confirm.
[ ] Per ENT: will require follow up in ___ clinic.
Please call ___ upon discharge to arrange f/u with Dr.
___.
[ ] Please ensure R arm superficial thrombophlebitis is
improving with warm compress. Note ___ is on apixaban 2.5mg BID
for stroke prophylaxis for Afib.
[ ] New Medications:
- apixaban 2.5mg BID. previously denied anticoagulation for
stroke prophylaxis but was open to it this admission.
ACTIVE ISSUES
=============
# HFrEF
# Severe MR
___ has HFrEF with 4+ MR, pHTN, and TR and is currently
undergoing outpatient workup with Dr. ___ transcatheter
mitral valve replacement. His pulmonary symptoms with which ___
presented are more likely due to his severe MR and pHTN. The
patient responded well to IV diuresis for 2 days and then was
euvolemic ___. Given that fact and had poor PO intake (due to
aspiration risk) and relative hypotension, no further diuresis
was given since ___ held iso relative hypotension. ___ developed
___ (ATN) ___ for which ___ was cautiously given fluid and
improved creatinine. ___ was euvolemic on discharge. His
evaluation for TMVR was deferred to the outpatient setting,
given his clinical euvolemia and patient desire to return home.
___ has close follow-up with Cardiology that was arranged while
in house. Discharge Cr 2.2, Discharge weight 101.1 lb. Not any
diuretics upon discharge.
# Dysphagia
Patient has had long standing dysphagia, secondary to R vocal
cord paralysis which is chronic issue for him since
esophagectomy. During this admission, the patient had repeated
evaluations by Speech and Swallow who initially had limited his
diet to NPO but then subsequently, after visualization, agreed
with advancing diet. ENT performed a laryngoscopy and reported
that the vocal cords approximate well even with L vocal cord
paralyzed, and recommended BID PPI.
# ___
Possibly in the setting worsening heart failure as above vs to
lisinopril which was restarted during his last admission. Cr
responded well to IV diuresis for 2 days and then was euvolemic
___. Given that fact and had poor PO intake (due to aspiration
risk) and relative hypotension, no further diuresis was given
since ___ held iso relative hypotension. ___ then developed an
___ (ATN) ___ for which ___ was cautiously given fluid and
improved creatinine. Discharge Cr was 2.2.
# Weight loss / FTT
Likely due to worsening heart failure and poor PO intake. ___
does have a history of malignancy, however CT CAP ___
without evidence of malignancy. Low concern at this time.
# Atrial fibrillation CHAD2VASC 5
Patient's beta blockade was adjusted throughout this
hospitalization, with blood pressures that were sensitive to the
escalating doses, and thus his lisinopril was held. Discharged
on metop succinate 25 mg daily.
#Superficial thrombophlebitis R arm
Patient has a marked off superficial thrombophlebitis on Right
lower arm from IV site. Treated with warm compress and plan for
re-evaluation on follow up. Note ___ was newly started on
apixaban 2.5mg for Afib dosing which is not ideal for VTE
dosing.
CHRONIC
=======
# Macrocytosis
Vit B12 previously greater than essay. Folate was wnl. Patient
denies ETOH use. Likely due to poor nutrition.
# Hypothyroidism
Patient was continued on home levothyroxine ___ M-F, 224 ___ and
___.
# GERD
Continued home lansoprazole. Also recommended by ENT for help
with vocal cord dysfunction.
# CODE STATUS: FULL CODE
# CONTACT: Name of health care proxy: ___
Relationship: wife
Phone number: ___
Cell phone: ___
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol Inhaler 1 PUFF IH Q6H:PRN wheezing
2. Aspirin 81 mg PO DAILY
3. Lansoprazole Oral Disintegrating Tab 30 mg PO BID
4. Levothyroxine Sodium 112 mcg PO DAILY
5. Levothyroxine Sodium 112 mcg PO 2X/WEEK (___)
6. Metoprolol Succinate XL 25 mg PO DAILY
7. Multivitamins W/minerals 1 TAB PO DAILY
8. Simvastatin 5 mg PO QPM
9. Torsemide 20 mg PO DAILY
10. Ipratropium Bromide MDI 2 PUFF IH TID
11. Zinc Sulfate 220 mg PO DAILY
12. Lisinopril 2.5 mg PO DAILY
13. Famotidine 40 mg PO QHS
14. Mirtazapine 7.5 mg PO QHS
Discharge Medications:
1. Apixaban 2.5 mg PO BID
RX *apixaban [Eliquis] 2.5 mg 1 tablet(s) by mouth twice a day
Disp #*60 Tablet Refills:*0
2. Albuterol Inhaler 1 PUFF IH Q6H:PRN wheezing
3. Aspirin 81 mg PO DAILY
4. Famotidine 40 mg PO QHS
5. Ipratropium Bromide MDI 2 PUFF IH TID
6. Lansoprazole Oral Disintegrating Tab 30 mg PO BID
7. Levothyroxine Sodium 112 mcg PO DAILY
8. Levothyroxine Sodium 112 mcg PO 2X/WEEK (___)
9. Metoprolol Succinate XL 25 mg PO DAILY
10. Mirtazapine 7.5 mg PO QHS
11. Multivitamins W/minerals 1 TAB PO DAILY
12. Simvastatin 5 mg PO QPM
13. Zinc Sulfate 220 mg PO DAILY
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
PRIMARY DIAGNOSIS
==================
# Heart Failure with Reduced Ejection Fraction
# Chronic Obstructive Pulmonary Disease
SECONDARY DIAGNOSIS
===================
# Malnutrition
# Chronic Dysphagia
# Gastrointestinal Reflux Disease
# R Arm Superficial Thrombophlebitis
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you at ___!
Why was I hospitalized?
========================
You were admitted to the hospital with worsening shortness of
breath.
What happened to me while I was here?
=======================================
You had a chest xray which showed extra fluid in the lung. You
received intravenous Lasix to help get the fluid out.
Your medications for heart rate and blood pressure were
adjusted.
You were seen by the ENT team and the Swallowing team for
evaluation of your swallowing ability. Your vocal cords are
intact. You are still at in increased risk of aspiration and
choking, however.
You were evaluated by the nutrition team who made
recommendations about your diet.
You had a superficial blood clot on your right arm, it is not
worrisome if you take your new medicine apixaban which is
primarily used for your atrial fibrillation.
What should I do when I go home?
==================================
Weigh yourself every morning, call MD if weight goes up more
than 3
lbs.
Please make sure that you take all of your medications and that
you go to all of your appointments.
Please contact speech and swallow in below information to
confirm appointment for test.
We wish you the best!
Your ___ care team
Followup Instructions:
___
|
10822122-DS-2
| 10,822,122 | 25,252,686 |
DS
| 2 |
2145-07-29 00:00:00
|
2145-07-29 12:57:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___
Chief Complaint:
L hip pain
Major Surgical or Invasive Procedure:
L hip aspiration by ___ (___)
History of Present Illness:
___ with PMH hx IVDU (on methadone), s/p L hip replacement
___ (at ___), HTN, and asthma p/w worsening L hip pain.
Following hip replacement, pt was in rehab until ___. Has been
walking with walker. Was initially on oxycodone 5mg q8h
following surgery, but has since run out of her prescription.
Had a fall 1 month ago, slipped on ice outside her home.
Reportedly went to ___ after the fall and was told
something may be broken, went to see her orthopedic surgeon at
___ on ___ and was told hip has fracture that will heal
without intervention. She states that pain has become
increasingly severe, and she has been unable to ambulate for the
last 2 days due to pain. Not currently taking anything for pain
at home other than usual methadone; states no relief from advil
or tylenol. Methadone dose is 120mg daily; pt already received
dose today prior to admission (confirmed with Ed ___,
Habit Opco, ___ Pt denies new trauma, fevers,
chills, joint swelling, warmth near joint, bleeding, abdominal
pain, N/V. Pt denies recent IVDU.
In the ED, initial vital signs were: 10 98.2 68 150/89 16 97%
Labs were notable for normal WBC. X ray L hip: on prelim read:
total left hip prosthesis appears intact without evidence of
loosening or fracture. In ED pt was given 1L IVF, 30mg toradol
without relief, 1mg dilaudid with mild relief; still unable to
ambulate.
On Transfer Vitals were: 97.5 68 161/92 18 97% RA.
Past Medical History:
-Arthritis s/p L hip replacement ___
-HTN
-Asthma
-Blind in R eye secondary to trauma
-Chronic back pain
-Abdominal hernia s/p surgery
-hx narcotic abuse, on methadone maintenance
Social History:
___
Family History:
Sister and son with DM.
Physical Exam:
On admission:
Vitals- 97.9 156/85 68 18 98%
General- Alert, oriented, no acute distress
HEENT- Sclera anicteric, MMM, oropharynx clear
Neck- supple, JVP not elevated, no LAD
Lungs- Clear to auscultation bilaterally, no wheezes, rales,
ronchi
CV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,
gallops
Abdomen- soft, non-tender, non-distended, bowel sounds present,
no rebound tenderness or guarding
GU- no foley
Ext- Scar over L lateral pelvis; L anterior and lateral thigh
and hip tender to palpation; Pt unable to actively flex L leg at
hip; pain with passive motion at L hipo; warm, well perfused, no
clubbing, cyanosis or edema
On discharge:
Vitals- 98.8 129/73 73 18 99%RA
General- Alert, oriented, NAD
HEENT- Sclera anicteric, MMM, oropharynx clear
Lungs- Clear to auscultation bilaterally, no wheezes, rales,
ronchi
CV- Regular rate and rhythm, systolic murmur best heart at L ___
intercostal space radiating to carotid
Abdomen- obese, soft, non-tender, non-distended, bowel sounds
present, no rebound tenderness or guarding
GU- no foley
Ext- Scar over L lateral pelvis; L lateral pelvis/flank tender
to palpation; unable to actively flex L leg at hip; able to
tolerate some passive L hip flexion without pain
Pertinent Results:
====================
Labs:
====================
___ 08:50AM BLOOD WBC-6.5 RBC-3.94* Hgb-11.3* Hct-37.2
MCV-94 MCH-28.7 MCHC-30.4* RDW-17.7* Plt ___
___ 08:50AM BLOOD Neuts-52.4 ___ Monos-5.3 Eos-3.0
Baso-0.9
___ 10:00AM BLOOD ___ PTT-32.8 ___
___ 10:00AM BLOOD ESR-50*
___ 08:50AM BLOOD Glucose-91 UreaN-14 Creat-0.8 Na-134
K-8.3* Cl-101 HCO3-25 AnGap-16
___ 08:50AM BLOOD ASA-NEG* Ethanol-NEG Acetmnp-NEG
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 10:00AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 08:05AM BLOOD WBC-6.3 RBC-4.07* Hgb-11.7* Hct-38.0
MCV-93 MCH-28.7 MCHC-30.7* RDW-16.9* Plt ___
___ 08:05AM BLOOD Glucose-91 UreaN-31* Creat-1.1 Na-135
K-4.6 Cl-102 HCO3-25 AnGap-13
====================
Micro:
====================
___ blood cultures: negative
___ blood cultures: negative
___ 3:00 pm JOINT FLUID LEFT HIP .
GRAM STAIN (Final ___:
NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
NO MICROORGANISMS SEEN.
FLUID CULTURE (Final ___: NO GROWTH.
ACID FAST SMEAR (Final ___:
SPECIMEN NOT PROCESSED DUE TO: QUANTITY NOT SUFFICIENT.
Reported to and read back by ___. ___ @ 1745 ON
___.
TEST CANCELLED, PATIENT CREDITED.
ACID FAST CULTURE (Final ___:
SPECIMEN NOT PROCESSED DUE TO: QUANTITY NOT SUFFICIENT.
Reported to and read back by ___ @ 1745 ON
___.
TEST CANCELLED, PATIENT CREDITED.
FUNGAL CULTURE (Preliminary): NO FUNGUS ISOLATED.
ANAEROBIC CULTURE (Final ___: NO GROWTH.
====================
Imaging:
====================
HIP UNILAT MIN 2 VIEWS LEFT Study Date of ___ 8:54 AM
FINDINGS: Patient is status post left total hip prosthesis with
non-cemented femoral stem. The femoral head component appears
symmetrically seated within the acetabular component. Several
plates and associated screws and a wire mesh type device also
noted securing the acetabulum. There is no periprosthetic
lucency to suggest loosening and no osteolysis is detected. No
significant heterotopic ossification is noted. There is
irregularity and cortical disruption of the left iliopectineal
line and left inferior pubic ramus, possibly from prior trauma
or related to surgery but margins appear sclerotic.
IMPRESSION: Total left hip prosthesis appears intact without
evidence of loosening or fracture. No prior for comparison.
Irregularity and cortical disruption of the left iliopectineal
line and left inferior pubic ramus, possibly from prior trauma
or related to surgery but margins appear sclerotic.
Brief Hospital Course:
___ with PMH hx IVDU (on methadone), s/p L hip replacement
___ (at ___), HTN, and asthma who presented with worsening L
hip pain.
# L hip pain, s/p L hip replacement ___: Xray negative for
acute fracture. Per ortho, pt with healing L ramus fracture on
xray. Despite lack of fever of leukocytosis, L hip aspiration
performed ___ to rule out infection, particularly given history
of IVDU. No growth to date from joint or blood cultures. Pt
continues to have pain with activity and unable to weight bear
on L ___. Pain being treated with tylenol, oxycodoen, lidocaine
patch, and gabapentin, in addition to home methadone. Tizanidine
was prescribed as recommended by Pain Service but discontinued
after pt developed asymptomatic hypotension (SBP 80). Ortho
recommended weight bearing as tolerated. She continued to work
with ___ daily. Pt to follow up with ortho as outpt.
# Hypotension, likely secondary to pain medications: Pt had an
episode of SBP drop to 80, without symptoms, which occured after
being started on tizanidine and increased doses of oxycodone.
SBP recovered to >90 after 1L NS. Oxycodone was reduced and
tizanidine was discontinued. Amlodipine was also discontinued
and lisinopril dose reduced. HCTZ dose being reduced on
discharge, as pt complaining of polyuria.
# H/o IVDU: Pt denies recent use. On methadone 120mg daily as
outpt (confirmed with clinic). Utox and serum tox negative. QTc
434 on ___. Was continued on home methadone 120mg daily.
# HTN: Pt was continued on home HCTZ and lisinopril. Amlodipine
was held after pt had an episode of hypotension (SBP 80), and
lisinopril dose was reduced from 40mg to 20mg daily. HCTZ dose
being reduced on discharge, as pt complaining of polyuria. Also
continued on home aspirin.
# Asthma: Was treated with albuterol neb prn.
Transitional issues:
-Gabapentin dose may be uptitrated to 600mg TID as tolerated
-Pt to follow up with ortho at ___
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Hydrochlorothiazide 25 mg PO DAILY
2. Lisinopril 40 mg PO DAILY
3. Aspirin 81 mg PO DAILY
4. albuterol sulfate 90 mcg/actuation inhalation unknown
5. Methadone 120 mg PO DAILY
6. Amlodipine 10 mg PO DAILY
Discharge Medications:
1. Aspirin 81 mg PO DAILY
2. Methadone 120 mg PO DAILY
3. Acetaminophen 1000 mg PO TID
4. Docusate Sodium 100 mg PO BID
5. Polyethylene Glycol 17 g PO DAILY constip
6. Senna 8.6 mg PO BID constip
7. albuterol sulfate 90 mcg/actuation inhalation unknown
8. Lidocaine 5% Patch 1 PTCH TD QAM hip
9. OxycoDONE (Immediate Release) 10 mg PO Q4H:PRN pain
10. Famotidine 20 mg PO BID
11. Gabapentin 300 mg PO TID
12. Lisinopril 20 mg PO DAILY
13. Hydrochlorothiazide 12.5 mg PO DAILY
Discharge Disposition:
Extended Care
Facility:
___
Discharge Diagnosis:
L hip pain s/p L hip replacement
History of IVDU
HTN
Asthma
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or
wheelchair.
Discharge Instructions:
Dear Ms. ___,
It was a pleasure to care for you. You were hospitalized due to
hip pain. We were concerned your about the possibility of
infection causing the left hip pain, and so interventional
radiology withdrew fluid from the joint. The joint fluid and
other tests did not show any evidence of infection. You have a
follow up appointment with Dr. ___. Please take
your medications as prescribed and attend your follow up
appointments.
Followup Instructions:
___
|
10822122-DS-3
| 10,822,122 | 29,536,759 |
DS
| 3 |
2145-09-07 00:00:00
|
2145-09-07 11:18:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
nuts
Attending: ___.
Chief Complaint:
L Hip Pain, R Leg Numbness
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ with PMH hx IVDU (on methadone), s/p L hip replacement
___ (at ___), HTN, and asthma, with recent admission
___ for hip pain, who presents with worsened hip
pain and L leg numbness.
Following hip replacement in ___, pt was in rehab until ___.
Was initially on oxycodone 5mg q8h following surgery, but then
ran out of medication. Had a fall in ___, slipped on ice
outside her home.
Reportedly went to ___ after the fall and was told
something may be broken, went to see her orthopedic surgeon at
___ on ___ and was told hip has fracture that will heal
without intervention. Pain increased to the point she was unable
to ambulation. Was admitted in ___ and given
analgesics.
On that admission, there was initialy concern for infection, but
blood and joint fluid cultures were negative. On discharge, went
to ___. Was discharged home ___ and has since been on
tylenol and gabapentin for pain (in addition to mathadone). 3
days ago L hip pain increased, which has prevented ambulation;
she had been ambulation with walker at home. Reports pain over L
low back, buttocks, and thigh. She also reports R leg numbness.
Pt denies new trauma, fevers, chills, SOB, dysuria, diarrhea,
feeling lightheaded. She reports intermittent nausea over last 2
weeks without emesis.
In the ED, initial vital signs were:98.4 90 161/85 20 96%. Labs
were notable for WBC 6.5, ESR 63, CRP 3.0. Patient was given
diazpema 5mg po, ketorolac 30mg IV, oxycodone-aceaminophen x
multipls doses, morphine 5mg IV x2, and percocet. Was also given
home meds: aspirin, HCTZ 25, lisinopril 40, gabapentin,
methadone 120mg daily.
Pt was evaluated by ortho who felt hip xray appeared unchanged
from priors obtained one month ago, without evidence of hardware
loosening or acute fracture. Felt no acute surgical intervention
needed at this time. Pt was admitted for pain control and
placement.
On Transfer Vitals were: Today ___ 77 160/99 16 98% RA
Past Medical History:
-Arthritis s/p L hip replacement ___
-HTN
-Asthma
-Blind in R eye secondary to trauma
-Chronic back pain
-Abdominal hernia s/p surgery
-hx narcotic abuse, on methadone maintenance
Social History:
___
Family History:
Sister and son with DM.
Physical Exam:
On admission:
Vitals- 98.0 150/90 79 16 99%RA
General- Alert, oriented, no acute distress
HEENT- Sclera anicteric, MMM, oropharynx clear
Neck- supple, JVP not elevated
Lungs- Clear to auscultation bilaterally, no wheezes, rales,
ronchi
CV- Regular rate and rhythm, +systolic murmur
Abdomen- soft, non-tender, non-distended, bowel sounds present,
no rebound tenderness or guarding
GU- no foley
Ext- Scar over L lateral pelvis without erythema or drainage; L
anterior and lateral thigh, L buttocks, and L lower back tender
to palpation; pt unable to actively flex L leg at hip; no pain
with passive flexion of L hip; no clubbing, cyanosis or edema;
sensation to light touch intact on ___ bilaterally
.
On discharge:
VS: 98.6/97.5 92 148/87 18 96% RA
GEN: Seated in chair, mildly uncomfortable ___ pain
HEENT: Sclera anicteric, MMM, oropharynx clear
RESP: CTABL, no w/r/r
CV: RR, S1+S2, systolic crescendo murmur throughout precordium
ABD: SNTND, normoactive BS
EXT: Scar over L hip well-healing without surrounding erythma,
exquisitely tender over L trochanter.
NEURO: no sensation to light touch on R lateral thigh, distal
strength and sensation intact
Pertinent Results:
Admission Labs
==============
___ 10:18AM BLOOD WBC-6.5 RBC-3.91* Hgb-11.2* Hct-36.4
MCV-93 MCH-28.6 MCHC-30.7* RDW-17.5* Plt ___
___ 07:30AM BLOOD WBC-5.0 RBC-3.80* Hgb-11.2* Hct-35.8*
MCV-94 MCH-29.5 MCHC-31.3 RDW-17.2* Plt ___
___ 10:18AM BLOOD Neuts-54.3 ___ Monos-6.4 Eos-2.8
Baso-0.4
___ 10:18AM BLOOD ESR-63*
___ 10:18AM BLOOD Glucose-104* UreaN-10 Creat-0.8 Na-141
K-3.7 Cl-101 HCO3-32 AnGap-12
___ 07:30AM BLOOD Glucose-83 UreaN-19 Creat-1.0 Na-136
K-4.4 Cl-100 HCO3-28 AnGap-12
___ 07:30AM BLOOD CK(CPK)-44
___ 03:30PM BLOOD CK(CPK)-44
___ 07:30AM BLOOD CK-MB-3 cTropnT-<0.01
___ 03:30PM BLOOD CK-MB-3 cTropnT-<0.01
___ 10:18AM BLOOD Calcium-9.0 Phos-3.3 Mg-1.6
___ 07:30AM BLOOD Calcium-8.9 Phos-3.9 Mg-1.8
___ 10:18AM BLOOD CRP-3.0
___ 07:58PM URINE Color-Yellow Appear-Clear Sp ___
___ 07:58PM URINE Blood-NEG Nitrite-NEG Protein-30
Glucose-NEG Ketone-TR Bilirub-SM Urobiln-4* pH-6.0 Leuks-TR
___ 07:58PM URINE RBC-0 WBC-1 Bacteri-NONE Yeast-NONE Epi-4
___ 07:58PM URINE CastHy-4*
___ 07:58PM URINE Mucous-FEW
.
.
Imaging
=======
HIP UNILAT MIN 2 VIEWS LEFT Study Date of ___ 10:29 AM
FINDINGS: AP pelvis and multiple views of the left hip were
provided. In comparison with the prior exam, there are again
noted to be fractures
involving the left inferior pubic ramus and left acetabulum,
which appears similar in overall alignment from prior exam. The
left hip prosthesis is also similarly positioned although given
the findings of the acetabular fracture, compromise of the
hardware is a strong concern. Please correlate clinically and
consider CT to further assess. Alternatively, if there are
prior imaging studies to assess the postoperative appearance of
this left hip arthroplasty that would be helpful for overall
assessment.
.
TTE (Complete) Done ___ at 3:42:54 ___
The left atrium is mildly dilated. There is mild symmetric left
ventricular hypertrophy with normal cavity size. Right
ventricular chamber size and free wall motion are normal. The
aortic arch is mildly dilated. The aortic valve leaflets (3) are
mildly thickened but aortic stenosis is not present. There is no
valvular aortic stenosis. The increased transaortic velocity is
likely related to high cardiac output. No aortic regurgitation
is seen. The mitral valve leaflets are mildly thickened. Mild
(1+) mitral regurgitation is seen. [Due to acoustic shadowing,
the severity of mitral regurgitation may be significantly
UNDERestimated.] The pulmonary artery systolic pressure could
not be determined. There is no pericardial effusion.
IMPRESSION: Suboptimal image quality due to body habitus. Left
and right ventricular systolic function are probably normal, a
focal wall motion abnormality cannot be excluded. Mild mitral
regurgitation. Unable to assess pulmonary artery systolic
pressure.
.
.
Discharge Labs
==============
No labs gathered since admission.
Brief Hospital Course:
___ with PMH hx IVDU (on methadone), s/p L hip replacement
___ (at ___), HTN, and asthma, with recent admission
___ for hip pain, who presents with worsened L hip
pain and R leg numbness.
.
Acute Issues
=============
# L hip pain, R thigh numbness: S/p L hip replacement ___,
with reported intermittent severe pain since. Had admission
___ with negative infectious workup including joint fluid and
blood cultures. Ongoing pain may be secondary to prior
fractures. Secondary gain thought also possible. Infection less
likely given no fevers, normal WBC and symptoms similar to prior
presentation with negative infectious workup. ESR elevated on
admission, but similar to prior. Evaluated by ortho, who did not
recommend acute surgical intervention. Pain treated with tylenol
and oxycodone. Also continued on home gabapentin. R thigh
pain/numbness deemed due to nerve injury that occured in
operative period, as has been an issue since that time.
Discharged with short course of oxycodone.
.
# EKG changes: Pt with biphasic T waves in precordial leads on
admission. However, lack of chest pain, negative cardiac
enzymes, and lack of wall motion abnormalities on echo made
acute ischemia/infarction is unlikely. Asymptomatic throughout
admission.
.
# Nausea: Pt reported intermittent nausea for weeks prior to
admission. ___ be secondary to opiate use or constipation.
Cardiac ischemia considered unlikely, per above. Pt did not have
emesis during admission and appeared to have good po intake. Was
treated with bowel regimen and discharged with this for duration
of oxycodone prescription.
.
.
Chronic Issues
==============
# H/o IVDU: Pt denied recent use. On methadone 120mg daily as
outpt, which was continued during admission. QTc was not
prolonged.
.
# HTN: Continued on lisinopril and HCTZ.
.
# Asthma: Stable. Treated with albuterol prn.
.
.
Transitional issues
===================
- Please continue to wean off oxycodone as tolerated
- Code: Full
- Emergency Contact: sister ___ (___)
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY
2. Methadone 120 mg PO DAILY
3. Acetaminophen 650 mg PO Q8H:PRN pain
4. Docusate Sodium 100 mg PO BID
5. Polyethylene Glycol 17 g PO DAILY constip
6. Senna 8.6 mg PO BID constip
7. albuterol sulfate 2 puffs inhalation BID prn shortness of
breath
8. Gabapentin 300 mg PO TID
9. Lisinopril 20 mg PO DAILY
10. Hydrochlorothiazide 12.5 mg PO DAILY
Discharge Medications:
1. Acetaminophen 650 mg PO Q8H:PRN pain
2. albuterol sulfate 2 puffs inhalation BID prn shortness of
breath
3. Aspirin 81 mg PO DAILY
4. Docusate Sodium 100 mg PO BID
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day
Disp #*14 Capsule Refills:*0
5. Gabapentin 300 mg PO TID
RX *gabapentin [Neurontin] 300 mg 1 capsule(s) by mouth three
times a day Disp #*90 Capsule Refills:*0
6. Hydrochlorothiazide 12.5 mg PO DAILY
7. Lisinopril 20 mg PO DAILY
8. Methadone 120 mg PO DAILY
9. Polyethylene Glycol 17 g PO DAILY constip
RX *polyethylene glycol 3350 17 gram 1 packet by mouth daily
Disp #*7 Packet Refills:*0
10. Senna 8.6 mg PO BID constip
RX *sennosides [senna] 8.6 mg 1 capsule by mouth twice a day
Disp #*14 Capsule Refills:*0
11. Ibuprofen 400 mg PO Q8H:PRN pain
RX *ibuprofen 400 mg 1 tablet(s) by mouth q8h:prn Disp #*90
Tablet Refills:*0
12. Lidocaine 5% Patch 1 PTCH TD QAM
RX *lidocaine 5 % (700 mg/patch) Apply one patch, remove after
12 hours QAM:prn Disp #*30 Unit Refills:*0
13. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN pain
RX *oxycodone 5 mg 1 tablet(s) by mouth q4h:prn Disp #*28 Tablet
Refills:*0
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
Primary:
-L hip pain status/post L hip replacement
Secondary:
-History of IV drug use
-HTN
-Asthma
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Dear Ms. ___,
It was a pleasure to care for you. You were hospitalized due to
hip pain. You were evaluated by orthopedics, who did not
recommend a surgical intervention. Imaging of your hip was
similar to prior imaging. You were given medications for pain
control.
Please take your medication as prescribed, and attend your
follow up appointments.
Thank you for allowing us to be part of your care.
Followup Instructions:
___
|
10822122-DS-4
| 10,822,122 | 21,384,244 |
DS
| 4 |
2145-10-28 00:00:00
|
2145-10-30 10:48:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
nuts
Attending: ___
Chief Complaint:
Hip/back pain status-post fall
Major Surgical or Invasive Procedure:
None
History of Present Illness:
Ms. ___ is a ___ F with a PMH notable for left total hip
arthroplasty ___ and h/o IVDU on methadone, presenting
status-post fall off rolling walker earlier today found to have
___.
The patient states that she has been home-bound since her last
hospitalization over 1 month ago and went out today for the
first time. She was heading to the courthouse to watch her sons
trial, assisted by her friends. She ascended the courthouse
steps and then sat down on her rolling walker at the top of the
steps. Her friend then began to roll her walker while the
patient was seated, wheels hit a crack in the sidewalk, then
patient fell backward hitting her posterior head and left hip.
No loss of consciousness. She has had ongoing left sided hip
pain that radiates down to her knee as well as exacerbation of
her chronic back pain. She also has posterior head pain. No new
paresthesias in extremities, no visual changes, no loss of
strength, no neck pain.
Of note, the patient has a history of frequent hospital
admissions for L hip pain control ever since her L hip
replacement last fall. She was most recently hospitalized at
___ ___ for pain control, treated with oxycodone 5mg Q4H
PRN. She was discharged with a short course but has not had
oxycodone since. She continues to take methadone 120mg QAM, as
well as gabapentin 300mg TID. She does not take Tylenol at home,
but does take ___ tablets of ibuprofen daily as needed for pain.
She has not had increased dosing of her ibuprofen lately. She
has been staying well hydrated ("I chew ice all day long") and
has not had any changes to her diet. No nausea or vomiting
lately. No recent illnesses.
In the ED, initial vs were: 97.4, 53, 109/67, 20 94% RA. Labs
were remarkable for creatinine 2.2 up from baseline 0.9 for
which the patient reportedly received 1L NS bolus and also had
urinary electrolytes tested. Unclear of the timing between IVF
and urine lytes. CBC revealed chronic anemia, slightly worsened
thrombocytopenia at 116, normal ___ ct. Patient was given
morphine 5mg IV and well as oxycodone 10mg PO 2.5 hours later.
Per patient report, she was unable to void on the bedpan, so a
Foley was placed. She has not had any difficulty voiding at home
recently. Vitals on Transfer: T 98.1, HR 54, RR 16, BP 116/64,
O2 96% RA, pain ___.
On the floor, VS were: T 98.4 P 55 BP 111/72 R 20 O2 sat 100%
RA. The patient is asking for pain medication.
Past Medical History:
-Arthritis s/p L hip replacement ___
-HTN
-Asthma
-Blind in R eye secondary to trauma
-Chronic back pain
-Abdominal hernia s/p surgery
-hx narcotic abuse, on methadone maintenance since ___.
___ clinic at ___, on RN home delivery service
through ___.
-Hepatitis C
Social History:
___
Family History:
Mom: CAD
Dad: deceased, unknown cause
Sister: ___, DM
Son: DM
Physical ___:
ADMISSION EXAM:
Vitals: T 98.4 P 55 BP 111/72 R 20 O2 sat 100% RA
General: Obese ___ female moaning/wincing with
every turn in bed, alert, oriented, no acute distress
HEENT: Sclera anicteric, MMM, oropharynx clear
Neck: supple, unable to assess JVD given body habitus, no LAD
Lungs: Clear to auscultation bilaterally, no wheezes, rales,
rhonchi
CV: Regular rate and rhythm, normal S1 + S2, SEM loudest at
___.
Abdomen: obese, soft, non-distended, bowel sounds present, no
rebound tenderness, no organomegaly. Tenderness to palpation
mostly on left side with voluntary guarding. Pt very jumpy with
examination and winces with minimal pressure on skin.
Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis.
Trace edema on b/l ankles. Pt has exquisite tenderness to
palpation of left hip and grimaces with light palpation of skin.
Able to internally and externally rotate hip although she does
grimace with external rotation.
Skin: No rashes or lesions. Well healed scar on L anterior shin
and L hip.
Neuro: CN ___ intact. Strength ___ in b/l upper extremities.
4+/5 strength in right knee flex/ext. ___ in left knee
flex/ext. ___ strength in plantar flexion and dorsiflexion b/l.
DISCHARGE EXAM:
Tm 98.5, Tc 98.4, BP 115/75, HR 54, RR 20, O2 100% RA
General: Obese woman sitting in bed in NAD
Ext: Tenderness to light palpation of left hip, good ROM and
4+/5 strength in left hip strength.
Pertinent Results:
ADMISSION LABS:
___ 03:30PM BLOOD WBC-6.2 RBC-3.55* Hgb-11.1* Hct-35.9*
MCV-101*# MCH-31.3 MCHC-31.0 RDW-17.2* Plt ___
___ 03:30PM BLOOD Neuts-53.8 ___ Monos-4.5 Eos-4.2*
Baso-0.7
___ 03:30PM BLOOD ___ PTT-30.6 ___
___ 03:30PM BLOOD Glucose-102* UreaN-47* Creat-2.2*# Na-137
K-4.4 Cl-103 HCO3-26 AnGap-12
___ 02:46PM URINE Color-Straw Appear-Clear Sp ___
___ 02:46PM URINE Blood-NEG Nitrite-NEG Protein-NEG
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG
___ 02:46PM URINE Hours-RANDOM UreaN-326 Creat-61 Na-78
K-11 Cl-66
___ 02:46PM URINE Osmolal-323
DISCHARGE LABS:
___ 06:50AM BLOOD WBC-4.2 RBC-3.42* Hgb-10.6* Hct-34.5*
MCV-101* MCH-31.0 MCHC-30.7* RDW-17.1* Plt ___
___ 06:50AM BLOOD Glucose-123* UreaN-41* Creat-1.3* Na-140
K-4.3 Cl-105 HCO3-25 AnGap-14
IMAGING:
Lumbo-sacral spine xrays ___: No fracture or malalignment in
the lumbosacral spine, noting that the lumbosacral junction is
not well assessed due to overlying soft tissues.
Pelvis and femur xrays ___: No significant interval change
of left total hip arthroplasty with additional orthopedic
hardware in place. Left superior and inferior pubic rami and
acetabular fractures are all similar when compared to prior
without significant callus formation. No acute fracture.
Brief Hospital Course:
Ms. ___ is a ___ F with a history of left total hip
arthroplasty ___ and history of intravenous drug use on
methadone, who presented status-post fall off rolling walker
found to have prerenal acute kidney injury.
ACTIVE DIAGNOSES:
# Pre-renal acute kidney injury: Labs on admission were notable
for Cr 2.2 up from baseline of 0.9. HCTZ, lisinopril, and
ibuprofen were all held. She was treated with 2L normal saline
and her creatinine the following day was 1.3. She was sent home
with instructions to remain OFF hydrochlorothiazide but to
restart lisinopril and to use Tylenol for pain control rather
than ibuprofen. She has follow up with her PCP ___ 1 week, at
which time repeat Chem-7 should be checked to ensure return to
baseline kidney function.
# Acute on chronic hip and back pain: The patient had fallen
backwards from a seated position off her rolling walker, while a
friend was pushing her up an incline. Plain film x-rays in the
ED of her L/S spine and left hip were negative for fracture. Her
neurologic exam was intact so head imaging was not obtained. Her
pain was controlled with standing Tylenol. The patient was
instructed to restart lisinopril on discharge, but STOP taking
HCTZ and ibuprofen.
CHRONIC, INACTIVE DIAGNOSES:
# Hypertension: Well controlled, even while holding ACEi and
HCTZ. She was discharged OFF of hydrochlorothiazide given her
dehydration on admission, but was instructed to restart
lisinopril. BP and chemistries should be rechecked by PCP next
week. She was continued on aspirin 81mg daily.
# Asthma: No exacerbations. She should continue using albuterol
as needed.
TRANSITIONAL ISSUES:
-STOP hydrochlorothiazide
-STOP ibuprofen
-START acetaminophen 500mg QID:PRN pain
-Repeat chem-7 at PCP ___ appt
-___ pt to stay well hydrated
-Last dose of methadone given 8:00am on ___
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. albuterol sulfate 2 puffs inhalation BID prn shortness of
breath
2. Aspirin 81 mg PO DAILY
3. Docusate Sodium 100 mg PO BID
4. Gabapentin 300 mg PO TID
5. Hydrochlorothiazide 12.5 mg PO DAILY
6. Lisinopril 20 mg PO DAILY
7. Methadone 120 mg PO DAILY
8. Senna 8.6 mg PO BID constip
9. Ibuprofen 400 mg PO Q8H:PRN pain
Discharge Medications:
1. albuterol sulfate 2 puffs inhalation BID prn shortness of
breath
2. Aspirin 81 mg PO DAILY
3. Docusate Sodium 100 mg PO BID
4. Gabapentin 300 mg PO TID
5. Methadone 120 mg PO DAILY
6. Senna 8.6 mg PO BID constip
7. Acetaminophen 500 mg PO Q6H:PRN pain
8. Lisinopril 20 mg PO DAILY
9. Outpatient Lab Work
Please draw Na, K, Cl, HCO3, BUN, Cr on ___ and fax to Dr.
___ at ___.
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
PRIMARY:
-Acute Kidney Injury
-Dehydration
-Acute on chronic back and left hip pain
SECONDARY:
-Hepatitis C
-Hypertension
-Osteoarthritis status-post left hip replacement
-History of narcotic abuse, now on methadone
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Dear Ms. ___,
It was a pleasure to care for you at ___. You were admitted
after falling off your walker. X-rays of your hip and back were
normal and did not show breaks in the bones. We treated your
pain with Tylenol.
Your labwork in the ER showed worsening kidney function. We
treated you with IV fluid and your kidneys improved greatly.
That means that you were dehydrated, likely worsened by the use
of your blood pressure medication called hydrochlorothiazide
(HCTZ) and also by the use of ibuprofen. It will be very
important for you to drink plenty of fluid throughout the day
(At least 8 glasses of water daily). STOP taking
hydrochlorothiazide and ibuprofen. Use Tylenol (also called
acetaminophen) for pain control instead of ibuprofen. Do not
take more than 2000mg of Tylenol per day. Please ___ with
your primary care doctor on ___ (see appointment
information below). You will need repeat blood work checked at
that visit.
We wish you all the best,
Your ___ Team
Followup Instructions:
___
|
10822122-DS-7
| 10,822,122 | 26,296,201 |
DS
| 7 |
2146-07-11 00:00:00
|
2146-07-11 16:03:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
nuts
Attending: ___.
Chief Complaint:
Left hip pain
Major Surgical or Invasive Procedure:
None
History of Present Illness:
Ms. ___ is a ___ with history of bilateral hip replacements
(___) with multiple admission for hip/back pain following
surgery since then, IV drug use currently on methadone
maintenance who presents with worsening left hip pain for two
days as well as fevers, chills, and sweats. She reports a
temperature to ___ yesterday, and despite being afebrile today,
has had chills and nightsweats. She reports not having tried
anything for pain. She reports being hospitalized at ___ two to
three weeks ago for asthma exacerbation and has had some ongoing
wheezing.
In the ED initial vitals were 98.6 84 166/96 16 96%/RA.
Orthopedics was consulted for extreme tenderness on exam; it was
felt that the pain was greatest with hip flexion >60 degrees and
internal/external rotation thus making it less likely that it
was a septic joint. Labs were remarkable for a normal CBC
without leukocytosis, normal chemistries, CRP, and UA. The
patient was given morphine 5mg and ipratropium-albuterol nebs
and admitted for futher evaluation.
On the floor, the patient reports ongoing hip pain.
Past Medical History:
-Arthritis s/p L hip replacement ___
-Hypertension
-Asthma
-Blind in R eye secondary to trauma
-Chronic back pain
-Abdominal hernia s/p surgery
-Narcotic abuse, on methadone maintenance since ___.
___ clinic at ___, on ___ home delivery service
through ___.
-Hepatitis C virus
Social History:
___
Family History:
Mother with CAD. Father (deceased) from unknown cause. Sister
with asthma and diabetes and a son with diabetes.
Physical Exam:
EXAM ON ADMISSION:
===================
Vitals: 97.4 89 22 98%RA, patient not tolerating BP measurement
GENERAL: NAD, in bed
HEENT: NCAT, MMM, poor dentition
NECK: Supple without LAD
CARDIAC: RRR, S1/S2, SEM at RUSB/LUSB
LUNG: Scattered expiratory wheezes, otherwise clear
ABDOMEN: Soft, non-tender, non-distended
EXTREMITIES: no cyanosis, clubbing or edema
PULSES: 2+ DP pulses bilaterally
NEURO: CN II-XII grossly intact
MSK: patient refusing MSK exam given discomfort
EXAM ON DISCHARGE:
==================
Vitals: 98.0, BP 138/84, HR 73, RR 20, 100% RA
GENERAL: NAD, in bed
HEENT: NCAT, MMM, poor dentition
NECK: Supple without LAD
CARDIAC: RRR, S1/S2, SEM at LUSB
LUNG: CTAB, no wheezes, or rhonci, adequate air movement
CTAB ABDOMEN: Soft, non-distended, mild tenderness to palpation
diffusely
EXTREMITIES: minimal lower extremity edema
PULSES: 2+ DP pulses bilaterally
MSK: patient with hip pain with abjuction, adduction, flexion on
hip; pain with light palpation over left hip
Pertinent Results:
LABS ON ADMISSION:
==================
___ 11:37PM BLOOD WBC-4.5 RBC-3.47* Hgb-11.8* Hct-35.6*
MCV-103* MCH-34.0* MCHC-33.2 RDW-16.5* Plt Ct-97*
___ 09:25AM BLOOD ___ PTT-31.8 ___
___ 09:25AM BLOOD Glucose-106* UreaN-10 Creat-1.0 Na-139
K-3.4 Cl-101 HCO3-26 AnGap-15
___ 11:37PM BLOOD CRP-4.3
___ 11:43PM BLOOD Glucose-120* Na-139 K-3.6 Cl-108
calHCO3-25
___ 11:43PM BLOOD Hgb-11.8* calcHCT-35
___ 03:12AM BLOOD SED RATE-PND
___ 12:30AM URINE Color-Yellow Appear-Hazy Sp ___
___ 12:30AM URINE Blood-NEG Nitrite-NEG Protein-TR
Glucose-TR Ketone-10 Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG
___ 12:30AM URINE RBC-<1 WBC-1 Bacteri-FEW Yeast-NONE Epi-4
LABS ON DISCHARGE:
==================
___ CXR:
IMPRESSION:
In comparison with the study of ___, there again is
enlargement of the cardiac silhouette with mild elevation of
pulmonary venous pressure. There is suggestion of some
coalescence of opacification at the right base, which is not
definitely seen on the lateral view. Nevertheless, in the
appropriate clinical setting, this could represent a developing
consolidation.
IMAGING:
========
___ CTAP
IMPRESSION:
1. No acute intra-abdominal process.
2. Mildly prominent distal common bile duct just prior to the
ampulla is nonspecific but could be evaluated via MRCP or a
nonemergent basis, if hepatobiliary pathology is suggested.
3. Prior left hip fracture with hardware fixation, and total hip
arthroplasty.
4. Hepatic steatosis.
___ Hip: IMPRESSION:
Status post left hip total arthoplasty and fracture fixation
with no sign of hardware complication or new fracture.
Brief Hospital Course:
___ ___ history of total left hip arthroplasty ___ with
multiple admission for hip/back pain following surgery including
recent admissions ___, and ___,
distant hx of IVDU currently on methadone maintenance (with
concern for narcotic dependence/abuse) who was admitted for
recurrent left hip pain.
#Acute on chronic left hip pain s/p hip total arthroplasty:
Patient initially presented with acute on chronic hip pain.
Given patient's report of fever initially on admission there was
some concern for septic joint however she did not have
leukocytosis, did not have any documented fevers in the hospital
and joint exam was not consistent with septic joint.
Additionally her CRP level was completely normal. X-ray of her
left hip and pelvis did not show any evidence of fracture or
hardware complication She was seen by orthopedics consult
service who felt her exam was not consistent with septic joint
and recommended against arthrocensis or other imaging. She was
asked to follow up in the speciality orthopedics clinic for
further management. For pain control she was treated with
ibuprofen, tylenol, lidocaine patch and her home methadone dose.
She was also treated with oxycodone 5 mg Q8 hours as needed for
pain as well as ultram 50 mg Q6 hours PRN for pain as these were
her home medications prescribed for limited amount of time by
her PCP. ___ worked with that patient while in the hospital and
felt she was back at her baseline prior to discharge. She was
discharged with limited 5 day supply of oxycodone and ultram to
continue until follow up with her PCP for further determination
of pain regimen at that time. In addition orthopedics follow up
with Dr. ___ scheduled.
# COPD
# Acute on chronic COPD: likely triggered by acute bacterial
pneumonia
# Pneumonia: Acute bacterial pneumonia likely health care
associated
Patient developed cough and shortness of breath during hospital
course with diffuse expiratory wheezing and dyspnea in setting
of known asthma as well as smoking history. She does not carry a
formal history of COPD though presumed based on symptoms and
extensive smoking history. CXR obtained showing evidence of
focal developing RLL opacity on ___. Patient initially started
on treatment for asthma exacerbation however given lack of
improvement of symptoms care was escalated to that of COPD
exacerbation with addition of azithromycin to inahled
ipratropium-albuterol nebulizers and 40 mg PO prednisone for 5
day course. Lastly when CXR revealed developing pneumonia in
setting of recent hospitalization within the last few weeks at
___ patient was started on IV ceftriaxone and once clinically
improved to PO levofloxacin to complete total 7 day treatment
course for HCAP. Patient also continued on inhaled fluticasone
throughout hospital course. It was thought that patient would
benefit from pulmonary follow up for evaluation and treatment of
her COPD and asthma given her recent hospitalizations for this
issue. She was started on advair prior to discharge and it was
thought that further consideration for starting agent such as
tiotropium could be made.
#Hypertension complicated by orthostatic hypotension
Antihypertensive medications including lisinopril and amlodipine
continued. Patient noted to be orthostatic with HCTZ and
atenolol so these were held. The patient remained persistently
orthostatic by vital signs with endorsement of feeling
lightheaded and dizzy with standing so amlodipine was decreased
to 5 mg and lisinopril decreased to 20 mg daily. The patient was
no longer orthostatic by vital signs prior to discharge.
#Mild elevation of pulmonary venous pressure on CXR
Patient had noted mild elevation of pulmonary venous pressure on
CXR could be indication of underlying COPD/asthma as well as
OSA. Ms. ___ had multiple episodes of shortness of breath
particularly while sleeping. She did endorse daytime fatigue as
well and it was thought that given her body habitus and episodes
of shortness of breath particularly while sleeping that she
could benefit from OSA work up.
#History of IVDU with plan for Methadone Taper
Per patient's outpatient notes she is undergoing methadone
taper. Per discussion with ___ Healthcare and Habit Opco
patient confirmed to be on methadone taper 5mg every week. She
is administered methadone by ___ healthcare and prescribed
it by habit OPCO. She was tapered to 35 mg methadone dose on
___ with plan to decrease to 30 mg on ___. She was
provided with prescription for 5 day supply of methadone.
#Constipation
Ms. ___ was noted to be constipated during her hospital
course in the setting of methadone and oxycodone use as above.
She was given senna/colace, miralax, and PO and PR dulcolax that
with resolution of her constipation prior to discharge. She was
discharged with miralax and senna prior to discharge to prevent
constipation in the future.
#Tobacco Abuse
Patient encouraged to quit smoking in the setting of her
recurrent hospitalizations for COPD and asthma exacerbations
recently. She was placed on nicotine patch throughout her
hospital course.
# Code: Full
# Emergency Contact: ___ ___
Transitional Issues:
=====================
-Medications started during this hospitalization: Advair
-Medications stopped or changed during this hospitalization:
Lisinopril decreased to 20 mg, amlodipine decreased to 5 mg,
atenolol and hydrochlorothiazed stopped. fluticasone stopped
(advair started in its place)
-Patient started on Advair discus this hospitalization for COPD;
consider starting further agents such as tiotropium
-Consider restarting patient's atenolol and hydrochlorothiazide
pending patient's blood pressure on follow up and resolution of
her orthostatic symptoms
-Patient noted to be thrombocytopenic from unclear etiology. She
should have repeat CBC on follow to assess for
stabilization/improvement of her platelet
-Methadone taper--should continue with planned taper to
decreased at 5 mg each week. Patient's should decrease to 30 mg
methadone on ___.
-consider need to continue oxycodone 5 mg Q8 hours pending
severity of patient's hip pain and ultram 50 mg Q8 hours for
pain. Given limited 5 day supply until follow up.
-Patient should likely have PFT testing in the outpatient
setting for diagnosis and management of her presumed
-Consider sleep study for questionable OSA
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires
futher investigation.
1. Albuterol Inhaler ___ PUFF IH Q4H:PRN shortness of breath
2. Aspirin 81 mg PO DAILY
3. Docusate Sodium 100 mg PO BID
4. Methadone 40 mg PO DAILY
5. Lisinopril 40 mg PO DAILY
6. Acetaminophen 1000 mg PO TID pain
7. Gabapentin 400 mg PO TID
8. CloniDINE 0.3 mg PO BID
9. Tizanidine 2 mg PO TID
Discharge Medications:
1. Acetaminophen 1000 mg PO TID pain
2. Albuterol Inhaler ___ PUFF IH Q4H:PRN shortness of breath
RX *albuterol sulfate 90 mcg 1 mcg inhaled every four (4) hours
Disp #*1 Inhaler Refills:*3
3. Citalopram 40 mg PO DAILY
4. CloniDINE 0.3 mg PO BID
5. Docusate Sodium 100 mg PO BID
6. Furosemide 20 mg PO DAILY
7. Gabapentin 300 mg PO TID
8. Lidocaine 5% Patch 1 PTCH TD QAM
9. Omeprazole 20 mg PO DAILY
10. OxycoDONE (Immediate Release) 5 mg PO Q8H:PRN severe pain
RX *oxycodone 5 mg 1 capsule(s) by mouth every eight (8) hours
Disp #*15 Capsule Refills:*0
11. TraMADOL (Ultram) 50 mg PO ___ TABS PO TID PRN MODERATE TO
SEVERE PAIN moderate to severe pain
RX *tramadol 50 mg 1 tablet(s) by mouth every eight (8) hours
Disp #*15 Tablet Refills:*0
12. Amlodipine 5 mg PO DAILY
RX *amlodipine 5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet
Refills:*1
13. Aspirin 81 mg PO DAILY
14. Duloxetine 60 mg PO DAILY
15. Methadone 35 mg PO DAILY
Will be continued at 35 mg dose until ___ and then
decreased to 30 mg.
RX *methadone 5 mg 7 tablets by mouth once a day Disp #*28
Tablet Refills:*0
16. Cepastat (Phenol) Lozenge 2 LOZ PO Q4H:PRN cough
17. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID COPD
RX *fluticasone-salmeterol [Advair Diskus] 250 mcg-50 mcg/Dose 1
INH inhaled twice a day Disp #*1 Disk Refills:*3
18. Calcium Carbonate 500 mg PO TID
19. Hydrocortisone Oint 2.5% 1 Appl TP BID
20. LOPERamide 2 mg PO 2 CAPS INITIALLY THEN 1 CAP PO AFTER EACH
LOOSE STOOL UP TO 8 MAX DAILY
21. Naproxen 500 mg PO Q12H
22. Lisinopril 20 mg PO DAILY
RX *lisinopril 20 mg 1 tablet(s) by mouth once a day Disp #*30
Tablet Refills:*1
23. Vitamin D 1000 UNIT PO DAILY
24. Polyethylene Glycol 17 g PO DAILY
RX *polyethylene glycol 3350 [Miralax] 17 gram/dose 17 grams by
mouth once a day Refills:*2
25. Senna 8.6 mg PO BID:PRN constipation
RX *sennosides [___] 8.6 mg 1 tab by mouth twice a day Disp
#*60 Tablet Refills:*0
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
Primary:
Chronic obstructive pulmonary disease exacerbation
Asthma
Healthcare Associated Pneumonia
Orthostatic hypotension
Secondary:
Hypertension
Arthritis s/p L hip replacement ___
Blind in R eye secondary to trauma
Chronic back pain
Abdominal hernia s/p surgery
Narcotic abuse, on methadone maintenance since ___.
___ clinic at ___, on RN home delivery service
through ___. Habit OPCO prescribes methadone
Hepatitis C virus
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
Dear Ms. ___,
It was a pleasure being involved in your care. You were admitted
to the hospital for hip pain. Our evaluation of the hip did not
show any evidence of new injury, fracture, or infection. You
were noted to have shortness of breath and difficulty breathing
and were treated for worsening of your chronic obstructive
pulmonary disease (COPD) from longtime smoking and asthma. We
also felt that you were in the early stages of developing a
pneumonia so we treated you with antibiotics. We strongly
recommend that you quit smoking to prevent future infections in
your lungs and the need to be hospitalized. We started you on
an inhaler called Advair that is very important for you to take
every day regardless of if you feel short of breath. Your blood
pressure was low and you also had dizziness with standing.
Because of this we decreased your blood pressure medications to
lisinopril 20 mg and amlodipine 5 mg. We stopped your
medications for blood pressure called atenolol and
hydrochlorothiazide.
Sincerely,
Your ___ Team
Followup Instructions:
___
|
10822193-DS-20
| 10,822,193 | 23,542,322 |
DS
| 20 |
2178-11-15 00:00:00
|
2178-11-19 08:33:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: UROLOGY
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___
Chief Complaint:
fever, pain
Major Surgical or Invasive Procedure:
___: Cystoscopy, Left Ureteral Stent Placement, Left
Retrograde Pyelogram
History of Present Illness:
___ with left side 0.9mm obstructing left proximal ureteral
stone with sepsis now s/p urgent cystoscopy, Left Ureteral Stent
Placement, Left Retrograde Pyelogram
Past Medical History:
Two prior C-sections
Social History:
___
Family History:
No Family History currently on file.
Physical Exam:
WdWn female, NAD, AVSS
Interactive, cooperative
Abdomen soft, Nt/Nd
Flank pain improved
Lower extremities w/out edema or pitting and no report of calf
pain
Pertinent Results:
___ 07:45AM BLOOD WBC-12.1* RBC-3.76* Hgb-10.8* Hct-34.5
MCV-92 MCH-28.7 MCHC-31.3* RDW-12.7 RDWSD-42.0 Plt ___
___ 06:02AM BLOOD WBC-14.9* RBC-4.04 Hgb-11.6 Hct-36.1
MCV-89 MCH-28.7 MCHC-32.1 RDW-12.7 RDWSD-41.3 Plt ___
___ 12:30AM BLOOD WBC-17.6* RBC-4.31 Hgb-12.4 Hct-38.1
MCV-88 MCH-28.8 MCHC-32.5 RDW-12.5 RDWSD-40.7 Plt ___
___ 12:30AM BLOOD Neuts-85.9* Lymphs-7.2* Monos-4.6*
Eos-1.4 Baso-0.2 Im ___ AbsNeut-15.14* AbsLymp-1.27
AbsMono-0.82* AbsEos-0.25 AbsBaso-0.04
___ 07:45AM BLOOD Glucose-98 UreaN-16 Creat-0.9 Na-144
K-4.1 Cl-106 HCO3-24 AnGap-14
___ 06:02AM BLOOD Glucose-128* UreaN-15 Creat-0.9 Na-146
K-3.9 Cl-109* HCO3-23 AnGap-14
___ 12:30AM BLOOD Glucose-117* UreaN-19 Creat-1.0 Na-139
K-4.7 Cl-102 HCO3-21* AnGap-16
___ 5:09 am URINE Site: CYSTOSCOPY
LEFT RENAL PELVIC URINE FOR CULTURE.
**FINAL REPORT ___
URINE CULTURE (Final ___:
ESCHERICHIA COLI. ~300 CFU/mL.
Cefepime MIC OF <=2 MCG/ML test result performed by
Microscan.
SENSITIVITIES: MIC expressed in
MCG/ML
_________________________________________________________
ESCHERICHIA COLI
|
AMPICILLIN------------ =>32 R
AMPICILLIN/SULBACTAM-- 4 S
CEFAZOLIN------------- =>64 R
CEFEPIME-------------- S
CEFTAZIDIME----------- 4 S
CEFTRIAXONE----------- =>64 R
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------ <=1 S
MEROPENEM-------------<=0.25 S
NITROFURANTOIN-------- <=16 S
PIPERACILLIN/TAZO----- <=4 S
TOBRAMYCIN------------ <=1 S
TRIMETHOPRIM/SULFA---- <=1 S
Brief Hospital Course:
Ms. ___ was admitted to urology for nephrolithiasis
management with a known 0.9mm obstructing left proximal ureteral
stone and presenting with fever, tachycardia; sirs. She was
immediately started on IV antibiotics and tolerated the
procedure well and recovered in the PACU before transfer to the
general surgical floor. See the dictated operative note for full
details. Overnight, the patient was hydrated with intravenous
fluids and received appropriate perioperative prophylactic
antibiotics. On POD1, catheter was removed. At discharge on
POD1, patients pain was controlled with oral pain medications,
tolerating regular diet, ambulating without assistance, and
voiding without difficulty and without fever for over 24hrs. She
was explicitly advised to follow up as directed as the
indwelling ureteral stent must be removed and or exchanged.
Medications on Admission:
NONE
Discharge Medications:
1. Acetaminophen 650 mg PO Q8H:PRN Pain - Mild
2. Cephalexin 500 mg PO Q6H Duration: 9 Days
RX *cephalexin 500 mg ONE capsule(s) by mouth Q6HRS Disp #*36
Capsule Refills:*0
3. Docusate Sodium 100 mg PO BID
RX *docusate sodium 100 mg ONE capsule(s) by mouth twice a day
Disp #*60 Capsule Refills:*0
4. Phenazopyridine 200 mg PO TID:PRN bladd pain Duration: 3
Days
RX *phenazopyridine 100 mg ONE TAB by mouth Q8HRS Disp #*9
Tablet Refills:*0
5. Senna 8.6 mg PO BID
6. Tamsulosin 0.4 mg PO DAILY
RX *tamsulosin 0.4 mg ONE capsule(s) by mouth DAILY Disp #*30
Capsule Refills:*0
Discharge Disposition:
Home
Discharge Diagnosis:
SIRS: fever, + Urinalysis, leukocytosis, pain, tachycardia
Surgeon's Preop Diagnosis: Left Ureteral Calculus, obstructing
Findings: large left proximal ureteral stone
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
-You can expect to see occasional blood in your urine and to
possibly experience some urgency and frequency over the next
month; this may be related to the passage of stone fragments or
the indwelling ureteral stent.
-The kidney stone may or may not have been removed AND/or there
may fragments/others still in the process of passing.
-You may experience some pain associated with spasm of your
ureter.; This is normal. Take the narcotic pain medication as
prescribed if additional pain relief is needed.
-Ureteral stents MUST be removed or exchanged and therefore it
is IMPERATIVE that you follow-up as directed.
-Do not lift anything heavier than a phone book (10 pounds)
-You may continue to periodically see small amounts of blood in
your urine--this is normal and will gradually improve
-Resume your pre-admission/home medications EXCEPT as noted. You
should ALWAYS call to inform, review and discuss any medication
changes and your post-operative course with your primary care
doctor. HOLD ASPIRIN and aspirin containing products for one
week unless otherwise advised.
-IBUPROFEN (the ingredient of Advil, Motrin, etc.) may be taken
even though you may also be taking Tylenol/Acetaminophen. You
may alternate these medications for pain control. For pain
control, try TYLENOL FIRST, then ibuprofen, and then take the
narcotic pain medication as prescribed if additional pain relief
is needed.
-Ibuprofen should always be taken with food. Please discontinue
taking and notify your doctor should you develop blood in your
stool (dark, tarry stools)
-You MAY be discharged home with a medication called PYRIDIUM
that will help with the "burning" pain you may experience when
voiding. This medication may turn your urine bright orange.
-You may be given prescriptions for a stool softener and/or a
gentle laxative. These are over-the-counter medications that
may be health care spending account reimbursable.
-Colace (docusate sodium) may have been prescribed to avoid
post-surgical constipation or constipation related to use of
narcotic pain medications. Discontinue if loose stool or
diarrhea develops. Colace is a stool-softener, NOT a laxative.
-Senokot (or any gentle laxative) may have been prescribed to
further minimize your risk of constipation.
-Do not eat constipating foods for ___ weeks, drink plenty of
fluids to keep hydrated
-No vigorous physical activity or sports for 4 weeks and while
Foley catheter is in place.
Followup Instructions:
___
|
10822372-DS-22
| 10,822,372 | 22,180,093 |
DS
| 22 |
2195-04-11 00:00:00
|
2195-04-11 19:23:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: F
Service: MEDICINE
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___
Chief Complaint:
Cough, SOB
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ woman with h/o restrictive lung disease, massive hiatal
hernia, reactive airway disease, remote breast ca, HTN,
osteoporosis/arthritis, and dementia presents with SOB and
cough. the pt is unable to provide significant history because
of her dementia. Per her husband and ___ note from ___
clinic yesterday she has had several days of worsening dyspnea,
cough and chills. She was sent in from clinic with the concern
for pneumonia vs asthma exacerbation. She uses 3L O2 at home
intermittently.
.
In the ED, initial VS: 98.0 107 130/48 26 87% on RA (improved to
95% on 3L nc). Labs revealed WBC of 11.2 w/ left-shift. EKG
showed ST at 111, otherwise unremarkable. I reviewed CXR with ED
rads resident -> massive hiatal hernia, probably some
consolidation lateral to hernia on R; possibly with
consolidation/atelectasis/effusion on L as well -> no overt
volume overload. In the ED, she was given 125 mg IV methylpred,
1g ceftriaxone, 500 mg azithro, and nebs.
.
On the floor, VS 98.1 126/68 91 34 (for which she triggered) and
96% on 4L. She speaks in full sentences, does appear tachypneic,
but is not in any distress. She is very pleasant, oriented, but
has short-term memory loss and repeats questions. She isn't
coughing at present. States her diarrhea hasn't been severe or
watery. No abd pain at present.
.
REVIEW OF SYSTEMS:
Denies night sweats, headache, vision changes, rhinorrhea,
congestion, sore throat, chest pain, abdominal pain, vomiting,
constipation, BRBPR, melena, hematochezia, dysuria, hematuria.
Past Medical History:
R breast cancer - stage II, s/p lumpectomy/XRT/tamoxifen x ___
years; off all therapy x ___ yrs
Asthma - as a child, reports of 'reactive airway dz' in ___
Restrictive and obstructive lung disease - followed by pulm, on
3L home O2 (FEV1 is 0.39 (49% predicted), FVC 0.56
(39% predicted) with a FEV1/FVC ratio of 0.70.)
Glaucoma
Large Hiatal Hernia
HL
Dementia
Osteoporosis
Arthritis
H/O DEEP VENOUS THROMBOPHLEBITIS
*S/P APPENDECTOMY
*S/P HYSTERECTOMY
*S/P TONSILLECTOMY
Social History:
___
Family History:
Reviewed and noncontributory
Physical Exam:
ADMISSION EXAM:
VS - 97.4 ___ 96-100% on 4L
GENERAL - Alert, interactive, tachypneic but not in distress;
A&Ox1; repeats questions frequently
HEENT - pupils reactive, EOMI, MMM, OP clear
NECK - Supple, no JVD, no carotid bruits
HEART - RRR, nl S1-S2, harsh ___ systolic murmur heard best at
RUSB
LUNGS - tachypneic, expiratory wheezes, very poor air movement
throughout
ABDOMEN - NABS, soft/NT/ND
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses
NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength
___ throughout
.
Discharge Exam:
VS - 98.0 118-137/40-56 60-80s 20 93% on 3L
UOP 300cc/8hrs
GENERAL - Alert, interactive, not in distress; A&Ox1; repeats
questions frequently
HEENT - pupils reactive, EOMI, MMM, OP clear
NECK - Supple, no JVD, no carotid bruits
HEART - RRR, nl S1-S2, harsh ___ systolic murmur heard best at
RUSB
LUNGS - not tachypneic, minimal coarse breath sounds, productive
cough, good air movement throughout
ABDOMEN - NABS, soft/NT/ND
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses
NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength
___ throughout
Pertinent Results:
ADMISSION LABS:
___ 06:05PM WBC-11.2* RBC-4.09* HGB-12.6 HCT-35.5* MCV-87
MCH-30.7 MCHC-35.4* RDW-13.0
___ 06:05PM NEUTS-88.9* LYMPHS-6.7* MONOS-4.0 EOS-0.2
BASOS-0.2
___ 06:05PM PLT COUNT-195
___ 06:05PM GLUCOSE-126* UREA N-12 CREAT-0.6 SODIUM-140
POTASSIUM-3.5 CHLORIDE-94* TOTAL CO2-36* ANION GAP-14
___ 06:05PM estGFR-Using this
___ 06:05PM proBNP-188
___ 06:05PM CALCIUM-9.9 PHOSPHATE-2.7 MAGNESIUM-1.7
___ 06:12PM LACTATE-1.6
.
UA: ___ 10:50PM URINE Color-Yellow Appear-Clear Sp
___
___ 10:50PM URINE Blood-NEG Nitrite-NEG Protein-NEG
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG
.
DISCHARGE LABS:
___ 07:45AM BLOOD WBC-10.7 RBC-3.88* Hgb-11.8* Hct-34.0*
MCV-88 MCH-30.5 MCHC-34.8 RDW-13.0 Plt ___
___ 07:45AM BLOOD Glucose-89 UreaN-22* Creat-0.6 Na-144
K-4.6 Cl-99 HCO3-40* AnGap-10
___ 07:45AM BLOOD Calcium-8.4 Phos-2.8 Mg-2.3
.
Micro:
___ Urine legionella negative
___ blood cultures NGTD on discharge
.
Imaging:
___ ECG: Sinus tachycardia. Non-specific repolarization
abnormalities. Compared to the
previous tracing of ___ the findings are simlilar.
.
___ CXR
FINDINGS: Frontal and lateral radiographs of the chest show new
opacities in the right mid lung consistent with pneumonia. The
pulmonary vasculature is mildly engorged. Evaluation of the lung
bases is limited due to low inspiratory lung volumes and a
massive but stable hiatal hernia. The lung apices are well
aerated without pneumothorax. Rightward deviation of the trachea
is unchanged. The mediastinal and hilar contours are within
normal limits and unchanged. The cardiac silhouette cannot be
assessed. The thoracic spine is kyphotic with severe
degenerative changes. Large, dense calcifications are noted in
the bilateral breasts, unchanged from diagnostic mammogram of
___.
IMPRESSION:
1. Pneumonia of the right lung.
2. Stable massive hiatal hernia.
.
___ ECHO
The left atrium is elongated. There is mild symmetric left
ventricular hypertrophy. The left ventricular cavity size is
normal. Due to suboptimal technical quality, a focal wall motion
abnormality cannot be fully excluded. Left ventricular systolic
function is hyperdynamic (EF 75%). There is no left ventricular
outflow obstruction at rest or with Valsalva. Right ventricular
chamber size and free wall motion are normal. The aortic valve
is not well seen. There is mild aortic valve stenosis (valve
area 1.7 cm2). The mitral valve leaflets are mildly thickened.
There is no mitral valve prolapse. The pulmonary artery systolic
pressure could not be determined. There is no pericardial
effusion. Compared with the findings of the prior study (images
reviewed) of ___, mild aortic stenosis is now
present.
Brief Hospital Course:
___ woman with h/o restrictive and obstructive lung disease,
massive hiatal hernia, remote breast ca, HTN,
osteoporosis/arthritis, and mild dementia presents with SOB and
cough, found to have a PNA.
.
# Pneumonia: She presented with cough, SOB, elevated WBC count
to 13.0, and right sided consolidation on her chest xray. She
did not have significant health care exposure so we initiated
treatment with ceftriaxone azithromycin for CAP. She did well
and was transitioned to cefpodoxime and azithromycin for a
planned seven day course.
.
# Asthma and Restrictive: She has a history of asthma and an
ill defined restrictive lung disease that may be related to her
massive hiatal hernia. She had prominent wheezing on
presentation so she was started on ipratropium and albuterol
nebulizers as well as prednisone. Her respiratory status
significantly improved prior to discharge. She was continued on
her nebulizers and her prednisone will be tapered off slowly
(30mg daily for several days until ___, then 20mg for 2 days,
then 10mg for 2 days, then off).
.
# Aortic stenosis: She had a significant ___ murmur loudest at
the RUSB that was not previously noted. She underwent an
echocardiogram which showed mild aortic stenosis.
.
CHRONIC ISSUES:
.
# HTN: continued hydrochlorathiazide 25 mg qday and blood
pressures were well controlled.
.
# Dementia: continued donepezil 10 mg qday.
.
# GERD: continued omeprazole 20 mg qday.
.
# HL: continued pravastatin 10 mg qday.
.
# Osteoporosis: Ca + D continued.
.
TRANSITIONAL ISSUES:
-Blood cultures are pending at time of discharge
Medications on Admission:
DONEPEZIL [ARICEPT] - (Prescribed by Other Provider) - 10 mg
Tablet - 1 Tablet(s) by mouth qday
FLUTICASONE [FLOVENT HFA] - 110 mcg/Actuation Aerosol - 2
puffs(s) inhaled twice a day Rinse mouth after use. To be used
with spacer.
HYDROCHLOROTHIAZIDE - 25 mg Tablet - 1 Tablet(s) by mouth daily
IPRATROPIUM BROMIDE - 0.2 mg/mL (0.02 %) Solution - 1 vial(s)
nebulized ___ times daily
OLOPATADINE [PATADAY] - (Prescribed by Other Provider) - 0.2 %
Drops - once a day
OMEPRAZOLE [PRILOSEC] - 20 mg Capsule, Delayed Release(E.C.) - 1
Capsule(s) by mouth daily
PRAVASTATIN - 10 mg Tablet - 1 Tablet(s) by mouth daily - No
Substitution
TRIAMCINOLONE ACETONIDE [NASACORT AQ] - 55 mcg Aerosol, Spray -
2
sprays each nostril daily
.
Medications - OTC
BISACODYL - (OTC) - 5 mg Tablet, Delayed Release (E.C.) - 1
Tablet(s) by mouth qday as needed for PRN for constipation
CHOLECALCIFEROL (VITAMIN D3) - (OTC) - 1,000 unit Capsule - 0.5
(One half) Capsule(s) by mouth daily
GLUCOSAMINE-CHONDROIT-VIT C-MN [GLUCOSAMINE CHONDROITIN MAXSTR]
-
500-400 mg Capsule - 3 Capsule(s) by mouth daily
MULTIVITAMIN - Tablet - 1 Tablet(s) by mouth daily
Discharge Medications:
1. donepezil 10 mg Tablet Sig: One (1) Tablet PO once a day.
2. fluticasone 110 mcg/actuation Aerosol Sig: Two (2) Puff
Inhalation BID (2 times a day).
3. hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO
DAILY (Daily).
4. ipratropium bromide 0.02 % Solution Sig: One (1) Inhalation
three times a day.
5. olopatadine 0.2 % Drops Sig: One (1) Ophthalmic once a day
as needed for Allergy symptoms.
6. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1)
Capsule, Delayed Release(E.C.) PO DAILY (Daily).
7. pravastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
8. triamcinolone acetonide 55 mcg Aerosol, Spray Sig: Two (2)
Nasal once a day.
9. cefpodoxime 200 mg Tablet Sig: Two (2) Tablet PO twice a day
for 2 days.
Disp:*8 Tablet(s)* Refills:*0*
10. azithromycin 500 mg Tablet Sig: One (1) Tablet PO once a day
for 2 days.
Disp:*2 Tablet(s)* Refills:*0*
11. prednisone 10 mg Tablet Sig: Three (3) Tablet PO once a day
for 7 days: Please take 3 tabs until ___, then 2 tabs for two
days, then 1 tab for two days, then stop.
Disp:*15 Tablet(s)* Refills:*0*
12. dextromethorphan-guaifenesin ___ mg/5 mL Syrup Sig: Five
(5) ML PO Q6H (every 6 hours) as needed for cough.
Disp:*50 ML(s)* Refills:*0*
13. bisacodyl 5 mg Tablet Sig: One (1) Tablet PO once a day as
needed for constipation.
14. cholecalciferol (vitamin D3) 1,000 unit Capsule Sig: 0.5
Capsule PO once a day.
15. glucosamine-chondroit-vit C-Mn Oral
16. multivitamin Tablet Sig: One (1) Tablet PO DAILY
(Daily).
Discharge Disposition:
Home With Service
Facility:
___
Discharge Diagnosis:
Primary diagnoses:
Pneumonia
Asthma exacerbation
Secondary Diagnoses:
Asthma
Restrictive lung disease
Hiatal Hernia
Dementia
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker
or cane).
Discharge Instructions:
Dear ___ was a pleasure taking part in your medical care. You were in
the hospital because you had pneumonia. You were treated with IV
antibiotics and you got much better. We switched to oral
antibiotics. You should continue to take these for two more
days. We also started steroids for your asthma.
.
Medication Recommendations:
Please START:
-Cefpodoxime for 400 mg twice daily two more days
-Azithromycin 500 mg daily for two more days
-Albuterol nebulizer every 6 hours as needed for shortness of
breath
-Guafenesin/dextromethorphan every six hours as needed for cough
-Prednisone 30 mg until ___, then 20 mg for two days
then 10 mg for two days then stop in the following order:
___: 30mg
___: 30mg
___: 30mg
___: 20mg
___: 20mg
___: 10mg
___: 10mg
Followup Instructions:
___
|
10822532-DS-5
| 10,822,532 | 25,566,527 |
DS
| 5 |
2123-02-17 00:00:00
|
2123-02-17 22:49:00
|
Name: ___ Unit No: ___
Admission Date: ___ Discharge Date: ___
Date of Birth: ___ Sex: M
Service: SURGERY
Allergies:
No Known Allergies / Adverse Drug Reactions
Attending: ___.
Chief Complaint:
Trauma: fall from ladder
L cerebellopontine angle hemorrhage
Subgaleal hematoma
L ribs fxs ___
tiny L ptx
L1-L2 transverse process fx
R buttocks hematoma
Major Surgical or Invasive Procedure:
None
History of Present Illness:
___ M h/o CVA w/ RIGHT sided motor deficits on Plavix, HTN, DM
was taking down Christmas lights when he fell 10 feet from a
ladder. Per report he struck his head and had + LOC. Vomited
multiple times at scene. At ___ ED was collared as a
precaution. CT scanning revealed a small LEFT
cerebelllar-pontine angle hemorrhage for which Neurosurgery was
consulted. He also had rib fractures and lumbar spine fractures
for which Orthopedics was consulted.
Past Medical History:
- CVA ___: w/ RIGHT sided deficits: arthralgias, facial droop,
hand weakness (s/p LEFT carotid stent, on Plavix)
- Seizures
- HTN
- Type II diabetes
Social History:
___
Family History:
NC
Physical Exam:
PHYSICAL EXAMINATION: upon admission: ___
Temp: 96 HR: 103 BP: 200/100 Resp: 26 O(2)Sat: 100%
on 2 L Normal
Constitutional: General appearance: The patient arrives
boarded and collared and is in no acute distress. The GCS is
15.
Head: The scalp shows a small occipital laceration.
HEENT: The extraocular muscles are intact and the pupils
both constrict to light.
Neck: There is no C-spine tenderness or step off.
Upper extremities: The upper extremities show no trauma.
Thorax: The chest wall is nontender.
Lungs: The lungs are clear and symmetrical.
Heart: The heart sounds are crisp.
Abdomen: soft, scaphoid, and nontender.
Spine: There is no thoracic or lumbar spine tenderness.
Hips and pelvis: The pelvis is stable and the hips are
nontender.
Lower extremities: no long bone signs but he has deep
abrasions on both anterior knees.
Back: NT
Neurological: The patient moves all 4 extremities equally
but is weak on the right (which is old).
Physical examination upon discharge:
___
vital signs: t=98, hr=72, bp=142/67, room air sat 97% room air
General: Reclining in bed, NAD
CV: Ns1, s2, -s, -s4
LUNGS: clear
ABDOMEN: soft, non-tender
EXT: feet cool, + dp bil, no calf tendernes bil
SKIN: Ecchymotic area right hip, abrasions knees bil.
NEURO: speech slow, slurred, alert and oriented x 3, no tremors
Pertinent Results:
CONSULTS:
- Neurosurgery: no emergent neurosurgical intervention; reviewed
repeat head CT with no acute changes
- Ortho/spine re L1-2 transverse process fx: corset for comfort.
No weight bearing or activity restrictions
___ 05:00AM BLOOD WBC-7.3 RBC-3.46* Hgb-10.2* Hct-29.4*
MCV-85 MCH-29.5 MCHC-34.7 RDW-14.7 Plt ___
___ 06:00PM BLOOD Hct-30.0*
___ 10:47AM BLOOD Hct-29.8*
___ 01:00PM BLOOD WBC-14.4* RBC-4.57* Hgb-14.1 Hct-39.5*
MCV-87 MCH-30.9 MCHC-35.8* RDW-14.5 Plt ___
___ 05:00AM BLOOD Plt ___
___ 05:00AM BLOOD ___ PTT-26.7 ___
___ 11:47PM BLOOD ___
___ 05:00AM BLOOD Glucose-100 UreaN-18 Creat-1.0 Na-138
K-4.5 Cl-104 HCO3-25 AnGap-14
___ 05:00AM BLOOD Calcium-8.6 Phos-2.9 Mg-2.0
___: head cat scan:
Tiny focus of extra-axial hemorrhage in the left
cerebellopontine angle.
Large posterior subgaleal hematoma with soft tissue laceration.
No acute
fracture. Old areas of encephalomalacia in the left ACA and MCA
territories.
___: cat scan of the c-spine:
IMPRESSION: Degenerative changes as stated with small disc
osteophytes
indenting the thecal sac. No acute fracture or malalignment.
Left carotid
stent in place.
___: cat scan of the abdomen and pelvis:
IMPRESSION:
1. Large hematoma in the right low back/buttock region with
active bleeding.
2. Acute fractures in the left posterior rib cage at ribs 9
through 12,
segmental at the twelfth rib. Tiny associated left pneumothorax
and left low lung contusion.
3. Fractures involving the left L1 and L2 transverse processes,
non-displaced.
___: cat scan of the head:
IMPRESSION:
1. Previously seen tiny focus of hemorrhage in the left
cerebellopontine angle is not well visualized on this exam and
may be due to evolution of blood. No evidence of new hemorrhage.
No new acute infarction.
2. Old area of encephalomalacia in the left frontal brain is
unchanged.
___: chest x-ray:
FINDINGS: In comparison with study of ___, there is little
change in the
appearance of the heart and lungs. No evidence of pneumothorax,
acute
pneumonia, or vascular congestion. On this study and the prior
one, there
appears to be some narrowing of the tracheal air column at the
level of the clavicles. This raises the possibility of true
tracheal narrowing. Ifthere is no clinical explanation for this
appearance, CT of the trachea could be considered.
Brief Hospital Course:
___ year old gentleman admitted to the acute care service after
falling off a ladder and stricking his head. Upon admission, he
was made NPO, given intravenous fluids, and underwent
radiographic imaging. The head cat scan showed a bleed in the
cerebellopontine angle. He also sustained left sided ___ rib
fractures, a left L1-L2 transverse process fracture, and a tiny
left pneumothorax. As a result of the fall, he also sustained a
buttock hematoma. Because of his injures, the Neurology and
orthopedic services were consulted. Neurosurgery recommended
neurological assessments and a repeat head cat scan.
Orthopedics recommended a corset for comfort for the L1-L2
transverse process fracture.
He was admitted to Trauma-SICU overnight for monitoring of his
vital signs and neurological assessment. Because of the
buttocks hematoma, his hematocrits were followed and found to be
stable. Per neurosurgery recommendations, he underwent a repeat
head CT the morning after admission to follow any change in the
cerebellar-pontine angle hematoma; there was no change and they
were in agreement with restarting the patient's Plavix. He was
mentating appropriately and restarted on his oral home
medications as well as oral pain control. He was felt to be
stable for transfer out to the surgical floor on HD#2.
He was transferred to the surgical floor on HD #2. Social
services met with his family and provided support. His vital
signs are stable. His hematocrit has stabilized at 29. His
oxygen saturation has been stable at 98% on room air. He is
tolerating a regular diet. He was evaluated by physical and
occupational therapy and recommendations made for discharge home
with ___ services. He was dischaged home with planned follow-up
in the acute care clinic.
Of note: CXR did show narrowing of trachea, at the level of the
clavicle, no resp. compromise noted. Primary care provider
___.
Medications on Admission:
- plavix 75mg daily
- keppra 500mg bid
- metformin 850mg bid
- citalopram 40mg daily
- viagra 50mg PRN
Discharge Medications:
1. levetiracetam 500 mg Tablet Sig: One (1) Tablet PO BID (2
times a day).
2. citalopram 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
3. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every
4 hours) as needed for fever/pain.
4. hydromorphone 2 mg Tablet Sig: ___ Tablets PO Q3H (every 3
hours): may cause drowsiness, avoid driving while on this
medication.
Disp:*25 Tablet(s)* Refills:*0*
5. famotidine 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a
day).
6. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
7. metformin 850 mg Tablet Sig: One (1) Tablet PO BID (2 times a
day): ___ monitor blood sugars.
8. lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
9. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day:
hold for loose stools.
10. senna 8.6 mg Tablet Sig: One (1) Tablet PO twice a day as
needed for constipation.
11. Lipitor 80 mg Tablet Sig: One (1) Tablet PO at bedtime.
Discharge Disposition:
Home With Service
Facility:
___
___:
Trauma: fall
L cerebellopontine angle hemorrhage
Subgaleal hematoma
L ribs fxs ___
tiny L ptx
L1-L2 transverse process fx
R buttocks hematoma
Discharge Condition:
Mental Status: Clear and coherent ( speech slow)
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
Discharge Instructions:
You were admitted to the hospital after you fell off a ladder.
You did hit your head and sustain loss of consciousness. You
sustained a small bleed in your head, rib fractures, fractures
of parts of your spinal column, and a collapsed left lung. You
also sustained a bruise to your right buttock. You were
monitored in the intensive care unit after your fall. You were
seen by the Spine and Neurology service. You did not require
any surgery for your injuries. You are now preparing for
discharge home with the following instructions:
Your injury caused left sided rib fractures which can cause
severe pain and subsequently cause you to take shallow breaths
because of the pain.
* You should take your pain medication as directed to stay
ahead of the pain otherwise you won't be able to take deep
breaths. If the pain medication is too sedating take half the
dose and notify your physician.
* Pneumonia is a complication of rib fractures. In order to
decrease your risk you must use your incentive spirometer 4
times every hour while awake. This will help expand the small
airways in your lungs and assist in coughing up secretions that
pool in the lungs.
* You will be more comfortable if you use a cough pillow to
hold against your chest and guard your rib cage while coughing
and deep breathing.
* Symptomatic relief with ice packs or heating pads for short
periods may ease the pain.
* Narcotic pain medication can cause constipation therefore you
should take a stool softener twice daily and increase your fluid
and fiber intake if possible.
* Do NOT smoke
* Return to the Emergency Room right away for any acute
shortness of breath, increased pain or crackling sensation
around your ribs ( crepitus )
Please report:
*shortness of breath
*difficulty breating
*chills/sweats
*congested cough
Please report:
*increased pain and swelling right buttock
*weakness
*dizziness
Please apply bacitracin ointment to the abrasions on your knees
daily and as needed
___ wear corset for comfort
Followup Instructions:
___
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.